id,label
chembl:CHEMBL272682,CHEMBL:CHEMBL272682
MONDO:0011272,retinitis pigmentosa 25
MONDO:0011529,spinocerebellar ataxia type 13
HGNC:5024,HNF4A
HP:0002548,Parkinsonism with favorable response to dopaminergic medication
HP:0002614,Hepatic periportal necrosis
iuphar.ligand:12118,COMPOUND 20 [PMID: 35584373]
ncit:C1868,VATALANIB
UBERON:0011220,mastoid process of temporal bone
HGNC:17091,NCSTN
ncit:C87242,HYDROXYPROGESTERONE
chembl:CHEMBL1605629,CHEMBL:CHEMBL1605629
HGNC:4087,GABRG2
MONDO:0010774,"striatonigral degeneration, infantile, mitochondrial"
HGNC:9307,PPP2R3A
drugbank:DB12686,PHA-793887
MONDO:0005394,brain infarction
MP:0003076,increased susceptibility to ischemic brain injury
iuphar.ligand:2308,NS1643
HGNC:15685,B4GAT1
MONDO:0010723,retinitis pigmentosa 2
chembl:CHEMBL202243,CHEMBL:CHEMBL202243
HGNC:1395,CACNA1H
CL:0000097,mast cell
iuphar.ligand:8322,ML290
iuphar.ligand:932,(+)-ADTN
GO:0005813,centrosome
HGNC:3800,FOXC1
rxcui:2404,CHLORPROPAMIDE
hemonc:99,CHIDAMIDE
HGNC:16090,PGRMC1
HP:0010982,Polygenic inheritance
iuphar.ligand:176,EGIS-7625
CHEBI:29991,L-aspartate(1-)
chembl:CHEMBL1473252,TANSHINONE IIA SULFONATE
EMAPA:18548,tail of caudate nucleus
chembl:CHEMBL602922,CHEMBL:CHEMBL602922
MGI:5511058,Tg(Camk2a-tTA)1Mmay/0 Fgf14<sup>Tg(tetO-MAPT*P301L)4510Kha</sup>/Fgf14<sup>+</sup>  [background:] involves: FVB/N
MONDO:0016293,congenital stationary night blindness
HP:0030640,Complete congenital stationary night blindness
iuphar.ligand:2647,RO 40-6055
CHEBI:53662,biguanides
chembl:CHEMBL530149,CHEMBL:CHEMBL530149
ncit:C96292,NAFAMOSTAT
HGNC:14258,CD2AP
MP:0003242,loss of basal ganglia neurons
iuphar.ligand:580,RPR121154
iuphar.ligand:8811,COMPOUND 53 [PMID: 19631533]
MONDO:0008716,acrogeria
ncit:C142993,VABICASERIN HYDROCHLORIDE
CHEBI:29016,arginine
rxcui:16738,RACECADOTRIL
HGNC:621,NAE1
iuphar.ligand:4170,D-CCPENE
iuphar.ligand:10170,AM-461
Xenbase:XB-GENE-480628,traf6
HGNC:11427,STUB1
HGNC:7786,NFIC
ncit:C81062,DARBUFELONE MESYLATE
iuphar.ligand:8189,CEP-11981
ZFIN:ZDB-GENE-121214-12,si:ch211-202n12.2
dictyBase:DDB_G0269196,tubB
iuphar.ligand:1226,IMPROMIDINE
drugbank:DB05890,VEGLIN
iuphar.ligand:1278,JNJ 7777120
chembl:CHEMBL84472,CHEMBL:CHEMBL84472
iuphar.ligand:9368,CX-6258
iuphar.ligand:8752,ML355
rxcui:4617,GAMMA-AMINOBUTYRIC ACID
rxcui:2049106,ENCORAFENIB
ncit:C175781,EPITUMOMAB CITUXETAN
rxcui:9895,SODIUM NITROPRUSSIDE
CHEBI:28694,copper atom
MONDO:0003406,sleep-wake disorder
rxcui:1366567,RAXIBACUMAB
iuphar.ligand:5206,JNJ1661010
chembl:CHEMBL576208,CHEMBL:CHEMBL576208
chembl:CHEMBL585269,CHEMBL:CHEMBL585269
RGD:628852,Cacna1b
rxcui:8160,PHENYLBUTAZONE
HP:0002195,Dysgenesis of the cerebellar vermis
MONDO:0021011,hereditary progressive chorea without dementia
iuphar.ligand:8138,COMPOUND 2C [PMID: 24900538]
ncit:C63678,METHYLSELENOCYSTEINE
MONDO:0859309,"spastic paraplegia 88, autosomal dominant"
ncit:C163686,PHENTHOATE
HGNC:853,ATP6V1B1
iuphar.ligand:8229,IOX2
MONDO:0030063,"neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities"
rxcui:91163,METHANTHELINE BROMIDE
HGNC:18513,ZHX2
HP:0002198,Dilated fourth ventricle
MP:0030171,absent extraocular muscles
iuphar.ligand:5917,AG 9
HP:0003688,Cytochrome C oxidase-negative muscle fibers
iuphar.ligand:1735,UTP&GAMMA;S
MONDO:0012523,retinitis pigmentosa 36
MONDO:0013486,spinocerebellar ataxia type 32
iuphar.ligand:489,5-METHYLURAPIDIL
ncit:C174790,SEMORINEMAB
rxcui:3966,EPHEDRINE
drugbank:DB12254,ABT-751
NCBIGene:281126,DRD2
MGI:3848974,Tg(Prnp-FTL*)4Ruvi/Tg(Prnp-FTL*)4Ruvi  [background:] B6.C3Fe-Tg(Prnp-FTL*)4Ruvi
NCBIGene:100138645,LOC100138645
HGNC:5385,IDH3B
chembl:CHEMBL578675,CHEMBL:CHEMBL578675
rxcui:2262278,CROCIN
chembl:CHEMBL211045,CHEMBL:CHEMBL211045
ncit:C171665,EDASALONEXENT
iuphar.ligand:6174,5-(6-CHLORO-2-HEXYL-1H-INDOL-1-YL)-5-OXO-VALERIC ACID
MONDO:0010830,neuronal ceroid lipofuscinosis 8
MP:0010063,abnormal circulating creatine level
MONDO:0013549,N-acetylaspartate deficiency
ncit:C1422,PERFLUBRON
HGNC:2289,COX7A2L
HGNC:17194,NDUFA13
ncit:C521,THERAPEUTIC GLUCOCORTICOID
CHEBI:76359,butylated hydroxyanisole
HP:0012712,Mild hearing impairment
HGNC:26941,UFC1
CHEBI:16412,lipopolysaccharide
GO:0036464,cytoplasmic ribonucleoprotein granule
rxcui:9471,ROSE BENGAL
iuphar.ligand:8899,(S)-LIQUIRITIGENIN
MGI:88039,Apc
rxcui:73710,PARICALCITOL
chembl:CHEMBL554475,CHEMBL:CHEMBL554475
ncit:C924,VALINOMYCIN
HGNC:4925,HK3
HGNC:5359,MRPL58
CHEBI:17833,gentamycin
MONDO:0011401,Alzheimer disease without neurofibrillary tangles
HP:0030529,Ring scotoma
MONDO:0018555,hypogonadotropic hypogonadism
ncit:C166671,MIRIPIRIUM CHLORIDE
chembl:CHEMBL423081,CHEMBL:CHEMBL423081
rxcui:2105845,GLASDEGIB
chembl:CHEMBL506069,GERANIIN
ncit:C79920,CLOSANTEL
MGI:3829657,Xist<sup>tm5Sado</sup>/Xist<sup>+</sup>  [background:] involves: 129S4/SvJae
drugbank:DB12247,AZD-4547
ncit:C75992,AXITIROME
HP:0032874,Focal impaired awareness cognitive seizure with auditory agnosia
CHEBI:29073,L-ascorbic acid
HGNC:11208,SP3
MONDO:0000001,disease
iuphar.ligand:10227,ORYZATENSIN
MGI:3850173,Otc<sup>spf</sup>/Y  [background:] involves: C57BL/6
ncit:C113333,ANTI-ERBB3 MONOCLONAL ANTIBODY CDX-3379
rxcui:612865,TOCILIZUMAB
ncit:C64762,RIVICICLIB
WB:WBGene00001503,fum-1
chembl:CHEMBL428768,(S)-FELODIPINE
ZFIN:ZDB-FISH-190206-1,abcd1<sup>sa509/sa509</sup>
rxcui:262307,FELBINAC
WB:WBGene00020838,trak-1
rxcui:227778,PROPARACAINE HYDROCHLORIDE
chembl:CHEMBL211501,ANTIMYCIN A
HGNC:7670,NCOA3
iuphar.ligand:3261,VU0029767
chembl:CHEMBL187266,TANSHINONE IIA
HP:0007020,Progressive spastic paraplegia
ncit:C129383,SIMLUKAFUSP ALFA
chembl:CHEMBL3545085,XL-228
CHEBI:17359,sulfite
HGNC:22197,AP5Z1
HP:0001824,Weight loss
HGNC:870,ATP7B
MONDO:0013188,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3"
HGNC:29918,NDUFAF3
HGNC:2228,COMT
UPHENO:0076296,extra-ocular muscle fibrosis
iuphar.ligand:8768,COMPOUND 38 [PMID: 20817473]
GO:0017171,serine hydrolase activity
ncit:C2233,PHENETHYL ISOTHIOCYANATE
MGI:107202,Atm
chembl:CHEMBL601400,CHEMBL:CHEMBL601400
chembl:CHEMBL2333541,ARISTOYUNNOLIN A
chembl:CHEMBL2104419,MINOPAFANT
ncit:C91059,OSEMOZOTAN
MGI:893586,Snu13
MONDO:0019046,leukodystrophy
iuphar.ligand:5274,STO609
chembl:CHEMBL1097456,"N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-YL]-4,4,4-TRIFLUORO-3-HYDROXYBUTANAMIDE (DIASTEREOMERIC MIX)"
iuphar.ligand:11469,BRD9185
iuphar.ligand:9101,BRIMAPITIDE
ncit:C79587,ATACIGUAT
chembl:CHEMBL1517425,ACETOCHLOR
HGNC:14282,IRF2BPL
MGI:1889642,Elp2
MGI:4430223,Scn8a<sup>Clth</sup>/Scn8a<sup>+</sup>  [background:] involves: BALB/cAnN * C3H/HeH
drugbank:DB13061,MLN8054
ncit:C158093,ZETELETINIB
drugbank:DB12360,PF-03654764
chembl:CHEMBL453818,CHEMBL:CHEMBL453818
MONDO:0008890,progressive bulbar palsy
EMAPA:36652,levator palpebrae superioris
chembl:CHEMBL1254091,CHEMBL:CHEMBL1254091
OBA:2001004,age of onset of cataract
HGNC:14573,ENTPD4
MGI:2180716,Gy
CHEBI:27560,boron atom
HGNC:7479,MT-TE
rxcui:8698,PROBENECID
HP:0008527,Congenital sensorineural hearing impairment
rxcui:1311261,MALTOSE
rxcui:103755,MEPERIDINE HYDROCHLORIDE
chembl:CHEMBL1077391,CHEMBL:CHEMBL1077391
HGNC:3214,EEF2
GO:0007420,brain development
chembl:CHEMBL598270,CHEMBL:CHEMBL598270
HGNC:4817,HARS2
iuphar.ligand:10742,SKF-82958
MONDO:0012098,spinocerebellar ataxia type 20
chembl:CHEMBL589920,CHEMBL:CHEMBL589920
chembl:CHEMBL221190,DIPHYLLIN
MGI:3764515,Gba1<sup>tm2Karl</sup>/Gba1<sup>tm2Karl</sup> Tg(KRT14-cre)8Brn/?  [background:] involves: 129S1/Sv * 129X1/SvJ * FVB/N
ncit:C911,TUBERCIDIN
iuphar.ligand:2309,PAXILLINE
chembl:CHEMBL1983317,CHEMBL:CHEMBL1983317
HGNC:16831,TSPOAP1
chembl:CHEMBL327919,BENOMYL
HGNC:1865,CES3
rxcui:4107,ETHACRIDINE LACTATE
iuphar.ligand:10639,WJYK50
HGNC:83,ACAA2
chembl:CHEMBL600306,CHEMBL:CHEMBL600306
iuphar.ligand:12070,VIC 1911
iuphar.ligand:9783,MK6-83
rxcui:36122,PHENYL SALICYLATE
MONDO:0007301,cerebrocostomandibular syndrome
chembl:CHEMBL1673039,CHEMBL:CHEMBL1673039
HGNC:652,ARF1
HGNC:34528,TOMM6
iuphar.ligand:10596,COMPOUND 29 [PMID: 31934767]
ncit:C166661,ESOXYBUTYNIN
ncit:C166815,METITEPINE
chembl:CHEMBL242011,HINOKININ
rxcui:1484277,TRENBOLONE ACETATE
HGNC:16059,PAK4
GO:0005096,GTPase activator activity
ncit:C129717,VEBRELTINIB
rxcui:1102261,TELAPREVIR
ncit:C76389,CARBARIL
chembl:CHEMBL1343568,CHEMBL:CHEMBL1343568
rxcui:2046360,PEGVALIASE
chembl:CHEMBL1364144,METHYLPREDNISOLONE ACETATE
HP:0100704,Cerebral visual impairment
GO:0098609,cell-cell adhesion
MP:0003633,abnormal nervous system physiology
rxcui:8762,PROPANTHELINE BROMIDE
chembl:CHEMBL1834096,CHEMBL:CHEMBL1834096
chembl:CHEMBL17329,CHEMBL:CHEMBL17329
chembl:CHEMBL2109574,ASG-5ME
MGI:5517669,Snca<sup>tm1.1Koks</sup>/Snca<sup>+</sup>  [background:] either: B6.129P2-Snca<sup>tm1.1Koks</sup> or (involves: 129P2/OlaHsd * C57BL/6)
chembl:CHEMBL109317,GITOXIN
chembl:CHEMBL1994620,DINOTERB
iuphar.ligand:8146,COMPOUND 23 [PMID: 17600705]
MONDO:0010808,fatal familial insomnia
MONDO:0010970,"cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies"
HGNC:713,ARSA
chembl:CHEMBL215853,MONOCILLIN I
MONDO:0014874,"pontocerebellar hypoplasia, type 2F"
GO:0060041,retina development in camera-type eye
MONDO:0014662,congenital insensitivity to pain-hypohidrosis syndrome
HP:0000658,Eyelid apraxia
HGNC:4196,GCKR
Reactome:R-DRE-500753,Pyrimidine biosynthesis
chembl:CHEMBL1574420,CHEMBL:CHEMBL1574420
rxcui:753340,SAPROPTERIN
HP:0006955,Olivopontocerebellar hypoplasia
iuphar.ligand:2118,R396
HGNC:24452,DCP2
HGNC:29314,CACHD1
HGNC:2873,CYB5R3
HGNC:19696,GRPEL1
ncit:C160603,CAMIZESTRANT
HGNC:16287,NFU1
MONDO:0015427,paroxysmal dyskinesia
iuphar.ligand:11898,COMPOUND 54
MGI:3778628,Vangl2<sup>Lp</sup>/Vangl2<sup>+</sup>  [background:] involves: A
MGI:3040640,Pex2<sup>tm1Plf</sup>/Pex2<sup>tm1Plf</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6
rxcui:1114195,RIVAROXABAN
MGI:5052112,Tg(Mapt-MAPT*)#Hanr/0  [background:] involves: BALB/c * C57BL/6
chembl:CHEMBL3545133,JNJ-26483327
rxcui:10239,SULPIRIDE
chembl:CHEMBL1442783,CHEMBL:CHEMBL1442783
HP:0001338,Partial agenesis of the corpus callosum
rxcui:1442172,ENILCONAZOLE
MONDO:0018696,corticobasal syndrome
chembl:CHEMBL17645,CGP-71683A
MGI:97594,Prkacb
HP:0200127,Atrial cardiomyopathy
rxcui:3628,DOPAMINE
CLINVAR:143549,NM_001110792.2(MECP2):c.408G>C (p.Leu136Phe)
chembl:CHEMBL602807,CHEMBL:CHEMBL602807
ncit:C87587,NORLEUCINE
MGI:103010,Epb41l1
HP:0011166,Focal myoclonic seizure
HGNC:6572,LGI1
MONDO:0011551,TH-deficient dopa-responsive dystonia
iuphar.ligand:7907,7-HYDROXYSTAUROSPORINE
rxcui:21149,CIPROFIBRATE
iuphar.ligand:775,CCL24
iuphar.ligand:8249,RN486
CHEBI:35842,antirheumatic drug
HP:0003565,Elevated erythrocyte sedimentation rate
ncit:C83953,METHAPYRILENE FUMARATE
chembl:CHEMBL1200796,CYCLOPHOSPHAMIDE
HGNC:3046,PIGP
chembl:CHEMBL151649,PHENETHYLISOTHIOCYANATE
MGI:92356,Csde1
iuphar.ligand:1711,2MESATP
HP:0001643,Patent ductus arteriosus
HGNC:4922,HK1
HP:0002027,Abdominal pain
HP:0000193,Bifid uvula
iuphar.ligand:232,[3H]MESULERGINE
HGNC:961,BAZ1B
ncit:C126646,PADNARSERTIB
iuphar.ligand:7571,PROTOXIN II
chembl:CHEMBL1527943,PTAEROXYLIN
ncit:C48404,TANDUTINIB
chembl:CHEMBL460100,FERBAM
rxcui:2198359,PRETOMANID
HP:0007158,Progressive extrapyramidal muscular rigidity
HGNC:4824,HBA2
ncit:C84864,PIMASERTIB
iuphar.ligand:2026,BIM 23454
iuphar.ligand:6019,PDGF RECEPTOR TYROSINE KINASE INHIBITOR III
EMAPA:18555,cerebellum intraventricular portion
rxcui:2623641,OLUTASIDENIB
chembl:CHEMBL592124,CHEMBL:CHEMBL592124
HP:0002549,Deficit in phonologic short-term memory
HP:0001000,Abnormality of skin pigmentation
ncit:C245,ANESTHETIC AGENT
GO:0034205,amyloid-beta formation
UPHENO:0080596,abnormal impulsive behavior
chembl:CHEMBL116955,CONGO RED
MONDO:0011728,benign essential blepharospasm
Reactome:R-XTR-211945,Phase I - Functionalization of compounds
ncit:C99903,HER2 ECD+TM VIRUS-LIKE REPLICON PARTICLES VACCINE AVX901
MP:0014237,decreased tumor-free survival time
rxcui:2117,ARTICAINE HYDROCHLORIDE
iuphar.ligand:5733,N-ME-AMINOPYRIMIDINONE 9
WB:WBGene00022394,natb-1
rxcui:2166037,DIHYDROCAPSAICIN
chembl:CHEMBL1406948,CHEMBL:CHEMBL1406948
iuphar.ligand:2084,BIM 23313
HP:0003768,Periodic paralysis
HP:0009926,Epiphora
MONDO:0020836,"autism, susceptiblity to"
HGNC:6867,MAP4K5
HGNC:9707,NECTIN2
iuphar.ligand:8200,TAK-441
drugbank:DB12461,GLPG-0492
iuphar.ligand:4260,N1-DANSYL-SPERMINE
MP:0005402,abnormal action potential
MONDO:0025699,Coffin-Siris syndrome 12
chembl:CHEMBL1173445,LARGAZOLE
rxcui:82018,FENFLURAMINE HYDROCHLORIDE
MONDO:0060671,"epilepsy, juvenile myoclonic, susceptibility to, 10"
rxcui:3339,DIBUCAINE
chembl:CHEMBL276915,7-HYDROXYFLAVONE
chembl:CHEMBL510801,HEMOPRESSIN
iuphar.ligand:167,S 16924
rxcui:59639,ATOSIBAN
ncit:C66290,PACTIMIBE
rxcui:90,EICOSAPENTAENOIC ACID
ZFIN:ZDB-FISH-200326-3,pycr1a<sup>cy51/cy51</sup> (AB)
chembl:CHEMBL600747,CHEMBL:CHEMBL600747
chembl:CHEMBL506538,TRIPHENYLSTANNANOL
HGNC:7436,MTHFR
MONDO:0014475,spinocerebellar ataxia type 40
iuphar.ligand:656,JMV1431
HGNC:2933,DMPK
HGNC:17994,TRPM7
ZFIN:ZDB-GENE-040426-1792,uqcrc1
chembl:CHEMBL1445650,CHEMBL:CHEMBL1445650
HGNC:1787,CDKN2A
rxcui:83947,TAZAROTENE
GO:0004118,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity
iuphar.ligand:2036,BIM 23056
MP:0001396,unidirectional circling
drugbank:DB04179,BENZOFURAN
GO:0002282,microglial cell activation involved in immune response
MONDO:0011464,spinocerebellar ataxia type 11
chembl:CHEMBL179611,CHEMBL:CHEMBL179611
iuphar.ligand:4209,GYKI53655
ncit:C81358,SANGUINARIUM
iuphar.ligand:6701,GR148672X
iuphar.ligand:5259,RO31-8220
iuphar.ligand:8184,COMPOUND 32 [PMID: 20471253]
ncit:C114975,BAZLITORAN
HGNC:7029,MET
drugbank:DB04005,URIDINE 5'-TRIPHOSPHATE
chembl:CHEMBL1622802,CHEMBL:CHEMBL1622802
MONDO:0006811,intracranial hypotension
CL:0012001,neuron of the forebrain
HP:0032815,Neonatal electro-clinical myoclonic seizure
MONDO:0011181,"fibrosis of extraocular muscles, congenital, 2"
ZFIN:ZDB-GENE-091204-32,nsmfa
rxcui:3024,CYSTEINE
iuphar.ligand:5762,PMX205
HP:0007024,Pseudobulbar paralysis
iuphar.ligand:9002,BW373U86
rxcui:10362,TENIPOSIDE
ncit:C97512,FAMITINIB
chembl:CHEMBL268368,STAUROSPORINE AGLYCON
chembl:CHEMBL457091,KASANOSIN B
CHEBI:82979,"1-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine"
chembl:CHEMBL443683,TELOMESTATIN
ncit:C83940,MESULERGINE
chembl:CHEMBL1317986,CHEMBL:CHEMBL1317986
CHEBI:144644,a tetracycline zwitterion
MONDO:0007473,Duane retraction syndrome
rxcui:2622,CLOTIAZEPAM
iuphar.ligand:5919,AKT INHIBITOR IV
HP:0003390,Sensory axonal neuropathy
MONDO:0005347,hypertriglyceridemia
chembl:CHEMBL21745,TECTOQUINONE
iuphar.ligand:6418,TETRAHYDROCANNABIVARIN
chembl:CHEMBL585628,CHEMBL:CHEMBL585628
iuphar.ligand:6059,VX-702
rxcui:2565692,BELUMOSUDIL MESYLATE
iuphar.ligand:1252,IMPENTAMINE
chembl:CHEMBL494669,CHEMBL:CHEMBL494669
chembl:CHEMBL1088186,TRIBUTYLCHLOROSTANNANE
HP:0012444,Brain atrophy
chembl:CHEMBL581152,CHEMBL:CHEMBL581152
ncit:C111689,HLA-A*0201 RESTRICTED TERT(572Y)/TERT(572) PEPTIDES VACCINE VX-001
iuphar.ligand:11277,AZD1390
MGI:5532923,Tor1a<sup>tm2Wtd</sup>/Tor1a<sup>+</sup>  [background:] B6.129S1-Tor1a<sup>tm2Wtd</sup>
iuphar.ligand:8058,JNK-IN-8
rxcui:8042,PERAZINE
GO:0006661,phosphatidylinositol biosynthetic process
MONDO:0014963,Shashi-Pena syndrome
rxcui:10237,SULINDAC
MGI:3605770,Htt<sup>tm1Szi</sup>/Htt<sup>tm2Szi</sup> Tg(Camk2a-cre)2Szi/0  [background:] involves: 129S/SvEv * 129S1/Sv * C57BL/6 * CBA
drugbank:DB02527,CYCLIC ADENOSINE MONOPHOSPHATE
rxcui:253191,PANTOPRAZOLE SODIUM
iuphar.ligand:7896,PL37
drugbank:DB15173,JNJ-42165279
HGNC:3594,FASN
ZFIN:ZDB-FISH-150901-8233,vps18<sup>hi2499aTg</sup>
MGI:2446589,Abcd1<sup>tm1Kds</sup>/Y  [background:] either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6)
GO:0008021,synaptic vesicle
CL:0000598,pyramidal neuron
rxcui:1426451,KOJIC ACID
drugbank:DB01852,KAEMPHEROL
ncit:C170278,OXYPHENISATIN ACETATE
HGNC:6563,LGALS3
MONDO:0033480,spinocerebellar ataxia 45
UBERON:0002567,basal part of pons
MGI:5306241,Mecp2<sup>tm1.1Jae</sup>/Y  [background:] involves: 129S4/SvJae * C57BL/6
ncit:C87598,SURINABANT
rxcui:10402,DRONABINOL
chembl:CHEMBL1797713,CHEMBL:CHEMBL1797713
ncit:C77255,ALNIDITAN
CHEBI:18344,kynurenic acid
MGI:107489,Phex
drugbank:DB16874,CB-5083
CL:0000626,olfactory granule cell
chembl:CHEMBL601918,CHEMBL:CHEMBL601918
chembl:CHEMBL3189057,TOLYLFLUANID
chembl:CHEMBL1998001,CHEMBL:CHEMBL1998001
HGNC:5301,HTR6
GO:0005515,protein binding
chembl:CHEMBL1256019,GABACULINE HYDROCHLORIDE
chembl:CHEMBL239439,CHEMBL:CHEMBL239439
iuphar.ligand:1052,LINOLEIC ACID
SGD:S000005496,PFK27
HGNC:3010,DPP6
ncit:C75049,XYLAZINE
HGNC:25969,DEF8
MONDO:0042980,Westphal disease
MONDO:0019257,hemochromatosis type 2
chembl:CHEMBL9960,AZD-7624
chembl:CHEMBL589444,CHEMBL:CHEMBL589444
chembl:CHEMBL606460,CHEMBL:CHEMBL606460
chembl:CHEMBL4650277,TAS0612
chembl:CHEMBL506929,LICOFLAVANONE A
rxcui:6834,METERGOLINE
CHEBI:66924,creatinate
HGNC:26052,INTS11
chembl:CHEMBL579742,CHEMBL:CHEMBL579742
iuphar.ligand:2426,GD3+
chembl:CHEMBL493737,METHYLINOSITOL
rxcui:632,MITOMYCIN
rxcui:2001986,PALMIDROL
ncit:C87212,NAFTIDROFURYL
HGNC:11370,STAU1
CL:0000083,epithelial cell of pancreas
UPHENO:0014082,hippocampal formation atrophy
rxcui:6308,LEUCINE
HGNC:23077,OTUB1
MONDO:0060759,"neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures"
ncit:C175805,IZENCITINIB
iuphar.ligand:12903,STX-478
UBERON:0002250,popliteal artery
drugbank:DB04440,NEBULARINE
GO:0020037,heme binding
HP:0002033,Poor suck
ncit:C2694,GREEN TEA EXTRACT
rxcui:4108,ETHACRYNATE SODIUM
iuphar.ligand:8391,CHR-3996
NCBIGene:537043,DRD3
ncit:C78474,TIGAPOTIDE
HP:0000511,Vertical supranuclear gaze palsy
HP:0000980,Pallor
chembl:CHEMBL1568605,"7-OXOCALLITRISIC ACID, METHYL ESTER"
drugbank:DB16107,BI 2536
HP:0002064,Spastic gait
rxcui:1298842,"PAROXETINE HYDROCHLORIDE, HEMIHYDRATE"
chembl:CHEMBL1232792,FENAMIDONE
iuphar.ligand:4055,AC55649
HGNC:10896,SKI
chembl:CHEMBL41680,CHEMBL:CHEMBL41680
chembl:CHEMBL468439,CYCLOPROPARADICICOL
UPHENO:0080043,increased glial cell growth in hypothalamus
chembl:CHEMBL405914,CHEMBL:CHEMBL405914
OBA:2001002,age of onset of urinary bladder carcinoma
chembl:CHEMBL83154,2-AMINOANTHRACENE
rxcui:11246,VITAMIN A
HP:0032713,Focal impaired awareness motor seizure with version
HGNC:3312,ELAVL1
GO:0090158,endoplasmic reticulum membrane organization
HGNC:18550,IER3IP1
ncit:C2189,SIGNAL TRANSDUCTION INHIBITOR
ncit:C29549,ZOLIMOMAB ARITOX
HGNC:28883,PPA2
ncit:C64183,ACOLBIFENE
HP:0012047,Hemeralopia
chembl:CHEMBL515505,CHEMBL:CHEMBL515505
rxcui:1546413,METHYLHOMATROPINE
HP:0008504,Moderate sensorineural hearing impairment
rxcui:343047,ATAZANAVIR
ncit:C85465,EPRENETAPOPT
HGNC:395,ALAD
chembl:CHEMBL12252,"5,7-DIHYDROXY-4-METHYLCOUMARIN"
chembl:CHEMBL3545180,THELIATINIB
iuphar.ligand:6167,5-OXO-15-HETE
HGNC:17296,RRM2B
MONDO:0005134,experimental autoimmune encephalomyelitis
chembl:CHEMBL513678,PROCYMIDONE
HP:0002334,Abnormal cerebellar vermis morphology
HGNC:6502,RPSA
MONDO:0008856,immunodeficiency 27A
GO:0032815,negative regulation of natural killer cell activation
rxcui:203115,AMPICILLIN TRIHYDRATE
iuphar.ligand:4493,[3H]HEMICHOLINIUM-3
HP:0002173,Hypoglycemic seizures
CHEBI:27656,camptothecin
rxcui:28863,LOFEXIDINE
HGNC:9153,PNKD
MONDO:0859324,"developmental delay, language impairment, and ocular abnormalities"
chembl:CHEMBL31088,DEOXIEPINEPHRINE
ncit:C163712,TRIAZOPHOS
MONDO:0012477,retinitis pigmentosa 33
MONDO:0013584,hereditary sensory neuropathy-deafness-dementia syndrome
GO:0007605,sensory perception of sound
HP:0012768,Neonatal asphyxia
iuphar.ligand:11922,RLF-(A11-B10)-ISOPEPTIDE AMIDEA26 (XA11-B10)
iuphar.ligand:5738,COMPOUND 3J [PMID: 21444206]
HGNC:11908,TNFRSF11A
MP:0000792,abnormal cortical marginal zone morphology
rxcui:136561,CISATRACURIUM BESYLATE
CHEBI:18154,polysaccharide
CHEBI:16189,sulfate
iuphar.ligand:338,KT 5823
MGI:5697374,Hdc<sup>tm1Nagy</sup>/Hdc<sup>+</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ
HGNC:26458,TEPSIN
ncit:C1495,INTOPLICINE
rxcui:235765,BENSERAZIDE HYDROCHLORIDE
ncit:C73219,SPIROGLUMIDE
GO:0090160,Golgi to lysosome transport
UBERON:0001377,quadriceps femoris
rxcui:1291609,TALIGLUCERASE ALFA
chembl:CHEMBL580819,CHEMBL:CHEMBL580819
MONDO:0015905,syndromic dyslipidemia
ncit:C103863,ISTIRATUMAB
chembl:CHEMBL1688556,CHEMBL:CHEMBL1688556
HGNC:9200,POLRMT
MONDO:0010827,retinitis pigmentosa 14
ncit:C103859,ANTI-ERBB3 MONOCLONAL ANTIBODY REGN1400
chembl:CHEMBL578220,CHEMBL:CHEMBL578220
chembl:CHEMBL1369632,CHEMBL:CHEMBL1369632
chembl:CHEMBL1335833,CHEMBL:CHEMBL1335833
iuphar.ligand:5949,CDK2 INHIBITOR IV
ncit:C80857,LAUROGUADINE
rxcui:89717,THYMOL IODIDE
HP:0007123,Subcortical dementia
rxcui:1442981,IBRUTINIB
HP:0001376,Limitation of joint mobility
rxcui:34369,PREDNICARBATE
Reactome:R-MMU-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
rxcui:2181419,BRUCINE
HP:0009765,Low hanging columella
HGNC:13740,SNTG1
chembl:CHEMBL1327256,CAPENSIN
MONDO:0012153,Alzheimer disease 9
ncit:C83989,NAPROXCINOD
HGNC:9026,PKP4
drugbank:DB17053,SCRIPTAID
iuphar.ligand:6702,COMPOUND 41 [PMID: 15026062]
chembl:CHEMBL598263,CHEMBL:CHEMBL598263
MONDO:0013576,recurrent infections associated with rare immunoglobulin isotypes deficiency
iuphar.ligand:8241,GSK-LSD1
CLINVAR:421342,NC_000013.11:g.32316475del
ncit:C147125,ABIVERTINIB
ncit:C152971,FUTUXIMAB
chembl:CHEMBL1712057,OXYCARBOXIN
HP:0032388,Periventricular nodular heterotopia
drugbank:DB05422,OPC-14523
MP:0001392,abnormal locomotor behavior
CHEBI:27961,"1,8-cineole"
CLINVAR:219896,NM_000059.4(BRCA2):c.632-3C>G
HP:0004303,Abnormal muscle fiber morphology
rxcui:4077,ESTAZOLAM
rxcui:4453,FLUFENAMIC ACID
chembl:CHEMBL1818442,AMITIFADINE HYDROCHLORIDE
ncit:C758,POLY IC
chembl:CHEMBL584452,CHEMBL:CHEMBL584452
ncit:C152348,SETIPIPRANT
chembl:CHEMBL580727,CHEMBL:CHEMBL580727
MGI:98869,Tuba1a
CHEBI:134396,secondary allylic alcohol
HGNC:2518,CTNS
CHEBI:38824,fluorocarbon
HGNC:8982,PIK3R4
HGNC:16758,COPS7A
ncit:C77635,CINOLAZEPAM
chembl:CHEMBL565893,CHEMBL:CHEMBL565893
ncit:C1125,HEXAMETHYLENE BISACETAMIDE
iuphar.ligand:2641,BMS493
chembl:CHEMBL606241,KANZONOL X
chembl:CHEMBL2109364,AR-20.5
rxcui:1865953,CRISABOROLE
MGI:104563,Napa
chembl:CHEMBL2109390,MAB-425
HGNC:8021,NT5E
HGNC:8851,PEX10
HGNC:6501,LAMP2
iuphar.ligand:12525,OPTOBI-1
ncit:C62530,VARLITINIB
chembl:CHEMBL225869,CHEMBL:CHEMBL225869
HP:0008954,Intrinsic hand muscle atrophy
iuphar.ligand:11907,WNN0109-C011
HP:0031761,Infantile constant esotropia
HP:0012001,EEG with generalized polyspikes
iuphar.ligand:12777,EST73502
MGI:3693880,Tg(SOD1*G93A)1Gur/0  [background:] B6.Cg-Tg(SOD1*G93A)1Gur/J
HGNC:30747,COPS2
drugbank:DB15980,LEVOCARNITINE PROPIONATE
rxcui:69120,TIOTROPIUM
HP:0032838,Neonatal unilateral epileptic spasm
HGNC:11953,TNR
HP:0000381,Stapes ankylosis
MONDO:0011175,Friedreich ataxia 2
HGNC:6855,MAP3K3
HP:0001838,Rocker bottom foot
chembl:CHEMBL1520512,DEHYDROVARIABILIN
chembl:CHEMBL519873,PYRACLOSTROBIN
MONDO:0013485,spinocerebellar ataxia type 35
ncit:C76887,TABIMORELIN
iuphar.ligand:8156,COMPOUND 20 [PMID: 22136433]
iuphar.ligand:5154,BRL50481
MONDO:0011872,Griscelli syndrome type 2
NCBIGene:281002,AOC3
MONDO:0004979,asthma
HGNC:333,AGT
GO:0000049,tRNA binding
HP:0008936,Axial hypotonia
rxcui:1362696,BUTYRIC ACID
rxcui:203211,DILTIAZEM HYDROCHLORIDE
drugbank:DB12890,DIHYDREXIDINE
iuphar.ligand:9780,COMPOUND 7F [PMID: 29283260]
iuphar.ligand:10595,JR14A
HP:0006801,Hyperactive deep tendon reflexes
rxcui:2395271,SAPANISERTIB
rxcui:134748,RASAGILINE
MONDO:0012721,progressive myoclonic epilepsy type 3
rxcui:1592893,BAICALEIN
MONDO:0800330,"myoclonic epilepsy, juvenile, 2"
rxcui:10878,TRYPAN BLUE
iuphar.ligand:5776,YSFKPMPLAR
ncit:C165479,PICTILISIB
chembl:CHEMBL16300,BENZOHYDROXAMATE
rxcui:27403,IFENPRODIL
rxcui:10432,THALIDOMIDE
HP:0004334,Dermal atrophy
NCBIGene:327690,NDUFB1
HP:0032687,Focal cognitive seizure with memory impairment
iuphar.ligand:10356,PURMORPHAMINE
HP:0040202,Abnormal consumption behavior
HP:0000027,Azoospermia
iuphar.ligand:385,8-CYCLOPENTYLTHEOPHYLLINE
HGNC:20452,INSIG2
rxcui:190521,ABACAVIR
MONDO:0005383,panic disorder
HGNC:218,ADAMTS2
HGNC:9970,RFC2
ncit:C82306,LINOPIRDINE
rxcui:1223,ATROPINE
iuphar.ligand:5615,CVT-6883
chembl:CHEMBL48310,HINOKITIOL
MP:0003312,abnormal locomotor coordination
MP:0001405,impaired coordination
HGNC:11522,TACC1
iuphar.ligand:8923,OPICINUMAB
HGNC:17171,LOXL4
iuphar.ligand:9261,LUMINESPIB
drugbank:DB11765,PF-04991532
CHEBI:17688,(S)-nicotine
chembl:CHEMBL1412710,CHEMBL:CHEMBL1412710
MONDO:0002046,alcohol abuse
chembl:CHEMBL475536,"1R,9S-HYDRASTINE"
iuphar.ligand:8190,COMPOUND 1 [PMID: 21742770]
rxcui:8196,PHLOROGLUCINOL
HGNC:28722,COQ5
HP:0003739,Myoclonic spasms
HGNC:24035,APPL1
HGNC:24323,CARTPT
HGNC:11923,TNFRSF8
HGNC:26035,SLC48A1
MGI:103022,Reln
HGNC:7504,MTX1
Reactome:R-DDI-71403,Citric acid cycle (TCA cycle)
drugbank:DB12432,CC-401
MONDO:0010524,X-linked sideroblastic anemia with ataxia
HGNC:25928,WDR73
rxcui:6805,METARAMINOL
chembl:CHEMBL3545020,MBX-2044
ncit:C76104,LYSERGIDE
MGI:6113845,Gatm<sup>m1Btlr</sup>/Gatm<sup>m1Btlr</sup>  [background:] C57BL/6J-Gatm<sup>m1Btlr</sup>
ZFIN:ZDB-GENE-141211-77,pimr181
UPHENO:0051894,abnormal blood creatinine level
MGI:3608686,Vangl2<sup>Lp</sup>/Vangl2<sup>+</sup>  [background:] LPT/LeJ
ncit:C96747,VERUBULIN
chembl:CHEMBL1433292,QUINALDINE BLUE
iuphar.ligand:650,KALLIDIN
HP:0003355,Aminoaciduria
chembl:CHEMBL2333550,MADOLIN T
HP:0006879,Pontocerebellar atrophy
HP:0002321,Vertigo
HP:0032015,Dysmetric horizontal saccades
HGNC:16712,FBXW7
chembl:CHEMBL383015,RADANAMYCIN
HGNC:4834,HBS1L
CHEBI:16480,nitric oxide
HP:0000104,Renal agenesis
MONDO:0016064,cleft palate
HGNC:362,AK2
MP:0013838,small caudate nucleus
HP:0008347,Decreased activity of mitochondrial complex IV
iuphar.ligand:12690,ODRONEXTAMAB
iuphar.ligand:8105,UMI-77
ncit:C73286,ELTOPRAZINE
drugbank:DB06109,YKP-1358
MONDO:0700002,ATP1A3-associated neurological disorder
HGNC:19034,MAST1
MONDO:0008024,"neuronopathy, distal hereditary motor, type 7A"
ncit:C1284,DEXTRAN SULFATE SODIUM
MONDO:0011783,ALG12-congenital disorder of glycosylation
UPHENO:0081582,abnormal pons morphology
ncit:C92591,BRAF(V600E) KINASE INHIBITOR RO5212054
CHEBI:17334,penicillin
rxcui:1312397,REGORAFENIB
chembl:CHEMBL60718,TPCK
HGNC:4236,GFER
HP:0011727,Peroneal muscle weakness
rxcui:38413,TORSEMIDE
iuphar.ligand:6021,PDGF RTK INHIBITOR
HGNC:12713,VPS41
MP:0005554,decreased circulating creatinine level
HGNC:17129,SLC39A4
ncit:C1539,TEZACITABINE
ncit:C104267,DERAZANTINIB
ncit:C99131,IDASANUTLIN
chembl:CHEMBL495852,CHEMBL:CHEMBL495852
rxcui:1399,BENZOCAINE
chembl:CHEMBL580609,CHEMBL:CHEMBL580609
ncit:C152263,ROVAZOLAC
ncit:C90588,STAT3 INHIBITOR OPB-31121
HGNC:587,APEX1
chembl:CHEMBL578883,CHEMBL:CHEMBL578883
HP:0006979,Sleep-wake cycle disturbance
HGNC:12461,UBAP1
HP:0011006,Abnormal morphology of the musculature of the neck
MGI:2653814,Vdac1<sup>tm1Wjc</sup>/Vdac1<sup>tm1Wjc</sup> Vdac3<sup>tm1Wjc</sup>/Vdac3<sup>tm1Wjc</sup>  [background:] involves: 129S7/SvEvBrd
MGI:1097716,Arx
CHEBI:474053,cefazolin
GO:0016328,lateral plasma membrane
HGNC:7672,NCOR1
ncit:C308,IMMUNOTHERAPEUTIC AGENT
MONDO:0005084,mental disorder
MP:0009990,abnormal cerebellum vermis lobule III morphology
TS:19,
chembl:CHEMBL1969664,AZD-1080
iuphar.ligand:2005,CGP 23996
CHEBI:30616,ATP(4-)
iuphar.ligand:6387,SF-51
chembl:CHEMBL600298,CHEMBL:CHEMBL600298
iuphar.ligand:11395,MK-7110
GO:0004112,cyclic-nucleotide phosphodiesterase activity
MONDO:0001976,chorea gravidarum
HP:0003401,Paresthesia
chembl:CHEMBL421431,CHEMBL:CHEMBL421431
HGNC:4283,GJB1
HP:0002305,Athetosis
FB:FBgn0260397,Su(var)3-3
HGNC:1020,BCS1L
CHEBI:63580,ribavirin
HP:0011003,High myopia
iuphar.ligand:754,CCL15
rxcui:4821,GLIPIZIDE
MONDO:0013392,autosomal recessive spinocerebellar ataxia 10
rxcui:8699,PROBUCOL
HP:0001878,Hemolytic anemia
iuphar.ligand:9246,UPADACITINIB
rxcui:596554,VILDAGLIPTIN
HP:0012043,Pendular nystagmus
HP:0000358,Posteriorly rotated ears
rxcui:282388,IMATINIB
chembl:CHEMBL2063681,CHEMBL:CHEMBL2063681
HP:0007048,Large basal ganglia
MGI:5825026,Slc6a8<sup>tm1.2Lbar</sup>/Y  [background:] involves: 129 * 129S1/Sv * C57BL/6J * C57BL/6N
HGNC:30871,MGAT4C
chembl:CHEMBL260560,CHEMBL:CHEMBL260560
chembl:CHEMBL267458,BMS-182874
HP:0010993,Abnormal cerebral subcortex morphology
drugbank:DB07426,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)"
HP:0001421,Abnormality of the musculature of the hand
MGI:3702932,Slc6a3<sup>tm1(cre)Lrsn</sup>/Slc6a3<sup>+</sup> Tfam<sup>tm1Lrsn</sup>/Tfam<sup>tm1Lrsn</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
drugbank:DB02967,N-ETHYLMALEIMIDE
iuphar.ligand:4168,D-AP5
HGNC:25355,SLC30A10
chembl:CHEMBL505661,THIDIAZURON
HGNC:25951,AFTPH
chembl:CHEMBL571700,BIS(DIMETHYLAMINETHIOCARBONYL)MONOSULFIDE
HP:0100595,Camptocormia
chembl:CHEMBL1453126,CHEMBL:CHEMBL1453126
ncit:C132273,MILAMELINE
ncit:C115111,BELAPECTIN
iuphar.ligand:9849,GW274150
MGI:2668527,Hprt1<sup>tm6Detl</sup>/Hprt1<sup>tm6Detl</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
HGNC:1618,CCT5
HGNC:17082,MLC1
rxcui:7300,NEOMYCIN SULFATE
chembl:CHEMBL547101,CHEMBL:CHEMBL547101
GO:0072757,cellular response to camptothecin
iuphar.ligand:8383,BIMIRALISIB
iuphar.ligand:5907,AR-C118925XX
UPHENO:0047944,increased thickness of the cerebral cortex
HGNC:6081,INS
MONDO:0005559,neurodegenerative disease
rxcui:10328,TANNIC ACID
HP:0025584,Hypotropia
chembl:CHEMBL104255,FLAVOKAWAIN B
HGNC:16803,UBE3C
ncit:C171738,EDIFOLIGIDE SODIUM
chembl:CHEMBL1553566,CHEMBL:CHEMBL1553566
HGNC:704,ARPC1B
MP:0001429,dehydration
iuphar.ligand:2903,GSK4112
chembl:CHEMBL454246,REDIOCIDE A
CHEBI:23527,cytochalasin B
CL:0000555,neuronal brush cell
rxcui:203121,DOBUTAMINE HYDROCHLORIDE
chembl:CHEMBL457246,CHEMBL:CHEMBL457246
chembl:CHEMBL1079109,RALOXIFEN
HGNC:10560,ATXN7
MONDO:0014669,cone-rod dystrophy 21
MGI:3839772,Hfe<sup>tm1Gfn</sup>/Hfe<sup>tm1Gfn</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6
MP:0004142,abnormal muscle tone
HGNC:2701,DCC
HP:0003396,Syringomyelia
chembl:CHEMBL1200598,DIETHYLSTILBESTROL DIPHOSPHATE
iuphar.ligand:13186,CINNAMTANNIN B1
HP:0012751,Abnormal basal ganglia MRI signal intensity
MGI:1859251,Dctn3
HGNC:1404,CACNB4
rxcui:8754,PROPAFENONE
ncit:C116861,PAN-RAF INHIBITOR LY3009120
iuphar.ligand:9107,CABIRALIZUMAB
ncit:C166950,EPETRABOROLE
iuphar.ligand:8070,P505-15
drugbank:DB05894,GT 389-255
HP:0007704,Paroxysmal involuntary eye movements
PomBase:SPBC2G2.15c,mrm2
GO:0008320,protein transmembrane transporter activity
CHEBI:46081,fluconazole
PomBase:SPAC1565.08,cdc48
MGI:3804449,Ercc1<sup>tm1Jhjh</sup>/Ercc1<sup>tm1Jhjh</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6 * FVB
HP:0012242,Superior rectus atrophy
CLINVAR:478159,NM_000540.3(RYR1):c.11314C>T (p.Arg3772Trp)
chembl:CHEMBL4167360,IDH305
MGI:3837130,"Tg(APPswe,PSEN1dE9)85Dbo/0  [background:] involves: C3H * C57BL/6"
iuphar.ligand:12577,MK-912
FB:FBgn0036882,Dred
HP:0011808,Decreased patellar reflex
rxcui:25789,GLIMEPIRIDE
chembl:CHEMBL17594,QUINIZARIN
HGNC:11537,TAF4
iuphar.ligand:9571,ECF309
HGNC:9894,RBL2
UPHENO:0067863,basal ganglion calcification
chembl:CHEMBL2182009,CHEMBL:CHEMBL2182009
rxcui:2983,CYCLOFENIL
chembl:CHEMBL278489,DCMU
chembl:CHEMBL2088730,CHEMBL:CHEMBL2088730
HGNC:10585,SCN1A
chembl:CHEMBL1740701,CHEMBL:CHEMBL1740701
HP:0011151,Atypical absence status epilepticus
HP:0004757,Paroxysmal atrial fibrillation
rxcui:4325,FENBENDAZOLE
iuphar.ligand:11073,S‐Y048
HGNC:18348,TICAM1
drugbank:DB04528,"2,4-DINITROPHENOL"
GO:0045254,pyruvate dehydrogenase complex
wikidata:Q21044462,DEL-22379
rxcui:7716,ORPHENADRINE CITRATE
MONDO:0013366,"spondylocostal dysostosis 4, autosomal recessive"
chembl:CHEMBL591126,CHEMBL:CHEMBL591126
rxcui:1592254,PIRFENIDONE
iuphar.ligand:3193,COMPOUND 19 [PMID: 18800762]
HGNC:14348,HTRA2
HGNC:6746,NBR1
HP:0031432,Restricted or repetitive behaviors or interests
iuphar.ligand:11660,COMPOUND 38K [PMID: 34351741]
ncit:C1821,SELECTIVE ESTROGEN RECEPTOR MODULATOR
chembl:CHEMBL1509789,CHEMBL:CHEMBL1509789
rxcui:1656052,CANGRELOR
HP:0031007,Orofacial action-specific dystonia induced by speech
UPHENO:0078554,increased level of organic molecular entity in independent continuant
MONDO:0011012,African iron overload
CHEBI:30879,alcohol
ncit:C162629,SACUBITRIL/VALSARTAN
rxcui:7674,OPIPRAMOL
HP:0032854,Focal aware hemifacial clonic seizure
iuphar.ligand:9468,PSB-416
chembl:CHEMBL583824,CHEMBL:CHEMBL583824
HGNC:11185,SORL1
chembl:CHEMBL1094681,AESCULIOSIDE IVB
chembl:CHEMBL533954,CHEMBL:CHEMBL533954
ncit:C1177,OLTIPRAZ
iuphar.ligand:9401,NMS-P715
EMAPA:36927,inferior oblique extraocular muscle
rxcui:6857,METHOXYFLURANE
MONDO:0008457,spinocerebellar ataxia type 6
HGNC:30600,UBXN11
WB:WBGene00009664,idha-1
HP:0034335,Inheritance qualifier
HGNC:28636,B9D2
ncit:C84856,RESMINOSTAT
HP:0100298,Motheaten muscle fibers
ncit:C95719,TAREXTUMAB
iuphar.ligand:11459,B1-27
ncit:C234,AMINOLEVULINIC ACID
MGI:5445435,Tg(Prnp-FUS)WT3Cshw/Tg(Prnp-FUS)WT3Cshw  [background:] involves: C57BL/6 * Crl:CD-1(ICR)
rxcui:12062,ALFACALCIDOL
MGI:103071,Rangap1
chembl:CHEMBL1567571,CHEMBL:CHEMBL1567571
CHEBI:3745,clindamycin
ncit:C152535,TEDATIOXETINE
ncit:C211,THERAPEUTIC CORTICOSTEROID
GO:0001568,blood vessel development
drugbank:DB01950,AR-AO-14418
FB:FBgn0000212,brm
chembl:CHEMBL2036124,CHEMBL:CHEMBL2036124
rxcui:23350,DIOXYBENZONE
GO:0008650,rRNA (uridine-2'-O-)-methyltransferase activity
GO:0042733,embryonic digit morphogenesis
HGNC:18798,SLC44A1
chembl:CHEMBL527584,CHEMBL:CHEMBL527584
HP:0032114,Saccadic intrusion
HP:0000395,Prominent antihelix
UPHENO:0084426,abnormally decreased rate of locomotory behavior
RGD:708433,Cdon
HP:0007675,Progressive night blindness
UBERON:0010707,appendage girdle complex
chembl:CHEMBL146525,CHEMBL:CHEMBL146525
iuphar.ligand:2063,[111IN]DOTA-BOC-ATE
chembl:CHEMBL526981,CHEMBL:CHEMBL526981
chembl:CHEMBL526763,CHEMBL:CHEMBL526763
rxcui:2665621,AGATOLIMOD SODIUM
MP:0001402,decreased locomotor activity
HGNC:2752,PIAS1
GO:0016241,regulation of macroautophagy
HGNC:25198,SLC25A46
CHEBI:64203,methiothepin
HGNC:29594,UQCRQ
HP:0001413,Micronodular cirrhosis
rxcui:11289,WARFARIN
chembl:CHEMBL1308346,CHEMBL:CHEMBL1308346
MONDO:0000114,cerebelloparenchymal disorder
chembl:CHEMBL1946449,CHEMBL:CHEMBL1946449
HGNC:4886,HFE
chembl:CHEMBL192264,CHEMBL:CHEMBL192264
HGNC:11619,ELOB
GO:0050881,musculoskeletal movement
HGNC:10946,SLC20A1
HP:0000958,Dry skin
rxcui:2578,CLEMASTINE
MGI:5565691,Tg(UBC-GFP/HTT*84Q)22Shya/0  [background:] involves: FVB
MGI:4418484,Hif1a<sup>tm3Rsjo</sup>/Hif1a<sup>tm3Rsjo</sup> Tg(Camk2a-cre)2Szi/0  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
HGNC:29598,MACROD1
ncit:C175961,P53 Y220C MUTANT REACTIVATOR PC14586
ncit:C95979,ANDROSTENEDIOL
iuphar.ligand:2222,"D(CH2)5[TYR(ME)2,THR4]OVT"
chembl:CHEMBL186784,XANTHONE
HGNC:34295,TMEM212
ncit:C28580,AGATOLIMOD SODIUM
iuphar.ligand:1323,MT-II
MP:0008143,abnormal dendrite morphology
iuphar.ligand:10662,BMS-986260
ncit:C102535,ANTI-ERBB3 MONOCLONAL ANTIBODY AV-203
iuphar.ligand:11860,ESTRADIOL 3-METHYL ETHER
iuphar.ligand:11390,PD-146176
MONDO:0007496,dystonia 12
rxcui:236486,OMEPRAZOLE MAGNESIUM
ncit:C87682,RESATORVID
HP:0008404,Nail dystrophy
chembl:CHEMBL601137,CHEMBL:CHEMBL601137
MP:0000786,abnormal embryonic neuroepithelial layer differentiation
ncit:C1679,EXATECAN MESYLATE
ncit:C1025,BRUCEANTIN
ncit:C77392,ENZASTAURIN
ncit:C152325,SELISISTAT
rxcui:20875,CHLOROXINE
MONDO:0014353,immunodeficiency 23
drugbank:DB17023,ABT-737
HGNC:21396,ABHD5
iuphar.ligand:6478,ODANACATIB
CHEBI:47788,3-oxo steroid
MONDO:0014243,Schaaf-Yang syndrome
HP:0001923,Reticulocytosis
rxcui:220982,YOHIMBINE
MP:0002687,oligozoospermia
chembl:CHEMBL1353528,CHEMBL:CHEMBL1353528
rxcui:7005,MITOXANTRONE
chembl:CHEMBL2252949,(-)-CAMPHOR
HP:0008872,Feeding difficulties in infancy
UBERON:0005384,nasal cavity epithelium
chembl:CHEMBL107131,DIMETHYLPINOCEMBRIN
ncit:C83547,BENZPIPERYLON
ncit:C126355,ANTI-HER2 ANTIBODY-DRUG CONJUGATE MEDI4276
ncit:C65782,FURAZABOL
HGNC:16406,EFHC1
ncit:C166429,ORDOPIDINE
HP:0002311,Incoordination
chembl:CHEMBL1186581,RTI-336
CLINVAR:65996,NM_000540.3(RYR1):c.14126C>T (p.Thr4709Met)
GO:0018904,ether metabolic process
rxcui:15226,FOMEPIZOLE
iuphar.ligand:6448,COMPOUND 8 [PMID: 15482908]
chembl:CHEMBL588501,CHEMBL:CHEMBL588501
ncit:C77887,SAPITINIB
UBERON:0001385,tibialis anterior
chembl:CHEMBL1478462,CHEMBL:CHEMBL1478462
iuphar.ligand:1778,MRS2603
CLINVAR:207024,NM_001040142.2(SCN2A):c.5317G>A (p.Ala1773Thr)
HP:5200126,Aggression toward cargivers
MGI:4420470,Rb1<sup>tm1Tyj</sup>/Rb1<sup>tm1Tyj</sup> Tg(Rb1)1Blg/0 Trp53<sup>tm1Tyj</sup>/Trp53<sup>tm1Tyj</sup>  [background:] involves: 129S2/SvPas
iuphar.ligand:5906,COMPOUND 20O [PMID: 22984835]
chembl:CHEMBL411085,CHEMBL:CHEMBL411085
MONDO:0023659,developmental and epileptic encephalopathy 96
MGI:4418567,Ehmt2<sup>tm1.1Tara</sup>/Ehmt2<sup>tm1.1Tara</sup> Tg(Camk2a-cre)2Gsc/0  [background:] involves: 129P2/OlaHsd * C57BL/6 * FVB/N
rxcui:6845,METHOCARBAMOL
MGI:98326,Sst
MONDO:0008919,systemic primary carnitine deficiency disease
RGD:11568040,SD-<i>Fmr1<sup>em1Sage</sup></i>
chembl:CHEMBL1862887,IPRODIONE
HP:0010821,Focal emotional seizure with laughing
MGI:1346542,Bace1
HGNC:13727,RANBP9
iuphar.ligand:9187,CCT245737
rxcui:84158,METHYLERGONOVINE MALEATE
ncit:C1363,DIAZIQUONE
HGNC:92,ACADVL
MGI:3842462,Ache<sup>tm4Pata</sup>/Ache<sup>tm4Pata</sup>  [background:] involves: 129X1/SvJ
MONDO:0003847,hereditary disease
MP:0002916,increased synaptic depression
chembl:CHEMBL582666,CHEMBL:CHEMBL582666
UPHENO:0079830,abnormal regulation of behavior
MONDO:0018346,ferro-cerebro-cutaneous syndrome
CHEBI:24261,glucocorticoid
ncit:C152865,VERNAKALANT HYDROCHLORIDE
HGNC:12034,TRAF4
MONDO:0008178,inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1
HP:0012585,Renal atrophy
chembl:CHEMBL1256875,SPIPERONE HYDROCHLORIDE
chembl:CHEMBL5095288,RP-6306
chembl:CHEMBL1077259,BISLEUCONOTHINE A
UPHENO:0068157,increased level of creatine in blood
HGNC:12642,VAMP1
WB:WBGene00012375,mecr-1
HGNC:792,ATF7
HP:0008207,Primary adrenal insufficiency
GO:0051453,regulation of intracellular pH
rxcui:31819,NITAZOXANIDE
HGNC:6757,MAB21L1
iuphar.ligand:11951,ASAPIPRANT
MGI:2139279,Hrh3
HGNC:6853,MAP3K14
MONDO:0011439,spinocerebellar ataxia type 12
ncit:C166910,OXELUMAB
UBERON:0001148,median nerve
iuphar.ligand:2062,[125I]TYR3 SMS 201-995
HP:0006498,Aplasia/Hypoplasia of the patella
CHEBI:29105,zinc(2+)
UPHENO:0080062,abnormally decreased rate of thigmotaxis
EMAPA:36925,superior rectus extraocular muscle
rxcui:993449,DENOSUMAB
rxcui:1649479,IVABRADINE HYDROCHLORIDE
iuphar.ligand:5731,PYRROLOPYRIMIDINE 48 [PMID: 22318156]
HP:0000007,Autosomal recessive inheritance
ncit:C139552,MEVOCICLIB
HGNC:23621,MIGA2
HP:0033691,Procedural memory loss
ncit:C95888,PLOCABULIN
rxcui:2473,CHONDROITIN SULFATES
ncit:C113444,RODUCITABINE
chembl:CHEMBL463686,PHENAZINE-1-CARBOXYLIC ACID
iuphar.ligand:2904,SR8278
HGNC:17753,TSPAN5
ncit:C170364,RAVOXERTINIB
chembl:CHEMBL1333386,CHEMBL:CHEMBL1333386
iuphar.ligand:12804,J27644
chembl:CHEMBL597744,TRIACETYLRESVERATROL
HGNC:29668,H2AC19
iuphar.ligand:11747,BPR1R024
iuphar.ligand:152,&ALPHA;-METHYL-5-HT
ncit:C81556,ASCORBYL PALMITATE
rxcui:9009,PYRILAMINE
chembl:CHEMBL4298077,PRASINEZUMAB
chembl:CHEMBL511667,TRIBUTYLTIN-OXIDE
MONDO:0010498,MEND syndrome
iuphar.ligand:9579,COMPOUND II [PMID: 21329883]
chembl:CHEMBL446567,CHEMBL:CHEMBL446567
chembl:CHEMBL117487,CHEMBL:CHEMBL117487
chembl:CHEMBL2109495,E2.3
rxcui:10114,STREPTOZOCIN
drugbank:DB05559,NF-KAPPAB DECOY
iuphar.ligand:10711,T‐495
rxcui:69036,RUFINAMIDE
chembl:CHEMBL16117,PHILANTHOTOXIN 343
CLINVAR:65979,NM_000540.3(RYR1):c.7354C>T (p.Arg2452Trp)
chembl:CHEMBL555242,CHEMBL:CHEMBL555242
MGI:1915127,Naa20
iuphar.ligand:1422,CDPPB
iuphar.ligand:3880,GR100679
chembl:CHEMBL587892,CHEMBL:CHEMBL587892
GO:0048812,neuron projection morphogenesis
UBERON:0002082,cardiac ventricle
chembl:CHEMBL1522104,ISOKOBUSONE
ncit:C64540,CENISERTIB
rxcui:4170,ETHYNODIOL DIACETATE
MONDO:0006741,encephalomalacia
GO:0034333,adherens junction assembly
CLINVAR:143742,NM_001110792.2(MECP2):c.946A>G (p.Lys316Glu)
HP:0005257,Thoracic hypoplasia
MONDO:0014671,"neuropathy, hereditary motor and sensory, type 6B"
iuphar.ligand:5078,FAS LIGAND
CHEBI:39270,naphthofuran
MONDO:0011886,torsion dystonia 13
chembl:CHEMBL1900522,FLUSILAZOLE
ncit:C76088,ARBACLOFEN PLACARBIL
MGI:3836724,Efhc1<sup>tm1Kzy</sup>/Efhc1<sup>tm1Kzy</sup>  [background:] B6.129P2-Efhc1<sup>tm1Kzy</sup>
drugbank:DB14066,TETRANDRINE
chembl:CHEMBL516616,CHEMBL:CHEMBL516616
chembl:CHEMBL577851,CHEMBL:CHEMBL577851
iuphar.ligand:231,LY334362
MGI:1347464,Foxg1
rxcui:282415,AMANTADINE HYDROCHLORIDE
UPHENO:0081886,decreased level of coenzyme Q10 in independent continuant
MONDO:0016563,progressive supranuclear palsy-corticobasal syndrome
HGNC:23792,PLD4
HGNC:26068,LAMTOR1
chembl:CHEMBL1172228,CHEMBL:CHEMBL1172228
HGNC:9725,PYGL
CHEBI:17824,propan-2-ol
iuphar.ligand:11393,BW B70C
rxcui:42355,FLUVOXAMINE
iuphar.ligand:9586,AZ7188
rxcui:3642,DOXYLAMINE
ncit:C1472,BIZELESIN
WB:WBGene00006459,tag-89
rxcui:236158,APRINDINE HYDROCHLORIDE
HGNC:14279,MRPL14
FB:FBgn0261885,osa
MP:0001515,abnormal grip strength
chembl:CHEMBL1095515,SCLEROTIORIN
NCBIGene:415129,CYP3A12
chembl:CHEMBL525103,CHEMBL:CHEMBL525103
UPHENO:0088336,abnormally decreased number of anatomical entity in the basal ganglion
HGNC:5300,HTR5A
rxcui:1368643,CARMINIC ACID
MGI:3588732,Cln8<sup>mnd</sup>/Cln8<sup>mnd</sup>  [background:] AK.B6(Cg)-Cln8<sup>mnd</sup>
HP:0031879,Abnormal eyelid physiology
chembl:CHEMBL589479,CHEMBL:CHEMBL589479
chembl:CHEMBL1256361,IPRONIAZID PHOSPHATE
HGNC:37234,TMEM231
NCBIGene:397405,TYROBP
rxcui:203142,GUANFACINE HYDROCHLORIDE
iuphar.ligand:576,N-METHYL-PHE-LYS-PRO-D-CHA-TRP-D-ARG-CO2H
rxcui:7243,NALTREXONE
chembl:CHEMBL194881,CHEMBL:CHEMBL194881
chembl:CHEMBL538798,CHEMBL:CHEMBL538798
chembl:CHEMBL3580737,MK-0941
ncit:C75204,RILOPIROX
chembl:CHEMBL3545119,BMS-794833
chembl:CHEMBL3545326,TAS-119
MGI:1096398,Cd81
CHEBI:16347,(R)-carnitine
HGNC:2974,DNM2
MGI:5312912,b2b954Clo/b2b954Clo  [background:] C57BL/6J-b2b954Clo
Xenbase:XB-GENE-484865,sox17b.1
MONDO:0017572,tick-borne encephalitis
HP:0002313,Spastic paraparesis
rxcui:720,AMODIAQUINE
chembl:CHEMBL579550,CHEMBL:CHEMBL579550
CHEBI:30839,orotate
drugbank:DB01931,"5,7-DICHLOROKYNURENIC ACID"
HP:0001924,Sideroblastic anemia
HP:0000839,Pituitary dwarfism
chembl:CHEMBL1256708,APOMORPHINE HYDROCHLORIDE HEMIHYDRATE
rxcui:29365,CALCIPOTRIENE
HP:0002795,Abnormal respiratory system physiology
rxcui:1242806,INGENOL MEBUTATE
HGNC:1400,CACNA2D2
HP:0000763,Sensory neuropathy
HP:0025190,Bilateral tonic-clonic seizure with generalized onset
iuphar.ligand:5669,BMS-345541
MONDO:0014265,Alzheimer disease 18
ncit:C111895,PYROTINIB
iuphar.ligand:5652,LYSOPHOSPHATIDYLETHANOLAMINE
ncit:C61494,SELECTIVE ESTROGEN RECEPTOR MODULATOR TAS-108
drugbank:DB15151,RO-6870810
ncit:C72813,LECOZOTAN HYDROCHLORIDE
MONDO:0006254,intestinal type adenocarcinoma
iuphar.ligand:1579,NEUROTENSIN
ncit:C128632,MTOR KINASE INHIBITOR PP242
chembl:CHEMBL259422,CHEMBL:CHEMBL259422
ncit:C28699,THERAPEUTIC TUMOR INFILTRATING LYMPHOCYTES
NCBIGene:418118,NDUFB2
rxcui:29523,MEPREDNISONE
HGNC:25416,ATXN7L3
HGNC:17189,OLFM2
chembl:CHEMBL242172,CHEMBL:CHEMBL242172
RGD:621585,Scaper
rxcui:11473,PAMIDRONATE
rxcui:20890,LORNOXICAM
dictyBase:DDB_G0277307,DDB_G0277307
UBERON:0004811,endometrium epithelium
EMAPA:17788,cerebellum mantle layer
rxcui:4488,FLOXURIDINE
ZFIN:ZDB-GENE-030131-6506,mob1a
MGI:103300,Rbl1
iuphar.ligand:9124,ANTI-ILT7 ANTIBODY
chembl:CHEMBL3545385,WX-037
HP:0002179,Opisthotonus
UBERON:0001893,telencephalon
MONDO:0010534,X-linked spinocerebellar ataxia type 4
HP:0011218,Abnormal shape of the frontal region
FBbt:00001761,imaginal disc
HGNC:11152,SNRPA1
MONDO:0034976,iatrogenic Creutzfeldt-Jakob disease
UBERON:0002080,heart right ventricle
chembl:CHEMBL528807,CHEMBL:CHEMBL528807
chembl:CHEMBL350719,ESMETHADONE
GO:0006281,DNA repair
FB:FBgn0036892,Lon
iuphar.ligand:1263,VUF 4904
chembl:CHEMBL173530,STICTIC ACID
GO:0031901,early endosome membrane
MGI:1860433,Pigp
HGNC:7090,MICA
MONDO:0010435,"nystagmus 6, congenital, X-linked"
CL:1001434,olfactory bulb interneuron
MP:0012284,increased sternebra number
ncit:C174126,OLITIGALTIN
rxcui:60842,REBOXETINE
MGI:2680904,Abcd1<sup>tm1Kds</sup>/Abcd1<sup>tm1Kds</sup>  [background:] involves: 129/Sv * 129S4/SvJae * C57BL/6J
ncit:C1122,RECOMBINANT HEPATOCYTE GROWTH FACTOR
ncit:C37451,TESETAXEL
HP:0000678,Dental crowding
chembl:CHEMBL1306556,CHEMBL:CHEMBL1306556
ncit:C152567,TERGURIDE
MONDO:0016650,paternal uniparental disomy of chromosome 1
chembl:CHEMBL291481,HEXAMETHYLENEBISACETAMIDE
HP:0032798,Focal impaired awareness cognitive seizure with neglect
chembl:CHEMBL1256661,PROPIONYLPROMAZINE HYDROCHLORIDE
CLINVAR:1143525,NM_001379110.1(SLC9A6):c.81G>A (p.Leu27=)
ncit:C63948,HYDROXYFLUTAMIDE
chembl:CHEMBL59356,ATRELEUTON
chembl:CHEMBL600173,CHEMBL:CHEMBL600173
iuphar.ligand:5065,TRAIL
HGNC:4566,GRB2
chembl:CHEMBL1893025,ZOXAMIDE
HGNC:6570,LGALS9
GO:0006783,heme biosynthetic process
MONDO:0011963,Joubert syndrome 2
HGNC:14064,HDAC6
HGNC:4403,GNG11
rxcui:73494,TELMISARTAN
chembl:CHEMBL416038,CHEMBL:CHEMBL416038
iuphar.ligand:6420,COMPOUND 41 [PMID: 23434029]
MONDO:0042965,Machado-Joseph disease type 5
OBA:2001012,age of onset of type 1 diabetes mellitus
HGNC:4769,H3C6
GO:0005524,ATP binding
rxcui:203155,DIPHENYLPYRALINE HYDROCHLORIDE
rxcui:104123,OLSALAZINE SODIUM
UBERON:0006320,inferior oblique extraocular muscle
HP:0031833,Hypometric upward saccades
HP:0001655,Patent foramen ovale
HP:5200051,Excessive hand washing
ncit:C291,6-AZAURIDINE
iuphar.ligand:10181,COMPOUND 19A [PMID: 30503936]
iuphar.ligand:16,"L-772,405"
rxcui:1000112,MEDROXYPROGESTERONE ACETATE
iuphar.ligand:8231,OICR-9429
MONDO:0019952,congenital myopathy
ncit:C152873,VIDOFLUDIMUS
iuphar.ligand:5701,PI-103
HP:0006999,Basal ganglia gliosis
MONDO:0014867,spinocerebellar ataxia 43
ncit:C81614,OCINAPLON
rxcui:1999574,APALUTAMIDE
MGI:104885,Psma2
HP:0001156,Brachydactyly
rxcui:1490468,TASIMELTEON
iuphar.ligand:934,N-PROPYLNORAPOMORPHINE
iuphar.ligand:10383,ARS-1620
chembl:CHEMBL530049,CHEMBL:CHEMBL530049
ncit:C1717,IROFULVEN
ncit:C152731,TREQUINSIN
ncit:C131335,TEMUTERKIB
rxcui:8742,PROMAZINE
MONDO:0013947,"neuronopathy, distal hereditary motor, autosomal recessive 5"
ncit:C91724,MDM2 ANTAGONIST RO5045337
MONDO:0005359,drug-induced liver injury
rxcui:275635,DESLORATADINE
chembl:CHEMBL1606022,SAPPANONE A TRIMETHYL ETHER
drugbank:DB05905,TD-2749
chembl:CHEMBL2028050,CHEMBL:CHEMBL2028050
chembl:CHEMBL372375,CHEMBL:CHEMBL372375
iuphar.ligand:8377,PF-00489791
iuphar.ligand:344,N-CHLOROMETHYL-BRUCINE
HP:0004326,Cachexia
chembl:CHEMBL419564,DINITRO CRESOL
iuphar.ligand:11114,DCLK1-IN-1
chembl:CHEMBL1224512,HISPIDIN
chembl:CHEMBL255033,(S)-NIMODIPINE
chembl:CHEMBL499609,NAKIJIQUINONE I
HGNC:6157,ITGB3BP
CHEBI:7809,oxacillin
HP:0010296,Ankyloglossia
iuphar.ligand:308,P-F-HHSID
HGNC:13083,ZBTB21
chembl:CHEMBL285848,MANUMYCIN A
iuphar.ligand:5685,GW-2580
iuphar.ligand:8851,17-OCTADECYNOIC ACID
ncit:C1863,ENTINOSTAT
UPHENO:0081435,abnormal anatomical entity morphology in the brain
drugbank:DB17099,SY-5609
chembl:CHEMBL268089,WR-159412
iuphar.ligand:8074,NG-25
iuphar.ligand:2067,PRL-2970
iuphar.ligand:4450,(+)-ADRENALINE
ncit:C152482,SUTEZOLID
NCBIGene:281617,ALDH3A1
MONDO:0007325,"choreoathetosis, familial inverted"
chembl:CHEMBL3545389,LY2245461
ncit:C1405,VALSPODAR
iuphar.ligand:4977,IL-12
iuphar.ligand:62,(+)-BUTACLAMOL
iuphar.ligand:8583,UH-AH 37
HP:0009821,Forearm undergrowth
MGI:1098264,Kif13a
iuphar.ligand:12894,STC-15
rxcui:819300,GOLIMUMAB
ncit:C121550,ANTI-EGFR MONOCLONAL ANTIBODY SYN004
HGNC:10683,SDHD
drugbank:DB13048,PAC-1
HGNC:16639,SRRM2
UBERON:0004086,brain ventricle
chembl:CHEMBL548338,CHEMBL:CHEMBL548338
ncit:C1811,PRINOMASTAT
MGI:3843824,Pdha1<sup>tm1Ptl</sup>/Pdha1<sup>tm1Ptl</sup> Tg(Nes-cre)1Kln/0  [background:] involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL
HGNC:15750,DSTN
drugbank:DB04892,PHENSERINE
rxcui:1494066,MILTEFOSINE
ncit:C74143,ROBALZOTAN
drugbank:DB08626,THIORPHAN
MONDO:0014885,Hermansky-Pudlak syndrome 10
HGNC:12649,VAPB
CHEBI:16856,glutathione
chembl:CHEMBL3990042,GOSURANEMAB
iuphar.ligand:8043,PF-477736
HGNC:9577,PSPH
drugbank:DB16836,VITEXIN
rxcui:3328,DIBEKACIN
rxcui:15080,MEQUINOL
chembl:CHEMBL456295,OXOPURPUREINE
ncit:C170289,PEFCALCITOL
HGNC:8993,PIP
HGNC:2738,DHX15
HP:0002527,Falls
HGNC:2027,CLCNKB
rxcui:231049,ELETRIPTAN
MGI:5792057,Cacna1a<sup>tg</sup>/Cacna1a<sup>tm2.1Maag</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6J * DBA/2J * FVB/N
MP:0003354,astrocytosis
GO:0008219,cell death
HP:0002322,Resting tremor
iuphar.ligand:3198,BPH-252
rxcui:7247,NAPHAZOLINE
iuphar.ligand:10115,J-2156
MONDO:0008947,bilateral striopallidodentate calcinosis
MGI:6317190,Tg(Prnp-MAPT*)2652Gds/0  [background:] B6.Cg-Tg(Prnp-MAPT*)2652Gds
Xenbase:XB-GENE-984218,cyp3a4.1
iuphar.ligand:4346,ZK93423
MGI:3037863,Fgf8<sup>tm1.3Mrt</sup>/Fgf8<sup>tm1.4Mrt</sup> Tg(Tbx1-cre)1Joe/0  [background:] involves: 129P2/OlaHsd
chembl:CHEMBL2333548,CHEMBL:CHEMBL2333548
HGNC:8708,PCDHGB1
ncit:C1306,O6-BENZYLGUANINE
HP:0001304,Torsion dystonia
HGNC:9606,PTH
MONDO:0010877,Charcot-Marie-Tooth disease type 5
iuphar.ligand:3926,[11C]AZ10419369
ncit:C90713,NEMIFITIDE
HP:0012547,Abnormal involuntary eye movements
HP:0007183,Focal T2 hyperintense basal ganglia lesion
MONDO:0011149,"premature aging syndrome, Okamoto type"
chembl:CHEMBL1209491,DAPHNORIN
ncit:C99905,ROCILETINIB
HGNC:9870,RARS1
ncit:C80380,SATAVAPTAN
chembl:CHEMBL606456,CHEMBL:CHEMBL606456
MGI:5825029,Slc6a8<sup>tm1.1Lbar</sup>/Y Tg(Nes-cre)1Kln/0  [background:] involves: 129 * C57BL/6 * C57BL/6J * C57BL/6N * SJL
GO:0055074,calcium ion homeostasis
HGNC:7579,MYH9
HP:0003438,Absent Achilles reflex
MGI:5752054,"Tg(Prnp-rtTA2S*M2)#Rkhu/0 Tg(tetO-FMR1*,-EGFP)#Rkhu/0  [background:] involves: C57BL/6JRj"
MONDO:0009839,progressive supranuclear palsy-parkinsonism syndrome
HP:0032906,Focal head nodding automatism seizure
HP:0005484,Secondary microcephaly
chembl:CHEMBL529939,CHEMBL:CHEMBL529939
iuphar.ligand:9,BMY-7378
HGNC:27301,CRTC2
UPHENO:0014134,telencephalon atrophy
ncit:C83819,EFATUTAZONE
MGI:3828112,Sall1<sup>tm1Jkoh</sup>/Sall1<sup>+</sup> Sall4<sup>Gt(W097E01)Flo</sup>/Sall4<sup>+</sup>  [background:] involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
iuphar.ligand:9932,SETANAXIB
chembl:CHEMBL579956,CHEMBL:CHEMBL579956
CHEBI:22984,calcium atom
chembl:CHEMBL534319,CHEMBL:CHEMBL534319
iuphar.ligand:837,CXCL9
rxcui:2921,CROMOGLYCATE
iuphar.ligand:4366,[3H]CGS8216
MGI:107619,Hrh1
HP:0010557,Overlapping fingers
HGNC:15514,PICALM
HGNC:25332,C1orf131
HP:0004373,Focal dystonia
HP:0002070,Limb ataxia
MGI:106679,Zic2
rxcui:1191,ASPIRIN
chembl:CHEMBL23957,OXOTREMORINE METHIODIDE
iuphar.ligand:8104,LY2874455
ncit:C82684,TOVETUMAB
chembl:CHEMBL602561,CHEMBL:CHEMBL602561
MGI:1921494,Atg7
iuphar.ligand:10121,F215
iuphar.ligand:6147,[3H]PSB-0413
chembl:CHEMBL1873440,MESOTRIONE
EMAPA:19050,cerebellum dorsal part ventricular layer
MP:0001364,decreased anxiety-related response
HGNC:5182,HRH1
HP:0005445,Enlarged posterior fossa
HP:0002900,Hypokalemia
iuphar.ligand:4264,NBQX
rxcui:1307619,BOSUTINIB
iuphar.ligand:2037,BIM 23059
chembl:CHEMBL2178586,CHEMBL:CHEMBL2178586
chembl:CHEMBL591361,CHEMBL:CHEMBL591361
iuphar.ligand:8600,ALEXA-488-TELENZEPINE
chembl:CHEMBL396848,MACROCARPAL B
iuphar.ligand:6307,BENZOQUINONE
iuphar.ligand:4198,GATX1
HGNC:20303,SLC30A8
HGNC:16014,CASD1
MONDO:0012048,endogenous depression
rxcui:7833,AMINOSALICYLIC ACID
rxcui:2598,CLONAZEPAM
MONDO:0020653,vaginal adenocarcinoma
chembl:CHEMBL578915,CHEMBL:CHEMBL578915
chembl:CHEMBL1256674,RILMENIDINE HEMIFUMARATE
HGNC:3213,EEF1G
GO:0000932,P-body
rxcui:4639,GALLAMINE TRIETHIODIDE
MONDO:0005371,mood disorder
chembl:CHEMBL581677,CHEMBL:CHEMBL581677
iuphar.ligand:12616,DS-7423
HGNC:8873,PFKFB2
rxcui:10824,METIPRANOLOL
ncit:C72927,NAFTOPIDIL
MONDO:0100372,disorder of peroxisomal transporter
ZFIN:ZDB-GENE-090618-1,apobec2b
MGI:2652189,Del(9Hspb2-Cryab)1Wawr/Del(9Hspb2-Cryab)1Wawr  [background:] involves: 129S4/SvJae
chembl:CHEMBL2208195,CHEMBL:CHEMBL2208195
iuphar.ligand:10514,RO0094889
HGNC:7967,NR1H4
ncit:C1612,GLUFOSFAMIDE
HGNC:10898,SKIC2
rxcui:1720597,MEPOLIZUMAB
drugbank:DB17059,TW-37
rxcui:1439834,VORTIOXETINE HYDROBROMIDE
chembl:CHEMBL486226,BMS-707035
HGNC:9655,PTPN3
HP:0000767,Pectus excavatum
rxcui:203199,PROTRIPTYLINE HYDROCHLORIDE
ncit:C72740,DIFLOXACIN HYDROCHLORIDE
chembl:CHEMBL1425995,DIFLUFENICAN
MONDO:0011038,cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
rxcui:31494,NANDROLONE DECANOATE
MONDO:0021137,not rare
UPHENO:0081548,abnormal metabolite independent continuant level
chembl:CHEMBL451039,RETINYLRETINOATE
ncit:C63672,PENTOSALEN
rxcui:1545992,DOXYCYCLINE ANHYDROUS
HGNC:4931,HLA-A
CHEBI:26216,potassium atom
ncit:C76219,CARBENICILLIN INDANYL
ncit:C2012,MATUZUMAB
RGD:708379,Cyp3a2
chembl:CHEMBL590670,CHEMBL:CHEMBL590670
rxcui:1796444,METHYLBENZETHONIUM CHLORIDE
chembl:CHEMBL2146143,ATROPINE METHYLBROMIDE
MGI:103567,Cxcr5
HP:0011932,Abnormal superior cerebellar peduncle morphology
HGNC:17306,TAF9B
RGD:1308152,Creb3l3
iuphar.ligand:12099,TUNODAFIL
chembl:CHEMBL467590,GETIACAULEIN
HP:0009072,Decreased Achilles reflex
HGNC:23337,ACBD4
HP:0003166,Increased urinary taurine
chembl:CHEMBL22062,CHEMBL:CHEMBL22062
ncit:C87291,ELDECALCITOL
rxcui:26237,GRANISETRON
iuphar.ligand:8598,CY3B-TELENZEPINE
iuphar.ligand:11096,MAPK13-IN-1
HP:0002714,Downturned corners of mouth
HGNC:7798,NFKBIB
chembl:CHEMBL587849,CHEMBL:CHEMBL587849
TS:27,
chembl:CHEMBL1256186,CHEMBL:CHEMBL1256186
chembl:CHEMBL530664,CHEMBL:CHEMBL530664
chembl:CHEMBL1354316,2-METHYL GRAMINE
ncit:C65687,FISPEMIFENE
iuphar.ligand:6040,SKF-86002
chembl:CHEMBL1170485,CHEMBL:CHEMBL1170485
HP:0032831,Neonatal bilateral asymmetric tonic seizure
chembl:CHEMBL544713,BENOXATHIAN HYDROCHLORIDE
rxcui:1433764,TBO-FILGRASTIM
ncit:C978,DOXIFLURIDINE
rxcui:11253,VITAMIN D
rxcui:3820,EMETINE
chembl:CHEMBL580155,CHEMBL:CHEMBL580155
HGNC:29029,TTI1
HP:0002601,Paresis of extensor muscles of the big toe
MGI:2653752,anx/anx  [background:] B6C3Fe a/a-anx/J
HGNC:13631,RPL36
chembl:CHEMBL24057,FURAMIDINE
MGI:3044676,Gamt<sup>tm1Isb</sup>/Gamt<sup>tm1Isb</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ
MONDO:0002269,gastroenteritis
ncit:C171762,BAVISANT
chembl:CHEMBL219557,CHEMBL:CHEMBL219557
MONDO:0010997,"supranuclear palsy, progressive, 1"
ncit:C143088,NOLATREXED
chembl:CHEMBL3545378,MK-6592
MP:0020620,increased dorsal striatum total cell area
iuphar.ligand:6154,BIIL 260
HGNC:20157,HECTD1
ncit:C166835,IDALOPIRDINE
chembl:CHEMBL1529479,CHEMBL:CHEMBL1529479
chembl:CHEMBL4297361,1.ALPHA.-HYDROXYVITAMIN D5
iuphar.ligand:10081,KINASE INHIBITOR 2 [PMID: 30199702]
ncit:C119747,ERK INHIBITOR CC-90003
ncit:C83692,EPERISONE
ncit:C76016,CILUPREVIR
ncit:C152966,ZOXAZOLAMINE
iuphar.ligand:11085,HTH-02-006
CLINVAR:650932,NM_000540.3(RYR1):c.11947C>T (p.Arg3983Cys)
chembl:CHEMBL1417951,MECARBAM
FB:FBgn0001108,DCTN1-p150
CHEBI:15372,"5,6,7,8-tetrahydrobiopterin"
HP:0033606,Bone marrow maturation arrest
HP:0002073,Progressive cerebellar ataxia
iuphar.ligand:668,FR190997
HP:0003103,Abnormal cortical bone morphology
UBERON:0002245,cerebellar hemisphere
chembl:CHEMBL235891,CHEMBL:CHEMBL235891
ncit:C170243,OLACAFTOR
UPHENO:0053011,decreased qualitatively angular vestibuloocular reflex
MP:0020671,decreased stria medullaris cell density
ncit:C138994,COPANLISIB HYDROCHLORIDE
MGI:99919,Vcp
HP:0001640,Cardiomegaly
MONDO:0009054,"autosomal recessive cutis laxa type 2, classic type"
iuphar.ligand:4735,MICROCYSTIN-LR
MGI:104781,Kcnj6
rxcui:253198,ROSIGLITAZONE MALEATE
chembl:CHEMBL509523,IOXYNIL
HP:0025401,Staring gaze
chembl:CHEMBL599165,CHEMBL:CHEMBL599165
HP:0100018,Nuclear cataract
MONDO:0006636,Actinobacillus infectious disease
ncit:C80039,DEVIMISTAT
CHEBI:3962,curcumin
HGNC:4948,HLA-DRB1
chembl:CHEMBL3545220,LY2590443
rxcui:7008,SOTALOL HYDROCHLORIDE
HGNC:10467,RTN1
ncit:C66949,ELISIDEPSIN
chembl:CHEMBL144472,NILE RED
chembl:CHEMBL597874,CHEMBL:CHEMBL597874
MONDO:0009133,"cerebellar ataxia, intellectual disability, and dysequilibrium"
iuphar.ligand:3187,DIGERANYL BISPHOSPHONATE
HP:0005110,Atrial fibrillation
chembl:CHEMBL252925,GAMMA-FAGARINE
rxcui:19831,BUDESONIDE
MONDO:0011487,Huntington disease-like 3
ncit:C83611,CEPHARANTHINE
rxcui:1311397,CAFFEIC ACID
chembl:CHEMBL1342336,CHEMBL:CHEMBL1342336
HGNC:17383,HRH4
rxcui:1368201,DICLAZURIL
iuphar.ligand:6447,COMPOUND 13 [PMID: 15686941]
chembl:CHEMBL528694,CHEMBL:CHEMBL528694
MP:0002175,decreased brain weight
iuphar.ligand:12645,VIXOTRIGINE
rxcui:114970,ZAFIRLUKAST
HP:0001618,Dysphonia
drugbank:DB14942,BMS-986141
iuphar.ligand:5180,ESCULETIN
chembl:CHEMBL578929,CHEMBL:CHEMBL578929
ncit:C90865,CRILVASTATIN
GO:0110165,cellular anatomical entity
iuphar.ligand:12466,6-METHYLFLAVONE
ncit:C1008,AZARIBINE
rxcui:10834,TRIMIPRAMINE
drugbank:DB03694,N-PHENYLTHIOUREA
drugbank:DB17021,JQ1
UPHENO:0014081,cerebellar vermis atrophy
HGNC:18083,TRPV4
HP:0008167,Very long chain fatty acid accumulation
HP:0032694,Focal cognitive seizure with dyslexia/alexia
GO:0048487,beta-tubulin binding
iuphar.ligand:8938,FRAX486
chembl:CHEMBL1223741,CRYPTOCHINONE B
HGNC:5383,IDH2
HGNC:6781,MAFG
HGNC:25605,TMEM19
MONDO:0044807,inherited dystonia
ncit:C82363,GOLVATINIB
ncit:C175136,MEVIDALEN
rxcui:81998,DIETHYLPROPION HYDROCHLORIDE
rxcui:20791,CHLORHEXIDINE GLUCONATE
iuphar.ligand:750,AM-630
iuphar.ligand:7026,PBIT
MONDO:0009658,mucopolysaccharidosis type 3D
HGNC:3287,EIF4E
MGI:2668523,Hprt1<sup>tm2Detl</sup>/Hprt1<sup>tm2Detl</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
chembl:CHEMBL592786,CHEMBL:CHEMBL592786
drugbank:DB05969,SNS-032
chembl:CHEMBL378104,CARDAMOMIN
iuphar.ligand:4862,AG1478
iuphar.ligand:498,SNAP5089
GO:0002790,peptide secretion
iuphar.ligand:2487,LTB4
HGNC:7863,NNT
chembl:CHEMBL598279,CHEMBL:CHEMBL598279
HP:0032113,Semidominant inheritance
iuphar.ligand:160,AL-37350A
GO:0031167,rRNA methylation
rxcui:3920,ENFLURANE
ncit:C78034,CLOFENOXYDE
rxcui:103244,PILOCARPINE NITRATE
chembl:CHEMBL201761,SALINAZID
iuphar.ligand:500,[125I]HEAT (BE2254)
iuphar.ligand:5562,GSK494581A
MGI:5698523,Htt<sup>tm2Detl</sup>/Htt<sup>+</sup>  [background:] B6J.129P2-Htt<sup>tm2Detl</sup>
CHEBI:50852,glycinyl ester
CHEBI:16737,creatinine
MGI:3844928,Gt(ROSA)26Sor<sup>tm1(Smo/EYFP)Amc</sup>/Gt(ROSA)26Sor<sup>+</sup> Olig3<sup>tm1(cre)Ynka</sup>/Olig3<sup>+</sup>  [background:] involves: 129X1/SvJ * C57BL/6 * SJL
iuphar.ligand:7713,AZD7762
GO:1901503,ether biosynthetic process
HP:0002571,Achalasia
rxcui:235953,BENFLUOREX HYDROCHLORIDE
chembl:CHEMBL1449575,HARMOL HYDROCHLORIDE
MGI:1919746,Sec24c
CLINVAR:143754,NM_001110792.2(MECP2):c.1001C>T (p.Pro334Leu)
iuphar.ligand:9382,NVP-TAE 226
iuphar.ligand:3883,GYPGKF-NH2
rxcui:1951,CAMBENDAZOLE
ncit:C77068,NICOXAMAT
UBERON:0002107,liver
MONDO:0019251,oligosaccharidosis
HP:0500074,Dissociated vertical deviation
HGNC:2661,DAB1
HP:0000508,Ptosis
iuphar.ligand:10003,GNE-131
iuphar.ligand:944,SKF-83566
iuphar.ligand:9891,MARBOSTAT-100
ncit:C242,ANTI-ANDROGEN
chembl:CHEMBL4297392,IOWH-032
drugbank:DB14856,PF-05089771
rxcui:25193,FLUPIRTINE
HGNC:7067,CIITA
UPHENO:0014137,cerebral cortex atrophy
MP:0000815,abnormal Ammon gyrus morphology
GO:0000467,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)"
ncit:C29505,TOPICAL CORTICOSTEROID
GO:0001547,antral ovarian follicle growth
GO:0003697,single-stranded DNA binding
chembl:CHEMBL449928,BIFENOX
HGNC:4407,GNG4
rxcui:235828,MECYSTEINE HYDROCHLORIDE
iuphar.ligand:2007,CORTISTATIN-14
rxcui:83885,PROXIBARBAL
chembl:CHEMBL1513686,12A-HYDROXY-5-DEOXYDEHYDROMUNDUSERONE
chembl:CHEMBL1284,"3,4-DIHYDROXYPHENYLACETIC ACID"
iuphar.ligand:2225,"D[PEN1,TYR(ME)2]AVP"
rxcui:1309680,INTERLEUKIN-12
RGD:1302645,DMY/Kyo
iuphar.ligand:2828,DAIDZEIN
chembl:CHEMBL4297892,ARX-788
MP:0006108,abnormal hindbrain development
CHEBI:5391,glucagon
iuphar.ligand:7025,DAMINOZIDE
rxcui:6883,METHYLERGONOVINE
HGNC:463,AMFR
iuphar.ligand:2674,GW7647
drugbank:DB08653,TRYPTAMINE
MONDO:0005154,liver disorder
HP:0030301,Abnormality of the anterior commissure
chembl:CHEMBL2177350,NEOPETROFORMYNE A
HP:0004322,Short stature
HGNC:1082,BNIP1
MGI:102551,Ccnf
ZFIN:ZDB-FISH-150901-18534,tpp1<sup>sa11/sa11</sup>
HP:0002586,Peritonitis
HGNC:9965,RERE
rxcui:6373,LEVONORGESTREL
rxcui:1815,BUPIVACAINE
iuphar.ligand:332,N-BENZYL BRUCINE
chembl:CHEMBL595912,CHEMBL:CHEMBL595912
HGNC:9552,PSMC5
HGNC:12669,VDAC1
ncit:C2160,PROTEASOME INHIBITOR
HGNC:30076,POLR3C
HGNC:8931,PHKG2
SGD:S000002612,COQ4
iuphar.ligand:188,RS-127445
MGI:1329042,Sgce
rxcui:1299928,ZINC SULFATE ANHYDROUS
rxcui:4815,GLYBURIDE
rxcui:2479690,TRILACICLIB
iuphar.ligand:8047,WZ4003
CHEBI:9212,sparfloxacin
HGNC:18291,DMAP1
chembl:CHEMBL51697,CHEMBL:CHEMBL51697
iuphar.ligand:8424,BF-1
rxcui:1426401,CYSTAMINE
chembl:CHEMBL476501,CHEMBL:CHEMBL476501
GO:0071362,cellular response to ether
GO:0004596,peptide alpha-N-acetyltransferase activity
ncit:C75979,HEXAMETHONIUM
rxcui:7517,NORFLOXACIN
ncit:C166437,FURAPREVIR
HP:0000549,Abnormal conjugate eye movement
UPHENO:0079822,decreased role blood level
iuphar.ligand:7881,CP-547632
ncit:C91090,CARBOXYAMIDOTRIAZOLE OROTATE
ncit:C2570,ARGININE BUTYRATE
chembl:CHEMBL5095096,DIMDAZENIL
HGNC:6291,KCNN2
rxcui:10995,URACIL
ncit:C169912,DIMPYLATE
MP:0008770,decreased survivor rate
CL:0000655,secondary oocyte
HGNC:329,AGRN
iuphar.ligand:2547,MARGATOXIN
MGI:1313297,Gpr37
HGNC:6316,KHSRP
rxcui:2584304,ASCIMINIB
rxcui:38668,TRILOSTANE
HGNC:21652,OSTM1
WB:WBGene00004780,ser-7
chembl:CHEMBL2094789,CHEMBL:CHEMBL2094789
GO:0006412,translation
rxcui:2282017,AFLATOXIN B1
ZFIN:ZDB-GENE-030131-5408,vcp
RGD:2290311,SD-Tg(SOD1*G93A)26Dwc
NCBIGene:100684983,LOC100684983
iuphar.ligand:12559,OXOGLAUCINE
HP:0031832,Hypermetric downward saccades
HP:0011951,Aspiration pneumonia
MONDO:0018117,"disorder of phospholipids, sphingolipids and fatty acids biosynthesis"
MONDO:0043267,rheumatoid vasculitis
HP:0000407,Sensorineural hearing impairment
MONDO:0017853,hypersensitivity pneumonitis
MONDO:0009597,"metaphyseal chondrodysplasia, Spahr type"
HP:0000751,Personality changes
HGNC:430,ALOX12B
HGNC:16873,FIG4
HP:0007650,Progressive ophthalmoplegia
MP:0013438,dysmyelination
rxcui:37418,SUMATRIPTAN
drugbank:DB05103,AN-9
drugbank:DB12579,JNJ-37822681
HGNC:3951,FXN
Reactome:R-HSA-500753,Pyrimidine biosynthesis
chembl:CHEMBL1336287,"3,4-DIDESMETHYL-5-DESHYDROXY-3'-ETHOXYSCLEROIN"
drugbank:DB11673,PYRIDOXAMINE
HGNC:19743,POMT2
iuphar.ligand:6439,AZD9272
rxcui:2603494,HEPARAN SULFATE
chembl:CHEMBL354349,EUFLAVINE
drugbank:DB05824,CNS-5161
rxcui:12574,GEMCITABINE
HGNC:14129,EHMT2
iuphar.ligand:193,SB 242084
rxcui:1307404,LINACLOTIDE
rxcui:1483262,SPERMIDINE
ncit:C96776,SURONACRINE MALEATE
WB:WBGene00004259,pyr-1
NCBIGene:416391,NDUFB6
rxcui:22759,DIACETYLRHEIN
iuphar.ligand:7965,ZSTK474
HP:0001010,Hypopigmentation of the skin
chembl:CHEMBL265686,CHEMBL:CHEMBL265686
HGNC:7687,NDUFA4
UBERON:0000941,cranial nerve II
rxcui:35302,SIROLIMUS
iuphar.ligand:11900,5-HYDROXYINDOLEACETIC ACID
CHEBI:8116,phorbol
HP:0000735,Impaired social interactions
GO:0042066,perineurial glial growth
chembl:CHEMBL3545000,MK-2201
drugbank:DB06314,SGX-523
HP:0007811,Horizontal pendular nystagmus
MONDO:0000425,X-linked disease
chembl:CHEMBL1288830,SPINASAPONIN A METHYL ESTER
MONDO:0009560,oculotrichoanal syndrome
HP:0010819,Atonic seizure
HP:5200018,Abnormal movements of the upper extremities
rxcui:30003,MILNACIPRAN HYDROCHLORIDE
iuphar.ligand:5771,ZM 253270
HP:0001436,Abnormality of the foot musculature
rxcui:2634355,APRINOCARSEN
HP:0030212,Collectionism
rxcui:1886,CAFFEINE
iuphar.ligand:5564,CID1172084
ncit:C63662,BETA-SITOSTEROL
HGNC:3555,FABP1
HP:0032325,Lacunar stroke
UBERON:0004533,left testis
ncit:C152189,REMTOLUMAB
ncit:C82676,IRINOTECAN SUCROSOFATE
iuphar.ligand:5412,PGF1&ALPHA;
chembl:CHEMBL544911,IMETIT DIHYDROBROMIDE
chembl:CHEMBL600374,CHEMBL:CHEMBL600374
HP:0011924,Decreased activity of mitochondrial complex III
CL:0000115,endothelial cell
chembl:CHEMBL1534035,CHEMBL:CHEMBL1534035
HGNC:668,RHOB
ncit:C90824,DIFLOMOTECAN
chembl:CHEMBL1275654,CHLORBROMURON
drugbank:DB07841,GERANYLGERANYL DIPHOSPHATE
HGNC:1491,CAPZB
HP:0032668,Myoclonic status epilepticus without coma
chembl:CHEMBL1939691,CHEMBL:CHEMBL1939691
ncit:C148241,AUTOLOGOUS DENDRITIC CELLS TRANSDUCED WITH WILD-TYPE P53 ADENOVIRUS VACCINE
HP:0001998,Neonatal hypoglycemia
drugbank:DB13712,DIXANTHOGEN
ncit:C83791,IMIGLITAZAR
MONDO:0012004,parathyroid gland carcinoma
HGNC:24110,TXNDC9
NCBIGene:403741,HTR1B
chembl:CHEMBL1605837,SIMAZINE
UPHENO:0034329,decreased level of creatinine in urine
rxcui:4134,PROFENAMINE
chembl:CHEMBL344127,CHEMBL:CHEMBL344127
iuphar.ligand:5282,U0126
HGNC:25265,ZCCHC8
chembl:CHEMBL52387,(RS)-ROSCOVITINE
ncit:C169765,ADRIFORANT
chembl:CHEMBL464707,WISTIN
ncit:C152683,TOLIMIDONE
HP:0000622,Blurred vision
MONDO:0100428,progressive bulbar palsy of childhood
HGNC:3040,RCAN1
HP:0002204,Pulmonary embolism
rxcui:3435,IODOQUINOL
rxcui:84857,ANASTROZOLE
ncit:C129448,CETRELIMAB
rxcui:2557200,PLASMINOGEN
HGNC:19960,KIAA0586
hemonc:160,DINACICLIB
drugbank:DB05054,AN0128
HGNC:3721,FKBP5
ncit:C90741,AFACIFENACIN
rxcui:10639,TOLPERISONE
ncit:C91759,ERITORAN TETRASODIUM
iuphar.ligand:566,ZN2+
HGNC:10807,SGCD
chembl:CHEMBL1242101,CHEMBL:CHEMBL1242101
MGI:1919686,Tbcd
MGI:2444631,Bltp1
ncit:C75211,BUNAMIDINE HYDROCHLORIDE
SGD:S000003691,FBP26
MP:0020618,increased dorsal striatum cell number
HP:0002226,White eyebrow
ncit:C170078,IRDABISANT
chembl:CHEMBL602763,CHEMBL:CHEMBL602763
chembl:CHEMBL203135,BERBERRUBINE
MGI:1329014,Stam
MONDO:0016058,paroxysmal dystonia
chembl:CHEMBL1256735,CHEMBL:CHEMBL1256735
MGI:1306797,Aoc3
chembl:CHEMBL1288253,CHEMBL:CHEMBL1288253
MGI:102949,Foxn1
HGNC:10372,RPLP1
iuphar.ligand:9131,PLIXORAFENIB
iuphar.ligand:77,SB 714786
chembl:CHEMBL1312050,CHEMBL:CHEMBL1312050
GO:0097352,autophagosome maturation
rxcui:1302966,CARFILZOMIB
chembl:CHEMBL445177,GINGKOLIC ACID
HGNC:8522,OTX2
ncit:C65840,HALOPEMIDE
HGNC:26089,ZNHIT6
CHEBI:145565,macrolide lactam
HP:0100786,Hypersomnia
MONDO:0021042,glioma
chembl:CHEMBL1721885,SU-014813
rxcui:114289,INDINAVIR
chembl:CHEMBL3545031,MK-1029
MONDO:0010773,mitochondrial myopathy with diabetes
MONDO:0009582,Mietens syndrome
MONDO:0008377,retinitis pigmentosa 1
RGD:2202,Bdnf
ncit:C132252,EZABENLIMAB
drugbank:DB11962,GSK-1059615
HP:0000078,Abnormality of the genital system
ncit:C75216,DITHIAZANINE IODIDE
rxcui:42359,TOCAINIDE
ncit:C2007,BRENTUXIMAB
ncit:C72685,ALAPROCLATE
HGNC:6722,BCAM
HGNC:1622,CCT7
ncit:C166480,NERELIMOMAB
MGI:3513600,Mtmr2<sup>tm1.1Abol</sup>/Mtmr2<sup>tm1.1Abol</sup>  [background:] involves: 129S2/SvPas
ncit:C170034,GRAMICIDIN S
MONDO:0019794,autosomal dominant cerebellar ataxia type IV
chembl:CHEMBL1972216,CHEMBL:CHEMBL1972216
iuphar.ligand:8737,IGN523
ncit:C75228,NOCODAZOLE
FB:FBgn0263979,Caf1-55
rxcui:1855064,CALCIFEDIOL ANHYDROUS
iuphar.ligand:8185,COMPOUND 3 [PMID: 19097791]
iuphar.ligand:5112,2-OLEOYL GLYCEROL
chembl:CHEMBL1094674,CHEMBL:CHEMBL1094674
rxcui:16818,ACITRETIN
ncit:C72620,BIAPENEM
MGI:5644283,Tg(Prnp-lacZ/ATXN10*)#Teas/0  [background:] involves: FVB/N
MGI:5644693,"Meox2<sup>tm1(cre)Sor</sup>/Meox2<sup>+</sup> Tg(CAG-lacZ,-FUS*R521G,-EGFP)682Gyu/0  [background:] involves: 129S4/SvJaeSor * C57BL/6"
HP:0032721,Focal motor seizure with paresis/paralysis
iuphar.ligand:10490,SS-208
drugbank:DB17030,GSK-269962A
HP:0000746,Delusions
rxcui:31565,NEFAZODONE
chembl:CHEMBL1865517,CHEMBL:CHEMBL1865517
HGNC:10588,SCN2A
HP:0000399,Prelingual sensorineural hearing impairment
iuphar.ligand:1245,VUF 5207
rxcui:1442171,BAZEDOXIFENE ACETATE
HGNC:8876,PFKL
HGNC:11101,SMARCA5
ncit:C170091,LANABECESTAT
rxcui:19551,PEMIROLAST
rxcui:10355,TEMAZEPAM
chembl:CHEMBL1939433,CHEMBL:CHEMBL1939433
iuphar.ligand:638,MET-LYS-BRADYKININ
ncit:C80775,NALUZOTAN
ncit:C152954,ZIMELDINE
iuphar.ligand:2214,"D(CH2)5[D-ILE2,ILE4,ALA-NH29]AVP"
drugbank:DB05157,KC706
ncit:C81158,DACINOSTAT
HP:0000455,Broad nasal tip
rxcui:47324,BRAIN-DERIVED NEUROTROPHIC FACTOR
HGNC:237,ADCY6
EMAPA:35214,cerebellum vermis
HGNC:31369,TOMM5
MONDO:0060752,neurodevelopmental disorder with spasticity and poor growth
drugbank:DB15054,TAS-117
HP:0004308,Ventricular arrhythmia
chembl:CHEMBL3545285,XL-999
HGNC:13870,NUDT21
HGNC:8794,PDE8B
drugbank:DB16886,TANSHINONE I
ncit:C95905,INDIMITECAN
HGNC:17579,STARD3
HGNC:1099,BRAP
rxcui:35163,PYRVINIUM
rxcui:2054252,MIGALASTAT
iuphar.ligand:1265,CIPROXIFAN
HGNC:10541,SATB1
ncit:C77018,MOZAVAPTAN
HGNC:367,AKAP1
HGNC:1771,CDK2
HGNC:32222,FAM86B2
chembl:CHEMBL1405979,CHEMBL:CHEMBL1405979
rxcui:83929,ABCIXIMAB
iuphar.ligand:12243,CP-640186
HGNC:1863,CES1
HGNC:11127,SIGLEC1
chembl:CHEMBL1989750,CHEMBL:CHEMBL1989750
MGI:5806112,Foxg1<sup>tm1(cre)Skm</sup>/Foxg1<sup>+</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6J
RGD:1587326,Polr2a
chembl:CHEMBL1546223,CHEMBL:CHEMBL1546223
rxcui:5021,GRISEOFULVIN
chembl:CHEMBL1094675,CHEMBL:CHEMBL1094675
MONDO:0021104,alcoholic fatty liver disease
chembl:CHEMBL1462710,CHEMBL:CHEMBL1462710
rxcui:279645,ALMOTRIPTAN
chembl:CHEMBL118378,CHEMBL:CHEMBL118378
MONDO:0007593,facial spasm
chembl:CHEMBL600769,CHEMBL:CHEMBL600769
rxcui:2346,CHLORAMBUCIL
GO:0007635,chemosensory behavior
rxcui:6902,METHYLPREDNISOLONE
chembl:CHEMBL579640,CHEMBL:CHEMBL579640
iuphar.ligand:8477,AZ20
MONDO:0007920,lymphatic malformation 5
chembl:CHEMBL4650280,ASN007
drugbank:DB07995,H-89
chembl:CHEMBL1329443,CHEMBL:CHEMBL1329443
HGNC:6251,KCNH2
Reactome:R-HSA-1614517,Sulfide oxidation to sulfate
chembl:CHEMBL379975,CHEMBL:CHEMBL379975
HP:0031726,Incyclotropia
HP:0002153,Hyperkalemia
HP:0032729,Focal emotional seizure with pleasure
rxcui:36224,SCARLET RED
chembl:CHEMBL547175,CHEMBL:CHEMBL547175
RGD:1303081,Tyrobp
ncit:C1516,LISOFYLLINE
iuphar.ligand:9398,PHA-408
HGNC:9302,PPP2R1A
MGI:2446089,Flnb
Reactome:R-DME-549127,Organic cation transport
chembl:CHEMBL481049,CITROPTEN
GO:0033617,mitochondrial cytochrome c oxidase assembly
iuphar.ligand:7724,TTA-A2
ncit:C132166,INAVOLISIB
chembl:CHEMBL602408,CHEMBL:CHEMBL602408
HGNC:6569,LGALS8
rxcui:2669905,ZURANOLONE
ncit:C121625,SPARTALIZUMAB
ncit:C2670,MEK INHIBITOR CI-1040
ncit:C76817,TEPOXALIN
ncit:C13008,LYMPHOKINE-ACTIVATED KILLER CELLS
chembl:CHEMBL600778,CHEMBL:CHEMBL600778
HGNC:25156,SGF29
chembl:CHEMBL587923,CHEMBL:CHEMBL587923
rxcui:11124,VANCOMYCIN
chembl:CHEMBL257158,CHEMBL:CHEMBL257158
MGI:2177207,Fxn<sup>tm2Mkn</sup>/Fxn<sup>tm2.1Mkn</sup> Tg(Ckmm-cre)1Lrsn/0  [background:] involves: 129 * C57BL/6J
CL:0002605,astrocyte of the cerebral cortex
iuphar.ligand:4705,SKF89976A
iuphar.ligand:9921,TAFETINIB
HP:0001605,Vocal cord paralysis
iuphar.ligand:1991,[33P]RELAXIN (HUMAN)
iuphar.ligand:6152,IL-27 SUBUNIT &ALPHA;
MONDO:0016562,progressive supranuclear palsy-pure akinesia with gait freezing syndrome
HGNC:9379,PRKAB2
HGNC:14950,PPP1R13B
iuphar.ligand:12334,COMPOUND 25C [PMID: 36649216]
ZFIN:ZDB-GENE-040426-1631,ndufa11
MONDO:0016387,mitochondrial oxidative phosphorylation disorder
ncit:C77066,ROSABULIN
MONDO:0011025,Cayman type cerebellar ataxia
MONDO:0020127,hereditary peripheral neuropathy
HP:0040064,Abnormality of limbs
OBA:2001008,age of onset of osteoarthritis
rxcui:995897,ORBIFLOXACIN
HP:0032836,Neonatal bilateral symmetric myoclonic seizure
MONDO:0019262,juvenile neuronal ceroid lipofuscinosis
HGNC:3151,ECHS1
ncit:C77302,DEBRISOQUIN SULFATE
MONDO:0009856,Peters plus syndrome
MGI:6400710,Htt<sup>tm5Detl</sup>/Htt<sup>+</sup>  [background:] involves: C57BL/6
iuphar.ligand:10354,ELIMUSERTIB
HGNC:18165,STYXL1
rxcui:10582,LEVOTHYROXINE
HP:0001537,Umbilical hernia
chembl:CHEMBL1358137,CHEMBL:CHEMBL1358137
rxcui:1094833,IPILIMUMAB
iuphar.ligand:3513,NNC269100
HGNC:5281,FOXN2
rxcui:6606,MALATHION
MONDO:0007159,arthrogryposis-like hand anomaly-sensorineural deafness syndrome
HGNC:12032,TRAF2
iuphar.ligand:284,OLEAMIDE
MONDO:0020667,Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis
hemonc:499,TIVANTINIB
MGI:88610,Cyp3a13
rxcui:7813,OXYMETHOLONE
MGI:7310312,Akr1c14<sup>tm1.1Penn</sup>/Akr1c14<sup>tm1.1Penn</sup>  [background:] involves: FVB
UBERON:0001235,adrenal cortex
iuphar.ligand:6678,PRE-084
Reactome:R-CFA-390666,Serotonin receptors
rxcui:2104603,EMAPALUMAB-LZSG
GO:0097305,response to alcohol
HGNC:8960,PIGC
UBERON:0009835,anterior cingulate cortex
HP:0000568,Microphthalmia
MONDO:0000414,childhood electroclinical syndrome
chembl:CHEMBL585591,CHEMBL:CHEMBL585591
chembl:CHEMBL4297884,PEPINEMAB
iuphar.ligand:9095,ZOTIRACICLIB
chembl:CHEMBL554190,QUINACRINE DIHYDROCHLORIDE
chembl:CHEMBL2171795,CHEMBL:CHEMBL2171795
chembl:CHEMBL548458,CHEMBL:CHEMBL548458
MP:0000157,abnormal sternum morphology
GO:0071035,nuclear polyadenylation-dependent rRNA catabolic process
MONDO:0006435,submandibular gland adenocarcinoma
MP:0031122,areflexia
rxcui:7804,OXYCODONE
chembl:CHEMBL491636,BELACTOSIN A
chembl:CHEMBL1797711,CHEMBL:CHEMBL1797711
MONDO:0035159,dermoid or epidermoid cyst of the central nervous system
HP:0002007,Frontal bossing
HP:0002627,Right aortic arch with mirror image branching
HP:0031766,Convergence excess esotropia
MGI:4421038,Dmrt3<sup>tm1Hgc</sup>/Dmrt3<sup>tm1Hgc</sup>  [background:] Not Specified
HGNC:1711,ADGRE5
HGNC:7696,NDUFB10
chembl:CHEMBL419296,ZOLANTIDINE
rxcui:2383941,REMIMAZOLAM
ncit:C80797,ETOCRYLENE
HP:0000079,Abnormality of the urinary system
drugbank:DB15124,PF-05241328
rxcui:203168,AMITRIPTYLINE HYDROCHLORIDE
HGNC:7758,NEU1
ncit:C81409,OXETHAZAINE
iuphar.ligand:12338,RMC-5552
CHEBI:68508,diethyl maleate
iuphar.ligand:4996,IL-4
MONDO:0013558,Hermansky-Pudlak syndrome 6
HGNC:28739,ETFBKMT
ncit:C29883,ARSANILIC ACID
MONDO:0850282,chronic asthma
chembl:CHEMBL1232132,DIBROMOTYROSINE
GO:1904151,positive regulation of microglial cell mediated cytotoxicity
MGI:102966,Ptgdr
iuphar.ligand:5525,O-1602
MONDO:0018306,Griscelli syndrome
HP:0032653,Elevated lactate:pyruvate ratio
ncit:C1742,ANGIOGENESIS INHIBITOR
chembl:CHEMBL579315,CHEMBL:CHEMBL579315
HGNC:11100,SMARCA4
iuphar.ligand:10343,GSK8612
MGI:3832875,bpck/bpck  [background:] B6C3Fe a/a-bpck/J
HGNC:11117,SMN1
MGI:5526018,Abcb4<sup>tm1Bor</sup>/Abcb4<sup>tm1Bor</sup>  [background:] C.129P2-Abcb4<sup>tm1Bor</sup>
CHEBI:57865,uridine 5'-monophosphate(2-)
iuphar.ligand:1249,IMBUTAMINE
iuphar.ligand:8553,COMPOUND 15C [PMID: 21536437]
ncit:C170052,IGMESINE
ncit:C170018,GALICAFTOR
iuphar.ligand:8354,HESPERADIN
HGNC:25839,GRHL3
MGI:97610,Plat
HGNC:21406,RARS2
iuphar.ligand:4449,PTH-(1-34) (RAT)
MONDO:0013217,Diamond-Blackfan anemia 10
MONDO:0012400,cortical dysplasia-focal epilepsy syndrome
CHEBI:17650,cortisol
RGD:155631259,Taiep
iuphar.ligand:10709,WF-47-JS03
HGNC:4839,HCFC1
chembl:CHEMBL64391,ITRACONAZOLE
chembl:CHEMBL1431115,CHEMBL:CHEMBL1431115
rxcui:712566,OFATUMUMAB
HGNC:7461,MT-ND5
chembl:CHEMBL587449,CHEMBL:CHEMBL587449
EMAPA:35225,cerebellum vermis lobule I
HP:0002542,Olivopontocerebellar atrophy
HP:0001083,Ectopia lentis
rxcui:2633005,LENIOLISIB
ncit:C152411,SOVAPREVIR
HGNC:28497,TMEM151A
chembl:CHEMBL353764,CHEMBL:CHEMBL353764
MONDO:0010585,X-linked hypohidrotic ectodermal dysplasia
HP:0100659,Abnormal cerebral vascular morphology
ncit:C76441,OCAPERIDONE
iuphar.ligand:8067,NVP-AEW541
chembl:CHEMBL1223743,7-O-METHYLCRYPTOCHINONE B
chembl:CHEMBL22373,CL-976
chembl:CHEMBL309917,CHEMBL:CHEMBL309917
HP:0000764,Peripheral axonal degeneration
iuphar.ligand:8119,COMPOUND 35 [PMID: 22902653]
iuphar.ligand:21,LY344864
iuphar.ligand:10702,COMPOUND 15A [PMID: 32069401]
Xenbase:XB-GENE-5953697,scaper
GO:0042065,glial cell growth
MGI:1098221,Gamt
rxcui:1603349,PANOBINOSTAT LACTATE
iuphar.ligand:11436,[125I]HPP-HOE140
ncit:C80867,CEDIRANIB
rxcui:60207,DORZOLAMIDE
rxcui:1368173,NARINGENIN
Reactome:R-HSA-9725370,Signaling by ALK fusions and activated point mutants
rxcui:221130,OCTREOTIDE ACETATE
CHEBI:70773,capsazepine
iuphar.ligand:4313,SULFONAMIDE-01
rxcui:3327,DIAZOXIDE
MONDO:0009727,atelosteogenesis type II
chembl:CHEMBL532143,CHEMBL:CHEMBL532143
rxcui:30257,MOXONIDINE
iuphar.ligand:9109,LY3022855
MGI:3046796,Tbx1<sup>tm2Bld</sup>/Tbx1<sup>tm2Bld</sup>  [background:] involves: 129S7/SvEvBrd * C57BL/6
chembl:CHEMBL602206,CHEMBL:CHEMBL602206
ncit:C118674,TRASTUZUMAB DUOCARMAZINE
chembl:CHEMBL1385558,CHEMBL:CHEMBL1385558
HGNC:4393,GNAT1
chembl:CHEMBL468759,PENTACHLORONITROBENZENE
HP:0002451,Limb dystonia
rxcui:1300701,LORCASERIN
rxcui:1491625,METRELEPTIN
iuphar.ligand:8117,COMPOUND 31 [PMID: 22902653]
HGNC:3690,FGFR3
chembl:CHEMBL601492,CHEMBL:CHEMBL601492
HP:0025066,Decreased mean corpuscular volume
rxcui:2118525,TRICLABENDAZOLE
chembl:CHEMBL1329029,TETROQUINONE
iuphar.ligand:7850,SSR128129E
HP:0025233,Sleep paralysis
chembl:CHEMBL245030,SR-13668
ncit:C152249,RONOPTERIN
chembl:CHEMBL522983,CHEMBL:CHEMBL522983
iuphar.ligand:3492,BMS COMPOUND 87B
HGNC:14490,MRPL36
ncit:C152963,ZONAMPANEL
iuphar.ligand:2831,CHLORDANE
ncit:C1805,ARZOXIFENE
HP:0012241,Levator palpebrae superioris atrophy
HGNC:13744,HERPUD1
chembl:CHEMBL1236924,INT131
HGNC:1442,CALM1
iuphar.ligand:12464,THEAFLAVIN
HP:0002141,Gait imbalance
HGNC:560,AP1S2
rxcui:5321,HEXYLRESORCINOL
HP:0030190,Oral motor hypotonia
HP:0001844,Abnormal hallux morphology
ncit:C81434,PIRMENOL
MGI:6314805,Cfh<sup>tm1.1Song</sup>/Cfh<sup>tm1.1Song</sup>  [background:] involves: C57BL/6
chembl:CHEMBL528373,CHEMBL:CHEMBL528373
MGI:94925,Drd3
MONDO:0014593,"developmental and epileptic encephalopathy, 29"
rxcui:784,ANDROSTENEDIONE
rxcui:1422,BENZPHETAMINE
HP:0002134,Abnormal basal ganglia morphology
CHEBI:17790,methanol
HGNC:6400,KPNB1
iuphar.ligand:8693,GSK9772
HGNC:1932,CHI3L1
FB:FBgn0051851,Naa20B
rxcui:103468,HYDROCORTISONE BUTYRATE
rxcui:31945,NONIVAMIDE
FB:FBgn0283658,muc
ncit:C143162,ONVANSERTIB
ncit:C77886,ANTI-CD30 MONOCLONAL ANTIBODY MDX-1401
iuphar.ligand:7028,AMI-1
HP:0012651,Abasia
MGI:2685397,Rc3h1
GO:0031149,sorocarp stalk cell differentiation
MONDO:0005157,lymphoid neoplasm
rxcui:18600,AZATADINE
iuphar.ligand:12806,"COMPOUND 9 [LIN ET AL., 2023]"
HP:0032860,Generalized non-convulsive status epilepticus without coma
drugbank:DB06548,MINODRONIC ACID
UBERON:0004070,cerebellum vermis lobule
ncit:C74385,INDIPLON
ncit:C137818,ANDROGEN RECEPTOR ANTAGONIST TAS3681
HGNC:28913,HSCB
chembl:CHEMBL3545195,LY-3009120
MGI:104328,Rhbdf1
UBERON:0002661,superior frontal gyrus
HP:0002062,Morphological abnormality of the pyramidal tract
MGI:3037942,Trf<sup>hpx</sup>/Trf<sup>hpx</sup>  [background:] BALB/cJ-Trf<sup>hpx</sup>
rxcui:53694,NIMESULIDE
NCBIGene:280976,ACO2
HGNC:2714,DCX
MGI:4361717,Tg(Prnp-TARDBP*A315T)95Balo/0  [background:] involves: C57BL/6 * CBA
chembl:CHEMBL4297934,DIAPEP-277
iuphar.ligand:10151,NEOLYMPHOSTIN A
HP:0004349,Reduced bone mineral density
HP:0200147,Neuronal loss in basal ganglia
MGI:105084,Satb1
HGNC:6083,INSIG1
chembl:CHEMBL164841,TECHTOCHRYSIN
CHEBI:8081,phentolamine
MGI:5300032,Sptbn2<sup>Gt(XK442)Byg</sup>/Sptbn2<sup>Gt(XK442)Byg</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6J
rxcui:2393,CHLOROQUINE
HP:0005469,Flat occiput
chembl:CHEMBL582439,ZAMPANOLIDE
chembl:CHEMBL1232076,CHEMBL:CHEMBL1232076
chembl:CHEMBL1491809,PIMPINELLIN
RGD:621255,Ago2
drugbank:DB16244,MK-0773
CLINVAR:1342669,NM_001040142.2(SCN2A):c.1108T>C (p.Phe370Leu)
MONDO:0021001,hemochromatosis type 1
HGNC:19963,TTLL5
ncit:C1420,PHOTOSENSITIZING AGENT
ncit:C119617,SURATADENOTUREV
ncit:C81115,SEMAGACESTAT
ncit:C80807,AMCINAFIDE
ncit:C169852,CINPANEMAB
chembl:CHEMBL3707401,MK-8777
iuphar.ligand:4145,BENZAMIL
GO:0035197,siRNA binding
iuphar.ligand:765,[125I]CCL7 (HUMAN)
MGI:1923690,Slc30a9
HGNC:5005,HMGCL
HGNC:9381,PRKACB
iuphar.ligand:10105,DDR1/2 INHIBITOR 5N
ncit:C1196,PIMONIDAZOLE
MGI:4410605,Prnp<sup>tm1Cwe</sup>/Prnp<sup>tm1Cwe</sup> Tg(Prnp-tTA)F959Sbp/Tg(Prnp-tTA)F959Sbp Tg(tetO-ATXN3)2904Olri/Tg(tetO-ATXN3)2904Olri  [background:] involves: 129S7/SvEvBrd * C57BL/6 * FVB
HGNC:24283,KMT5B
HGNC:13830,CNTNAP2
GO:0048666,neuron development
HGNC:11506,SYP
rxcui:1746906,OBILTOXAXIMAB
HGNC:8853,PEX11B
UPHENO:0034148,decreased level of creatine in urine
ncit:C82294,ZOTAROLIMUS
drugbank:DB11948,LAPACHONE
rxcui:1940635,GLECAPREVIR
HGNC:1321,TIMMDC1
iuphar.ligand:11353,BERBERINE
HGNC:30595,PPP1R21
UPHENO:0084155,abnormally dilated fourth ventricle
iuphar.ligand:480,A61603
RGD:2690,Gja1
UPHENO:0088320,abnormally decreased number of pyramidal neuron in the Ammon's horn
ncit:C171889,FLURPIRIDAZ F-18
rxcui:1546032,HEXYLCAINE HYDROCHLORIDE
iuphar.ligand:2500,4&ALPHA;-PDD
iuphar.ligand:7647,BMS-599626
chembl:CHEMBL586937,CHEMBL:CHEMBL586937
rxcui:27169,LEFLUNOMIDE
chembl:CHEMBL2028068,CHEMBL:CHEMBL2028068
iuphar.ligand:11611,CGP-37157
chembl:CHEMBL101168,CHEMBL:CHEMBL101168
GO:0051603,proteolysis involved in protein catabolic process
MGI:5317923,Pla2g6<sup>m1J</sup>/Pla2g6<sup>m1J</sup>  [background:] C3H/HeJ-Pla2g6<sup>m1J</sup>
MONDO:0020102,hereditary stomatocytosis
HGNC:8907,PGM3
HP:0007166,Paroxysmal dyskinesia
GO:0071038,TRAMP-dependent tRNA surveillance pathway
chembl:CHEMBL1503729,CHEMBL:CHEMBL1503729
rxcui:8629,PRAZOSIN
ncit:C38711,SELECTIVE ESTROGEN RECEPTOR MODULATOR CC-8490
ncit:C76401,RILAPLADIB
HP:0031358,Vegetative state
HGNC:9559,PSMD2
chembl:CHEMBL1277315,CHEMBL:CHEMBL1277315
rxcui:2667741,FISETIN
rxcui:119565,TOLTERODINE
ncit:C66165,MITONAFIDE
MGI:103032,Scg3
MONDO:0044997,midbrain disorder
MONDO:0009669,"spinal muscular atrophy, type 1"
Reactome:R-RNO-211945,Phase I - Functionalization of compounds
iuphar.ligand:1571,JMV457
HGNC:24276,SAMM50
HGNC:1065,BLZF1
chembl:CHEMBL411317,RICCARDI C
HGNC:11584,TBK1
rxcui:2377031,LEVAMLODIPINE MALEATE
chembl:CHEMBL1337502,BENZO[B]FLUORANTHENE
chembl:CHEMBL578504,CHEMBL:CHEMBL578504
ncit:C176964,MYELOID CELL LEUKEMIA 1 INHIBITOR PRT1419
HP:0100021,Cerebral palsy
ZFIN:ZDB-GENE-030131-5735,traf6
HP:0008211,Parathyroid agenesis
HP:0010920,Zonular cataract
iuphar.ligand:9931,COMPOUND 7C [PMID: 22041175]
rxcui:24441,ETIFOXINE
chembl:CHEMBL1892429,FLUORODIFEN
HGNC:10519,SACS
HGNC:23571,COBLL1
iuphar.ligand:4339,URB597
drugbank:DB17277,CBP-501
CHEBI:18248,iron atom
HGNC:22407,TMEM106B
MGI:5516453,Tg(Prnp-ATXN3*70Q)70.61Olri/0  [background:] involves: C57BL/6N
iuphar.ligand:8235,(R)-PFI-2
HGNC:2908,DLL1
HGNC:11621,HNF1A
drugbank:DB05739,CYT006-ANGQB
iuphar.ligand:9162,COMPOUND C10 [PMID: 24297249]
MGI:101920,Ap2a2
iuphar.ligand:3197,COMPOUND 47 [PMID: 18800762]
rxcui:2174385,COLCHICEINE
iuphar.ligand:4270,NPPB
HP:0002069,Bilateral tonic-clonic seizure
MONDO:0015990,"focal, segmental or multifocal dystonia"
ncit:C92572,HSP90 INHIBITOR DEBIO 0932
rxcui:1525,BEZAFIBRATE
rxcui:625,AMBROXOL
chembl:CHEMBL19954,CHEMBL:CHEMBL19954
chembl:CHEMBL555196,SILVESTROL
MP:0008259,abnormal optic disk morphology
drugbank:DB06134,SNS-314
HP:0003076,Glycosuria
iuphar.ligand:8833,COMPOUND 9 [PMID: 11606127]
CHEBI:64355,posaconazole
rxcui:19777,BROMPERIDOL
drugbank:DB14876,TAS-116
GO:0008503,benzodiazepine receptor activity
ncit:C75214,CRUFOMATE
ncit:C125548,EMACTUZUMAB
ncit:C116872,OSUGACESTAT
MGI:97769,Prnp
MGI:3698040,Htt<sup>tm4Mem</sup>/Htt<sup>+</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * CD-1
HP:0001660,Truncus arteriosus
iuphar.ligand:8884,COMPOUND 21 [PMID: 23981033]
chembl:CHEMBL1877460,NAPROPAMIDE
CHEBI:16709,pyridoxine
HP:0032670,Tonic status epilepticus
chembl:CHEMBL442906,CHEMBL:CHEMBL442906
ncit:C2079,CARDIOPROTECTIVE AGENT
ncit:C163587,AZINPHOS-ETHYL
chembl:CHEMBL1201438,ALDESLEUKIN
chembl:CHEMBL1308677,CHEMBL:CHEMBL1308677
HGNC:1497,CASK
chembl:CHEMBL2109529,MU-BC-1
HGNC:2551,CUL1
chembl:CHEMBL581251,CHEMBL:CHEMBL581251
chembl:CHEMBL2103858,NARONAPRIDE
HP:0003546,Exercise intolerance
chembl:CHEMBL2109395,ZATUXIMAB
MGI:3055190,Pla2g6<sup>tm1Turk</sup>/Pla2g6<sup>tm1Turk</sup>  [background:] involves: 129X1/SvJ
ncit:C389,ORAL CONTRACEPTIVE
HP:5200230,Maladaptive fear-related cognitions
rxcui:40048,CARBOPLATIN
iuphar.ligand:2741,ALL-TRANS-4-OXO-RETINOIC ACID
HP:0001949,Hypokalemic alkalosis
rxcui:20217,CARBETAPENTANE
HP:0025104,Capillary malformation
HGNC:26703,SYNE4
chembl:CHEMBL211405,CHEMBL:CHEMBL211405
ncit:C1610,LURTOTECAN
HGNC:3006,DPM2
chembl:CHEMBL2333547,ARISTOLACTONE
MGI:88059,App
HP:0011772,Abnormal thyroid morphology
ncit:C80055,HTERT VACCINE V934/V935
CHEBI:27732,caffeine
MONDO:0044907,metastatic squamous cell carcinoma
HP:0030187,Titubation
UBERON:0000178,blood
CL:0000737,striated muscle cell
iuphar.ligand:8166,COMPOUND 72 [WO2013026806]
iuphar.ligand:776,CCL26
GO:0046928,regulation of neurotransmitter secretion
chembl:CHEMBL1256484,CHEMBL:CHEMBL1256484
iuphar.ligand:9702,TUBASTATIN A
HGNC:30384,NENF
HP:0001138,Optic neuropathy
GO:0006086,acetyl-CoA biosynthetic process from pyruvate
drugbank:DB12675,PF-04995274
iuphar.ligand:3,1-NAPHTHYLPIPERAZINE
rxcui:591781,ECULIZUMAB
HGNC:6881,MAPK8
iuphar.ligand:12375,ADRIXETINIB
HP:0002304,Akinesia
HP:0030454,Abnormal electrooculogram
HGNC:25570,DNAJC11
rxcui:8134,PHENOBARBITAL
rxcui:18330,ARSENIC TRIOXIDE
HGNC:9440,THAP12
HP:0001332,Dystonia
iuphar.ligand:4299,RO4938581
chembl:CHEMBL23731,AMIDATE
HP:0011443,Abnormality of coordination
chembl:CHEMBL1385840,ERGOCORNINE
RGD:1566014,F8a1
chembl:CHEMBL4650297,HMPL-453
chembl:CHEMBL243596,IMINOSTILBENE
MGI:3772885,Tg(Prnp-TBP*)105Xjl/0  [background:] FVB/N-Tg(Prnp-TBP*)105Xjl
rxcui:21877,CYAMEMAZINE
chembl:CHEMBL1979636,"FUCHSIN, BASIC"
chembl:CHEMBL404954,CHEMBL:CHEMBL404954
iuphar.ligand:12313,COMPOUND 29 [PMID: 36356320]
rxcui:19041,BENZQUINAMIDE
rxcui:24347,ERYTHROMYCIN LACTOBIONATE
HGNC:10857,SIAH1
ncit:C69076,RINDOPEPIMUT
HP:0012852,Hepatic bridging fibrosis
rxcui:2670179,FRUQUINTINIB
iuphar.ligand:10062,ABX-1431
chembl:CHEMBL1568699,CHLOROXURON
rxcui:2955,CURCUMIN
chembl:CHEMBL1466186,CHEMBL:CHEMBL1466186
HGNC:16695,BCAP31
GO:0001514,selenocysteine incorporation
rxcui:1994358,TRICETIN
ncit:C1606,LABRADIMIL
ncit:C177068,CLESACOSTAT
HGNC:1943,CHN1
GO:0070837,dehydroascorbic acid transport
CL:0011005,GABAergic interneuron
HGNC:14935,SIRT7
iuphar.ligand:8179,PF-03715455
MGI:1343094,Kat2b
HGNC:3005,DPM1
OBA:2040166,age of onset of depressive disorder
ncit:C152924,XALIPRODEN
chembl:CHEMBL1256910,TREQUINSIN HYDROCHLORIDE
chembl:CHEMBL472437,KAMEBANIN
chembl:CHEMBL574737,UCN-01
chembl:CHEMBL4594539,TRENIBOTULINUMTOXINE
rxcui:91065,BROMODIPHENHYDRAMINE HYDROCHLORIDE
iuphar.ligand:11526,SARUPARIB
ncit:C171660,FELEZONEXOR
chembl:CHEMBL354676,DIPHENYLUREA
ncit:C39619,DNA VACCINE
HGNC:2631,CYP2E1
GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator
MGI:102812,Lmo1
MGI:3770676,Ngfr<sup>tm1Jae</sup>/Ngfr<sup>tm1Jae</sup> Ntf3<sup>tm1Jae</sup>/Ntf3<sup>+</sup>  [background:] involves: 129S4/SvJae * BALB/c
HP:0002506,Diffuse cerebral atrophy
chembl:CHEMBL1518159,3-METHOXYCATECHOL
iuphar.ligand:4998,IL-6
UBERON:0002810,right frontal lobe
HP:0041051,Ageusia
drugbank:DB12541,SAR-405838
rxcui:1425426,CHOLINE CHLORIDE
iuphar.ligand:10224,CASOXIN C
HP:0002104,Apnea
MONDO:0008979,"chorea, benign familial"
HGNC:26038,TMEM127
SGD:S000004337,YLR345W
RGD:619859,Dlat
ncit:C1825,U-0126
iuphar.ligand:3742,TFLLR-NH2
CLINVAR:125980,NC_000013.11:g.32316497_32316498insT
rxcui:31476,NAFTIFINE
chembl:CHEMBL522782,PROCHLORAZ
iuphar.ligand:8705,TM38837
NBO:0001786,regulation of behavior
iuphar.ligand:8608,ABL127
HP:0008640,Congenital macroorchidism
chembl:CHEMBL15137,MICHLER'S KETONE
rxcui:14448,3-IODOBENZYLGUANIDINE
chembl:CHEMBL60796,DESMETHEYLASTEMIZOLE
iuphar.ligand:6077,A68930
HGNC:25573,KLHDC8A
MONDO:0060502,"neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies"
iuphar.ligand:4173,DCDPC
chembl:CHEMBL1782605,CONICASTEROL D
iuphar.ligand:3268,[11C]BUTYLTHIO-TZTP
MONDO:0011710,specific language impairment 1
chembl:CHEMBL318782,DICHLON
ncit:C90581,AKT INHIBITOR MK2206
GO:0004114,"3',5'-cyclic-nucleotide phosphodiesterase activity"
rxcui:8687,PRIMAQUINE
MGI:108476,Fzd3
HP:0008020,Cone dystrophy
HP:0012427,Increased femoral anteversion
MGI:88296,Cacna1b
MONDO:0010660,"intellectual disability, X-linked 9"
HP:0000646,Amblyopia
ncit:C2543,TOSITUMOMAB
EMAPA:32815,peripheral nerve
rxcui:3477,DINOPROST
ncit:C184934,IDREVLORIDE
MONDO:0024770,"autoinflammatory syndrome, familial, X-linked, Behcet-like 2"
UPHENO:0005518,decreased sensory perception of sound
iuphar.ligand:9521,GSK8814
CL:0000118,basket cell
rxcui:733003,PLERIXAFOR
HP:0011960,Substantia nigra gliosis
WB:WBGene00006742,unc-2
chembl:CHEMBL478960,MACLURAXANTHONE
ncit:C2155,TYROSINE HYDROXYLASE INHIBITOR
HGNC:31708,LRP12
chembl:CHEMBL591641,CHEMBL:CHEMBL591641
chembl:CHEMBL2108341,SONTUZUMAB
HGNC:12585,UQCRC1
iuphar.ligand:2047,"L-363,301"
iuphar.ligand:6450,COMPOUND 10 [PMID: 15482906]
HP:0032913,Focal aware pedal automatism seizure
FB:FBgn0038737,Mrm2
iuphar.ligand:11150,GSK1795091
HGNC:28727,APOO
MONDO:0033542,immunodeficiency 70
iuphar.ligand:6020,PDGF RECEPTOR TYROSINE KINASE INHIBITOR IV
rxcui:20881,CHLORPHENOXAMINE
chembl:CHEMBL308688,"5,7-DIMETHOXYISOFLAVONE"
MP:0010061,increased creatine level
HGNC:8127,OGT
chembl:CHEMBL570408,"1,4-DIMETHOXYANTHRAQUINONE"
HGNC:4661,GTF2IRD1
drugbank:DB02116,OLOMOUCINE
HP:0002063,Rigidity
rxcui:2626143,LECANEMAB
HP:0032750,Focal impaired awareness emotional seizure with laughing
chembl:CHEMBL576362,CHEMBL:CHEMBL576362
ncit:C48401,RETASPIMYCIN HYDROCHLORIDE
HP:0025169,Left ventricular systolic dysfunction
CHEBI:168396,mycophenolic acid
iuphar.ligand:10420,CHMFL-KIT-64
HP:0002090,Pneumonia
HGNC:1397,CACNA1S
HP:0002463,Language impairment
rxcui:342369,LENALIDOMIDE
HP:0000605,Supranuclear gaze palsy
rxcui:3444,DIMENHYDRINATE
ncit:C190488,CETUXIMAB SAROTALOCAN
HP:0030219,Semantic dementia
rxcui:18469,SPARFLOXACIN
HP:0032701,Focal cognitive seizure with anomia
FB:FBgn0033883,Mecr
HGNC:5253,HSP90AA1
iuphar.ligand:2619,BATRACHOTOXIN
UPHENO:0076708,abnormal caudate nucleus morphology
HP:0012649,Increased inflammatory response
HGNC:11802,TIA1
iuphar.ligand:11610,HONOKIOL
rxcui:19257,BETHANECHOL
HGNC:11071,SLC9A1
iuphar.ligand:2184,D[D-PAL2]AVP
HP:0000572,Visual loss
ncit:C132992,SINTILIMAB
chembl:CHEMBL79513,CHEMBL:CHEMBL79513
HGNC:391,AKT1
MGI:1277215,Bbs1
UBERON:0003027,cingulate cortex
iuphar.ligand:7936,PF-04691502
GO:1902645,tertiary alcohol biosynthetic process
iuphar.ligand:4148,CACA
chembl:CHEMBL85139,RUTAECARPINE
HP:0002119,Ventriculomegaly
iuphar.ligand:1994,RELAXIN
chembl:CHEMBL584458,CHEMBL:CHEMBL584458
iuphar.ligand:161,BW723C86
HGNC:10601,SCNN1D
rxcui:135091,MOSAPRIDE
HGNC:6242,KCNE2
HP:0002080,Intention tremor
iuphar.ligand:7360,AZD1283
HGNC:11131,SNAP23
iuphar.ligand:1714,ATP&GAMMA;S
MONDO:0043510,brain injury
MONDO:0043544,nosocomial infection
MONDO:0008119,spinocerebellar ataxia type 1
HP:0000277,Abnormal mandible morphology
ncit:C699,NITROSOUREA COMPOUND
rxcui:61686,CLOSTEBOL
rxcui:9899,SODIUM OXYBATE
MONDO:0000914,"cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1"
rxcui:10772,TRICHLORMETHIAZIDE
HGNC:10847,FBXW4
CLINVAR:38260,NM_000059.4(BRCA2):c.9699_9702del (p.Cys3233fs)
CHEBI:16436,CDP-choline
MONDO:0021698,alcohol-related disorders
MONDO:0021187,hyperlipidemia
CA2586970245,NM_001165963.4:c.5511del
ncit:C152955,ZIMELDINE HYDROCHLORIDE
HP:0003577,Congenital onset
ncit:C1288,RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
iuphar.ligand:2121,YM44781
ncit:C166619,BASIMGLURANT
ncit:C994,ALANOSINE
ncit:C77884,TLR AGONIST CADI-05
chembl:CHEMBL586029,CHEMBL:CHEMBL586029
ncit:C96757,ONERCEPT
rxcui:38085,THIOCOLCHICOSIDE
chembl:CHEMBL10835,CHEMBL:CHEMBL10835
drugbank:DB11870,RG-4733
rxcui:21949,CYCLOBENZAPRINE
HGNC:29094,CLUH
chembl:CHEMBL1498652,CHEMBL:CHEMBL1498652
CHEBI:18946,delta-lactone
ncit:C29072,GINKGO
chembl:CHEMBL84685,CHEMBL:CHEMBL84685
rxcui:94,5-HYDROXYTRYPTOPHAN
ncit:C80010,THIOPROPERAZINE MESYLATE
ncit:C1237,STAUROSPORINE
CHEBI:43968,meropenem
chembl:CHEMBL1092508,CHEMBL:CHEMBL1092508
MONDO:0008724,"adducted thumbs-arthrogryposis syndrome, Christian type"
MONDO:0015161,multiple congenital anomalies/dysmorphic syndrome without intellectual disability
HGNC:16776,KRTAP4-12
rxcui:2472186,HEPTANE
MP:0008948,decreased neuron number
chembl:CHEMBL534288,CHEMBL:CHEMBL534288
HP:0100738,Abnormal eating behavior
MGI:5432178,Gt(ROSA)26Sor<sup>tm50(HTT)Arte</sup>/Gt(ROSA)26Sor<sup>+</sup>  [background:] Not Specified
CHEBI:48132,tetracenomycin
rxcui:1425098,TRAMETINIB DIMETHYL SULFOXIDE
chembl:CHEMBL592044,CHEMBL:CHEMBL592044
rxcui:42545,CHLORTETRACYCLINE HYDROCHLORIDE
ncit:C270,ANTIHYPERTENSIVE AGENT
HGNC:23357,MCTS1
MONDO:0012247,spinocerebellar ataxia type 27
MONDO:0008199,late-onset Parkinson disease
HP:0033690,Retrograde memory impairment
HP:0002352,Leukoencephalopathy
ncit:C152880,VINBURNINE
HGNC:19706,ADAMTSL4
HP:0007270,Atypical absence seizure
MONDO:0008811,XK aprosencephaly
GO:0048471,perinuclear region of cytoplasm
HP:0010677,Enuresis nocturna
Reactome:R-MMU-390651,Dopamine receptors
rxcui:1368153,CINNAMIC ALDEHYDE
chembl:CHEMBL153505,CHEMBL:CHEMBL153505
HGNC:11905,TNFRSF10B
chembl:CHEMBL201325,CHEMBL:CHEMBL201325
chembl:CHEMBL564009,CHEMBL:CHEMBL564009
rxcui:10735,TRAPIDIL
chembl:CHEMBL1094408,NMS-1286937
GO:0000956,nuclear-transcribed mRNA catabolic process
rxcui:6135,KETOCONAZOLE
chembl:CHEMBL3545134,LY-2780301
rxcui:24852,FENOFIBRIC ACID
chembl:CHEMBL1482446,DEOXYSAPPANONE B TRIMETHYL ETHER
UBERON:0002106,spleen
HGNC:2092,CLTC
rxcui:2592,CLOFAZIMINE
rxcui:5880,INTERFERON ALFA-2B
MGI:1333776,Ahrr
ncit:C148511,NANOPARTICLE SN-38-ENCAPSULATED MICELLE FORMULATION IT-141
MONDO:0014248,autism spectrum disorder - epilepsy - arthrogryposis syndrome
HGNC:3468,ESR2
MONDO:0032594,intellectual developmental disorder and retinitis pigmentosa; IDDRP
MONDO:0009611,3-methylglutaconic aciduria type 4
drugbank:DB16844,BMS-833923
iuphar.ligand:11382,LUNACALCIPOL
drugbank:DB17042,PD-98059
iuphar.ligand:1757,BZATP
rxcui:10318,TACRINE
iuphar.ligand:2574,JINGZHAOTOXIN-III
chembl:CHEMBL268584,CHEMBL:CHEMBL268584
rxcui:8331,PIMOZIDE
ncit:C466,EMODIN
chembl:CHEMBL1256796,CHEMBL:CHEMBL1256796
iuphar.ligand:2175,"[3H]AVP (HUMAN, MOUSE, RAT)"
iuphar.ligand:9361,WYE-354
MONDO:0009644,sulfite oxidase deficiency due to molybdenum cofactor deficiency type B
HGNC:7712,NDUFS5
HGNC:30207,ARHGAP29
HP:0010307,Stridor
rxcui:134527,NELFINAVIR
MONDO:0014144,autosomal recessive limb-girdle muscular dystrophy type R18
SGD:S000006335,NAT3
ncit:C269,CELL SURFACE ANTIGEN
iuphar.ligand:3192,COMPOUND 12  [PMID: 12014956]
NCBIGene:488824,DRD5
rxcui:1546021,CEFIXIME ANHYDROUS
ncit:C116066,SULFATINIB
iuphar.ligand:4090,[3H]MUSCIMOL
chembl:CHEMBL74852,CHEMBL:CHEMBL74852
HP:0000577,Exotropia
ncit:C804,RETINOIC ACID AGENT
chembl:CHEMBL460293,CHEMBL:CHEMBL460293
chembl:CHEMBL398765,CHEMBL:CHEMBL398765
CHEBI:58297,glutathione disulfide(2-)
chembl:CHEMBL4303309,CX-5461
HP:0003774,Stage 5 chronic kidney disease
HGNC:11634,TCF4
HGNC:4693,GUK1
HGNC:3942,MTOR
RGD:1559047,SHRSP/Ezo
CHEBI:7852,oxycodone
iuphar.ligand:7358,E2012
iuphar.ligand:9746,NDT9513727
chembl:CHEMBL2170582,R-343
HGNC:15848,SEPTIN6
MONDO:0018908,non-Hodgkin lymphoma
drugbank:DB05565,PBT-1033
rxcui:1314409,DL-LACTIC ACID
HP:0001177,Preaxial hand polydactyly
ZFIN:ZDB-GENE-110218-1,tdp2a
rxcui:11645,DEFERIPRONE
rxcui:59839,PENCICLOVIR
rxcui:5084,HALCINONIDE
CHEBI:64618,phosphagen
HGNC:3606,FBP1
chembl:CHEMBL68810,THUNBERGINOL A
HGNC:19902,RRAGC
MGI:2662503,Cdkn1b<sup>tm1Mlf</sup>/Cdkn1b<sup>tm1Mlf</sup> Cdkn2d<sup>tm1Maro</sup>/Cdkn2d<sup>tm1Maro</sup>  [background:] involves: 129X1/SvJ * C57BL/6
HP:0000664,Synophrys
rxcui:1543543,BELINOSTAT
HP:0001308,Tongue fasciculations
MONDO:0010587,"epidermodysplasia verruciformis, X-linked"
HP:0008734,Decreased testicular size
MONDO:0033619,"myopathy, epilepsy, and progressive cerebral atrophy"
rxcui:8794,PROPYLTHIOURACIL
iuphar.ligand:5984,HERBIMYCIN A
iuphar.ligand:7973,XL388
HGNC:28358,D2HGDH
HP:0006919,"Abnormal aggressive, impulsive or violent behavior"
chembl:CHEMBL1762593,CHEMBL:CHEMBL1762593
HP:0025373,Interictal EEG abnormality
rxcui:91130,TRIFLUOPERAZINE HYDROCHLORIDE
HP:0000848,Increased circulating renin level
HGNC:7095,MID1
HGNC:2934,DMRT1
chembl:CHEMBL258316,CHEMBL:CHEMBL258316
chembl:CHEMBL586195,CHEMBL:CHEMBL586195
iuphar.ligand:11151,GSK2881078
ncit:C1902,RAS INHIBITOR
HGNC:7658,NCBP1
ncit:C174853,TAVAPADON
HGNC:20982,SMYD2
CHEBI:60761,floxuridine
iuphar.ligand:8671,ANTAQ
rxcui:2002,CARBAMAZEPINE
rxcui:1737,BRETYLIUM TOSYLATE
iuphar.ligand:11159,COMPOUND 3 [PMID: 32636746]
rxcui:59743,QUINETHAZONE
HGNC:21709,TMUB1
iuphar.ligand:5930,AURORA KINASE INHIBITOR II
rxcui:9907,SODIUM SALICYLATE
CL:1001571,hippocampal pyramidal neuron
HGNC:613,APOE
NCBIGene:415752,UQCRFS1
NCBIGene:475214,NDUFA5
GO:0042734,presynaptic membrane
iuphar.ligand:7975,BPH-675
chembl:CHEMBL2089002,DEMETHYLWEDELOLACTONE
drugbank:DB07453,ALPHA-NAPHTHOFLAVONE
rxcui:2642274,ROZANOLIXIZUMAB
rxcui:738,INAMRINONE
ncit:C83617,CETYLPYRIDINIUM BROMIDE
HGNC:9456,PROS1
EMAPA:17309,iliac artery
MONDO:0022025,boylan dew greco syndrome
MP:0000872,abnormal cerebellum external granule cell layer morphology
GO:0034475,U4 snRNA 3'-end processing
chembl:CHEMBL589238,CHEMBL:CHEMBL589238
HGNC:5035,HNRNPC
MONDO:0958009,"spastic ataxia 10, autosomal recessive"
iuphar.ligand:10268,I-191
HGNC:7456,MT-ND2
chembl:CHEMBL1614725,TAK-285
HP:0001417,X-linked inheritance
MGI:1100513,Lmx1b
rxcui:3108,DAPSONE
HP:0000492,Abnormal eyelid morphology
rxcui:2265690,CENOBAMATE
HP:0011167,Focal tonic seizure
chembl:CHEMBL1434057,2-BENZOYL-5-METHOXYBENZOQUINONE
rxcui:105443,PAMIDRONATE DISODIUM
ncit:C90945,IFERANSERIN
HP:0011157,Focal sensory seizure
ncit:C114980,MDM2 ANTAGONIST RO6839921
drugbank:DB15665,SEP-363856
iuphar.ligand:1426,MPEP
rxcui:2604685,ILODECAKIN
ncit:C97713,HARMINE
ncit:C79554,ANATIBANT
HGNC:2553,CUL3
rxcui:33283,PHENINDAMINE
drugbank:DB08463,(2R)-2-({9-(1-METHYLETHYL)-6-[(4-PYRIDIN-2-YLBENZYL)AMINO]-9H-PURIN-2-YL}AMINO)BUTAN-1-OL
rxcui:974779,OBINUTUZUMAB
rxcui:71533,TRIPELENNAMINE CITRATE
iuphar.ligand:5087,VEGFC
rxcui:17627,ALVERINE
HP:0000113,Polycystic kidney dysplasia
rxcui:1091836,ROFLUMILAST
iuphar.ligand:2083,BIM 23268
iuphar.ligand:4202,GLYH-101
chembl:CHEMBL538104,CHEMBL:CHEMBL538104
MGI:3817462,Mecp2<sup>tm1Bird</sup>/Y  [background:] (129S6.129P2-Mecp2<sup>tm1Bird</sup> x FVB/N)F1
MONDO:0044970,mitochondrial disease
HP:0020207,Reflex seizure
MGI:1920546,Rhobtb3
MP:0001513,limb grasping
HP:0000243,Trigonocephaly
HP:0001803,Nail pits
HP:0003677,Slowly progressive
chembl:CHEMBL154580,CHEMBL:CHEMBL154580
rxcui:233698,DRONEDARONE
iuphar.ligand:1258,A-304121
MGI:3046801,Tbx1<sup>tm1Bld</sup>/Tbx1<sup>tm3Bld</sup> Tg(Tek-cre)1Ywa/0  [background:] involves: 129S7/SvEvBrd * C57BL/6
chembl:CHEMBL312487,CHEMBL:CHEMBL312487
ncit:C175551,ZILURGISERTIB
MGI:5693885,Tbp<sup>tm1Xjl</sup>/Tbp<sup>+</sup> Tg(CAG-cre/Esr1*)5Amc/0  [background:] involves: 129S/SvEv * C57BL/6 * CBA
rxcui:1603350,PANOBINOSTAT
rxcui:203220,BETAMETHASONE SODIUM PHOSPHATE
rxcui:5764,INDAPAMIDE
GO:0071317,cellular response to isoquinoline alkaloid
HGNC:2077,CLN6
iuphar.ligand:11057,NSC 23766
ncit:C83801,INDOPROFEN
rxcui:36514,SIBUTRAMINE
MP:0005113,decreased spinal cord ventral horn cell number
HGNC:10606,SCP2
EMAPA:18562,rest of cerebellum ventricular layer
iuphar.ligand:670,JMV1116
MONDO:0013521,"dyskeratosis congenita, autosomal dominant 2"
MONDO:0009026,Costello syndrome
iuphar.ligand:8276,PALOVAROTENE
chembl:CHEMBL589946,CHEMBL:CHEMBL589946
HP:0000341,Narrow forehead
HGNC:6296,KCNQ2
CHEBI:18050,L-glutamine
HP:0000528,Anophthalmia
UPHENO:0068029,increased level of creatine in independent continuant
EMAPA:36846,cerebellum lobule
HP:0010950,Abnormal fourth ventricle morphology
rxcui:996051,CABAZITAXEL
HP:0000696,Delayed eruption of permanent teeth
ncit:C76821,TINORIDINE
rxcui:3478,DINOPROSTONE
MGI:4360537,Grin2d<sup>tm1Mim</sup>/Grin2d<sup>tm1Mim</sup>  [background:] involves: C57BL/6 * CBA
NCBIGene:327691,NDUFS6
HP:0020219,Motor seizure
ncit:C95732,EMIBETUZUMAB
MONDO:0011671,Huntington disease-like 2
HGNC:941,BAG5
HP:0001770,Toe syndactyly
MONDO:0006328,odontogenic cyst
rxcui:35350,REMOXIPRIDE
chembl:CHEMBL3545071,SERIBANTUMAB
drugbank:DB05767,ANDROGRAPHOLIDE
iuphar.ligand:3264,AFDX384
iuphar.ligand:9837,CZ415
MGI:5804131,Stk39<sup>tm2.1Arte</sup>/Stk39<sup>tm2.1Arte</sup>  [background:] involves: C57BL/6J
iuphar.ligand:12798,REZVILUTAMIDE
chembl:CHEMBL455056,CUCURBITACIN E
MP:0013718,galactostasis
iuphar.ligand:9255,F16357
ncit:C169878,DAVUNETIDE
chembl:CHEMBL3185422,IPCONAZOLE
HGNC:28617,CBARP
HGNC:11241,SPI1
HGNC:9537,PSMB1
GO:0034098,VCP-NPL4-UFD1 AAA ATPase complex
MP:0003689,ophthalmoplegia
chembl:CHEMBL530361,CHEMBL:CHEMBL530361
HP:0003196,Short nose
HP:0033689,Anterograde memory impairment
HGNC:9863,RAPSN
HP:0005518,Increased mean corpuscular volume
rxcui:228790,DUTASTERIDE
HP:0000044,Hypogonadotropic hypogonadism
chembl:CHEMBL603739,CHEMBL:CHEMBL603739
MONDO:0012790,amyotrophic lateral sclerosis type 10
HGNC:30688,CAND1
ncit:C77404,CETILISTAT
rxcui:5981,IPRONIAZID
HGNC:16829,RRP9
HGNC:1481,CAPNS1
rxcui:9061,QUINACRINE
chembl:CHEMBL538943,VINORELBINE TARTRATE
ncit:C72122,PERZINFOTEL
MGI:1891428,Pcdh15
MONDO:0013994,Joubert syndrome 20
iuphar.ligand:2219,"D(CH2)5[TYR(ME)2,THR4,PHE(3I,4N3)-NH29]OVT"
MONDO:0013522,"dyskeratosis congenita, autosomal dominant 3"
HP:0000265,Mastoiditis
rxcui:1673265,ARIPIPRAZOLE LAUROXIL
rxcui:2564025,BELUMOSUDIL
ncit:C1594,ANTHRACYCLINE ANTINEOPLASTIC ANTIBIOTIC
WB:WBGene00016844,sucg-1
chembl:CHEMBL89786,2-PHENYLQUINOLINE
MGI:3840842,Asxl2<sup>Gt(AQ0356)Wtsi</sup>/Asxl2<sup>Gt(AQ0356)Wtsi</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6J
CHEBI:7660,nystatin
FB:FBgn0052174,Coq4
HP:0020221,Clonic seizure
chembl:CHEMBL548017,CHEMBL:CHEMBL548017
iuphar.ligand:8268,VELTUZUMAB
iuphar.ligand:219,[3H]LSD
ncit:C103861,PI3K ALPHA/BETA INHIBITOR BAY1082439
chembl:CHEMBL1534034,CHEMBL:CHEMBL1534034
rxcui:203186,MESORIDAZINE BESYLATE
HGNC:23805,ASXL2
ncit:C77083,BECOCALCIDIOL
NCBIGene:100858928,HRH1
iuphar.ligand:7679,AZD3778
MONDO:0017569,de Barsy syndrome
HP:0000490,Deeply set eye
HP:0003535,3-Methylglutaconic aciduria
iuphar.ligand:2064,[111IN]DOTA-NOC-ATE
MGI:4462381,Inpp4a<sup>tm1Tsak</sup>/Inpp4a<sup>tm1Tsak</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6
iuphar.ligand:314,MUSCARINIC TOXIN 7
dictyBase:DDB_G0276345,naa20
rxcui:2471078,TIRBANIBULIN
HGNC:3363,ENTPD1
iuphar.ligand:5273,SP600125
MONDO:0007217,brachydactyly type A3
MGI:99578,Drd1
ncit:C162573,LUXEPTINIB
CHEBI:4911,etoposide
ncit:C152874,VIDUPIPRANT
iuphar.ligand:2661,N-OLEOYLETHANOLAMIDE
rxcui:616739,ROTIGOTINE
GO:0062023,collagen-containing extracellular matrix
MGI:1289172,Scyl2
HGNC:9722,ALDH18A1
chembl:CHEMBL1235854,CHEMBL:CHEMBL1235854
HP:0005280,Depressed nasal bridge
iuphar.ligand:8966,ONARTUZUMAB
ncit:C2517,MELANOMA VACCINE
iuphar.ligand:4500,BENZYLSERINE
ncit:C62502,BARASERTIB
rxcui:1292,BACLOFEN
rxcui:262323,IBRITUMOMAB TIUXETAN
rxcui:203214,DICLOFENAC SODIUM
HGNC:30213,ATP13A2
chembl:CHEMBL264141,EUGENYL BENZOAT
GO:0016251,RNA polymerase II general transcription initiation factor activity
ncit:C96285,MEVASTATIN
ncit:C61319,TOZASERTIB LACTATE
rxcui:23370,DIPHENIDOL
chembl:CHEMBL41541,METHAPHIT
ncit:C122834,SELECTIVE ESTROGEN RECEPTOR DEGRADER AZD9496
iuphar.ligand:5027,NEUREGULIN-1
iuphar.ligand:4331,TRIM
HP:0002350,Cerebellar cyst
HP:0030313,Abnormal periosteum morphology
ncit:C174957,PEGAMOTECAN
CHEBI:27504,mitomycin C
RGD:1595126,Uqcr10
rxcui:2184,CEFOPERAZONE
rxcui:5032,GUAIFENESIN
HP:0030185,Isometric tremor
rxcui:150596,COPPER CHLORIDE
HGNC:7121,MKS1
MONDO:0024575,pregnancy disorder
HGNC:4162,GARS1
ncit:C152345,SERIDOPIDINE
OBA:2040156,age of onset of coronary stenosis
ncit:C776,PROGESTIN
HP:0032843,Focal-onset epileptic spasm
HGNC:7656,NCAM1
HGNC:1302,RWDD2B
chembl:CHEMBL1566650,ACACETIN DIACETATE
HP:0007132,Pallidal degeneration
MONDO:0013969,combined oxidative phosphorylation defect type 11
HP:0031765,Partially accomodative esotropia
iuphar.ligand:3885,INSL3 B-CHAIN ANALOGUE
chembl:CHEMBL4751394,BAY-1125976
iuphar.ligand:10690,JD5037
HGNC:9887,RBBP4
HGNC:7714,NDUFS7
ncit:C167030,FASITIBANT CHLORIDE
chembl:CHEMBL590184,CHEMBL:CHEMBL590184
chembl:CHEMBL1256742,PREGNENOLONE SULFATE SODIUM
rxcui:155137,SERTRALINE HYDROCHLORIDE
MONDO:0000565,infective endocarditis
chembl:CHEMBL1504869,TALIPEXOLE HYDROCHLORIDE
iuphar.ligand:11515,K777
chembl:CHEMBL2109589,L19TNFA
iuphar.ligand:6496,MRS 2219
HGNC:1541,CBL
ncit:C166483,AMPRELOXETINE
ncit:C152698,TOREFORANT
chembl:CHEMBL1492516,CLOPERASTINE HYDROCLORIDE
rxcui:9001,PYRIDOSTIGMINE BROMIDE
iuphar.ligand:8171,COMPOUND 5B [PMID: 24900464]
HP:0032845,Focal aware epileptic spasm
iuphar.ligand:5156,CALPHOSTIN C
MONDO:0011561,Alzheimer disease 6
iuphar.ligand:11862,PRU-12
rxcui:4462,FLUOCINONIDE
HP:0011902,Abnormal hemoglobin
HP:0001270,Motor delay
MGI:2156841,Recql5
GO:0017020,myosin phosphatase regulator activity
HP:0006554,Acute hepatic failure
HP:0032790,Focal impaired awareness behavior arrest seizure
iuphar.ligand:10270,P4PAL-10
iuphar.ligand:7024,NCL-1
iuphar.ligand:12485,"COMPOUND 7 [NGUYEN ET AL., 2023]"
HGNC:29238,ZNF608
HGNC:4507,GABBR2
CHEBI:35681,secondary alcohol
rxcui:658552,BEPOTASTINE BESILATE
rxcui:15657,DECITABINE
MGI:5904770,Mocs2<sup>tm1(KOMP)Vlcg</sup>/Mocs2<sup>tm1(KOMP)Vlcg</sup>  [background:] involves: C57BL/6NTac
HGNC:17679,RANGRF
MGI:4438493,Tg(Thy1-TARDBP)6Singh/Tg(Thy1-TARDBP)6Singh  [background:] involves: C57BL/6 * C57BL/6J * SJL
MONDO:0859519,neurodevelopmental disorder with absent speech and movement and behavioral abnormalities
HGNC:11817,TIMM8A
CHEBI:17347,testosterone
HP:0033205,Biceps hyperreflexia
iuphar.ligand:3392,5-OXO-C20:3
MONDO:0014150,developmental and epileptic encephalopathy 94
HGNC:6762,MAD1L1
rxcui:6779,MESORIDAZINE
iuphar.ligand:13046,ORDESEKIMAB
HGNC:9299,PPP2CA
ncit:C122836,MTORC1/2 KINASE INHIBITOR BI 860585
HGNC:4691,GUCY2F
rxcui:203160,LOSARTAN POTASSIUM
rxcui:10450,THIABENDAZOLE
drugbank:DB06669,ARVERAPAMIL
MP:0000920,abnormal myelination
rxcui:2557217,ADUCANUMAB
MONDO:0013925,"methylmalonic acidemia with homocystinuria, type cblJ"
MONDO:0035646,congenital-onset Steinert myotonic dystrophy
chembl:CHEMBL490355,SULFURETIN
rxcui:772,ANCROD
rxcui:69722,ZANAMIVIR
chembl:CHEMBL91638,CHEMBL:CHEMBL91638
ncit:C174906,PRALICIGUAT
HP:0000732,Inflexible adherence to routines
MONDO:0009671,intellectual disability-myopathy-short stature-endocrine defect syndrome
chembl:CHEMBL1526167,CHEMBL:CHEMBL1526167
HP:0002421,Poor head control
rxcui:32592,OXALIPLATIN
ncit:C77048,DICHLOROXYLENOL
GO:0032286,central nervous system myelin maintenance
iuphar.ligand:10050,VM24
MONDO:0018211,Balint syndrome
HGNC:8031,NTRK1
iuphar.ligand:4081,[3H]CNQX
MP:0003234,enhanced NMDA-mediated synaptic currents
MONDO:0011002,"neuropathy, hereditary motor and sensory, type 6A"
HP:0011149,Absence seizure with eyelid myoclonia
HGNC:2955,DNAL4
HP:0011110,Recurrent tonsillitis
ncit:C104058,LUMRETUZUMAB
rxcui:10207,SULFISOXAZOLE
ncit:C1258,TRIAZINATE
HP:0002921,Abnormal cerebrospinal fluid morphology
rxcui:108088,ALCLOMETASONE
HGNC:12648,VAPA
rxcui:8150,PHENPROCOUMON
ncit:C73168,STILONIUM IODIDE
CHEBI:17196,L-asparagine
MGI:6188926,Opa1<sup>tm1.1Geno</sup>/Opa1<sup>+</sup>  [background:] involves: 129S2/SvPas
HGNC:16239,MTG2
HGNC:6898,MARS1
HGNC:16821,NOP14
chembl:CHEMBL602970,CHEMBL:CHEMBL602970
OBA:1000516,
ncit:C65685,FIPEXIDE
MP:0004079,abnormal putamen morphology
rxcui:66887,RACEPINEPHRINE
chembl:CHEMBL274440,AP-7
drugbank:DB15644,OCHROMYCINONE
rxcui:235824,AZELASTINE HYDROCHLORIDE
HP:0000544,External ophthalmoplegia
HGNC:6838,MAP1LC3A
chembl:CHEMBL1223740,CRYPTOCHINONE A
HGNC:11102,SMARCAL1
chembl:CHEMBL42355,CHEMBL:CHEMBL42355
MGI:5697200,Tg(ATXN2*72Q)#Plt/0  [background:] FVB/N-Tg(ATXN2*72Q)#Plt
iuphar.ligand:189,SB 206553
chembl:CHEMBL1517542,CHEMBL:CHEMBL1517542
ncit:C96721,VAPITADINE
MONDO:0015642,benign partial infantile seizures
FB:FBgn0034033,CG8204
rxcui:4021,ERGONOVINE
rxcui:72302,ROPINIROLE
iuphar.ligand:9929,XILIERTINIB
HGNC:11280,SQSTM1
chembl:CHEMBL109747,TRIMETHYL-TETRADECYL-AMMONIUM CHLORIDE
HGNC:2888,DISC1
iuphar.ligand:8623,COMPOUND 4 [PMID: 19954973]
MONDO:0013651,"intellectual disability, autosomal recessive 18"
rxcui:2198943,LEFAMULIN ACETATE
ncit:C128057,ANTI-PD-L1 MONOCLONAL ANTIBODY
chembl:CHEMBL579919,CHEMBL:CHEMBL579919
HGNC:5961,IKBKG
rxcui:221126,MORICIZINE HYDROCHLORIDE
UPHENO:0025338,absent cerebellar vermis in the cerebellar cortex
chembl:CHEMBL3545040,AZD7009
HP:0012232,Shortened QT interval
EMAPA:17073,metencephalon alar plate
HGNC:30581,SSH3
ncit:C75939,DIHYDROERGOCRISTINE MESYLATE
HGNC:9542,PSMB5
MGI:98809,Tpm1
iuphar.ligand:3846,"[PHE8,&PSI;(CH2-NH)ARG9]BK"
iuphar.ligand:8183,PD166285
UBERON:0001114,right lobe of liver
ncit:C76618,CIPRALISANT
chembl:CHEMBL1504679,CHEMBL:CHEMBL1504679
drugbank:DB13101,4SC-202
iuphar.ligand:5512,DIOLEOYLPHOSPHATIDIC ACID
chembl:CHEMBL580183,CHEMBL:CHEMBL580183
MP:0001475,reduced long-term depression
iuphar.ligand:44,NAFADOTRIDE
MGI:3712286,Mecp2<sup>tm2Bird</sup>/Mecp2<sup>+</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6
iuphar.ligand:5971,FLT-3 INHIBITOR II
iuphar.ligand:23,RU 24969
chembl:CHEMBL2392545,TAK-960
MP:0002206,abnormal CNS synaptic transmission
CHEBI:15866,2-deoxy-D-glucose
HP:0100952,Enlarged sylvian cistern
UPHENO:0080573,decreased first dorsal interosseous of manus strength
OBA:2050078,blood metabolite level
HGNC:5382,IDH1
GO:0060004,reflex
HGNC:9871,RASA1
chembl:CHEMBL3545025,INSM-18
HGNC:11231,ATL1
HGNC:9305,PPP2R2B
CHEBI:4290,"1,1-dimethyl-4-phenylpiperazinium iodide"
rxcui:2473230,PACLITAXEL POLIGLUMEX
chembl:CHEMBL411066,KINETIN RIBOSIDE
ncit:C173995,DIVARASIB
iuphar.ligand:2112,[&BETA;ALA8]NEUROKININ A-(4-10)
CHEBI:6078,ivermectin
HGNC:16636,KIF1B
rxcui:4508,FLUTAMIDE
HP:0003002,Breast carcinoma
ncit:C70651,FIRTECAN PEGOL
chembl:CHEMBL1917739,LUCIDUMOL A
CHEBI:25681,omega-3 fatty acid
HGNC:3518,EXTL3
ncit:C170349,PRIDOPIDINE
ncit:C154627,DAROMUN
rxcui:2683,COLCHICINE
chembl:CHEMBL590168,CHEMBL:CHEMBL590168
chembl:CHEMBL66279,CHEMBL:CHEMBL66279
iuphar.ligand:3525,RWJ-56110
HP:0000632,Lacrimation abnormality
GO:0006979,response to oxidative stress
HGNC:16122,FAM83D
chembl:CHEMBL449063,CHEMBL:CHEMBL449063
rxcui:236809,GINKGO BILOBA EXTRACT
chembl:CHEMBL549216,CHEMBL:CHEMBL549216
HGNC:9112,PMF1
chembl:CHEMBL17784,CHEMBL:CHEMBL17784
HGNC:20390,SQOR
iuphar.ligand:11643,CALPEPTIN
drugbank:DB07352,APIGENIN
chembl:CHEMBL4227505,BLZ945
HP:0007332,Focal hemifacial clonic seizure
HP:0002150,Hypercalciuria
rxcui:2174090,POLATUZUMAB VEDOTIN
rxcui:227225,GUANABENZ ACETATE
rxcui:6996,MITOBRONITOL
CLINVAR:143656,NM_001110792.2(MECP2):c.715C>G (p.Gln239Glu)
ncit:C72919,AZEPEXOLE
chembl:CHEMBL2356687,ESTRADIOL PROPIONATE
GO:0005768,endosome
chembl:CHEMBL3545282,KC-706
CHEBI:45716,vorinostat
HGNC:16264,TRAP1
HGNC:20566,SV2A
ncit:C142980,SELECTIVE ESTROGEN RECEPTOR COVALENT ANTAGONIST H3B-6545
HP:0008963,Tibialis muscle weakness
rxcui:10032,STANOZOLOL
Reactome:R-CEL-549127,Organic cation transport
HP:0034694,Substantia nigra dopaminergic neuron loss
chembl:CHEMBL8747,REV-5901
chembl:CHEMBL1257002,ZIMELIDINE DIHYDROCHLORIDE
iuphar.ligand:7708,AZD4877
MP:0000854,abnormal cerebellum development
drugbank:DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE"
HGNC:784,ATF2
ncit:C169919,DORZAGLIATIN
HP:0001510,Growth delay
Reactome:R-MMU-549127,Organic cation transport
ncit:C174206,CAMONSERTIB
HP:0030147,Truncal titubation
MP:0001265,decreased body size
chembl:CHEMBL2374078,CHEMBL:CHEMBL2374078
HP:0032720,Focal motor seizure with dysarthria/anarthria
ncit:C176768,IDH2 MUTANT INHIBITOR TQB3455
rxcui:10171,SULFADIAZINE
NCBIGene:281125,DRD1
HGNC:14180,PDIA2
chembl:CHEMBL47814,DIMETHYLPHENYLPIPERAZINIUM IODIDE
MGI:103020,Syn2
HP:0100962,Shyness
ncit:C78853,PATRITUMAB
HP:0005010,Osteomyelitis leading to amputation due to slow healing fractures
GO:0050883,"musculoskeletal movement, spinal reflex action"
HGNC:24624,SIL1
HGNC:3282,EIF4A1
ncit:C148488,PELCITOCLAX
MONDO:0010754,van den Bosch syndrome
MONDO:0020067,infectious encephalitis
rxcui:91188,DYCLONINE HYDROCHLORIDE
HGNC:21191,DAOA
chembl:CHEMBL4594410,SULCARDINE SULFATE
HP:0011732,Abnormality of adrenal morphology
GO:0060005,vestibular reflex
rxcui:3254,DESONIDE
chembl:CHEMBL177809,CHEMBL:CHEMBL177809
chembl:CHEMBL1408276,CHEMBL:CHEMBL1408276
rxcui:53654,NEVIRAPINE
chembl:CHEMBL2109323,IMC-CS4
MONDO:0022424,alpha-mannosidosis type 1
drugbank:DB12707,AR-42
HGNC:6923,MBNL1
ncit:C61689,CLOXYQUIN
iuphar.ligand:10471,ZAGOTENEMAB
rxcui:173,ACETOHEXAMIDE
chembl:CHEMBL44011,CHEMBL:CHEMBL44011
MGI:4950068,"Met<sup>tm1Sst</sup>/Met<sup>tm1Sst</sup> Tg(mI56i-cre,EGFP)1Kc/0  [background:] involves: 129P2/OlaHsd * C57BL/6J * FVB"
HP:0009921,Duane anomaly
rxcui:1723735,IXAZOMIB
MONDO:0859169,White-Kernohan syndrome
HGNC:14214,CIC
ncit:C29709,ALPHA-ADRENERGIC AGONIST
ncit:C80765,PARDOPRUNOX
HGNC:18806,CAMTA1
iuphar.ligand:2433,2-APB
HGNC:12463,UBB
chembl:CHEMBL1328677,CHEMBL:CHEMBL1328677
ncit:C170295,PEGCANTRATINIB
ncit:C166907,DEXIBUPROFEN
HGNC:4274,GJA1
chembl:CHEMBL373822,CHEMBL:CHEMBL373822
rxcui:1374802,POTASSIUM CITRATE ANHYDROUS
MONDO:0014402,severe neurodegenerative syndrome with lipodystrophy
HGNC:4901,HHEX
rxcui:164308,TRIMEPRAZINE TARTRATE
iuphar.ligand:12074,ASNUCICLIB
rxcui:4494,FLUOXYMESTERONE
iuphar.ligand:8897,AC-186
chembl:CHEMBL1095337,AESCULIOSIDE IIE
MGI:3620632,Hdc<sup>tm1Nagy</sup>/Hdc<sup>tm1Nagy</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ
HP:0010534,Transient global amnesia
chembl:CHEMBL471004,CHEMBL:CHEMBL471004
rxcui:328134,GEFITINIB
iuphar.ligand:4980,IL-13
HP:0010808,Protruding tongue
MGI:98931,Ezr
rxcui:282446,POSACONAZOLE
UBERON:0002037,cerebellum
MGI:4418758,Esr2<sup>tm1Unc</sup>/Esr2<sup>tm1Unc</sup>  [background:] involves: 129P2/OlaHsd
ncit:C101262,LIPOSOMAL MUC1/PET-LIPID A VACCINE ONT-10
HP:0002871,Central apnea
HP:0005978,Type II diabetes mellitus
chembl:CHEMBL1997335,CHEMBL:CHEMBL1997335
MGI:3839782,Hfe<sup>tm1.1Gfn</sup>/Hfe<sup>tm1.1Gfn</sup>  [background:] B6.129P2-Hfe<sup>tm1.1Gfn</sup>
GO:0014075,response to amine
iuphar.ligand:9905,COMPOUND 8I [PMID: 22765894]
chembl:CHEMBL74635,PHENYLETHENYLSEMICARBAZONE
HGNC:7455,MT-ND1
iuphar.ligand:2633,NH-3
MGI:1202717,Psen1
iuphar.ligand:12781,TPN171
CLINVAR:590582,NM_000540.2(RYR1):c.7123G>A (p.Gly2375Arg)
HGNC:30343,DNAJC13
iuphar.ligand:1431,SIB-1757
chembl:CHEMBL444109,GAMBOGIC AMIDE
iuphar.ligand:10149,SLC-0111
iuphar.ligand:3853,ACPHE-ORN-PRO-D-CHA-TRP-ARG
rxcui:18997,BENZOPHENONE
MONDO:0006874,obstructive jaundice
MGI:107812,Tubb5
MONDO:0014086,osteogenesis imperfecta type 15
GO:0005743,mitochondrial inner membrane
HGNC:11321,SSNA1
HP:0001663,Ventricular fibrillation
MP:0003006,abnormal hippocampal fornix morphology
HP:0003593,Infantile onset
iuphar.ligand:3936,"L-162,313"
ncit:C78032,CHLORMIDAZOLE
HGNC:8784,PDE5A
HGNC:583,APC
HP:0031722,Near esotropia
MONDO:0100093,"myoclonus, familial, 1"
MGI:6197218,Slc6a8<sup>tm1e(KOMP)Wtsi</sup>/Y  [background:] involves: C57BL/6J * C57BL/6N
MONDO:0004884,eye degenerative disorder
HP:0410030,Cleft lip
chembl:CHEMBL75967,PENTACHLOROPHENOL
HP:0000963,Thin skin
chembl:CHEMBL1528531,PHOSALONE
iuphar.ligand:10302,OSTHOLE
HGNC:10477,RXRA
HP:0003130,Abnormal peripheral myelination
rxcui:7396,NICARDIPINE
drugbank:DB15034,PRI-724
iuphar.ligand:11516,TAK-418
drugbank:DB07401,AZOXYSTROBIN
MONDO:0013959,Charcot-Marie-Tooth disease type 4F
drugbank:DB05959,ENMD-1198
chembl:CHEMBL1488393,"5,7-DIHYDROXYISOFLAVONE"
rxcui:1716278,TRABECTEDIN
HP:0000662,Nyctalopia
MONDO:0014104,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4"
chembl:CHEMBL4297348,"BRIMAPITIDE, C-TERMINAL ACID"
UBERON:0000992,ovary
CL:0000107,autonomic neuron
rxcui:190376,LINEZOLID
ncit:C87623,TENELIGLIPTIN
rxcui:2665622,AGATOLIMOD
HP:0001273,Abnormal corpus callosum morphology
chembl:CHEMBL584514,CHEMBL:CHEMBL584514
ncit:C1636,THERAPEUTIC STEROID HORMONE
rxcui:22968,DIENOGEST
HGNC:16646,SPINK4
drugbank:DB04310,2-[(FORMYL-HYDROXY-AMINO)-METHYL]-HEPTANOIC ACID [1-(2-HYDROXYMETHYL-PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL]-AMIDE
drugbank:DB17579,SS1(DSFV)-PE38
chembl:CHEMBL578890,CHEMBL:CHEMBL578890
chembl:CHEMBL3544936,XL-844
chembl:CHEMBL256967,CHEMBL:CHEMBL256967
iuphar.ligand:12555,CIMIFUGIN
HP:0000970,Anhidrosis
MP:0002804,abnormal motor learning
MONDO:0015653,monogenic epilepsy
ncit:C1459,LIATERMIN
NCBIGene:415826,COX4I1
CHEBI:48120,anthracycline
rxcui:2055907,ERAVACYCLINE DIHYDROCHLORIDE
rxcui:3364,DIDANOSINE
HGNC:30829,TUBB2B
CHEBI:50996,tertiary amino compound
rxcui:1311380,INTERLEUKIN-11
ncit:C152453,SULFACARBAMIDE
HP:0032722,Focal aware tonic seizure
MONDO:0005016,diabetic kidney disease
MP:0006158,vertical supranuclear palsy
HGNC:29911,C1D
rxcui:6466,LOMUSTINE
HGNC:344,AHCYL1
chembl:CHEMBL433680,ANGUIDIN
HGNC:1982,CIRBP
iuphar.ligand:4166,CX546
iuphar.ligand:6158,RO5101576
GO:1902775,mitochondrial large ribosomal subunit assembly
rxcui:2598119,INDOLE-3-CARBINOL
MONDO:0859297,neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities
HGNC:28352,CUEDC2
HGNC:9813,RAD23B
HP:0006562,Viral hepatitis
UPHENO:0081544,abnormal role urine level
MONDO:0012143,hereditary cryohydrocytosis with reduced stomatin
chembl:CHEMBL1782599,THEONELLASTEROL C
ncit:C91072,IPATASERTIB
MONDO:0000004,adrenocortical insufficiency
HGNC:2345,CREB1
iuphar.ligand:3384,ARL66096
HP:0000776,Congenital diaphragmatic hernia
chembl:CHEMBL2216904,DARUISOLINE
HP:0100494,Abnormal mast cell morphology
EMAPA:17413,arm
HGNC:3026,DRD5
HGNC:3670,FGF13
HGNC:3999,FTL
HP:0025586,Hypertropia
MGI:3718076,Tg(PDGFB-MAPT*V337M)1Atak/0  [background:] involves: C57BL/6 * SJL
rxcui:1297882,AMOXICILLIN ANHYDROUS
HGNC:25632,CPPED1
MONDO:0012363,retinitis pigmentosa 32
HGNC:4281,GJA8
HGNC:4315,GLE1
MGI:4420468,Rb1<sup>tm1Tyj</sup>/Rb1<sup>tm1Tyj</sup> Tg(Rb1)1Blg/0  [background:] involves: 129S2/SvPas
HP:0005180,Tricuspid regurgitation
HP:0000494,Downslanted palpebral fissures
iuphar.ligand:9201,PHENYLARSINE OXIDE
iuphar.ligand:3251,[3H]WAY100635
MGI:107423,Numb
CHEBI:350546,serotonin(1+)
HGNC:10808,SGCE
rxcui:32675,OXYBUTYNIN
ncit:C174600,FUNAPIDE
MONDO:0010584,"dyskeratosis congenita, X-linked"
CHEBI:50694,minocycline
iuphar.ligand:4768,AMINOBENZOVESAMICOL
iuphar.ligand:10216,KH7
HP:0030587,Abnormal Hardy-Rand-Rittler plate test
MGI:3850161,Tbx1<sup>tm1Pa</sup>/Tbx1<sup>tm1Pa</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ
chembl:CHEMBL592314,CHEMBL:CHEMBL592314
HP:0032844,Focal impaired awareness epileptic spasm
HGNC:21575,AHI1
HP:0002086,Abnormality of the respiratory system
ncit:C2416,GIMERACIL
HP:0045010,Abnormal peripheral nerve morphology by anatomical site
ncit:C81088,BUTACLAMOL
ncit:C170004,FORIGERIMOD ACETATE
HGNC:10982,SLC25A12
chembl:CHEMBL1880739,GW305074X
HP:0010761,Broad columella
HGNC:20860,SLC39A12
chembl:CHEMBL609570,CHEMBL:CHEMBL609570
HGNC:7553,MYC
GO:0007399,nervous system development
CHEBI:16857,L-threonine
MONDO:0019384,encephalitis lethargica
CHEBI:59770,cyclic acetal
HP:0033505,Livedo reticularis
UPHENO:0082905,prominent forehead
ncit:C170129,LOREDIPLON
iuphar.ligand:1223,CLOBENPROPIT
chembl:CHEMBL401565,CHEMBL:CHEMBL401565
iuphar.ligand:6017,PD 174265
HP:0001057,Aplasia cutis congenita
HGNC:9817,RAD51
HGNC:3023,DRD2
HGNC:5173,HRAS
MGI:2444848,Ptrh2
HP:0001513,Obesity
rxcui:10804,TRIFLUPERIDOL
HGNC:13352,MAP1LC3B
iuphar.ligand:1424,"3,3'-DIFLUOROBENZALDAZINE"
ncit:C81482,ADOPRAZINE
HP:0000272,Malar flattening
rxcui:2394936,PRALSETINIB
MONDO:0014118,congenital neutropenia-myelofibrosis-nephromegaly syndrome
iuphar.ligand:11581,FP-1039
chembl:CHEMBL410484,CHEMBL:CHEMBL410484
MP:0000853,absent cerebellar foliation
HP:0001999,Abnormal facial shape
HGNC:24824,FZR1
HGNC:14493,MRPL42
ncit:C65453,DOCARPAMINE
HGNC:25890,TMEM25
MP:0003857,abnormal hindlimb zeugopod morphology
rxcui:376,CORTICOTROPIN
ncit:C61441,TERAMEPROCOL
CL:2000005,brain macroglial cell
HP:0007747,Monocular horizontal nystagmus
HP:0025331,Upgaze palsy
ncit:C152828,VANIPREVIR
HP:0002544,Retrocollis
drugbank:DB02818,IODO-WILLARDIINE
ncit:C1620,BECATECARIN
HP:0031857,Ineffective esophageal peristalsis
MONDO:0001485,atypical depressive disorder
ncit:C78845,TETRODOTOXIN
HGNC:6835,MAP1A
chembl:CHEMBL581044,CHEMBL:CHEMBL581044
ncit:C1089,EPITIOSTANOL
rxcui:104728,CHLORPROMAZINE HYDROCHLORIDE
HGNC:4601,GRN
chembl:CHEMBL198666,CHEMBL:CHEMBL198666
MONDO:0800088,lysosomal storage disease with skeletal involvement
ncit:C65517,EPLIVANSERIN
chembl:CHEMBL2109587,AZ9773
HGNC:11532,TAF1A
drugbank:DB01034,CERULENIN
MGI:5766068,Morc1<sup>Tg(Tyr)1Az</sup>/Morc1<sup>Tg(Tyr)1Az</sup>  [background:] involves: C57BL/6N * FVB/N
HGNC:3434,ERCC2
HGNC:16235,DNAJC5
CHEBI:59769,acetal
chembl:CHEMBL399530,CHEMBL:CHEMBL399530
HGNC:28951,ARHGAP25
GO:0098863,nuclear migration by microtubule mediated pushing forces
iuphar.ligand:1254,METHIMEPIP
CHEBI:50733,nutraceutical
CHEBI:33853,phenols
MONDO:0011652,Phelan-McDermid syndrome
ncit:C171754,CILNIDIPINE
rxcui:8737,PROLINE
HGNC:10582,SCN10A
rxcui:9794,SILYMARIN
MP:0009974,decreased cerebral cortex pyramidal cell number
HGNC:10561,ATXN8OS
ZFIN:ZDB-GENE-010724-6,fh
iuphar.ligand:2003,BIM 23050
ncit:C170170,METILDIGOXIN
MGI:106099,Cyp3a16
HP:0040165,Periostitis
MONDO:0012655,"myoclonic epilepsy, juvenile, susceptibility to, 4"
rxcui:1536070,FLAVONE
ncit:C97947,CERTOLIZUMAB
MGI:4838433,Stk39<sup>tm1.2Slin</sup>/Stk39<sup>tm1.2Slin</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6
HGNC:5292,HTR1F
HGNC:12643,VAMP2
rxcui:2044896,FOSTAMATINIB
NCBIGene:100141309,RAD51
CHEBI:26789,streptothricin
rxcui:40003,ZOTEPINE
drugsatfda.nda:008378,DRUGSATFDA.NDA:008378
HP:0001922,Vacuolated lymphocytes
rxcui:283821,RASBURICASE
chembl:CHEMBL70582,CHEMBL:CHEMBL70582
chembl:CHEMBL1257013,CHEMBL:CHEMBL1257013
iuphar.ligand:2387,PIP2
chembl:CHEMBL1522984,CHEMBL:CHEMBL1522984
rxcui:968170,POLIDOCANOL
ncit:C94221,ANTI-EGFR MONOCLONAL ANTIBODY GT-MAB 5.2-GEX
chembl:CHEMBL180127,SALUBRINAL
iuphar.ligand:5349,OKADAIC ACID
chembl:CHEMBL3989476,PEGAMOTECAN
chembl:CHEMBL464381,PALINURIN
MONDO:0054602,"gaze palsy, familial horizontal, with progressive scoliosis, 2"
MGI:2679448,Slitrk5
ncit:C74960,ALPHA-TOCOPHEROL
HP:0032669,Myoclonic status epilepticus with coma
rxcui:203123,ENALAPRIL MALEATE
rxcui:229369,DALFOPRISTIN
MGI:107374,Pitx1
CHEBI:44137,tiamulin
rxcui:2049122,BINIMETINIB
rxcui:72937,TOLCAPONE
iuphar.ligand:12426,PROCYANIDIN C2
HP:0000504,Abnormality of vision
iuphar.ligand:8285,S(+)-APOMORPHINE
HP:0025587,Hyperdeviation
rxcui:8700,PROCAINAMIDE
rxcui:27748,IODOFORM
MONDO:0035344,acute bilirubin encephalopathy
ncit:C73158,SARPOGRELATE
HGNC:4399,RACK1
MONDO:0956980,vascular parkinsonism
chembl:CHEMBL258893,CHELERYTHRINE CHLORIDE
HP:0030216,Inertia
drugbank:DB02860,CALYCULIN A
ZFA:0001094,whole organism
rxcui:32915,TERIPARATIDE
CHEBI:28971,ampicillin
MGI:108052,Bcl2l2
CLINVAR:133028,NM_000540.3(RYR1):c.1201C>G (p.Arg401Gly)
chembl:CHEMBL528245,CHEMBL:CHEMBL528245
UPHENO:0081740,increased biological_process in patella
MONDO:0012205,autosomal dominant striatal neurodegeneration type 1
chembl:CHEMBL532525,CHEMBL:CHEMBL532525
ncit:C174754,MAZAPERTINE SUCCINATE
rxcui:283792,ALMOTRIPTAN MALATE
HGNC:6266,KCNJ5
ncit:C122987,SCYLLITOL
ncit:C72111,BRETAZENIL
ncit:C166885,DELTIBANT
ncit:C158603,IZORLISIB
iuphar.ligand:9458,YD-3
chembl:CHEMBL233194,CHEMBL:CHEMBL233194
HGNC:4384,GNAI1
ncit:C83939,MESTANOLONE
MGI:1346861,Mapk8
CHEBI:15428,glycine
HGNC:80,AOC1
MONDO:0032678,"developmental and epileptic encephalopathy, 71"
ncit:C171712,CYCLOHEXIMIDE
ncit:C171842,ZAGOTENEMAB
MGI:2662559,cg/cg  [background:] involves: C57BL/6Ga
RGD:1304638,Coq4
HP:0045084,Limb myoclonus
UPHENO:0079839,abnormal physiologic nystagmus
drugbank:DB03860,ICI-164384
iuphar.ligand:5747,COMPOUND 36 [PMID: 21273063]
HP:0002835,Aspiration
rxcui:57954,VINBURNINE
HGNC:3068,DUSP2
drugbank:DB12812,PALOMID 529
iuphar.ligand:5712,SU-14813
rxcui:2557372,PEGCETACOPLAN
HGNC:11799,THRB
HP:0012171,Stereotypical hand wringing
CHEBI:26523,reactive oxygen species
ZFIN:ZDB-FISH-150901-6036,AB + MO3-ca8
HP:0011172,Complex febrile seizure
MONDO:0008393,Rubinstein-Taybi syndrome due to CREBBP mutations
MGI:3832989,Tg(CMV-TOR1A*)2Nush/0  [background:] involves: C3H * C57BL/6
rxcui:203183,KANAMYCIN SULFATE
rxcui:29275,MANIDIPINE
rxcui:56092,METHSCOPOLAMINE BROMIDE
chembl:CHEMBL563919,CHEMBL:CHEMBL563919
chembl:CHEMBL2109393,RG-7160
chembl:CHEMBL464812,HYDRAMETHYLNON
ncit:C29619,DIHYDROTESTOSTERONE
wikidata:Q29006063,KADCYLA
chembl:CHEMBL1494650,CHEMBL:CHEMBL1494650
chembl:CHEMBL3545176,DB959
rxcui:81992,DAUNORUBICIN HYDROCHLORIDE
MONDO:0011540,spinocerebellar ataxia type 14
MONDO:0007104,amyotrophic lateral sclerosis-parkinsonism-dementia complex
iuphar.ligand:2748,DESMOSTEROL
rxcui:1368374,MYRICETIN
HGNC:4667,GTF3C4
rxcui:8702,PROCARBAZINE
chembl:CHEMBL531710,CHEMBL:CHEMBL531710
HGNC:30722,TEX101
iuphar.ligand:65,(R)-FLUROCARAZOLOL
HGNC:11542,TAF9
rxcui:4177,ETOMIDATE
rxcui:58275,AZATADINE MALEATE
rxcui:3992,EPINEPHRINE
iuphar.ligand:4024,IMMETHRIDINE
ncit:C65901,IMPLITAPIDE
rxcui:11201,VINCAMINE
HGNC:24284,TRAPPC12
chembl:CHEMBL2448348,CARBOXYMETHYL-TRIMETHYL-ARSONIUM
GO:0030016,myofibril
MONDO:0016612,X-linked cerebellar ataxia
CHEBI:35618,aromatic ether
rxcui:21224,CLEBOPRIDE
chembl:CHEMBL1614702,SCIO-323
ncit:C2026,TYRPHOSTIN A9
HGNC:8634,PBX3
rxcui:187832,PREGABALIN
drugbank:DB15584,LUTEOLIN
UBERON:0018303,adrenal tissue
HGNC:1172,VPS51
drugbank:DB13062,ME-344
iuphar.ligand:1731,5BRUTP
drugbank:DB05758,CYT007-TNFQB
HGNC:15988,MPPE1
iuphar.ligand:8821,MT47-100
iuphar.ligand:340,"WIN 62,577"
HGNC:16702,COPS4
HGNC:9217,POU3F4
iuphar.ligand:10004,KX2-361
iuphar.ligand:2029,[L-TYR8]CYN 154806
ncit:C171866,ASAPIPRANT
drugbank:DB12588,AZD-1480
iuphar.ligand:8731,COMPOUND 10B [PMID: 26222319]
HP:0032796,Focal impaired awareness cognitive seizure with left-right confusion
ncit:C29770,ESTRADIOL DIPROPIONATE
HP:0005069,Rhizo-meso-acromelic limb shortening
chembl:CHEMBL1082508,LANDIPIRDINE
iuphar.ligand:4227,ISONIPECOTIC ACID
chembl:CHEMBL77387,CHEMBL:CHEMBL77387
iuphar.ligand:5241,PD98059
RGD:1589491,Sepsecs
chembl:CHEMBL21396,SKIMMIANINE
ncit:C61756,MONOETHANOLAMINE
ncit:C73041,SINEFUNGIN
ncit:C1057,CORDYCEPIN
MONDO:0012796,retinitis pigmentosa 41
chembl:CHEMBL2109411,RG-7444
HGNC:830,ATP5F1B
chembl:CHEMBL105350,BISDEMETHOXYCURCUMIN
chembl:CHEMBL1086446,TOLUENE DIISOCYANATE
chembl:CHEMBL473735,CHEMBL:CHEMBL473735
chembl:CHEMBL8443,NITIDINE CHLORIDE
iuphar.ligand:6475,LY2886721
ncit:C29554,GP-120 ANTIGEN
HGNC:5439,IFNGR1
HP:0002545,Patchy demyelination of subcortical white matter
MONDO:0859380,episodic kinesigenic dyskinesia 3
UBERON:0000397,colonic epithelium
HP:0007646,Absent lower eyelashes
chembl:CHEMBL2036277,SEIMATOPOLIDE A
rxcui:42736,DEXRAZOXANE
MONDO:0016651,maternal uniparental disomy of chromosome 1
chembl:CHEMBL587259,CHEMBL:CHEMBL587259
CLINVAR:133174,NM_000540.3(RYR1):c.7007G>A (p.Arg2336His)
drugbank:DB07664,K-00546
MP:0013218,abnormal substantia nigra pars reticulata morphology
drugbank:DB05146,XL820
HGNC:23352,PIBF1
iuphar.ligand:8038,BI-D1870
HGNC:25009,UBE2T
HGNC:903,AXIN1
rxcui:642274,RETAPAMULIN
rxcui:6387,LIDOCAINE
iuphar.ligand:333,N-DESMETHYLCLOZAPINE
rxcui:236146,DEXTROMETHORPHAN POLISTIREX
CHEBI:18420,magnesium(2+)
HP:0040183,Encopresis
rxcui:1482502,ESLICARBAZEPINE
ncit:C87757,IOBENGUANE
rxcui:6929,MIANSERIN
HGNC:626,APRT
rxcui:2104548,LAROTRECTINIB SULFATE
chembl:CHEMBL4297646,AMPRELOXETINE
ZFIN:ZDB-GENE-040426-874,sdha
UPHENO:0076921,cytoplasm degeneration in independent continuant
ncit:C1946,HISTONE DEACETYLASE INHIBITOR
ncit:C26666,TARENFLURBIL
iuphar.ligand:3996,MUSCARINE
chembl:CHEMBL173395,ATRANORIN
HGNC:12679,VDR
iuphar.ligand:10131,UNC4203
HGNC:10785,SRSF3
HP:0033645,Midline brainstem cleft
chembl:CHEMBL1255743,TRANYLCYPROMINE HYDROCHLORIDE
chembl:CHEMBL1909073,PIPERILATE ETHOBROMIDE
HGNC:16637,HTATIP2
rxcui:1722365,COBIMETINIB
iuphar.ligand:2341,PHORBOL 12-MYRISTATE 13-ACETATE
HP:0032704,Focal aware cognitive seizure with illusion
chembl:CHEMBL329673,CHEMBL:CHEMBL329673
rxcui:5333,HISTAMINE
HP:0032832,Neonatal bilateral asymmetric myoclonic seizure
HP:0032716,Focal impaired awareness non-motor seizure
rxcui:1311287,CALCITONIN
ncit:C165549,OLVEREMBATINIB
GO:0006364,rRNA processing
rxcui:262150,IRON CARBONYL
MONDO:0002081,musculoskeletal system disorder
MONDO:0020800,demyelinating disease of central nervous system
chembl:CHEMBL3544968,GSK-610677
drugbank:DB05470,VX-702
rxcui:203193,NETILMICIN SULFATE
iuphar.ligand:770,CCL13
drugbank:DB05173,PTC299
iuphar.ligand:840,DIOSCIN
chembl:CHEMBL1519374,CHEMBL:CHEMBL1519374
MONDO:0045058,ACTH-producing pituitary gland neoplasm
chembl:CHEMBL1201540,INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
rxcui:1622,BLEOMYCIN
MONDO:0008867,biliary atresia
ZFIN:ZDB-GENE-990706-5,svila
iuphar.ligand:11027,OLEUROPEIN
HP:0034340,Pseudoautosomal dominant inheritance
ncit:C170108,LERIGLITAZONE
CHEBI:176497,geroprotector
iuphar.ligand:3738,PTHRP
MONDO:0017704,familial partial epilepsy
UBERON:0002084,heart left ventricle
iuphar.ligand:11885,TANUXICICLIB
MGI:105043,Ahr
rxcui:135056,LERCANIDIPINE
drugbank:DB12876,GS-9256
MGI:3838164,Tg(ATXN3*)67.2Cce/0  [background:] involves: C57BL/6 * CBA
iuphar.ligand:4268,NMDA
iuphar.ligand:11465,NANOLUC R3/I5 CHIMERA
chembl:CHEMBL184450,CHEMBL:CHEMBL184450
chembl:CHEMBL66,(+)-TAXIFOLIN
chembl:CHEMBL20562,ZAPA
MGI:1270129,Dnaja1
iuphar.ligand:4165,CX516
rxcui:235229,ETHAVERINE HYDROCHLORIDE
iuphar.ligand:5163,CGP53353
HGNC:7910,NPM1
ncit:C143046,RALIMETINIB
iuphar.ligand:6054,VEGF RECEPTOR 2 KINASE INHIBITOR II
MGI:3588731,Cln8<sup>mnd</sup>/Cln8<sup>mnd</sup>  [background:] involves: B6.KB2 * C3H/HeJ
chembl:CHEMBL275665,ICRF-193
chembl:CHEMBL3545332,CEP-2563
ncit:C29773,PREGNANT MARE SERUM GONADOTROPIN
HGNC:7372,MSMB
HGNC:9752,QDPR
MGI:3801152,Tph2<sup>tm1Mca</sup>/Tph2<sup>tm1Mca</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6J
rxcui:805452,ROMIPLOSTIM
chembl:CHEMBL3545238,CS-8080
rxcui:1294535,SIBUTRAMINE HYDROCHLORIDE
ncit:C1289,RECOMBINANT INTERLEUKIN-8
MGI:1921054,Kif2c
rxcui:236685,MEMANTINE HYDROCHLORIDE
HP:0002870,Obstructive sleep apnea
chembl:CHEMBL579028,CHEMBL:CHEMBL579028
GO:0006020,inositol metabolic process
ncit:C133691,AUMOLERTINIB
MONDO:0013659,microcephaly-capillary malformation syndrome
ncit:C1682,"L-744,832"
rxcui:1426903,DROMETRIZOLE
WB:WBGene00001519,gar-3
MONDO:0043878,hereditary optic atrophy
ncit:C1884,ORANTINIB
ncit:C2583,ROSIGLITAZONE MALEATE
ncit:C261,MACROLIDE ANTIBIOTIC
HGNC:5724,RBPJ
HGNC:11275,SPTBN1
HP:0012625,Stage 3 chronic kidney disease
HGNC:13488,VPS4A
HP:0000164,Abnormality of the dentition
rxcui:1311506,GLYCYRRHETINIC ACID
ncit:C175807,LAZUCIRNON
HP:0001276,Hypertonia
ncit:C88307,ANTI-EGFRVIII IMMUNOTOXIN MR1-1
CHEBI:16240,hydrogen peroxide
HP:0010852,EEG with photoparoxysmal response
chembl:CHEMBL1716091,SDX-101
ncit:C1748,TOPOISOMERASE INHIBITOR
ncit:C72726,CIGLITAZONE
rxcui:1193326,RUXOLITINIB
HP:0100293,Hypertrophied muscle fibers
HGNC:12036,TRAF6
HGNC:10520,SAFB
GO:0055127,vibrational conductance of sound to the inner ear
HGNC:9705,PVR
HGNC:368,AKAP10
UPHENO:0014062,cranial nerve II atrophy
chembl:CHEMBL77098,"3-HYDROXY-3',4'-DIMETHOXYFLAVONE"
iuphar.ligand:9844,CH-4051
iuphar.ligand:8006,BX-795
ncit:C1960,GIRENTUXIMAB
HGNC:21074,GINM1
CL:0000127,astrocyte
chembl:CHEMBL600554,CHEMBL:CHEMBL600554
chembl:CHEMBL228281,NORSTICTIC ACID
chembl:CHEMBL5095027,OMS405
ncit:C53399,ADH-1
HP:0001519,Disproportionate tall stature
MONDO:0859272,neurodevelopmental disorder with speech delay and variable ocular anomalies
MONDO:0010056,"spinal muscular atrophy, type IV"
HP:0000317,Facial myokymia
ncit:C74372,CLINAFLOXACIN
drugbank:DB15254,AVUTOMETINIB
iuphar.ligand:3741,SLIGRL-NH2
chembl:CHEMBL4594454,RIPASUDIL HYDROCHLORIDE DIHYDRATE
ncit:C94220,GATIPOTUZUMAB
ncit:C47457,CLOFLUCARBAN
ncit:C148147,LAZERTINIB
HP:0003376,Steppage gait
CHEBI:27666,actinomycin D
GO:0006506,GPI anchor biosynthetic process
rxcui:2410,CHLORZOXAZONE
chembl:CHEMBL1867031,AZAMETHIPHOS
CHEBI:24995,lactam
rxcui:194,ACETYLCHOLINE
MGI:2448558,Fancb
iuphar.ligand:10355,GNE-616
chembl:CHEMBL244948,DAPHNETIN
FB:FBgn0261955,Cs1
HP:0002151,Increased serum lactate
chembl:CHEMBL1323355,DEXTROMEPROMAZINE
MONDO:0017615,benign familial infantile epilepsy
ncit:C1725,TYROSINE KINASE INHIBITOR SU5402
chembl:CHEMBL2022241,CHEMBL:CHEMBL2022241
chembl:CHEMBL588525,CHEMBL:CHEMBL588525
drugbank:DB05780,ATX-101
MGI:98389,Spp1
MONDO:0012432,Joubert syndrome 5
chembl:CHEMBL261692,CHEMBL:CHEMBL261692
HGNC:5346,ICAM3
GO:0005615,extracellular space
chembl:CHEMBL590691,CHEMBL:CHEMBL590691
chembl:CHEMBL527620,CHEMBL:CHEMBL527620
chembl:CHEMBL317356,CHEMBL:CHEMBL317356
HP:0002133,Status epilepticus
iuphar.ligand:8044,CCT241533
HP:0000609,Optic nerve hypoplasia
iuphar.ligand:8481,LDN-214117
iuphar.ligand:10543,CLUL1 (52-77)
drugbank:DB04605,5-AMINOISOQUINOLINE
chembl:CHEMBL1488390,2-METHOXY-5 (6)EPOXY-TETRAHYDROCARYOPHYLLENE
ncit:C529,GOSSYPOL
rxcui:6964,MIFEPRISTONE
MGI:106227,Capza1
HP:0002185,Neurofibrillary tangles
iuphar.ligand:9750,NECROSTATIN-1
MONDO:0011200,torsion dystonia 7
HP:0000707,Abnormality of the nervous system
ncit:C167393,COMMENSAL BACTERIAL STRAIN FORMULATION VE800
HP:0001528,Hemihypertrophy
HGNC:801,ATP1A3
ncit:C122816,AZINTUXIZUMAB VEDOTIN
GO:0009200,deoxyribonucleoside triphosphate metabolic process
HGNC:17264,POLR1A
HP:0007688,Undetectable light- and dark-adapted electroretinogram
HGNC:8803,PDGFRA
MONDO:0006082,anal squamous cell carcinoma
MGI:5052367,"Tg(JPH3-GFP,-JPH3*)GXwy/0  [background:] involves: FVB/N"
HP:0001635,Congestive heart failure
MGI:3702933,Slc6a3<sup>tm1(cre)Lrsn</sup>/Slc6a3<sup>+</sup> Snca<sup>tm1Nbm</sup>/Snca<sup>tm1Nbm</sup> Tfam<sup>tm1Lrsn</sup>/Tfam<sup>tm1Lrsn</sup>  [background:] involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * SJL
iuphar.ligand:3415,[3H]CGS23131
chembl:CHEMBL1377408,FIPEXIDE HYDROCHLORIDE
CHEBI:16919,creatine
rxcui:4109,ETHACRYNIC ACID
drugbank:DB04365,ARECOLINE
ncit:C83549,BENZYL NICOTINATE
chembl:CHEMBL2435327,"(20S,21S)-FLUOROCAMPTOTHECIN"
NCBIGene:423016,DRD4
chembl:CHEMBL1595865,CHINOMETHIONAT
chembl:CHEMBL1594132,SERICETIN DIACETATE
HGNC:9864,RARA
chembl:CHEMBL499608,NAKIJIQUINONES H
iuphar.ligand:8094,AG14361
HGNC:24236,CCAR1
MONDO:0958236,Ullrich congenital muscular dystrophy 1C
MGI:1347466,Foxc1
iuphar.ligand:1773,PCMBS
rxcui:7533,NOSCAPINE
iuphar.ligand:3303,L745870
NCBIGene:770757,DRD3
UPHENO:0071321,abnormally formed posterior cranial fossa
GO:0042803,protein homodimerization activity
MGI:2659075,Cask<sup>Tg(Bnlf1)1Wln</sup>/Cask<sup>Tg(Bnlf1)1Wln</sup>  [background:] involves: C57BL/6J * CD-1 * DBA/2J
HGNC:24193,CALML6
rxcui:203136,RANITIDINE HYDROCHLORIDE
rxcui:228783,FROVATRIPTAN
iuphar.ligand:4138,ARGIOTOXIN
MGI:107430,Gdnf
chembl:CHEMBL3707253,BEVACIZUMAB 111IN
FB:FBgn0014032,Sptr
HP:0032819,Neonatal bilateral clonic seizure
ncit:C174710,SUVECALTAMIDE
chembl:CHEMBL1256291,CHEMBL:CHEMBL1256291
ncit:C71708,PRACINOSTAT
HP:0000979,Purpura
drugbank:DB02757,PYRAZOLE
chembl:CHEMBL454843,CANDIDIN
rxcui:73044,REPAGLINIDE
ncit:C2689,IH636 GRAPE SEED PROANTHOCYANIDIN EXTRACT
HP:0011275,Recurrent mycobacterium avium complex infections
rxcui:27392,TROPISETRON
UPHENO:0046323,abnormal creatine level
rxcui:2570737,MOBOCERTINIB SUCCINATE
NCBIGene:100848305,HIGD1C
MONDO:0001941,blindness (disorder)
HP:0001466,Contiguous gene syndrome
chembl:CHEMBL598663,CHEMBL:CHEMBL598663
chembl:CHEMBL494107,CHEMBL:CHEMBL494107
HP:0002126,Polymicrogyria
ncit:C81536,TUROFEXORATE ISOPROPYL
HP:0032707,Focal aware cognitive seizure with dyslexia/alexia
ncit:C72834,PRUVANSERIN
iuphar.ligand:6366,COMPOUND 24D [PMID: 23357634]
ncit:C65620,FARAMPATOR
iuphar.ligand:5050,PROTEIN S
chembl:CHEMBL1481974,CHEMBL:CHEMBL1481974
HGNC:24525,MMACHC
rxcui:1114345,BRONOPOL
HGNC:12644,VAMP3
MGI:3832331,Tmie<sup>sr</sup>/cir  [background:] involves: C57BL/6J * C57BL/How * ICR
rxcui:203151,FENOLDOPAM MESYLATE
rxcui:3143,PRASTERONE
HGNC:19129,PSAT1
rxcui:5293,HEXACHLOROPHENE
ncit:C2733,NIMOTUZUMAB
iuphar.ligand:404,XANTHINE AMINE CONGENER
chembl:CHEMBL592068,CHEMBL:CHEMBL592068
ncit:C29341,TALOTREXIN
chembl:CHEMBL3545289,AZD2207
HP:0000479,Abnormal retinal morphology
WB:WBGene00000833,cts-1
drugbank:DB07943,SD-0006
chembl:CHEMBL1208858,CALMIDAZOLIUM CHLORIDE
rxcui:6232,PROPIOMAZINE HYDROCHLORIDE
HP:0000603,Central scotoma
chembl:CHEMBL2022567,AMAUROMINE
HP:0007190,Neuronal loss in the cerebral cortex
MONDO:0014157,mandibular hypoplasia-deafness-progeroid syndrome
ncit:C1834,CILENGITIDE
MONDO:0011327,neuronal intranuclear inclusion disease
HP:0001761,Pes cavus
chembl:CHEMBL1095341,AESCULIOSIDE IIIC
ncit:C2471,CONTUSUGENE LADENOVEC
MGI:3706704,Cacna1a<sup>Wb</sup>/Cacna1a<sup>Wb</sup>  [background:] either: C3.B6-Cacna1a<sup>Wb</sup> or (involves: C3H/HeJ * C57BL/6J)
drugbank:DB05895,HGS-TR2J
rxcui:408142,MYCOPHENOLATE SODIUM
MGI:6715340,Fmr1<sup>tm1.1Ics</sup>/Fmr1<sup>tm1.1Ics</sup>  [background:] C57BL/6-Fmr1<sup>tm1.1Ics</sup>
chembl:CHEMBL244707,CHEMBL:CHEMBL244707
HP:0001396,Cholestasis
rxcui:37815,TERODILINE
ncit:C79109,CROMAKALIM
chembl:CHEMBL2171782,CHEMBL:CHEMBL2171782
chembl:CHEMBL1439833,CHEMBL:CHEMBL1439833
MONDO:0012078,Joubert syndrome 3
NCBIGene:100683846,NDUFB2
chembl:CHEMBL599957,CHEMBL:CHEMBL599957
ncit:C72841,RIVOGLITAZONE
HGNC:11114,KDM5C
chembl:CHEMBL453066,BETA-CCM
chembl:CHEMBL584883,CHEMBL:CHEMBL584883
MGI:3844642,Gt(ROSA)26Sor<sup>tm1(Nfatc2*)Rao</sup>/Gt(ROSA)26Sor<sup>+</sup> Tg(CMV-cre)1Cgn/0  [background:] involves: BALB/cJ
MONDO:0011866,pontocerebellar hypoplasia type 1A
HGNC:10583,SCN11A
HGNC:14981,PAPOLA
MGI:97453,Oxt
chembl:CHEMBL1336025,(+/-)-PENTAACETYLCATECHIN
chembl:CHEMBL592316,CHEMBL:CHEMBL592316
HP:0002240,Hepatomegaly
iuphar.ligand:11437,VU0409551
rxcui:6926,MEXILETINE
iuphar.ligand:4124,ADENOPHOSTIN A
NCBIGene:280878,NNT
MONDO:0005229,bacterial infectious disease with sepsis
HGNC:13919,BAG6
chembl:CHEMBL2109593,FGI-101-1A6
rxcui:203197,PHENAZOPYRIDINE HYDROCHLORIDE
CHEBI:17549,5-aminolevulinic acid
drugbank:DB16751,RLY-2608
chembl:CHEMBL175266,CHEMBL:CHEMBL175266
UPHENO:0075765,abnormal inferior rectus extraocular muscle
iuphar.ligand:9137,NEOCEPTIN-3
HP:0032919,Focal aware head nodding automatism seizure
chembl:CHEMBL591178,CHEMBL:CHEMBL591178
ncit:C152798,UMESPIRONE
chembl:CHEMBL1256995,CHEMBL:CHEMBL1256995
rxcui:190548,TIPRANAVIR
iuphar.ligand:1999,[125I]RELAXIN-3 (HUMAN)
UBERON:0010533,metanephros cortex
chembl:CHEMBL1701915,CHEMBL:CHEMBL1701915
HGNC:9360,PRF1
rxcui:6470,LORAZEPAM
ncit:C75036,DABUZALGRON
rxcui:8595,POTASSIUM DICHROMATE
HGNC:5384,IDH3A
UPHENO:0047365,dysgenesis of the cerebellar vermis
MGI:103008,Epb41l3
iuphar.ligand:4009,&ALPHA;-CONOTOXIN-GIC
UPHENO:0075766,abnormal inferior oblique extraocular muscle
MP:0000344,absent Cajal-Retzius cell
chembl:CHEMBL565540,CHEMBL:CHEMBL565540
iuphar.ligand:12845,KC-130
HP:0001712,Left ventricular hypertrophy
MP:0020870,decreased thigmotaxis
rxcui:2387211,TAFASITAMAB
drugbank:DB17048,PLUMBAGIN
HGNC:4688,GUCY2C
rxcui:49255,DOMIPHEN BROMIDE
CHEBI:27405,streptidine
HGNC:21051,MTRF1L
MONDO:0032632,"mitochondrial complex 1 deficiency, nuclear type 28"
GO:0042755,eating behavior
chembl:CHEMBL546576,CHEMBL:CHEMBL546576
rxcui:1219,ATRACURIUM BESYLATE
MONDO:0010725,X-linked retinoschisis
rxcui:114477,LEVETIRACETAM
rxcui:820,ANETHOLE TRITHIONE
HP:0000737,Irritability
chembl:CHEMBL3989861,DESVENLAFAXINE FUMARATE
rxcui:9991,SPIRAMYCIN
GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II
chembl:CHEMBL548681,CHEMBL:CHEMBL548681
drugbank:DB01892,HYPERFORIN
iuphar.ligand:5727,JNJ-38431055
HP:0011343,Moderate global developmental delay
HGNC:44317,PYURF
ncit:C75163,NERAMEXANE MESYLATE
HGNC:4070,GABBR1
chembl:CHEMBL1452359,STIROFOS
rxcui:203118,CEFOXITIN SODIUM
HGNC:30721,SPZ1
HP:0007859,Congenital horizontal nystagmus
drugbank:DB15579,CRYPTOTANSHINONE
iuphar.ligand:5570,"CP55,667"
MGI:106676,Zic3
ZFIN:ZDB-GENE-040426-1713,ndufv2
MONDO:0012631,Alzheimer disease 14
HP:0005155,Ventricular escape rhythm
HGNC:4714,H1-0
iuphar.ligand:4501,BENZYLCYSTEINE
rxcui:235758,BENAZEPRIL HYDROCHLORIDE
HGNC:33702,MICOS13
rxcui:2387308,MAGNESIUM OXYBATE
rxcui:25605,GAMMA-LINOLENIC ACID
FB:FBgn0003862,trx
chembl:CHEMBL1532097,DIHYDRODAPHNODORIN B
HGNC:6743,CAPRIN1
rxcui:11017,URIDINE
rxcui:1546428,FLUNISOLIDE ANHYDROUS
iuphar.ligand:8981,CONESSINE
GO:0070765,gamma-secretase complex
MONDO:0011061,"chorea, remitting, with nystagmus and cataract"
HGNC:5238,HSPA5
rxcui:38260,TIBOLONE
MONDO:0013150,"parkinsonism-dystonia, infantile"
GO:0030150,protein import into mitochondrial matrix
iuphar.ligand:8619,COMPOUND 28 [PMID: 16460935]
chembl:CHEMBL1255842,PRECLAMOL HYDROCHLORIDE
WB:WBGene00022456,pfkb-1.1
rxcui:66925,PROCARBAZINE HYDROCHLORIDE
chembl:CHEMBL119878,CHEMBL:CHEMBL119878
MGI:107848,Tubb4a
chembl:CHEMBL606166,CHEMBL:CHEMBL606166
ncit:C81447,COUMERMYCIN
rxcui:7486,NITROUS OXIDE
OBA:VT0000865,
drugbank:DB08633,TNP-470
UBERON:0001304,germinal epithelium of ovary
MONDO:0009772,oculorenocerebellar syndrome
HGNC:363,AK4
rxcui:1429044,"IBUPROFEN, SODIUM SALT"
iuphar.ligand:7886,FAMITINIB
ncit:C196,"BENZO(A)PYRENE-7,8-DIOL 9,10-EPOXIDE"
ncit:C74127,BENZIODARONE
HGNC:12508,UBQLN1
chembl:CHEMBL2109360,AS-1403
ncit:C73253,BROXYQUINOLINE
HP:0031982,Abnormal putamen morphology
MGI:3698041,Htt<sup>tm5Mem</sup>/Htt<sup>+</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * CD-1
NBO:0000339,motor coordination
chembl:CHEMBL3833346,TOFERSEN
CHEBI:456216,ADP(3-)
HP:0002540,Inability to walk
iuphar.ligand:7732,SM-337
MGI:3832988,Tg(CMV-TOR1A*)1Nush/0  [background:] involves: C3H * C57BL/6
MP:0000876,Purkinje cell degeneration
iuphar.ligand:6057,VEGF RECEPTOR TYROSINE KINASE INHIBITOR III
ncit:C103825,SMAC MIMETIC GDC-0917
rxcui:1987,CAPREOMYCIN SULFATE
MONDO:0850001,congenital neuronal ceroid lipofuscinosis
rxcui:10156,SUCRALFATE
chembl:CHEMBL294740,SCLAREOL
Xenbase:XB-GENE-5903984,cyp2a6.3
iuphar.ligand:9582,HSTX1[R14A]
chembl:CHEMBL251235,GISENOSIDE RK1
drugbank:DB15396,VAMOTINIB
HGNC:7803,NFX1
HGNC:21393,RWDD3
drugbank:DB16843,ODM-203
HGNC:6836,MAP1B
CHEBI:8707,quetiapine
GO:0005102,signaling receptor binding
chembl:CHEMBL478791,GERONTOXANTHONE I
CHEBI:84338,synthalin A
MONDO:0005059,leukemia
ncit:C156766,MECLINERTANT
iuphar.ligand:12513,BM213
rxcui:83008,BICALUTAMIDE
chembl:CHEMBL2106483,VILOXAZINE HYDROCHLORIDE
rxcui:18602,AZELAIC ACID
CHEBI:34848,mevastatin
HGNC:21606,MPC1
iuphar.ligand:7714,AZD8055
MONDO:0010639,laryngeal abductor paralysis-intellectual disability syndrome
UPHENO:0067996,increased level of creatine in urine
iuphar.ligand:1376,AIDA
CHEBI:25179,melanins
HP:0011388,Enlarged cochlear aqueduct
rxcui:3268,DEXFENFLURAMINE
HP:0032855,Photosensitive myoclonic-tonic-clonic seizure
ncit:C65877,ICLAPRIM
CHEBI:16796,melatonin
HP:0007367,Atrophy/Degeneration affecting the central nervous system
UBERON:0001614,superficial temporal artery
chembl:CHEMBL523200,CHEMBL:CHEMBL523200
chembl:CHEMBL225963,PYRIDABEN
ncit:C81040,CYCLOVALONE
HP:0007112,Temporal cortical atrophy
iuphar.ligand:12089,RUSERONTINIB
HP:0000275,Narrow face
GO:0004674,protein serine/threonine kinase activity
rxcui:35636,RISPERIDONE
MGI:1914342,Gatm
hemonc:337,MOCETINOSTAT
rxcui:4885,GLUTAMINE
drugbank:DB03095,TETRAMETHYLAMMONIUM
MONDO:0010709,early-onset parkinsonism-intellectual disability syndrome
chembl:CHEMBL1379900,CHEMBL:CHEMBL1379900
ncit:C163981,PIMURUTAMAB
rxcui:1314347,DIOSMETIN
rxcui:39879,MEPIRODIPINE
iuphar.ligand:5750,COMPOUND 20F [PMID: 21536438]
rxcui:1371041,ADO-TRASTUZUMAB EMTANSINE
chembl:CHEMBL530115,GUTHION
rxcui:25113,FLUMETHASONE PIVALATE
ncit:C77970,FGF RECEPTOR ANTAGONIST HGS1036
HP:0011933,Elongated superior cerebellar peduncle
HGNC:11277,SPTLC1
HP:0000331,Short chin
chembl:CHEMBL547833,CHEMBL:CHEMBL547833
chembl:CHEMBL2022560,APRATOXIN F
rxcui:1546387,CARBAMOYLCHOLINE
iuphar.ligand:8959,ENSARTINIB
drugbank:DB15311,DAVANAT
HGNC:1101,BRCA2
chembl:CHEMBL1487183,ALEXIDINE HYDROCHLORIDE
HGNC:7059,MGMT
ncit:C1310,RO 31-8220
HGNC:2529,CTSD
iuphar.ligand:8759,L-NNA
HP:0000565,Esotropia
iuphar.ligand:9552,NITROSOPRODENAFIL
MONDO:0043224,multi-infarct dementia
HP:0002345,Action tremor
chembl:CHEMBL367741,DIFFRACTAIC ACID
MP:0002183,gliosis
chembl:CHEMBL471225,CHEMBL:CHEMBL471225
chembl:CHEMBL1869353,ACEQUINOCYL
rxcui:1242999,AXITINIB
ncit:C80058,FORETINIB
ncit:C62435,DOVITINIB LACTATE
chembl:CHEMBL1824581,SOPHORIDINE
ncit:C97941,PONEZUMAB
GO:0017196,N-terminal peptidyl-methionine acetylation
ncit:C172382,MEK 1/2 INHIBITOR FCN-159
HGNC:11699,SERINC3
GO:0007005,mitochondrion organization
chembl:CHEMBL1702181,CHEMBL:CHEMBL1702181
iuphar.ligand:9637,A77636
chembl:CHEMBL3545074,LEO-15520
MONDO:0017998,PLA2G6-associated neurodegeneration
HGNC:1097,BRAF
HP:0100707,Abnormal astrocyte morphology
MONDO:0013469,retinitis pigmentosa 38
MONDO:0005988,toxocariasis
CHEBI:35341,steroid
ncit:C171871,CRENIGACESTAT
chembl:CHEMBL203014,TRIPHENYLBISMUTHINE
iuphar.ligand:4847,[125I]CNP (HUMAN)
HGNC:9179,POLG
HP:0000579,Nasolacrimal duct obstruction
Reactome:R-SPO-71288,Creatine metabolism
chembl:CHEMBL1897483,TRIFLOXYSTROBIN
chembl:CHEMBL5095232,DDP-225
MONDO:0003582,hereditary breast ovarian cancer syndrome
rxcui:6475,LOXAPINE
ncit:C79870,DINALINE
ncit:C123914,OLECLUMAB
ZFIN:ZDB-GENE-060810-80,pkmyt1
GO:0005507,copper ion binding
MONDO:0017639,carbon monoxide-induced parkinsonism
iuphar.ligand:1335,AGOUTI-RELATED PROTEIN
ncit:C83613,CETHROMYCIN
chembl:CHEMBL1077773,CHEMBL:CHEMBL1077773
UBERON:0001474,bone element
ncit:C77872,GANETESPIB
UBERON:0015828,cerebellum ventricular layer
iuphar.ligand:12735,GLPG1837
HGNC:28871,IER2
iuphar.ligand:12441,(&PLUSMN;)-EQUOL
MGI:102780,Six1
CHEBI:87113,antibiotic antifungal drug
chembl:CHEMBL2036119,CHEMBL:CHEMBL2036119
iuphar.ligand:2754,GW3965
chembl:CHEMBL265582,TNF-ALPHA
HP:0007670,Abnormal vestibulo-ocular reflex
iuphar.ligand:3325,U75302
HGNC:3671,FGF14
MGI:99698,Clock
HGNC:7208,MPDZ
chembl:CHEMBL1834952,ELATOSIDE D
HGNC:6973,MDM2
ncit:C61305,SIVIFENE
iuphar.ligand:11288,R-VK4-40
chembl:CHEMBL576412,CHEMBL:CHEMBL576412
RGD:1307713,Naa20
iuphar.ligand:3967,DMPP
chembl:CHEMBL1392,"2,4-DIHYDROXYBENZOPHENONE"
chembl:CHEMBL65675,GALLIC ACID METHYL ESTER
FB:FBgn0015270,Orc2
MONDO:0008201,Perry syndrome
MP:0003245,abnormal GABAergic neuron morphology
drugbank:DB12903,DEBIO-1347
rxcui:1440856,CHOLIC ACID
rxcui:2641822,EPICATECHIN
HP:0012706,Elevated brain choline level by MRS
rxcui:1440264,AMINOPTERIN
rxcui:237027,LOTEPREDNOL
ncit:C65450,DIZOCILPINE
HGNC:11596,TBX19
CHEBI:4887,ethosuximide
HGNC:13723,CTCF
HP:0001927,Acanthocytosis
HGNC:14037,MRPL24
MGI:103070,H2-Ab1
CHEBI:142517,tschimganine
HGNC:3554,HSD17B8
HP:0001065,Striae distensae
MONDO:0032679,combined oxidative phosphorylation deficiency 37
iuphar.ligand:1425,[3H]M-MPEP
drugbank:DB12138,PF-03715455
ncit:C66720,EXATECAN
iuphar.ligand:795,[3H]BANYU (I)
MONDO:0004648,vascular dementia
HP:0009734,Optic nerve glioma
iuphar.ligand:1363,LUZINDOLE
GO:0007637,proboscis extension reflex
HGNC:4195,GCK
MGI:3698042,Htt<sup>tm5Mem</sup>/Htt<sup>tm5Mem</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * CD-1
MGI:3836725,Efhc1<sup>tm1Kzy</sup>/Efhc1<sup>+</sup>  [background:] B6.129P2-Efhc1<sup>tm1Kzy</sup>
chembl:CHEMBL1224755,CHEMBL:CHEMBL1224755
chembl:CHEMBL582055,CHEMBL:CHEMBL582055
chembl:CHEMBL462721,GLABROL
rxcui:8001,PENTAZOCINE
ncit:C809,RICIN
iuphar.ligand:7912,LCL161
HP:0100830,Round ear
MGI:3793274,Atp7b<sup>tx-J</sup>/Atp7b<sup>tx-J</sup>  [background:] C3H/HeJ-Atp7b<sup>tx-J</sup>/J
rxcui:4495,FLUPENTHIXOL
iuphar.ligand:4239,L689560
iuphar.ligand:10283,SAR7334
rxcui:19759,BROMODIPHENHYDRAMINE
rxcui:236553,ROPINIROLE HYDROCHLORIDE
chembl:CHEMBL487185,FLUTOLANIL
MGI:3831436,Brca2<sup>tm1Cam</sup>/Brca2<sup>tm1Cam</sup>  [background:] 129S/SvEv-Brca2<sup>tm1Cam</sup>
HGNC:25128,OXNAD1
EMAPA:17844,eye skeletal muscle
ncit:C175863,TEREVALEFIM
MGI:1278315,Lrp5
iuphar.ligand:1798,"[ILE5,TRP23]PTHRP-(1-36) (HUMAN)"
HP:0000460,Narrow nose
chembl:CHEMBL119870,PHENAZINE
CHEBI:6636,magnesium dichloride
rxcui:6927,MEZLOCILLIN
CL:0000182,hepatocyte
MGI:4360690,Tg(Eno2-ATN1)3Tx/Tg(Eno2-ATN1)3Tx  [background:] B6.Cg-Tg(Eno2-ATN1)3Tx
HGNC:11167,SNTA1
rxcui:81999,DILTIAZEM MALATE
ncit:C1517,STALLIMYCIN
rxcui:68503,ZICONOTIDE
GO:0048588,developmental cell growth
rxcui:2556,CITALOPRAM
MONDO:0011764,autosomal dominant Parkinson disease 8
rxcui:81949,AMINACRINE HYDROCHLORIDE
iuphar.ligand:10947,NIK INHIBITOR 12F
HGNC:6879,MAPK6
HGNC:9534,PSMA5
MONDO:0035345,chronic bilirubin encephalopathy
ncit:C78040,BITHIONOLOXIDE
chembl:CHEMBL3545138,PRT-2607
rxcui:10493,THIOPENTAL
chembl:CHEMBL1726814,CHEMBL:CHEMBL1726814
MONDO:0007624,Flynn-Aird syndrome
MONDO:0010476,neurodegeneration with brain iron accumulation 5
ncit:C1198,POLY ICLC
HP:0002371,Loss of speech
iuphar.ligand:5950,CDK4 INHIBITOR
chembl:CHEMBL582180,CHEMBL:CHEMBL582180
drugbank:DB17025,DIPHENYLENEIODONIUM
chembl:CHEMBL1833984,CHEMBL:CHEMBL1833984
HGNC:4137,GAN
chembl:CHEMBL388342,BOLDINE
HGNC:3431,ERBB3
RGD:620305,Hip1
HGNC:1527,CAV1
MP:0001889,delayed brain development
iuphar.ligand:11326,ATIBUCLIMAB
CHEBI:45951,trifluoperazine
rxcui:1325,BARBITAL
FB:FBgn0051730,CG31730
rxcui:221072,CERIVASTATIN SODIUM
chembl:CHEMBL548615,CHEMBL:CHEMBL548615
HGNC:24519,TCTN3
chembl:CHEMBL254156,CHEMBL:CHEMBL254156
iuphar.ligand:7018,BROMO-DEAZA-SAH
ncit:C1124,HERBIMYCIN
HGNC:78,ABLIM1
EMAPA:35232,cerebellum vermis lobule VII
MGI:3617307,Abcd1<sup>tm1Kds</sup>/Y  [background:] involves: 129S4/SvJae * C57BL/6J
HGNC:11164,SNRPN
drugbank:DB15586,PATULIN
MONDO:0018055,pediatric hepatocellular carcinoma
rxcui:114176,ZUCLOPENTHIXOL
ncit:C1867,ORTATAXEL
chembl:CHEMBL44201,BIPHENYL-4-AMINE
HGNC:25507,VAC14
chembl:CHEMBL571228,CHEMBL:CHEMBL571228
ncit:C98053,TOZASERTIB
HP:0100033,Tics
chembl:CHEMBL2331680,RG-7603
ZFIN:ZDB-GENE-040426-1886,ndufb7
HP:0006237,Prominent interphalangeal joints
OBA:2001029,age of onset of multiple sclerosis
PR:000002064,macrosialin
HGNC:2976,DNMT1
MGI:3698039,Htt<sup>tm4Mem</sup>/Htt<sup>tm4Mem</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * CD-1
drugbank:DB05482,SN-38
MGI:3815023,Fmr1<sup>tm2Cgr</sup>/Y  [background:] involves: 129P2/OlaHsd * C57BL/6J * FVB
CHEBI:26355,heme b
iuphar.ligand:6528,UK-356618
HGNC:10555,ATXN2
CHEBI:46920,N-methylpiperazine
HGNC:8620,PAX6
iuphar.ligand:6565,S 17092
iuphar.ligand:5142,ARACHIDONYL TRIFLUOROMETHYL KETONE
rxcui:203128,MIDAZOLAM HYDROCHLORIDE
drugbank:DB12284,LY-2608204
ncit:C101895,ELGEMTUMAB
ncit:C79930,BICIFADINE
rxcui:641,AMIKACIN
chembl:CHEMBL2103857,EDIVOXETINE
chembl:CHEMBL590675,CHEMBL:CHEMBL590675
HGNC:1388,CACNA1A
HGNC:29239,INTU
HP:0001008,Accumulation of melanosomes in melanocytes
CHEBI:36699,corticosteroid hormone
chembl:CHEMBL1200512,IRINOTECAN HYDROCHLORIDE HYDRATE
chembl:CHEMBL580851,CHEMBL:CHEMBL580851
drugbank:DB11888,LANINAMIVIR OCTANOATE
iuphar.ligand:773,HIV-TAT
HP:0002518,Abnormal periventricular white matter morphology
iuphar.ligand:8062,MRT67307
drugbank:DB12556,MK-5108
chembl:CHEMBL1256754,CHEMBL:CHEMBL1256754
iuphar.ligand:6999,ANACARDIC ACID
MGI:1926387,Cdon
HGNC:6774,SMAD9
ZFIN:ZDB-FISH-170823-11,TL + MO1-cln3
ncit:C171677,DIPRAGLURANT
MONDO:0957386,"neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities"
ncit:C77876,GLESATINIB
ncit:C1545,RECOMBINANT HUMAN INTERLEUKIN-15
rxcui:5281,HESPERIDIN
HGNC:4868,HERC2
HGNC:12470,UBA3
UBERON:0004076,cerebellum vermis lobule III
chembl:CHEMBL305695,CHEMBL:CHEMBL305695
iuphar.ligand:230,YM348
CLINVAR:133074,NM_000540.3(RYR1):c.14512C>G (p.Leu4838Val)
chembl:CHEMBL583150,CHEMBL:CHEMBL583150
iuphar.ligand:8703,PK 11195
chembl:CHEMBL430893,(-)-ROLIPRAM
HP:0000666,Horizontal nystagmus
HGNC:14262,AUTS2
rxcui:3120,DEQUALINIUM CHLORIDE
GO:0043524,negative regulation of neuron apoptotic process
HP:0003309,Ovoid thoracolumbar vertebrae
chembl:CHEMBL601528,CHEMBL:CHEMBL601528
HP:0003109,Hyperphosphaturia
ncit:C77945,DEXPROPRANOLOL HYDROCHLORIDE
HGNC:937,BAG1
rxcui:9997,SPIRONOLACTONE
iuphar.ligand:6228,VU0001171
ncit:C76933,ADIPIPLON
Xenbase:XB-GENE-962418,cyb5r3
HP:0002167,Abnormality of speech or vocalization
iuphar.ligand:6173,GUE1654
HP:0031993,Hoffmann sign
HGNC:11424,STRN
HGNC:9834,RAI1
RGD:628595,Tubb3
UBERON:0001379,vastus lateralis
HP:0011173,Focal behavior arrest seizure
rxcui:115238,BECAPLERMIN
HGNC:6436,KRT19
MGI:5810133,Bicd2<sup>tm1.1Hgrd</sup>/Bicd2<sup>tm1.1Hgrd</sup>  [background:] involves: C57BL/6
MONDO:0016707,astroblastoma
FB:FBgn0027655,htt
iuphar.ligand:5057,SU11274
iuphar.ligand:9360,KU-0063794
HGNC:15518,DCTN4
HP:0032910,Focal aware automatism seizure
GO:0001822,kidney development
chembl:CHEMBL187734,TETRADECYLTHIOACETIC ACID
drugbank:DB05190,XL281
chembl:CHEMBL1383812,CHEMBL:CHEMBL1383812
iuphar.ligand:2630,&MU;-CONOTOXIN GIIIA
HP:0031629,Impaired tandem gait
chembl:CHEMBL436279,CHELIDONINE (+)
HP:0001260,Dysarthria
MONDO:0012430,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2"
chembl:CHEMBL1086397,CHEMBL:CHEMBL1086397
drugbank:DB08079,AMG-208
MONDO:0021147,disorder of development or morphogenesis
HP:0008629,Pulsatile tinnitus
HGNC:14598,IMMP2L
chembl:CHEMBL434750,ERGOSTEROL PEROXIDE
ncit:C318,BROXURIDINE
HP:0002324,Hydranencephaly
HP:0032904,Focal verbal automatism seizure
drugbank:DB15386,ALT-801
HP:0009830,Peripheral neuropathy
ncit:C72742,DIMETHISOQUIN HYDROCHLORIDE
ZFIN:ZDB-GENE-980526-561,myod1
ncit:C90890,ARBACLOFEN
iuphar.ligand:2215,"D(CH2)5[D-ILE2,ILE4,ALA-NH2]AVP"
ncit:C74069,ETIRINOTECAN PEGOL
MGI:97783,Psap
HGNC:29866,NFASC
MGI:106054,Psmc1
chembl:CHEMBL4303611,PFK-158
ncit:C75156,DIPHENADIONE
rxcui:3014,CYPROTERONE
chembl:CHEMBL401844,CHEMBL:CHEMBL401844
CHEBI:17203,L-proline
drugbank:DB05415,OSI-461
chembl:CHEMBL583578,CHEMBL:CHEMBL583578
iuphar.ligand:1417,CHPG
HP:0032673,Focal non-convulsive status epilepticus without coma
chembl:CHEMBL1797709,CHEMBL:CHEMBL1797709
HGNC:619,APOL2
ncit:C1639,IODINE I-131
ZFIN:ZDB-GENE-070719-1,sprb
Reactome:R-BTA-549127,Organic cation transport
HP:0009938,Sunken cheeks
HGNC:8805,PDGFRL
rxcui:2058848,DACOMITINIB ANHYDROUS
HGNC:16696,SNW1
HGNC:18858,PIGM
Reactome:R-GGA-211945,Phase I - Functionalization of compounds
rxcui:227221,ETIDOCAINE HYDROCHLORIDE
rxcui:161,ACETAMINOPHEN
ncit:C85481,PEXMETINIB
HGNC:11616,TCEAL1
iuphar.ligand:10971,SCH-79797
rxcui:1366666,ROTENONE
rxcui:477631,BUTABARBITAL
HGNC:14927,TSGA10
rxcui:18631,AZITHROMYCIN
HP:0000938,Osteopenia
HGNC:1306,MPPED1
HGNC:18704,NAA10
HGNC:24152,RSRC1
MONDO:0012816,"atrial fibrillation, familial, 6"
NBO:0000015,aggressive behavior
HGNC:10434,RPS6KA5
iuphar.ligand:67,9-OH-RISPERIDONE
rxcui:1661017,ABT-925
chembl:CHEMBL1332204,ARTHONIOIC ACID
CHEBI:36816,oxime O-ether
HP:0005661,Salmonella osteomyelitis
HGNC:10530,SAP18
MGI:5766948,Del(16Dgcr2-Hira)3Aam/+  [background:] involves: 129S7/SvEvBrd
MONDO:0002909,hyperglycemia
CL:0000188,cell of skeletal muscle
rxcui:3446,SUCCIMER
chembl:CHEMBL195953,ALDRIN
HGNC:5047,HNRNPR
ncit:C62791,PEGDINETANIB
chembl:CHEMBL601192,CHEMBL:CHEMBL601192
iuphar.ligand:5575,"[ALA1,12,AIB3,GLN10,HARG11,TRP14,ARG19]PTH-(1-21)-NH2 (HUMAN)"
rxcui:3255,DESOXIMETASONE
HGNC:7745,NEK2
GO:0010467,gene expression
rxcui:11055,UROKINASE
HGNC:18445,CALML4
drugbank:DB11721,MITOGLITAZONE
MGI:102850,Klk1
rxcui:1232150,AFLIBERCEPT
chembl:CHEMBL2171793,CHEMBL:CHEMBL2171793
MP:0000554,abnormal carpal bone morphology
rxcui:36676,SODIUM BICARBONATE
ncit:C116628,DULIGOTUZUMAB
rxcui:2550714,SOTORASIB
chembl:CHEMBL588143,CHEMBL:CHEMBL588143
iuphar.ligand:324,HIMBACINE
chembl:CHEMBL602740,CHEMBL:CHEMBL602740
HGNC:4398,GNB2
iuphar.ligand:137,5-HT-MODULINE
MGI:98365,Sox3
rxcui:142437,FLAVOXATE HYDROCHLORIDE
MONDO:0013598,myostatin-related muscle hypertrophy
rxcui:2183,CEFONICID
MONDO:0017730,"metachromatic leukodystrophy, adult form"
HGNC:15476,DYNLL1
UBERON:0001605,ciliary muscle
HGNC:6511,LARGE1
rxcui:1918,CALCIUM PANTOTHENATE
chembl:CHEMBL221300,CHEMBL:CHEMBL221300
rxcui:214470,DENILEUKIN DIFTITOX
rxcui:2592960,CHALCONE
chembl:CHEMBL1164992,TRICIFEROL
chembl:CHEMBL582507,CHEMBL:CHEMBL582507
CLINVAR:133012,NM_000540.3(RYR1):c.11315G>A (p.Arg3772Gln)
MP:0009937,abnormal neuron differentiation
rxcui:3100,DACTINOMYCIN
ncit:C2132,BOMBESIN ANTAGONIST
chembl:CHEMBL3545179,AZD-7451
iuphar.ligand:1420,ADX-47273
MP:0002757,decreased vertical activity
iuphar.ligand:11095,ARRY-371797
MONDO:0957210,neurooculorenal syndrome
NCBIGene:282200,COX6A2
HGNC:7744,NEK1
HGNC:3070,DUSP4
HP:0001278,Orthostatic hypotension
iuphar.ligand:9601,CATEQUENTINIB
chembl:CHEMBL109873,CHEMBL:CHEMBL109873
HP:0032789,Focal aware behavior arrest seizure
chembl:CHEMBL2094549,CHEMBL:CHEMBL2094549
HP:0000211,Trismus
ncit:C103298,BIRABRESIB
rxcui:72257,INTERFERON BETA-1B
Reactome:R-DRE-549127,Organic cation transport
MONDO:0859225,neurodevelopmental disorder with or without variable movement or behavioral abnormalities
chembl:CHEMBL590695,CHEMBL:CHEMBL590695
iuphar.ligand:12258,MONNA
HP:0002401,Stroke-like episode
rxcui:1921069,ABALOPARATIDE
ncit:C29812,BETA-NAPHTHOFLAVONE
HGNC:7001,MEIS2
ncit:C116326,ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDE AZD5312
HP:0032231,Hypochromia
MONDO:0010383,fragile X syndrome
MGI:3804729,Tpp1<sup>tm1Plob</sup>/Tpp1<sup>tm1.1Plob</sup>  [background:] B6.129S1-Tpp1<sup>tm1Plob</sup>/Tpp1<sup>tm1.1Plob</sup>
HGNC:16652,MRPL47
HGNC:12856,YY1
HGNC:26128,SPRING1
rxcui:42954,VITAMIN B6
UBERON:0001711,eyelid
HP:0032728,Focal impaired awareness atonic seizure
iuphar.ligand:8388,CHAETOCIN
rxcui:5036,GUANETHIDINE
chembl:CHEMBL1276446,CHEMBL:CHEMBL1276446
rxcui:1597582,OLAPARIB
rxcui:10800,TRIFLUOPERAZINE
HP:0000774,Narrow chest
HP:0032901,Focal pedal automatism seizure
HGNC:6996,MEF2C
rxcui:1598096,PERAMIVIR ANHYDROUS
ncit:C87494,ECOPIPAM HYDROCHLORIDE
HGNC:7464,MTNR1B
HP:0002453,Abnormal globus pallidus morphology
HP:0032748,Focal impaired awareness emotional seizure with anger
iuphar.ligand:4762,[123I]IODOBENZOVESAMICOL
rxcui:6782,MESTRANOL
MONDO:0006074,adenosquamous carcinoma
iuphar.ligand:5764,SB 218795
ncit:C169804,BELIZATINIB
HP:0001335,Bimanual synkinesia
HP:0002046,Heat intolerance
ncit:C74059,REFAMETINIB
MONDO:0007488,Lewy body dementia
chembl:CHEMBL528181,CHEMBL:CHEMBL528181
HP:0032821,Neonatal electro-clinical tonic seizure
HGNC:7795,NFKB2
EMAPA:17493,knee
MONDO:0015547,hereditary dementia
chembl:CHEMBL388823,CHEMBL:CHEMBL388823
iuphar.ligand:11348,PJ34
rxcui:2473850,MARGETUXIMAB-CMKB
HGNC:9330,PQBP1
MGI:2668531,Hprt1<sup>tm2Detl</sup>/Y  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
iuphar.ligand:707,CA2+
chembl:CHEMBL584829,CHEMBL:CHEMBL584829
iuphar.ligand:339,"WIN 51,708"
HP:0001336,Myoclonus
MP:0002797,increased thigmotaxis
HP:0003391,Gowers sign
MONDO:0010547,X-linked progressive cerebellar ataxia
MONDO:0020749,polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1
iuphar.ligand:10386,CELASTROL
rxcui:8163,PHENYLEPHRINE
rxcui:2623,CLOTRIMAZOLE
drugbank:DB17911,CEQ508
iuphar.ligand:128,5-OH-DPAT
HP:0012090,Abnormal pancreas morphology
CHEBI:31355,carboplatin
chembl:CHEMBL1395447,NITROVIN
chembl:CHEMBL579224,METHYSTICIN
MP:0004354,absent deltoid tuberosity
HGNC:7693,NDUFA9
drugbank:DB05525,EW-A-401
HGNC:19353,SIN3A
iuphar.ligand:8122,COMPOUND 25 [PMID: 17935989]
chembl:CHEMBL578061,CHEMBL:CHEMBL578061
chembl:CHEMBL129857,AS-602868
chembl:CHEMBL83159,CHEMBL:CHEMBL83159
HGNC:30239,CYSTM1
MONDO:1040015,infectious disease with sepsis
ncit:C95220,VOLINANSERIN
HGNC:9701,PURA
HGNC:14169,FAHD1
RGD:70896,Ces1d
HGNC:16509,SSX2IP
iuphar.ligand:14,GR 127935
ncit:C80870,TOCERANIB
iuphar.ligand:10389,RIPK3 INHIBITOR 18
ncit:C72599,NITROMIDE
chembl:CHEMBL60696,TETRABUTYLAMMONIUM BROMIDE
chembl:CHEMBL114957,TOLUIC ACID
PomBase:SPCC736.03c,msf1
iuphar.ligand:978,"L-750,667"
iuphar.ligand:6394,LSN2463359
iuphar.ligand:5350,CYCLOPIAZONIC ACID
chembl:CHEMBL502496,CHEMBL:CHEMBL502496
HP:0000473,Torticollis
chembl:CHEMBL39541,DOLASTATIN-10
MGI:3033221,Cacnb4<sup>lh-3J</sup>/Cacnb4<sup>lh-3J</sup>  [background:] C3HeB/FeJ-Cacnb4<sup>lh-3J</sup>/GrsrJ
wikidata:Q29006632,VARGATEF
iuphar.ligand:2916,DIOCTANOYLGLYCEROL PYROPHOSPHATE
chembl:CHEMBL72631,INDOMETHACIN MORPHOLINYLAMIDE
MONDO:0015967,monogenic diabetes
UBERON:0000956,cerebral cortex
OBA:2040167,age of onset of cervical dystonia
chembl:CHEMBL2133153,ETHOFUMESATE
iuphar.ligand:11099,COMPOUND 3M [PMID: 32603117]
GO:0060006,angular vestibuloocular reflex
chembl:CHEMBL525519,CHEMBL:CHEMBL525519
ncit:C26669,SEOCALCITOL
HGNC:7692,NDUFA8
HP:0000085,Horseshoe kidney
ncit:C116624,NAVTEMADLIN
MP:0021024,abnormal cerebrospinal fluid physiology
HP:0000822,Hypertension
CHEBI:35610,antineoplastic agent
iuphar.ligand:218,2-METHYL-5-HT
chembl:CHEMBL363207,DICHLORODIPHENYLDICHLOROETHYLENE
MONDO:0011007,diaphragmatic defect-limb deficiency-skull defect syndrome
iuphar.ligand:5215,LUTEOLIN
MONDO:0007020,Wernicke encephalopathy
CHEBI:10023,voriconazole
MONDO:0018940,congenital myasthenic syndrome
HP:0020218,Focal aware atonic seizure
MP:0009958,absent cerebellar granule cells
HP:0004855,Reduced protein S activity
ncit:C2347,FREUND'S ADJUVANT
HGNC:33711,MBLAC2
rxcui:6728,VITAMIN K3
HGNC:11206,SP100
HGNC:30879,ITFG2
MGI:1930780,Myh10
RGD:62038,Dctn1
MP:0013931,abnormal olfactory bulb position
HP:0000480,Retinal coloboma
MGI:3693305,Grin1<sup>tm1Yql</sup>/Grin1<sup>tm1Yql</sup> Rgs9<sup>tm1.1(cre)Yql</sup>/Rgs9<sup>+</sup>  [background:] involves: 129/Sv * BALB/c * C57BL/6
RGD:1563603,Rad51
MP:0000789,thickened cerebral cortex
iuphar.ligand:11541,SR-0813
rxcui:10173,SULFADOXINE
rxcui:1433347,BISPHENOL A
rxcui:23744,DYCLONINE
GO:0030182,neuron differentiation
MONDO:0700089,paroxysmal nonkinesigenic dyskinesia 1
MONDO:0006152,colon inflammatory polyp
rxcui:1294588,OLANZAPINE PAMOATE
ZFIN:ZDB-GENE-150115-1,ccdc50a
MGI:3718115,Tg(Camk2a-MAPT*R406W)748Atak/0  [background:] involves: C57BL/6 * SJL
HGNC:303,AEBP1
chembl:CHEMBL3137691,QUINUPRISTIN/DALFOPRISTIN
MONDO:0010061,autosomal recessive cerebellar ataxia-blindness-deafness syndrome
HGNC:7965,NR1H2
iuphar.ligand:361,TRIPITRAMINE
rxcui:8013,PENTOXIFYLLINE
HGNC:9410,PRKCQ
chembl:CHEMBL251647,(S)-PINACIDIL
MONDO:0018544,adrenoleukodystrophy
GO:0042802,identical protein binding
rxcui:11198,VINBLASTINE
HGNC:17173,BOC
MONDO:0011913,Alzheimer disease 3
chembl:CHEMBL493439,EMETINE HYDROCHLORIDE
CHEBI:34999,teicoplanin A3-1
GO:0005765,lysosomal membrane
rxcui:227240,PHENTOLAMINE MESYLATE
iuphar.ligand:10,BRL-15572
drugbank:DB12986,VS-5584
chembl:CHEMBL3545398,PG-760564
rxcui:6757,MEPHENYTOIN
iuphar.ligand:5554,O-ARACHIDONOYL ETHANOLAMINE
MGI:3767861,Ercc6<sup>tm1Gvh</sup>/Ercc6<sup>tm1Gvh</sup> Xpa<sup>tm1Hvs</sup>/Xpa<sup>tm1Hvs</sup>  [background:] B6.129P2-Xpa<sup>tm1Hvs</sup> Ercc6<sup>tm1Gvh</sup>
iuphar.ligand:11102,A-1331852
ncit:C116355,BERZOSERTIB
MONDO:0023249,polyarticular juvenile rheumatoid arthritis
rxcui:4448,FLOXACILLIN
HGNC:8777,PDE2A
MP:0000787,abnormal telencephalon morphology
HGNC:9457,PLPBP
HGNC:11579,TBCA
chembl:CHEMBL251254,HYPEROSIDE
chembl:CHEMBL610622,CHEMBL:CHEMBL610622
iuphar.ligand:2408,NIP-142
RGD:3208,Mecr
chembl:CHEMBL486133,LEPTOMYCIN B
ncit:C80874,CHLORACYZINE
chembl:CHEMBL581574,CHEMBL:CHEMBL581574
CHEBI:478164,cefepime
chembl:CHEMBL458094,CHEMBL:CHEMBL458094
MONDO:0013875,"3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome"
iuphar.ligand:4068,(RS)-(TETRAZOL-5-YL)GLYCINE
MONDO:0100517,PSAP-related sphingolipidosis
drugbank:DB17015,MRK-003
HGNC:7728,NEDD4L
HP:0011146,Dialeptic seizure
HGNC:2074,CLN3
HP:0032835,Neonatal seizure with bilateral symmetric automatism
iuphar.ligand:3976,[125I]EPIBATIDINE
chembl:CHEMBL601325,CHEMBL:CHEMBL601325
chembl:CHEMBL1520346,CHEMBL:CHEMBL1520346
HGNC:2514,CTNNB1
HP:0001349,Facial diplegia
iuphar.ligand:3296,[3H]7-OH-DPAT
rxcui:314845,SOMATROPIN (RECOMBINANT DNA ORIGIN)
ncit:C61576,CANTUZUMAB RAVTANSINE
HGNC:14415,ELOVL4
HGNC:2761,DEFA1
UPHENO:0068538,increased level of nitrogen molecular entity in independent continuant
HP:0000542,Impaired ocular adduction
ncit:C71467,LUMINESPIB
chembl:CHEMBL169300,DEHYDROXYMETHYLEPOXYQUINOMICIN
MONDO:0012278,"supranuclear palsy, progressive, 2"
drugbank:DB11795,GSK-2636771
rxcui:56946,PACLITAXEL
rxcui:1873752,PLECANATIDE
MONDO:0011194,Alzheimer disease 5
iuphar.ligand:8979,GSK-J4
HP:0002633,Vasculitis
NCBIGene:100526075,ALDH3A1
chembl:CHEMBL2059711,CHEMBL:CHEMBL2059711
rxcui:2477103,TEPOTINIB
ncit:C95726,LUCITANIB
ncit:C72627,AMBAZONE
ncit:C152866,VEROSUDIL
chembl:CHEMBL585243,CHEMBL:CHEMBL585243
chembl:CHEMBL597857,CHEMBL:CHEMBL597857
rxcui:5489,HYDROCODONE
rxcui:7814,OXYMORPHONE
chembl:CHEMBL483633,CHEMBL:CHEMBL483633
chembl:CHEMBL600334,CHEMBL:CHEMBL600334
chembl:CHEMBL3678076,EVENAMIDE
iuphar.ligand:11897,ORLUDODSTAT
ncit:C1011,BEAUVERICIN
iuphar.ligand:4269,NNC55-0396
HGNC:24160,BEAN1
MONDO:0859146,"growth restriction, hypoplastic kidneys, alopecia, and distinctive facies"
hemonc:252,GUADECITABINE
RGD:2933,Itpr1
ncit:C2049,INDIBULIN
rxcui:6142,KETOPROFEN
iuphar.ligand:1764,2MESAMP
chembl:CHEMBL502242,CHEMBL:CHEMBL502242
MONDO:0014348,"intellectual disability, autosomal recessive 42"
UPHENO:0005499,decreased aquatic locomotion
HGNC:1754,CDH15
rxcui:237162,DEXKETOPROFEN
HGNC:2964,DYNC1I2
HP:0005184,Prolonged QTc interval
rxcui:203190,METHYSERGIDE MALEATE
iuphar.ligand:676,NPC-567
iuphar.ligand:5609,CSC
chembl:CHEMBL15780,PHENOXYCARB
HGNC:13797,PRX
HGNC:42,ABCB11
MONDO:0013519,"dyskeratosis congenita, autosomal recessive 2"
rxcui:33199,PERMETHRIN
drugbank:DB16186,PEN-866
chembl:CHEMBL4297298,KW-2478
chembl:CHEMBL3545209,NKTR-171
iuphar.ligand:265,5-BENZYLOXYTRYPTAMINE
chembl:CHEMBL458347,GLAUCARUBINONE
HP:0001289,Confusion
iuphar.ligand:313,MUSCARINIC TOXIN 3
rxcui:9346,RIBOFLAVIN
HGNC:25529,WDR74
HP:4000169,Pontine T2 hypointensity
drugbank:DB05993,PRX-07034
WB:WBGene00016391,lonp-1
rxcui:337523,IXABEPILONE
rxcui:2233,CEPHALORIDINE
chembl:CHEMBL598509,CHEMBL:CHEMBL598509
drugsatfda.nda:210491,TEZACAFTOR AND IVACAFTOR
HGNC:2556,CUL5
rxcui:301542,ROSUVASTATIN
drugbank:DB02166,PROPIDIUM
ncit:C66493,PROPOXYCAINE HYDROCHLORIDE
MGI:106683,Zic1
iuphar.ligand:2172,LVP
HGNC:14256,BRPF3
ncit:C60770,OBATOCLAX
UPHENO:0080041,increased reflex in independent continuant
MONDO:0015333,progeroid syndrome
HGNC:28469,MRI1
rxcui:91185,METHOHEXITAL SODIUM
rxcui:1312358,ALDOSTERONE
HGNC:2527,CTSB
iuphar.ligand:10460,PAMUFETINIB
HP:0000020,Urinary incontinence
iuphar.ligand:7338,RO4929097
HGNC:6010,IL2RG
iuphar.ligand:1730,4-THIO-UTP
rxcui:10734,TRANYLCYPROMINE
iuphar.ligand:408,FLAVANONE
HP:0032699,Focal cognitive seizure with dysgraphia/agraphia
UPHENO:0008622,absent corpus callosum
HP:0001195,Single umbilical artery
HGNC:11582,TBCE
iuphar.ligand:8173,CEP-1347
chembl:CHEMBL601952,CHEMBL:CHEMBL601952
HGNC:29533,NAA50
ncit:C783,PROTEASE INHIBITOR
HP:0007772,Impaired smooth pursuit
HGNC:20297,SLITRK1
rxcui:8047,PERGOLIDE
rxcui:1116632,TICAGRELOR
chembl:CHEMBL3133037,LEQ506
rxcui:41996,SERTINDOLE
HP:0011887,Choroid hemorrhage
chembl:CHEMBL2164761,CHEMBL:CHEMBL2164761
iuphar.ligand:6416,CPPZ
MONDO:0005298,osteoporosis
iuphar.ligand:1818,TIP39-(9-39) (HUMAN/BOVINE)
HGNC:14339,PLEKHA4
MONDO:0010422,Alzheimer disease 16
MP:0009988,abnormal cerebellum vermis lobule I morphology
chembl:CHEMBL1079421,PHENMEDIPHAM
rxcui:9894,SODIUM NITRITE
ncit:C82367,ENOTICUMAB
rxcui:28200,KETOROLAC TROMETHAMINE
HP:0011174,Focal hyperkinetic seizure
MONDO:0011417,hemochromatosis type 3
chembl:CHEMBL429335,CHEMBL:CHEMBL429335
chembl:CHEMBL589924,CHEMBL:CHEMBL589924
chembl:CHEMBL487913,THIOCORALINE
GO:0042976,activation of Janus kinase activity
HP:0004467,Preauricular pit
ncit:C192810,MEK INHIBITOR IMM-1-104
iuphar.ligand:9271,MPS1-IN-1
iuphar.ligand:9911,TAK-733
iuphar.ligand:5905,COMPOUND 4 [PMID: 22984835]
iuphar.ligand:10710,IPTACOPAN
UBERON:0015488,sural nerve
HP:0032746,Focal impaired awareness emotional seizure
iuphar.ligand:2053,NOC-ATE
ncit:C169756,ABIVERTINIB MALEATE
CHEBI:38763,chromanone
rxcui:1272,AZTREONAM
HGNC:12811,XK
MGI:3848946,Tg(Pcp2-FMR1*)1Dln/0  [background:] C57BL/6-Tg(Pcp2-Fmr1*)1Dln
HP:0100739,Bulimia
Reactome:R-HSA-1250196,SHC1 events in ERBB2 signaling
rxcui:235775,PIRENZEPINE HYDROCHLORIDE
MGI:1913402,Uqcr10
MONDO:0014036,Alzheimer disease 17
HGNC:28638,GDPD3
chembl:CHEMBL1256832,DIHYDREXIDINE HYDROCHLORIDE
iuphar.ligand:9228,PF-06767832
rxcui:10594,TICLOPIDINE
iuphar.ligand:3317,AM251
ZFIN:ZDB-GENE-041014-1,met
ncit:C574,IMMUNOSUPPRESSANT
chembl:CHEMBL328540,CHEMBL:CHEMBL328540
chembl:CHEMBL31184,BENZO[DEF]CHRYSENE
drugbank:DB11775,PF-03758309
chembl:CHEMBL539954,CHEMBL:CHEMBL539954
HP:0002266,Focal clonic seizure
HP:0007030,Nonprogressive encephalopathy
rxcui:4191,EVANS BLUE
MONDO:0004335,digestive system disorder
HP:0003208,Fingerprint intracellular accumulation of autofluorescent lipopigment storage material
chembl:CHEMBL511995,LIQUIRITIN
HGNC:18187,SIAE
HGNC:11242,SPIB
iuphar.ligand:154,(+)-LSD
CHEBI:38101,organonitrogen heterocyclic compound
MGI:6783465,Washc4<sup>em1Ssod</sup>/Washc4<sup>em1Ssod</sup>  [background:] involves: C57BL/6J * SJL/J
rxcui:5033,GUANABENZ
drugbank:DB06194,ELOCALCITOL
MGI:3722379,Tg(Prnp-MAPT*P301L)JNPL3Hlmc/?  [background:] involves: C57BL/6 * DBA/2
HP:0011170,Generalized myoclonic-atonic seizure
MP:0002064,seizures
drugbank:DB03535,Z-PRO-PROLINAL
ncit:C88272,FEXAGRATINIB
ncit:C96531,DILMAPIMOD
rxcui:1872448,TELOTRISTAT ETIPRATE
ncit:C171780,RODATRISTAT
HGNC:8554,PABPC1
chembl:CHEMBL556001,"2- (2,6-DIMETHOXYPHENOXYETHYL)AMINOMETHYL-1,4-BENZODIOXANE HYDROCHLORIDE (WB 4101)"
iuphar.ligand:8937,PF-3758309
iuphar.ligand:8224,TRYPTANTHRIN
HP:0000708,Atypical behavior
iuphar.ligand:11064,(S)-CR8
iuphar.ligand:9018,NCX-4016
ncit:C62437,TIVANTINIB
ncit:C123902,FADRACICLIB
rxcui:10996,URACIL MUSTARD
ncit:C77563,APLINDORE
iuphar.ligand:5915,AG 1296
iuphar.ligand:10228,LACTOMEDIN 1
HGNC:9586,PTCH2
UBERON:0001302,right uterine tube
ncit:C62521,MOCETINOSTAT
ncit:C81530,ELDACIMIBE
HGNC:13449,SLITRK2
MP:0011380,enlarged brain ventricles
HGNC:29344,RIMBP3
rxcui:42405,MUROMONAB-CD3
ncit:C132017,ENAPOTAMAB VEDOTIN
MONDO:0023179,fragile X syndrome type 2
HGNC:17676,RABGEF1
MGI:3713120,Atg5<sup>tm1Nmz</sup>/Atg5<sup>tm1Nmz</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ
rxcui:142435,ETHAMBUTOL HYDROCHLORIDE
HGNC:30664,CLPB
MGI:2177208,Fxn<sup>tm2Mkn</sup>/Fxn<sup>tm2.1Mkn</sup> Tg(Eno2-cre)39Jme/0  [background:] involves: 129 * C57BL/6J
GO:0052816,long-chain fatty acyl-CoA hydrolase activity
ncit:C65436,DIQUAFOSOL
ncit:C178469,SHP2 INHIBITOR PF-07284892
GO:0005525,GTP binding
ncit:C119619,ANTI-C-MET MONOCLONAL ANTIBODY SAIT301
HP:0002071,Abnormality of extrapyramidal motor function
HP:0030222,Visual agnosia
iuphar.ligand:6925,SN-38
HGNC:29672,MICALL2
HGNC:29110,KIAA0753
chembl:CHEMBL494826,METHYLCURCUMIN
UPHENO:0074374,abnormally decreased rate of limb coordination
ncit:C77256,CAPESEROD
Reactome:R-HSA-390666,Serotonin receptors
GO:0005886,plasma membrane
chembl:CHEMBL3545042,SELURAMPANEL
MGI:5635161,Tg(HTT*)LXwy/0  [background:] involves: FVB/NJ
chembl:CHEMBL532504,CHEMBL:CHEMBL532504
iuphar.ligand:8983,ST-1006
HP:0009718,Subependymal giant-cell astrocytoma
HP:0032662,Focal-onset seizure evolving into bilateral convulsive status epilepticus
iuphar.ligand:5781,U101958
HGNC:20768,TUBA1C
HGNC:9568,PSME1
rxcui:203182,HYDROXYZINE PAMOATE
rxcui:10588,TIAPRIDE
MGI:2654522,Slc6a3<sup>tm2Mca</sup>/Slc6a3<sup>tm2Mca</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ
MGI:3610987,Tbx1<sup>tm1Bld</sup>/Tbx1<sup>tm1Bld</sup>  [background:] involves: 129S7/SvEvBrd * C57BL/6
iuphar.ligand:9212,RAPALINK-1
chembl:CHEMBL1173141,CHEMBL:CHEMBL1173141
ncit:C66984,DANIQUIDONE
rxcui:20767,CHLORAMPHENICOL PALMITATE
iuphar.ligand:5670,BMS-387032
chembl:CHEMBL1256868,CHEMBL:CHEMBL1256868
chembl:CHEMBL1243178,LACTOFEN
CLINVAR:51063,NC_000013.11:g.32316470G>T
rxcui:8985,PYRANTEL PAMOATE
HP:0009113,Diaphragmatic weakness
HP:0500018,Abnormal cardiac exercise stress test
MGI:3613373,Tor1a<sup>tm1Yql</sup>/Tor1a<sup>+</sup>  [background:] involves: 129S2/SvPas * C57BL/6
MONDO:0007614,congenital fibrosis of extraocular muscles
iuphar.ligand:8118,COMPOUND 30 [PMID: 22902653]
HP:0003431,Decreased motor nerve conduction velocity
MGI:3715473,Cln3<sup>tm1Nbm</sup>/Cln3<sup>tm1Nbm</sup>  [background:] 129S6/SvEvTac-Cln3<sup>tm1Nbm</sup>
HP:0020086,BCGitis
ncit:C95910,NAMITECAN
iuphar.ligand:5573,"[ALA1,12,AIB3,GLN10,HARG11,TRP14,ARG19]PTH-(1-34)-NH2"
iuphar.ligand:3724,CHIPS
HP:0032908,Focal aware undressing automatism seizure
chembl:CHEMBL532160,CHEMBL:CHEMBL532160
HGNC:33234,LIN37
iuphar.ligand:8161,COMPOUND 17 [PMID: 23642479]
CHEBI:38940,sunitinib
HGNC:30391,IFT172
chembl:CHEMBL4068108,CP-461
rxcui:82118,WARFARIN POTASSIUM
rxcui:7816,OXYPHENBUTAZONE
iuphar.ligand:10433,COMPOUND 5A [PMID: 31287314]
HGNC:17731,CLASRP
NCBIGene:504261,CAD
chembl:CHEMBL431525,BETUNOLIC ACID
HP:0005093,Absent proximal radial epiphyses
MP:0021149,abnormal amyloid beta protein level
iuphar.ligand:12704,TOLINAPANT
chembl:CHEMBL263116,DIMETHYL YELLOW
chembl:CHEMBL533074,CHEMBL:CHEMBL533074
MONDO:0019079,proximal spinal muscular atrophy
rxcui:1600439,TOTAROL
HGNC:17795,SAV1
UPHENO:0074037,cerebral hemisphere white matter degeneration
HP:0012760,Reduced social reciprocity
iuphar.ligand:2066,PRL-2915
iuphar.ligand:1342,AC-C[CYS-GLU-HIS-D-PHE-ARG-TRP-D-CYS]-PRO-PRO-LYS-ASP-NH2
iuphar.ligand:11727,ASTX029
MONDO:0700215,NTRK fusion positive cancer
rxcui:2102775,REVEFENACIN
chembl:CHEMBL2109500,LIRILUMAB
rxcui:508,ALLANTOIN
HP:0002380,Fasciculations
chembl:CHEMBL1493528,CHEMBL:CHEMBL1493528
EMAPA:35230,cerebellum vermis lobule V
drugbank:DB07810,PHLORETIN
ncit:C823,SAPONIN
iuphar.ligand:5921,AKT INHIBITOR VIII
rxcui:4331,FENOPROFEN
iuphar.ligand:8384,COMPOUND 4 [PMID: 25259874]
iuphar.ligand:657,NPC 17731
iuphar.ligand:4873,BETACELLULIN
chembl:CHEMBL592588,CHEMBL:CHEMBL592588
iuphar.ligand:8358,GSK1070916
chembl:CHEMBL1449007,2-(2'-METHOXYPHENYL)-1H-INDOLE
MP:0005445,abnormal neurotransmitter secretion
chembl:CHEMBL582503,CHEMBL:CHEMBL582503
ncit:C677,NAFOXIDINE
MONDO:0013928,dystonia 23
CHEBI:28262,dimethyl sulfoxide
MGI:4397489,Ilk<sup>tm8.1Ref</sup>/Ilk<sup>tm8.1Ref</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
chembl:CHEMBL362223,CHEMBL:CHEMBL362223
HGNC:20192,AP5M1
chembl:CHEMBL534535,CHEMBL:CHEMBL534535
rxcui:7762,OUABAIN
rxcui:32926,PAREGORIC
MONDO:0019977,parkinsonism with dementia of Guadeloupe
iuphar.ligand:10730,ABBV-744
MP:0002922,decreased post-tetanic potentiation
HP:0003468,Abnormal vertebral morphology
HP:0011590,Double aortic arch
ncit:C77882,LEXIBULIN
rxcui:203213,EPIRUBICIN HYDROCHLORIDE
iuphar.ligand:5690,KI-20227
iuphar.ligand:11732,BAY-8400
MONDO:0004970,adenocarcinoma
ncit:C65760,FOSFOSAL
MONDO:0008763,Alstrom syndrome
HGNC:7871,NONO
chembl:CHEMBL601605,CHEMBL:CHEMBL601605
HP:0011446,Abnormality of mental function
iuphar.ligand:10542,SPAG11B (61-103)
UBERON:0002628,tail of caudate nucleus
ncit:C116877,PAXALISIB
CHEBI:17823,calcitriol
MONDO:0015204,microlissencephaly
HGNC:16690,GJB7
MGI:3834193,Lyz2<sup>tm1(HBEGF)Mtka</sup>/Lyz2<sup>+</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6
MGI:107755,Neurod2
GO:0000122,negative regulation of transcription by RNA polymerase II
HP:0002268,Paroxysmal dystonia
chembl:CHEMBL72628,2-PICOLINIC ACID
iuphar.ligand:12383,RISVODETINIB
iuphar.ligand:1790,PTHRP-(1-36)
MONDO:0010568,Aicardi syndrome
HGNC:12031,TRAF1
HP:0007338,Hypermetric saccades
rxcui:288088,CETRIMIDE
ncit:C52182,CDK1/2/4 INHIBITOR AG-024322
rxcui:10898,TRYPTOPHAN
chembl:CHEMBL151797,CHEMBL:CHEMBL151797
iuphar.ligand:3431,AHPN
MGI:102805,Entpd1
iuphar.ligand:6435,GSK2210875
chembl:CHEMBL242171,CHEMBL:CHEMBL242171
GO:0005516,calmodulin binding
iuphar.ligand:12403,PZ-II-029
drugbank:DB14969,GTX-758
chembl:CHEMBL591773,SHINPTEROCARPIN
drugbank:DB15416,PX-102
HGNC:16825,MTMR8
drugbank:DB05121,1D09C3
CL:2000077,skeletal muscle tissue of pectoralis major striated muscle cell
UPHENO:0085060,abnormal medium spiny neuron morphology
HGNC:11000,SLC27A6
rxcui:9071,QUININE
iuphar.ligand:4335,UCCF-029
CHEBI:83707,"1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol"
chembl:CHEMBL401607,CHEMBL:CHEMBL401607
drugbank:DB05052,MF101
HP:0025660,Chiari type II malformation
HP:0032887,Generalized atonic seizure
HP:0000316,Hypertelorism
rxcui:2169285,ALPELISIB
MONDO:0014178,inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2
HP:0012081,Enlarged cerebellum
ncit:C171846,BLARCAMESINE
HGNC:8806,PDHA1
rxcui:236913,LEVOMETHADONE
chembl:CHEMBL365617,CHEMBL:CHEMBL365617
UPHENO:0014097,cerebellar cortex atrophy
chembl:CHEMBL187216,CHEMBL:CHEMBL187216
HGNC:549,AOC2
MONDO:0007661,Tourette syndrome
chembl:CHEMBL168075,CHEMBL:CHEMBL168075
ncit:C96894,TEMANOGREL
MGI:1194505,C1qbp
chembl:CHEMBL208484,KARANJIN
chembl:CHEMBL2109484,BB-10901
drugbank:DB03921,4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE
chembl:CHEMBL2271362,NONYL 4-HYDROXYBENZOATE
ncit:C71896,MOTESANIB
chembl:CHEMBL513221,VINCLOZOLIN
chembl:CHEMBL4303729,PLX-8394
rxcui:623033,LUBIPROSTONE
MONDO:0013470,"generalized epilepsy with febrile seizures plus, type 7"
MGI:1914004,Foxp1
chembl:CHEMBL555017,GAMBOGIC ACID
ncit:C28694,LAPACHONE
UPHENO:0077945,decreased bone resorption in patella
iuphar.ligand:2028,[D-TYR8]CYN 154806
iuphar.ligand:11686,ENITOCICLIB
HGNC:545,ANXA7
HP:0031258,Delirium
ncit:C1298,O-CHLOROACETYLCARBAMOYLFUMAGILLOL
MGI:2181403,Creb1<sup>tm1Gsc</sup>/Creb1<sup>tm1Gsc</sup>  [background:] involves: 129S2/SvPas
MONDO:0007105,frontotemporal dementia and/or amyotrophic lateral sclerosis 1
iuphar.ligand:10746,VBY-825
HP:0000497,Globe retraction and deviation on abduction
UPHENO:0009098,absent patella
drugbank:DB05687,BL-1020
rxcui:349730,ANHYDROUS DEXTROSE
chembl:CHEMBL487186,TEBUCONAZOLE
MGI:5500068,Vcp<sup>tm1Itl</sup>/Vcp<sup>tm1Itl</sup>  [background:] involves: 129S6/SvEvTac
HP:0007272,Progressive psychomotor deterioration
chembl:CHEMBL339587,CHEMBL:CHEMBL339587
FB:FBgn0030082,HP1b
ncit:C84198,THENALIDINE
HP:0002936,Distal sensory impairment
MONDO:0030930,neurodevelopmental disorder with or without early-onset generalized epilepsy
HGNC:18900,KRTAP4-2
iuphar.ligand:11846,ML1-SA1
HP:0001251,Ataxia
chembl:CHEMBL1256940,METHOXYVERAPAMIL HYDROCHLORIDE
ncit:C175766,DARIGABAT
iuphar.ligand:1305,ATC0175
MGI:2182596,Cln6<sup>nclf</sup>/Cln6<sup>nclf</sup>  [background:] involves: C57BL/6J * C57BL/10J * C3HeB/FeJLe
rxcui:2348,CHLORAMPHENICOL
chembl:CHEMBL1223066,DINITRAMINE
iuphar.ligand:2822,"R,R-THC"
chembl:CHEMBL1565133,SANGUINARINE SULFATE
ncit:C2358,TELIMOMAB ARITOX
ncit:C158506,OBEFAZIMOD
MGI:3833724,Aox4<sup>tm1Enga</sup>/Aox4<sup>tm1Enga</sup>  [background:] B6.129S7-Aox4<sup>tm1Enga</sup>
dictyBase:DDB_G0280197,sepsecs
ncit:C152948,ZENOCUTUZUMAB
iuphar.ligand:3262,LY2033298
iuphar.ligand:1720,MRS2179
HGNC:12651,VARS1
MONDO:0000589,autoimmune disorder of musculoskeletal system
chembl:CHEMBL543467,IDAZOXAN HYDROCHLORIDE
CHEBI:28494,cardiolipin
chembl:CHEMBL375600,PERBROMOBENZENE
rxcui:1306190,BATILOL
iuphar.ligand:4369,[35S]TBPS
HGNC:14889,DNAJB11
ncit:C448,DIURETIC
UBERON:0010708,pectoral complex
rxcui:1433211,LEVOMILNACIPRAN HYDROCHLORIDE
chembl:CHEMBL2109608,L19IL2
chembl:CHEMBL1915763,GANODERMANONTRIOL
chembl:CHEMBL607308,CHEMBL:CHEMBL607308
HP:0002120,Cerebral cortical atrophy
chembl:CHEMBL253570,GOSSYPETIN
HP:0002140,Ischemic stroke
ncit:C84120,PROROXAN HYDROCHLORIDE
HGNC:4559,GPX7
ncit:C1461,PERILLYL ALCOHOL
MP:0002106,abnormal muscle physiology
HP:0010831,Impaired proprioception
MP:0006007,abnormal basal ganglion morphology
rxcui:3455,DIMETHYL SULFOXIDE
Reactome:R-GGA-71288,Creatine metabolism
rxcui:1723738,NECITUMUMAB
HGNC:9380,PRKACA
ncit:C74594,REBEMADLIN
chembl:CHEMBL34398,4'-METHOXYCHALCONE
MONDO:0018054,familial atrial fibrillation
iuphar.ligand:1331,ACTH
rxcui:160372,LEVOMEPROMAZINE MALEATE
UPHENO:0077821,abnormal independent continuant nitrogen molecular entity level
chembl:CHEMBL1905010,PYRAFLUFEN-ETHYL
Reactome:R-SSC-211945,Phase I - Functionalization of compounds
rxcui:71532,TRIMIPRAMINE MALEATE
chembl:CHEMBL1214407,CHEMBL:CHEMBL1214407
chembl:CHEMBL1256655,AMSACRINE HYDROCHLORIDE
rxcui:1045452,ERIBULIN MESYLATE
FB:FBgn0027291,Idh3a
HGNC:30291,G3BP2
chembl:CHEMBL140220,CHEMBL:CHEMBL140220
iuphar.ligand:12846,NDPPC
HGNC:5001,HMG20A
HGNC:29525,GLIS1
ncit:C103820,LIRILUMAB
ncit:C76996,ESTRADIOL ENANTHATE
rxcui:83395,SAQUINAVIR
MONDO:0030088,"diabetes mellitus, permanent neonatal 3"
chembl:CHEMBL2057864,CHEMBL:CHEMBL2057864
NCBIGene:100300550,COX7B
chembl:CHEMBL578512,CHEMBL:CHEMBL578512
HGNC:4616,GSK3A
chembl:CHEMBL295337,CHEMBL:CHEMBL295337
iuphar.ligand:11505,COMPOUND 12D [PMID: 33821636]
iuphar.ligand:730,CP55940
MONDO:0000437,cerebellar ataxia
HP:0001403,Macrovesicular hepatic steatosis
chembl:CHEMBL387632,CHEMBL:CHEMBL387632
chembl:CHEMBL24510,FUSARIC ACID
HGNC:634,AQP2
MGI:3510312,Tbx1<sup>tm1Dsr</sup>/Tbx1<sup>tm1Dsr</sup>  [background:] either: 129/Sv or (involves: 129/Sv * C57BL/6)
FB:FBgn0030671,Hap40
iuphar.ligand:5691,KW-2449
HGNC:16919,VAT1
GO:0050432,catecholamine secretion
rxcui:47835,CEFPODOXIME PROXETIL
HP:0030773,Internuclear ophthalmoplegia
iuphar.ligand:1990,RELAXIN-3
EMAPA:36651,eyelid muscle
chembl:CHEMBL1098658,YANGONIN
iuphar.ligand:10108,GSK2646264
chembl:CHEMBL3707404,LUMRETUZUMAB
HGNC:12852,YWHAG
iuphar.ligand:988,BETA-ERGOCRIPTINE
MGI:104750,Nrcam
UBERON:0002240,spinal cord
MONDO:0044638,hypopharynx squamous cell carcinoma
ncit:C79121,DIMIRACETAM
rxcui:1940331,ENASIDENIB MESYLATE
MONDO:0015229,Bardet-Biedl syndrome
GO:0006457,protein folding
HGNC:18643,SUGP1
MGI:1202401,Fgf17
chembl:CHEMBL299853,CHEMBL:CHEMBL299853
chembl:CHEMBL602213,CHEMBL:CHEMBL602213
iuphar.ligand:13097,WITHAFERIN A
HGNC:7797,NFKBIA
ncit:C134967,BRAFV600/PI3K INHIBITOR ASN003
rxcui:10180,SULFAMETHOXAZOLE
rxcui:235759,QUINAPRIL HYDROCHLORIDE
Reactome:R-HSA-611105,Respiratory electron transport
HGNC:8964,PIGH
MONDO:0013060,autosomal recessive Parkinson disease 14
ZFIN:ZDB-GENE-030131-7715,cox6a1
rxcui:233272,BEXAROTENE
MGI:2662300,Adcy5<sup>tm1Yish</sup>/Adcy5<sup>tm1Yish</sup>  [background:] involves: 129X1/SvJ * C57BL/6
HGNC:16643,SLMAP
ncit:C84142,SALICYLANILIDE
chembl:CHEMBL413552,QUERCETAGETIN
chembl:CHEMBL224318,CHEMBL:CHEMBL224318
MP:0020560,abnormal pontine nuclei morphology
rxcui:81982,CLINDAMYCIN HYDROCHLORIDE
chembl:CHEMBL346516,METHYL PARATHIONE
rxcui:196102,BASILIXIMAB
Reactome:R-HSA-9700645,ALK mutants bind TKIs
rxcui:1370621,PALMITATE
UPHENO:0080601,abnormal physiologic nystagmus
HGNC:8011,CNTNAP1
rxcui:4099,"ESTROGENS, CONJUGATED (USP)"
CHEBI:83265,papuamide B
rxcui:1512,BETAINE
HP:0002003,Large forehead
MONDO:0013520,"dyskeratosis congenita, autosomal recessive 3"
rxcui:3105,DANTROLENE
MGI:3044689,Cp<sup>tm1Hrs</sup>/Cp<sup>tm1Hrs</sup>  [background:] involves: 129X1/SvJ * Black Swiss
HGNC:29845,XKRX
CHEBI:17968,butyrate
chembl:CHEMBL1173140,CHEMBL:CHEMBL1173140
chembl:CHEMBL16751,CHEMBL:CHEMBL16751
chembl:CHEMBL203567,RO-3201195
HP:0000076,Vesicoureteral reflux
rxcui:1872382,TELOTRISTAT
MGI:1349423,Racgap1
iuphar.ligand:8473,AZD5438
HP:0025330,Downgaze palsy
drugbank:DB17040,PD-169316
HP:0002186,Apraxia
HP:0007737,Bone spicule pigmentation of the retina
ncit:C429,DIDEOXYADENOSINE
ncit:C173165,FICERAFUSP ALFA
CHEBI:18019,L-lysine
iuphar.ligand:1325,SHU9119
HGNC:10936,SLC18A3
MGI:6192446,Hprt1<sup>tm1(MAPT)Dph</sup>/Y  [background:] involves: 129P2/OlaHsd * C57BL/6
rxcui:19605,BOPINDOLOL
CHEBI:51323,cinchona alkaloid
ncit:C95196,ABAMECTIN
HGNC:18667,PMPCA
SGD:S000000118,PIM1
MGI:6883630,Atf6<sup>tm1.1Rjk</sup>/Atf6<sup>tm1.1Rjk</sup>  [background:] involves: C57BL/6 * C57BL/6J
rxcui:1544460,IDELALISIB
drugbank:DB15954,STRYCHNINE
iuphar.ligand:12050,SAGE-718
chembl:CHEMBL590914,CHEMBL:CHEMBL590914
chembl:CHEMBL2346976,AZD3514
HP:0030641,Incomplete congenital stationary night blindness
HP:0032719,Focal impaired awareness motor seizure with dysarthria/anarthria
HGNC:4790,H4C5
MP:0008917,abnormal oligodendrocyte physiology
MP:0000836,abnormal substantia nigra morphology
HP:0001644,Dilated cardiomyopathy
iuphar.ligand:11887,TINENGOTINIB
UBERON:0001812,palpebral conjunctiva
HP:0003564,Folate-dependent fragile site at Xq28
iuphar.ligand:6688,[3H]PEMETREXED
drugbank:DB02207,7-NITROINDAZOLE
iuphar.ligand:131,"[3H]GR 125,743"
chembl:CHEMBL2208197,CHEMBL:CHEMBL2208197
ncit:C87380,ARGIPRESTOCIN
HGNC:23287,ETHE1
MP:0001524,impaired limb coordination
rxcui:340705,HUMAN CHORIONIC GONADOTROPIN
rxcui:221074,CHLORPHENIRAMINE POLISTIREX
MONDO:0005053,ischemic disease
iuphar.ligand:7505,SCRIPTAID
HGNC:9759,RAB10
NCBIGene:100512990,CBR3
ncit:C152485,SYROSINGOPINE
rxcui:8156,PHENYLALANINE
HGNC:1833,CEBPA
MONDO:0016681,gliosarcoma
HGNC:11742,TFAP2A
rxcui:1151,ASCORBIC ACID
chembl:CHEMBL1873684,CHEMBL:CHEMBL1873684
chembl:CHEMBL279556,CHEMBL:CHEMBL279556
MONDO:0011694,spinocerebellar ataxia type 15/16
iuphar.ligand:7962,MK-2461
iuphar.ligand:12758,GLOFITAMAB
HGNC:9717,PEX2
iuphar.ligand:7711,AZD6495
MONDO:0008438,hereditary spastic paraplegia 4
iuphar.ligand:2116,MEN 10376
ncit:C143099,C-MET INHIBITOR
GO:0015297,antiporter activity
rxcui:10634,TOLAZOLINE
chembl:CHEMBL1603788,SAPPANONE A 7-METHYL ETHER
rxcui:24947,FERROUS SULFATE
MGI:3847221,Tmie<sup>sr-J</sup>/Tmie<sup>sr-J</sup>  [background:] involves: A/J * C57BL/6J
HGNC:17257,SPDEF
MP:0000878,abnormal Purkinje cell number
chembl:CHEMBL417016,"LACTOSE, ANHYDROUS"
iuphar.ligand:759,CCL7
HGNC:18650,SPATS2
HP:0002509,Limb hypertonia
rxcui:36567,SIMVASTATIN
HP:0002144,Tethered cord
chembl:CHEMBL2336666,CHEMBL:CHEMBL2336666
chembl:CHEMBL85728,"4,4'-METHYLENEDIANILINE"
rxcui:6809,METFORMIN
iuphar.ligand:8585,GE-137
CHEBI:16027,adenosine 5'-monophosphate
MONDO:0019160,primary progressive freezing gait
chembl:CHEMBL16312,4'-METHOXYFLAVONE
CHEBI:78884,4-terpineol
HGNC:2717,DDB1
iuphar.ligand:410,GALANGIN
ncit:C96742,ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDE EZN-4176
iuphar.ligand:7657,RPR260243
MGI:103223,Vhl
HP:0000640,Gaze-evoked nystagmus
CHEBI:2637,amikacin
chembl:CHEMBL275516,CANTHARIDIC_ACID
HP:0000347,Micrognathia
MONDO:0010198,Wernicke-Korsakoff syndrome
PomBase:SPBC11C11.04c,alp1
UBERON:0005343,cortical plate
HP:0012745,Short palpebral fissure
ncit:C174675,AZELIRAGON
UPHENO:0078550,increased level of creatinine in blood serum
MONDO:0006850,maxillary sinus neoplasm
rxcui:22906,DICHLOROBENZYL ALCOHOL
ncit:C99165,DNA-DEPENDENT PROTEIN KINASE-TARGETING SIDNA DT01
UBERON:0002410,autonomic nervous system
rxcui:203210,PRAZOSIN HYDROCHLORIDE
iuphar.ligand:1815,TIP39
ncit:C280,ANTITUBERCULAR AGENT
MGI:2661970,Lrp6<sup>Cd</sup>/Lrp6<sup>Cd</sup>  [background:] A-Lrp6<sup>Cd</sup>
rxcui:1368147,CAPTAN
GO:0031410,cytoplasmic vesicle
rxcui:8886,PROTRIPTYLINE
HGNC:15911,NOP56
rxcui:70167,LENOGRASTIM
MP:0002912,abnormal excitatory postsynaptic potential
chembl:CHEMBL1351571,4-BENZYLOXYANILINE
ncit:C107555,BUFALIN
iuphar.ligand:4050,2-FUROYL-LIGRL[N-(ALEXA FLUOR 594)-O]-NH2
iuphar.ligand:9570,C391
chembl:CHEMBL210868,AURIN
iuphar.ligand:4177,DIDS
HP:0031718,Consecutive exotropia
ncit:C116748,VANDORTUZUMAB VEDOTIN
MONDO:0000415,adolescence-adult electroclinical syndrome
chembl:CHEMBL61133,SULOCHRIN
ncit:C29256,MICELLAR PACLITAXEL
UBERON:0002038,substantia nigra
rxcui:38409,TOREMIFENE
chembl:CHEMBL144757,CHEMBL:CHEMBL144757
rxcui:2670631,NIROGACESTAT
MONDO:0021165,Paget disease
HGNC:6297,KCNQ3
chembl:CHEMBL192627,CHLORANIL
chembl:CHEMBL224032,CHEMBL:CHEMBL224032
chembl:CHEMBL4297523,PIROMELATINE
chembl:CHEMBL1287980,CHEMBL:CHEMBL1287980
MP:0000243,myoclonus
ncit:C96750,IBUFENAC
rxcui:679314,PALIPERIDONE
drugbank:DB16763,TYRPHOSTIN AG 835
chembl:CHEMBL384441,CHEMBL:CHEMBL384441
UBERON:0008788,posterior cranial fossa
rxcui:1546356,DABIGATRAN
rxcui:235428,HOMATROPINE HYDROBROMIDE
HP:0500076,Alternating hypertropia
HP:0011728,Elbow clonus
rxcui:6024,ISOETHARINE MESYLATE
CL:0001035,bone cell
HGNC:9829,RAF1
chembl:CHEMBL4297620,SOLRIAMFETOL
MONDO:0100556,PRRT2-associated paroxysmal movement disorder
HGNC:8582,PAH
chembl:CHEMBL254218,DESMETHOXYYANGONIN
MP:0001388,abnormal stationary movement
HGNC:9449,PRNP
HGNC:365,AK5
HGNC:4124,GALNT2
HGNC:19349,KIF21A
HGNC:11168,SNTB1
ncit:C87763,EFUNGUMAB
HP:0030217,Limb apraxia
EMAPA:16974,midbrain
chembl:CHEMBL519243,HOLACANTHONE
iuphar.ligand:2448,H2O2
ncit:C75985,TESAGLITAZAR
MONDO:0011951,amyotrophic lateral sclerosis type 6
iuphar.ligand:8906,CD2314
iuphar.ligand:3390,5S-HETE
iuphar.ligand:10509,THIAMET-G
MGI:3838969,Atp8a2<sup>wl</sup>/Atp8a2<sup>wl</sup>  [background:] Not Specified
rxcui:1148138,ICATIBANT
ncit:C180661,SIMUFILAM
iuphar.ligand:7718,Z944
HGNC:9412,PRKCZ
ncit:C152643,TIOTIDINE
HP:0009803,Short phalanx of finger
HP:0045007,Abnormal substantia nigra morphology
iuphar.ligand:8213,COMPOUND R-16 [PMID: 21967808]
chembl:CHEMBL584442,CHEMBL:CHEMBL584442
HP:0009623,Proximal placement of thumb
HGNC:20774,TUBB4A
HP:0012463,Elevated transferrin saturation
NCBIGene:282517,NDUFB8
ncit:C152317,SEGLITIDE
MGI:3619802,Tbx1<sup>tm2.1Bem</sup>/Tbx1<sup>tm2.2Bem</sup> Foxg1<sup>tm1(cre)Skm</sup>/Foxg1<sup>+</sup>  [background:] involves: 129 * C57BL/6J * SJL * Swiss Webster
drugbank:DB08937,TAS-102
iuphar.ligand:4061,AYPGKF-NH2
HGNC:14929,SIRT1
rxcui:55347,PYRVINIUM PAMOATE
MONDO:0012497,congenital stationary night blindness autosomal dominant 3
CHEBI:23888,drug
HP:0033204,Triceps hyperreflexia
iuphar.ligand:8004,TORIN 1
MONDO:0000701,ischemic colitis
rxcui:8627,PRAZEPAM
HGNC:2973,DNM1L
rxcui:214549,"ESTROGENS, ESTERIFIED (USP)"
ncit:C77904,SERDEMETAN
rxcui:1372,BENORILATE
HGNC:1237,UBQLN4
rxcui:9601,SCOPOLAMINE
iuphar.ligand:4043,MRS2768
rxcui:155021,DICHLOROACETIC ACID
HGNC:24500,VIRMA
rxcui:19884,BUTOCONAZOLE
FB:FBgn0030041,CG12116
MONDO:0001627,dementia
HP:0011972,Hypoglycorrhachia
MONDO:0019113,benign paroxysmal torticollis of infancy
MONDO:0600001,glutaminase deficiency
ncit:C152144,RADRETUMAB
iuphar.ligand:3635,N-ARACHIDONOYLGLYCINE
chembl:CHEMBL1449651,"PYRROLIDINE DITHIOCARBAMIC ACID, AMMONIUM SALT"
HP:0002650,Scoliosis
rxcui:4129,ETHISTERONE
GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein
ncit:C84034,OTENABANT
rxcui:317836,RAUWOLFIA SERPENTINA (USP)
chembl:CHEMBL464637,CHEMBL:CHEMBL464637
iuphar.ligand:12305,VU0486846
iuphar.ligand:9858,GS-458967
HGNC:28172,ARK2N
iuphar.ligand:3740,SLIGKV-NH2
HGNC:18736,TRIM40
chembl:CHEMBL477841,CHEMBL:CHEMBL477841
ncit:C116845,CHK1 INHIBITOR GDC-0575
HGNC:9957,RELN
HP:0003712,Skeletal muscle hypertrophy
HGNC:8912,PHB1
rxcui:7974,PENFLURIDOL
MONDO:0002320,congenital nervous system disorder
MONDO:0011004,lissencephaly type 3-metacarpal bone dysplasia syndrome
MONDO:0000477,focal dystonia
HP:0000775,Abnormality of the diaphragm
ncit:C83927,MELEVODOPA
iuphar.ligand:8056,SCH772984
chembl:CHEMBL3707380,RG6029
HGNC:25944,MED18
ncit:C72985,DARAPLADIB
MONDO:0850048,classic eosinophilic pustular folliculitis
ncit:C72638,RUFLOXACIN
HGNC:6324,KIF5B
ncit:C65561,ETHOXZOLAMIDE
HP:0003392,First dorsal interossei muscle weakness
chembl:CHEMBL275787,PRODIGIOSIN
ZFIN:ZDB-GENE-040426-1649,arl3l1
HP:0002472,Small cerebral cortex
HP:0007334,Bilateral tonic-clonic seizure with focal onset
iuphar.ligand:5244,PF750
chembl:CHEMBL3545080,RG-7256
chembl:CHEMBL1534878,IPRONIAZID SULFATE
HGNC:14315,FCMR
rxcui:11118,VALPROIC ACID
HP:0100851,Abnormal emotion/affect behavior
HGNC:7413,MTAP
HGNC:4404,GNG2
HGNC:7884,NOTCH4
drugbank:DB05471,SGN-30
HP:0002436,Occipital meningocele
HGNC:15899,NDUFAF5
ncit:C62444,PLINABULIN
HP:0031763,Cyclic esotropia
drugbank:DB05434,ABT-510
HGNC:9760,RAB11A
MGI:102934,Scx
chembl:CHEMBL1207366,GW468816
rxcui:10864,TROLEANDOMYCIN
CHEBI:17579,beta-carotene
MGI:3709752,Drd1<sup>tm2Jcd</sup>/Drd1<sup>+</sup> Tg(EIIa-cre)C5379Lmgd/0  [background:] involves: 129S4/SvJae * BALB/c * CD-1 * FVB/N
NCBIGene:540236,TUBB4A
UBERON:0000473,testis
ncit:C71759,LINIFANIB
HGNC:2980,DNMT3L
drugbank:DB13065,LY-2811376
iuphar.ligand:532,CGP 12177
ncit:C28197,ANTIANXIETY AGENT
iuphar.ligand:8176,BS-194
iuphar.ligand:4759,VESAMICOL
chembl:CHEMBL1782581,THEONELLASTEROL F
iuphar.ligand:1725,PPADS
ncit:C166662,LENERCEPT
HP:0002094,Dyspnea
MGI:3844341,Hoxd9<sup>tm1Emca</sup>/Hoxd9<sup>tm1Emca</sup> Hoxd10<sup>tm1Emca</sup>/Hoxd10<sup>tm1Emca</sup>  [background:] involves: 129S7/SvEvBrd * C57BL/6
HGNC:11200,SOX4
HP:0032743,Focal aware emotional seizure with crying
chembl:CHEMBL601768,CHEMBL:CHEMBL601768
MP:0014235,abnormal tumor-free survival time
chembl:CHEMBL526034,CHEMBL:CHEMBL526034
MGI:2443415,Zpld1
MGI:1914434,Ndufa13
rxcui:1855735,OLARATUMAB
iuphar.ligand:11940,MAP855
drugbank:DB16835,GLPG-1837
MONDO:0010559,MASA syndrome
HP:0006827,Atrophy of the spinal cord
chembl:CHEMBL496867,CHELIDONINE
CHEBI:41879,dexamethasone
rxcui:2669407,TORIPALIMAB-TPZI
CHEBI:33570,benzenediols
rxcui:3287,DEXTROAMPHETAMINE SULFATE
HP:0003701,Proximal muscle weakness
chembl:CHEMBL600313,CHEMBL:CHEMBL600313
ncit:C90780,TRITIOZINE
HGNC:7673,NCOR2
HP:0200119,Acute hepatitis
HGNC:11524,TACC3
HP:0001433,Hepatosplenomegaly
rxcui:41493,MELOXICAM
ncit:C152264,ROVELIZUMAB
iuphar.ligand:9882,TIQ-15
ncit:C83521,AFEGOSTAT TARTRATE
MONDO:0035777,parenteral nutrition-associated cholestasis
iuphar.ligand:4347,ZK93426
HGNC:5295,HTR2C
MP:0009992,abnormal cerebellum vermis lobule IX morphology
GO:0006509,membrane protein ectodomain proteolysis
CHEBI:46691,"2,3-dihydroxy-5-methyl-1,4-benzoquinone"
iuphar.ligand:11498,PD 102807
CLINVAR:51508,NC_000013.11:g.32316496del
chembl:CHEMBL2109635,SAR-566658
rxcui:19959,ACRIVASTINE
HGNC:30097,PCF11
HGNC:26063,OXSM
rxcui:23033,DIFLORASONE DIACETATE
ncit:C81349,ALEMCINAL
ncit:C65596,ETONITAZENE
chembl:CHEMBL408850,CHEMBL:CHEMBL408850
iuphar.ligand:12609,COMPOUND 30 [PMID: 37057760]
rxcui:7004,MITOTANE
HGNC:9560,PSMD3
rxcui:155142,DEXFENFLURAMINE HYDROCHLORIDE
iuphar.ligand:5563,CID1792197
ncit:C173437,TUNLAMETINIB
ncit:C1031,PIRITREXIM
chembl:CHEMBL4650315,DESMETRAMADOL
HP:0000815,Hypergonadotropic hypogonadism
iuphar.ligand:1809,[TRP23]PTHRP-(1-36) (HUMAN)
chembl:CHEMBL602987,CHEMBL:CHEMBL602987
iuphar.ligand:11120,ACY-738
ncit:C174762,ZOLIGRATINIB
iuphar.ligand:11414,TASURGRATINIB
drugbank:DB07594,CCT-018159
MGI:103150,Slc12a1
iuphar.ligand:11875,FIDRISERTIB
MGI:103201,Aqp1
ZFIN:ZDB-GENE-030131-1269,uqcrc2b
MGI:1931237,Wwox
HP:0032930,Lacunar halos around chondrocytes
HP:0000029,Testicular atrophy
iuphar.ligand:789,RO116-4875/608
HGNC:28213,PIGY
CHEBI:17698,chloramphenicol
HGNC:14874,NOX5
chembl:CHEMBL2141712,PALOMID-529
MONDO:0010060,mitochondrial DNA depletion syndrome 7 (hepatocerebral type)
CHEBI:17544,hydrogencarbonate
MGI:3834850,Cp<sup>tm1Yos</sup>/Cp<sup>tm1Yos</sup>  [background:] C.129P2-Cp<sup>tm1Yos</sup>
iuphar.ligand:11563,PSEUDOCHELERYTHRINE
HGNC:25483,PIMREG
chembl:CHEMBL1234363,MALTOTRIOSE
HP:0002536,Abnormal cortical gyration
HGNC:6872,MAPK10
chembl:CHEMBL1554531,4-METHOXYDALBERGIONE
HGNC:6859,MAP3K7
rxcui:1300700,LORCASERIN HYDROCHLORIDE
chembl:CHEMBL2109512,MCS-110
rxcui:82023,GUANETHIDINE MONOSULFATE
rxcui:76887,QUINAGOLIDE
HP:0001394,Cirrhosis
UPHENO:0085795,absent Cajal-Retzius cell in the brain marginal zone
HP:0000090,Nephronophthisis
HP:0011463,Childhood onset
ncit:C171746,FALDAPREVIR
ncit:C78480,OMBRABULIN
iuphar.ligand:1952,"L-161,982 (EP4A)"
HGNC:12831,XRCC4
chembl:CHEMBL265325,1-AMINOCYCLOPROPANE CARBOXYLIC ACID
HP:0032667,Myoclonic status epilepticus
MONDO:0012450,spinocerebellar ataxia type 28
rxcui:3690,PENTETIC ACID
chembl:CHEMBL1354529,VIOLASTYRENE
chembl:CHEMBL527271,CHEMBL:CHEMBL527271
HGNC:4298,GLB1
iuphar.ligand:3915,E7
HP:0012735,Cough
chembl:CHEMBL3544998,LY-3007113
chembl:CHEMBL2109412,L19SIP 131I
MGI:4437435,Tg(Lrrk2)6Yue/0  [background:] involves: C3H * C57BL/6 * C57BL/6J
chembl:CHEMBL1256737,METHIOTHEPIN MESYLATE
HP:0001319,Neonatal hypotonia
chembl:CHEMBL546344,CHEMBL:CHEMBL546344
GO:0006352,DNA-templated transcription initiation
MONDO:0012334,hereditary spastic paraplegia 29
MP:0001417,decreased exploration in new environment
drugbank:DB05698,GI-4000
ncit:C71704,VOXTALISIB
iuphar.ligand:4249,LY404187
HGNC:15465,GPHN
HP:0007301,Oromotor apraxia
rxcui:1368130,APIGENIN
rxcui:8565,POLYTHIAZIDE
HGNC:12011,TPM2
iuphar.ligand:8060,AMG-900
HP:0011384,Abnormality of the internal auditory canal
HP:0000998,Hypertrichosis
rxcui:229367,QUINUPRISTIN
ncit:C87373,DUVOGLUSTAT
drugbank:DB13109,PKI-179
GO:0060079,excitatory postsynaptic potential
MONDO:0006507,hereditary hemochromatosis
HGNC:7452,MTMR4
HGNC:18481,ATP6V0A2
iuphar.ligand:745,[3H]RIMONABANT
MONDO:0005292,colitis
rxcui:1086768,VILAZODONE HYDROCHLORIDE
Xenbase:XB-GENE-922837,cdon
iuphar.ligand:384,CGS 15943
ncit:C526,ENOXOLONE
rxcui:1427158,EPIDERMAL GROWTH FACTOR
rxcui:1875534,AVELUMAB
ncit:C81340,NORDEFRIN
chembl:CHEMBL75756,2-PHENYL-1H-INDOLE
rxcui:135391,OLOPATADINE
HGNC:891,AUP1
HGNC:11581,TBCD
MP:0009975,absent cerebral cortex pyramidal cells
HP:0000574,Thick eyebrow
ncit:C52195,MIRDAMETINIB
MONDO:0032793,O'Donnell-Luria-Rodan syndrome
rxcui:1940332,ENASIDENIB
chembl:CHEMBL9249,(+)-EPITAXIFOLIN
HGNC:14537,NPC2
chembl:CHEMBL1591258,"3,4-DIMETHOXYDALBERGIONE"
chembl:CHEMBL1527,CHEMBL:CHEMBL1527
rxcui:41208,HALOBETASOL
HGNC:4599,GRM7
MGI:88276,Ctnnb1
HGNC:10872,ST3GAL5
MP:0009993,abnormal cerebellum vermis lobule V morphology
Reactome:R-GGA-549127,Organic cation transport
HP:0007249,Decreased number of small peripheral myelinated nerve fibers
MONDO:0002602,central nervous system disorder
ncit:C72810,ILEPCIMIDE
chembl:CHEMBL582073,CHEMBL:CHEMBL582073
HP:0008767,Self-mutilation of tongue and lips due to involuntary movements
MGI:3588420,Hjv<sup>tm1Nca</sup>/Hjv<sup>tm1Nca</sup>  [background:] involves: 129S4/SvJae * 129S6/SvEvTac
rxcui:42836,OXYQUINOLINE SULFATE
HGNC:19141,TTBK2
HGNC:23794,PACS2
HGNC:21735,LHX6
iuphar.ligand:2180,[VAL4]AVP
rxcui:19790,BROTIZOLAM
ncit:C90875,PEGSUNERCEPT
HGNC:24105,STAMBPL1
MONDO:0006165,colorectal squamous cell carcinoma
HP:0007007,Cavitation of the basal ganglia
HP:0005567,Renal magnesium wasting
drugbank:DB06140,SUVN-502
chembl:CHEMBL451321,METAGLIDASEN
MGI:2655506,Hfe<sup>tm2Nca</sup>/Hfe<sup>tm2Nca</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6J
chembl:CHEMBL3138665,QUININE ETHYLCARBONATE
rxcui:6664,MAZINDOL
chembl:CHEMBL587856,CHEMBL:CHEMBL587856
chembl:CHEMBL2108403,EPITUMOMAB
MONDO:0060745,intellectual developmental disorder with or without epilepsy or cerebellar ataxia
ncit:C175816,MESDOPETAM
ncit:C66212,MUBRITINIB
chembl:CHEMBL396609,MACROCARPAL A
HGNC:6607,LILRB3
HGNC:14463,SLC39A11
chembl:CHEMBL1797159,CHEMBL:CHEMBL1797159
HGNC:13596,FBXO25
HGNC:26629,ZNF554
rxcui:35617,RIFAPENTINE
MONDO:0000577,congenital anemia
MONDO:0010382,fragile X-associated tremor/ataxia syndrome
rxcui:4024,"ERGOLOID MESYLATES, USP"
UBERON:0002102,forelimb
ncit:C98250,BARDOXOLONE METHYL
chembl:CHEMBL1556035,BETA-TOXICAROL
HGNC:11818,TIMM8B
iuphar.ligand:15,"L-694,247"
HGNC:1908,VPS13A
HGNC:17927,SENP1
HGNC:20233,COQ6
HGNC:17366,AASS
MONDO:0016778,iatrogenic botulism
HP:0011227,Elevated circulating C-reactive protein concentration
SO:1000008,
chembl:CHEMBL598268,CHEMBL:CHEMBL598268
chembl:CHEMBL361362,SYRINGARESINOL
HGNC:3020,DRD1
chembl:CHEMBL1782598,THEONELLASTEROL B
WB:WBGene00022174,slc-30A9
HP:0034464,Homocitrullinuria
UBERON:0001875,globus pallidus
GO:0016531,copper chaperone activity
HGNC:23112,FAT3
GO:0004742,dihydrolipoyllysine-residue acetyltransferase activity
iuphar.ligand:10541,MSMB (91-114)
HGNC:13698,GTSE1
HGNC:9312,PPP2R5D
HGNC:10665,UTP14A
ncit:C90918,OLPRINONE
HGNC:9951,REG1A
ncit:C120553,PAMIPARIB
UPHENO:0068442,increased level of nitrogen molecular entity in blood
iuphar.ligand:9386,BMS-536924
ncit:C76776,DELUCEMINE
chembl:CHEMBL388979,CHEMBL:CHEMBL388979
MGI:4430387,Dst<sup>dt-39J</sup>/Dst<sup>dt-39J</sup>  [background:] involves: NOD
HGNC:7,A2M
HGNC:9077,PLK1
MONDO:0008980,ataxia-hypogonadism-choroidal dystrophy syndrome
iuphar.ligand:12993,TPT-004
HP:0002750,Delayed skeletal maturation
chembl:CHEMBL458602,CHEMBL:CHEMBL458602
HGNC:24818,FOXJ2
ncit:C65800,GARENOXACIN
chembl:CHEMBL580816,CHEMBL:CHEMBL580816
ncit:C153148,OLINCIGUAT
chembl:CHEMBL3545279,EFATUTAZONE HYDROCHLORIDE
chembl:CHEMBL451226,CHEMBL:CHEMBL451226
MONDO:0006709,common bile duct neoplasm
HP:0031392,Abnormal proportion of CD4-positive T cells
CL:2000076,hindlimb stylopod vein endothelial cell
Reactome:R-SCE-71288,Creatine metabolism
MONDO:0014288,Joubert syndrome 21
chembl:CHEMBL577365,CHEMBL:CHEMBL577365
rxcui:227239,MASOPROCOL
MONDO:0008943,autosomal recessive spinocerebellar ataxia 2
ncit:C78125,BALAGLITAZONE
HGNC:31859,TRIM67
HGNC:8859,PEX6
HGNC:2550,CELF2
iuphar.ligand:9125,MM-151
ncit:C91731,APITOLISIB
MGI:104708,Cct3
chembl:CHEMBL1668778,(S)-SARGACHROMENOL
MONDO:0006854,mesenchymoma
HP:0034221,Abnormal temporal lobe morphology
HP:0002814,Abnormality of the lower limb
chembl:CHEMBL1255589,LORGLUMIDE SODIUM
chembl:CHEMBL602150,CHEMBL:CHEMBL602150
rxcui:6826,METHAZOLAMIDE
ncit:C117236,VEGF/HGF-TARGETING DARPIN MP0250
UBERON:0002422,fourth ventricle
HP:0002218,Silver-gray hair
ncit:C77948,CRIDANIMOD
HGNC:6180,ITPR1
GO:0005874,microtubule
HGNC:10968,SLC22A4
HGNC:11633,TCF3
ncit:C76867,COUMAPHOS
RGD:628886,Optn
rxcui:2167673,BOTULINUM TOXIN TYPE B
drugbank:DB11687,E-6201
CHEBI:44185,methotrexate
chembl:CHEMBL1479114,CHEMBL:CHEMBL1479114
rxcui:613391,PRASUGREL
rxcui:196319,PALIFERMIN
HGNC:24934,MAGEE1
HGNC:23302,HKDC1
iuphar.ligand:8443,SKF-83959
iuphar.ligand:9912,ALLITINIB
ncit:C2229,VISILIZUMAB
HGNC:6893,MAPT
chembl:CHEMBL487402,EUPATORIN
NCBIGene:327669,IDH2
rxcui:32613,OXAPROZIN
rxcui:73107,LEVOSIMENDAN
MONDO:0000903,myoclonus-dystonia syndrome
rxcui:2046138,BEVACIZUMAB-AWWB
MONDO:0012627,"epilepsy, idiopathic generalized, susceptibility to, 13"
ZFIN:ZDB-GENE-061103-517,zgc:154093
rxcui:8410,ALTEPLASE
ncit:C76778,FLINDOKALNER
HGNC:11546,TAF13
HGNC:682,ARHGEF2
HGNC:567,AP3B2
ncit:C2242,TRIAPINE
drugbank:DB08180,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE
iuphar.ligand:1250,IMETIT
ncit:C72791,GABOXADOL
UBERON:0001966,substantia nigra pars reticulata
chembl:CHEMBL2109613,PF-04236921
HGNC:11934,TNFSF4
iuphar.ligand:372,2-CHLOROADENOSINE
GO:0042834,peptidoglycan binding
HP:0000969,Edema
WB:WBGene00015755,C14B9.10
HGNC:11449,SUCLG1
MGI:6273760,Tor1a<sup>tm1Calak</sup>/Tor1a<sup>tm1Calak</sup>  [background:] involves: 129 * C57BL/6
chembl:CHEMBL2332580,CHEMBL:CHEMBL2332580
HGNC:17867,NPTN
chembl:CHEMBL1358709,AZOCYCLOTIN
ncit:C150679,QUAVONLIMAB
drugbank:DB11736,PF-00489791
chembl:CHEMBL595911,CHEMBL:CHEMBL595911
rxcui:10825,TRIMEPRAZINE
chembl:CHEMBL1270169,CHEMBL:CHEMBL1270169
rxcui:11413,ZIDOVUDINE
HGNC:5386,IDH3G
HP:0033063,Shortened sleep cycle
ncit:C91381,FUTUXIMAB/MODOTUXIMAB MIXTURE
MONDO:0100315,isolated adrenal insufficiency
iuphar.ligand:9285,PRN694
HP:0012373,Abnormal eye physiology
HGNC:9451,PROC
UBERON:0001684,mandible
chembl:CHEMBL1094679,AESCULIOSIDE IVC
rxcui:9860,CEPHALOTHIN SODIUM
chembl:CHEMBL1883819,FOLPET
HGNC:7981,NR4A2
HGNC:238,ADCY7
chembl:CHEMBL508648,BYAKANGELICIN
rxcui:8352,PIRENZEPINE
rxcui:2653,COCAINE
HGNC:4653,GTF2F2
HGNC:15973,DTX2
chembl:CHEMBL404916,CHEMBL:CHEMBL404916
drugbank:DB05339,MN-305
MGI:102854,Rpl5
chembl:CHEMBL1477383,CHEMBL:CHEMBL1477383
HGNC:5201,HS6ST1
MP:0000559,abnormal femur morphology
chembl:CHEMBL2108510,INTERFERON BETA
HP:0010877,Monocular strabismus
HP:0034674,Abnormal ankle physiology
CHEBI:24532,organic heterocyclic compound
MONDO:0011562,autosomal dominant Parkinson disease 4
HGNC:10548,ATXN1
OBA:2001019,age of onset of bipolar disorder
iuphar.ligand:2058,"[111IN,90Y]DOTA-OC"
iuphar.ligand:2626,VERATRIDINE
MONDO:0012613,"intellectual disability, autosomal recessive 5"
chembl:CHEMBL491499,ZEARALANONE
rxcui:23638,DOPEXAMINE
CHEBI:78954,(omega-1)-hydroxy fatty acid
rxcui:1546019,DASATINIB ANHYDROUS
iuphar.ligand:10967,POSTSTATIN
chembl:CHEMBL465843,PIPLARTINE
GO:0005200,structural constituent of cytoskeleton
MONDO:0002254,syndromic disease
rxcui:897018,DALFAMPRIDINE
rxcui:221088,DEXTROAMPHETAMINE SACCHARATE
iuphar.ligand:3298,[3H]PD128907
HP:0000718,Aggressive behavior
UPHENO:0034270,decreased level of creatine in blood
ncit:C899,RECOMBINANT TRANSFORMING GROWTH FACTOR
HP:0000966,Hypohidrosis
chembl:CHEMBL1946014,CHEMBL:CHEMBL1946014
chembl:CHEMBL348436,CIRSIMARITIN
CHEBI:59676,nystatins
iuphar.ligand:12549,ISOCHLOROGENIC ACID B
CLINVAR:198090,NM_000540.2(RYR1):c.526G>A (p.Glu176Lys)
chembl:CHEMBL594772,CHEMBL:CHEMBL594772
chembl:CHEMBL529348,CHEMBL:CHEMBL529348
MGI:6402641,Tg(Ace2-ACE2)1Cqin/0  [background:] involves: ICR
HP:0032105,Macrosaccadic oscillations
HP:0002972,Reduced delayed hypersensitivity
HP:0001789,Hydrops fetalis
rxcui:2367409,ARTEMISININ
chembl:CHEMBL600347,CHEMBL:CHEMBL600347
iuphar.ligand:1328,HS024
rxcui:1992864,NETARSUDIL
ncit:C76041,FURTRETHONIUM IODIDE
MONDO:0036696,spleen neoplasm
HP:0002359,Frequent falls
GO:0090630,activation of GTPase activity
ncit:C118642,CADAZOLID
ncit:C174617,MIBAMPATOR
MGI:4420313,Gja1<sup>tm1Dlg</sup>/Gja1<sup>tm1Dlg</sup> Tg(GFAP-cre)1Kdmc/0  [background:] involves: 129S7/SvEvBrd * C3H * C57BL/6 * C57BL/6J
HGNC:9392,PRKAR2B
chembl:CHEMBL456881,DEOXYVASICINONE
rxcui:261715,AMINOLEVULINIC ACID HYDROCHLORIDE
ncit:C85454,ONALESPIB
rxcui:155036,MECHLORETHAMINE HYDROCHLORIDE
ncit:C104732,SAVOLITINIB
UPHENO:0079844,abnormal physical aggression behavior
MONDO:0100255,adenosine kinase deficiency
chembl:CHEMBL579882,CHEMBL:CHEMBL579882
MGI:4418498,Hif1a<sup>tm3Rsjo</sup>/Hif1a<sup>tm3Rsjo</sup> Tg(Camk2a-cre)1Szi/0  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
HGNC:11055,SLC6A8
ZFA:0000301,medial rectus
chemidplus:68917-49-7,ST. JOHN'S WORT
rxcui:236394,MIRISTALKONIUM CHLORIDE
HGNC:12303,TRIO
MP:0003224,neuron degeneration
ncit:C96799,VANTICTUMAB
chembl:CHEMBL205061,DICHLOROTRIPHENYLBISMUTHANE
chembl:CHEMBL2095095,CHEMBL:CHEMBL2095095
rxcui:1656328,SACUBITRIL
HGNC:711,ARRB1
MGI:1914090,Wdr45b
rxcui:9947,SOTALOL
HP:0011843,Abnormal musculoskeletal physiology
ncit:C72626,NITREFAZOLE
HP:0032870,Focal impaired awareness cognitive seizure with dyslexia/alexia
NBO:0000417,physiologic nystagmus
ncit:C121456,ATUVECICLIB
MONDO:0010065,spinocerebellar degeneration with slow eye movements
MP:0004081,abnormal globus pallidus morphology
HP:0002406,Limb dysmetria
iuphar.ligand:8059,AZD6482
ncit:C189967,ASNUCICLIB
iuphar.ligand:331,SILAHEXOCYCLIUM
iuphar.ligand:348,THIOCHROME
HGNC:6897,MARK3
HGNC:25541,TMEM33
chembl:CHEMBL1095026,AESCULIOSIDE IIIF
chembl:CHEMBL581929,CHEMBL:CHEMBL581929
iuphar.ligand:10155,RIPK1 INHIBITOR 22B
ncit:C29711,ANTI-DIABETIC AGENT
HGNC:16889,PSMD14
MONDO:0019430,X-linked intellectual disability-ataxia-apraxia syndrome
HGNC:23490,PABIR1
rxcui:82130,MEFLOQUINE HYDROCHLORIDE
MP:0000948,nonconvulsive seizures
HP:0000160,Narrow mouth
MONDO:0012003,autosomal recessive nonsyndromic hearing loss 39
HGNC:20651,SLC37A3
iuphar.ligand:5700,PHA-665752
chembl:CHEMBL228511,DICOFOL
MONDO:0009393,ornithine translocase deficiency
chembl:CHEMBL452477,"2,4,6-TRIHYDROXYACETOPHENONE"
iuphar.ligand:1261,GT2394
rxcui:6691,MEDROXYPROGESTERONE
iuphar.ligand:6680,BD-1047
iuphar.ligand:12917,ABBV-3373
CLINVAR:429893,NM_001110792.2(MECP2):c.1244dup (p.Pro415_Glu416insTer)
HGNC:9477,PRSS12
ncit:C95784,DROZITUMAB
HP:0002067,Bradykinesia
rxcui:1597373,PARITAPREVIR
HGNC:9306,PPP2R2C
iuphar.ligand:2210,"[PHAA1,D-TYR(ME)2,ARG6,TYR-NH29]AVP"
MONDO:0100545,hereditary neurological disease
ncit:C147908,HORMONE THERAPY AGENT
chembl:CHEMBL118678,CHEMBL:CHEMBL118678
HP:0002231,Sparse body hair
HP:0032661,Generalized convulsive status epilepticus
NCBIGene:327696,SDHC
HP:0000773,Short ribs
rxcui:81966,BETHANIDINE SULFATE
MONDO:0100151,nephropathic cystinosis
iuphar.ligand:486,(+)-CYCLAZOSIN
UPHENO:0081603,abnormal cerebral cortex morphology
HGNC:12854,YWHAQ
chembl:CHEMBL1738937,CHEMBL:CHEMBL1738937
ncit:C152829,VANUTIDE CRIDIFICAR
HGNC:17113,HIF1AN
HP:0003270,Abdominal distention
CHEBI:6887,methylphenidate
ncit:C125003,NAPORAFENIB
HP:0002715,Abnormality of the immune system
ncit:C65857,HOMIDIUM BROMIDE
CHEBI:8269,Pleuromutilin
MONDO:0009949,pyruvate carboxylase deficiency disease
HP:0003570,Molybdenum cofactor deficiency
ncit:C152191,RENZAPRIDE
HGNC:15875,AP5S1
HP:0001263,Global developmental delay
HGNC:37,ABCA7
iuphar.ligand:12558,GSK-BZ DERIVATIVE 2B
rxcui:10805,TRIFLUPROMAZINE
iuphar.ligand:8900,SR9011
rxcui:1313722,REGRELOR
rxcui:83719,GREPAFLOXACIN
ncit:C156804,EZH2 INHIBITOR
MONDO:0011904,"seizures, benign familial infantile, 3"
MONDO:0045057,delirium
UPHENO:0068489,increased level of iron atom in substantia nigra
chembl:CHEMBL268868,DAPH
HP:5200072,Immediate Echolalia
HGNC:12407,TUBA4A
chembl:CHEMBL1095016,AESCULIOSIDE IID
MGI:2442192,Eea1
HP:0004691,2-3 toe syndactyly
MONDO:0021640,grade III glioma
HGNC:9532,PSMA3
MGI:109482,Cacna1a
MP:0000790,abnormal stratification in cerebral cortex
GO:0033300,dehydroascorbic acid transmembrane transporter activity
HGNC:2362,CRK
ncit:C1831,SEMAXANIB
MGI:102845,Bdkrb2
UBERON:0003882,CA2 field of hippocampus
HP:0009733,Glioma
rxcui:25696,GENISTEIN
MONDO:0100478,brain malformations with or without urinary tract defects
NCBIGene:397639,EPHX1
HP:0032740,Focal aware autonomic seizure
chembl:CHEMBL525778,TOMATINE
MP:0000783,abnormal forebrain morphology
UBERON:0006322,inferior rectus extraocular muscle
rxcui:166551,RALOXIFENE HYDROCHLORIDE
ncit:C1080,ELSAMITRUCIN
ncit:C165776,REVUMENIB
ncit:C111898,BIMIRALISIB
HGNC:9547,PSMC1
HP:0012785,Flexion contracture of finger
chembl:CHEMBL2109460,SCH-708980
ncit:C170329,PLACULUMAB
HP:0032757,Focal aware hemiclonic seizure
drugbank:DB13113,JNJ-38877605
iuphar.ligand:6157,ONO-4057
MONDO:0002009,major depressive disorder
MONDO:0036591,adrenal cortex neoplasm
ncit:C740,PHENOTHIAZINE
chembl:CHEMBL1688952,2-MERCAPTOPYRIMIDINE
chembl:CHEMBL191044,BENZOXATHIAN
HP:0012044,Seesaw nystagmus
chembl:CHEMBL582697,CHEMBL:CHEMBL582697
MGI:103079,Pura
CHEBI:38104,oxacycle
CHEBI:36688,heterotricyclic compound
ncit:C278,ANTI-THYMOCYTE GLOBULIN
UBERON:0002995,substantia nigra pars lateralis
rxcui:1484911,SOFOSBUVIR
HGNC:76,ABL1
chembl:CHEMBL1373255,CHEMBL:CHEMBL1373255
iuphar.ligand:8827,COMPOUND 11J [PMID: 23021994]
ZFIN:ZDB-GENE-060421-7958,dab1b
NCBIGene:101903567,LOC101903567
chembl:CHEMBL4791762,CX-717
iuphar.ligand:10526,SIAIS178
chembl:CHEMBL2229452,PENCYCURON
HP:0100876,Infra-orbital crease
HGNC:17095,LARS2
HGNC:14215,TRIM55
chembl:CHEMBL718,METHYLDOPA (RACEMIC)
rxcui:9154,RAZOXANE
iuphar.ligand:10063,CDK12 INHIBITOR 2
rxcui:2447,CHOLESTYRAMINE RESIN
rxcui:203188,METHYLPHENIDATE HYDROCHLORIDE
ncit:C169899,DEXPRAMIPEXOLE
HGNC:21066,TBC1D7
chembl:CHEMBL514057,GERONTOXANTHONE H
chembl:CHEMBL1551165,IOPHENOXIC ACID
iuphar.ligand:3231,SB236057
iuphar.ligand:11832,COMPOUND 10 [PMID: 34989568]
CHEBI:4031,cyclosporin A
MONDO:0007053,"restless legs syndrome, susceptibility to, 1"
HGNC:7230,MRE11
HGNC:3595,FAT1
iuphar.ligand:12105,COMPOUND 19 [PMID: 35925768]
rxcui:1792776,ATEZOLIZUMAB
rxcui:115713,MONTELUKAST SODIUM
ncit:C127934,MICROPARTICLE MDP/BACTERIAL DNA-CONTAINING MIS416
rxcui:104973,PENTAZOCINE HYDROCHLORIDE
ncit:C82318,FLUOROSALAN
HGNC:21219,CILK1
GO:0045087,innate immune response
EMAPA:36923,lateral rectus extraocular muscle
HGNC:17104,CDON
ncit:C83806,HOMIDIUM
HGNC:9206,PON3
HGNC:11931,TNFSF15
ncit:C104167,PINATUZUMAB VEDOTIN
ncit:C171616,MDM2 INHIBITOR AMGMDS3
chembl:CHEMBL464443,GONIOTHALAMIN
CHEBI:175901,gemcitabine
HP:0025435,Increased circulating lactate dehydrogenase concentration
HGNC:18001,TOMM40
MP:0008924,decreased cerebellar granule cell number
ncit:C76199,DOVITINIB
chembl:CHEMBL1200443,MERETHOXYLLINE PROCAINE
iuphar.ligand:4083,[3H]GABAZINE
CL:0000062,osteoblast
ncit:C142998,TRICIRIBINE
iuphar.ligand:3992,LY2087101
rxcui:1147320,BRENTUXIMAB VEDOTIN
HP:0032914,Focal aware perseverative automatism seizure
iuphar.ligand:3388,ACDPP
MP:0011470,increased urine creatinine level
HP:0002495,Impaired vibratory sensation
rxcui:5882,INTERFERON GAMMA-1B
GO:0071539,protein localization to centrosome
HP:0011159,Focal autonomic seizure with epigastric sensation/nausea/vomiting/other gastrointestinal phenomena
HP:0004389,Intestinal pseudo-obstruction
HGNC:16999,CLP1
rxcui:2590743,TEBENTAFUSP
MONDO:0005335,colorectal neoplasm
HGNC:28486,MFSD8
ncit:C965,2-METHOXYESTRADIOL
rxcui:4162,ETHYLESTRENOL
MGI:2665400,Fmr1<sup>tm1Cgr</sup>/Fmr1<sup>tm1Cgr</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6J
MGI:106913,Abi2
iuphar.ligand:7687,AZD6703
ncit:C91388,OPROZOMIB
HGNC:14633,ADAMTSL3
rxcui:1311214,SEROTONIN
HGNC:30240,SNRNP27
chembl:CHEMBL77552,CENTAUREIDIN
NBO:0000268,dementia
MGI:3826786,Pkhd1<sup>tm1Gwu</sup>/Pkhd1<sup>tm1Gwu</sup>  [background:] Not Specified
rxcui:83214,MIBEFRADIL DIHYDROCHLORIDE
drugbank:DB05653,IRX-5183
chembl:CHEMBL1371125,BENZO[E]PYRENE
WB:WBGene00009082,dlat-1
HGNC:15772,ARFGEF1
chembl:CHEMBL15766,LY-255283
MGI:1924834,Spidr
chembl:CHEMBL582286,CHEMBL:CHEMBL582286
chembl:CHEMBL591887,CHEMBL:CHEMBL591887
UBERON:0001898,hypothalamus
CHEBI:17087,ketone
MONDO:0016364,Joubert syndrome with ocular defect
ncit:C115109,NAZARTINIB
HGNC:25679,ATG101
CHEBI:25696,organic anion
wikidata:Q48566634,ARTICAINE / EPINEPHRINE
rxcui:235426,PILOCARPINE HYDROCHLORIDE
UPHENO:0080048,increased glial cell growth in independent continuant
ncit:C175553,TINLORAFENIB
ncit:C67084,BARBITURATE
HGNC:7973,NR2E1
MONDO:0020046,autosomal recessive degenerative and progressive cerebellar ataxia
rxcui:267396,BUPIVACAINE HYDROCHLORIDE
rxcui:1311592,BENZODODECINIUM CHLORIDE
MP:0001525,impaired balance
drugbank:DB12468,PF-04531083
HP:0006644,Thoracic dysplasia
ncit:C90934,TENATOPRAZOLE
HGNC:572,AP4B1
NCBIGene:100517436,AOC1
HP:0010535,Sleep apnea
drugbank:DB02823,PHOSPHONOACETIC ACID
chembl:CHEMBL585654,CHEMBL:CHEMBL585654
chembl:CHEMBL592676,ISOSILYBIN A
rxcui:10464,THIAMYLAL
MONDO:0019144,hereditary thrombophilia due to congenital protein S deficiency
CHEBI:16827,corticosterone
WB:WBGene00009440,idhg-1
HP:0003065,Patellar hypoplasia
chembl:CHEMBL1472895,FENBUTATIN OXIDE
HP:0025102,Dysgenesis of the basal ganglia
GO:0099111,microtubule-based transport
rxcui:82065,OXYTETRACYCLINE CALCIUM
chembl:CHEMBL1256920,CHEMBL:CHEMBL1256920
chembl:CHEMBL57394,CHEMBL:CHEMBL57394
chembl:CHEMBL1834951,CHEMBL:CHEMBL1834951
rxcui:7975,PENICILLAMINE
rxcui:103,MERCAPTOPURINE
drugbank:DB17003,BMN-044
rxcui:1798288,OBETICHOLIC ACID
HP:0000506,Telecanthus
rxcui:139953,PRAMLINTIDE
drugbank:DB16742,RP-67580
rxcui:71722,DOCUSATE SODIUM
FB:FBgn0263116,5-HT1B
iuphar.ligand:10601,AZD7648
chembl:CHEMBL578502,CHEMBL:CHEMBL578502
HP:0032891,Focal aware motor seizure with version
MP:0001147,small testis
iuphar.ligand:646,[DES-ARG9]BRADYKININ
MONDO:0010583,"Dyggve-Melchior-Clausen syndrome, X-linked"
MGI:1353451,Aldh3a1
chembl:CHEMBL582722,CHEMBL:CHEMBL582722
rxcui:49247,DOFETILIDE
HGNC:9859,RAP1GDS1
chembl:CHEMBL584508,CHEMBL:CHEMBL584508
drugbank:DB05447,AVI-4557
ncit:C170949,CEVIDOPLENIB DIMESYLATE
MGI:3040187,Ctsd<sup>tm1Cptr</sup>/Ctsd<sup>tm1Cptr</sup>  [background:] either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd)
iuphar.ligand:310,HEXAHYDROSILADIFENIDOL
chembl:CHEMBL485833,FLUDIOXONIL
HP:0000713,Agitation
UBERON:0004991,mucosa of transverse colon
HP:0002332,Lack of peer relationships
HP:0002123,Generalized myoclonic seizure
rxcui:26420,HALOPERIDOL DECANOATE
iuphar.ligand:2023,[125I]LTT-SRIF-28
drugbank:DB12740,CC-115
HGNC:20175,GOLT1B
GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific"
HGNC:12932,TRIM25
MONDO:0021639,grade II glioma
HGNC:19683,UHMK1
iuphar.ligand:8646,COMPOUND 2 [PMID: 19097784]
ncit:C1260,TRIBUTYRIN
iuphar.ligand:2221,"D(CH2)5[TYR(ME)2,THR4,TYR-NH29]OVT"
MONDO:0010972,hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome
ncit:C83796,INDANTADOL
iuphar.ligand:6395,LSN2814617
iuphar.ligand:1738,AR-C126313
iuphar.ligand:497,RO-70-0004
chembl:CHEMBL462731,CHEMBL:CHEMBL462731
MGI:2388401,Cln8<sup>mnd</sup>/Cln8<sup>mnd</sup>  [background:] involves: AKR/J * B6.KB2
MP:0031391,increased locomotor activity
HGNC:21034,NDUFAF4
HGNC:11535,TAF1
iuphar.ligand:5722,AS1535907
rxcui:9060,QUERCETIN
HGNC:3236,EGFR
CHEBI:35523,bronchodilator agent
MONDO:0850514,inclusion body myopathy and brain white matter abnormalities
chembl:CHEMBL1271059,CHEMBL:CHEMBL1271059
SGD:S000005015,LAT1
HGNC:5474,IGFBP5
GO:0070887,cellular response to chemical stimulus
rxcui:1312359,ANDROSTERONE
HP:0005528,Bone marrow hypocellularity
CHEBI:28794,coumarin
MONDO:0010839,"neuronopathy, distal hereditary motor, autosomal dominant 8"
GO:0097306,cellular response to alcohol
rxcui:1592736,NINTEDANIB ESYLATE
ncit:C73073,AMPIROXICAM
ncit:C128036,ANTI-CTLA-4 MONOCLONAL ANTIBODY
UPHENO:0009308,absent cerebellar vermis
iuphar.ligand:6535,COMPOUND (R)-26 [PMID: 22686657]
MP:0005646,abnormal pituitary gland physiology
HGNC:11998,TP53
HP:0010804,Tented upper lip vermilion
HP:0001762,Talipes equinovarus
rxcui:1848,BUTYLATED HYDROXYTOLUENE
ncit:C98110,RADOTINIB
rxcui:1362907,BENZYL SALICYLATE
iuphar.ligand:2813,PHYTANIC ACID
chembl:CHEMBL1834675,SPHAEROPSIDIN A
ncit:C2000,TP3 IMMUNOTOXIN
chembl:CHEMBL495873,MAHANIMBINE
HP:0003455,Elevated circulating long chain fatty acid concentration
iuphar.ligand:190,SB 215505
rxcui:3304,HEROIN
iuphar.ligand:1998,R3/I5
rxcui:7442,NITRIC OXIDE
HGNC:7154,MME
HP:0000726,Dementia
MP:0020167,abnormal vertical activity
iuphar.ligand:5024,MURAMYL DIPEPTIDE
HGNC:8768,AIFM1
MONDO:0010259,retinitis pigmentosa 24
HGNC:17761,TREM2
HGNC:53924,NOTCH2NLC
MGI:4418566,Ehmt1<sup>tm1.1Tara</sup>/Ehmt1<sup>tm1.1Tara</sup> Tg(Camk2a-cre)2Gsc/0  [background:] involves: 129P2/OlaHsd * C57BL/6 * FVB/N
iuphar.ligand:11230,NF279
HP:0032588,Hand apraxia
HP:0007260,Type II lissencephaly
MONDO:0859159,"deafness, cataract, impaired intellectual development, and polyneuropathy"
ncit:C166774,OLVANIL
HGNC:9386,PRKAG2
Reactome:R-HSA-390651,Dopamine receptors
rxcui:3498,DIPHENHYDRAMINE
chembl:CHEMBL601757,CHEMBL:CHEMBL601757
MP:0004191,neuronal intranuclear inclusions
MP:0000819,abnormal olfactory bulb morphology
rxcui:10109,STREPTOMYCIN
rxcui:1367177,CATECHIN
GO:0032007,negative regulation of TOR signaling
chembl:CHEMBL226968,TEBUFENOZIDE
HGNC:1389,CACNA1B
CHEBI:28498,acadesine
CHEBI:50845,doxycycline
rxcui:142153,ALBUTEROL SULFATE
NCBIGene:100687033,NDUFB6
HP:0030286,Atrophic superior cerebellar peduncle
MONDO:0010640,"Leber optic atrophy, susceptibility to"
chembl:CHEMBL494255,AROMATICIN
MP:0001053,abnormal neuromuscular synapse morphology
ncit:C1497,RELCOVAPTAN
ZFIN:ZDB-GENE-031118-95,idh2
ncit:C79915,CARICOTAMIDE
chembl:CHEMBL535051,CHEMBL:CHEMBL535051
chembl:CHEMBL584235,CHEMBL:CHEMBL584235
HP:5200049,Atypical sorting
chembl:CHEMBL186311,VALPROPYLHYDROXAMIC ACID
HP:0000097,Focal segmental glomerulosclerosis
ncit:C661,MITOGUAZONE
GO:0035869,ciliary transition zone
HP:0033034,Anti-citrullinated protein antibody positivity
ncit:C72774,FANDOSENTAN POTASSIUM
MONDO:0012519,Rubinstein-Taybi syndrome due to 16p13.3 microdeletion
HP:0007307,Rapid neurologic deterioration
CHEBI:83748,"2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol"
HP:0032926,Focal impaired awareness head nodding automatism seizure
HP:0000618,Blindness
HP:0001533,Slender build
rxcui:4461,FLUOCINOLONE ACETONIDE
MONDO:0008713,acrodermatitis enteropathica
chembl:CHEMBL577415,CHEMBL:CHEMBL577415
ncit:C90625,ROXINDOLE
rxcui:596205,RAMELTEON
MONDO:0000702,microscopic colitis
MONDO:0005155,cirrhosis of liver
GO:0061817,endoplasmic reticulum-plasma membrane tethering
iuphar.ligand:7002,EPIGALLOCATECHIN-3-GALLATE
chembl:CHEMBL609438,CHEMBL:CHEMBL609438
rxcui:36117,SALMETEROL
RGD:619730,Tubb4a
rxcui:38609,TRICLOCARBAN
rxcui:673579,LISDEXAMFETAMINE DIMESYLATE
HGNC:4023,FXR1
HGNC:4165,GAS1
chembl:CHEMBL1668774,TUBERATOLIDE B
RGD:2153,Arnt
rxcui:1535457,CERITINIB
rxcui:4040,ERYTHRITYL TETRANITRATE
MGI:894332,Ebf2
chembl:CHEMBL1076891,DICHLORODIMETHYLSTANNANE
rxcui:221167,TAZOBACTAM SODIUM
rxcui:1945077,COPANLISIB
rxcui:1546438,GLYCOPYRRONIUM
drugbank:DB08849,NIPECOTIC ACID
rxcui:71534,TRIPROLIDINE HYDROCHLORIDE
chembl:CHEMBL487192,FUKINOLIC ACID
chembl:CHEMBL4594568,KN-026
HGNC:23656,TIMM50
rxcui:11202,VINCRISTINE
HP:0003656,Decreased beta-glucocerebrosidase level
rxcui:2571093,TISOTUMAB VEDOTIN-TFTV
UPHENO:0080047,increased biological_process in substantia nigra
HGNC:1735,CDC37
HP:0000717,Autism
HGNC:15574,RB1CC1
GO:0019933,cAMP-mediated signaling
chembl:CHEMBL55934,NAPHTHOQUINONE
chembl:CHEMBL89250,CHEMBL:CHEMBL89250
chembl:CHEMBL3545345,UR-63325
iuphar.ligand:290,MCN-A-343
chembl:CHEMBL1348974,(4-CHLOROPHENYL)(MORPHOLINO)METHANETHIONE
chembl:CHEMBL484663,CHEMBL:CHEMBL484663
HGNC:5232,HSPA1A
iuphar.ligand:7744,RGB-286638
HGNC:235,ADCY4
ncit:C83838,ISEPAMICIN
MONDO:0100016,early-onset generalized dystonia
rxcui:1827,BUSPIRONE
MP:0006300,abnormal entorhinal cortex morphology
HGNC:20076,USP47
iuphar.ligand:5551,WEDELOLACTONE
rxcui:10689,TRAMADOL
rxcui:10579,THYROTROPIN
drugbank:DB05032,REV131
HGNC:16779,KRTAP3-2
chembl:CHEMBL1902074,CHEMBL:CHEMBL1902074
ncit:C152799,UMIFENOVIR
iuphar.ligand:12643,RELUTRIGINE
EMAPA:17018,principal vein of forelimb
chembl:CHEMBL56393,CHEMBL:CHEMBL56393
ncit:C177916,OPNURASIB
HP:0007965,Undetectable visual evoked potentials
rxcui:235230,NICARDIPINE HYDROCHLORIDE
iuphar.ligand:8333,CYCLIC INSL3 B-CHAIN ANALOGUE 6
chembl:CHEMBL1201644,INSULIN ZINC SUSP RECOMBINANT HUMAN
HGNC:4056,G6PC1
HP:0032833,Neonatal epileptic spasm
HP:3000057,Abnormality of inferior oblique extraocular muscle
MONDO:0032631,"mitochondrial complex 1 deficiency, nuclear type 27"
HP:0002346,Head tremor
HP:0002310,Orofacial dyskinesia
chembl:CHEMBL295960,ORYZALIN
rxcui:1012892,FINGOLIMOD
rxcui:17747,AMINOQUINURIDE
dictyBase:DDB_G0288065,cdcD
chembl:CHEMBL1789985,BRILLIANT GREEN OXALATE
HGNC:14270,PCDH19
HGNC:21906,CHCHD3
HP:0100314,Cerebral inclusion bodies
MGI:103099,Cox6a1
Xenbase:XB-GENE-6455809,sox15
MONDO:0021921,Arnold stickler bourne syndrome
UPHENO:0084537,abnormal amino acid derivative level
NCBIGene:287027,NDUFS8
chembl:CHEMBL486706,CHEMBL:CHEMBL486706
drugbank:DB17507,COTI-2
GO:0007219,Notch signaling pathway
drugbank:DB12359,BIIB021
rxcui:82041,MECLIZINE HYDROCHLORIDE
iuphar.ligand:8958,LIFIRAFENIB
HGNC:28115,TBCEL
chembl:CHEMBL510279,DIHYDROXANTHOHUMOL
chembl:CHEMBL1569494,CHEMBL:CHEMBL1569494
ncit:C174598,PETESICATIB
drugbank:DB11913,LY-2090314
MONDO:0013361,congenital prothrombin deficiency
WB:WBGene00011559,umps-1
rxcui:1546354,2-MERCAPTOETHANESULFONIC ACID
HP:0000616,Miosis
WB:WBGene00006537,tbb-2
chembl:CHEMBL600353,CHEMBL:CHEMBL600353
HGNC:11132,SNAP25
rxcui:4719,GEMFIBROZIL
MP:0004098,abnormal cerebellar granule cell morphology
chembl:CHEMBL414890,PROTOAPIGENONE
HP:0009553,Abnormality of the hairline
HGNC:29099,TELO2
CHEBI:86478,antibiotic antifungal agent
MP:0021145,abnormal amino acid derivative level
UPHENO:0034235,decreased level of chemical entity in urine
ncit:C152843,VEDROPREVIR
ncit:C82353,TLR-DIRECTED CATIONIC LIPID-DNA COMPLEX JVRS-100
drugbank:DB17250,MDX-210
HGNC:7713,NDUFS6
chembl:CHEMBL2177349,HALICLONADIAMINE
chembl:CHEMBL534423,CHEMBL:CHEMBL534423
HGNC:17441,RCOR1
chembl:CHEMBL1489223,SAPPANONE A DIMETHYL ETHER
ncit:C73157,PICOTAMIDE
rxcui:47579,CABERGOLINE
iuphar.ligand:13269,PNU-37883
rxcui:2361,CHLORHEXIDINE HYDROCHLORIDE
HGNC:17259,LSM4
rxcui:82060,NYLIDRIN HYDROCHLORIDE
chembl:CHEMBL532849,CHEMBL:CHEMBL532849
ncit:C97664,LISAVANBULIN
WB:WBGene00303002,Y48E1B.17
iuphar.ligand:1804,[ILE5]PTHRP-(1-36) (HUMAN)
chembl:CHEMBL584619,CHEMBL:CHEMBL584619
iuphar.ligand:5000,IL-9
chembl:CHEMBL261118,CHEMBL:CHEMBL261118
chembl:CHEMBL133342,(S)-ROSCOVITINE
MGI:108090,Ei24
HGNC:16386,OSBPL9
chembl:CHEMBL2109322,AMG-820
chembl:CHEMBL1077759,GRACILIN J
MGI:4410603,Prnp<sup>tm1Cwe</sup>/Prnp<sup>tm1Cwe</sup> Tg(Prnp-tTA)F959Sbp/Tg(Prnp-tTA)F959Sbp Tg(tetO-ATXN3)2904Olri/0  [background:] involves: 129S7/SvEvBrd * C57BL/6 * FVB
MONDO:0010737,"spondyloepiphyseal dysplasia tarda, X-linked"
MGI:1277959,Dlg4
MONDO:0014800,progressive scapulohumeroperoneal distal myopathy
iuphar.ligand:1772,CLOPIDOGREL (ACTIVE METABOLITE)
chembl:CHEMBL545184,CHEMBL:CHEMBL545184
rxcui:142144,BETAXOLOL HYDROCHLORIDE
chembl:CHEMBL261693,CHEMBL:CHEMBL261693
HP:0008507,Static ophthalmoparesis
rxcui:299635,ALEFACEPT
rxcui:38298,TIOCONAZOLE
chembl:CHEMBL481161,CHEMBL:CHEMBL481161
chembl:CHEMBL1290347,RETUSIN 7-METHYL ETHER
chembl:CHEMBL593254,CHEMBL:CHEMBL593254
chembl:CHEMBL512578,MORACIN M
iuphar.ligand:547,SR59230A
HGNC:17586,MTCH1
MONDO:0800112,non-atopic asthma
iuphar.ligand:10295,LARIXYL ACETATE
HP:0032792,Tonic seizure
HP:0003144,Increased serum serotonin
GO:0005794,Golgi apparatus
chembl:CHEMBL118417,CHEMBL:CHEMBL118417
HP:0032714,Focal impaired awareness bilateral motor seizure
MONDO:0006642,alcohol withdrawal delirium
UPHENO:0001440,increased size of the brain ventricle
chembl:CHEMBL2272973,FLUROCHLORIDONE
HGNC:24969,NPRL2
iuphar.ligand:12484,YL5084
HP:0001361,Nystagmus-induced head nodding
chembl:CHEMBL584841,CHEMBL:CHEMBL584841
HP:0002019,Constipation
rxcui:1311387,CHLOROGENIC ACID
rxcui:1665509,FLIBANSERIN
HP:0000006,Autosomal dominant inheritance
MONDO:0016418,"multiple system atrophy, cerebellar type"
MGI:103286,Atp6v0a1
MONDO:0011249,torsion dystonia with onset in infancy
HP:0030186,Kinetic tremor
UBERON:0001103,diaphragm
iuphar.ligand:10361,RG-1530
MP:0004980,increased neuronal precursor cell number
chembl:CHEMBL585656,CHEMBL:CHEMBL585656
rxcui:58331,ZOMEPIRAC SODIUM
chembl:CHEMBL1892987,DINOSEB
MONDO:0011035,neurofibromatosis-Noonan syndrome
ncit:C166612,LITENIMOD
MGI:107733,Dctn2
iuphar.ligand:73,NAN 190
chembl:CHEMBL276139,"2,4-DIACETYLPHLOROGLUCINOL"
UPHENO:0077991,decreased reflex in calcaneal tendon
ZFIN:ZDB-GENE-030131-4449,etfa
MGI:4412280,Prnp<sup>tm2Lnq</sup>/Prnp<sup>tm2Lnq</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6N
rxcui:20220,CARBINOXAMINE
rxcui:91070,BUCLIZINE HYDROCHLORIDE
iuphar.ligand:2832,XCT790
HP:0012448,Delayed myelination
rxcui:9259,RESCINNAMINE
CHEBI:3992,cyclic ketone
rxcui:91138,LOXAPINE HYDROCHLORIDE
rxcui:6774,MERSALYL
HGNC:29427,SH3TC2
chembl:CHEMBL42624,PHYSCION
HP:0003394,Muscle spasm
rxcui:8348,PIPOTHIAZINE
MONDO:0011631,hemochromatosis type 4
ncit:C578,RECOMBINANT INHIBIN
ncit:C1239,EXISULIND
GO:0031593,polyubiquitin modification-dependent protein binding
ncit:C90585,AURORA A KINASE INHIBITOR MK5108
MP:0004948,abnormal neuronal precursor proliferation
HP:0002020,Gastroesophageal reflux
ncit:C65624,FASUDIL
rxcui:6980,MINOCYCLINE
iuphar.ligand:2115,GR 159897
HGNC:2433,CSF1R
MONDO:0007947,Marfan syndrome
rxcui:54236,OXATOMIDE
HGNC:5010,HMGA1
CHEBI:28793,beta-D-glucan
MGI:5607614,Myo5a<sup>d-l34J</sup>/Myo5a<sup>d-l34J</sup>  [background:] BALB/cJ-Myo5a<sup>d-l34J</sup>/GrsrJ
Reactome:R-MMU-71288,Creatine metabolism
iuphar.ligand:1716,2-CHLOROADENOSINE-5-TRIPHOSPHATE
rxcui:4179,ETOPOSIDE
iuphar.ligand:1710,2MESADP
chembl:CHEMBL547285,CHEMBL:CHEMBL547285
MP:0020624,decreased dorsal striatum cell density
chembl:CHEMBL591628,CHEMBL:CHEMBL591628
iuphar.ligand:12490,AZ2429
iuphar.ligand:5116,3-HYDROXYBENZYLHYDRAZINE
ncit:C116626,ANTI-ENPP3/MMAF ANTIBODY-DRUG CONJUGATE AGS-16M8F
UBERON:0004079,cerebellum vermis lobule V
MGI:97747,Pparg
rxcui:1981,CANRENOATE POTASSIUM
CHEBI:38922,dibenzofurans
rxcui:236186,TENONITROZOLE
chembl:CHEMBL1537719,PYRAZOPHOS
ZFIN:ZDB-GENE-030131-3157,dhodh
rxcui:18346,ARTESUNATE
HP:0007058,Generalized cerebral atrophy/hypoplasia
iuphar.ligand:9942,AZD0156
CLINVAR:133072,NM_000540.3(RYR1):c.14497C>T (p.His4833Tyr)
HGNC:17882,SREK1
rxcui:236167,LANREOTIDE ACETATE
ncit:C169809,BEVASIRANIB
HP:0100833,Neoplasm of the small intestine
rxcui:91066,CARBINOXAMINE MALEATE
CL:0002676,neural crest derived neuroblast
HP:0032905,Focal sexual automatism seizure
iuphar.ligand:7848,CGP13501
Reactome:R-DDI-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
ncit:C62756,TERTOMOTIDE
chembl:CHEMBL458765,CHEMBL:CHEMBL458765
iuphar.ligand:8944,EMACTUZUMAB
MGI:5566830,Myo7a<sup>sh1-13J</sup>/Myo7a<sup>sh1-13J</sup>  [background:] C.Cg-Myo7a<sup>sh1-13J</sup>/GrsrJ
iuphar.ligand:4494,HEMICHOLINIUM-3
rxcui:22537,DESOXYCORTICOSTERONE PIVALATE
UBERON:0010709,pelvic complex
ncit:C174607,LANRAPLENIB
GO:0055038,recycling endosome membrane
HGNC:25590,OGDHL
ncit:C82677,C-MET INHIBITOR AMG 208
MONDO:0010659,FRAXE intellectual disability
chembl:CHEMBL4802222,OSTABOLIN-C
HP:0011442,Abnormal central motor function
HGNC:1390,CACNA1C
chembl:CHEMBL85109,ORTHOTOLIDINE
HGNC:24682,FLVCR1
ncit:C95738,MEK INHIBITOR GDC-0623
CHEBI:85616,viridicatumtoxin
drugbank:DB16752,CIPATINIB
HP:0004343,Abnormal glycosphingolipid metabolism
rxcui:2199577,INDOCYANINE GREEN ACID FORM
HP:0002074,Increased neuronal autofluorescent lipopigment
MGI:1932395,Rrbp1
ncit:C117730,MAGROLIMAB
iuphar.ligand:10372,COMPOUND 14 [PMID: 30925062]
MGI:107563,Nab2
rxcui:2602286,TAPINAROF
MONDO:0011781,spinocerebellar ataxia type 17
HGNC:19691,MECR
ncit:C152226,RIPASUDIL
MGI:103024,Whl
MONDO:0005260,autism
CHEBI:7528,netilmycin
HP:0001892,Abnormal bleeding
ncit:C121817,SAMOTOLISIB
chembl:CHEMBL3545265,MLN-0415
ncit:C226,EFLORNITHINE
iuphar.ligand:4216,HOMOQUINOLINIC ACID
HGNC:10353,RPL4
TS:28,
iuphar.ligand:10570,OSTN (115-133)
iuphar.ligand:9383,OSI-930
rxcui:266959,PHENIRAMINE MALEATE
ncit:C127906,ANTI-MET MONOCLONAL ANTIBODY MIXTURE SYM015
GO:0006954,inflammatory response
chembl:CHEMBL529741,CHEMBL:CHEMBL529741
HGNC:25302,COQ9
HP:0002367,Visual hallucinations
iuphar.ligand:8919,AR-67
rxcui:203173,CHLORDIAZEPOXIDE HYDROCHLORIDE
MONDO:0005495,adrenal gland disorder
UPHENO:0086695,abnormal piriform cortex morphology
HP:0001139,Choroideremia
HGNC:8648,PCBP2
rxcui:1314368,MEDRONIC ACID
ncit:C188540,AZETUKALNER
drugbank:DB14008,HISPIDULIN
MGI:1270850,Slc6a2
HP:0000745,Diminished motivation
HP:0032799,Focal impaired awareness hemiclonic seizure
UPHENO:0088139,abnormal basal ganglion morphology
ncit:C166432,PADSEVONIL
HP:0032824,Neonatal focal tonic seizure
chembl:CHEMBL467888,LGD-2941
ncit:C61936,SARCOLYSIN
ncit:C169794,ATOPAXAR
iuphar.ligand:8172,COMPOUND 7 [PMID: 22464456]
MONDO:0016295,neuronal ceroid lipofuscinosis
ZFIN:ZDB-GENE-030131-274,prpf40a
HGNC:11273,SPTAN1
UPHENO:0080591,abnormal irritability behavior
chembl:CHEMBL361506,PENTAMIDINE ISETHIONATE
iuphar.ligand:168,VER-3323
MP:0000947,convulsive seizures
HP:0002396,Cogwheel rigidity
RGD:1309501,Wdpcp
HGNC:234,ADCY3
RGD:620190,Becn1
GO:0016887,ATP hydrolysis activity
rxcui:214468,DAUNORUBICIN LIPOSOMAL
HP:0007377,Abnormality of somatosensory evoked potentials
iuphar.ligand:7836,E6201
ZFIN:ZDB-GENE-040426-1688,ndufa8
iuphar.ligand:4324,TNP-ATP
rxcui:2629338,PIRTOBRUTINIB
ncit:C80813,CORTODOXONE
HGNC:3395,EPHB4
ncit:C180835,EXARAFENIB
HP:0000122,Unilateral renal agenesis
iuphar.ligand:12287,CHIGLITAZAR
chembl:CHEMBL1288831,PESUDOGINSENOSIDE RP1 METHYL ESTER
chembl:CHEMBL403063,NITROBLUE TETRAZOLIUM CHLORIDE
chembl:CHEMBL1437888,CHEMBL:CHEMBL1437888
HP:0003552,Muscle stiffness
rxcui:10803,TRIFLURIDINE
rxcui:197,ACETYLCYSTEINE
rxcui:2176312,BREMELANOTIDE
chembl:CHEMBL492528,CHEMBL:CHEMBL492528
HGNC:11541,TAF7
HGNC:30500,PRRT2
chembl:CHEMBL1172241,NERVIANO
iuphar.ligand:3623,OLEOYL-LYSOPHOSPHATIDYLCHOLINE
HGNC:21648,TOMM7
iuphar.ligand:9036,RESATORVID
HGNC:1677,CD247
HP:0001945,Fever
rxcui:91272,BENZQUINAMIDE HYDROCHLORIDE
drugbank:DB15192,ABT-288
rxcui:20498,CELIPROLOL
iuphar.ligand:5662,AT-7519
HGNC:6244,KCNE4
HP:0032842,Generalized-onset epileptic spasm
HGNC:16627,CHEK2
chembl:CHEMBL413376,SURAMIN HEXASODIUM
MGI:3644960,Ces3b
MGI:3839946,En1<sup>tm1Gld</sup>/En1<sup>+</sup> En2<sup>tm1Alj</sup>/En2<sup>tm1Alj</sup>  [background:] involves: 129S/SvEv * 129S2/SvPas * C57BL/6 * Swiss Webster
HP:0007979,Gaze-evoked horizontal nystagmus
MGI:6455041,Tg(K18-ACE2)2Prlmn/0  [background:] B6.Cg-Tg(K18-ACE2)2Prlmn/J
HP:0000256,Macrocephaly
UBERON:0000988,pons
MP:0031392,hypoactivity
HGNC:6204,JUN
rxcui:1940642,NERATINIB MALEATE
MONDO:0015306,Lemierre syndrome
chembl:CHEMBL1269022,CHEMBL:CHEMBL1269022
rxcui:1603522,GLABRIDIN
HP:0000215,Thick upper lip vermilion
chembl:CHEMBL4594491,REMLARSEN
ZFIN:ZDB-GENE-090806-3,msc
CHEBI:15356,cysteine
RGD:628878,Hspa4
MP:0011101,"prenatal lethality, incomplete penetrance"
GO:0005829,cytosol
iuphar.ligand:5047,POLY(I:C)
HGNC:2348,CREBBP
FB:FBgn0003257,r-l
HGNC:1424,CAD
HP:0008573,Low-frequency sensorineural hearing impairment
HGNC:3093,DYRK2
HGNC:23186,CLINT1
HP:0002199,Hypocalcemic seizures
iuphar.ligand:12556,AM404
rxcui:221183,ZOLPIDEM TARTRATE
ncit:C72867,TILIQUINOL
ncit:C462,ECHINOMYCIN
iuphar.ligand:6939,AZ-4217
HGNC:12617,USP19
MONDO:0012603,episodic kinesigenic dyskinesia 2
MP:0010009,abnormal piriform cortex morphology
chembl:CHEMBL258867,EUPALININ A
iuphar.ligand:9405,BS-181
MONDO:0000483,oculogyric crisis
MP:0001473,reduced long-term potentiation
MGI:1921772,Morc2a
MGI:104783,Atxn1
iuphar.ligand:12844,GRASP
ncit:C154569,CURCUMIN/DOXORUBICIN-ENCAPSULATING NANOPARTICLE IMX-110
chembl:CHEMBL588859,CHEMBL:CHEMBL588859
chembl:CHEMBL485756,CHEMBL:CHEMBL485756
MONDO:0007256,hepatocellular carcinoma
HP:0020216,Visually-induced seizure
ncit:C975,AFIMOXIFENE
rxcui:235827,MEBEVERINE HYDROCHLORIDE
ncit:C1454,BISPECIFIC ANTIBODY
HP:0032834,Neonatal seizure with unilateral automatism
rxcui:48936,DEXBROMPHENIRAMINE MALEATE
iuphar.ligand:257,SB 207710
rxcui:1362888,CHRYSIN
HGNC:6694,LRP2
HP:0003202,Skeletal muscle atrophy
HP:0000818,Abnormality of the endocrine system
iuphar.ligand:8123,COMPOUND 1D [PMID: 21493067]
HGNC:6269,KCNJ8
HGNC:7224,MPV17
chembl:CHEMBL601554,CHEMBL:CHEMBL601554
iuphar.ligand:311,MUSCARINIC TOXIN 1
rxcui:38404,TOPIRAMATE
HGNC:17328,DTNBP1
Xenbase:XB-GENE-1007523,mecr
HGNC:1509,CASP8
MGI:5702951,Mecp2<sup>tm5.1Bird</sup>/Y  [background:] involves: 129P2/OlaHsd * C57BL/6
iuphar.ligand:4300,RO 8-4304
rxcui:133041,YOHIMBINE HYDROCHLORIDE
HGNC:9955,RELA
chembl:CHEMBL601933,CHEMBL:CHEMBL601933
chembl:CHEMBL274921,CHEMBL:CHEMBL274921
iuphar.ligand:61,(S)-UH 301
chembl:CHEMBL2109402,MM-121
iuphar.ligand:6,7-METHOXY-1-NAPHTHYLPIPERAZINE
iuphar.ligand:10712,MK-7622
chembl:CHEMBL561004,NITROFEN
ncit:C125080,TILSOTOLIMOD SODIUM
MONDO:0013813,dystonia 21
HGNC:16352,MRM2
chembl:CHEMBL448213,LINURON
HGNC:20202,CACNA2D4
HP:0032769,Focal aware autonomic seizure with hypoventilation/hyperventilation/altered respiration
chembl:CHEMBL1436543,CHEMBL:CHEMBL1436543
HP:0000912,Sprengel anomaly
drugbank:DB16856,FURFURAL
chembl:CHEMBL4297555,RESIMMUNE
HGNC:9039,PLA2G6
HGNC:31802,NSUN4
chembl:CHEMBL95770,4-METHOXYCINNAMIC ACID
ncit:C210,IMMUNOADJUVANT
HGNC:18401,RNF41
chembl:CHEMBL1397833,VITAMIN B2
ncit:C626,MAYTANSINE
rxcui:5095,HALOTHANE
CHEBI:28304,heparin
ncit:C1643,PNEUMOCOCCAL POLYVALENT VACCINE
MGI:4418721,nad/nad  [background:] C(D2)-nad
HP:0000017,Nocturia
iuphar.ligand:4266,NF023
HP:0032327,Interhemispheric cyst
ncit:C72586,ENOXAMAST
HP:0001596,Alopecia
rxcui:6674,MECHLORETHAMINE
ncit:C83536,ARHALOFENATE
CL:1001602,cerebral cortex endothelial cell
HP:0032857,Focal aware motor seizure with negative myoclonus
HGNC:14504,MRPS15
HP:0007369,Atrophy/Degeneration affecting the cerebrum
CLINVAR:38215,NM_000059.4(BRCA2):c.9117G>A (p.Pro3039=)
HGNC:3581,BPTF
HGNC:21604,EPN1
MP:0000550,abnormal forelimb morphology
HGNC:24351,PHRF1
HGNC:10604,SCO2
chembl:CHEMBL1890813,METHABENZTHIAZURON
MONDO:0002816,adrenal cortex disorder
HGNC:791,ATF6
rxcui:42333,TRIMETREXATE
chembl:CHEMBL4297529,RISUTEGANIB
chembl:CHEMBL43612,JUGLONE
chembl:CHEMBL275938,AURINTRICARBOXYLIC ACID
drugbank:DB05750,AVE-1625
FB:FBgn0004168,5-HT1A
CHEBI:8871,risperidone
ncit:C26645,MULTI-NEO-EPITOPE VACCINE OSE 2101
MONDO:0009567,Marinesco-Sjogren syndrome
WB:WBGene00000764,coq-4
rxcui:2403,CHLORPROMAZINE
HP:0032672,Autonomic status epilepticus
UBERON:0005368,hippocampus molecular layer
HP:0032718,Focal motor seizure with dystonia
rxcui:155056,PROCAINAMIDE HYDROCHLORIDE
iuphar.ligand:8144,COMPOUND 13R [PMID: 23639540]
iuphar.ligand:12229,ZWB67
chembl:CHEMBL1327172,CHEMBL:CHEMBL1327172
HGNC:167,ACTR1A
UBERON:0002988,first dorsal interosseous of manus
iuphar.ligand:729,2-ARACHIDONOYLGLYCEROL
iuphar.ligand:4872,BDNF
chembl:CHEMBL273862,HYDROXYCAMPTOTHECIN
rxcui:1373,BENPERIDOL
HP:0000964,Eczematoid dermatitis
rxcui:40036,BENZETHONIUM CHLORIDE
iuphar.ligand:526,RX821002
rxcui:6923,METYRAPONE
HGNC:19693,COQ4
HGNC:15714,LRPPRC
MONDO:0005021,dilated cardiomyopathy
ncit:C75267,ENPIROLINE
rxcui:266604,METYROSINE
chembl:CHEMBL3545245,BAY-1082439
drugbank:DB06321,R-348
chembl:CHEMBL4802150,NAVOCAFTOR
ncit:C77934,DENOPAMINE
HGNC:2865,DHH
ncit:C87421,ACONITINE
HGNC:7391,MSX1
chembl:CHEMBL1560680,PROTHIOFOS
iuphar.ligand:2789,ZK159222
chembl:CHEMBL591404,CHEMBL:CHEMBL591404
HP:0007064,Progressive language deterioration
iuphar.ligand:8891,SGI-1027
HGNC:1329,SLC30A9
HGNC:11896,TNFAIP3
HP:0001987,Hyperammonemia
drugbank:DB05490,AMG-131
HGNC:7691,NDUFA7
HGNC:3801,FOXC2
iuphar.ligand:9826,GSK1059615
HGNC:10985,SLC25A15
MGI:94893,Cyb5r3
ncit:C128462,BET INHIBITOR
HGNC:16915,HAX1
drugbank:DB14680,COMBRETASTATIN A4
GO:0000177,cytoplasmic exosome (RNase complex)
GO:0000290,deadenylation-dependent decapping of nuclear-transcribed mRNA
HGNC:16395,OSBPL10
GO:0006829,zinc ion transport
rxcui:618365,"SYNTHETIC CONJUGATED ESTROGENS, B"
HGNC:11993,TOP3B
iuphar.ligand:9130,ZM336372
MONDO:0016146,caveolinopathy
iuphar.ligand:4023,A331440
HGNC:4187,GC
iuphar.ligand:9821,RO5508887
rxcui:139462,MOXIFLOXACIN
chembl:CHEMBL259327,CHEMBL:CHEMBL259327
UBERON:0001088,urine
chembl:CHEMBL243148,SOPHORAFLAVANONE G
HP:0032795,Generalized myoclonic-tonic-clonic seizure
GO:0046449,creatinine metabolic process
HP:0000364,Hearing abnormality
HGNC:1050,BID
HP:0007165,Periventricular heterotopia
HP:0007440,Generalized hyperpigmentation
HP:0032793,Focal impaired awareness cognitive seizure with receptive dysphasia/aphasia
HGNC:11588,TBP
iuphar.ligand:9797,COMPOUND 37 [PMID: 29193967]
MONDO:0044306,"neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination"
rxcui:8153,PHENTOLAMINE
chembl:CHEMBL1210769,CHEMBL:CHEMBL1210769
rxcui:190353,DACLIZUMAB
HGNC:16380,TRIM32
chembl:CHEMBL1372046,CHEMBL:CHEMBL1372046
drugbank:DB17057,SRT-1720
chembl:CHEMBL490125,SCHISANHENOL
chembl:CHEMBL463783,CHEMBL:CHEMBL463783
drugbank:DB04557,ARACHIDONIC ACID
HP:0007200,Episodic hypersomnia
HGNC:10537,SARS1
HGNC:6742,LZTR1
rxcui:29008,LYCOPENE
chembl:CHEMBL580340,CHEMBL:CHEMBL580340
MP:0020371,abnormal glymphatic system physiology
Reactome:R-GGA-419469,Pyrimidine metabolism: de novo synthesis of UMP
iuphar.ligand:5779,C089
ncit:C112205,ROGARATINIB
chembl:CHEMBL3545236,BPI-9016
chembl:CHEMBL2071525,ALTISSIMACOUMARIN C
chembl:CHEMBL428971,RHODAMINE
rxcui:1926478,ALFATRADIOL
MONDO:0017160,behavioral variant of frontotemporal dementia
chembl:CHEMBL573111,CHEMBL:CHEMBL573111
MONDO:0016820,Moyamoya disease
WB:WBGene00012389,scpr-1
MGI:1888939,Septin6
rxcui:1311146,PIPERINE
chembl:CHEMBL1408927,AMARANTH
MONDO:0006402,salivary gland basal cell adenocarcinoma
MONDO:0005661,babesiosis
chembl:CHEMBL1554674,CHARTREUSIN
wikidata:Q48566743,HYDRALAZINE / ISOSORBIDE DINITRATE
iuphar.ligand:10640,COMPOUND 21B [PMID: 31944697]
HP:0031826,Abnormal reflex
drugbank:DB08052,PP-121
HGNC:29812,DCPS
chembl:CHEMBL610767,CHEMBL:CHEMBL610767
CLINVAR:12966,NM_000540.3(RYR1):c.7304G>A (p.Arg2435His)
GO:0005856,cytoskeleton
MONDO:0020120,skeletal muscle disorder
rxcui:1599538,EDOXABAN
iuphar.ligand:7346,MK-0249
rxcui:104416,AMLODIPINE BESYLATE
HGNC:6133,ISLR
HP:0007885,Slowed horizontal saccades
GO:0016301,kinase activity
rxcui:82133,XAMOTEROL FUMARATE
HP:0000414,Bulbous nose
iuphar.ligand:10440,MS48107
rxcui:2262435,ZANUBRUTINIB
rxcui:203129,MITOXANTRONE HYDROCHLORIDE
chembl:CHEMBL1077108,FUROSPONGOLIDE
HGNC:11278,SPTLC2
iuphar.ligand:7640,SIMOTINIB
CHEBI:33295,diagnostic agent
chembl:CHEMBL592566,CHEMBL:CHEMBL592566
CHEBI:7731,ofloxacin
HGNC:23056,ALG3
drugbank:DB16772,RHAMNETIN
rxcui:358258,BORTEZOMIB
rxcui:2539031,ESTETROL
MONDO:0006268,liver diffuse large B-cell lymphoma
HGNC:6972,MDK
HGNC:3066,DUSP11
chembl:CHEMBL546531,CHEMBL:CHEMBL546531
MONDO:0016305,atypical pantothenate kinase-associated neurodegeneration
MONDO:0005311,atherosclerosis
iuphar.ligand:5269,SB203580
NCBIGene:481907,HTR1E
chembl:CHEMBL78010,PECTOLINARIGENIN
rxcui:8766,PERICIAZINE
MONDO:0012719,combined PSAP deficiency
CHEBI:15422,ATP
chembl:CHEMBL582675,CHEMBL:CHEMBL582675
iuphar.ligand:9155,OGERIN
GO:0006508,proteolysis
MP:0004679,xiphoid process foramen
iuphar.ligand:3649,CCL28
iuphar.ligand:5998,JNK INHIBITOR VIII
HGNC:14938,PIGT
HP:0031960,Arm dystonia
chembl:CHEMBL1601846,CHEMBL:CHEMBL1601846
iuphar.ligand:12248,D6808
rxcui:1484518,SIMEPREVIR SODIUM
rxcui:2047232,BARICITINIB
HP:0025588,Hypodeviation
HP:0000411,Protruding ear
MGI:88071,Arnt
chembl:CHEMBL260213,CHEMBL:CHEMBL260213
HGNC:7804,NFYA
MONDO:0021095,parkinsonian disorder
chembl:CHEMBL284028,"2,3-DIHYDROXY-6,7-DICHLOROQUINOXALINE"
HP:0031605,Abnormality of fundus pigmentation
MONDO:0012813,retinitis pigmentosa 29
HGNC:779,ATCAY
chembl:CHEMBL407391,DIMETHYLADENINE
iuphar.ligand:12106,FARUDODSTAT
iuphar.ligand:7650,UNC9975
iuphar.ligand:9933,NSC 780521
MONDO:0013170,"cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies"
rxcui:6963,MIDODRINE
HP:0025354,Abnormal cellular phenotype
chembl:CHEMBL3545296,ARQ-736
MONDO:0000507,inclusion body myopathy with Paget disease of bone and frontotemporal dementia
chembl:CHEMBL2016893,XL-418
MGI:1917655,Calml3
ncit:C98235,DEVAZEPIDE
chembl:CHEMBL264938,GALLOCATECHIN GALLATE
MONDO:0009008,heart defect - tongue hamartoma - polysyndactyly syndrome
drugbank:DB17983,MM-111
ncit:C129048,IBERDOMIDE
drugbank:DB16106,GSK2256098
iuphar.ligand:4205,GSK1016790A
MONDO:0018614,undetermined early-onset epileptic encephalopathy
rxcui:117466,TENOFOVIR
HGNC:29914,NUP107
CHEBI:37407,cyclic ether
MONDO:0035449,atelencephaly
drugbank:DB15498,BOS172722
iuphar.ligand:9352,HARMINE
MP:0009630,absent axillary lymph nodes
Reactome:R-HSA-390650,Histamine receptors
ncit:C95737,AKT INHIBITOR LY2780301
ncit:C72775,FANETIZOLE
CHEBI:72564,temozolomide
CLINVAR:143749,NM_001110792.2(MECP2):c.961C>T (p.Arg321Trp)
rxcui:23386,DIPHENYLPYRALINE
rxcui:1372539,GUANINE
chembl:CHEMBL314639,CHEMBL:CHEMBL314639
iuphar.ligand:110,CP-122288
chembl:CHEMBL348856,"4,4'-THIODIANILINE"
HP:0100543,Cognitive impairment
HGNC:17180,ASB5
HGNC:6149,ITGAM
ncit:C174804,EVENAMIDE
chembl:CHEMBL588749,CHEMBL:CHEMBL588749
HP:0000651,Diplopia
HP:0008959,Distal upper limb muscle weakness
HP:0002754,Osteomyelitis
ncit:C148134,SAFUSIDENIB
HGNC:25018,TMEM216
HGNC:25985,PIGG
HGNC:9308,PTPA
ncit:C98295,ANTI-C-FMS MONOCLONAL ANTIBODY AMG 820
rxcui:47998,CHLORAMPHENICOL SODIUM SUCCINATE
ncit:C72822,NETOGLITAZONE
PomBase:SPCC16C4.12,naa20
rxcui:9260,RESERPINE
RGD:2661,Gapdh
rxcui:3384,DIETHYLCARBAMAZINE
chembl:CHEMBL252721,DERRUSTONE
HGNC:10483,RYR1
rxcui:37806,TERCONAZOLE
ncit:C97357,SORBINIL
ncit:C2551,"CP-609,754"
rxcui:59763,STAVUDINE
HP:0007286,Horizontal jerk nystagmus
HGNC:31709,ARL13A
HP:0007033,Cerebellar dysplasia
MGI:1100498,Pitx3
chembl:CHEMBL586031,CHEMBL:CHEMBL586031
chembl:CHEMBL592558,CHEMBL:CHEMBL592558
HP:0007598,Bilateral single transverse palmar creases
rxcui:89810,TALBUTAL
ncit:C152139,RACLOPRIDE
rxcui:27196,HYDROCORTISONE PROBUTATE
iuphar.ligand:4059,VU-1545
HP:0002474,Expressive language delay
CHEBI:10106,zearalenone
HGNC:15720,STRN3
iuphar.ligand:7511,(+)-JQ1
rxcui:8723,PROFLAVINE
GO:0140582,adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway
HP:0100248,Hemiballismus
MGI:2138968,Clp1
HGNC:24040,ADIPOR1
iuphar.ligand:1652,U50488
drugbank:DB05842,AI-850
rxcui:337525,ERLOTINIB
iuphar.ligand:4595,MPA
HP:0011175,Focal motor seizure with version
chembl:CHEMBL584635,CHEMBL:CHEMBL584635
HGNC:2013,AP3S1
chembl:CHEMBL580071,CHEMBL:CHEMBL580071
rxcui:739,AMSACRINE
ncit:C131827,BOMEDEMSTAT
HGNC:2459,CSNK2A2
GO:0097541,axonemal basal plate
HGNC:9855,RAP1A
chembl:CHEMBL198759,CHEMBL:CHEMBL198759
HGNC:25121,NCBP2AS2
CHEBI:15378,hydron
HP:0032738,Focal aware emotional seizure with fear/anxiety/panic
iuphar.ligand:4153,CFTRINH-172
HP:0002529,Neuronal loss in central nervous system
rxcui:235402,DIBUCAINE HYDROCHLORIDE
HGNC:4856,HDGF
CL:2000079,mesenchymal stem cell of femoral bone marrow
GO:0006631,fatty acid metabolic process
HP:0000370,Abnormality of the middle ear
HGNC:132,ACTB
HGNC:3796,FOS
ncit:C77879,GLYCOSYLATED RECOMBINANT HUMAN INTERLEUKIN-7
ncit:C1833,TEGAFUR-GIMERACIL-OTERACIL POTASSIUM
iuphar.ligand:8065,GNF-5
rxcui:1100071,ABIRATERONE ACETATE
MONDO:0008243,Pick disease
ncit:C550,HYCANTHONE
rxcui:1596,BISACODYL
HP:0011968,Feeding difficulties
chembl:CHEMBL588683,CHEMBL:CHEMBL588683
rxcui:4089,ESTRAMUSTINE
MONDO:0004069,inborn mitochondrial metabolism disorder
ncit:C153377,CDK9 INHIBITOR AZD4573
MGI:6771478,Clp1<sup>em1Slac</sup>/Clp1<sup>em2Slac</sup>  [background:] C57BL/6J-Clp1<sup>em1Slac</sup>/Clp1<sup>em2Slac</sup>
MONDO:0006917,posterior cerebral artery infarction
chembl:CHEMBL1605700,TETRAHYDROGAMBOGIC ACID
rxcui:1297880,CAMPHOR OIL
GO:0000463,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)"
HGNC:12687,VHL
ncit:C923,VACCINE
ZFIN:ZDB-GENE-040426-2592,nnt
MONDO:0020790,"gaze palsy, familial horizontal, with progressive scoliosis 1"
HP:0000023,Inguinal hernia
ncit:C45515,RECOMBINANT HUMAN ENDOSTATIN
rxcui:8701,PROCAINE
rxcui:203148,ONDANSETRON HYDROCHLORIDE
ncit:C66655,VIOMYCIN SULFATE
rxcui:2369,CHLORMADINONE ACETATE
rxcui:8310,PHYTOSTEROLS
chembl:CHEMBL3545135,NV-128
rxcui:2262250,AFAMELANOTIDE
rxcui:236540,REMIFENTANIL HYDROCHLORIDE
iuphar.ligand:4295,RN1747
HP:0032681,Focal aware cognitive seizure
MP:0001516,abnormal motor coordination/balance
chembl:CHEMBL2107801,RESEQUINIL
HP:0100301,Muscle fiber tubular inclusions
HGNC:25543,SHQ1
HP:0006323,Premature loss of primary teeth
HP:0010579,Cone-shaped epiphysis
chembl:CHEMBL3545327,TTP-607
ncit:C133878,ANTI-EGFR MONOCLONAL ANTIBODY
MGI:1096392,Hcn1
HGNC:9395,PRKCB
iuphar.ligand:675,NPC-349
HP:0007086,Social and occupational deterioration
WB:WBGene00007824,dlat-2
NCBIGene:424256,UMPS
HGNC:6257,KCNJ11
CHEBI:2682,amphotericin B
FB:FBgn0031043,Naa20A
HGNC:1408,CACNG4
chembl:CHEMBL80155,CHEMBL:CHEMBL80155
ncit:C113293,P-P68 INHIBITOR RX-5902
chembl:CHEMBL1256667,CHEMBL:CHEMBL1256667
drugbank:DB05984,RAF-265
chembl:CHEMBL4594562,ISIS-2503
iuphar.ligand:5704,PP-242
HP:0000369,Low-set ears
chembl:CHEMBL581257,CHEMBL:CHEMBL581257
rxcui:81993,DEMECLOCYCLINE HYDROCHLORIDE
Reactome:R-HSA-71288,Creatine metabolism
rxcui:4388,PLASMIN
rxcui:486126,ZICONOTIDE ACETATE
chembl:CHEMBL599088,CHEMBL:CHEMBL599088
ncit:C352,CARUBICIN
UPHENO:0052915,decreased qualitatively response to stimulus
EMAPA:18208,lentiform nucleus
MONDO:0014578,congenital myasthenic syndrome 17
HGNC:10923,SLC16A2
CLINVAR:383439,NM_001042537.1(SLC9A6):c.2T>G (p.Met1Arg)
HGNC:4947,HLA-DRA
ncit:C986,ACIVICIN
MGI:103581,Musk
EMAPA:35227,cerebellum vermis lobule III
drugbank:DB14835,SUVN-G3031
iuphar.ligand:4077,[3H]AMPA
ZFIN:ZDB-FISH-170823-12,TL + MO2-cln3
chembl:CHEMBL491820,AMORFRUTIN A
chembl:CHEMBL139935,CHEMBL:CHEMBL139935
MONDO:0010662,paraplegia-intellectual disability-hyperkeratosis syndrome
ncit:C61499,NITRIC OXIDE-RELEASING ACETYLSALICYLIC ACID DERIVATIVE
MGI:5617140,Fmr1<sup>tm1Usdn</sup>/Fmr1<sup>tm1Usdn</sup>  [background:] B6.129S6(Cg)-Fmr1<sup>tm1Usdn</sup>
HP:0007676,Hypoplasia of the iris
HP:0032659,Non-convulsive status epilepticus with coma
Reactome:R-MMU-390650,Histamine receptors
rxcui:2262279,CRIZANLIZUMAB
NBO:0000013,locomotory behavior
chembl:CHEMBL2109634,ONCOLYSIN S
iuphar.ligand:12749,USMARAPRIDE
HP:0001763,Pes planus
HP:0006934,Congenital nystagmus
rxcui:281189,ENCAINIDE HYDROCHLORIDE
ncit:C72585,TEDISAMIL
MP:0000813,abnormal hippocampus layer morphology
ncit:C96535,SEMAPIMOD
iuphar.ligand:3576,C5A
HP:0002360,Sleep disturbance
rxcui:55685,RISEDRONIC ACID
HGNC:25095,DCAF15
MONDO:0957203,"intellectual developmental disorder, X-linked 111"
iuphar.ligand:31,[3H]8-OH-DPAT
RGD:10401208,"F344-Tg(Prp-APP,Prp-PS1)19/Rrrc"
HGNC:10596,SCN8A
CHEBI:17303,morphine
MGI:5491040,Mecp2<sup>tm1.1Bird</sup>/Y Tg(MECP2*R270X/GFP)AHzo/0  [background:] involves: 129P2/OlaHsd * FVB
MONDO:0010847,spinocerebellar ataxia type 4
rxcui:2550729,INFIGRATINIB
MGI:1914302,Ndc80
iuphar.ligand:2549,SHK TOXIN
HGNC:28405,KMT5C
CL:2000014,fibroblast of upper leg skin
UPHENO:0025127,absent CA2 field of hippocampus in the hippocampal field
ncit:C74429,LIXIVAPTAN
rxcui:73689,FEBUXOSTAT
rxcui:10762,TRIAMCINOLONE DIACETATE
iuphar.ligand:11220,SUPRASTAT
HGNC:3373,EP300
GO:0005308,creatine transmembrane transporter activity
HP:0003400,Basal lamina onion bulb formation
CHEBI:46845,N-alkylpiperazine
drugbank:DB14765,RIVOCERANIB
ncit:C142953,BEVASIRANIB SODIUM
MGI:5702941,Mecp2<sup>tm4.1Bird</sup>/Y  [background:] involves: 129P2/OlaHsd * C57BL/6
MONDO:0009318,Hallermann-Streiff syndrome
chembl:CHEMBL4650289,KBP5209
chembl:CHEMBL225513,CHEMBL:CHEMBL225513
chembl:CHEMBL3545091,XEN403
iuphar.ligand:4078,[3H]CGP39653
chembl:CHEMBL1407826,DAZOMET
MP:0004415,abnormal cochlear nerve compound action potential
chembl:CHEMBL1871992,CHEMBL:CHEMBL1871992
iuphar.ligand:7721,ABT-639
chembl:CHEMBL123,ELLIPTECINE
drugbank:DB17283,CHRYSOERIOL
MONDO:0014076,"dyskeratosis congenita, autosomal recessive 5"
iuphar.ligand:5398,[125I]RELAXIN (HUMAN)
chembl:CHEMBL475813,CHEMBL:CHEMBL475813
MGI:103012,E2f4
drugbank:DB17537,6-DIAZO-5-OXO-L-NORLEUCINE
drugbank:DB12819,GSI-136
Reactome:R-BTA-611105,Respiratory electron transport
HP:0032677,Generalized-onset motor seizure
chembl:CHEMBL1094683,AESCULIOSIDE IIIB
rxcui:1596450,GENTAMICIN
HP:0001315,Reduced tendon reflexes
HGNC:7183,MNDA
rxcui:31748,NICORANDIL
HP:0000750,Delayed speech and language development
chembl:CHEMBL1448187,FLUPHENAZINE HYDROCHLORIDE
wikidata:Q6816906,MENERBA
rxcui:5650,IDARUBICIN
rxcui:10256,SURAMIN
MONDO:0019469,T-cell large granular lymphocyte leukemia
chembl:CHEMBL166486,CHEMBL:CHEMBL166486
rxcui:1862579,RUCAPARIB
MONDO:0019792,autosomal dominant cerebellar ataxia type I
iuphar.ligand:1712,ADP
ncit:C113792,DORDAVIPRONE
MONDO:0012449,spinocerebellar ataxia type 23
HGNC:3720,FKBP4
iuphar.ligand:5663,BARASERTIB-HQPA
iuphar.ligand:7818,PH-797804
HP:0000021,Megacystis
MONDO:0013970,branched-chain keto acid dehydrogenase kinase deficiency
HGNC:16950,STAMBP
SGD:S000003449,CCH1
WB:WBGene00006536,tbb-1
rxcui:2557,PRILOCAINE HYDROCHLORIDE
CHEBI:57783,NADPH(4-)
UPHENO:0087524,abnormal nucleus accumbens morphology
HP:0031797,Clinical course
rxcui:1546369,GENTIAN VIOLET CATION
chembl:CHEMBL2109401,AV-203
chembl:CHEMBL4298043,ROLUPERIDONE HYDROCHLORIDE
ncit:C175183,OZORALIZUMAB
CHEBI:33216,bisphenol A
chembl:CHEMBL580076,CHEMBL:CHEMBL580076
chembl:CHEMBL367966,CHEMBL:CHEMBL367966
iuphar.ligand:3882,GR94800
ncit:C162879,CONBERCEPT
chembl:CHEMBL179512,DEMETHOXYCURCUMIN
MONDO:0100030,adolescent/adult-onset epilepsy syndrome
ncit:C95229,NILOTINIB HYDROCHLORIDE MONOHYDRATE
chembl:CHEMBL548469,CHEMBL:CHEMBL548469
chembl:CHEMBL54909,FRAXETIN
MONDO:0010441,CK syndrome
chembl:CHEMBL1556958,STROBOPININ
drugbank:DB02656,LY-294002
HP:0032829,Neonatal electro-clinical motor seizure with automatism
iuphar.ligand:12998,COMPOUND 108 [PMID: 37918435]
chembl:CHEMBL3545300,CP-459632
rxcui:8591,POTASSIUM CHLORIDE
OBA:2040155,age of onset of stroke disorder
GO:0005869,dynactin complex
HGNC:10766,SF3A2
iuphar.ligand:12404,LAU159
MONDO:0859568,"macular dystrophy, retinal, 4"
HGNC:26559,ZFYVE27
OBA:2001032,age of onset of narcolepsy-cataplexy syndrome
rxcui:60307,ENTACAPONE
GO:0006605,protein targeting
chembl:CHEMBL2358118,MENADIONE SODIUM BISULPHITE
rxcui:1552358,HESPERADIN
CHEBI:63618,pravastatin
CHEBI:62064,"butane-2,3-diol"
iuphar.ligand:5558,JWH015
EMAPA:17279,ulnar nerve
ncit:C419,DEMECOLCINE
CHEBI:39832,methoxyethane
iuphar.ligand:1993,RELAXIN
MONDO:0100532,"blepharospasm, benign essential, susceptibility to"
MGI:1929913,Bcl11b
drugbank:DB04468,AFIMOXIFENE
MGI:5289971,Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-SNCA*A53T)33Vle/0  [background:] involves: C3H/HeH * C57BL/6
chembl:CHEMBL3545147,IMD-2560
rxcui:1424911,DABRAFENIB
MGI:4440450,Tg(CAG-VCP*A232E)93Jpat/0  [background:] involves: C57BL/6 * SJL
UPHENO:0080586,abnormal regulation of behavior
chembl:CHEMBL2171781,CHEMBL:CHEMBL2171781
iuphar.ligand:2569,"3-BICYCLO[2.2.1]HEPT-2-YL-BENZENE-1,2-DIOL"
chembl:CHEMBL1333049,CHEMBL:CHEMBL1333049
GO:0009986,cell surface
Reactome:R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
iuphar.ligand:5724,COMPOUND 3 [PMID: 21310611]
HP:0006913,Frontal cortical atrophy
rxcui:71484,FLURAZEPAM HYDROCHLORIDE
HGNC:6174,ITM2B
ncit:C171872,DANOPREVIR
MONDO:0009591,"metachromatic leukodystrophy, juvenile form"
HP:0003689,Multiple mitochondrial DNA deletions
RGD:2557,Ephx1
iuphar.ligand:285,(&PLUSMN;)YM796
iuphar.ligand:2090,NEUROKININ B
chembl:CHEMBL3545150,AZM-475271
rxcui:21107,CILOSTAZOL
MONDO:0010717,pyruvate dehydrogenase E1-alpha deficiency
HGNC:1362,FRRS1L
ncit:C2586,PSORALEN
MGI:103147,Dync1h1
Xenbase:XB-GENE-5961869,ndufa13
rxcui:3541,DISOPYRAMIDE
chembl:CHEMBL1797707,CHEMBL:CHEMBL1797707
CHEBI:57613,phosphatidylethanolamine zwitterion
HP:0000505,Visual impairment
ncit:C28310,DENDRITIC CELL VACCINE
iuphar.ligand:5576,"[ALA1,12,AIB3,GLN10,HARG11,TRP14]PTH-(1-14)-NH2"
MONDO:0003334,demyelinating polyneuropathy
chembl:CHEMBL1687979,CHEMBL:CHEMBL1687979
HGNC:9461,PRPH
ncit:C174789,CRENEZUMAB
MONDO:0014290,neurodegeneration with brain iron accumulation 6
NCBITaxon:2,Bacteria
chembl:CHEMBL562095,CHEMBL:CHEMBL562095
MGI:4429156,Tg(GFAP-HTT*160Q)1Xjl/0  [background:] either: (involves: FVB/NCrl) or (involves: C3H * C57BL/6 * FVB/NCrl)
rxcui:82003,DOCUSATE
UBERON:0001303,left uterine tube
iuphar.ligand:11932,BMS-820132
drugbank:DB06070,SNX-5422
chembl:CHEMBL509999,AROMOLINE
chembl:CHEMBL590884,CYCLOPENTYL PALMITATE
rxcui:2099704,TALAZOPARIB
chembl:CHEMBL602552,CHEMBL:CHEMBL602552
iuphar.ligand:5545,2-ARACHIDONYL GLYCERYL ETHER
HP:0012049,Laryngeal dystonia
chembl:CHEMBL1911631,YUANHUADINE
iuphar.ligand:9818,ELENBECESTAT
iuphar.ligand:10203,ENDOXIFEN
CHEBI:39867,valproic acid
iuphar.ligand:11908,H3 AC-B10-27(13-17 HC)
CHEBI:84327,torin 1
iuphar.ligand:6426,COMPOUND 11A [PMID: 14697765]
OBA:2001016,age of onset of alcohol dependence
HP:0001369,Arthritis
rxcui:4497,FLUPREDNISOLONE
chembl:CHEMBL455679,KUSHENOL A
chembl:CHEMBL306147,CHEMBL:CHEMBL306147
HP:0007738,Uncontrolled eye movements
iuphar.ligand:11946,AZD9574
HGNC:9883,RASSF2
drugbank:DB12068,T-900607
NBO:0000266,cognitive behavior phenotype
drugbank:DB03444,6-BROMOINDIRUBIN-3'-OXIME
chembl:CHEMBL1346025,CHEMBL:CHEMBL1346025
iuphar.ligand:157,(R)-DOI
rxcui:1357536,TOFACITINIB
chembl:CHEMBL513197,SANDARACOPIMARIC ACID
iuphar.ligand:6428,GRN-529
chembl:CHEMBL461462,LISSOCLINIDINE B
HGNC:5956,IHH
ncit:C95215,EPLIVANSERIN FUMARATE
iuphar.ligand:9989,COMPOUND 11 [PMID: 26431428]
chembl:CHEMBL308106,CHEMBL:CHEMBL308106
EMAPA:36576,ventral striatum
chembl:CHEMBL2313444,CHEMBL:CHEMBL2313444
HGNC:7700,NDUFB5
HGNC:16645,TRA2A
chembl:CHEMBL2028044,CHEMBL:CHEMBL2028044
iuphar.ligand:11714,AZD7624
chembl:CHEMBL528316,CHEMBL:CHEMBL528316
HGNC:23604,KRTAP5-9
UPHENO:0088149,abnormal glial cell morphology
chembl:CHEMBL1403041,METHYL ROBUSTONE
HGNC:25419,ARL13B
rxcui:32968,CLOPIDOGREL
chembl:CHEMBL408500,CHEMBL:CHEMBL408500
iuphar.ligand:5287,VU0364739
Xenbase:XB-GENE-947653,pigp
ncit:C1689,PLITIDEPSIN
ncit:C38127,6-AMINONICOTINAMIDE
UBERON:0002385,muscle tissue
rxcui:30129,FLUPHENAZINE ENANTHATE
chembl:CHEMBL2348314,TYROSOL SINAPATE
MONDO:0009904,Gitelman syndrome
rxcui:18867,BENAZEPRIL
EMAPA:35934,hindlimb bone
UPHENO:0081381,corpus callosum hypoplasia
rxcui:221153,QUETIAPINE FUMARATE
HGNC:5183,HRH2
HP:0012026,Hyperornithinemia
GO:0005041,low-density lipoprotein particle receptor activity
chembl:CHEMBL586000,CHEMBL:CHEMBL586000
HP:0002312,Clumsiness
iuphar.ligand:1218,ABT-239
HP:0002166,Impaired vibration sensation in the lower limbs
UPHENO:0068190,increased level of creatinine in independent continuant
iuphar.ligand:578,NDT9520492
MONDO:0044705,paranasal sinus squamous cell carcinoma
iuphar.ligand:11510,M4205
MONDO:0010558,choroideremia-deafness-obesity syndrome
HGNC:10910,SLC12A1
chembl:CHEMBL136344,CHEMBL:CHEMBL136344
iuphar.ligand:4219,IDRA-21
MGI:1336167,Prkab1
HGNC:16206,DEFB127
iuphar.ligand:11559,COMPOUND II [PMID: 29351497]
ncit:C83619,CHLORISONDAMINE
rxcui:709271,CERTOLIZUMAB PEGOL
MONDO:0005138,lung carcinoma
HP:0012080,Cerebellar granular layer atrophy
CHEBI:44423,hydroxyurea
iuphar.ligand:2834,DY131
HP:0009063,Progressive distal muscle weakness
ncit:C66172,MIZORIBINE
rxcui:237005,LEVOMETHADYL
rxcui:39937,ZINC CHLORIDE
rxcui:1054,APRINDINE
MP:0001504,abnormal posture
chembl:CHEMBL451722,CHEMBL:CHEMBL451722
ncit:C169880,DEFOSLIMOD
iuphar.ligand:5095,&ALPHA;-PROPYLDOPACETAMIDE
chembl:CHEMBL456237,LXR-623
ncit:C72978,SARAKALIM
HGNC:4854,HDAC3
HP:0011999,Paranoia
MP:0003861,abnormal nervous system development
chembl:CHEMBL531611,CHEMBL:CHEMBL531611
HGNC:7727,NEDD4
rxcui:1046243,ALPHA-TOCOPHEROL ACETATE
TS:21,
iuphar.ligand:5029,NEUREGULIN-2
chembl:CHEMBL316796,CHEMBL:CHEMBL316796
HGNC:16077,DUSP22
MONDO:0000104,"anemia, hypochromic microcytic with iron overload"
rxcui:4018,ERGOCALCIFEROL
iuphar.ligand:671,[TYR8]BRADYKININ
CHEBI:529996,cytochalasin D
iuphar.ligand:12906,COMPOUND 77A [PMID: 37639383]
HGNC:11474,SURF1
drugbank:DB18167,ANG1005
rxcui:2598123,METHOXYCHLOR
MP:0002764,short tibia
rxcui:30121,MOCLOBEMIDE
iuphar.ligand:3979,[3H]CYTISINE
wikidata:Q383260,INFLUENZA VACCINE
HGNC:9255,PPIB
iuphar.ligand:5131,ABT702
HP:0032663,Focal motor status epilepticus
iuphar.ligand:2098,SUBSTANCE P
HGNC:26707,KRT40
rxcui:91109,BUTABARBITAL SODIUM
iuphar.ligand:8095,AC710
iuphar.ligand:108,"BMS 181,101"
chembl:CHEMBL584269,CHEMBL:CHEMBL584269
chembl:CHEMBL578063,ALAZANINE
UBERON:0001383,muscle of leg
rxcui:236474,FEXOFENADINE HYDROCHLORIDE
MONDO:0011451,"cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1"
iuphar.ligand:2114,FK-888
OBA:2040153,age of onset of cancer
Reactome:R-GGA-611105,Respiratory electron transport
chembl:CHEMBL1307453,CHEMBL:CHEMBL1307453
chembl:CHEMBL305195,CHEMBL:CHEMBL305195
chembl:CHEMBL504381,ALLISAN
HGNC:12729,WARS1
ncit:C76770,DORAMAPIMOD
chembl:CHEMBL1363249,CHEMBL:CHEMBL1363249
PomBase:SPCC794.07,lat1
MGI:2446591,Abcd1<sup>tm1Ymd</sup>/Abcd1<sup>tm1Ymd</sup>  [background:] involves: 129S/SvEv * C57BL/6J * DBA/2J
TS:26,
rxcui:24351,ERYTHROMYCIN STEARATE
HGNC:6181,ITPR2
rxcui:1310594,POLYETHYLENE GLYCOL 4000
chembl:CHEMBL602126,CHEMBL:CHEMBL602126
chembl:CHEMBL251941,(S)-ALAPROCLATE
RGD:2317278,Taiep/Dun
chembl:CHEMBL1329349,CHEMBL:CHEMBL1329349
HP:0003383,Onion bulb formation
rxcui:6476,LOXAPINE SUCCINATE
HGNC:8848,PES1
rxcui:85762,RITONAVIR
MONDO:0011935,retinitis pigmentosa 30
ncit:C76492,APLAVIROC HYDROCHLORIDE
iuphar.ligand:2613,AFT-II
chembl:CHEMBL4206033,BAY1436032
HP:0001182,Tapered finger
chembl:CHEMBL465339,MUNDULONE
ncit:C1450,PLATINUM COMPOUND
drugbank:DB02224,TAXIFOLIN
HGNC:24329,UTP11
chembl:CHEMBL78920,CHEMBL:CHEMBL78920
ncit:C122835,INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE INHIBITOR FF-10501-01
UPHENO:0002416,abnormality of glymphatic system physiology
ncit:C121646,BELVARAFENIB
chembl:CHEMBL462861,CHEMBL:CHEMBL462861
iuphar.ligand:4949,HEPATOCYTE GROWTH FACTOR
ncit:C74123,ZANOTERONE
HGNC:10549,ATXN10
CHEBI:41922,diethylstilbestrol
ncit:C96530,PLOVAMER ACETATE
HGNC:9479,LONP1
rxcui:2282403,BEMPEDOIC ACID
rxcui:6910,METHYPRYLON
MONDO:0018203,LMNA-related cardiocutaneous progeria syndrome
drugbank:DB05044,PSN357
iuphar.ligand:2000,INSL5
HP:0000488,Retinopathy
HP:0040272,Hyperintensity of MRI T2 signal of the spinal cord
rxcui:161203,ACEPROMETAZINE
MONDO:0850283,acute asthma
ncit:C29107,IV FLUID
iuphar.ligand:9457,AC-98170
HGNC:10563,SCAMP1
CHEBI:15377,water
iuphar.ligand:8135,COMPOUND 21 [PMID: 23312943]
rxcui:235839,TERODILINE HYDROCHLORIDE
HP:0001285,Spastic tetraparesis
ncit:C81371,FIDUXOSIN HYDROCHLORIDE
iuphar.ligand:9056,CP-601927
HP:0001252,Hypotonia
HP:0032747,Focal impaired awareness emotional seizure with pleasure
drugbank:DB16838,BLZ-945
chembl:CHEMBL219553,GIGANTOL
ncit:C120474,2-HYDROXYESTRADIOL
HP:0001284,Areflexia
iuphar.ligand:12932,COMPOUND 25AP [PMID: 37796543]
iuphar.ligand:11499,PCS1055
HGNC:7708,NDUFS2
HP:0011152,Early onset absence seizures
NBO:0000448,vertical activity
MP:0000818,abnormal amygdala morphology
iuphar.ligand:4952,HS-142-1
rxcui:1299637,ANHYDROUS ZINC ACETATE
ncit:C70982,LINSITINIB
Reactome:R-CFA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
chembl:CHEMBL909,7-HYDROXYCHLORPROMAZINE
chembl:CHEMBL3545153,DE-104
OBA:0000001,biological attribute
rxcui:9624,SECOBARBITAL
MONDO:0010611,X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
Reactome:R-BTA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
HGNC:11572,TARS1
iuphar.ligand:4577,BILIRUBIN
MONDO:0010761,retinitis pigmentosa Y-linked
MONDO:0018214,generalized epilepsy with febrile seizures plus
ZFIN:ZDB-GENE-060522-1,smyd1b
MONDO:0005070,neoplasm
HP:0002227,White eyelashes
ncit:C118669,SULANEMADLIN
rxcui:3118,DEBRISOQUIN
HP:0003045,Abnormal patella morphology
drugbank:DB17039,NUTLIN-3
CHEBI:16610,spermidine
UPHENO:0066739,decreased level of chemical entity
ncit:C955,CARMOFUR
chembl:CHEMBL47986,ERBSTATIN
rxcui:6147,KHELLIN
iuphar.ligand:9967,ML193
CHEBI:38164,organic heteropentacyclic compound
iuphar.ligand:8762,WP814
rxcui:6852,METHOTRIMEPRAZINE
chembl:CHEMBL454173,ZEARALENONE
rxcui:1311625,MAGNESIUM SULFATE ANHYDROUS
MGI:4415714,Fmr1<sup>tm1Rbd</sup>/Y  [background:] B6.129-Fmr1<sup>tm1Rbd</sup>
MGI:4949761,Shank3<sup>tm2Gfng</sup>/Shank3<sup>tm2Gfng</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6
MONDO:0024237,inherited neurodegenerative disorder
chemidplus:72-54-8,TDE
rxcui:4135,ETHOSUXIMIDE
rxcui:24805,FEBANTEL
UBERON:0004819,kidney epithelium
HP:0033203,Brachioradialis hyperreflexia
HGNC:24592,STEAP3
MGI:104689,Cct4
dictyBase:DDB_G0292620,coq4
MONDO:0012505,"pigmented nodular adrenocortical disease, primary, 2"
HP:0006956,Lateral ventricle dilatation
chembl:CHEMBL557670,CHEMBL:CHEMBL557670
HGNC:620,APP
chembl:CHEMBL600255,CHEMBL:CHEMBL600255
ncit:C1703,TIPIFARNIB
rxcui:227897,BETAMETHASONE VALERATE
MONDO:0019383,acute disseminated encephalomyelitis
HGNC:6839,MAP2
HP:0045082,Decreased body mass index
rxcui:10471,THIETHYLPERAZINE
rxcui:1029,APAZONE
HGNC:890,AUH
MGI:103060,Ecm1
rxcui:353103,ATOMOXETINE HYDROCHLORIDE
iuphar.ligand:491,A-123189
iuphar.ligand:8908,GSK5182
MONDO:0010404,X-linked non progressive cerebellar ataxia
HGNC:9551,PSMC4
HP:0002366,Abnormal lower motor neuron morphology
MGI:103038,Stat3
MGI:109355,Stx1a
rxcui:2406,CHLORPROTHIXENE
drugbank:DB05887,TAFA-93
rxcui:10753,TRETINOIN
drugbank:DB01833,CANAVANINE
rxcui:1102129,BOCEPREVIR
MP:0002207,abnormal long-term potentiation
chembl:CHEMBL1256647,CHEMBL:CHEMBL1256647
rxcui:2549198,AMIVANTAMAB-VMJW
Reactome:R-CFA-611105,Respiratory electron transport
iuphar.ligand:3399,20-HYDROXY-LTB4
rxcui:84108,ROSIGLITAZONE
MGI:1926334,Ppp2r1a
ncit:C76028,CARIPORIDE
MONDO:0005459,human African trypanosomiasis
iuphar.ligand:8147,COMPOUND 24 [PMID: 23441572]
NCBIGene:428525,LOC428525
ncit:C1270,ADOZELESIN
chembl:CHEMBL580140,CHEMBL:CHEMBL580140
HGNC:11138,SNCA
HP:0002827,Hip dislocation
HGNC:16990,C11orf58
iuphar.ligand:12269,KA2507
chembl:CHEMBL602776,CHEMBL:CHEMBL602776
ncit:C170951,BRAF(V600E) KINASE INHIBITOR ABM-1310
ncit:C78854,DINACICLIB
chembl:CHEMBL459729,CHEMBL:CHEMBL459729
HGNC:2422,CS
MONDO:0003689,familial hemolytic anemia
chembl:CHEMBL211042,CHEMBL:CHEMBL211042
HP:0001680,Coarctation of aorta
iuphar.ligand:3196,BPH-715
rxcui:68244,LAMIVUDINE
rxcui:1870193,GENTAMICIN SULFATE
ncit:C78856,MTOR KINASE INHIBITOR AZD8055
MONDO:0010785,maternally-inherited diabetes and deafness
CHEBI:61049,tacrolimus (anhydrous)
rxcui:7019,MOLINDONE
rxcui:2619313,TREMELIMUMAB
drugbank:DB13371,DIFENPIRAMIDE
HGNC:10019,RIPK1
MGI:3801487,Mecp2<sup>tm1Pplt</sup>/Y  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6
rxcui:2103477,ADALIMUMAB-ADBM
OBA:2001031,age of onset of refractive error
ncit:C1727,PERIFOSINE
HP:0032012,Heterotropia
chembl:CHEMBL2109284,CMB-401
CL:0000122,stellate neuron
chembl:CHEMBL1567041,CHEMBL:CHEMBL1567041
CLINVAR:52919,NM_000059.4(BRCA2):c.9925G>T (p.Glu3309Ter)
ncit:C121212,APRUTUMAB IXADOTIN
iuphar.ligand:1788,PTHRP-(1-21)/PTH-(22-34) (HUMAN)
CHEBI:66933,N-alkylglycine
chembl:CHEMBL257748,CHEMBL:CHEMBL257748
HGNC:20665,SCN3B
HGNC:6112,IRAK1
GO:0003713,transcription coactivator activity
ncit:C146825,BRD4 INHIBITOR PLX2853
ncit:C95209,GUADECITABINE
iuphar.ligand:7880,AGERAFENIB
HP:0000112,Nephropathy
HP:0003324,Generalized muscle weakness
HGNC:1473,CANX
chembl:CHEMBL468167,CHLOROTHALONIL
ZFIN:ZDB-GENE-050327-47,naa20
MGI:3772883,Tg(Prnp-TBP*)71-16Xjl/0  [background:] FVB/N-Tg(Prnp-TBP*)71-16Xjl
rxcui:2236,CEPHALOTHIN
MGI:1918995,Cul2
MGI:3813927,Pts<sup>tm1Ich</sup>/Pts<sup>tm1Ich</sup> Tg(DBH-PTS)6Csic/0  [background:] involves: 129X1/SvJ * C57BL/6J
chembl:CHEMBL1895252,BENSULIDE
chembl:CHEMBL584668,CHEMBL:CHEMBL584668
MONDO:0018321,atypical juvenile parkinsonism
rxcui:2643210,AMENTOFLAVONE
rxcui:4492,FLUOROURACIL
HGNC:13554,ATP11C
chembl:CHEMBL3545165,AFACIFENACIN
rxcui:1482501,ESLICARBAZEPINE ACETATE
chembl:CHEMBL577673,CHEMBL:CHEMBL577673
HGNC:18415,HIP1R
rxcui:3409,DIHYDRALAZINE
chembl:CHEMBL590212,CHEMBL:CHEMBL590212
HP:0011123,Inflammatory abnormality of the skin
HGNC:19440,SBDS
HGNC:30287,RPTOR
HP:0004808,Acute myeloid leukemia
rxcui:1546014,ZOLEDRONIC ACID ANHYDROUS
NCBIGene:489110,DRD1
chembl:CHEMBL1456697,(Z)-PIPLARTINE
iuphar.ligand:2687,GW501516
chembl:CHEMBL2094833,CHEMBL:CHEMBL2094833
OBA:2001011,age of onset of schizophrenia
chembl:CHEMBL450348,DODINE
MP:0020394,decreased neuronal precursor proliferation
chembl:CHEMBL191958,GENZ-644282
HGNC:11393,AURKA
rxcui:2275602,LUMATEPERONE
MGI:5317102,Tg(Pcp2-tTA)3Horr/0 Tg(tetO-ATXN1*82Q)#Horr/Tg(tetO-ATXN1*82Q)#Horr  [background:] involves: FVB/N
ncit:C166890,DRINABANT
chembl:CHEMBL590949,CHEMBL:CHEMBL590949
CHEBI:9948,verapamil
chembl:CHEMBL602940,CHEMBL:CHEMBL602940
MONDO:0013665,"epilepsy, juvenile myoclonic, susceptibility to, 9"
iuphar.ligand:5714,NVP-TAE684
ncit:C171861,BAMOCAFTOR
ncit:C90565,BUPARLISIB
HGNC:15979,TP63
MGI:3797844,Fxn<sup>tm1Mkn</sup>/Fxn<sup>tm1Mkn</sup> Tg(FXN)YG8Pook/0  [background:] involves: 129/Sv * C57BL/6 * CBA
chembl:CHEMBL1800368,CHEMBL:CHEMBL1800368
MGI:3584256,Bdnf<sup>tm1Krj</sup>/Bdnf<sup>tm1Lfr</sup> Emx1<sup>tm1(cre)Krj</sup>/Emx1<sup>+</sup>  [background:] involves: 129S2/SvPas * C57BL/6J
Reactome:R-HSA-71403,Citric acid cycle (TCA cycle)
MONDO:0014580,"intellectual disability, autosomal dominant 33"
iuphar.ligand:11696,XYT528B
rxcui:1450910,CEFACLOR ANHYDROUS
ncit:C99381,DEXANABINOL
FB:FBgn0003231,ref(2)P
chembl:CHEMBL29197,CHEMBL:CHEMBL29197
rxcui:203117,CEFOTAXIME SODIUM
HP:0008897,Postnatal growth retardation
rxcui:3390,DIETHYLSTILBESTROL
MONDO:0013241,spinocerebellar ataxia type 30
HGNC:758,ASS1
HGNC:13805,NEUROG2
HGNC:18883,TAS2R41
chembl:CHEMBL3545055,INK-1117
MONDO:0006143,cervical squamous cell carcinoma
HGNC:10602,SCNN1G
HP:0410170,Hippocampal atrophy
iuphar.ligand:8369,MLS1547
GO:0036038,MKS complex
rxcui:39841,XYLOMETAZOLINE
HGNC:8607,PRKN
EMAPA:36926,oblique extraocular muscle
CHEBI:9997,pristinamycin IIA
CHEBI:63607,linezolid
MP:0009142,decreased prepulse inhibition
Reactome:R-HSA-1169092,Activation of RAS in B cells
GO:0050906,detection of stimulus involved in sensory perception
Reactome:R-CFA-71288,Creatine metabolism
ncit:C169853,CIPARGAMIN
UPHENO:0051196,abnormal voluntary skeletal muscle contraction
HGNC:8979,PIK3R1
rxcui:2466730,ALLOXAN
iuphar.ligand:6006,MEK INHIBITOR I
chembl:CHEMBL255683,CHEMBL:CHEMBL255683
iuphar.ligand:153,(+)-DOI
drugbank:DB04947,ALTROPANE
chembl:CHEMBL3544945,SAR-113945
chembl:CHEMBL527586,CHEMBL:CHEMBL527586
MGI:5691394,Hap1<sup>tm2Xjl</sup>/Hap1<sup>tm2Xjl</sup> Tg(CAG-cre/Esr1*)5Amc/0  [background:] involves: 129 * C57BL/6 * CBA
GO:0006511,ubiquitin-dependent protein catabolic process
HP:0006493,Aplasia/hypoplasia involving bones of the lower limbs
chembl:CHEMBL583555,CHEMBL:CHEMBL583555
MGI:1930016,Shank3
HGNC:10524,SALL1
rxcui:236539,ROPIVACAINE HYDROCHLORIDE
chembl:CHEMBL531322,CHEMBL:CHEMBL531322
MGI:1101358,Npepps
ncit:C116850,HDAC INHIBITOR REC-2282
MONDO:0024771,"myopathy, distal, 7, adult-onset, X-linked"
iuphar.ligand:1774,[33P]2MESADP
drugbank:DB17403,IMMUCIN
drugbank:DB08190,N-[2-(2-IODO-5-METHOXY-1H-INDOL-3-YL)ETHYL]ACETAMIDE
chembl:CHEMBL135115,CHEMBL:CHEMBL135115
drugbank:DB17152,DRF-1042
MONDO:0006552,folliculitis
iuphar.ligand:8175,COMPOUND 8H [PMID: 22765894]
ncit:C2083,DNA METHYLTRANSFERASE INHIBITOR
chembl:CHEMBL588234,CHEMBL:CHEMBL588234
MP:0030633,decreased urine creatine level
MGI:3624553,Mecp2<sup>tm1Hzo</sup>/Y  [background:] 129S7/SvEvBrd-Mecp2<sup>tm1Hzo</sup>
GO:0035264,multicellular organism growth
ncit:C47768,TRIBROMSALAN
chembl:CHEMBL4297235,OMBIPEPIMUT-S
MP:0000885,ectopic Purkinje cell
rxcui:16689,ACECLOFENAC
FB:FBgn0027621,Pfrx
iuphar.ligand:731,HU-210
rxcui:2475166,VOCLOSPORIN
HP:0010566,Hamartoma
ncit:C95782,CANTUZUMAB MERTANSINE
rxcui:626,AMDINOCILLIN
HGNC:5302,HTR7
UBERON:0009834,dorsolateral prefrontal cortex
chembl:CHEMBL1897070,TEBUFENPYRAD
MGI:102791,Prph2
HGNC:2531,CTSF
iuphar.ligand:10150,K-604
ncit:C74581,TIPELUKAST
HGNC:28611,RICTOR
rxcui:3007,CYCLOSERINE
iuphar.ligand:12095,EXARAFENIB
HP:0025116,Fetal distress
rxcui:60548,EXENATIDE
iuphar.ligand:1243,GR 175737
iuphar.ligand:4940,GDNF
drugbank:DB16871,HEMATOXYLIN
HP:0001744,Splenomegaly
iuphar.ligand:3391,5-OXO-ETE
HGNC:9607,PTHLH
rxcui:4158,ETHYLENEDIAMINE
HGNC:25330,CTTNBP2NL
MGI:1914513,Zswim6
HGNC:30661,UBA2
chembl:CHEMBL504936,HERNANDEZINE
HGNC:16185,ROMO1
HGNC:2889,DISC2
HGNC:1972,CHST4
chembl:CHEMBL1668776,YEZOQUINOLIDE
CHEBI:84057,trapoxin A
MONDO:0002420,tic disorder
GO:0030970,"retrograde protein transport, ER to cytosol"
chembl:CHEMBL451197,OXIDOPAMINE HYDROCHLORIDE
rxcui:7240,NALIDIXIC ACID
UBERON:0006566,left ventricle myocardium
chembl:CHEMBL1242194,CYCLOSTREPTIN
iuphar.ligand:9449,COMPOUND 17 [PMID: 24257095]
HGNC:6768,SMAD2
HP:0006852,Episodic generalized hypotonia
HGNC:4249,GGPS1
HGNC:11641,TCF7L2
MP:0004102,abnormal dorsal striatum morphology
MONDO:0012204,familial pseudohyperkalemia
HGNC:1748,CDH1
MONDO:0005300,chronic kidney disease
drugbank:DB07404,BPH-608
HP:0002169,Clonus
MGI:4429405,Tg(Htt-ATXN3*148Q)3746Thsc/0  [background:] involves: C57BL/6N
HGNC:25443,C19orf12
MONDO:0000032,"febrile seizures, familial"
ZFA:0000383,lateral rectus
CL:0002319,neural cell
HP:0025312,Esophoria
iuphar.ligand:5684,GSK-461364A
HGNC:33867,SDHAF1
iuphar.ligand:2459,DECAVANADATE
chembl:CHEMBL3707353,RG7893
rxcui:203217,LEUPROLIDE ACETATE
HGNC:11808,DNAJA3
HGNC:20595,MTUS2
MONDO:0014552,lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome
HP:0002353,EEG abnormality
RGD:621411,Klc1
chembl:CHEMBL2109399,T-DM1
chembl:CHEMBL1923999,CHEMBL:CHEMBL1923999
drugbank:DB05149,XL844
HP:0001538,Protuberant abdomen
iuphar.ligand:343,BRUCINE N-OXIDE
MGI:5007765,Ahi1<sup>tm1Jgg</sup>/Ahi1<sup>tm1Jgg</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ
HGNC:7138,MLLT6
HP:0011516,Achromatopsia
HP:0004311,Abnormal macrophage morphology
chembl:CHEMBL4290141,BRANAPLAM
UPHENO:0074609,increased inflammatory response in mastoid process of temporal bone
HGNC:7787,NFIL3
MONDO:0030702,autoimmune atherosclerosis
chembl:CHEMBL1642763,ESTRADIOL PHOSPHATE
HP:0007034,Generalized hyperreflexia
CL:0000128,oligodendrocyte
chembl:CHEMBL4297804,PF-06263507
chembl:CHEMBL1094689,AESCULIOSIDE IIK
drugbank:DB05182,AS1409
HP:0003434,Sensory ataxic neuropathy
ncit:C87286,NAFRONYL OXALATE
HGNC:18854,CREB3L4
MONDO:0006499,hamartoma
chembl:CHEMBL1256726,CHEMBL:CHEMBL1256726
drugbank:DB12774,AZD-8055
HGNC:26746,C5orf24
CHEBI:83811,proteinogenic amino acid derivative
HP:0002464,Spastic dysarthria
MGI:3831004,Tg(Neurod2-Smo*A1)199Jols/Tg(Neurod2-Smo*A1)199Jols  [background:] C57BL/6-Tg(Neurod2-Smo*A1)199Jols
HP:0000176,Submucous cleft hard palate
ncit:C91392,PREXASERTIB
MONDO:0012683,pontocerebellar hypoplasia type 6
iuphar.ligand:12405,LAU463
ncit:C258,ANTIBIOTIC
MGI:3838167,Tg(ATXN3*)84.2Cce/Tg(ATXN3*)84.2Cce  [background:] involves: C57BL/6 * CBA
rxcui:7646,OMEPRAZOLE
HGNC:19686,SEPHS2
rxcui:1661328,"1,2-NAPHTHOQUINONE"
ncit:C162375,PLOGOSERTIB
drugbank:DB05432,DAS-431 IV
rxcui:196238,SOY PROTEIN ISOLATE
ncit:C1283,RECOMBINANT CYTOKINE
chembl:CHEMBL1256916,CHEMBL:CHEMBL1256916
ncit:C79835,HSP90 INHIBITOR XL888
ncit:C163668,ISOFENPHOS
FB:FBgn0010389,htl
chembl:CHEMBL513024,GLYCITEIN
iuphar.ligand:1816,TIP39-(3-39) (HUMAN/BOVINE)
chembl:CHEMBL233302,2-(PHENOXYMETHYL)BENZOTHIAZOLE
chembl:CHEMBL592598,CHEMBL:CHEMBL592598
HP:0011098,Speech apraxia
HP:0007361,Abnormal pons morphology
ncit:C66598,THIETHYLPERAZINE MALATE
ncit:C175142,MIROGABALIN BESYLATE
rxcui:72435,ANAKINRA
rxcui:283547,CARBETAPENTANE CITRATE
iuphar.ligand:8890,COMPOUND 9 [PMID: 15615544]
ncit:C65671,FENTICLOR
UPHENO:0049798,abnormal eating behavior
ncit:C157632,ERFONRILIMAB
HGNC:30423,CACYBP
HGNC:1968,LYST
rxcui:3332,DIBENZEPIN
dictyBase:DDB_G0283669,DDB_G0283669
HGNC:14131,GNG13
CLINVAR:133240,NM_000540.3(RYR1):c.9310G>A (p.Glu3104Lys)
ZFIN:ZDB-GENE-071004-47,cyp2aa12
HP:0000772,Abnormal rib morphology
HP:0001943,Hypoglycemia
iuphar.ligand:9103,GSK334429
MONDO:0006796,hypertensive encephalopathy
HGNC:9171,PODXL
chembl:CHEMBL546797,CHEMBL:CHEMBL546797
rxcui:42686,FLECAINIDE ACETATE
chembl:CHEMBL463175,CEPHALOCHROMIN
RGD:1306952,Cmbl
chembl:CHEMBL582030,CHEMBL:CHEMBL582030
chembl:CHEMBL487611,PINORESINOL
chembl:CHEMBL461308,MANASSANTIN B
iuphar.ligand:7743,IZORLISIB
CL:0000029,neural crest derived neuron
chembl:CHEMBL4297789,MT-3724
MGI:2174931,Aqp1<sup>tm1Ask</sup>/Aqp1<sup>tm1Ask</sup>  [background:] involves: C57BL/6J
HGNC:2040,CLDN19
HP:0100806,Sepsis
rxcui:2480096,CASIMERSEN
ncit:C75148,PUROMYCIN HYDROCHLORIDE
rxcui:596,ALPRAZOLAM
MGI:3713123,Atg5<sup>tm1Myok</sup>/Atg5<sup>tm1Myok</sup> Tg(Nes-cre)1Kln/?  [background:] involves: 129S/SvEv * C57BL/6 * SJL
HP:0003537,Hypouricemia
rxcui:4103,ESTRONE
MP:0011469,abnormal urine creatinine level
chembl:CHEMBL613,PYRAZINOIC ACID
iuphar.ligand:5561,GSK575594A
ZFIN:ZDB-GENE-070308-4,pdlim2
HP:0004802,Episodic hemolytic anemia
iuphar.ligand:11910,H3 14S18 STAPLED B-CHAIN
iuphar.ligand:28,SB 216641
CHEBI:26895,tetracyclines
ncit:C90532,ENSITUXIMAB
iuphar.ligand:10226,ALBUTENSIN A
ncit:C1429,VAPREOTIDE
MP:0011471,decreased urine creatinine level
rxcui:290,ADENINE
MGI:3624435,Myo5a<sup>d-n</sup>/Myo5a<sup>d-n</sup>  [background:] B10.D2-H2<sup>d</sup>/nSnJ
iuphar.ligand:2081,"H-C[DCYS-PHE-LAGL(N&BETA;ME,BENZOYL)-DTRP-LYS-THR-PHE-CYS]-OH"
chembl:CHEMBL1729579,LISINOPRIL HYDRATE
HP:0007305,CNS demyelination
chembl:CHEMBL2181041,CHEMBL:CHEMBL2181041
rxcui:7512,NOREPINEPHRINE
rxcui:1307298,ENZALUTAMIDE
MGI:3813867,Rgsc1152/Rgsc1152<sup>+</sup>  [background:] involves: C57BL/6JJcl * DBA/2JJcl
MGI:7316678,Serac1<sup>em1Bcgen</sup>/Serac1<sup>em1Bcgen</sup>  [background:] C57BL/6N-Serac1<sup>em1Bcgen</sup>
rxcui:2023,CARBOCYSTEINE
UPHENO:0013942,cerebellum atrophy
rxcui:142436,FENTANYL CITRATE
ncit:C1477,MILODISTIM
ncit:C126798,PIDNARULEX
MP:0002917,decreased synaptic depression
chembl:CHEMBL3545050,BMS-817378
iuphar.ligand:11339,SBI-0206965
chembl:CHEMBL338314,CHEMBL:CHEMBL338314
chembl:CHEMBL264931,(R)-INDOPROFEN
CHEBI:29985,L-glutamate(1-)
MGI:3051596,Znhit3
EMAPA:17277,median nerve
HP:0000597,Ophthalmoparesis
HP:0000729,Autistic behavior
HGNC:13239,EVA1C
HP:0000264,Abnormal mastoid morphology
HP:0012187,Increased erythrocyte protoporphyrin concentration
rxcui:31538,NARINGIN
iuphar.ligand:8616,MG-132
rxcui:17652,AMCINONIDE
MGI:4868120,Dicer1<sup>tm1Bdh</sup>/Dicer1<sup>tm1Bdh</sup> H2az2<sup>Tg(Wnt1-cre)11Rth</sup>/H2az2<sup>+</sup>  [background:] involves: 129 * C57BL/6 * CBA/J
HP:0010795,Cerebellar glioma
chembl:CHEMBL3545395,BI-811283
NCBIGene:512590,RECQL5
rxcui:9524,SULFASALAZINE
SGD:S000001495,PRP40
chembl:CHEMBL450802,CHEMBL:CHEMBL450802
ncit:C1140,MITOMYCIN C ANALOG KW-2149
MONDO:0009561,alpha-mannosidosis
iuphar.ligand:5769,SB 414240
rxcui:102170,PIPERIDOLATE HYDROCHLORIDE
MONDO:0010288,adrenomyodystrophy
HGNC:10547,SC5D
ncit:C98844,SERABELISIB
chembl:CHEMBL461193,CHEMBL:CHEMBL461193
rxcui:8126,PHENYLETHYL ALCOHOL
HGNC:17993,TRPM4
HGNC:12974,RNF113A
HP:0007018,Attention deficit hyperactivity disorder
MGI:3835593,Npas4<sup>tm1Ooe</sup>/Npas4<sup>tm1Ooe</sup>  [background:] involves: 129/Sv * C57BL/6
HP:0007642,Congenital stationary night blindness
MONDO:0041086,mixed anxiety and depressive disorder
HGNC:25994,NSUN2
chembl:CHEMBL87333,CIS-RESVERATROL
HGNC:16285,TRIM35
HP:0000280,Coarse facial features
chembl:CHEMBL473721,CHEMBL:CHEMBL473721
ncit:C65315,CHLORMERODRIN
chembl:CHEMBL16685,CHEMBL:CHEMBL16685
CHEBI:35475,non-steroidal anti-inflammatory drug
HP:0002376,Developmental regression
GO:0005634,nucleus
HGNC:17310,TIMM17B
MP:0004103,abnormal ventral striatum morphology
ncit:C71705,PILARALISIB
chembl:CHEMBL77030,TYRPHOSTIN 47
GO:0071051,poly(A)-dependent snoRNA 3'-end processing
HGNC:11617,ELOC
MONDO:0035819,cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome
ZFIN:ZDB-GENE-991105-4,gja1b
iuphar.ligand:1379,LY367385
chembl:CHEMBL1201628,INSULIN SUSP PROTAMINE ZINC BEEF/PORK
iuphar.ligand:6980,AZIDOPINE
ncit:C151943,BIVALENT BRD4 INHIBITOR AZD5153
MGI:95474,F8a
HGNC:15469,DNAJC6
ncit:C495,RECOMBINANT INTERFERON BETA
MGI:102541,Tbx5
HGNC:5299,HTR4
HGNC:2666,DAG1
iuphar.ligand:7625,BP 897
chembl:CHEMBL4297276,DIAZOXIDE CHOLINE
HGNC:8773,PDE11A
iuphar.ligand:8143,COMPOUND 1O [PMID: 24210504]
chembl:CHEMBL1431017,CHEMBL:CHEMBL1431017
HGNC:6854,MAP3K2
HGNC:16268,PNPLA6
iuphar.ligand:256,SB 204070
rxcui:17804,AMOROLFINE
iuphar.ligand:1368,L-CCG-I
ncit:C2594,THERAPEUTIC AUTOLOGOUS DENDRITIC CELLS
ncit:C81680,BENIDIPINE
HP:5200125,Aggression toward others
ncit:C169848,CILOFEXOR
iuphar.ligand:9692,STK16-IN-1
CHEBI:48626,pyranoindolizinoquinoline
HP:0007263,Spinocerebellar atrophy
GO:0030421,defecation
iuphar.ligand:4363,[3H]L655708
HP:0012698,Cerebellar gliosis
CHEBI:22315,alkaloid
iuphar.ligand:1704,SB-408124
HP:0012501,Abnormal brainstem white matter morphology
MONDO:0009521,"leukemia, acute myelocytic, with polyposis coli and colon cancer"
chembl:CHEMBL4650279,BDTX189
HP:0034392,Joint contracture
chembl:CHEMBL2109365,HUPAM4
rxcui:27199,HYDROCORTISONE VALERATE
HGNC:5033,HNRNPA2B1
MGI:5700053,Fxn<sup>tm1Mkn</sup>/Fxn<sup>tm1Mkn</sup> Tg(FXN)YG22Pook/0  [background:] involves: 129/Sv * C57BL/6 * CBA
MGI:4366442,Fmr1<sup>tm1Cgr</sup>/Y  [background:] involves: 129P2/OlaHsd
rxcui:27901,ISOCONAZOLE
chembl:CHEMBL210287,BROMOPYROGALLOL RED
HGNC:24123,B9D1
chembl:CHEMBL1432305,CHEMBL:CHEMBL1432305
HP:0020041,Double elevator palsy
HP:0012240,Increased intramyocellular lipid droplets
HP:0009827,Amelia
MONDO:0012177,posterior column ataxia-retinitis pigmentosa syndrome
HP:0032725,Focal impaired awareness clonic seizure
HGNC:5411,IFIT3
HGNC:3025,DRD4
chembl:CHEMBL403233,MANZAMINE A
HGNC:251,ADH1C
HGNC:13505,ZNF304
HGNC:9975,TRIM27
FB:FBgn0261929,5-HT2B
chembl:CHEMBL2071528,ALTISSIMACOUMARIN F
rxcui:10382,TESTOSTERONE PROPIONATE
MGI:5825021,Slc6a8<sup>tm1.2Lbar</sup>/Y  [background:] involves: 129 * 129S1/Sv * C57BL/6N
MGI:3852394,Dlg4<sup>tm2.1Grnt</sup>/Dlg4<sup>tm2.1Grnt</sup>  [background:] involves: 129P2/OlaHsd
MP:0001847,brain inflammation
HGNC:18311,ERP44
HGNC:1759,CDH2
chembl:CHEMBL463526,LICARIN A
MONDO:0014641,frontotemporal dementia and/or amyotrophic lateral sclerosis 4
HGNC:35418,GTF2H2C_2
iuphar.ligand:9397,SNS-314
chembl:CHEMBL4297993,EMD-1201081
ZFIN:ZDB-GENE-040426-2724,pfkfb3
HP:0000010,Recurrent urinary tract infections
GO:0070761,pre-snoRNP complex
ncit:C28211,ENCLOMIPHENE
HGNC:4396,GNB1
iuphar.ligand:5743,COMPOUND 1 [PMID: 21939274]
MONDO:0008932,premature centromere division
MP:0004372,bowed fibula
HGNC:28095,BICDL1
chembl:CHEMBL589711,CHEMBL:CHEMBL589711
iuphar.ligand:9515,SRT2104
chembl:CHEMBL463781,TRIFLUMIZOLE
chembl:CHEMBL5095448,COBITOLIMOD SODIUM
rxcui:2582,CLINDAMYCIN
HGNC:3413,EPM2A
HGNC:6766,MADD
chembl:CHEMBL599924,CHEMBL:CHEMBL599924
rxcui:21245,CLOBETASOL PROPIONATE
ncit:C81139,CLEMIZOLE
HGNC:3579,FAH
rxcui:2359268,PEMIGATINIB
iuphar.ligand:4530,BROMOCRESOL GREEN
MONDO:0019064,hereditary spastic paraplegia
HP:0003474,Somatic sensory dysfunction
rxcui:34568,PROGABIDE
iuphar.ligand:10442,UDM-001651
CLINVAR:12970,NM_000540.3(RYR1):c.7300G>A (p.Gly2434Arg)
chembl:CHEMBL605084,CHEMBL:CHEMBL605084
rxcui:2541,CIMETIDINE
chembl:CHEMBL555260,CHEMBL:CHEMBL555260
MONDO:0011918,anxiety
ncit:C77030,BITHIONOL
MONDO:0005401,colonic neoplasm
HGNC:2208,COL4A6
ncit:C174604,OLESOXIME
chembl:CHEMBL374308,LACTACYSTIN
MGI:4430894,Abcg5<sup>trac</sup>/Abcg5<sup>trac</sup>  [background:] A/J-Abcg5<sup>trac</sup>
drugbank:DB14980,AZD-6482
HP:0000721,Lack of spontaneous play
iuphar.ligand:12442,(+/-)-ERIODICTYOL
MONDO:0012784,autosomal recessive ataxia due to ubiquinone deficiency
chembl:CHEMBL1078442,BERGAMOTTIN
CLINVAR:65980,NM_000540.3(RYR1):c.7361G>A (p.Arg2454His)
chembl:CHEMBL1440119,IRIGINOL HEXAACEATATE
HP:0002136,Broad-based gait
rxcui:1306284,COBICISTAT
iuphar.ligand:6659,P2PAL18S
HGNC:11051,SLC6A5
chembl:CHEMBL1257092,CHEMBL:CHEMBL1257092
CHEBI:82873,"1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole"
HGNC:4648,GTF2B
rxcui:1540824,TEDIZOLID PHOSPHATE
rxcui:203140,CEFMETAZOLE SODIUM
ncit:C79720,BENANSERIN HYDROCHLORIDE
HP:0006252,Interphalangeal joint erosions
ZFIN:ZDB-GENE-030131-670,ndufa10
HGNC:11849,TLR3
ncit:C79117,LAFUTIDINE
drugbank:DB13072,GDC-0349
HGNC:1578,CCNA2
HP:0011154,Focal autonomic seizure
rxcui:10767,TRIAZOLAM
CHEBI:15891,taurine
HP:0500079,Alternating hypophoria
drugbank:DB12806,GSK-1004723
chembl:CHEMBL1572261,CHEMBL:CHEMBL1572261
rxcui:847083,USTEKINUMAB
HP:0025478,Atrial standstill
rxcui:1006469,DOCONEXENT
rxcui:2626,CLOZAPINE
CHEBI:6801,metformin
HP:0000625,Eyelid coloboma
CHEBI:35702,diethyl ether
rxcui:31447,NABILONE
HGNC:15917,PLCB1
ncit:C79719,AVITRIPTAN
NCBIGene:288380,NDUFS1
HGNC:3782,FNTA
iuphar.ligand:1246,VUF 8328
MGI:2140230,Camta1
iuphar.ligand:3297,[3H]NGD941
HGNC:29877,UBAP2L
rxcui:2109054,TAGRAXOFUSP-ERZS
HGNC:8621,PAX7
chembl:CHEMBL3545047,BMS-852927
iuphar.ligand:669,FR191413
iuphar.ligand:9872,COMPOUND 3A [PMID: 18606542]
ncit:C1410,RECOMBINANT HUMAN STEM CELL FACTOR
GO:0043327,chemotaxis to cAMP
UPHENO:0076676,increased glial cell growth
HP:0032909,Focal impaired awareness automatism seizure
rxcui:2287,CETYLPYRIDINIUM CHLORIDE
rxcui:1545987,AMIFOSTINE ANHYDROUS
iuphar.ligand:1378,LY341495
EMAPA:19095,caudate-putamen
chembl:CHEMBL1313005,PHENAMIPHOS
RGD:1583609,Dlat-ps1
rxcui:2360232,SACITUZUMAB GOVITECAN
chembl:CHEMBL687,ACETYLSULFANILAMIDE
HGNC:17300,TAF8
HGNC:17258,AGTPBP1
MP:0005150,cachexia
HGNC:19355,JMJD6
HGNC:10941,SLC1A3
MONDO:0019771,oromandibular dystonia
rxcui:6922,METRONIDAZOLE
chembl:CHEMBL119405,BENZENETHIOL
HP:0002059,Cerebral atrophy
ncit:C62783,SELICICLIB
HGNC:10717,SEL1L
HGNC:1529,CAV3
HGNC:1401,CACNB1
HGNC:19685,SEPHS1
HGNC:11322,SSPN
chembl:CHEMBL172439,SLAZINIC ACID
HP:0001645,Sudden cardiac death
rxcui:8896,PSEUDOEPHEDRINE
HGNC:563,AP2B1
ncit:C1300,DOLASTATIN 10
CL:0000101,sensory neuron
rxcui:1372538,THYMIDINE
rxcui:1829,BUTACAINE
iuphar.ligand:12120,RLX-33
MONDO:0009637,inborn mitochondrial myopathy
drugbank:DB16305,XEVINAPANT
iuphar.ligand:6155,CP-195543
UPHENO:0081742,increased reflex in patella
UPHENO:0079829,abnormal aggressive behavior
iuphar.ligand:186,GLEMANSERIN
rxcui:2567226,BELZUTIFAN
CHEBI:28364,"all-cis-5,8,11,14,17-icosapentaenoic acid"
CHEBI:28073,chromium atom
HGNC:8756,PCYT2
HP:0032817,Neonatal focal myoclonic seizure
ncit:C38126,BETULINIC ACID
chembl:CHEMBL541230,CHEMBL:CHEMBL541230
chembl:CHEMBL1883234,PYRIPROXYFEN
rxcui:3264,DEXAMETHASONE
MONDO:0003409,colonic disorder
iuphar.ligand:8466,COMPOUND 10 [PMID: 19402633]
chembl:CHEMBL457504,CHEMBL:CHEMBL457504
drugbank:DB05387,NEOVASTAT
CHEBI:6067,isotretinoin
iuphar.ligand:194,SB 243213
ncit:C94207,LEFITOLIMOD
ncit:C76978,SULFANITRAN
HP:0002354,Memory impairment
chembl:CHEMBL224214,CARBONYL CYANIDE M-CHLOROPHENYLHYDRAZONE
chembl:CHEMBL138649,6-HYDROXYFLAVONE
CHEBI:5280,gatifloxacin
ncit:C1744,MULTIDRUG RESISTANCE MODULATOR
chembl:CHEMBL476351,GW775608X
CLINVAR:65981,NM_000540.2(RYR1):c.7522C>T (p.Arg2508Cys)
HGNC:14581,PINK1
HGNC:16760,COPS7B
iuphar.ligand:2004,BIM 23052
rxcui:2274802,TEPROTUMUMAB-TRBW
HGNC:11503,SYNJ1
HP:0002180,Neurodegeneration
UPHENO:0076713,abnormal putamen morphology
chembl:CHEMBL484662,CHEMBL:CHEMBL484662
rxcui:236677,2-PHENYLPHENOL
MGI:7260147,Adcy3<sup>tm1Drs</sup>/Adcy3<sup>tm1Drs</sup>  [background:] involves: 129X1/SvJ * C57BL/6J
HP:0002197,Generalized-onset seizure
rxcui:8167,PHENYLHYDRAZINE
ZFIN:ZDB-GENE-040426-1672,ndufa13
HGNC:6205,JUNB
MONDO:0016987,neuroacanthocytosis
RGD:1565358,Ndufa13-ps1
HP:0100716,Self-injurious behavior
CHEBI:9588,ticlopidine
HP:0000426,Prominent nasal bridge
CHEBI:17895,L-tyrosine
rxcui:142446,TETRACYCLINE HYDROCHLORIDE
iuphar.ligand:2432,RUTHENIUM RED
HP:0031908,Micrographia
ncit:C104280,P53/HDM2 INTERACTION INHIBITOR CGM097
chembl:CHEMBL265945,IRISOLIDONE
chembl:CHEMBL1346468,CHEMBL:CHEMBL1346468
CLINVAR:38132,NM_000059.4(BRCA2):c.7977-1G>C
HGNC:11834,TKT
chembl:CHEMBL599098,CHEMBL:CHEMBL599098
rxcui:1734630,GRAZOPREVIR
MGI:1276123,Ucn
MP:0004435,abnormal cochlear outer hair cell electromotility
ncit:C180425,IDH2 MUTANT INHIBITOR SH1573
MONDO:0008846,atransferrinemia
HP:0032852,Focal impaired awareness cognitive seizure with conduction dysphasia/aphasia
HGNC:5213,HSD17B4
chembl:CHEMBL3545384,SB-85635
CHEBI:3095,biguanide
rxcui:19861,BUTAMBEN
rxcui:203201,THIAMYLAL SODIUM
HP:0010653,Abnormality of the falx cerebri
rxcui:8299,PHYSOSTIGMINE
iuphar.ligand:5951,CDK4 INHIBITOR II
rxcui:17599,ALTHIAZIDE
HGNC:1248,C2
MONDO:0014094,severe congenital hypochromic anemia with ringed sideroblasts
drugbank:DB08544,(S)-FLUOXETINE
HGNC:15519,BOP1
HGNC:4952,HLA-DRB4
iuphar.ligand:8639,COMPOUND 7R [PMID: 26080733]
HGNC:6315,KHK
MGI:5700536,Tg(PGK1-FTL*)#Sle/0  [background:] B6J.FVB-Tg(PGK1-FTL*)#Sle
ncit:C29105,HYPOXANTHINE
iuphar.ligand:5737,COMPOUND 3A [PMID: 21444206]
iuphar.ligand:9577,AZ13102909
chembl:CHEMBL227725,ALLANTODAPSONE
HGNC:555,AP1G1
MGI:105098,Ube3a
ncit:C143006,CPG OLIGODEOXYNUCLEOTIDE TLR9 AGONIST DV281
rxcui:228080,PIRENOXINE
HGNC:14865,ESX1
chembl:CHEMBL599469,CHEMBL:CHEMBL599469
HGNC:2741,DDX18
HGNC:3208,EEF1B2
HGNC:17697,SARS2
iuphar.ligand:1229,BURIMAMIDE
iuphar.ligand:195,SDZ SER-082
iuphar.ligand:1769,INS49266
HP:0031762,Distance esotropia
rxcui:2106739,RESORCINOL MONOACETATE
HP:0002757,Recurrent fractures
HP:0000939,Osteoporosis
rxcui:1546022,LISINOPRIL ANHYDROUS
rxcui:10844,TRIOXSALEN
HGNC:6945,MCM3
MGI:3837829,Mbtps1<sup>Gt(PST115)Byg</sup>/Mbtps1<sup>+</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6
chembl:CHEMBL242385,CHEMBL:CHEMBL242385
ncit:C2530,DNMT1 MIXED-BACKBONE ANTISENSE OLIGONUCLEOTIDE MG 98
HP:0001038,Warfarin-induced skin necrosis
iuphar.ligand:6427,COMPOUND 16A [PMID: 14697765]
iuphar.ligand:6679,NE-100
rxcui:2625882,ADAGRASIB
rxcui:10627,TOBRAMYCIN
dictyBase:DDB_G0280435,dynA
ncit:C179130,ULOTARONT
iuphar.ligand:10597,BAY-985
rxcui:1828,BUSULFAN
rxcui:2534233,TIVOZANIB
chembl:CHEMBL1256878,BENZAMIL HYDROCHLORIDE
chembl:CHEMBL449520,ATRACTYLENOLIDE I
rxcui:5933,IODINE
rxcui:10485,THIOGUANINE
CHEBI:50427,platelet aggregation inhibitor
CHEBI:72581,rotenones
MONDO:0024479,epithelial tumor of colon
chembl:CHEMBL2364609,ESKETAMINE HYDROCHLORIDE
ncit:C148410,MILCICLIB
HGNC:23215,PIGO
chembl:CHEMBL1135,DIMETHYLAMINOETHANOL
rxcui:358263,TADALAFIL
chembl:CHEMBL1200797,TECHNETIUM TC 99M SUCCIMER
ncit:C784,PROTEIN SYNTHESIS INHIBITOR
HP:0200136,Oral-pharyngeal dysphagia
ncit:C62771,OBATOCLAX MESYLATE
chembl:CHEMBL502774,CHEMBL:CHEMBL502774
FB:FBgn0263111,cac
rxcui:91127,ACETOPHENAZINE MALEATE
MONDO:0010085,Schilder disease
HGNC:9055,PLCB2
iuphar.ligand:12437,COUMESTROL
drugbank:DB16830,PAEONOL
UBERON:0000451,prefrontal cortex
GO:0007165,signal transduction
ncit:C87372,LAROPIPRANT
HP:0006892,Frontotemporal cerebral atrophy
UBERON:0001017,central nervous system
iuphar.ligand:309,OTENZEPAD
drugbank:DB00272,BETAZOLE
HP:0030825,Absent foveal reflex
HP:0000722,Compulsive behaviors
ncit:C80053,ERITORAN
HGNC:9467,PRPSAP2
NCBIGene:100685609,BLM
HGNC:4387,GNAI3
UBERON:0001021,nerve
ncit:C171693,CONTEZOLID
chembl:CHEMBL273103,CHEMBL:CHEMBL273103
chembl:CHEMBL2171812,CHEMBL:CHEMBL2171812
HGNC:8878,PFKP
HGNC:6332,KIR2DL4
HP:0007697,Hypoplasia of the lower eyelids
MONDO:0012123,congenital disorder of glycosylation type 1E
drugbank:DB12003,THYMOSIN BETA-4
SGD:S000002845,GPI19
MONDO:0100310,hereditary cerebellar ataxia
HGNC:2280,COX6B1
HGNC:3356,ENPP1
drugbank:DB03083,IC261
chembl:CHEMBL5095026,DSP-2230
iuphar.ligand:7488,MG149
MGI:6827352,Atg4d<sup>Gt(OST254045)Lex</sup>/Atg4d<sup>Gt(OST254045)Lex</sup> Tg(CAG-EGFP/Map1lc3b)53Nmz/0  [background:] involves: 129S5/SvEvBrd * C57BL/6J * C57BL/6NCrlj * DBA/2J
drugbank:DB05913,OSI-930
HP:0008070,Sparse hair
iuphar.ligand:11913,NANOLUC-INSL3
ncit:C74557,DIETHYLSTILBESTROL DIPROPIONATE
ncit:C116888,HTERT-LAMP MRNA-LOADED AUTOLOGOUS DENDRITIC CELL VACCINE GRNVAC1
ncit:C76757,PINAFIDE
MGI:5467323,Tg(Pcp2-ATXN2*127Q)#Plt/0  [background:] involves: C57BL/6 * DBA/2
chembl:CHEMBL1940735,ENSACULIN HYDROCHLORIDE
rxcui:1251,AZACITIDINE
rxcui:274332,NATEGLINIDE
chembl:CHEMBL1623028,CHEMBL:CHEMBL1623028
rxcui:1549556,DIHYDROSTREPTOMYCIN SULFATE
HGNC:24501,PLEKHG4
ncit:C29819,ETHER
rxcui:115698,ZIPRASIDONE
ncit:C2642,IDRONOXIL
HGNC:24860,ENTPD8
ncit:C80060,AVUTOMETINIB
MGI:109555,Psmc2
chembl:CHEMBL585045,CHEMBL:CHEMBL585045
HP:0003323,Progressive muscle weakness
GO:0010628,positive regulation of gene expression
rxcui:56161,SENNOSIDE B
HGNC:943,ADGRB1
rxcui:1603296,LENVATINIB
rxcui:2634995,TOFERSEN
chembl:CHEMBL589922,CHEMBL:CHEMBL589922
Reactome:R-GGA-500753,Pyrimidine biosynthesis
HGNC:11540,TAF6
chembl:CHEMBL1256719,CHEMBL:CHEMBL1256719
iuphar.ligand:9925,BALAMAPIMOD
MONDO:0060760,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities
iuphar.ligand:495,RS-17053
chembl:CHEMBL1528359,CHEMBL:CHEMBL1528359
chembl:CHEMBL597248,CHEMBL:CHEMBL597248
chembl:CHEMBL446991,PHOMOPSIN A
iuphar.ligand:6055,VEGF RECEPTOR 2 KINASE INHIBITOR IV
rxcui:430,ALBENDAZOLE
rxcui:2373950,INEBILIZUMAB-CDON
chembl:CHEMBL496451,CHEMBL:CHEMBL496451
chembl:CHEMBL58033,(-)-U-50488
GO:0019621,creatinine catabolic process to formate
ncit:C2703,MISTLETOE EXTRACT
HP:0010871,Sensory ataxia
HGNC:18155,TXNRD2
chembl:CHEMBL338066,"4,2',4',6'-TETRAHYDROXYCHALCONE"
chembl:CHEMBL1094691,AESCULIOSIDE IIA
UBERON:0001873,caudate nucleus
WB:WBGene00013361,fars-2
HGNC:13590,FBXO11
iuphar.ligand:11665,XMD-12
drugbank:DB16891,ENMD-981693
ncit:C80378,RETASPIMYCIN
HP:0032706,Focal aware cognitive seizure with left-right confusion
iuphar.ligand:4307,SB202190
GO:0048675,axon extension
WB:WBGene00020110,hsp-75
ncit:C75185,ALAGEBRIUM CHLORIDE
chembl:CHEMBL3763743,TTC-352
rxcui:6371,LEVAMISOLE
iuphar.ligand:2008,CST-17
chembl:CHEMBL435295,CALOTHRIXIN A
GO:0022904,respiratory electron transport chain
WB:WBGene00000248,ben-1
NBO:0000119,impulsive behavior
drugbank:DB17877,S-NITROSOGLUTATHIONE
HGNC:29685,IARS2
iuphar.ligand:8160,COMPOUND 9B [PMID: 18986805]
rxcui:2178390,SELINEXOR
iuphar.ligand:4240,L701324
HGNC:24626,TXNDC12
CL:4023057,cerebellar inhibitory GABAergic interneuron
HP:0032409,Subcortical band heterotopia
chembl:CHEMBL3092650,GSK239512
HP:0002283,Global brain atrophy
HGNC:17158,PLD3
HP:0002591,Polyphagia
HGNC:25916,STRIP1
CHEBI:26195,polyphenol
MONDO:0013967,peroxisome biogenesis disorder 14B
MGI:2665401,Fmr1<sup>tm1Cgr</sup>/Fmr1<sup>tm1Cgr</sup>  [background:] involves: 129P2/OlaHsd
HGNC:7468,MTR
rxcui:14851,VIGABATRIN
HP:0002448,Progressive encephalopathy
rxcui:4118,ETHCHLORVYNOL
rxcui:52582,MESALAMINE
HP:0010851,EEG with burst suppression
HP:0100502,Vitamin B12 deficiency
iuphar.ligand:11909,[G(B24)S]R3/I5
chembl:CHEMBL599943,CHEMBL:CHEMBL599943
HGNC:4238,GFI1B
rxcui:22054,CYPROTERONE ACETATE
HP:0100022,Abnormality of movement
chembl:CHEMBL521373,SERGEOLIDE
UPHENO:0051585,abnormal urine creatine level
drugbank:DB16821,S-49076
drugbank:DB02966,FLUORO-WILLARDIINE
ncit:C1870,OBLIMERSEN
dictyBase:DDB_G0292310,psenB
rxcui:142430,CLEMASTINE FUMARATE
chembl:CHEMBL1185260,NITROBLUE TETRAZOLIUM
rxcui:2464540,PYRITHIONE SODIUM
MP:0030631,abnormal urine creatine level
HP:0007221,Progressive truncal ataxia
HGNC:11276,SPTBN2
rxcui:6816,METHAMPHETAMINE
rxcui:1986808,ACALABRUTINIB
rxcui:227224,FLUOXETINE HYDROCHLORIDE
CHEBI:25461,myxothiazol
chembl:CHEMBL599013,CHEMBL:CHEMBL599013
rxcui:6758,MEPHOBARBITAL
iuphar.ligand:7518,I-BET151
iuphar.ligand:10340,COMPOUND 58L [PMID: 30843696]
WB:WBGene00006433,sdhb-1
GO:0043249,erythrocyte maturation
chembl:CHEMBL580516,CHEMBL:CHEMBL580516
chembl:CHEMBL77675,CHEMBL:CHEMBL77675
HP:0006855,Cerebellar vermis atrophy
MGI:103076,Vdr
rxcui:6835,METHIMAZOLE
HGNC:700,ARNT
HP:0001939,Abnormality of metabolism/homeostasis
iuphar.ligand:12093,ZANZALINTINIB
EMAPA:35185,brain nucleus
MONDO:0011830,lissencephaly due to LIS1 mutation
ncit:C243,THERAPEUTIC ANDROGEN
GO:0001725,stress fiber
MP:0003313,abnormal locomotor activation
rxcui:873,ANTHRALIN
HP:0007668,Impaired pursuit initiation and maintenance
HP:0032917,Focal aware sexual automatism seizure
HGNC:1770,CDK10
chembl:CHEMBL579045,CHEMBL:CHEMBL579045
rxcui:1242127,GLUCARPIDASE
rxcui:2104331,CENEGERMIN-BKBJ
chembl:CHEMBL585622,CHEMBL:CHEMBL585622
iuphar.ligand:6414,5PAM523
HP:0002716,Lymphadenopathy
HGNC:2963,DYNC1I1
MONDO:0002277,arteriosclerosis disorder
HGNC:7459,MT-ND4
chembl:CHEMBL1782601,THEONELLASTEROL E
chembl:CHEMBL62231,CHEMBL:CHEMBL62231
ncit:C75132,NIFEKALANT
ncit:C77587,PIRAGLIATIN
CHEBI:29035,manganese(2+)
chembl:CHEMBL533577,CHEMBL:CHEMBL533577
chembl:CHEMBL59532,CHEMBL:CHEMBL59532
ncit:C80630,SOTRASTAURIN
chembl:CHEMBL197655,MANSONONE F
PomBase:SPCC1682.01,qcr9
drugbank:DB14810,AZD-1656
HP:0003440,Horizontal sacrum
HP:0032907,Focal undressing automatism seizure
rxcui:37801,TERBINAFINE
HGNC:7883,NOTCH3
ncit:C1880,CANERTINIB DIHYDROCHLORIDE
rxcui:857492,TAPENTADOL HYDROCHLORIDE
iuphar.ligand:10271,RAG8
iuphar.ligand:11464,NANOLUCIFERASE-LABELLED RELAXIN
HGNC:10778,SFRP4
dictyBase:DDB_G0274311,DDB_G0274311
HGNC:25608,VPS53
rxcui:3008,CYCLOSPORINE
MONDO:0009267,Gaucher disease type III
chembl:CHEMBL1256885,CHEMBL:CHEMBL1256885
ncit:C48369,MULTIKINASE INHIBITOR AEE788
ncit:C162555,PUQUITINIB
HGNC:1728,CDC27
CHEBI:28077,rifampicin
iuphar.ligand:6660,[3H]2-FUROYL-LIGRL-NH2
rxcui:108118,MOMETASONE
ncit:C80379,TEZAMPANEL ANHYDROUS
CL:0000103,bipolar neuron
rxcui:2477104,TEPOTINIB HYDROCHLORIDE
HGNC:3113,E2F1
chembl:CHEMBL412603,CHEMBL:CHEMBL412603
ncit:C75147,HELIOMYCIN
rxcui:53744,NOMEGESTROL ACETATE
HGNC:2850,DGKB
iuphar.ligand:10461,FADRACICLIB
HGNC:16783,CDC73
HGNC:12666,VCP
HGNC:1685,CD5
chembl:CHEMBL154533,WHILE OLIVETOL
iuphar.ligand:9219,AL-78898A
MONDO:0006358,parotid gland squamous cell carcinoma
HP:0010663,Abnormality of thalamus morphology
rxcui:7631,OLEIC ACID
chembl:CHEMBL532510,CHEMBL:CHEMBL532510
ncit:C152218,RIMCAZOLE
HGNC:18002,TOMM22
EMAPA:35224,cerebellum vermis lobule
iuphar.ligand:5741,COMPOUND 29A [PMID: 21444206]
HGNC:26006,TTC19
CHEBI:36963,organooxygen compound
iuphar.ligand:8629,SL422
wikidata:Q47521991,PHOTOFRIN
HGNC:1912,CHAT
MONDO:0005402,lymphoid leukemia
MONDO:0007171,atrial standstill 1
FBbt:00000001,organism
HGNC:1066,BMI1
iuphar.ligand:335,G&OUML; 7874
chembl:CHEMBL1459149,CHEMBL:CHEMBL1459149
iuphar.ligand:4203,GMQ
MONDO:0016216,adult hepatocellular carcinoma
MONDO:0010698,optic atrophy 2
ncit:C130010,ZANIDATAMAB
UBERON:0001233,right adrenal gland
HP:0000343,Long philtrum
iuphar.ligand:1996,[125I]INSL3 (HUMAN)
MP:0014185,cerebellum atrophy
ncit:C667,MONOAMINE OXIDASE INHIBITOR
HGNC:6407,KRAS
rxcui:1311280,PLATINUM
MGI:3712126,Psap<sup>tm1Ggb</sup>/Psap<sup>tm1Ggb</sup>  [background:] involves: 129S/SvEv * C57BL/6J
HP:0001442,Typified by somatic mosaicism
ncit:C71531,GANITUMAB
iuphar.ligand:4241,L838417
MONDO:0013956,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
HGNC:3041,RCAN2
HGNC:3296,EIF4G1
chembl:CHEMBL348290,TRICHLOROMONOFLUOROMETHANE
rxcui:2361285,TUCATINIB
ncit:C80963,DITIOCARB SODIUM
HGNC:12335,TRPC3
chembl:CHEMBL1415851,CHEMBL:CHEMBL1415851
rxcui:152761,ACAMPROSATE CALCIUM
MONDO:0012895,torsion dystonia 17
HGNC:28834,CEACAM21
HP:0007875,Congenital blindness
drugbank:DB07873,LAURYL ALCOHOL DIPHOSPHONIC ACID
rxcui:41127,FLUVASTATIN
MONDO:0019303,premature aging syndrome
ncit:C38690,MUPARFOSTAT
HP:0003458,EMG: myopathic abnormalities
HP:0003810,Late-onset distal muscle weakness
HP:0007565,Multiple cafe-au-lait spots
rxcui:29654,METHENOLONE ENANTHATE
chembl:CHEMBL1528028,PUTRESCINE DIHYDROCHLORIDE
SGD:S000000230,ETR1
UBERON:0001871,temporal lobe
HGNC:3756,FLNC
HGNC:26354,UBXN10
rxcui:217483,HALOPERIDOL LACTATE
NCBIGene:102154035,NDUFA1
chembl:CHEMBL476302,CHEMBL:CHEMBL476302
iuphar.ligand:5965,EGFR/ERBB-2/ERBB-4 INHIBITOR
iuphar.ligand:10104,(S)-DIMETINDENE
HGNC:9309,PPP2R5A
ncit:C62482,TIGATUZUMAB
HP:0100724,Hypercoagulability
ncit:C65262,BIFEPRUNOX
ncit:C74086,UDENAFIL
rxcui:62174,DESERPIDINE
iuphar.ligand:75,SB 272183
HP:0008770,Obsessive-compulsive trait
iuphar.ligand:7694,SB269652
ncit:C1963,RETRO-INVERSO PEPTIDE
ncit:C2140,ADJUVANT
rxcui:1156,ASPARAGINASE
chembl:CHEMBL1088184,DIBUTYLDICHLOROSTANNANE
HP:0004452,Abnormality of the middle ear ossicles
iuphar.ligand:10672,"COMPOUND 5 [TOMASSI ET AL., 2020]"
ncit:C63669,CARBENOXOLONE
HGNC:2979,DNMT3B
UPHENO:0080042,increased biological_process in basal ganglion
UBERON:0010230,eyeball of camera-type eye
rxcui:2105806,GILTERITINIB
chembl:CHEMBL157844,PUUPEHENONE
ncit:C163673,METHIOCARB
NCBIGene:282290,NDUFV2
ncit:C37455,ZEBULARINE
MONDO:0010912,"fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement"
HGNC:16862,RAPGEF5
HP:0012708,Reduced brain N-acetyl aspartate level by MRS
chembl:CHEMBL1255647,CHEMBL:CHEMBL1255647
iuphar.ligand:7951,BGT-226
CHEBI:24353,glycerol ether
iuphar.ligand:9390,CERALASERTIB
rxcui:2469247,SETMELANOTIDE
iuphar.ligand:12337,COMPOUND 16D [PMID: 36573286]
MONDO:0100137,telomere syndrome
rxcui:1999382,TEZACAFTOR
HGNC:3042,RCAN3
ncit:C81084,VANOXERINE
iuphar.ligand:1320,&ALPHA;-MSH
HP:0032734,Focal aware emotional seizure
iuphar.ligand:6564,PHENYLACETYL-ARG-VAL-ARG-4-AMIDINOBENZYLAMIDE
chembl:CHEMBL899,LANSOPRAZOLE SULFIDE
HP:0100541,Femoral hernia
MONDO:0002050,depressive disorder
ncit:C29723,PROTON PUMP INHIBITOR
HGNC:17070,SWAP70
iuphar.ligand:9974,MK-8353
chembl:CHEMBL338604,C-1311
ncit:C73084,CINTAZONE
MGI:1096584,Psmd2
MONDO:0020683,acute disease
rxcui:714438,PAZOPANIB
drugbank:DB16739,MK-886
HGNC:14203,JPH3
chembl:CHEMBL486817,HARMOL
chembl:CHEMBL530698,CHEMBL:CHEMBL530698
chembl:CHEMBL1946013,CHEMBL:CHEMBL1946013
MP:0030859,absent sesamoid bone of gastrocnemius
rxcui:1483263,SPERMINE
HGNC:13429,RLIM
HP:0010830,Impaired tactile sensation
HP:0001311,Abnormal nervous system electrophysiology
HP:0012795,Abnormal optic disc morphology
HGNC:9652,PTPN22
ZFIN:ZDB-GENE-050417-399,mecr
HP:0100660,Dyskinesia
HP:0000759,Abnormal peripheral nervous system morphology
HGNC:12363,TSC2
chembl:CHEMBL530682,CHEMBL:CHEMBL530682
iuphar.ligand:8148,COMPOUND 31 [PMID: 24915291]
MP:0008028,pregnancy-related premature death
rxcui:1424,BENZTROPINE
ncit:C132725,VABICASERIN
HGNC:22923,GMPPA
HP:0006454,Delayed patellar ossification
HP:0000185,Cleft soft palate
MGI:102790,Rab18
MGI:3846455,Dp(16Cbr1-Fam3b)1Rhr/0  [background:] involves: 129S6/SvEvTac * C3H/HeSnJ * C57BL/6Ei
HGNC:9804,RACGAP1
EMAPA:17278,radial nerve
MGI:103232,Grb10
HGNC:2637,CYP3A4
HP:0000954,Single transverse palmar crease
MONDO:0013600,insomnia
MONDO:0054581,Townes-Brocks syndrome 1
chembl:CHEMBL589670,CHEMBL:CHEMBL589670
rxcui:18475,ATIPAMEZOLE
iuphar.ligand:7948,TIVANTINIB
HP:0012520,Dilation of Virchow-Robin spaces
HGNC:29119,UBXN7
HGNC:10760,SET
HGNC:5270,DNAJB1
chembl:CHEMBL2333543,CHEMBL:CHEMBL2333543
HP:0032011,Heterophoria
chembl:CHEMBL253553,LYCOBETAINE
ncit:C48382,BARDOXOLONE
chembl:CHEMBL303846,XANTHYLETIN
chembl:CHEMBL123349,CHEMBL:CHEMBL123349
iuphar.ligand:937,SKF-76783
drugbank:DB12387,OSI-027
HP:0010553,Oculogyric crisis
rxcui:117055,ALEMTUZUMAB
chembl:CHEMBL1224789,VOLVALERENAL D
iuphar.ligand:9903,SAMURACICLIB
CLINVAR:429629,NM_001042537.1(SLC9A6):c.137G>A (p.Gly46Asp)
rxcui:203116,BUSPIRONE HYDROCHLORIDE
rxcui:6854,METHOXSALEN
chembl:CHEMBL517514,GERONTOXANTHONE A
ncit:C81392,BEFIRADOL
chembl:CHEMBL1492017,CHEMBL:CHEMBL1492017
HGNC:882,ATR
GO:0043202,lysosomal lumen
HP:0000012,Urinary urgency
NCBIGene:403882,HTR2A
rxcui:2642208,DEOXYCYTIDINE
HGNC:7193,MOCS2
MONDO:0054794,"hydrocephalus, congenital, 3, with brain anomalies"
chembl:CHEMBL580130,CHEMBL:CHEMBL580130
HGNC:2896,DLAT
MONDO:0008783,Tangier disease
iuphar.ligand:2429,ICILIN
iuphar.ligand:5744,COMPOUND 2 [PMID: 21939274]
HP:0007017,Progressive forgetfulness
ncit:C174748,VODOBATINIB
iuphar.ligand:2185,D[D-PHE2]AVP
ncit:C79725,AFELETECAN
drugbank:DB16091,EMB-01
MONDO:0014975,autosomal recessive spastic paraplegia type 78
chembl:CHEMBL120580,CHEMBL:CHEMBL120580
ncit:C119620,NAVICIXIZUMAB
iuphar.ligand:5666,BI-2536
rxcui:55679,RILMENIDINE
chembl:CHEMBL582764,CHEMBL:CHEMBL582764
chembl:CHEMBL3138617,DIMETHOMORPH
HGNC:17613,BFAR
iuphar.ligand:8846,CGS-27023A
HP:0032570,Pontine ischemic lacunes
chembl:CHEMBL1310701,CHEMBL:CHEMBL1310701
ncit:C171615,ALK INHIBITOR TAE684
rxcui:1294605,ICATIBANT ACETATE
iuphar.ligand:4698,[3H]D-ASPARTIC ACID
MGI:3846911,l4Jus31/l4Jus31  [background:] involves: 129S7/SvEvBrd * C57BL/6
HGNC:15971,TSG101
rxcui:235721,METHAPYRILENE HYDROCHLORIDE
CHEBI:100241,ciprofloxacin
HGNC:1391,CACNA1D
rxcui:60661,ESTRADIOL 3-BENZOATE
drugbank:DB06069,XMT-1001
HGNC:1100,BRCA1
ncit:C166572,INTEPIRDINE
ncit:C2386,GP100 ANTIGEN
rxcui:33169,PERHEXILINE MALEATE
ncit:C170304,PEGPLERANIB SODIUM
iuphar.ligand:7001,GARCINOL
iuphar.ligand:1079,CGP7930
ncit:C175088,INFIGRATINIB PHOSPHATE
MGI:4420469,E2f1<sup>tm1Meg</sup>/E2f1<sup>tm1Meg</sup> Rb1<sup>tm1Tyj</sup>/Rb1<sup>tm1Tyj</sup> Tg(Rb1)1Blg/0  [background:] involves: 129S2/SvPas * 129S4/SvJae
HGNC:9390,PRKAR1B
iuphar.ligand:12320,SLC-391
HP:0002539,Cortical dysplasia
iuphar.ligand:5134,AMA
GO:0005802,trans-Golgi network
rxcui:1368125,ACRYLAMIDE
FBbt:00001919,larval central nervous system
rxcui:26412,HALAZEPAM
GO:0005811,lipid droplet
CHEBI:18012,fumaric acid
rxcui:2272107,AVAPRITINIB
drugbank:DB11645,PF-4191834
rxcui:203203,ALFENTANIL HYDROCHLORIDE
ncit:C2407,MUC-1 ANTIGEN
chembl:CHEMBL607253,CHEMBL:CHEMBL607253
iuphar.ligand:653,B-9430
rxcui:142448,LIOTHYRONINE SODIUM
iuphar.ligand:11343,EST64454
rxcui:78904,CHLORMADINONE
chembl:CHEMBL600336,CHEMBL:CHEMBL600336
drugbank:DB12998,PF-00217830
HGNC:6448,KRT31
CLINVAR:51509,NC_000013.11:g.32316496dup
CHEBI:17076,streptomycin
ncit:C76649,APLINDORE FUMARATE
CHEBI:57540,NAD(1-)
UPHENO:0088330,abnormally decreased number of neuron in the cerebral cortex
HP:0002465,Poor speech
ncit:C141504,SNX 5422
rxcui:32673,OXYBENZONE
chembl:CHEMBL609036,CHEMBL:CHEMBL609036
HGNC:19439,KCNK18
HP:0002522,Areflexia of lower limbs
MP:0004097,abnormal cerebellar cortex morphology
rxcui:3322,DIAZEPAM
rxcui:142432,CLONIDINE HYDROCHLORIDE
HP:0000550,Undetectable electroretinogram
ncit:C96722,VAPITADINE DIHYDROCHLORIDE
iuphar.ligand:4905,M-CSF
ZFIN:ZDB-GENE-040426-1675,pycr1a
dictyBase:DDB_G0282759,DDB_G0282759
MGI:3574842,Grid2<sup>ho-15J</sup>/Grid2<sup>ho-15J</sup>  [background:] C3(Cg)-Grid2<sup>ho-15J</sup>/GrsrJ
MONDO:0016621,juvenile Huntington disease
drugbank:DB07286,BMS-564929
MONDO:0016167,optic pathway glioma
drugbank:DB18345,CN-105
MGI:108030,Hyou1
drugbank:DB04338,SB220025
GO:0034485,"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity"
chembl:CHEMBL502529,NAKIJIQUINONES G
HGNC:25774,TCTN2
iuphar.ligand:8797,COMPOUND 13 [PMID: 17502136]
HP:0009381,Short finger
GO:0031393,negative regulation of prostaglandin biosynthetic process
MONDO:0013199,tuberous sclerosis 2
HP:0011814,Increased urinary hypoxanthine level
rxcui:2387833,BELANTAMAB MAFODOTIN-BLMF
rxcui:9022,PYROGALLOL
rxcui:8132,PHENIRAMINE
ncit:C63667,MOFAROTENE
HGNC:18301,SLC2A14
rxcui:8372,PIVAMPICILLIN
HGNC:612,APOD
rxcui:152021,DICYCLOMINE HYDROCHLORIDE
RGD:2147,Ar
rxcui:2256930,LASMIDITAN
HGNC:10494,S100A4
ncit:C97364,TIDEGLUSIB
rxcui:4452,FLUDROCORTISONE
ncit:C171908,ANECORTAVE ACETATE
chembl:CHEMBL589207,CHEMBL:CHEMBL589207
iuphar.ligand:12202,LECANEMAB
iuphar.ligand:10298,NARINGENIN
FB:FBgn0037347,SecS
HP:0007002,Motor axonal neuropathy
HP:0002617,Vascular dilatation
chembl:CHEMBL470648,GYROPHORIC ACID
iuphar.ligand:3930,JP1302
ncit:C1803,SOY PROTEIN ISOLATE
chembl:CHEMBL1412002,CHEMBL:CHEMBL1412002
chembl:CHEMBL1420370,CHEMBL:CHEMBL1420370
chembl:CHEMBL2204435,CHEMBL:CHEMBL2204435
HP:0011330,Metopic synostosis
rxcui:1437,BERBERINE
rxcui:10814,LIOTHYRONINE
rxcui:2197862,ENTRECTINIB
UPHENO:0081577,abnormal superior cerebellar peduncle of pons morphology
MONDO:0005870,necatoriasis
iuphar.ligand:8141,COMPOUND 66 [PMID: 19788238]
HGNC:4425,GOLGA2
HP:0000403,Recurrent otitis media
MONDO:0008768,"ceroid lipofuscinosis, neuronal, 6B (Kufs type)"
MGI:5467734,Cacna1a<sup>tm2.1Kewa</sup>/Cacna1a<sup>tm2.1Kewa</sup>  [background:] B6.Cg-Cacna1a<sup>tm2.1Kewa</sup>
rxcui:1992,CAPSAICIN
iuphar.ligand:8247,LDC1267
iuphar.ligand:5755,COMPOUND 36J [PMID: 21536438]
rxcui:10638,TOLONIUM CHLORIDE
chembl:CHEMBL1449731,CHEMBL:CHEMBL1449731
HGNC:10912,SLC12A3
chembl:CHEMBL3545092,CR 1447
HP:0007942,Internal ophthalmoplegia
rxcui:1982,CANRENONE
HGNC:6254,KCNH5
HP:0012302,Herpes simplex encephalitis
HP:0003272,Abnormal hip bone morphology
HP:0032828,Neonatal bilateral symmetric tonic seizure
NCBIGene:282214,CYP3A28
EMAPA:32633,hindlimb skeleton
chembl:CHEMBL253998,GLABRANIN
ncit:C174799,LENABASUM
CHEBI:25000,lactone
drugbank:DB05081,JB991
ncit:C77906,PEVONEDISTAT
iuphar.ligand:1347,6-HYDROXYMELATONIN
iuphar.ligand:8464,DROXINOSTAT
chembl:CHEMBL1476898,CADMIUM ACETATE
chembl:CHEMBL407501,CHEMBL:CHEMBL407501
ncit:C81077,CARMOXIROLE
chembl:CHEMBL1076184,CIMIRACEMATE A
MGI:7495510,Slc12a3<sup>em3Gpt</sup>/Slc12a3<sup>em4Gpt</sup>  [background:] involves: C57BL/6
Reactome:R-GGA-390650,Histamine receptors
GO:0030889,negative regulation of B cell proliferation
ncit:C166939,ONFEKAFUSP ALFA
MGI:4360692,Tg(Eno2-ATN1)14Tx/0  [background:] B6.Cg-Tg(Eno2-ATN1)14Tx
MONDO:0015285,Carney complex
NBO:0000128,irritability behavior
rxcui:132871,ACETYLDIGITOXIN
HGNC:3033,ATN1
MGI:2148202,Ces1d
MONDO:0008845,atonic-astatic syndrome of Foerster
CLINVAR:424578,NM_001110792.2(MECP2):c.289C>T (p.Arg97Cys)
ZFIN:ZDB-GENE-991119-4,psen1
MONDO:0029000,poisoning
drugbank:DB13051,CH-5132799
HP:0000739,Anxiety
HGNC:816,ATP2B3
rxcui:1362740,4-PHENYLENEDIAMINE
HGNC:3148,TYMP
iuphar.ligand:8178,COMPOUND 16 [PMID: 18945615]
rxcui:236961,EPINASTINE HYDROCHLORIDE
rxcui:1366930,SODIUM DICHLOROACETATE
HGNC:3358,ENPP3
HP:0100023,Recurrent hand flapping
HP:0032872,Focal impaired awareness cognitive seizure with illusion
rxcui:1314411,PROPYLENE GLYCOL MONOSTEARATE
HP:0003749,Pelvic girdle muscle weakness
HP:0032737,Focal emotional seizure with paranoia
rxcui:1537034,VORAPAXAR
MGI:1929282,Ptges3
rxcui:6448,LITHIUM
chembl:CHEMBL127579,CHEMBL:CHEMBL127579
HGNC:11103,SMARCB1
ncit:C77567,SARIZOTAN
HP:0010952,Mild fetal ventriculomegaly
iuphar.ligand:5441,LY593093
HGNC:2739,DHX16
HP:0001231,Abnormal fingernail morphology
iuphar.ligand:2611,ROTTLERIN
chembl:CHEMBL2137654,TETRACONAZOLE
MGI:2446586,Abcd1<sup>tm1Kan</sup>/Y  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
RGD:1304562,Tbc1d1
iuphar.ligand:5345,CORYNANTHINE
iuphar.ligand:2614,ATX-II
iuphar.ligand:911,SPHINGOSINE 1-PHOSPHATE
HGNC:16002,MPLKIP
MGI:6194786,Abcd1<sup>tm1Kan</sup>/Y Gt(ROSA)26Sor<sup>tm2.1(CAG-ELOVL1)Geno</sup>/Gt(ROSA)26Sor<sup>+</sup> Cnp<sup>tm1(cre)Kan</sup>/Cnp<sup>+</sup>  [background:] involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J
HGNC:11079,SLC9A6
drugbank:DB13059,PF-03814735
MONDO:0004975,Alzheimer disease
chembl:CHEMBL43078,CHEMBL:CHEMBL43078
CHEBI:38093,phenothiazines
chembl:CHEMBL493646,CUCURBITACIN D
chembl:CHEMBL487046,CHEMBL:CHEMBL487046
HP:0011451,Primary microcephaly
chembl:CHEMBL122701,CHEMBL:CHEMBL122701
chembl:CHEMBL1723657,6-CHLORONICOTINIC ACID
HP:0020206,Simple ear
chembl:CHEMBL40275,ALOE-EMODIN
iuphar.ligand:11192,IACS-9439
HGNC:15832,BSCL2
MGI:103078,Spr
rxcui:107770,MEPENZOLATE
HP:0033249,Focal substantia nigra T2 hyperintensity
drugbank:DB01629,5-FLUOROURIDINE
rxcui:6873,METHYLCELLULOSE
drugbank:DB05410,NCX 1022
HGNC:7989,NRAS
HP:0000716,Depression
ncit:C52197,ANAMORELIN
iuphar.ligand:11362,IMR-1
chembl:CHEMBL592611,CHEMBL:CHEMBL592611
chembl:CHEMBL176570,PSOROMIC ACID
rxcui:105694,EPOETIN ALFA
HGNC:3432,ERBB4
rxcui:10473,THIOTEPA
rxcui:352374,DROTRECOGIN ALFA
MONDO:0018342,Joubert syndrome with Jeune asphyxiating thoracic dystrophy
HP:0012471,Thick vermilion border
iuphar.ligand:10564,ARV-771
iuphar.ligand:11309,4‐BCCA
iuphar.ligand:2906,LPA
chembl:CHEMBL1253688,R-RUGULACTONE
MGI:4867201,Kcna2<sup>Pgu</sup>/Kcna2<sup>+</sup>  [background:] involves: C3H/HeJ * C57BL/6J
MGI:3706705,Cacna1a<sup>tg-la</sup>/Cacna1a<sup>Wb</sup>  [background:] involves: AKR/J * C3H/HeJ * C57BL/6J
ncit:C1652,MARIMASTAT
Reactome:R-DDI-611105,Respiratory electron transport
rxcui:1721560,OSIMERTINIB
rxcui:52071,LINOLENIC ACID
chembl:CHEMBL1873703,DIELDRIN
HP:0001662,Bradycardia
GO:0001654,eye development
chembl:CHEMBL598679,CHEMBL:CHEMBL598679
chembl:CHEMBL1886718,FLUFENACET
ncit:C152162,REBASTINIB
UBERON:0001874,putamen
rxcui:6837,METHIONINE
rxcui:39541,VINORELBINE
rxcui:4106,ETHACRIDINE
MGI:2385311,Dlat
HGNC:492,ANK1
rxcui:82012,DOXYCYCLINE CALCIUM
ncit:C75226,NITROSCANATE
chembl:CHEMBL529984,CHEMBL:CHEMBL529984
chembl:CHEMBL600030,CHEMBL:CHEMBL600030
MP:0005553,increased circulating creatinine level
HGNC:3265,EIF2S1
MONDO:0020257,supranuclear oculomotor palsy
iuphar.ligand:649,BRADYKININ
chembl:CHEMBL4297400,MB-07803
UPHENO:0080581,abnormal eye movement
HGNC:11824,TINF2
HGNC:12732,WASF1
HP:0030285,Splayed superior cerebellar peduncle
hemonc:278,IPATASERTIB
iuphar.ligand:11554,DSM705
chembl:CHEMBL586061,CHEMBL:CHEMBL586061
ncit:C98838,POZIOTINIB
rxcui:26143,GLYCYRRHIZIC ACID
HP:0001265,Hyporeflexia
rxcui:32941,PARTHENOLIDE
rxcui:265323,MYCOPHENOLATE
chembl:CHEMBL77705,GARDENIN
iuphar.ligand:4141,ATPO
drugbank:DB05500,AVN-944
ncit:C76234,TOSUFLOXACIN TOSYLATE
HP:0003477,Peripheral axonal neuropathy
HGNC:16686,MRPL55
rxcui:1727455,ALECTINIB
ncit:C1491,TYRPHOSTIN AG 879
ncit:C170368,RESMETIROM
HP:0025708,Early young adult onset
chembl:CHEMBL606532,CHEMBL:CHEMBL606532
HP:0010527,Astereognosia
ncit:C120307,MAVELERTINIB
rxcui:203153,INDINAVIR SULFATE
HGNC:18305,ATP6AP2
rxcui:7426,NIMODIPINE
chembl:CHEMBL45830,MILTIRONE
HGNC:3821,FOXO3
MONDO:0010589,"Aarskog-Scott syndrome, X-linked"
chembl:CHEMBL193093,CHEMBL:CHEMBL193093
ncit:C66540,SOBUZOXANE
MGI:4441292,Gla<sup>tm1Kul</sup>/Y Itpr1<sup>wblo</sup>/Itpr1<sup>wblo</sup>  [background:] B6;129-Gla<sup>tm1Kul</sup> Itpr1<sup>wblo</sup>/GrsrJ
HGNC:8875,PFKFB4
MONDO:0000833,bone remodeling disease
HP:0001942,Metabolic acidosis
chembl:CHEMBL418661,E-64C
ncit:C75982,INGLIFORIB
HGNC:18128,HDAC10
MONDO:0015160,multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome
MGI:2177138,Gba1<sup>tm1Nsb</sup>/Gba1<sup>tm1Nsb</sup>  [background:] involves: 129S/SvEv * C57BL/6
HGNC:11587,TBL3
HGNC:19097,RBPMS
rxcui:1511,BETAHISTINE
HGNC:16926,KRTAP9-2
HP:0004527,Large clumps of pigment irregularly distributed along hair shaft
ncit:C338,CAMPTOTHECIN
chembl:CHEMBL4091801,APG115
rxcui:1364105,PASIREOTIDE
ZFIN:ZDB-GENE-030429-12,ccnb2
HGNC:10994,SLC26A2
HP:0031764,Fully accomodative esotropia
UBERON:0003876,hippocampal field
MGI:87904,Actb
iuphar.ligand:7012,GSK126
ncit:C166960,AFELIMOMAB
drugbank:DB04769,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE"
rxcui:1311634,MERCURIC CHLORIDE
HGNC:4012,FUT1
chembl:CHEMBL602580,CHEMBL:CHEMBL602580
CHEBI:84340,hydrazinocurcumin
HP:0031466,Impairment in personality functioning
iuphar.ligand:2350,ALL-TRANS-RETINAL
MP:0005447,abnormal synaptic norepinephrine release
HP:0010885,Avascular necrosis
HGNC:11119,SMO
ncit:C76054,BEGACESTAT
rxcui:6818,METHANDROSTENOLONE
HGNC:8064,NUP214
chembl:CHEMBL528647,CHEMBL:CHEMBL528647
rxcui:8782,PROPOFOL
MONDO:0012643,hereditary spastic paraplegia 32
OBA:2001000,age of onset of Alzheimer disease
HP:0011459,Esophageal carcinoma
HGNC:857,ATP6V1E1
rxcui:7405,NIACINAMIDE
RGD:1358918,W-<i>Plp1<sup>md</sup></i>/Nya
chembl:CHEMBL592600,CHEMBL:CHEMBL592600
HP:0001408,Bile duct proliferation
drugbank:DB16938,D-157495
CHEBI:39268,dibenzothiazepine
Xenbase:XB-GENE-5888837,coq4
HP:0008850,Severe postnatal growth retardation
HGNC:6117,IRF2
iuphar.ligand:9027,L6H21
UBERON:0036145,glymphatic system
HP:0001903,Anemia
rxcui:1700,BORIC ACID
ncit:C74197,LEVISOPRENALINE
UBERON:0001876,amygdala
chembl:CHEMBL1099140,CHEMBL:CHEMBL1099140
MP:0000884,delaminated Purkinje cell layer
ncit:C1593,RECOMBINANT CHEMOKINE
iuphar.ligand:1771,R-138727
rxcui:19295,BIFONAZOLE
iuphar.ligand:8668,FURIN INHIBITOR PEPTIDE
UBERON:0001485,knee joint
rxcui:5499,HYDROGEN PEROXIDE
chembl:CHEMBL382277,EX-527
iuphar.ligand:5918,AGL 2043
chembl:CHEMBL225563,CHEMBL:CHEMBL225563
SGD:S000003104,MRM2
rxcui:10472,THIMEROSAL
iuphar.ligand:9761,COMPOUND 9 [PMID: 26006010]
HGNC:4685,GUCY1A1
RGD:1359454,Sdhc
HGNC:16463,PRPF40A
rxcui:91135,THIOTHIXENE HYDROCHLORIDE
ncit:C66990,PALIFOSFAMIDE
HGNC:11012,SLC30A1
HP:0003326,Myalgia
iuphar.ligand:8939,FRAX597
iuphar.ligand:10676,AZ1366
rxcui:519,ALLOPURINOL
rxcui:1544577,ALFAXALONE
RGD:3247,Pacsin1
ncit:C1798,SHARK CARTILAGE EXTRACT AE-941
rxcui:25190,FLUPHENAZINE DECANOATE
ncit:C2139,IMMUNOSTIMULANT
HGNC:3242,EHD1
HP:0007159,Fluctuations in consciousness
MGI:102793,Fstl1
HP:0000546,Retinal degeneration
HGNC:13398,NSDHL
iuphar.ligand:7676,PD-118057
CHEBI:15956,biotin
rxcui:8123,PHENELZINE
chembl:CHEMBL4650292,CDX-3379
ncit:C73303,TIOSPIRONE
MONDO:0014284,short-rib thoracic dysplasia 10 with or without polydactyly
rxcui:29998,OCRIPLASMIN
ncit:C147521,CET KRAS ANTISENSE OLIGONUCLEOTIDE AZD4785
HGNC:24768,PNPLA7
FB:FBgn0027509,Tbcd
HP:0002457,Abnormal head movements
HGNC:5039,HNRNPF
HP:0032736,Focal emotional seizure with anger
HP:0001268,Mental deterioration
HP:0032656,Febrile status epilepticus
MGI:3793729,Atp7a<sup>Mo-vbr</sup>/Y  [background:] Not Specified
rxcui:2187,CEFOTETAN
ncit:C1178,TILARGININE
iuphar.ligand:482,HEAT (BE2254)
HGNC:32685,ARMS2
ncit:C84238,VELUSETRAG
HGNC:9462,PRPS1
MGI:5512911,Tpp1<sup>m1J</sup>/Tpp1<sup>m1J</sup>  [background:] STOCK Tpp1<sup>m1J</sup>/GrsrJ
ncit:C174857,ELECLAZINE
MONDO:0017399,"frontotemporal dementia, right temporal atrophy variant"
HP:0002072,Chorea
ncit:C28696,RECOMBINANT 70-KD HEAT-SHOCK PROTEIN
HGNC:4593,GRM1
HGNC:3602,FBLN5
HGNC:20080,USP45
HGNC:28128,TMEM107
GO:0045472,response to ether
MGI:3829004,Fa2h<sup>tm1Meck</sup>/Fa2h<sup>tm1Meck</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6N
MGI:107186,Cct2
chembl:CHEMBL541265,SALVIANOLIC ACID B
ncit:C163672,METHIDATHION
chembl:CHEMBL586135,CHEMBL:CHEMBL586135
HP:0012378,Fatigue
rxcui:91251,CIMETIDINE HYDROCHLORIDE
MONDO:0023076,eosinophilic pustular folliculitis
ncit:C74073,PI3K INHIBITOR BGT226
MGI:1928386,Rassf1
chembl:CHEMBL200102,PU-H71
ncit:C174620,ICENTICAFTOR
MGI:5505784,a/a Rab27a<sup>ash</sup>/Rab27a<sup>ash</sup>  [background:] involves: C3H/HeSnJ * C57BL/6J
rxcui:135775,ZOLMITRIPTAN
iuphar.ligand:6164,5-OXO-ODE
chembl:CHEMBL2181039,CHEMBL:CHEMBL2181039
rxcui:6718,MELPHALAN
iuphar.ligand:8011,KU-0060648
HGNC:13920,GPANK1
CHEBI:32600,tetracene
HGNC:30791,UBIAD1
drugbank:DB12795,CMX-2043
rxcui:3403,DIGITOXIN
rxcui:1299922,DOCETAXEL ANHYDROUS
HGNC:4983,HMGB1
chembl:CHEMBL1081326,CHEMBL:CHEMBL1081326
HGNC:20239,FNDC4
HGNC:12499,UBE4A
HGNC:28533,SLC25A41
HGNC:2769,DENR
HP:0000338,Hypomimic face
rxcui:1598,DICUMAROL
iuphar.ligand:12428,PARTHENOLIDE
chembl:CHEMBL199592,CHEMBL:CHEMBL199592
RGD:620218,Creb1
chembl:CHEMBL74913,CHEMBL:CHEMBL74913
rxcui:235482,HYDROCORTISONE SODIUM PHOSPHATE
MGI:5569760,Tg(Prnp-MAPT)7Vle/0  [background:] involves: C57BL/6 * SJL
chembl:CHEMBL1556914,METHYL 7-DESHYDROXYPYROGALLIN-4-CARBOXYLATE
CHEBI:9215,spectinomycin
drugbank:DB15411,ABP-700
rxcui:196239,RALTITREXED
HGNC:47,ABCB6
CHEBI:46245,coenzyme Q10
HGNC:11269,SPRY1
MP:0012468,decreased striatum size
MGI:103248,Phc1
HGNC:3094,DYRK3
HP:0100034,Motor tics
ZFIN:ZDB-GENE-021115-4,cdon
HP:0032731,Focal aware hyperkinetic seizure
HGNC:1918,CHD3
HP:0002075,Dysdiadochokinesis
HP:0031882,Agyria
rxcui:1364347,PONATINIB
chembl:CHEMBL2074871,PHENETHYL ISOCYANATE
rxcui:235554,METHACYCLINE HYDROCHLORIDE
HP:0000613,Photophobia
MONDO:0002679,cerebral infarction
chembl:CHEMBL525888,CHEMBL:CHEMBL525888
chembl:CHEMBL589258,CHEMBL:CHEMBL589258
CHEBI:52289,wortmannin
HGNC:9202,POMT1
chembl:CHEMBL533602,CHEMBL:CHEMBL533602
chembl:CHEMBL324053,CHEMBL:CHEMBL324053
chembl:CHEMBL603024,CHEMBL:CHEMBL603024
chembl:CHEMBL135561,CHEMBL:CHEMBL135561
chembl:CHEMBL3545172,CNV2197944
MONDO:0010726,Rett syndrome
rxcui:17698,AMINEPTIN
iuphar.ligand:1568,JMV2004
rxcui:2049549,PLAZOMICIN
CHEBI:132124,"1,4-benzoquinones"
MONDO:0023180,fragile X syndrome type 3
drugbank:DB12201,PF-03654746
GO:0006810,transport
UBERON:0002100,trunk
MGI:2664356,Col5a2<sup>tm1Rmz</sup>/Col5a2<sup>tm1Rmz</sup>  [background:] either: (involves: 129S4/SvJae * 129T2/SvEms) or (involves: 129S4/SvJae * C57BL/6)
HP:0032689,Focal cognitive seizure with dissociation
chembl:CHEMBL590672,CHEMBL:CHEMBL590672
chembl:CHEMBL590674,CHEMBL:CHEMBL590674
drugbank:DB11412,FENTHION
HP:0011145,Symptomatic seizures
TS:22,
wikidata:Q2869808,EMTRICITABINE/TENOFOVIR/EFAVIRENZ
chembl:CHEMBL4297380,VALNIVUDINE HYDROCHLORIDE
HP:0005109,Abnormality of the Achilles tendon
iuphar.ligand:6079,CV-3988
MP:0030632,increased urine creatine level
HP:0200020,Corneal erosion
ncit:C66017,LINTITRIPT
CHEBI:27690,acetazolamide
MONDO:0014776,spinocerebellar ataxia type 42
iuphar.ligand:5681,GDC-0879
rxcui:282416,THIOPENTAL SODIUM
drugbank:DB04302,"4-HYDROXY-3,5-DIMETHYL-5-(2-METHYL-BUTA-1,3-DIENYL)-5H-THIOPHEN-2-ONE"
iuphar.ligand:771,CCL2
ncit:C162341,BERBAMINE
HGNC:11233,SPAST
Reactome:R-HSA-9865881,Complex III assembly
SGD:S000006356,URN1
rxcui:1314370,NARASIN
iuphar.ligand:8342,EUROPIUM-LABELLED R3(B1-22R)
chembl:CHEMBL1390716,CHEMBL:CHEMBL1390716
chembl:CHEMBL1513392,CHEMBL:CHEMBL1513392
GO:0015232,heme transmembrane transporter activity
MONDO:0006669,bacterial endocarditis
HGNC:29248,KIAA1328
UPHENO:0067139,arrested animal organ development in corpus callosum
MONDO:0100447,ATF6-related retinopathy
drugbank:DB12064,BMS-777607
iuphar.ligand:1238,(S)-&ALPHA;-METHYLHISTAMINE
rxcui:1430438,AFATINIB
OBA:2001001,age of onset of asthma
UBERON:0001965,substantia nigra pars compacta
chembl:CHEMBL4297962,GNKG-168
MGI:5516455,Tg(Prnp-ATXN3*148Q)148.19Olri/0  [background:] involves: C57BL/6N
HP:0025068,Incomitant strabismus
MONDO:0010626,hyper-IgM syndrome type 1
ncit:C2152,PHOSPHATIDYLINOSITIDE 3-KINASE INHIBITOR
CHEBI:16831,3-hydroxy-3-methylglutaric acid
MP:0000812,abnormal dentate gyrus morphology
UPHENO:0081573,abnormal cerebellar vermis morphology
HP:0100576,Amaurosis fugax
rxcui:7417,NIFEDIPINE
chembl:CHEMBL601351,CHEMBL:CHEMBL601351
HP:0003409,Distal sensory impairment of all modalities
EMAPA:18234,extrinsic ocular muscle
HGNC:12496,UBE3A
CHEBI:29036,copper(2+)
HP:0031843,Bradyphrenia
HP:0003487,Babinski sign
rxcui:2372,CHLORMETHIAZOLE
Reactome:R-GGA-390651,Dopamine receptors
GO:0031416,NatB complex
iuphar.ligand:674,FR173657
ncit:C62600,DAVAMOTECAN PEGADEXAMER
CHEBI:2038,5-azacytidine
UPHENO:0088214,abnormal cochlear outer hair cell electromotile response
ncit:C1519,ROQUINIMEX
HP:0030203,Unfavorable response of muscle weakness to acetylcholine esterase inhibitors
MGI:5427703,Wnk4<sup>tm1Pfi</sup>/Wnk4<sup>tm1Pfi</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6J
rxcui:1099914,CITICOLINE SODIUM
chembl:CHEMBL534084,CHEMBL:CHEMBL534084
chembl:CHEMBL1522900,MENTHOFURAN
iuphar.ligand:1801,"[ILE5,TRP23]PTHRP-(4-36) (HUMAN)"
rxcui:221078,CITALOPRAM HYDROBROMIDE
HGNC:16844,CREB5
drugbank:DB07159,TAMATINIB
MGI:6771475,Clp1<sup>em1Slac</sup>/Clp1<sup>em1Slac</sup>  [background:] C57BL/6J-Clp1<sup>em1Slac</sup>/J
rxcui:235398,BENOXINATE HYDROCHLORIDE
ncit:C2714,ANTI-EGFR MONOCLONAL ANTIBODY EMD 55900
ncit:C155294,AUTOLOGOUS CD30CAR-CD28-CD3ZETA-EXPRESSING T-LYMPHOCYTES
rxcui:2970,CYCLANDELATE
ncit:C29091,HEPATITIS B VACCINE
HP:0012606,Renal sodium wasting
ncit:C84119,PROROXAN
rxcui:1364478,LOMITAPIDE MESYLATE
MGI:102556,Tbx4
iuphar.ligand:474,MRS1523
Xenbase:XB-GENE-5960546,cyp2a6.6
GO:0000340,RNA 7-methylguanosine cap binding
iuphar.ligand:12661,BI-847325
MONDO:0006637,acute kidney tubular necrosis
HGNC:6880,MAPK7
GO:0051780,behavioral response to nutrient
iuphar.ligand:4301,RY024
MONDO:0008138,syndromic orbital border hypoplasia
HGNC:1084,BNIP3
iuphar.ligand:5565,CID2440433
iuphar.ligand:10524,MW150
chembl:CHEMBL1516007,"8,2'-DIMETHOXYFLAVONE"
HGNC:18180,CALML5
ncit:C78755,BETAMETHASONE BUTYRATE PROPIONATE
rxcui:343048,TREPROSTINIL
ncit:C28269,PHYTOCHEMICAL
rxcui:2268306,ENFORTUMAB VEDOTIN-EJFV
HGNC:29504,ZACN
MP:0008337,increased thyrotroph cell number
HP:0020043,Vertical incomitant strabismus
rxcui:10391,TETRACAINE
HP:0032682,Focal aware non-motor seizure
HGNC:10940,SLC1A2
HGNC:11700,TDG
UPHENO:0001056,increased size of the telencephalic ventricle
ncit:C76531,ADINAZOLAM
UBERON:0002165,endocardium
rxcui:4556,FRAMYCETIN
HP:0001760,Abnormal foot morphology
drugbank:DB12231,TEMEFOS
ncit:C175602,IDH1/IDH2 DUAL INHIBITOR HMPL-306
rxcui:2597,CLOMIPRAMINE
iuphar.ligand:716,NPS 2143
rxcui:38377,TOLFENAMIC ACID
chembl:CHEMBL1814509,CHEMBL:CHEMBL1814509
iuphar.ligand:9399,MPI-0479605
ncit:C75190,MURAGLITAZAR
chembl:CHEMBL1256663,CHEMBL:CHEMBL1256663
MONDO:0010983,dystonia 9
iuphar.ligand:4896,C-TYPE NATRIURETIC PEPTIDE
CL:0000129,microglial cell
rxcui:1921217,BRIGATINIB
HP:0000158,Macroglossia
NCBIGene:526221,DRD5
UBERON:0007709,superior cerebellar peduncle of pons
chembl:CHEMBL3545354,CAFUSERTIB
ncit:C83923,NEBICAPONE
MONDO:0016163,autosomal dominant cerebellar ataxia type II
rxcui:2193,CEFTRIAXONE
ncit:C1415,VESNARINONE
iuphar.ligand:12623,CFT1946
rxcui:4888,GLUTARAL
rxcui:203130,NORTRIPTYLINE HYDROCHLORIDE
MONDO:0000335,parenchymatous neurosyphilis
MGI:6098717,Crtc1<sup>Gt(XK522)Byg</sup>/Crtc1<sup>Gt(XK522)Byg</sup>  [background:] B6N.129P2-Crtc1<sup>Gt(XK522)Byg</sup>
HGNC:3700,FH
iuphar.ligand:7760,GXTX-1E
MGI:5448853,Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-TARDBP*)4Vle/0  [background:] involves: C3H/HeJ * C57BL/6J
chembl:CHEMBL1256660,CHEMBL:CHEMBL1256660
HGNC:6106,FOXP3
chembl:CHEMBL591137,CHEMBL:CHEMBL591137
NCBIGene:100855975,NDUFB3
chembl:CHEMBL601385,CHEMBL:CHEMBL601385
rxcui:235559,"NITROFURANTOIN, MACROCRYSTALS"
chembl:CHEMBL493863,CHEMBL:CHEMBL493863
HGNC:6815,MAGOH
iuphar.ligand:192,SB 228357
chembl:CHEMBL253989,CHEMBL:CHEMBL253989
rxcui:142433,DOXORUBICIN HYDROCHLORIDE
HGNC:20567,NME6
chembl:CHEMBL1237255,CHEMBL:CHEMBL1237255
HGNC:19218,PLCZ1
GO:0006882,intracellular zinc ion homeostasis
ncit:C118285,DENIFANSTAT
HP:0040082,Happy demeanor
ncit:C65230,AMLODIPINE MALEATE
UBERON:0034708,cerebellum marginal layer
iuphar.ligand:10346,MK-571
chembl:CHEMBL500996,METHOCTRAMINE HYDROCHLORIDE
MGI:3714859,Cyp3a41b
HGNC:2375,MED17
MONDO:0100435,Schwartz-Jampel syndrome type 1
CLINVAR:143560,NM_001110792.2(MECP2):c.434G>T (p.Arg145Leu)
CHEBI:28368,novobiocin
UBERON:0002098,apex of heart
HGNC:565,AP2S1
CHEBI:16410,pyridoxamine
GO:0000922,spindle pole
chembl:CHEMBL590706,CHEMBL:CHEMBL590706
chembl:CHEMBL1707907,CHEMBL:CHEMBL1707907
rxcui:2053281,IOBENGUANE I-131
drugbank:DB04228,DIHYDROXYPHENYLGLYCINE
HGNC:9876,RASGRF2
chembl:CHEMBL3545298,AZD-6918
iuphar.ligand:9513,MLKL COMPOUND 1
HGNC:18399,DHRSX
rxcui:2045371,CANNABIDIOL
iuphar.ligand:10572,POMC (141-162)
HGNC:8574,PAFAH1B1
HGNC:2595,CYP1A1
chembl:CHEMBL1333512,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE"
chembl:CHEMBL1458880,CADMIUM DICHLORIDE
FB:FBgn0086782,amn
HGNC:3449,ERN1
chembl:CHEMBL230156,(2-NITROVINYL)BENZENE
chembl:CHEMBL600773,CHEMBL:CHEMBL600773
MONDO:0054737,Fraser syndrome 1
iuphar.ligand:8563,ARI-3099
GO:0045184,establishment of protein localization
ncit:C65572,ETICLOPRIDE
HGNC:15453,ACBD3
chembl:CHEMBL55860,OCTADECYLAMINE
chembl:CHEMBL1410398,PIMARIC ACID
ncit:C174693,ABICIPAR PEGOL
ncit:C66589,TESOFENSINE
chembl:CHEMBL592344,CHEMBL:CHEMBL592344
HP:0007867,Restrictive partial external ophthalmoplegia
rxcui:2563966,ODEVIXIBAT
chembl:CHEMBL1552997,RHODOMYRTOXIN B
chembl:CHEMBL2358130,DIFLUCORTOLONE 21-VALERATE
MONDO:0010364,X-linked intellectual disability-retinitis pigmentosa syndrome
MONDO:0006186,duodenal adenocarcinoma
HP:0007207,Photosensitive tonic-clonic seizure
NCBIGene:100847700,LOC100847700
MGI:1915472,Tubb4b
HGNC:11431,STX16
HGNC:12621,USP22
HP:0000456,Bifid nasal tip
chembl:CHEMBL405317,CHEMBL:CHEMBL405317
rxcui:1358845,2-MERCAPTOBENZOTHIAZOLE
MGI:5467984,Atxn2<sup>tm2.1Aub</sup>/Atxn2<sup>tm2.1Aub</sup>  [background:] B6.129S2-Atxn2<sup>tm2.1Aub</sup>
MGI:6107696,Thap1<sup>tm1.1Meeh</sup>/Thap1<sup>+</sup>  [background:] involves: 129S/SvEv * C3H * C57BL/6
MGI:3843615,Hnf1a<sup>tm2Mya</sup>/Hnf1a<sup>tm2Mya</sup>  [background:] involves: 129S2/SvPas
drugbank:DB05165,LY2275796
iuphar.ligand:6937,IPEROXO
MONDO:0017732,"alpha-mannosidosis, infantile form"
iuphar.ligand:8330,A(10-24)INSL3
MONDO:0011829,"coenzyme Q10 deficiency, primary, 1"
rxcui:7515,NORETHYNODREL
MONDO:0024614,neurotic depression
rxcui:104592,CYPROHEPTADINE HYDROCHLORIDE
HP:0003700,Generalized amyotrophy
GO:0031625,ubiquitin protein ligase binding
rxcui:20352,CARVEDILOL
ncit:C175196,PRADEMAGENE ZAMIKERACEL
iuphar.ligand:12557,GSK2798745
HP:0007099,Chiari type I malformation
MGI:5755137,Dp(7Herc2-Mkrn3)1Taku/0  [background:] B6J.129S7-Dp(7Herc2-Mkrn3)1Taku
HP:0006915,Inability to walk by childhood/adolescence
HGNC:8808,PDHB
CHEBI:100246,norfloxacin
HGNC:18421,AGO3
RGD:1305944,Mrm2
iuphar.ligand:3278,[11C]XANOMELINE
MGI:5491051,Mecp2<sup>tm1.1Bird</sup>/Y  [background:] involves: 129P2/OlaHsd * FVB
chembl:CHEMBL19032,PENTAMETHYLQUERCETIN
CHEBI:46848,N-arylpiperazine
ncit:C77013,FLUROGESTONE ACETATE
HGNC:2255,CORO2A
HP:0002172,Postural instability
iuphar.ligand:12647,ACT-709478
rxcui:40001,ZOPICLONE
MP:0030635,increased taurine level
rxcui:10110,STREPTOMYCIN SULFATE
rxcui:267417,CEFSULODIN SODIUM
iuphar.ligand:5451,N-ACETYLSEROTONIN
rxcui:4124,ETHINYL ESTRADIOL
drugbank:DB17484,BI-836880
chembl:CHEMBL73933,4'-HYDROXY-FLAVANONE
rxcui:142431,CLOMIPHENE CITRATE
chembl:CHEMBL1200874,"TOLBUTAMIDE SODIUM, STERILE"
HP:5200029,Social disinhibition
HGNC:6874,MAPK12
rxcui:11203,VINCRISTINE SULFATE
HP:0025613,Focal emotional seizure
HGNC:25593,PACC1
HGNC:26153,INTS3
chembl:CHEMBL151146,CHEMBL:CHEMBL151146
rxcui:2180325,DAROLUTAMIDE
HGNC:7604,MYO5C
drugbank:DB13875,HARMALINE
MONDO:0006056,squamous cell breast carcinoma
chembl:CHEMBL538921,SAPONARIN
rxcui:1788871,ICARIIN
HGNC:24615,EEF2K
chembl:CHEMBL3545069,PELAREOREP
MONDO:0010548,"spinocerebellar ataxia, X-linked 2"
iuphar.ligand:11833,COMPOUND 21K [PMID: 34985886]
HP:0002857,Genu valgum
rxcui:6058,ISOSORBIDE DINITRATE
HGNC:3401,EPHX1
HP:0001320,Cerebellar vermis hypoplasia
HGNC:11255,SPP1
rxcui:60223,ADAPALENE
UPHENO:0079838,abnormal impulsive behavior
GO:0003676,nucleic acid binding
HGNC:6876,MAPK14
HP:0009928,Thick nasal alae
rxcui:4182,ETRETINATE
HP:0005462,Calcification of falx cerebri
chembl:CHEMBL1358735,"12-HYDROXY-4,4-BISNOR-4,8,11,13-PODOCARPATETRAEN-3-ONE"
MGI:5447056,Kat6a<sup>tm1Avo</sup>/Kat6a<sup>+</sup> Tbx1<sup>tm1Bld</sup>/Tbx1<sup>+</sup>  [background:] involves: 129 * 129S7/SvEvBrd * BALB/c * C57BL/6
MONDO:0005328,eye disorder
chembl:CHEMBL40583,3-METHYLCHOLANTHRENE
HGNC:4402,GNG10
chembl:CHEMBL604664,CHEMBL:CHEMBL604664
rxcui:25037,CEFDINIR
drugbank:DB15435,BMS-986158
iuphar.ligand:2045,[111IN]DOTA-NOC
iuphar.ligand:481,NS-49
rxcui:1364586,ISOFLUPREDONE ACETATE
HGNC:11139,SNCAIP
ncit:C902,TRIAZENE COMPOUND
iuphar.ligand:8329,A(9-26)INSL3
MGI:3700665,Slc40a1<sup>ffe</sup>/Slc40a1<sup>+</sup>  [background:] either: (involves: 129X1/SvJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6J)
ncit:C47761,TOCAINIDE HYDROCHLORIDE
HGNC:7419,MT-CO1
HGNC:9086,PLP1
CHEBI:27902,tetracycline
MGI:3852389,Slc18a2<sup>tm1Mca</sup>/Slc18a2<sup>+</sup>  [background:] B6.129X1-Slc18a2<sup>tm1Mca</sup>
MONDO:0005797,HIV wasting syndrome
HGNC:992,BCL2L1
HP:0000463,Anteverted nares
drugbank:DB12174,CUDC-101
iuphar.ligand:11239,NSC212069
iuphar.ligand:8331,A(C10/15S)INSL3
rxcui:2367440,GOLOTIMOD
ncit:C99577,METIZOLINE
ncit:C78064,BUTINOLINE
MONDO:0021637,low grade glioma
chembl:CHEMBL1371413,"2,3-DIHYDROXY-4-METHOXY-4'-ETHOXYBENZOPHENONE"
MP:0014252,abnormal paired-pulse ratio
ncit:C163590,BENFURACARB
iuphar.ligand:4918,EPIREGULIN
chembl:CHEMBL1784521,CHEMBL:CHEMBL1784521
ncit:C29767,EXPECTORANT
HP:0000570,Abnormal saccadic eye movements
chembl:CHEMBL374632,CHEMBL:CHEMBL374632
chembl:CHEMBL602363,CHEMBL:CHEMBL602363
drugbank:DB12672,ICARITIN
rxcui:2353,CLORAZEPATE
chembl:CHEMBL372629,CHEMBL:CHEMBL372629
chembl:CHEMBL569460,SODIUM DIMETHYLCARBAMODITHIOATE
HP:0000924,Abnormality of the skeletal system
HGNC:20,AARS1
OBA:2001028,age of onset of migraine without aura
HGNC:11140,SNCB
MGI:3577344,inad/inad  [background:] C57BL/6-inad
HGNC:3775,FMR1
chembl:CHEMBL79261,DU 125530
MONDO:0018307,neurodegeneration with brain iron accumulation
HP:0006378,Osteolysis of patellae
MGI:103063,Stat1
MONDO:0030922,"intellectual disability, autosomal dominant 56"
HP:0008003,Jerky ocular pursuit movements
GO:0030431,sleep
iuphar.ligand:10908,BAY1125976
CHEBI:16335,adenosine
iuphar.ligand:8215,CCT244747
rxcui:4638,GALLAMINE
chembl:CHEMBL1565444,CHEMBL:CHEMBL1565444
CHEBI:58349,NADP(3-)
HP:0002061,Lower limb spasticity
MONDO:0012930,autosomal recessive severe congenital neutropenia due to G6PC3 deficiency
MP:0008128,abnormal brain internal capsule morphology
iuphar.ligand:4382,CCL18
HGNC:4083,GABRB3
CHEBI:16526,carbon dioxide
chembl:CHEMBL535307,CHEMBL:CHEMBL535307
rxcui:2048018,PEGFILGRASTIM-JMDB
HP:0008625,Severe sensorineural hearing impairment
rxcui:4780,OXYTETRACYCLINE HYDROCHLORIDE
ncit:C111906,LAPRITUXIMAB EMTANSINE
HGNC:11548,TAF7L
chembl:CHEMBL600572,CHEMBL:CHEMBL600572
HGNC:10430,RPS6KA1
HGNC:9536,PSMA7
MGI:2175043,Gja8<sup>No2</sup>/Gja8<sup>No2</sup>  [background:] involves: 101 * C3H
HP:0000738,Hallucinations
GO:0044753,amphisome
chembl:CHEMBL421088,CHEMBL:CHEMBL421088
HP:0011153,Focal motor seizure
chembl:CHEMBL2107771,RALFINAMIDE
HGNC:21591,TAFA4
rxcui:1363267,CABOZANTINIB S-MALATE
HGNC:26404,NADK2
GO:0099129,cochlear outer hair cell electromotile response
rxcui:31805,NILUTAMIDE
rxcui:1593128,MENINGOCOCCAL GROUP B VACCINE
HP:0003798,Nemaline bodies
HGNC:11592,TBX1
iuphar.ligand:11163,S312
HGNC:2383,CRX
drugbank:DB12558,AEE-788
iuphar.ligand:7652,UNC9994
HGNC:2555,CUL4B
HGNC:15679,CTTNBP2
ncit:C79926,ARASERTACONAZOLE
chembl:CHEMBL400777,ROBUSTIC ACID
ncit:C83585,CAPTAMINE
MONDO:0013785,"intellectual disability, autosomal recessive 34"
chembl:CHEMBL1275969,ALPHA-THUJAPLICIN
HP:0002419,Molar tooth sign on MRI
MP:0001004,abnormal retina photoreceptor morphology
rxcui:81965,BETAINE HYDROCHLORIDE
wikidata:Q48566821,SULFAMETHOXAZOLE / TRIMETHOPRIM
HGNC:2567,OFD1
MP:0003463,abnormal single cell response
rxcui:2643048,QUIZARTINIB
HP:0000915,Pectus excavatum of inferior sternum
HGNC:12640,UVRAG
HP:0000748,Inappropriate laughter
HGNC:3024,DRD3
HGNC:18222,RBFOX1
ncit:C72743,DITHIAZANINE
rxcui:81864,ALITRETINOIN
HP:0032709,Focal aware cognitive seizure with dysgraphia/agraphia
HP:0031725,Hypophoria
ZFIN:ZDB-GENE-040426-859,sepsecs
HP:0002521,Hypsarrhythmia
chembl:CHEMBL135191,TIFENAZOXIDE
HGNC:14432,TMEM237
HP:0032705,Focal aware cognitive seizure with forced thinking
UPHENO:0053014,decreased qualitatively vestibular reflex
HGNC:12862,ZFP36
UPHENO:0078456,absent visual perception
rxcui:2607,CLORAZEPATE DIPOTASSIUM
HGNC:9585,PTCH1
CHEBI:17489,"3',5'-cyclic AMP"
rxcui:1547545,PEMBROLIZUMAB
HGNC:3076,DUSP9
MP:0001891,hydrocephaly
MONDO:0010651,Menkes disease
rxcui:17300,ALFUZOSIN
HP:0004934,Vascular calcification
MONDO:0011513,"Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology"
GO:0004396,hexokinase activity
GO:0003014,renal system process
HP:0006397,Lateral displacement of patellae
MONDO:0009086,deafness-small bowel diverticulosis-neuropathy syndrome
UBERON:0002285,telencephalic ventricle
ncit:C75285,TELENZEPINE
rxcui:3154,DEMECLOCYCLINE
HP:0002374,Diminished movement
chembl:CHEMBL388757,N6-BENZYLADENOSINE
HGNC:4776,H3C2
HGNC:8874,PFKFB3
MP:0003073,abnormal metacarpal bone morphology
rxcui:142143,VILOXAZINE HYDROCHLORIDE
HGNC:5289,HTR1D
GO:2000304,positive regulation of ceramide biosynthetic process
rxcui:1589,BIPERIDEN
drugbank:DB05552,TG100-115
chembl:CHEMBL14282,4-NITROANILINE
HP:0008619,Bilateral sensorineural hearing impairment
MONDO:0036870,lymphatic vessel neoplasm
MGI:1929095,Uso1
rxcui:24855,FENOVERINE
rxcui:11256,VITAMIN E
iuphar.ligand:12082,TUVUSERTIB
MGI:2441787,Washc4
rxcui:19836,BUFLOMEDIL
ncit:C106262,TELISOTUZUMAB
rxcui:1944734,PITAVASTATIN SODIUM
chembl:CHEMBL1416084,PROPARGITE
HP:0007647,Congenital extraocular muscle anomaly
HP:0032912,Focal aware manual automatism seizure
CLINVAR:143589,NM_001110792.2(MECP2):c.507C>G (p.Phe169Leu)
MONDO:0021178,injury
drugbank:DB06089,ICA-105665
ncit:C64776,NAVITOCLAX
rxcui:2058825,CEMIPLIMAB-RWLC
MGI:3826274,Gdf3<sup>tm1Zuk</sup>/Gdf3<sup>tm1Zuk</sup>  [background:] involves: 129S7/SvEvBrd * C57BL/6J
MGI:106612,Myo1c
iuphar.ligand:957,(+)-UH232
HGNC:9788,RAB7A
HGNC:28971,SPIDR
iuphar.ligand:10143,SR1001
chembl:CHEMBL1725250,OXAPIUM
HGNC:23483,DOCK11
rxcui:8351,PIRACETAM
MGI:1344313,Zeb1
chembl:CHEMBL1221911,LACTIMIDOMYCIN
rxcui:1546373,IPRATROPIUM CATION
rxcui:263034,PANITUMUMAB
HP:0030188,Tremor by anatomical site
ncit:C2313,VACCINIA VACCINE
UPHENO:0012541,decreased size of the anatomical entity in the independent continuant
rxcui:4055,ERYTHROMYCIN ESTOLATE
iuphar.ligand:12151,APD668
HP:0032664,Adversive status epilepticus
MGI:2671488,nur22
HGNC:9751,QARS1
MONDO:0006465,thyroid gland oncocytic follicular carcinoma
FB:FBgn0039405,PIG-P
HP:0001159,Syndactyly
MONDO:0000508,syndromic intellectual disability
HGNC:10590,SCN3A
MONDO:0017161,frontotemporal dementia with motor neuron disease
HGNC:4390,GNAQ
ncit:C152868,VERUBECESTAT
chembl:CHEMBL4650989,TALETRECTINIB
rxcui:26879,HEXYLCAINE
drugbank:DB13706,EOSIN
HP:0002355,Difficulty walking
HP:0032665,Repeated focal motor seizures
MONDO:0032791,Coffin-Siris syndrome 10
MGI:4418196,Trpv1<sup>tm1Jul</sup>/Trpv1<sup>tm1Jul</sup>  [background:] B6.129X1-Trpv1<sup>tm1Jul</sup>
iuphar.ligand:12937,PCC0208017
ncit:C101791,OLMUTINIB
MP:0008266,absent hippocampus CA2 region
ncit:C2148,PROTEIN KINASE A INHIBITOR
rxcui:2632852,TROFINETIDE
chembl:CHEMBL1255835,DIAMIDE
chembl:CHEMBL534214,CHEMBL:CHEMBL534214
ncit:C1146,LONIDAMINE
rxcui:1368873,TROPOLONE
WB:WBGene00020932,dhod-1
HGNC:3797,FOSB
HGNC:5407,IFIT1
MONDO:0003233,essential tremor
chembl:CHEMBL528791,CHEMBL:CHEMBL528791
iuphar.ligand:6389,SF-22
chembl:CHEMBL260342,CHEMBL:CHEMBL260342
rxcui:35623,RILUZOLE
HGNC:4053,ISG15
rxcui:6218,LACTULOSE
ZFIN:ZDB-GENE-040426-1762,ndufb2
WB:WBGene00009027,F21G4.6
chembl:CHEMBL338474,HELENALIN
iuphar.ligand:5923,ALOISINE
HGNC:11580,TBCC
chembl:CHEMBL3545053,EMD-1204831
iuphar.ligand:3302,L741742
chembl:CHEMBL485053,LEUCETTAMINE B
HGNC:9314,PPP3CA
chembl:CHEMBL1863429,CYAZOFAMID
iuphar.ligand:4851,[125I]GDNF (RAT)
iuphar.ligand:5954,CHK2 INHIBITOR II
MGI:88385,Cfh
chembl:CHEMBL602312,CHEMBL:CHEMBL602312
CHEBI:17026,progesterone
CHEBI:47985,enol ether
ncit:C28239,COBALT CO-60
iuphar.ligand:3461,PHTPP
ncit:C593,RECOMBINANT INTERLEUKIN
chembl:CHEMBL596631,CHEMBL:CHEMBL596631
drugbank:DB12326,ANTROQUINONOL
iuphar.ligand:433,VISNAGIN
drugbank:DB04705,25-HYDROXYCHOLESTEROL
MONDO:0957197,"diffuse glioma, H3 G34 mutant"
HGNC:33531,NME1-NME2
iuphar.ligand:8941,COMPOUND 4 [PMID: 24432870]
MONDO:0010529,X-linked spinocerebellar ataxia type 3
CHEBI:15379,dioxygen
chembl:CHEMBL577862,CHEMBL:CHEMBL577862
rxcui:8048,PERGOLIDE MESYLATE
rxcui:13982,TIRATRICOL
drugbank:DB14768,PF-06459988
rxcui:1545976,CODEINE ANHYDROUS
chembl:CHEMBL481160,CHEMBL:CHEMBL481160
MP:0010053,decreased grip strength
MONDO:0001751,cholestasis
chembl:CHEMBL263664,CHEMBL:CHEMBL263664
HGNC:9498,PSAP
FB:FBgn0000447,Dhod
HGNC:8157,SIGMAR1
HP:0025402,Square-wave jerks
HGNC:6512,LARS1
MONDO:0020065,combined dystonia
MP:0001389,abnormal eye movement
chembl:CHEMBL2229892,FENCHLORAZOL-ETHYL
rxcui:2370147,SELPERCATINIB
chembl:CHEMBL1396626,DICHLOFENTHION
iuphar.ligand:7710,AZD5582
HP:0034341,Pseudoautosomal recessive inheritance
MONDO:0014626,spinocerebellar ataxia type 41
iuphar.ligand:8898,FERB 033
iuphar.ligand:9290,ELEZANUMAB
HGNC:12799,WWOX
ncit:C73244,RIMONABANT
MGI:4940059,Tg(Prnp-ATXN3*79Q)#Hlw/0  [background:] FVB/N-Tg(Prnp-ATXN3*79Q)#Hlw
MONDO:0010578,deafness dystonia syndrome
chembl:CHEMBL1520837,CHEMBL:CHEMBL1520837
ncit:C38697,SONTUZUMAB
ncit:C28788,8-AZAGUANINE
MONDO:0016318,progressive multifocal leukoencephalopathy
HGNC:9119,PMPCB
GO:0034451,centriolar satellite
HP:0002415,Leukodystrophy
chembl:CHEMBL4583691,LXH254
HGNC:21216,BLTP3A
chembl:CHEMBL422872,AZD-4769
chembl:CHEMBL466465,CHEMBL:CHEMBL466465
HP:0000431,Wide nasal bridge
rxcui:2105628,LAROTRECTINIB
ncit:C1001,RINTATOLIMOD
MONDO:0000336,meningovascular neurosyphilis
chembl:CHEMBL97858,CHEMBL:CHEMBL97858
MGI:109609,Faah
MP:0000807,abnormal hippocampus morphology
MONDO:0024458,disorder of visual system
chembl:CHEMBL563553,MULBERROFURAN H
ncit:C174831,PRASINEZUMAB
HP:0100785,Insomnia
HP:0000556,Retinal dystrophy
chembl:CHEMBL1094677,AESCULIOSIDE IVA
rxcui:11404,KETOTIFEN FUMARATE
HGNC:7794,NFKB1
rxcui:2105,CARMUSTINE
MP:0005332,abnormal amino acid level
HP:0011347,Abnormality of ocular abduction
iuphar.ligand:287,(-)-YM796
rxcui:32894,PARAMETHADIONE
MONDO:0006190,endolymphatic sac tumor
chembl:CHEMBL589245,CHEMBL:CHEMBL589245
chembl:CHEMBL581240,CHEMBL:CHEMBL581240
MONDO:0006810,intracranial hypertension
chembl:CHEMBL55659,ANTHRAQUINONE
Reactome:R-DME-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL578896,CHEMBL:CHEMBL578896
CL:4023111,cerebral cortex pyramidal neuron
rxcui:1918231,NIRAPARIB
ncit:C152632,TILSOTOLIMOD
MONDO:0005525,T-cell leukemia
chembl:CHEMBL1762594,CHEMBL:CHEMBL1762594
MONDO:0009152,"ectopia lentis 2, isolated, autosomal recessive"
HGNC:9283,PPP1CC
ncit:C167009,BASMISANIL
drugbank:DB17197,AMG-900
chembl:CHEMBL2062868,CHEMBL:CHEMBL2062868
HGNC:7995,NRDC
HGNC:18268,LMBR1L
ncit:C587,RECOMBINANT INTERLEUKIN-2
MONDO:0004169,premenstrual tension
HGNC:17996,NAGS
HGNC:24164,TPPP
rxcui:25916,GLUTAMIC ACID
MP:0008286,abnormal hippocampus molecular cell layer
ncit:C95717,LIPOSOMAL SN-38
HP:0007750,Hypoplasia of the fovea
rxcui:4500,FLURANDRENOLIDE
rxcui:33272,PHENDIMETRAZINE
chembl:CHEMBL238188,OSAJIN
ncit:C78859,SERIBANTUMAB
MGI:102706,Fdft1
chembl:CHEMBL1782604,CONICASTEROL B
HP:0100555,Asymmetric growth
CHEBI:35337,central nervous system stimulant
ncit:C186402,VALILTRAMIPROSATE
rxcui:1311566,SALINOMYCIN
HGNC:19997,GPR141
HGNC:25783,NAA25
RO:0002577,system
iuphar.ligand:8152,RKI-1447
chembl:CHEMBL530609,CHEMBL:CHEMBL530609
HP:0000802,Impotence
chembl:CHEMBL4298005,MITIGLINIDE CALCIUM DIHYDRATE
HGNC:6396,KPNA3
HP:0031295,Left atrial enlargement
iuphar.ligand:8015,SB 216763
chembl:CHEMBL464658,GITOXIGENIN
chembl:CHEMBL375781,NEOCUPROINE
HP:0003128,Lactic acidosis
chembl:CHEMBL508649,5-METHOXYCANTHINONE
MGI:3510652,Psen1<sup>tm1Lpr</sup>/Psen1<sup>tm1Lpr</sup> Tg(Thy1-APP<sup>SL</sup>)28Lpr/0  [background:] either: 129/Sv or (involves: 129/Sv * C57BL/6)
MGI:2668431,Aoc2
MONDO:0006382,poorly differentiated thyroid gland carcinoma
chembl:CHEMBL2047666,CHEMBL:CHEMBL2047666
chembl:CHEMBL1160008,IODOPHTHALEIN
HGNC:2265,COX4I1
HP:0032711,Focal aware clonic seizure
rxcui:91121,METHDILAZINE HYDROCHLORIDE
GO:0032355,response to estradiol
HP:0010838,High nonceruloplasmin-bound serum copper
HGNC:25900,C1orf198
MGI:3841584,Dst<sup>dt-30J</sup>/Dst<sup>dt-30J</sup>  [background:] C57BL/6J-Dst<sup>dt-30J</sup>/J
UBERON:0002435,striatum
MONDO:0005355,coronary restenosis
chembl:CHEMBL600694,CHEMBL:CHEMBL600694
ncit:C81420,TARANABANT
EMAPA:35837,substantia nigra pars lateralis
chembl:CHEMBL581910,CHEMBL:CHEMBL581910
chembl:CHEMBL3544930,SC-80036
HP:0004372,Reduced consciousness/confusion
HP:0032690,Focal aware cognitive seizure with dyscalculia/acalculia
HGNC:4037,FYN
HGNC:7376,MSR1
CHEBI:39201,phenazines
chembl:CHEMBL1570199,CHEMBL:CHEMBL1570199
MONDO:0060758,"spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits"
HP:0000133,Gonadal dysgenesis
rxcui:1310469,DEHYDRATED ALCOHOL
iuphar.ligand:187,RS-102221
GO:0005622,intracellular anatomical structure
chembl:CHEMBL303958,CHEMBL:CHEMBL303958
MONDO:0010716,X-linked lethal multiple pterygium syndrome
ncit:C143004,SQUALAMINE
GO:0006601,creatine biosynthetic process
HP:0001511,Intrauterine growth retardation
iuphar.ligand:6577,CID16020046
rxcui:1876366,OCRELIZUMAB
HGNC:18423,DEPDC5
chembl:CHEMBL1549738,CHEMBL:CHEMBL1549738
rxcui:8770,PROPIOMAZINE
HP:0001604,Vocal cord paresis
ncit:C104008,FIMEPINOSTAT
rxcui:72610,TROGLITAZONE
ncit:C152303,SAROGLITAZAR
HGNC:12830,XRCC3
ncit:C77829,BUFOGENIN
GO:0004176,ATP-dependent peptidase activity
MONDO:0019942,distal arthrogryposis
wikidata:Q6804161,MEASLES VACCINE
rxcui:68091,DOLASETRON
HGNC:9300,PPP2CB
rxcui:2621548,MIRVETUXIMAB SORAVTANSINE
MGI:94926,Drd4
chembl:CHEMBL524407,CHEMBL:CHEMBL524407
HP:0032723,Focal aware motor seizure with dystonia
rxcui:1546168,PEGINTERFERON BETA-1A
CL:2000032,peripheral nervous system neuron
MONDO:0009217,Fanconi-like syndrome
ncit:C80766,BEMESETRON
rxcui:1294532,LEVOCABASTINE HYDROCHLORIDE
iuphar.ligand:955,(+)-S-14297
ncit:C129688,CSF1R INHIBITOR PLX73086
chembl:CHEMBL3545168,IMD-1041
rxcui:2264108,"FIBRINOGEN, HUMAN"
HP:0001531,Failure to thrive in infancy
HGNC:9089,PLRG1
HGNC:5958,IK
MGI:104562,Napb
HGNC:21075,TMEM200A
rxcui:1147220,VEMURAFENIB
MGI:3573789,Vps13a<sup>tm1Asan</sup>/Vps13a<sup>tm1Asan</sup>  [background:] involves: 129S/SvEv * C57BL/6J
chembl:CHEMBL469036,ENNIATIN B
MGI:103014,Il15
MONDO:0859340,"spinocerebellar ataxia 27B, late-onset"
chembl:CHEMBL527336,CHEMBL:CHEMBL527336
HGNC:28020,WDR86
rxcui:2362167,OPICAPONE
chembl:CHEMBL2109300,GSK933776
ncit:C274,ANTINEOPLASTIC AGENT
MGI:6423629,Stk39<sup>tm1Pawe</sup>/Stk39<sup>tm1Pawe</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6J
CHEBI:35560,"1,2,4-triazole"
chembl:CHEMBL1436860,DIMETHYL GAMBOGATE
chembl:CHEMBL333177,CHEMBL:CHEMBL333177
iuphar.ligand:8137,COMPOUND 8E [PMID: 24432909]
CHEBI:142677,triazinoindole
CHEBI:15765,L-dopa
HP:0002118,Abnormal cerebral ventricle morphology
CL:0000639,basophil cell of pars distalis of adenohypophysis
rxcui:66912,PAROMOMYCIN SULFATE
iuphar.ligand:3189,BPH-742
ncit:C166610,ERTEBEREL
ncit:C155322,BRAF INHIBITOR
HGNC:3806,FOXE1
CHEBI:47898,4'-epidoxorubicin
iuphar.ligand:9019,NAVOXIMOD
HP:0000712,Emotional lability
rxcui:30125,MODAFINIL
rxcui:7327,NERVE GROWTH FACTOR
rxcui:623400,LACOSAMIDE
iuphar.ligand:7500,RGFP966
chembl:CHEMBL530733,CHEMBL:CHEMBL530733
chembl:CHEMBL590635,SHINFLAVANONE
ncit:C1437,RECOMBINANT CD40-LIGAND
iuphar.ligand:2625,SAXITOXIN
ncit:C81590,METHYLTHIOURACIL
ncit:C113173,CERDULATINIB
HP:0010796,Brainstem glioma
rxcui:1540825,TEDIZOLID
HGNC:20861,SLC39A10
rxcui:1426889,INDIGO
chembl:CHEMBL2028056,CHEMBL:CHEMBL2028056
MONDO:0007841,coxopodopatellar syndrome
GO:0006600,creatine metabolic process
chembl:CHEMBL1094358,CHEMBL:CHEMBL1094358
ncit:C95907,INDOTECAN
rxcui:26290,GUAIAZULENE
chembl:CHEMBL602718,CHEMBL:CHEMBL602718
GO:0048513,animal organ development
iuphar.ligand:935,SKF-38393
HP:0001382,Joint hypermobility
HGNC:28296,DYNC2I2
HGNC:26526,AK8
HGNC:6515,LATS2
HGNC:8957,PIGA
chembl:CHEMBL4297341,RM-2 GA-68
chembl:CHEMBL4594418,ARM-210
chembl:CHEMBL546168,CHEMBL:CHEMBL546168
chembl:CHEMBL222556,CHEMBL:CHEMBL222556
HGNC:3769,FMO1
HGNC:29011,TRANK1
HP:0025234,Parasomnia
HP:0012675,Iron accumulation in brain
HP:0003447,Axonal loss
rxcui:203189,METHYLPREDNISOLONE SODIUM SUCCINATE
chembl:CHEMBL362573,CALOTHRIXIN B
iuphar.ligand:1385,JNJ16259685
MGI:97550,Pfn2
MONDO:0008458,spinocerebellar ataxia type 2
iuphar.ligand:2740,ALRT 1550
chembl:CHEMBL145725,CHEMBL:CHEMBL145725
HP:0000601,Hypotelorism
HGNC:1620,CCT6A
chembl:CHEMBL1368313,DROFENINE HYDROCHLORIDE
ncit:C95021,CINOBUFAGIN
dictyBase:DDB_G0271998,fsjB
HGNC:8071,NXF1
HGNC:61,ABCD1
ncit:C128037,ANTI-PD1 MONOCLONAL ANTIBODY
chembl:CHEMBL587564,CHEMBL:CHEMBL587564
MONDO:0000485,spasmodic dystonia
MGI:5644692,"Meox2<sup>tm1(cre)Sor</sup>/Meox2<sup>+</sup> Tg(CAG-lacZ,-FUS,-EGFP)629Gyu/0  [background:] involves: 129S4/SvJaeSor * C57BL/6"
chembl:CHEMBL582737,CHEMBL:CHEMBL582737
rxcui:2391541,SATRALIZUMAB
WB:WBGene00003162,mdh-2
iuphar.ligand:106,5-(NONYLOXY)-TRYPTAMINE
chembl:CHEMBL600315,CHEMBL:CHEMBL600315
rxcui:287734,METHOTREXATE SODIUM
rxcui:39998,ZONISAMIDE
rxcui:37840,TERTATOLOL
CHEBI:27899,cisplatin
iuphar.ligand:1428,MTEB
rxcui:1721603,TENOFOVIR ALAFENAMIDE
MP:0008453,decreased retina rod cell number
rxcui:36453,SEVOFLURANE
MGI:109340,Pitx2
HP:0002718,Recurrent bacterial infections
chembl:CHEMBL550495,METHYLENE BLUE
chembl:CHEMBL51931,"9,10-PHENANTHRENEQUINONE"
CHEBI:26188,polyketide
ncit:C120040,BEMARITUZUMAB
HGNC:3508,EWSR1
ncit:C129693,GARTISERTIB
chembl:CHEMBL2109283,BICIROMAB BRALLOBARBITAL
chembl:CHEMBL474376,TRIPHENYLSTANNYL ACETATE
rxcui:1921877,EDARAVONE
ncit:C63666,DEGUELIN
HP:0005621,Trapezoidal vertebral body
rxcui:183379,RIVASTIGMINE
drugbank:DB11665,BMS-690514
rxcui:37798,TERAZOSIN
chembl:CHEMBL1256390,CHEMBL:CHEMBL1256390
HGNC:19306,SLC30A7
drugbank:DB17642,AEM-28
UPHENO:0068346,increased level of creatinine in blood
iuphar.ligand:12486,[3H]IPEROXO
rxcui:861634,PITAVASTATIN
MGI:3851446,"Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-HTT*94Q,-lacZ)1Rhn/0  [background:] involves: C57BL/6 * CBA"
iuphar.ligand:5696,MLN-8054
GO:0035864,response to potassium ion
iuphar.ligand:8653,COMPOUND 51 [PMID: 19743866]
MONDO:0014225,hemochromatosis type 5
ncit:C78484,IAP INHIBITOR HGS1029
iuphar.ligand:9163,PEPTIDE P19 [PMID: 15652659]
HP:0031723,Secondary esotropia
HP:0002174,Postural tremor
HGNC:9118,PMP22
GO:0048704,embryonic skeletal system morphogenesis
iuphar.ligand:4093,&ALPHA;&BETA;-MEATP
ncit:C152764,TROPIFEXOR
ncit:C72142,AMTOLMETIN GUACIL
MONDO:0017733,"alpha-mannosidosis, adult form"
UBERON:0001882,nucleus accumbens
rxcui:2121777,BREXANOLONE
drugbank:DB15008,GO-203-2C
UPHENO:0005507,decreased musculoskeletal movement
UBERON:0000043,tendon
MONDO:0020043,autosomal recessive congenital cerebellar ataxia
chembl:CHEMBL3989948,LANABECESTAT
UBERON:0013540,Brodmann (1909) area 9
HGNC:6206,JUND
ncit:C66018,LINTOPRIDE
rxcui:54828,DEXCHLORPHENIRAMINE MALEATE
chembl:CHEMBL591876,CHEMBL:CHEMBL591876
iuphar.ligand:9106,AMG820
MGI:5646304,Tg(CMV-ATXN3*135Q)CPama/0  [background:] C57BL/6-Tg(CMV-ATXN3*135Q)CPama
HGNC:10080,RNPS1
HP:0001266,Choreoathetosis
HGNC:17367,IFT57
rxcui:21216,CLAVULANIC ACID
HP:0001706,Endocardial fibroelastosis
chembl:CHEMBL591501,PF-03049423
rxcui:1369,BENDROFLUMETHIAZIDE
HP:0002558,Supernumerary nipple
chembl:CHEMBL1402376,CHEMBL:CHEMBL1402376
WB:WBGene00001053,dop-2
chembl:CHEMBL1451874,LECANORIC ACID
rxcui:136198,DARIFENACIN
MGI:3044770,Cln3<sup>tm1.1Mem</sup>/Cln3<sup>tm1.1Mem</sup>  [background:] involves: 129S/SvEv * CD-1
rxcui:150816,IMIPRAMINE HYDROCHLORIDE
rxcui:17128,LANSOPRAZOLE
MP:0002882,abnormal neuron morphology
HGNC:24337,C1GALT1
chembl:CHEMBL1095870,1-HYDROXY-6-(4-HYDROXY-PHENYL)-1-PHENYL-HEXAN-3-ONE (ENANTIOMERIC MIX)
chembl:CHEMBL196814,CHEMBL:CHEMBL196814
iuphar.ligand:9842,COMPOUND 19A [PMID: 26506089]
chembl:CHEMBL297304,CHEMBL:CHEMBL297304
rxcui:72965,LETROZOLE
ZFIN:ZDB-GENE-100712-2,rock1
ncit:C169790,ATAGABALIN
chembl:CHEMBL1782602,THEONELLASTEROL G
iuphar.ligand:2078,&BETA;3-TETRAPEPTIDE
drugbank:DB17551,AGS-16C3F
CL:0000023,oocyte
ncit:C106120,P53-HDM2 INTERACTION INHIBITOR MI-773
rxcui:141366,NARATRIPTAN
HGNC:19737,TNS2
ncit:C166751,LESOGABERAN
ncit:C75966,BUTONATE
chembl:CHEMBL603154,CHEMBL:CHEMBL603154
GO:0000176,nuclear exosome (RNase complex)
chembl:CHEMBL584655,CHEMBL:CHEMBL584655
HP:0025585,Hyperphoria
UPHENO:0081741,increased biological_process in pectoral complex
rxcui:8640,PREDNISONE
ncit:C1657,OPIATE
MGI:103219,Meox2
CL:0000031,neuroblast (sensu Vertebrata)
HGNC:19104,NPHP4
ncit:C166553,ATABECESTAT
MGI:5573196,Tg(Thy1-Snca)1S13Putt/?  [background:] involves: C57BL/6
GO:0014823,response to activity
iuphar.ligand:6287,ISOVELLERAL
rxcui:203184,KETAMINE HYDROCHLORIDE
drugbank:DB02932,(R)-BICALUTAMIDE
MONDO:0014242,van Maldergem syndrome 2
drugbank:DB05502,AG-858
HP:0000457,Depressed nasal ridge
chembl:CHEMBL2449003,ENDO-ATROPINE
hemonc:19,ALISERTIB
MONDO:0006243,hepatoid adenocarcinoma
HGNC:26430,IKBIP
HP:0001541,Ascites
CHEBI:43474,hydrogenphosphate
rxcui:10612,TINIDAZOLE
iuphar.ligand:4257,MRK016
CHEBI:16947,citrate(3-)
MONDO:0036193,parkinsonism with polyneuropathy
rxcui:228656,AMPRENAVIR
HGNC:17312,TIMM23
chembl:CHEMBL483531,ALTENUSIN
ncit:C87331,BERBERINE CHLORIDE
chembl:CHEMBL453384,CHEMBL:CHEMBL453384
rxcui:8691,PRIMIDONE
rxcui:461016,ESZOPICLONE
MONDO:0013784,neonatal-onset encephalopathy with rigidity and seizures
chembl:CHEMBL447876,CAULIBUGULONE D
HP:0000175,Cleft palate
rxcui:7435,NISOLDIPINE
MONDO:0005890,osteitis fibrosa
MONDO:0000167,Huntington disease and related disorders
chembl:CHEMBL597845,SALERMIDE
MONDO:0005567,substance withdrawal syndrome
ncit:C151929,CINOBUFOTALIN
chembl:CHEMBL448114,DOLASTATIN 12
MP:0006320,abnormal interscapular fat pad morphology
rxcui:1546025,GATIFLOXACIN ANHYDROUS
iuphar.ligand:12501,SA10SC-RLX
HP:0002446,Astrocytosis
HGNC:877,ALDH7A1
ncit:C95217,RITANSERIN
rxcui:306674,VARDENAFIL
HGNC:4067,GABARAP
rxcui:203175,DIETHYLCARBAMAZINE CITRATE
iuphar.ligand:9873,VUF14738
iuphar.ligand:12714,M8891
chembl:CHEMBL156378,BROMOETHANE
rxcui:596723,CERIVASTATIN
HGNC:30697,ITFG1
rxcui:2628469,ELACESTRANT
chembl:CHEMBL1334191,CHEMBL:CHEMBL1334191
CHEBI:37941,clopidogrel
chembl:CHEMBL283078,THIOGUANOSINE
HP:0032758,Focal aware myoclonic seizure
chembl:CHEMBL491981,7-HYDROXY ISOFLAVONE
chembl:CHEMBL578719,CHEMBL:CHEMBL578719
drugbank:DB01796,QUINOLINIC ACID
HGNC:946,MAGI1
rxcui:37859,TESTOSTERONE ENANTHATE
FB:FBgn0037643,ScsβA
HGNC:7704,NDUFB9
MP:0003492,abnormal involuntary movement
drugbank:DB16828,MK-2206
HP:0010994,Abnormal corpus striatum morphology
HP:0031956,Elevated circulating aspartate aminotransferase concentration
HGNC:6871,MAPK1
HGNC:10983,SLC25A13
HGNC:7994,NRCAM
rxcui:7895,PAPAVERINE
MP:0003856,abnormal hindlimb stylopod morphology
HP:0000303,Mandibular prognathia
chembl:CHEMBL1256180,5-(N-METHYL-N-ISOBUTYL)AMILORIDE
chembl:CHEMBL1201466,"ESTROGENS, CONJUGATED SYNTHETIC A"
HGNC:8008,NRXN1
ncit:C79910,MASITINIB
HP:0002510,Spastic tetraplegia
rxcui:258494,EXEMESTANE
HGNC:2712,DCTN2
ncit:C26672,SOBLIDOTIN
MGI:2668525,Hprt1<sup>tm4Detl</sup>/Hprt1<sup>tm4Detl</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
ncit:C171711,FIRUGLIPEL
ncit:C153478,DOLCANATIDE
iuphar.ligand:10079,5-LOX INHIBITOR 2M [PMID: 30199704]
iuphar.ligand:8245,ZM-306416
iuphar.ligand:2016,"L-817,818"
iuphar.ligand:943,SCH-23390
ncit:C257,NONSTEROIDAL ANTIINFLAMMATORY DRUG
chembl:CHEMBL585240,CHEMBL:CHEMBL585240
chembl:CHEMBL1555467,ANAZOLENE
MONDO:0005015,diabetes mellitus
rxcui:44157,CLADRIBINE
HP:0000634,Impaired ocular abduction
rxcui:29451,MEGESTROL ACETATE
chembl:CHEMBL2397751,SAD448
HGNC:18362,IMPG2
HGNC:2711,DCTN1
HP:0032658,Status epilepticus with prominent motor symptoms
iuphar.ligand:2830,TOXAPHENE
ncit:C333,CALCIUM CHANNEL BLOCKER
HGNC:7756,NES
dictyBase:DDB_G0268116,DDB_G0268116
MGI:3841626,Ogt<sup>tm1Gwh</sup>/Y Tg(Syn1-cre)671Jxm/0  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
chembl:CHEMBL1509103,CHEMBL:CHEMBL1509103
chembl:CHEMBL513116,N-AMINOHEXYL-5-CHLORO-1-NAPTHALENESULFONAMIDE HYDROCHLORIDE
rxcui:6995,PLICAMYCIN
ncit:C107684,PI3KBETA INHIBITOR AZD8186
EMAPA:36928,superior oblique extraocular muscle
iuphar.ligand:8192,COMPOUND 5 [PMID: 23232060]
HGNC:2900,DLG1
MONDO:0003441,dystonic disorder
BFO:0000004,independent continuant
chembl:CHEMBL329785,CHEMBL:CHEMBL329785
ncit:C83787,IMAZODAN
GO:0003351,epithelial cilium movement involved in extracellular fluid movement
HGNC:15630,TCERG1
HGNC:14124,NPRL3
rxcui:236767,FENDILINE HYDROCHLORIDE
chembl:CHEMBL1869551,CHLORFENAPYR
ncit:C104292,PANULISIB
iuphar.ligand:9646,COMPOUND 47 [PMID: 28737909]
chembl:CHEMBL581872,CHEMBL:CHEMBL581872
ncit:C82348,ONARTUZUMAB
HGNC:7849,NME1
HGNC:3189,EEF1A1
MP:0012006,abnormal hippocampus physiology
iuphar.ligand:9583,PSORA-4
iuphar.ligand:12309,TDI-11861
ncit:C1286,RECOMBINANT TRANSFORMING GROWTH FACTOR-BETA-2
HGNC:15968,GDAP1
HP:0011220,Prominent forehead
MONDO:0100056,exercise-induced anaphylaxis
MGI:1339753,Csf1
rxcui:2204915,BROLUCIZUMAB
MGI:5516463,Tg(Prnp-ATXN3*148Q)NLS.28Olri/0  [background:] involves: C57BL/6N
rxcui:4601,FURAZOLIDONE
iuphar.ligand:8915,AZD8835
chembl:CHEMBL601743,CHEMBL:CHEMBL601743
ncit:C65389,DILAZEP
iuphar.ligand:223,[3H]RAUWOLSCINE
HGNC:30000,BBS9
chembl:CHEMBL527730,CHEMBL:CHEMBL527730
HGNC:7449,MTMR1
rxcui:6468,LOPERAMIDE
rxcui:73137,TIROFIBAN
rxcui:21264,CLOFOCTOL
iuphar.ligand:4284,PHENYLGLYCINE-01
hemonc:260,IPH-2101
HGNC:9279,PDP1
ncit:C116890,NANOPARTICLE ALBUMIN-BOUND THIOCOLCHICINE DIMER NAB-5404
HP:0001262,Excessive daytime somnolence
chembl:CHEMBL2272397,MILBEMYCIN A4
ncit:C83563,BUDIODARONE
chembl:CHEMBL546170,CHEMBL:CHEMBL546170
HP:0005135,Abnormal T-wave
HGNC:11544,TAF11
HGNC:691,PHOX2A
HGNC:9854,RANGAP1
MGI:5660030,"Tg(Pcp2-tTA)3Horr/0 Tg(tetO-PRKCG*S361G,-GFP)3Jpka/0  [background:] involves: FVB/N"
rxcui:2586354,VOSORITIDE
ncit:C81044,ACECLIDINE
GO:0005742,mitochondrial outer membrane translocase complex
ncit:C61637,ANDROGRAPHOLIDE
MGI:1100881,Prss12
iuphar.ligand:6938,LY2119620
HP:0008994,Proximal muscle weakness in lower limbs
ncit:C95889,STAT3 INHIBITOR OPB-51602
HGNC:26119,SIKE1
HP:0200134,Epileptic encephalopathy
chembl:CHEMBL99408,CHEMBL:CHEMBL99408
chembl:CHEMBL1465049,CHEMBL:CHEMBL1465049
chembl:CHEMBL137498,CHEMBL:CHEMBL137498
chembl:CHEMBL373114,LAMELLARIN D
chembl:CHEMBL269733,DEPHOSTATIN
MONDO:0008843,atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome
ncit:C2721,C-RAF ANTISENSE OLIGONUCLEOTIDE ISIS 5132
HP:0007021,Pain insensitivity
rxcui:42933,TIMOLOL MALEATE
rxcui:2001252,PITAVASTATIN MAGNESIUM
ncit:C1881,MOTEXAFIN GADOLINIUM
HGNC:6239,KCND3
iuphar.ligand:5745,COMPOUND 1 [PMID: 21273063]
ncit:C584,RECOMBINANT INTERFERON
MGI:3623411,Tgfbr2<sup>tm1Karl</sup>/Tgfbr2<sup>tm1Karl</sup> H2az2<sup>Tg(Wnt1-cre)11Rth</sup>/H2az2<sup>+</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MONDO:0005550,infectious disease
MONDO:0010321,"autism, susceptibility to, X-linked 1"
HGNC:30811,CD300LB
rxcui:274786,TELITHROMYCIN
chembl:CHEMBL582767,CHEMBL:CHEMBL582767
rxcui:6038,ISONIAZID
HGNC:4024,FXR2
chembl:CHEMBL1547715,CHEMBL:CHEMBL1547715
GO:0033149,FFAT motif binding
iuphar.ligand:11026,MEPLAZUMAB
rxcui:2591519,FARICIMAB
HP:0007359,Focal-onset seizure
UBERON:0008949,lower lobe of lung
rxcui:235450,TOLAZOLINE HYDROCHLORIDE
UBERON:0014890,right hemisphere of cerebellum
HP:0001344,Absent speech
iuphar.ligand:5756,1-OLEOYL GLYCEROL
iuphar.ligand:4304,S18986
iuphar.ligand:9190,COMPOUND 3 [PMID: 23134120]
ncit:C116750,DILPACIMAB
chembl:CHEMBL118280,CHEMBL:CHEMBL118280
MONDO:0100118,hereditary skin disorder
CHEBI:7025,mupirocin
UBERON:0002286,third ventricle
iuphar.ligand:8370,(-)-STEPHOLIDINE
iuphar.ligand:11289,NYX-2925
MONDO:0010714,Pelizeaus-Merzbacher spectrum disorder
chembl:CHEMBL1601166,"ORSELLINIC ACID, ETHYL ESTER"
rxcui:1368167,PHLORETIN
EMAPA:17412,forelimb
HGNC:29079,KDM1A
GO:0003677,DNA binding
chembl:CHEMBL2109124,DORLIMOMAB ARITOX
HGNC:29932,COASY
chembl:CHEMBL3545417,GLPG0492
rxcui:25734,GESTODENE
iuphar.ligand:1236,(R)-&ALPHA;-METHYLHISTAMINE
drugbank:DB15317,POSIPHEN
chembl:CHEMBL457583,ORSELLINIC ACID
chembl:CHEMBL322333,DIMETHYLSPINGOSINE
rxcui:1112990,EZOGABINE
MONDO:0010181,oculogastrointestinal muscular dystrophy
MP:0001399,hyperactivity
HP:0002344,Progressive neurologic deterioration
HGNC:18154,RNF115
MONDO:0006915,polyradiculoneuropathy
MP:0000867,abnormal cerebellum anterior vermis morphology
GO:0043217,myelin maintenance
iuphar.ligand:1259,FUB 349
CL:0002604,hippocampal astrocyte
HGNC:13745,FSD1
NCBIGene:504662,ZNHIT3
iuphar.ligand:951,7-TRANS-OH-PIPAT
ncit:C141430,VORUCICLIB
rxcui:203132,PAPAVERINE HYDROCHLORIDE
MONDO:0010482,X-linked parkinsonism-spasticity syndrome
drugbank:DB13988,SB-269970
ncit:C61307,OPORTUZUMAB MONATOX
chembl:CHEMBL591618,CHEMBL:CHEMBL591618
chembl:CHEMBL1226,AMINODIMETHOXYQUINAZOLINYLPIPERAZINE
chembl:CHEMBL74644,CHEMBL:CHEMBL74644
HGNC:7707,NDUFS1
rxcui:2099295,MOXETUMOMAB PASUDOTOX
chembl:CHEMBL53628,DESMOSDUMOTIN C
chembl:CHEMBL517449,LIMONIN
MONDO:0009749,giant axonal neuropathy 1
HGNC:18039,KDM5B
HGNC:7508,MUC1
rxcui:2048124,HARPAGOSIDE
iuphar.ligand:7501,RGFP109
rxcui:339270,TEGASEROD MALEATE
ncit:C83849,ISTAROXIME
iuphar.ligand:3728,RIBOSOMAL PROTEIN S19
iuphar.ligand:12440,DATISCETIN
iuphar.ligand:165,MK-212
HGNC:13667,AP1M1
iuphar.ligand:10505,AMIVANTAMAB
CHEBI:17933,calcidiol
HP:0007824,Total ophthalmoplegia
iuphar.ligand:1611,SNC80
ncit:C84018,NIGULDIPINE
HGNC:11005,SLC2A1
MONDO:0010788,Leber hereditary optic neuropathy
chembl:CHEMBL1448793,CHEMBL:CHEMBL1448793
HGNC:29450,GLIS2
HGNC:11387,STIP1
FB:FBgn0086698,frtz
ncit:C75768,QUERCETIN DIHYDRATE
chembl:CHEMBL2108107,TETANUS ANTITOXIN
iuphar.ligand:3970,&ALPHA;-CONOTOXIN MII
iuphar.ligand:12585,6-PRENYLNARINGENIN
MP:0000791,delaminated cerebral cortex
MONDO:0006692,central pontine myelinolysis
MGI:5448415,Slc6a8<sup>tm1.1Clar</sup>/Y Tg(Camk2a-cre)2Gsc/0  [background:] involves: C57BL/6 * C57BL/6J * FVB/N
HP:0002553,Highly arched eyebrow
UPHENO:0081701,paralysed extra-ocular muscle
rxcui:1976,CANNABINOL
MGI:2144467,Wdpcp
HP:0100753,Schizophrenia
chembl:CHEMBL1242196,DEHYDROMUTACTIN
HGNC:1639,CD2
chembl:CHEMBL2002849,CHEMBL:CHEMBL2002849
HGNC:575,AP4S1
chembl:CHEMBL598477,CHEMBL:CHEMBL598477
MONDO:0023370,neoplastic disease or syndrome
ncit:C152950,ZICRONAPINE
HP:0031713,Constant exotropia
ncit:C166554,NARLAPREVIR
iuphar.ligand:8072,GW5074
CHEBI:42355,erythromycin A
ncit:C166556,LANIFIBRANOR
iuphar.ligand:11617,GLPG4716
chembl:CHEMBL1201775,SAPROPTERIN DIHYDROCHLORIDE
chembl:CHEMBL536166,CHEMBL:CHEMBL536166
MP:0000774,decreased brain size
chembl:CHEMBL3545111,HEMAY-022
rxcui:105556,ESTRAMUSTINE PHOSPHATE
CHEBI:16180,N-acylglycine
HP:0034251,Abnormal corneal reflex
chembl:CHEMBL2109391,MDX-447
HP:0002483,Bulbar signs
rxcui:55471,RANITIDINE BISMUTH CITRATE
ncit:C2438,RAS PEPTIDE CANCER VACCINE
chembl:CHEMBL2333546,MADOLIN U
MP:0008265,abnormal hippocampus CA2 region morphology
HP:0000637,Long palpebral fissure
rxcui:106101,OXYMETAZOLINE HYDROCHLORIDE
iuphar.ligand:12061,BI-3406
CHEBI:38921,pyridoquinoline
iuphar.ligand:292,NNC 11-1585
chembl:CHEMBL525826,CHEMBL:CHEMBL525826
rxcui:322249,FROVATRIPTAN SUCCINATE
drugbank:DB16773,TYRPHOSTIN AG 555
chembl:CHEMBL529361,CHEMBL:CHEMBL529361
HGNC:20593,VPS39
HP:0008026,Horizontal opticokinetic nystagmus
chembl:CHEMBL4650286,M4344
rxcui:4090,ESTRAMUSTINE PHOSPHATE SODIUM
chembl:CHEMBL580918,CHEMBL:CHEMBL580918
HGNC:9196,POLR2I
rxcui:1102270,RILPIVIRINE
rxcui:236082,NEFAZODONE HYDROCHLORIDE
FB:FBgn0260945,Atg1
HGNC:12853,YWHAH
chembl:CHEMBL320497,SUBEROHYDROXAMIC ACID
NBO:0000092,anxiety-related behavior
rxcui:142429,CHLORPHENIRAMINE MALEATE
CHEBI:26144,piperazines
PomBase:SPAC1687.12c,coq4
HP:0011171,Simple febrile seizure
drugbank:DB15412,LB-100
MGI:3711319,Psap<sup>tm1Suz</sup>/Psap<sup>tm1Suz</sup>  [background:] involves: 129P2/OlaHsd
rxcui:23665,DOXYLAMINE SUCCINATE
ZFIN:ZDB-GENE-040426-2879,zgc:55461
MGI:1920992,Lima1
chembl:CHEMBL591834,CHEMBL:CHEMBL591834
drugbank:DB12007,ISOFLAVONE
CL:2000057,femural osteoblast
rxcui:236303,ISOSPAGLUMIC ACID
HP:0010669,Hypoplasia of the zygomatic bone
chembl:CHEMBL426404,CHEMBL:CHEMBL426404
HP:0005165,Shortened PR interval
HGNC:9998,RGS2
chembl:CHEMBL553503,CHEMBL:CHEMBL553503
ncit:C1098,FENRETINIDE
rxcui:153718,BALSALAZIDE DISODIUM
HGNC:16807,SMURF1
chembl:CHEMBL9470,SHIKONIN
chembl:CHEMBL532412,CHEMBL:CHEMBL532412
rxcui:6646,MAPROTILINE
iuphar.ligand:1341,PG-901
drugbank:DB05882,CHF 4227
iuphar.ligand:3831,[3H]NPC17731
HGNC:9761,RAB11B
MONDO:0006303,middle ear squamous cell carcinoma
iuphar.ligand:6538,UAMC00039
HP:0200016,Acrokeratosis
rxcui:3041,CYTARABINE
drugbank:DB08059,WORTMANNIN
MP:0031185,sudden unexpected death in epilepsy
chembl:CHEMBL2109530,ASK-8007
GO:0005783,endoplasmic reticulum
HP:0001450,Y-linked inheritance
chembl:CHEMBL3218390,GGTI-2418
ncit:C74388,REPINOTAN
ncit:C1060,DAIDZEIN
iuphar.ligand:9298,LHVS
HP:0006510,Chronic pulmonary obstruction
rxcui:1819,BUPRENORPHINE
MONDO:0024537,Brown-Vialetto-van Laere syndrome 1
iuphar.ligand:8008,GSK2334470
ncit:C1106,FOTEMUSTINE
drugbank:DB05607,PRX-08066
HGNC:2552,CUL2
ncit:C1142,LAVENDUSTIN A
HP:0007328,Impaired pain sensation
MONDO:0015674,late infantile neuronal ceroid lipofuscinosis
chembl:CHEMBL55895,PHENYLBUTYRYLHYDROXAMIC ACID
iuphar.ligand:5916,AG 490
HGNC:9416,PRKG2
HP:0001234,Hitchhiker thumb
HP:0002013,Vomiting
HGNC:23373,NTMT1
ZFA:0000738,dorsal oblique extraocular muscle
ncit:C26441,IRATUMUMAB
MONDO:0021125,disease characteristic
rxcui:1043181,ELLAGIC ACID
rxcui:356887,LEVOCETIRIZINE
ncit:C64634,MARIZOMIB
MGI:4418570,Ehmt1<sup>tm1.1Tara</sup>/Ehmt1<sup>tm1.1Tara</sup> Ehmt2<sup>tm1.1Tara</sup>/Ehmt2<sup>tm1.1Tara</sup> Tg(Camk2a-cre)2Gsc/0  [background:] involves: 129P2/OlaHsd * C57BL/6 * FVB/N
MGI:3606092,nmf356
MONDO:0004944,neurosyphilis
drugbank:DB02417,"2,4,6-TRIBROMOPHENOL"
HP:0034369,Decreased level of coenzyme Q10 in skeletal muscle
drugbank:DB11872,ZD-6126
rxcui:6375,LEVODOPA
iuphar.ligand:3887,IRL 2500
MONDO:0036779,axillary neoplasm
CL:1001474,medium spiny neuron
ncit:C142973,BUPARLISIB HYDROCHLORIDE
chembl:CHEMBL197676,INDOXACARB
MGI:4366351,Fmr1<sup>tm1Cgr</sup>/Y  [background:] involves: 129P2/OlaHsd * C57BL/6J
HP:0012004,Focal cognitive seizure with deja vu/jamais vu
iuphar.ligand:769,CCL11
MP:0009295,decreased interscapular fat pad weight
UBERON:0002400,parietal pleura
MONDO:0007739,Huntington disease
iuphar.ligand:11238,NSC151066
iuphar.ligand:12571,ST-1478
CHEBI:16467,L-arginine
UPHENO:0047976,increased thickness of the superior cerebellar peduncle of pons
chembl:CHEMBL1456870,GARCINOLIC ACID
MONDO:0006055,sex cord-stromal tumor
HGNC:9280,PPOX
MONDO:0013220,hemochromatosis type 2B
drugbank:DB17385,LIPOTECAN
chembl:CHEMBL1306524,CHEMBL:CHEMBL1306524
iuphar.ligand:5760,WWGKKYRASKLGLAR
iuphar.ligand:5932,JNJ-7706621
rxcui:1546455,HYPERICIN
rxcui:10212,SULFOBROMOPHTHALEIN
drugbank:DB06073,CTS-21166
HP:0008278,Cerebellar cortical atrophy
HGNC:17118,RNF32
iuphar.ligand:741,AM281
drugbank:DB07080,TO-901317
chembl:CHEMBL163316,3-O-METHYLQUERCETIN
ncit:C62529,PSILOCYBINE
GO:0097333,response to olanzapine
rxcui:4094,ESTRIOL
HGNC:1405,CACNG1
MGI:109583,Pten
MONDO:0019268,epidermal disease
rxcui:8674,PRENYLAMINE
ncit:C2351,HYPERBARIC OXYGEN
MGI:1095406,Tuba3a
drugbank:DB03671,DIGOXIGENIN
CHEBI:25676,oligopeptide
hemonc:64,BELOTECAN
MONDO:0008769,neuronal ceroid lipofuscinosis 2
MONDO:0005071,nervous system disorder
HGNC:7819,SNU13
HGNC:11351,ST7
dictyBase:DDB_G0275861,katA
chembl:CHEMBL365100,FENPYROXYMATE
ncit:C2507,MKC-1
chembl:CHEMBL547488,CHEMBL:CHEMBL547488
HP:0032888,Focal impaired awareness cognitive seizure with forced thinking
drugbank:DB16181,ISIS 2503
CHEBI:15971,L-histidine
HGNC:16369,PARK7
HGNC:20127,TEDC1
rxcui:525,ALLYLESTRENOL
GO:0005737,cytoplasm
HGNC:10916,SLC13A1
HGNC:21749,COPS6
HP:0100303,Muscle fiber cytoplasmatic inclusion bodies
chembl:CHEMBL28319,QUESTIOMYCIN B
rxcui:39468,VERALIPRIDE
chembl:CHEMBL480356,CHEMBL:CHEMBL480356
drugbank:DB05192,MB07811
HP:0001581,Recurrent skin infections
UBERON:0004075,cerebellum vermis lobule II
rxcui:1436,BEPRIDIL
iuphar.ligand:10736,GSK-189254
CHEBI:25106,macrolide
chembl:CHEMBL1394829,PROPACHLOR
chembl:CHEMBL409450,6BIO
rxcui:736680,DRONEDARONE HYDROCHLORIDE
ncit:C175875,VIDUTOLIMOD
chembl:CHEMBL448515,"2,6-DIMETHOXYQUINONE"
MP:0009808,decreased oligodendrocyte number
rxcui:236701,CLEBOPRIDE MALEATE
HGNC:4400,GNB3
HP:0003763,Bruxism
ncit:C96286,ILOMASTAT
ncit:C851,SUNSCREEN
HGNC:33778,MYMK
HGNC:12744,MLXIPL
iuphar.ligand:6663,&RHO;-DA1A
CHEBI:5613,haloperidol
HP:0003026,Short long bone
iuphar.ligand:8862,BLU-9931
HP:0032712,Focal impaired awareness motor seizure
MONDO:0012868,"thrombophilia due to protein S deficiency, autosomal dominant"
ncit:C90899,TILARGININE ACETATE
ncit:C72842,ROLIPRAM
iuphar.ligand:327,METHOCTRAMINE
UPHENO:0086586,abnormal cerebellar cortex morphology
HP:0002901,Hypocalcemia
chembl:CHEMBL2063687,CHEMBL:CHEMBL2063687
rxcui:21102,CILAZAPRIL
chembl:CHEMBL4297574,TEPRASIRAN
rxcui:68149,MYCOPHENOLATE MOFETIL
MGI:104661,Rora
HGNC:10594,SCN7A
HGNC:4296,GLA
iuphar.ligand:3789,[125I]RELAXIN-3-B/INSL5 A CHIMERA
chembl:CHEMBL73380,CHEMBL:CHEMBL73380
chembl:CHEMBL2002487,CHEMBL:CHEMBL2002487
MONDO:0019806,primary progressive aphasia
rxcui:203176,DIHYDROERGOTAMINE MESYLATE
rxcui:2878,CORTISONE
iuphar.ligand:9421,ITOLIZUMAB
ncit:C1029,BUTHIONINE SULFOXIMINE
HGNC:29347,KLHL15
chembl:CHEMBL1873045,CHEMBL:CHEMBL1873045
iuphar.ligand:10269,BMS-986120
iuphar.ligand:8920,UBLITUXIMAB
HGNC:6601,LIG4
HP:0001386,Joint swelling
HP:3000058,Abnormality of inferior rectus extraocular muscle
iuphar.ligand:4210,GYKI53784
chembl:CHEMBL575867,4-CHLOROMERCURIBENZOIC ACID
MGI:3852509,Nfkb2<sup>tm1Brv</sup>/Nfkb2<sup>tm1Brv</sup>  [background:] involves: 129S1/Sv * C57BL/6
HGNC:3350,ENO1
HGNC:9087,PLP2
WB:WBGene00012970,Y48A6B.9
chembl:CHEMBL1802135,PROTUBOXEPIN A
rxcui:214525,DOXORUBICIN LIPOSOME
ncit:C66685,ZAPRINAST
HP:0001337,Tremor
chembl:CHEMBL589717,CHEMBL:CHEMBL589717
iuphar.ligand:2205,YM 471
MONDO:0044334,connective and soft tissue neoplasm
rxcui:401713,CARGLUMIC ACID
iuphar.ligand:5305,ADP-RIBOSYLATION FACTOR 1
chembl:CHEMBL602127,CHEMBL:CHEMBL602127
drugbank:DB14131,BASIC FIBROBLAST GROWTH FACTOR
chembl:CHEMBL559934,CHEMBL:CHEMBL559934
HGNC:2545,CTSS
CHEBI:50385,hemin
rxcui:2119365,ESKETAMINE
chembl:CHEMBL1097474,GANODERIC ACID TR
rxcui:1998,CAPTOPRIL
ncit:C116729,ILORASERTIB
chembl:CHEMBL3545137,PF-00477736
HP:0002024,Malabsorption
ncit:C79556,BEVANTOLOL
ncit:C1434,LOBAPLATIN
chembl:CHEMBL1255656,CHEMBL:CHEMBL1255656
OBA:1001005,creatine amount
chembl:CHEMBL3545401,X-82
chembl:CHEMBL75133,IRX-4204
MONDO:0019260,adult neuronal ceroid lipofuscinosis
chembl:CHEMBL595227,CHEMBL:CHEMBL595227
CHEBI:48339,"1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine"
MP:0000558,abnormal tibia morphology
chembl:CHEMBL590522,MAHANINE
HP:0003738,Exercise-induced myalgia
HP:0008610,Infantile sensorineural hearing impairment
HP:0011147,Typical absence seizure
rxcui:1946825,ABEMACICLIB
ncit:C72698,AMITRIPTYLINOXIDE
HGNC:7776,NFATC2
MONDO:0001074,chronic tic disorder
Reactome:R-CFA-390651,Dopamine receptors
HGNC:3467,ESR1
rxcui:30031,MINAPRINE
chembl:CHEMBL1224528,DIHYDROXIDINE
ncit:C170125,LOMOFUNGIN
rxcui:2184116,AMLODIPINE BENZOATE
chembl:CHEMBL1874081,CHLOROPHACINONE
iuphar.ligand:12855,BMS-303141
HP:0000519,Developmental cataract
iuphar.ligand:5526,ABNORMAL CANNABIDIOL
rxcui:2478438,UMBRALISIB TOSYLATE
CHEBI:27881,resveratrol
iuphar.ligand:1995,INSL3
Reactome:R-BTA-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL465226,GEDUNIN
chembl:CHEMBL1399036,BUTACHLOR
HP:0007787,Posterior subcapsular cataract
CHEBI:16452,oxaloacetate(2-)
drugbank:DB12854,BMS-908662
HP:5200073,Excessive cleaning
HGNC:33495,BLID
drugbank:DB05297,PACLITAXEL DOCOSAHEXAENOIC ACID
CHEBI:25107,magnesium atom
HGNC:25759,TTC31
HGNC:25490,NTAQ1
HGNC:4118,GALK1
HP:0000498,Blepharitis
HGNC:26202,MRM1
chembl:CHEMBL341898,"(R,S)-INDATRALINE"
iuphar.ligand:2113,[PHE(ME)7]NEUROKININ B
iuphar.ligand:5748,COMPOUND 58 [PMID: 21273063]
MONDO:0012116,spinocerebellar ataxia type 8
HGNC:4179,NIPSNAP2
rxcui:19768,BROMOPRIDE
CL:0000076,squamous epithelial cell
iuphar.ligand:11782,ZEMIRCICLIB
HP:0002282,Gray matter heterotopia
HP:0032104,Saccadic oscillation
Reactome:R-HSA-189200,Cellular hexose transport
MP:0004077,abnormal striatum morphology
iuphar.ligand:12814,GNE-7883
iuphar.ligand:6442,COMPOUND 18 [PMID: 21927650]
HGNC:12482,UBE2G1
chembl:CHEMBL1160819,"AMMONIA SOLUTION, STRONG"
HP:0000545,Myopia
MONDO:0012050,major depressive disorder 1
HGNC:17850,HINFP
HGNC:12590,UQCRH
chembl:CHEMBL601618,CHEMBL:CHEMBL601618
HGNC:30782,NAA15
chembl:CHEMBL2435326,"(20S,21R)-FLUOROCAMPTOTHECIN"
iuphar.ligand:7651,UNC0006
HP:0002999,Patellar dislocation
ncit:C96431,RICOLINOSTAT
CHEBI:3638,chloroquine
HP:0001298,Encephalopathy
HP:0002232,Patchy alopecia
iuphar.ligand:4349,HEME
iuphar.ligand:1066,CGP 47656
rxcui:1256,AZATHIOPRINE
chembl:CHEMBL1441574,BENZO(K)FLUORANTHENE
CHEBI:37565,GTP(4-)
UBERON:0002420,basal ganglion
CHEBI:58359,L-glutamine zwitterion
MONDO:0011057,cerebrovascular disorder
chembl:CHEMBL1607517,BENZANTHRONE
MGI:2663351,Clock<sup>m1Jt</sup>/Clock<sup>m1Jt</sup>  [background:] C57BL/6-Clock<sup>m1Jt</sup>
ZFIN:ZDB-GENE-030131-7691,cox7a2l
HP:0000408,Progressive sensorineural hearing impairment
ncit:C1228,SODIUM MOLYBDATE
MGI:103189,Mmp7
iuphar.ligand:611,LITHOCHOLIC ACID
ncit:C170350,PRITUMUMAB
CL:0002453,oligodendrocyte precursor cell
HP:0002578,Gastroparesis
chembl:CHEMBL2063052,CHEMBL:CHEMBL2063052
HP:0002342,"Intellectual disability, moderate"
HGNC:2190,COL13A1
chembl:CHEMBL1552837,AZORUBINE
MGI:1099442,Atxn3
HP:0004220,Short middle phalanx of the 5th finger
chembl:CHEMBL554041,ALEXIDINE DIHYDROCHLORIDE
iuphar.ligand:10539,MANSC (415-431)
HP:0200070,Peripheral retinal atrophy
chembl:CHEMBL458178,KASANOSIN A
iuphar.ligand:3405,12R-HETE
iuphar.ligand:8839,TORIN 2
rxcui:75635,EPTIFIBATIDE
HGNC:12518,UCP2
rxcui:578285,TOCOTRIENOLS
iuphar.ligand:7748,EMIBETUZUMAB
chembl:CHEMBL2228641,DITHIANON
CHEBI:10119,ziprasidone
HP:0003674,Onset
MONDO:0004967,acute lymphoblastic leukemia
rxcui:1101333,GABAPENTIN ENACARBIL
RGD:1307205,Pigp
rxcui:18927,BENZTROPINE MESYLATE
rxcui:2356,CHLORDIAZEPOXIDE
rxcui:7623,OFLOXACIN
HGNC:18056,TAF1L
chembl:CHEMBL141690,ISOBERGAPTENE
ncit:C152944,ZALOSPIRONE
iuphar.ligand:4154,CGP37849
iuphar.ligand:7632,VU0119498
HP:0002638,Superficial thrombophlebitis
MONDO:0010879,CODAS syndrome
ncit:C73002,ARTEMOTIL
iuphar.ligand:12301,VU0467154
MONDO:0009419,Woodhouse-Sakati syndrome
MGI:5806789,Tg(Thy1-SNCA*E57K)16Ema/0  [background:] involves: C57BL/6 * DBA/2
HP:0032841,Neonatal bilateral asymmetric epileptic spasm
rxcui:22293,DANTHRON
HGNC:9205,PON2
HGNC:2928,DMD
chembl:CHEMBL2178596,CHEMBL:CHEMBL2178596
chembl:CHEMBL273891,CHEMBL:CHEMBL273891
iuphar.ligand:9455,AY77
GO:0042417,dopamine metabolic process
rxcui:8727,PROGESTERONE
HP:0045048,Increased HbA2 hemoglobin
drugbank:DB02115,DAIDZIN
drugbank:DB03167,PENTABROMOPHENOL
iuphar.ligand:2555,CORREOLIDE
MONDO:0009723,Leigh syndrome
rxcui:6023,ISOETHARINE
HP:0020220,Focal atonic seizure
HGNC:1616,CCT3
ncit:C115970,IBCASERTIB
ncit:C116747,LIFASTUZUMAB VEDOTIN
iuphar.ligand:6227,VU0080241
UPHENO:0077942,decreased reflex in patella
MONDO:0007626,familial congenital palsy of trochlear nerve
chembl:CHEMBL3545216,FX-005
HGNC:7499,MT-TT
GO:0061952,midbody abscission
HP:5200241,Recurrent maladaptive behavior
HGNC:757,ASPH
MGI:108072,Traf6
iuphar.ligand:5088,VEGFD
drugbank:DB05014,XL999
HGNC:4068,GABARAPL1
HGNC:5229,DNAJA1
HP:0000723,Restrictive behavior
HGNC:13051,ZPR1
iuphar.ligand:4223,"INOSITOL 2,4,5-TRISPHOSPHATE"
chembl:CHEMBL600103,CHEMBL:CHEMBL600103
chembl:CHEMBL3545399,R-112
ncit:C72582,PILSICAINIDE
MGI:107184,Cct7
HP:0033683,Jaw hyperreflexia
HP:0000743,Frontal release signs
UPHENO:0068226,increased level of creatinine in urine
Xenbase:XB-GENE-5806009,cmbl
HP:0010664,Fusion of the left and right thalami
chembl:CHEMBL226034,TAMARIXETIN
chembl:CHEMBL502775,CHEMBL:CHEMBL502775
FB:FBgn0011227,ox
MP:0000921,demyelination
CHEBI:34994,teicoplanin A2
ncit:C99172,MIRANSERTIB
HP:0001137,Alternating esotropia
OBA:0002820,
MGI:107931,Sqstm1
iuphar.ligand:8355,COMPOUND 46 [PMID: 16451062]
HP:0003205,Curvilinear intracellular accumulation of autofluorescent lipopigment storage material
ncit:C73026,EFONIDIPINE
HGNC:4193,GCH1
ZFIN:ZDB-GENE-040426-1124,ndufa6
MONDO:0859307,cleidocranial dysplasia 2
UBERON:0004074,cerebellum vermis lobule I
HGNC:2184,COIL
EMAPA:35835,substantia nigra
HGNC:9846,RAN
rxcui:1545982,CARBIDOPA ANHYDROUS
HP:0011389,Functional abnormality of the inner ear
chembl:CHEMBL313737,CHEMBL:CHEMBL313737
GO:0000451,rRNA 2'-O-methylation
chembl:CHEMBL514499,GW843682X
chembl:CHEMBL328710,CHEMBL:CHEMBL328710
chembl:CHEMBL198877,AUS-131
HGNC:13626,CACNG7
MONDO:0009896,"polymyoclonus, infantile"
rxcui:1721073,CARIPRAZINE HYDROCHLORIDE
RGD:1303320,Nqo2
MONDO:0017582,pituitary adenocarcinoma
rxcui:2170225,ONASEMNOGENE ABEPARVOVEC-XIOI
HGNC:4617,GSK3B
HGNC:15766,ADNP
chembl:CHEMBL1393904,MIRIPIRIUM
HGNC:851,ATP6V1A
HP:0010529,Echolalia
rxcui:203085,PENTOBARBITAL SODIUM
ncit:C88295,BIRINAPANT
rxcui:61455,MIZOLASTINE
drugbank:DB17038,NSC-663284
chembl:CHEMBL2313445,CHEMBL:CHEMBL2313445
HP:0032678,Eyelid myoclonia seizure
drugbank:DB07768,EPITESTOSTERONE
MONDO:0008767,neuronal ceroid lipofuscinosis 3
rxcui:1919083,MIDOSTAURIN
chembl:CHEMBL606159,CHEMBL:CHEMBL606159
HGNC:21061,SERAC1
CHEBI:33019,diphosphate(3-)
Reactome:R-CEL-71403,Citric acid cycle (TCA cycle)
ncit:C38142,ALVESPIMYCIN
iuphar.ligand:4080,[3H]CGS19755
HP:0001269,Hemiparesis
EMAPA:18207,caudate nucleus
MONDO:0012103,spinocerebellar ataxia type 25
ncit:C74940,ALVOCIDIB
chembl:CHEMBL609027,CHEMBL:CHEMBL609027
rxcui:1791685,PIMAVANSERIN
ncit:C90833,AMFONELIC ACID
ncit:C745,PICIBANIL
HP:0001507,Growth abnormality
HP:0032883,Focal aware cognitive seizure with deja vu/jamais vu
CHEBI:45863,paclitaxel
iuphar.ligand:8984,JNJ-39758979
ncit:C96038,HER2-TARGETED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE MM-302
HP:0002533,Abnormal posturing
HGNC:15927,ERGIC3
UBERON:0004534,right testis
MONDO:0011743,Alzheimer disease 4
ncit:C142929,APTIGANEL HYDROCHLORIDE
rxcui:10827,TRIMETHADIONE
drugbank:DB14979,MARTINOSTAT
CL:2000007,articular chondrocyte of knee joint
MGI:3723224,Tg(PDGFB-SNCA)4Ema/0  [background:] involves: C57BL/6 * DBA/2
CHEBI:35352,organonitrogen compound
ncit:C169791,ATALUREN
HGNC:10526,SALL2
MGI:107286,Man2b1
chembl:CHEMBL521171,CHEMBL:CHEMBL521171
MGI:3834589,Tg(ATN1*)Q129Stsu/0  [background:] involves: 129S/SvEv * C57BL/6J
rxcui:318,ADENOSINE TRIPHOSPHATE
chembl:CHEMBL1098875,CHEMBL:CHEMBL1098875
GO:0016787,hydrolase activity
iuphar.ligand:4297,RO19-4603
CHEBI:26605,saponin
chembl:CHEMBL1459280,CHEMBL:CHEMBL1459280
MONDO:0010820,autosomal recessive juvenile Parkinson disease 2
NCBIGene:281193,GJA1
chembl:CHEMBL210574,PYROCATECHOL VIOLET
chembl:CHEMBL225852,GLAUCINE METHIODIDE
chembl:CHEMBL296411,TRISMETHOXYRESVERATROL
MP:0020449,decreased microglial cell activation
MP:0000160,kyphosis
HP:0003448,Decreased sensory nerve conduction velocity
chembl:CHEMBL1521174,2-MERCAPTONICOTINIC ACID
MGI:3624551,Mecp2<sup>tm1Hzo</sup>/Y  [background:] involves: 129S7/SvEvBrd * C57BL/6J
MONDO:0007088,Alzheimer disease type 1
CHEBI:28915,fosfomycin
chembl:CHEMBL2028066,CHEMBL:CHEMBL2028066
rxcui:37985,TETRAZEPAM
iuphar.ligand:3901,MEN10627
HP:0001317,Abnormal cerebellum morphology
MONDO:0014179,inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3
HGNC:10322,MRPL23
iuphar.ligand:8326,MINIMISED RELAXIN-3 ANALOGUE 3
CHEBI:64089,vanoxerine
HP:0000238,Hydrocephalus
HP:4000072,Abnormal language feature
iuphar.ligand:12843,LY3463251
CHEBI:82892,"1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole"
drugbank:DB16774,TYRPHOSTIN B48
rxcui:17939,ANIRACETAM
rxcui:2474340,CLASCOTERONE
chembl:CHEMBL403989,TG100-801
UBERON:0000311,extensor muscle
HP:0032802,Focal impaired awareness cognitive seizure with dyscalculia/acalculia
HP:0003745,Sporadic
chembl:CHEMBL581868,CHEMBL:CHEMBL581868
chembl:CHEMBL582715,CHEMBL:CHEMBL582715
chembl:CHEMBL282622,FAGARONINE
iuphar.ligand:4094,&ALPHA;3IA
chembl:CHEMBL11458,CHEMBL:CHEMBL11458
iuphar.ligand:1813,[TYR36]-PTHRP-(1-36) AMIDE (HUMAN)
chembl:CHEMBL121516,BIS(PIPERIDINYLTHIOCARBONYL)DISULFIDE
rxcui:27100,OMACETAXINE MEPESUCCINATE
HGNC:20692,TPH2
drugbank:DB12290,PUERARIN
HP:0032768,Focal aware autonomic seizure with pupillary dilation/constriction
HGNC:11585,TBL1X
HGNC:2154,PLK3
chembl:CHEMBL4297288,HYDRONIDONE
RGD:1302648,LEC/Hok
ncit:C87425,AMPHETAMINE ADIPATE
MONDO:0021189,intestinal motility disease
chembl:CHEMBL239559,ISOORIENTIN
chembl:CHEMBL608862,CHEMBL:CHEMBL608862
ZFIN:ZDB-GENE-030131-9076,anxa5b
drugbank:DB13022,LY-2874455
chembl:CHEMBL580421,CHEMBL:CHEMBL580421
CHEBI:63611,moxifloxacin
MONDO:0021193,neuroepithelial neoplasm
MGI:3698725,Tmie<sup>sr</sup>/Tmie<sup>sr</sup>  [background:] B6.B(CBA)-Tmie<sup>sr</sup>/J
ncit:C1279,PINGYANGMYCIN
rxcui:1670303,TIPIRACIL HYDROCHLORIDE
HP:0000543,Optic disc pallor
HGNC:6546,COG2
chembl:CHEMBL1339206,CHEMBL:CHEMBL1339206
HP:0010820,Focal emotional seizure with crying
HP:0034307,Elevated left ventricular end-diastolic diameter
HP:0001151,Impaired horizontal smooth pursuit
HP:0001264,Spastic diplegia
CLINVAR:51267,NC_000013.11:g.32316478AG[2]
HP:0007039,Symmetric lesions of the basal ganglia
MP:0005353,abnormal patella morphology
ncit:C107240,L-METHYLFOLATE
chembl:CHEMBL252417,CHEMBL:CHEMBL252417
MONDO:0011794,obsolete Dravet syndrome
MONDO:0012479,congenital malabsorptive diarrhea 4
chembl:CHEMBL1379243,CHEMBL:CHEMBL1379243
ncit:C163578,ALDICARB
ncit:C152322,SELFOTEL
HGNC:34412,TMEM132E-DT
chembl:CHEMBL4650278,SNDX-5613
HP:0002656,Epiphyseal dysplasia
chembl:CHEMBL582486,CHEMBL:CHEMBL582486
HGNC:9954,REL
HGNC:13575,BRD4
iuphar.ligand:7914,BV-6
chembl:CHEMBL362863,CHEMBL:CHEMBL362863
iuphar.ligand:3329,SR2640
ncit:C585,RECOMBINANT INTERLEUKIN-1-BETA
chembl:CHEMBL67535,CHEMBL:CHEMBL67535
chembl:CHEMBL486004,KLUGINE
drugbank:DB11448,PHOSMET
ncit:C81118,SOFALCONE
MONDO:0006173,conjunctival squamous cell carcinoma
HGNC:16049,PTGES3
HP:0007107,Segmental peripheral demyelination
ncit:C66041,LUMIRACOXIB
rxcui:89552,PHENOXYETHANOL
chembl:CHEMBL2105643,FOSBRETABULIN TROMETHAMINE
rxcui:325887,MICAFUNGIN
MONDO:0008617,inflammatory bowel disease 11
CHEBI:53665,oxazinoquinoline
HP:0001300,Parkinsonism
FB:FBgn0050169,Brca2
iuphar.ligand:10371,COMPOUND 20 [PMID: 30998356]
MGI:3838994,Atp8a2<sup>wl</sup>/Atp8a2<sup>wl</sup>  [background:] involves: C57BL/6J
iuphar.ligand:1217,A-349821
HGNC:4198,GCM2
iuphar.ligand:9389,SB590885
HP:0001370,Rheumatoid arthritis
ncit:C1571,ALVOCIDIB HYDROCHLORIDE
CHEBI:75885,2-pyranones
ncit:C131541,TIMOLUMAB
ncit:C90946,TRELANSERIN
HGNC:8638,KAT2B
chembl:CHEMBL1545737,CHEMBL:CHEMBL1545737
MONDO:0012933,"breast-ovarian cancer, familial, susceptibility to, 2"
iuphar.ligand:7000,CURCUMIN
HGNC:13825,ASPSCR1
MGI:4415286,Pla2g6<sup>m1Sein</sup>/Pla2g6<sup>m1Sein</sup>  [background:] C57BL/6JJcl-Pla2g6<sup>m1Sein</sup>
iuphar.ligand:10632,ITACNOSERTIB
HGNC:18402,UBXN1
ncit:C66029,LOMERIZINE
HP:0009592,Astrocytoma
MGI:4441291,Gla<sup>tm1Kul</sup>/Gla<sup>tm1Kul</sup> Itpr1<sup>wblo</sup>/Itpr1<sup>wblo</sup>  [background:] B6;129-Gla<sup>tm1Kul</sup> Itpr1<sup>wblo</sup>/GrsrJ
chembl:CHEMBL1092023,EOSIN_Y
iuphar.ligand:579,PMX53
HP:5200050,Excessive checking
HP:0012469,Infantile spasms
UBERON:0004081,cerebellum vermis lobule VII
MGI:1261831,Hap1
iuphar.ligand:5031,NEUREGULIN-4
iuphar.ligand:10166,MBX-2982
HGNC:30350,RPF1
chembl:CHEMBL3545295,AVE0847
iuphar.ligand:8975,IL-34
iuphar.ligand:11678,VEPAFESTINIB
iuphar.ligand:10255,NG291
rxcui:11248,VITAMIN B12
iuphar.ligand:5183,5-LOX ACTIVATING PROTEIN
rxcui:6984,MINOXIDIL
chembl:CHEMBL607309,CHEMBL:CHEMBL607309
chembl:CHEMBL1899565,GEOPYXIN A
iuphar.ligand:2019,SRIF-14
HGNC:10848,SHH
rxcui:1368451,GLYCEROL PHENYLBUTYRATE
chembl:CHEMBL1904600,"TRIS(2,3-DIBROMOPROPYL)PHOSPHATE"
HP:0100710,Impulsivity
rxcui:1314351,ESCULIN
rxcui:31435,VALRUBICIN
RGD:2088,Aldh3a1
HGNC:21636,KIAA0408
chembl:CHEMBL85685,CHRYSENE
HGNC:239,ADCY8
rxcui:7455,NITROFURAZONE
CL:0012000,astrocyte of the forebrain
iuphar.ligand:1739,REACTIVE BLUE-2
HGNC:14061,LPXN
ncit:C166623,AMILOMOTIDE
rxcui:1311137,ACETALDEHYDE
HP:0003737,Mitochondrial myopathy
iuphar.ligand:3272,[3H]PIRENZEPINE
chembl:CHEMBL1231413,BIPHENYL
MONDO:0008459,spinocerebellar atrophy with pupillary paralysis
MGI:107188,Arnt2
HGNC:10298,RPL10
chembl:CHEMBL4297935,RG-7841
ncit:C72089,BROMEBRIC ACID
rxcui:33717,PINACIDIL
chembl:CHEMBL284121,ILX23-7553
rxcui:258230,METHIXENE HYDROCHLORIDE
rxcui:16735,ACETOPHENAZINE
iuphar.ligand:8872,COMPOUND 1A [PMID: 18573659]
ZFIN:ZDB-GENE-031125-4,hipk2
MONDO:0014497,polyendocrine-polyneuropathy syndrome
MGI:3624718,Mecp2<sup>tm1.1Bird</sup>/Mecp2<sup>+</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6
GO:0099118,microtubule-based protein transport
HGNC:6692,LRP1
GO:0031156,regulation of sorocarp development
rxcui:9000,PYRIDOSTIGMINE
iuphar.ligand:6406,COMPOUND 47 [PMID: 21295468]
HGNC:29853,HECW2
rxcui:5552,HYDROXYUREA
rxcui:1347,BECLOMETHASONE
HP:0007830,Adult-onset night blindness
MGI:1915267,Mrm2
MGI:3812458,Gan<sup>tm1Jpj</sup>/Gan<sup>tm1Jpj</sup>  [background:] involves: C57BL/6
chembl:CHEMBL234338,CHEMBL:CHEMBL234338
iuphar.ligand:6419,COMPOUND 24 [PMID: 23374867]
HGNC:20772,TUBB3
HGNC:3067,DUSP12
iuphar.ligand:6308,OLEOCANTHAL
chembl:CHEMBL2171803,CHEMBL:CHEMBL2171803
MONDO:0044202,episodic kinesigenic dyskinesia
chembl:CHEMBL399249,(R)-PINOCEMBRIN
drugbank:DB15161,PITTSBURGH COMPOUND B
drugbank:DB13934,LIGANDROL
RGD:1311401,Prpf40a
rxcui:68139,ROCURONIUM
ncit:C80997,NERISPIRDINE
ncit:C827,SEMUSTINE
HP:0007325,Generalized dystonia
MONDO:0010556,X-linked chondrodysplasia punctata
rxcui:9010,PYRIMETHAMINE
rxcui:866,ANTAZOLINE PHOSPHATE
rxcui:25112,FLUMEQUINE
iuphar.ligand:10434,COMPOUND 5B  [PMID: 31287314]
HGNC:7602,MYO5A
MGI:3699323,Bckdk<sup>Gt(VICT48)710Lex</sup>/Bckdk<sup>Gt(VICT48)710Lex</sup>  [background:] B6.129S5/SvEvBrd-Bckdk<sup>Gt(VICT48)710Lex</sup>
chembl:CHEMBL1887067,NALED
rxcui:35208,QUINAPRIL
chembl:CHEMBL581880,CHEMBL:CHEMBL581880
rxcui:662019,PRALATREXATE
MONDO:0006647,anterior cerebral artery infarction
CL:0000695,Cajal-Retzius cell
iuphar.ligand:8036,PF-4708671
chembl:CHEMBL155265,DNQX
HGNC:11049,SLC6A3
HP:0100963,Hyperesthesia
NCBIGene:282705,PSEN1
chembl:CHEMBL3545287,LY2624803
MGI:104633,Tle4
drugbank:DB05263,CAPROSPINOL
drugbank:DB05403,CEP-1347
MONDO:0009784,ophthalmoplegic neuromuscular disorder with abnormal mitochondria
GO:0010243,response to organonitrogen compound
HP:0004447,Poikilocytosis
iuphar.ligand:3621,SEA
HGNC:4010,FUS
iuphar.ligand:5739,COMPOUND 8G [PMID: 21444206]
chembl:CHEMBL1491099,GANGALEOIDIN
ncit:C90620,PHANQUONE
MGI:6220717,Gt(ROSA)26Sor<sup>tm1(H1/tetO-RNAi:Fxn)Dhg</sup>/Gt(ROSA)26Sor<sup>+</sup>  [background:] B6.129-Gt(ROSA)26Sor<sup>tm1(H1/tetO-RNAi:Fxn)Dhg</sup>
HP:0001339,Lissencephaly
rxcui:236460,TIZANIDINE HYDROCHLORIDE
ncit:C28178,PHYTOSTEROL
ncit:C81147,QUIFENADINE
HGNC:20370,TEX29
iuphar.ligand:3982,&ALPHA;-CONOTOXIN PNIA
HP:0002460,Distal muscle weakness
ncit:C64621,LEXATUMUMAB
HGNC:320,AGER
HGNC:9811,RAD21
HGNC:9382,PRKACG
chembl:CHEMBL601367,CHEMBL:CHEMBL601367
iuphar.ligand:8426,TD-8954
EMAPA:16405,limb
rxcui:901805,VELAGLUCERASE ALFA
chembl:CHEMBL2171807,CHEMBL:CHEMBL2171807
HP:0012179,Craniofacial dystonia
HGNC:9352,PRDX1
chembl:CHEMBL1818099,SUVANINE'S SODIUM SALT
chembl:CHEMBL272005,CHEMBL:CHEMBL272005
HGNC:12627,USP4
MGI:5310735,Mecp2<sup>tm1.1Joez</sup>/Y  [background:] B6.129-Mecp2<sup>tm1.1Joez</sup>
MONDO:0032860,"intellectual developmental disorder, autosomal recessive 72"
CHEBI:2639,amiloride
rxcui:318341,CETUXIMAB
chembl:CHEMBL600701,CHEMBL:CHEMBL600701
drugbank:DB13088,AZD-0424
chembl:CHEMBL1269177,DICHLOFLUANID
MGI:4999987,Col1a1<sup>tm4(tetO-GFP/RNAi:Apc)Slowe</sup>/Col1a1<sup>+</sup> Gt(ROSA)26Sor<sup>tm1(rtTA*M2)Jae</sup>/Gt(ROSA)26Sor<sup>+</sup>  [background:] involves: 129S4/SvJae * C57BL/6
HGNC:5046,HNRNPM
rxcui:37925,ORLISTAT
iuphar.ligand:733,WIN55212-2
chembl:CHEMBL486196,ANGUSTIBALIN
HGNC:29898,C15orf48
CL:0002603,astrocyte of the cerebellum
MGI:5695547,Tg(NEFH-tTA)8Vle/0 Tg(tetO-TARDBP*)4Vle/0  [background:] involves: C3H/HeJ * C57BL/6J
ncit:C155293,AUTOLOGOUS CCR4-CD30CAR-CD28-CD3ZETA-EXPRESSING T-LYMPHOCYTES
HGNC:14294,SHANK3
GO:0016485,protein processing
iuphar.ligand:2223,D(CH2)5[TYR(ME)2]AVP
chembl:CHEMBL600692,CHEMBL:CHEMBL600692
HGNC:18270,HHAT
iuphar.ligand:126,(+)-WAY 100135
iuphar.ligand:8042,VE-821
rxcui:82005,DIPHENOXYLATE HYDROCHLORIDE
rxcui:2397,CHLOROTRIANISENE
chembl:CHEMBL311489,CHEMBL:CHEMBL311489
HP:0001773,Short foot
HGNC:8975,PIK3CA
MONDO:0012436,neonatal diabetes mellitus with congenital hypothyroidism
MGI:3819012,Dst<sup>tm1Efu</sup>/Dst<sup>tm1Efu</sup>  [background:] involves: C57BL/6
HP:0033048,Substantia nigra hypointensity on susceptibility-weighted imaging
HGNC:12637,KDM6A
EMAPA:35668,patella
HGNC:4908,HIBCH
chembl:CHEMBL607138,CHEMBL:CHEMBL607138
ncit:C138996,ICOTINIB
chembl:CHEMBL532909,CHEMBL:CHEMBL532909
HP:0002600,Hyporeflexia of lower limbs
CLINVAR:1478168,NM_001040142.2(SCN2A):c.5636T>C (p.Met1879Thr)
HP:0003691,Scapular winging
chembl:CHEMBL311469,2-ACETYLAMINOFLUORENE
MONDO:0010247,X-linked cerebral adrenoleukodystrophy
iuphar.ligand:9402,MLN0905
HGNC:20073,SNX27
HP:0002076,Migraine
UPHENO:0080280,decreased limb coordination
UBERON:0008266,periodontal ligament
iuphar.ligand:3432,7-HYDROXYCHOLESTEROL
rxcui:10528,THROMBIN
rxcui:476250,DULOXETINE HYDROCHLORIDE
MGI:6101473,Fxn<sup>tm1.1Pand</sup>/Fxn<sup>tm1Mkn</sup>  [background:] B6.Cg-Fxn<sup>tm1.1Pand</sup> Fxn<sup>tm1Mkn</sup>/J
chembl:CHEMBL585966,CHEMBL:CHEMBL585966
drugbank:DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
HGNC:14289,NLGN3
UPHENO:0051753,abnormal independent continuant creatinine level
chembl:CHEMBL211670,CHEMBL:CHEMBL211670
ncit:C173633,BRAF INHIBITOR BGB-3245
UPHENO:0080593,abnormal anxiety-related behavior
CHEBI:3393,carbenicillin
drugbank:DB06021,AV-412
chembl:CHEMBL1236602,CHEMBL:CHEMBL1236602
HGNC:2347,CREB3
ncit:C844,STREPTONIGRIN
MGI:2449470,Dmrt3
HGNC:24972,HCFC2
HGNC:7106,ATXN3
CHEBI:38166,organic heteropolycyclic compound
CHEBI:16349,L-citrulline
iuphar.ligand:2328,CHARYBDOTOXIN
ncit:C275,ANTIOXIDANT
ncit:C166736,GUSACITINIB
drugbank:DB13035,AG-24322
iuphar.ligand:4066,(+)-HA966
HGNC:18484,DUSP18
chembl:CHEMBL589715,CHEMBL:CHEMBL589715
chembl:CHEMBL592332,CHEMBL:CHEMBL592332
chembl:CHEMBL4594569,KY-1005
rxcui:7715,ORPHENADRINE
chembl:CHEMBL586982,CHEMBL:CHEMBL586982
RGD:628709,Cyp3a18
iuphar.ligand:2014,"L-362,855"
MGI:3832684,Mecp2<sup>tm2Bird</sup>/Y Tg(CAG-cre/Esr1*)5Amc/0  [background:] involves: 129P2/OlaHsd * C57BL/6 * CBA
HP:0001402,Hepatocellular carcinoma
iuphar.ligand:6689,[3H]N5-METHYLFOLATE
ncit:C877,THIOINOSINE
CL:0000094,granulocyte
iuphar.ligand:1664,NALOXONE BENZOYLHYDRAZONE
iuphar.ligand:8584,AQ-RA 741
HP:0003089,Hamstring contractures
chembl:CHEMBL259615,CHEMBL:CHEMBL259615
CHEBI:33572,resorcinols
iuphar.ligand:8951,NVS-1
Reactome:R-RNO-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
ncit:C2626,HUANG LIAN
MONDO:0007539,"encephalopathy, recurrent, of childhood"
ncit:C116867,HDM2 INHIBITOR MK-8242
HP:0003551,Difficulty climbing stairs
HP:0012108,Open angle glaucoma
chembl:CHEMBL576383,OLIVOMYCIN I
CHEBI:57762,L-valine zwitterion
ncit:C69145,MITOGEN-ACTIVATED PROTEIN KINASE KINASE INHIBITOR
iuphar.ligand:10445,COMPOUND 23 [PMID: 31398032]
rxcui:221057,AMPHETAMINE ASPARTATE
HP:0500078,Alternating hypotropia
HGNC:12509,UBQLN2
MONDO:0011819,spinocerebellar ataxia type 19/22
iuphar.ligand:3907,R3(B&DELTA;23-27)R/I5 CHIMERIC PEPTIDE
WB:WBGene00020506,dop-3
iuphar.ligand:12143,WNY0824
chembl:CHEMBL1934283,OPHIOBOLIN O
rxcui:218337,METHADONE HYDROCHLORIDE
iuphar.ligand:11252,C3A RECEPTOR AGONIST
rxcui:2438,CHOLESTEROL
WB:WBGene00009353,sdhd-1
HGNC:10832,SH3GL3
ncit:C2203,ACRIDINE CARBOXAMIDE
HGNC:8066,NUP62
HGNC:7608,MYO9A
UPHENO:0076807,abnormal corpus callosum morphology
HGNC:10680,SDHA
rxcui:135481,CANDESARTAN CILEXETIL
chembl:CHEMBL581194,CHEMBL:CHEMBL581194
chembl:CHEMBL293864,FRAXINE
HP:0032691,Focal cognitive seizure with dyscalculia/acalculia
chembl:CHEMBL90017,ALPHA-TERTHIENYL
HGNC:11205,SP1
HGNC:2240,COPS5
HGNC:17123,SLC9A7
HGNC:9950,RECQL5
RGD:628847,Mapk9
HGNC:26661,RNF168
rxcui:142442,NAPROXEN SODIUM
MONDO:0015339,adrenomyeloneuropathy
MGI:107404,Tbr1
HGNC:9216,POU3F3
chembl:CHEMBL1256763,NITRALIN
rxcui:5942,CLIOQUINOL
rxcui:58918,PROCATEROL HYDROCHLORIDE
HP:0008591,Congenital conductive hearing impairment
MONDO:0006054,reproductive system neoplasm
drugbank:DB08142,AT-7519
chembl:CHEMBL3545278,ATX08-001
iuphar.ligand:6645,VANILLYLMANDELIC ACID
rxcui:203177,HYDROMORPHONE HYDROCHLORIDE
MGI:1891808,Tollip
ncit:C2320,TEROXIRONE
MONDO:0005062,lymphoma
HP:0002135,Basal ganglia calcification
HP:0032692,Focal cognitive seizure with forced thinking
ncit:C1195,PICEATANNOL
chembl:CHEMBL1588679,CHEMBL:CHEMBL1588679
HGNC:10597,SCN9A
HP:0032680,Focal cognitive seizure
rxcui:3131,DEFEROXAMINE
MONDO:0033361,"developmental and epileptic encephalopathy, 52"
CHEBI:36386,dichloroacetic acid
HGNC:17142,OPTN
rxcui:10759,TRIAMCINOLONE
ncit:C1344,PIVALOYLOXYMETHYLBUTYRATE
HGNC:5960,IKBKB
HP:0001873,Thrombocytopenia
HGNC:17895,UBE2S
HP:0008736,Hypoplasia of penis
chembl:CHEMBL86464,CHEMBL:CHEMBL86464
iuphar.ligand:2827,HPTE
drugbank:DB12848,PF-04217903
rxcui:3616,DOBUTAMINE
HGNC:13404,PCDH10
iuphar.ligand:1649,GR 89696
iuphar.ligand:2190,D[LEU4]AVP
HGNC:1775,CDK5R1
iuphar.ligand:4149,CALCISEPTINE
HGNC:18171,CD244
iuphar.ligand:1192,"5-(N,N-HEXAMETHYLENE)-AMILORIDE"
HGNC:6482,LAMA2
RGD:1306853,Traf6
HGNC:16684,MRPL53
chembl:CHEMBL109480,TANESPIMYCIN
ncit:C76820,TILNOPROFEN ARBAMEL
rxcui:52769,MILRINONE
MONDO:0018585,pediatric arterial ischemic stroke
rxcui:1364430,APIXABAN
chembl:CHEMBL260028,CHEMBL:CHEMBL260028
HP:0010521,Gait apraxia
rxcui:1294580,GEMTUZUMAB OZOGAMICIN
chembl:CHEMBL17442,CHEMBL:CHEMBL17442
rxcui:1523,BETHANIDINE
iuphar.ligand:9451,DF2593A
CHEBI:600103,daptomycin
chembl:CHEMBL608855,CHEMBL:CHEMBL608855
CLINVAR:95378,NM_001042537.1(SLC9A6):c.1072C>T (p.Gln358Ter)
chembl:CHEMBL2108328,AMILOMOTIDE
RGD:1306040,Creb3l2
chembl:CHEMBL1591080,METHOXYVONE
iuphar.ligand:9104,PLX7486
iuphar.ligand:4948,HB-EGF
FB:FBgn0014028,SdhB
CHEBI:55370,imidazolidinone
HGNC:17286,EXOSC1
MONDO:0015494,isolated dystonia
iuphar.ligand:8010,NU-7441
HP:0007371,Corpus callosum atrophy
HGNC:18730,H2BC1
MGI:4360542,Grin2a<sup>tm1Nak</sup>/Grin2a<sup>tm1Nak</sup>  [background:] involves: 129S/SvEv
HP:0032742,Focal aware emotional seizure with pleasure
UPHENO:0088328,abnormally decreased number of neuron in the central nervous system
MGI:5056392,Tg(Prnp-ATN1)124Dbo/?  [background:] involves: C3H * C57BL/6
HGNC:17620,NDEL1
HGNC:2093,CLTCL1
ncit:C117985,NELIPEPIMUT-S
MONDO:0011364,autosomal recessive nonsyndromic hearing loss 16
rxcui:24464,ETHAVERINE
HGNC:20766,TUBA1A
HGNC:8810,PDK2
HGNC:16372,FAM8A1
chembl:CHEMBL1256778,CHEMBL:CHEMBL1256778
chembl:CHEMBL1090440,METHYL YELLOW
ncit:C97997,PROPICONAZOLE
HP:0032856,Focal aware bilateral motor seizure
ncit:C166706,EDIVOXETINE
iuphar.ligand:6449,COMPOUND 10 [PMID: 15482908]
HGNC:568,AP3D1
HP:0000037,Male pseudohermaphroditism
GO:0004115,"3',5'-cyclic-AMP phosphodiesterase activity"
MGI:3767200,Cp<sup>tm1Hrs</sup>/Cp<sup>tm1Hrs</sup> Heph<sup>sla</sup>/Y  [background:] involves: 129X1/SvJ * C57BL/6
MONDO:0007603,Felty syndrome
iuphar.ligand:9459,ML354
iuphar.ligand:4086,[3H]L689560
TS:17,
HGNC:20771,TUBB4B
iuphar.ligand:2776,2MD
iuphar.ligand:1821,"[ILE5,TRP23]PTHRP-(5-36)"
NCBIGene:415876,DHODH
HGNC:11495,SYN2
MGI:5052366,Tg(JPH3*)CXwy/0  [background:] involves: FVB/N
HP:0002607,Bowel incontinence
drugbank:DB02877,AROTINOID ACID
ncit:C97948,RUTHENIUM-BASED TRANSFERRIN TARGETING AGENT NKP-1339
iuphar.ligand:1241,N-[3H]METHYLHISTAMINE
ncit:C97362,OMIGAPIL
iuphar.ligand:9600,MIVAVOTINIB
chembl:CHEMBL1489769,LASALOCID A SODIUM
iuphar.ligand:8586,AE9C90CB
iuphar.ligand:2183,DVDAVP
MONDO:0011216,hemochromatosis type 2A
rxcui:203204,BUPROPION HYDROCHLORIDE
chembl:CHEMBL3544981,TAVILERMIDE
iuphar.ligand:3219,[3H]N-METHYL-AZ10419369
MGI:97515,Pcsk5
MGI:103227,Cmah
GO:0014070,response to organic cyclic compound
GO:0051592,response to calcium ion
rxcui:9793,SILVER SULFADIAZINE
rxcui:2570736,MOBOCERTINIB
iuphar.ligand:403,SCH 58261
MGI:5750701,Atxn3<sup>tm2.1(ATXN3*)Mfig</sup>/Atxn3<sup>+</sup>  [background:] involves: 129 * C57BL/6J
chembl:CHEMBL1330352,CHEMBL:CHEMBL1330352
rxcui:225852,LEUCOVORIN CALCIUM
CHEBI:46774,polyether
UPHENO:0084118,abnormally dilated third ventricle
chembl:CHEMBL1560118,APIOL
GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activity"
HP:0000992,Cutaneous photosensitivity
chembl:CHEMBL84281,CHEMBL:CHEMBL84281
iuphar.ligand:8432,JNJ-18038683
chembl:CHEMBL528734,CHEMBL:CHEMBL528734
rxcui:1362698,CHLOROFORM
chembl:CHEMBL1438389,CHEMBL:CHEMBL1438389
HP:0045081,Abnormality of body mass index
ZFIN:ZDB-GENE-030131-2921,dlat
chembl:CHEMBL186141,ANDROGRAPHOLIDE
chembl:CHEMBL75267,"7,8-DIHYDROXYFLAVONE"
HGNC:5269,HSPE1
ncit:C2036,KETANSERIN TARTRATE
iuphar.ligand:4248,LY392098
rxcui:1368647,FERULIC ACID
CHEBI:42820,guanidine
chembl:CHEMBL1669042,TERPESTACIN
HGNC:4332,BICRA
rxcui:2596,CLOMIPHENE
HP:0001427,Mitochondrial inheritance
ncit:C82390,AFURESERTIB
iuphar.ligand:4272,NS1619
MGI:3513541,Slc12a3<sup>tm1Ges</sup>/Slc12a3<sup>tm1Ges</sup>  [background:] Not Specified
rxcui:2054984,LUSUTROMBOPAG
HGNC:4963,HLA-F
ncit:C81535,LAPAQUISTAT ACETATE
iuphar.ligand:4095,&ALPHA;5IA
chembl:CHEMBL3833333,NABIXIMOLS
MP:0001961,abnormal reflex
rxcui:274964,CICLESONIDE
chembl:CHEMBL230686,CHEMBL:CHEMBL230686
ncit:C1194,PHYTOESTROGEN
CHEBI:194135,"9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid"
CHEBI:6121,ketamine
GO:0032695,negative regulation of interleukin-12 production
HP:0000957,Cafe-au-lait spot
iuphar.ligand:484,NORADRENALINE
HP:0000054,Micropenis
iuphar.ligand:3221,CP94253
ncit:C79844,VOLASERTIB
rxcui:236690,NARATRIPTAN HYDROCHLORIDE
chembl:CHEMBL515617,CHEMBL:CHEMBL515617
chembl:CHEMBL593110,CHEMBL:CHEMBL593110
iuphar.ligand:6658,GB88
MGI:94924,Drd2
chembl:CHEMBL588804,CHEMBL:CHEMBL588804
FB:FBgn0001223,Hsp22
NCBIGene:403568,RAD51
MGI:102897,Pcsk6
HP:0002200,Pseudobulbar signs
iuphar.ligand:221,SB 204741
chembl:CHEMBL144530,CHLORALIN
ncit:C1531,RECOMBINANT EOTAXIN
chembl:CHEMBL1305393,CHEMBL:CHEMBL1305393
iuphar.ligand:12502,LY3540378
drugbank:DB12853,DA-6886
GO:0043951,negative regulation of cAMP-mediated signaling
HP:0100705,Abnormal glial cell morphology
drugbank:DB14944,TARLOXOTINIB
iuphar.ligand:1253,IODOPROXYFAN
MGI:3849712,Mycbp2<sup>m274-4Tpo</sup>/Mycbp2<sup>m274-4Tpo</sup>  [background:] involves: C57BL/6J * SSL/LeJ
HGNC:13867,SH3KBP1
HGNC:21957,KCTD7
ncit:C70948,POLO-LIKE KINASE 1 INHIBITOR GSK461364
MP:0000823,abnormal lateral ventricle morphology
MONDO:0014167,"epilepsy, familial adult myoclonic, 5"
HGNC:3118,E2F4
MONDO:0010798,proximal tubulopathy-diabetes mellitus-cerebellar ataxia syndrome
FB:FBgn0032723,ssp3
MONDO:0006684,brain edema
drugbank:DB02056,PROSTAGLANDIN D2
chembl:CHEMBL560303,N-METHYLCALOTHRIXIN B
drugbank:DB17612,INTERMEDINE
chembl:CHEMBL165064,ISOKAEMPFERIDE
rxcui:6294,LOFEPRAMINE HYDROCHLORIDE
MONDO:0010803,Eiken syndrome
HP:0002977,Aplasia/Hypoplasia involving the central nervous system
MONDO:0009255,galactokinase deficiency
HGNC:22932,GMPPB
iuphar.ligand:8963,BO1
iuphar.ligand:10547,THAL-SNS-032
MGI:2181202,Pfkfb3
ncit:C62518,PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER AVI-4126
rxcui:203179,DOXEPIN HYDROCHLORIDE
chembl:CHEMBL449081,AGROCLAVINE
HGNC:13890,ITCH
chembl:CHEMBL4650301,VALILTRAMIPROSATE
MONDO:0006617,vesiculobullous skin disease
chembl:CHEMBL604321,CHEMBL:CHEMBL604321
GO:0060176,regulation of aggregation involved in sorocarp development
rxcui:4648,GALLOPAMIL
NCBIGene:281515,TBCD
ncit:C77601,LANICEMINE
MONDO:0006368,phosphaturic mesenchymal tumor
Reactome:R-GGA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
iuphar.ligand:11934,ASP5878
MONDO:0017640,cyanide-induced parkinsonism
rxcui:4053,ERYTHROMYCIN
chembl:CHEMBL449158,BRYOSTATIN
HP:0032698,Focal cognitive seizure with conduction dysphasia/aphasia
rxcui:235955,CLENBUTEROL HYDROCHLORIDE
MGI:107810,Tfam
HP:0100615,Ovarian neoplasm
rxcui:6064,ISOTRETINOIN
chembl:CHEMBL277346,OCTYL_GALLATE
MONDO:0010814,chondrodysplasia-pseudohermaphroditism syndrome
HGNC:20842,FOXP4
ncit:C153094,TETMYB DNA VACCINE
MONDO:0011630,retinitis pigmentosa 28
drugbank:DB06973,BISPHENOL A
ncit:C61919,QUIPAZINE
chembl:CHEMBL600309,CHEMBL:CHEMBL600309
iuphar.ligand:9913,FLUMBATINIB
MONDO:0859165,"neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities"
rxcui:91118,IMIPRAMINE PAMOATE
RGD:3729,Snca
MONDO:0850130,gastroesophageal adenocarcinoma
UBERON:0001509,triceps brachii
rxcui:4603,FUROSEMIDE
chembl:CHEMBL4795065,BORUSSERTIB
iuphar.ligand:5280,TOFA
iuphar.ligand:4079,[3H]CGP61594
iuphar.ligand:10489,COMPOUND 12B [PMID: 31465220]
UBERON:0005030,mucosa of paranasal sinus
MONDO:0014941,"arthrogryposis, distal, with impaired proprioception and touch"
HP:0003226,Rectilinear intracellular accumulation of autofluorescent lipopigment storage material
HGNC:24537,CHMP2B
iuphar.ligand:8343,135PAM1
HGNC:20947,TOMM20
ncit:C163638,CARBOSULFAN
chembl:CHEMBL1883512,METCONAZOLE
OBA:2001017,age of onset of allergic disease
iuphar.ligand:8788,HM50316
HGNC:25070,ACD
iuphar.ligand:4,5-CT
rxcui:29648,METHDILAZINE
rxcui:1919503,DURVALUMAB
iuphar.ligand:2825,DIARYLPROPIONITRILE
chembl:CHEMBL10118,FAMOXADONE
HGNC:257,ADK
iuphar.ligand:1669,5'-GUANIDINONALTRINDOLE
ncit:C166519,ELPETRIGINE
rxcui:1364449,CROFELEMER
FB:FBgn0262432,mir-8
drugbank:DB04098,BALANOL
ncit:C2089,PROTEIN KINASE C INHIBITOR
CHEBI:40303,lovastatin
iuphar.ligand:7495,APICIDIN
HGNC:8800,PDGFB
iuphar.ligand:10508,MK-8719
HGNC:7699,NDUFB4
OBA:2001030,age of onset of myopia
CHEBI:9150,simvastatin
ncit:C76885,CIPRALISANT MALEATE
rxcui:2383942,REMIMAZOLAM BESYLATE
chembl:CHEMBL122005,(S)-WILLARDIINE
rxcui:10565,THYROGLOBULIN
iuphar.ligand:2440,CD2+
HGNC:6393,KIF2C
iuphar.ligand:10023,LRE1
drugbank:DB14633,PREDNISOLONE HEMISUCCINATE
MONDO:0009266,Gaucher disease type II
drugbank:DB05966,TAS-108
HGNC:7683,NDUFA1
iuphar.ligand:5902,PSB1114
ncit:C114287,ALK/TRK INHIBITOR TSR-011
HP:0010837,Decreased circulating ceruloplasmin concentration
drugbank:DB16095,APG-1387
ncit:C71355,RIGOSERTIB SODIUM
rxcui:1299782,CEPHALEXIN ANHYDROUS
HGNC:4927,SLC39A7
UBERON:0002446,patella
chembl:CHEMBL596839,CHEMBL:CHEMBL596839
drugbank:DB12096,PF-05175157
HP:0003756,Skeletal myopathy
HP:0000154,Wide mouth
rxcui:59064,PIPERIDOLATE
HGNC:4008,FUCA2
chembl:CHEMBL1481721,CHEMBL:CHEMBL1481721
HGNC:9787,KIF20A
HGNC:12962,TRIM26
rxcui:10811,TRIHEXYPHENIDYL
drugbank:DB16044,PF-05212377
MONDO:0010683,X-linked myotubular myopathy
ncit:C103179,PINOMETOSTAT
chembl:CHEMBL585769,CHEMBL:CHEMBL585769
HGNC:15633,TLR9
rxcui:221100,FENOFIBRATE MICRONIZED
chembl:CHEMBL3120215,OSI-027
iuphar.ligand:7720,ML218
chembl:CHEMBL106562,"2-METHOXY-1,4-NAPHTHOQUINONE"
chembl:CHEMBL1606248,IRETOL
iuphar.ligand:3319,PSN632408
iuphar.ligand:9663,KA1010
ncit:C179280,ALLITINIB
HGNC:17032,VSIG4
rxcui:31782,NIFUROXAZIDE
chembl:CHEMBL3544960,AT-13148
MONDO:0016430,Balo concentric sclerosis
drugbank:DB07430,"(10R)-10-METHYL-3-(6-METHYLPYRIDIN-3-YL)-9,10,11,12-TETRAHYDRO-8H-[1,4]DIAZEPINO[5',6':4,5]THIENO[3,2-F]QUINOLIN-8-ONE"
HGNC:4410,GNG7
MP:0004080,abnormal nucleus accumbens morphology
HGNC:17440,COP1
HGNC:12674,VDAC3
MONDO:0005578,arthritic joint disease
ncit:C111997,ANTI-HER3 MONOCLONAL ANTIBODY GSK2849330
rxcui:42351,LITHIUM CARBONATE
CHEBI:474180,caspofungin
MGI:103169,Scn8a
FB:FBgn0265464,Traf6
iuphar.ligand:7643,AEE788
UBERON:0000964,cornea
chembl:CHEMBL1078244,CHEMBL:CHEMBL1078244
ncit:C152301,SAREDUTANT
HGNC:21701,BRAT1
HGNC:7939,NPPA
rxcui:203114,AMIODARONE HYDROCHLORIDE
iuphar.ligand:10116,S5A1
ncit:C1120,HALOFUGINONE
UBERON:0004720,cerebellar vermis
rxcui:24395,ESTRADIOL VALERATE
ncit:C153137,ORLUDODSTAT
MGI:103266,Fgl2
ncit:C156880,HSP90 INHIBITOR
iuphar.ligand:3795,"[125I]NKA (HUMAN, MOUSE, RAT)"
MONDO:0015780,dyskeratosis congenita
rxcui:203185,MEPIVACAINE HYDROCHLORIDE
ncit:C76963,ESMIRTAZAPINE
MONDO:0014455,cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome
MGI:894681,Usp9x
MONDO:0006757,extrahepatic cholestasis
HP:0007370,Aplasia/Hypoplasia of the corpus callosum
chembl:CHEMBL533921,CHEMBL:CHEMBL533921
rxcui:34372,PREDNISOLONE ACETATE
iuphar.ligand:8913,AMG-337
HGNC:24583,DOK3
MP:0000755,hindlimb paralysis
iuphar.ligand:9460,AC264613
chembl:CHEMBL2109413,AS-1409
rxcui:6853,METHOXAMINE
MGI:6278937,Atp2b1<sup>Tg(Thy1-CHMP2B*)1Rene</sup>/Atp2b1<sup>+</sup>  [background:] involves: C57BL/6 * DBA/2 * FVB/N
HP:0001395,Hepatic fibrosis
rxcui:10635,TOLBUTAMIDE
EMAPA:36922,inferior rectus extraocular muscle
HGNC:12672,VDAC2
rxcui:11065,URSODIOL
HP:0007311,Short stepped shuffling gait
rxcui:352372,DEXMETHYLPHENIDATE
iuphar.ligand:1569,JMV431
MP:0012506,brain atrophy
NCBIGene:326346,NDUFA11
HP:0003307,Hyperlordosis
HP:0000218,High palate
MGI:103288,Polr1c
chembl:CHEMBL3545314,DUSQUETIDE
iuphar.ligand:1572,JMV458
chembl:CHEMBL228132,CHEMBL:CHEMBL228132
HGNC:18996,VRK3
MP:0003995,abnormal uterine artery morphology
chembl:CHEMBL254609,(R)-FELODIPINE
GO:1904659,glucose transmembrane transport
iuphar.ligand:12530,BI 749327
chembl:CHEMBL1364172,CHEMBL:CHEMBL1364172
HP:0030584,Color vision test abnormality
iuphar.ligand:302,OXOTREMORINE
UBERON:0002371,bone marrow
drugbank:DB06096,NXN-188
iuphar.ligand:10540,CHGB (511-532)
HP:0032830,Neonatal seizure with bilateral asymmetric automatism
MGI:97588,Pou1f1
chembl:CHEMBL560296,CHEMBL:CHEMBL560296
HGNC:11509,SYT1
rxcui:47858,METHSUXIMIDE
HP:0002168,Scanning speech
HGNC:573,AP4E1
chembl:CHEMBL589421,CHEMBL:CHEMBL589421
rxcui:1291301,AVANAFIL
ncit:C80994,ELIPRODIL
iuphar.ligand:274,RO 04-6790
UBERON:0001150,body of pancreas
CL:0000527,efferent neuron
ncit:C170291,PEFICITINIB
chembl:CHEMBL1613209,CEAROIN
iuphar.ligand:8949,A-196
ncit:C79569,BAPINEUZUMAB
UBERON:0004510,skeletal muscle tissue of pectoralis major
iuphar.ligand:147,DOI
ncit:C112001,LADIRATUZUMAB VEDOTIN
UBERON:0005363,inferior vagus X ganglion
HGNC:15521,KCNIP1
MGI:6393456,Spast<sup>tm1.1Evre</sup>/Spast<sup>tm1.1Evre</sup>  [background:] C57BL/6-Spast<sup>tm1.1Evre</sup>
iuphar.ligand:9321,(B7-33)H2
rxcui:1098,ARGIPRESSIN
rxcui:319868,"1,4-BENZOQUINONE"
ncit:C85523,THIOACETAZONE
drugbank:DB00466,PICROTOXIN
HP:0002171,Gliosis
MONDO:0001973,Brucella abortus brucellosis
HGNC:10979,SLC25A1
rxcui:3247,DESIPRAMINE
chembl:CHEMBL466426,DIFENOCONAZOLE
CHEBI:50851,hydrocortamate
HGNC:25815,CEP63
iuphar.ligand:9735,GROWTH DIFFERENTIATION FACTOR 15
ncit:C65607,EXALAMIDE
chembl:CHEMBL4101487,GALICAFTOR
MONDO:0014959,"mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant"
HGNC:7007,RAB8A
HP:0002110,Bronchiectasis
chembl:CHEMBL1310138,CHEMBL:CHEMBL1310138
chembl:CHEMBL477052,CHEMBL:CHEMBL477052
ncit:C73022,ARANIDIPINE
iuphar.ligand:2195,OH-LVA
HGNC:11825,NKX2-1
MGI:3033772,Hoxa3<sup>tm1Mrc</sup>/Hoxa3<sup>tm1Mrc</sup>  [background:] involves: 129S7/SvEvBrd
iuphar.ligand:3874,EUROPIUM-LABELLED RELAXIN
MONDO:0021135,rare or common
rxcui:1362,DIPHENHYDRAMINE HYDROCHLORIDE
chembl:CHEMBL1223742,7-O-METHYLCRYPTOCHINONE A
rxcui:5302,HEXOBARBITAL
rxcui:154876,THIOPHENE
ncit:C79911,FADROZOLE
MONDO:0010857,semantic dementia
MP:0009972,absent hippocampus pyramidal cells
GO:0000776,kinetochore
iuphar.ligand:9209,ZOLBETUXIMAB
chembl:CHEMBL1331995,CHEMBL:CHEMBL1331995
HGNC:17358,TPK1
rxcui:262302,NOMIFENSINE MALEATE
CLINVAR:126203,NM_000059.4(BRCA2):c.9227G>T (p.Gly3076Val)
iuphar.ligand:3774,[125I]C5A (HUMAN)
HGNC:13741,SNTG2
HP:0032813,Neonatal electro-clinical motor seizure
HGNC:9706,NECTIN1
ncit:C155850,VOCIPROTAFIB
CHEBI:17754,glycerol
HP:0012196,Cheyne-Stokes respiration
HP:0000465,Webbed neck
rxcui:221058,AMPICILLIN (ANHYDROUS)
UPHENO:0034434,decreased level of creatinine in blood
iuphar.ligand:10257,GR-389988
HP:0025336,Delayed ability to sit
WB:WBGene00006411,octr-1
drugbank:DB16045,TERN-101
RGD:2154,Arnt2
iuphar.ligand:8336,MINIMISED RELAXIN-3 ANALOGUE 2
iuphar.ligand:7027,GSK-J1
MGI:108482,Hrh2
iuphar.ligand:9610,CBS-3595
rxcui:9863,SODIUM CHLORIDE
iuphar.ligand:12663,TRULI
MGI:104627,Dst
ncit:C170121,LIAFENSINE
rxcui:42837,P-AMINOHIPPURATE
HGNC:2295,CP
GO:0045944,positive regulation of transcription by RNA polymerase II
MONDO:0100053,anaphylaxis
rxcui:2597523,HYPOTAURINE
iuphar.ligand:12073,CAMONSERTIB
GO:0030553,cGMP binding
GO:0099191,trans-synaptic signaling by BDNF
HGNC:8633,PBX2
PATO:0070006,cortical bipolar morphology
chembl:CHEMBL578905,CHEMBL:CHEMBL578905
HGNC:10071,RNF8
HP:0000126,Hydronephrosis
MONDO:0011842,GRN-related frontotemporal lobar degeneration with Tdp43 inclusions
HGNC:20461,NME7
MP:0004078,abnormal caudate nucleus morphology
MP:0004166,abnormal limbic system morphology
MONDO:0012134,"myoclonic epilepsy, juvenile, susceptibility to, 3"
chembl:CHEMBL2208196,CHEMBL:CHEMBL2208196
iuphar.ligand:1791,"[125I][NLE8,21,TYR34]PTH-(1-34)-NH2 (RAT)"
UPHENO:0085541,abnormally increased number of thyrotroph
CLINVAR:189732,NM_001110792.2(MECP2):c.907_1080del (p.Ile305_Ser362del)
MGI:4420466,Cdkn1a<sup>tm1Tyj</sup>/Cdkn1a<sup>tm1Tyj</sup> Rb1<sup>tm1Tyj</sup>/Rb1<sup>tm1Tyj</sup> Tg(Rb1)1Blg/0  [background:] involves: 129S2/SvPas
HGNC:2746,DDX5
MGI:104626,Strbp
iuphar.ligand:10198,INT-767
HGNC:4851,HTT
MONDO:0011849,psoriatic arthritis
ncit:C2363,AMINOGLYCOSIDE ANTIBIOTIC
chembl:CHEMBL4747845,BGP-15
ncit:C117229,TUSAMITAMAB RAVTANSINE
ncit:C73023,AZELNIDIPINE
MONDO:0043537,cluster headache syndrome
iuphar.ligand:5037,PD173074
iuphar.ligand:5169,CJ13610
iuphar.ligand:114,"L-775,606"
iuphar.ligand:12554,QUINAZOLIN-4(3H) DERIVATIVE 36
iuphar.ligand:9054,PF-04191834
WB:WBGene00008887,tbcd-1
CHEBI:3647,chlorpromazine
HP:0001583,Rotary nystagmus
iuphar.ligand:5189,FMH
CHEBI:24789,indanones
HP:0012622,Chronic kidney disease
ncit:C2496,ANTI-VEGF MONOCLONAL ANTIBODY
CHEBI:35476,antipsychotic agent
iuphar.ligand:8159,COMPOUND 25 [PMID: 20855207]
rxcui:203135,PROPAFENONE HYDROCHLORIDE
chembl:CHEMBL105310,"2',4'-DIHYDROXYCHALCONE"
CHEBI:77906,minocycline zwitterion
ncit:C152413,SPARSOMYCIN
HP:0007843,Attenuation of retinal blood vessels
iuphar.ligand:2356,CS+
iuphar.ligand:8153,COMPOUND 22M [PMID: 19831390]
FB:FBgn0286784,TER94
ncit:C201513,ANTI-CD30 CAR T CELLS PREPARATION
rxcui:2595243,PACRITINIB
HGNC:28127,CPLANE2
HGNC:9612,PTK2B
chembl:CHEMBL487356,CHEMBL:CHEMBL487356
HGNC:4431,GOSR2
HP:0000298,Mask-like facies
MONDO:0014677,achromatopsia 7
UPHENO:0078006,decreased reflex in cornea
HP:0003657,Vascular granular osmiophilic material deposition
iuphar.ligand:8259,CM-352
HGNC:4446,GPAA1
iuphar.ligand:12088,DALMELITINIB
MONDO:0042972,meningococcemia
rxcui:853491,CANAKINUMAB
HGNC:11364,STAT3
iuphar.ligand:7822,AZD6088
UPHENO:0051271,abnormal vestibular reflex
HP:0001283,Bulbar palsy
ncit:C77178,BACILLUS CALMETTE-GUERIN ANTIGEN
rxcui:1362743,DIPYRITHIONE
HGNC:9539,PSMB2
MONDO:0015362,"neuronopathy, distal hereditary motor, autosomal dominant"
chembl:CHEMBL2181046,CHEMBL:CHEMBL2181046
MGI:102959,Ube2a
chembl:CHEMBL1256835,CHEMBL:CHEMBL1256835
rxcui:28981,LORACARBEF
ncit:C1941,RECOMBINANT TUMOR NECROSIS FACTOR FAMILY PROTEIN
MGI:5008273,Hipk2<sup>tm1Ejh</sup>/Hipk2<sup>tm1Ejh</sup>  [background:] involves: 129X1/SvJ * C57BL/6
HGNC:12825,XPO1
chembl:CHEMBL122355,CHEMBL:CHEMBL122355
chembl:CHEMBL452954,CHEMBL:CHEMBL452954
ncit:C65338,CLIOXANIDE
rxcui:2058509,DUVELISIB
MONDO:0044720,cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
rxcui:2362165,CAPMATINIB
HGNC:9812,RAD23A
UPHENO:0074388,abnormally decreased rate of aquatic locomotion
EMAPA:18547,head of caudate nucleus
drugbank:DB15092,LY-2624803
iuphar.ligand:3195,COMPOUND 16 [PMID: 18800762]
rxcui:2059173,TIOXOLONE
MONDO:0007191,Behcet disease
rxcui:1808,BUMETANIDE
drugbank:DB12055,MK-0767
rxcui:657797,TEMSIROLIMUS
iuphar.ligand:11911,R3/I5- SMBIT
chembl:CHEMBL398363,CHEMBL:CHEMBL398363
CLINVAR:207239,NM_001042537.1(SLC9A6):c.643G>A (p.Ala215Thr)
HP:0031767,Consecutive esotropia
iuphar.ligand:12141,XY-06-007
MONDO:0012849,Joubert syndrome 9
chembl:CHEMBL249447,"3,5-DICAFFEOYLQUINIC ACID"
wikidata:Q4803642,ACETYLSALICYLIC ACID/DIPYRIDAMOLE
rxcui:59838,HALAZONE
MGI:1345964,Coro1c
ncit:C1685,DULANERMIN
HP:0030319,Weakness of facial musculature
rxcui:31448,NABUMETONE
ncit:C118281,ANTI-MET/EGFR MONOCLONAL ANTIBODY LY3164530
ncit:C111993,CERALASERTIB
rxcui:89729,ACRISORCIN
UBERON:0001601,extra-ocular muscle
MGI:2147834,Slc6a8
HP:0020046,Accommodative esotropia
iuphar.ligand:10073,COMPOUND 6 [PMID: 30125504]
rxcui:6847,METHOHEXITAL
ncit:C1925,LYSOZYME
MGI:4420391,Nfe2l2<sup>tm1Mym</sup>/Nfe2l2<sup>tm1Mym</sup>  [background:] involves: 129P2/OlaHsd * CD-1
chembl:CHEMBL124162,CAMPTOTHECIN-20-O-PROPIONATE
MGI:6415340,Tg(FOXJ1-ACE2)1Rba/0  [background:] involves: C3H * C57BL/6
CHEBI:456215,adenosine 5'-monophosphate(2-)
HGNC:17514,HOMER3
UBERON:0001604,levator palpebrae superioris
HP:0001133,Constriction of peripheral visual field
rxcui:6825,METHARBITAL
HP:0006530,Abnormal pulmonary interstitial morphology
iuphar.ligand:4251,LY503430
iuphar.ligand:8121,ML347
rxcui:7995,PENTAMIDINE ISETHIONATE
HGNC:7715,NDUFS8
FB:FBgn0033762,ZnT49B
chembl:CHEMBL81782,CHEMBL:CHEMBL81782
HGNC:6040,ILK
MONDO:0014561,"3-methylglutaconic aciduria, type VIIB"
ncit:C175739,ALDUMASTAT
HP:0007281,Developmental stagnation
iuphar.ligand:10671,MC2050
ncit:C97703,PIMETHIXENE MALEATE
HGNC:7685,NDUFA2
HP:0003744,Genetic anticipation with paternal anticipation bias
MONDO:0018181,staphylococcal scalded skin syndrome
iuphar.ligand:9978,ONC201
rxcui:1421444,ETILEVODOPA
ZFIN:ZDB-GENE-030131-8062,cox7c
HP:0007350,Hyperreflexia in upper limbs
MONDO:0030971,immunodeficiency 78 with autoimmunity and developmental delay
MGI:3707972,Disc1<sup>Rgsc1393</sup>/Disc1<sup>Rgsc1393</sup>  [background:] B6.Cg-Disc1<sup>Rgsc1393</sup>
iuphar.ligand:2819,PROPYLPYRAZOLETRIOL
iuphar.ligand:2022,[125I]CGP 23996
iuphar.ligand:2040,BIM 23068
chembl:CHEMBL12014,HARMAN
drugbank:DB08660,QUINALIZARIN
rxcui:1426941,MERCURIC IODIDE
HGNC:30074,POLR3A
HGNC:7125,MLF1
HGNC:21176,RMND1
HGNC:1014,BCR
rxcui:6398,LINCOMYCIN
rxcui:1546446,OMACETAXINE
HGNC:2207,COL4A5
HP:0003698,Difficulty standing
rxcui:38365,TOFISOPAM
Xenbase:XB-GENE-22069487,cbr1.2
HGNC:800,ATP1A2
FB:FBgn0029868,ND-B16.6
HP:0001347,Hyperreflexia
MP:0012676,dilated brain ventricle
rxcui:33764,PIRARUBICIN
MGI:4867520,Clock<sup>m1Jt</sup>/Clock<sup>m1Jt</sup>  [background:] involves: BALB/cJ * C57BL/6 * C57BL/6J
MGI:95405,Ephx1
HP:0001419,X-linked recessive inheritance
HP:0007126,Proximal amyotrophy
MGI:5702952,Mecp2<sup>tm6.1Bird</sup>/Y  [background:] involves: 129P2/OlaHsd * C57BL/6
HGNC:13586,FBXO7
HGNC:8666,PCDHA12
chembl:CHEMBL1256646,FENOLDOPAM BROMIDE
rxcui:2199291,EVODIAMINE
MGI:4822571,Tg(CMV-ATXN3*94Q)94Pama/0  [background:] B6.FVB-Tg(CMV-ATXN3*94Q)94Pama
HP:0011031,Abnormality of iron homeostasis
rxcui:236774,FLUPIRTINE MALEATE
rxcui:33253,PHENACEMIDE
MGI:107444,Efna5
rxcui:236400,MINAPRINE HYDROCHLORIDE
FB:FBgn0013717,not
rxcui:719,AMOBARBITAL
rxcui:8686,PRILOCAINE
MONDO:0016591,sporadic adult-onset ataxia of unknown etiology
ncit:C74234,VANITIOLIDE
HP:0030642,Fundus albipunctatus
OBA:2001020,age of onset of Buruli ulcer disease
HP:0000514,Slow saccadic eye movements
GO:1905515,non-motile cilium assembly
iuphar.ligand:11544,BELVARAFENIB
HGNC:13178,IKZF3
chembl:CHEMBL595682,CHEMBL:CHEMBL595682
ncit:C84866,GALETERONE
chembl:CHEMBL275391,CHRYSIN DIMETHYL ETHER
HP:0001886,Foot osteomyelitis
WB:WBGene00006539,tbb-6
chembl:CHEMBL3545299,BMS-698769
MONDO:0958203,"intellectual developmental disorder, autosomal dominant 74"
HP:0007250,Recurrent external ophthalmoplegia
drugbank:DB07931,HEXESTROL
iuphar.ligand:6386,ML SA1
iuphar.ligand:6408,[3H]CTEP
iuphar.ligand:8196,COMPOUND 17D [PMID: 23099093]
UBERON:0035825,left adrenal gland cortex
HGNC:14479,MRPL21
ncit:C170326,PIROMELATINE
rxcui:2590,CLOBETASOL
HP:0002829,Arthralgia
chembl:CHEMBL2105671,AFEGOSTAT TARTRATE
rxcui:2274378,TAZEMETOSTAT
TS:25,
UBERON:0000033,head
HGNC:1615,CCT2
chembl:CHEMBL15193,LAPACHOL
rxcui:2670644,REPOTRECTINIB
drugbank:DB11881,AUY922
ncit:C289,AZASERINE
UBERON:0001234,left adrenal gland
HGNC:16905,KLHL41
HGNC:12796,WT1
dictyBase:DDB_G0290009,spr
HGNC:12840,YARS1
HP:0000096,Glomerular sclerosis
chembl:CHEMBL30432,GW282974X
rxcui:4637,GALANTAMINE
MONDO:0012789,dystonia 16
ncit:C47778,UNOPROSTONE ISOPROPYL
ncit:C97277,TONABERSAT
chembl:CHEMBL1405447,VITAMIN K3H2
HP:0003690,Limb muscle weakness
rxcui:9806,SISOMICIN
GO:0003886,DNA (cytosine-5-)-methyltransferase activity
ncit:C66938,CROLIBULIN
MP:0003232,abnormal forebrain development
dictyBase:DDB_G0277847,pdhC
HP:0011150,Myoclonic absence seizure
ncit:C74393,PIBOSEROD
chembl:CHEMBL184074,CHEMBL:CHEMBL184074
rxcui:593411,SITAGLIPTIN
HP:0006817,Aplasia/Hypoplasia of the cerebellar vermis
chembl:CHEMBL1514569,DALBERGIONE
chembl:CHEMBL1501622,CHEMBL:CHEMBL1501622
rxcui:83213,MIBEFRADIL
HP:0200085,Limb tremor
NCBIGene:395278,GJA1
HGNC:4084,GABRD
HGNC:7732,NEDD8
MONDO:0016089,infantile Krabbe disease
ncit:C80814,DEXBUDESONIDE
rxcui:1655922,LUMACAFTOR
GO:0005654,nucleoplasm
iuphar.ligand:6671,13-CIS-RETINAL
chembl:CHEMBL7660,PHENIDONE
ncit:C1135,INDOLE-3-CARBINOL
ZFIN:ZDB-GENE-040426-1114,znhit3
iuphar.ligand:3306,OLEANOLIC ACID
chembl:CHEMBL3545196,PD-0166285
rxcui:477320,ERLOTINIB HYDROCHLORIDE
ncit:C81463,CLORINDIONE
HGNC:25671,RNASEH2B
ncit:C76665,ALVESPIMYCIN HYDROCHLORIDE
HGNC:18601,RTN4R
rxcui:236495,TAMSULOSIN HYDROCHLORIDE
MP:0000887,delaminated cerebellar granule layer
HP:0000378,Cupped ear
rxcui:21241,CLOBAZAM
iuphar.ligand:4344,XESTOSPONGIN C
HGNC:15448,GOLIM4
chembl:CHEMBL571948,Y-39983
NCBIGene:396086,RAD51
HGNC:6294,KCNQ1
MP:0004753,abnormal miniature excitatory postsynaptic currents
HP:0000742,Self-mutilation
MONDO:0005240,kidney disorder
HP:0002514,Cerebral calcification
HGNC:2867,DHODH
HP:0100727,Histiocytosis
rxcui:45045,AVOBENZONE
RGD:621557,Sdha
ncit:C1967,TYROSINE KINASE INHIBITOR
HGNC:17468,PDLIM5
HP:0032724,Focal impaired awareness tonic seizure
MGI:2176492,Gja8<sup>tm1Paul</sup>/Gja8<sup>tm1Paul</sup>  [background:] involves: 129S4/SvJae * C57BL/6J
HP:0002515,Waddling gait
iuphar.ligand:8125,COMPOUND 12 [PMID: 22521646]
iuphar.ligand:11564,IRIGENOL
MP:0010060,abnormal creatine level
chembl:CHEMBL192626,CHEMBL:CHEMBL192626
HP:0007291,Posterior fossa cyst
rxcui:828682,FOSPROPOFOL
ncit:C72684,AGOMELATINE
chembl:CHEMBL1326164,CHEMBL:CHEMBL1326164
rxcui:1596928,DODECYL GALLATE
drugbank:DB15006,FLUFENOXURON
MP:0000869,abnormal cerebellum posterior vermis morphology
rxcui:12488,HYDROXYPROGESTERONE CAPROATE (USP)
drugbank:DB11982,GDC-0623
ncit:C131175,ANTI-EGFR/HER2/HER3 MONOCLONAL ANTIBODY MIXTURE SYM013
chembl:CHEMBL508779,CAULIBUGULONE B
EMAPA:17019,principal vein of hindlimb
iuphar.ligand:11623,GUMARONTINIB
HGNC:11173,SNX2
UBERON:0004262,upper leg skin
rxcui:3393,DIFLUNISAL
MONDO:0015150,complex hereditary spastic paraplegia
HGNC:13585,FBXO6
rxcui:2549,CINNARIZINE
HP:0012082,Cerebellar Purkinje layer atrophy
CHEBI:16134,ammonia
RGD:2320148,Tbcd
chembl:CHEMBL2326966,SF-1126
ncit:C107384,MILADEMETAN TOSYLATE
HGNC:2294,COX8A
chembl:CHEMBL5095344,CEBSULFASE ALFA
iuphar.ligand:8061,MK-5108
CLINVAR:133180,NM_001042723.2(RYR1):c.7039_7041GAG[1] (p.Glu2348del)
ncit:C1480,DAMNACANTHAL
ncit:C72628,LINSIDOMINE
rxcui:2106337,AMIFAMPRIDINE PHOSPHATE
GO:0006432,phenylalanyl-tRNA aminoacylation
iuphar.ligand:7704,AZD2927
HGNC:13448,SLC38A2
ncit:C65289,CARPHENAZINE MALEATE
MGI:3818068,Scn8a<sup>med-J</sup>/Scn8a<sup>med-J</sup>  [background:] involves: STOCK Krt71<sup>Ca</sup>
MONDO:0006323,non-seminomatous lesion
HGNC:5021,FOXA1
MGI:98325,Smpd1
HGNC:9862,RAP2B
iuphar.ligand:8390,ORY-1001
HP:0000510,Rod-cone dystrophy
HP:0007083,Hyperactive patellar reflex
rxcui:46307,AMLEXANOX
HP:0000083,Renal insufficiency
iuphar.ligand:11759,GALEGENIMAB
ncit:C174657,NIDUFEXOR
HP:0007326,Progressive choreoathetosis
ncit:C73045,BILASTINE
rxcui:588250,MILNACIPRAN
rxcui:91217,CHLOROTHIAZIDE SODIUM
ncit:C79841,TALMAPIMOD
HGNC:4942,HLA-DQA1
HGNC:14857,COG5
CLINVAR:143585,NM_001110792.2(MECP2):c.505T>A (p.Phe169Ile)
MONDO:0957875,"neuronopathy, distal hereditary motor, autosomal dominant 11"
GO:0005929,cilium
MONDO:0006732,drug-induced dyskinesia
chembl:CHEMBL535331,CHEMBL:CHEMBL535331
ncit:C71537,ACADESINE
HGNC:1185,TIGAR
chembl:CHEMBL581225,CHEMBL:CHEMBL581225
chembl:CHEMBL1332182,CHEMBL:CHEMBL1332182
ncit:C84511,IMETELSTAT SODIUM
HGNC:592,XIAP
HGNC:13433,ROBO3
HGNC:18116,KHDRBS1
iuphar.ligand:11624,NINGETINIB
rxcui:1427193,DIETHYLDITHIOCARBAMATE
iuphar.ligand:2829,BIOCHANIN A
iuphar.ligand:375,CGS 21680
iuphar.ligand:5437,ML169
rxcui:1367175,ARBUTIN
ncit:C76959,PRINABEREL
iuphar.ligand:4152,CBIQ
MONDO:0010733,hereditary spastic paraplegia 2
HGNC:11433,STX1A
ZFIN:ZDB-GENE-040426-1566,cox6b2
rxcui:20473,CEFAMANDOLE NAFATE
iuphar.ligand:8069,CP-673451
chembl:CHEMBL3545079,PLX-5622
CLINVAR:51330,NC_000013.11:g.32316486del
HP:0002164,Nail dysplasia
ncit:C81539,SOBETIROME
ncit:C71146,SALIRASIB
ncit:C264,ANTICONVULSANT AGENT
HGNC:3367,ENTPD5
ncit:C77440,EBROTIDINE
HP:0001363,Craniosynostosis
chembl:CHEMBL200762,CHEMBL:CHEMBL200762
chembl:CHEMBL599255,CHEMBL:CHEMBL599255
MGI:1278321,Epc2
HGNC:17975,REEP2
MONDO:0019052,inborn errors of metabolism
rxcui:5657,IFOSFAMIDE
rxcui:27130,CEFPIROME
iuphar.ligand:2612,ERGTX-1
HGNC:5275,KAT5
ncit:C90944,PICLOZOTAN
MONDO:0019118,inherited retinal dystrophy
chembl:CHEMBL1426508,CHEMBL:CHEMBL1426508
rxcui:7781,OXAZEPAM
iuphar.ligand:680,BRADYZIDE
HGNC:25845,NAA40
iuphar.ligand:8521,PF-01247324
rxcui:3356,DICLOXACILLIN
chembl:CHEMBL1420457,CHEMBL:CHEMBL1420457
HP:0000400,Macrotia
chembl:CHEMBL275260,CHEMBL:CHEMBL275260
ncit:C123925,ZANDELISIB
CHEBI:57538,orotidine 5'-phosphate(3-)
HGNC:14631,ADAMTSL2
Reactome:R-DRE-611105,Respiratory electron transport
ncit:C64620,ZALUTUMUMAB
CLINVAR:156615,NM_001110792.2(MECP2):c.1165_1234del (p.Lys389fs)
HGNC:10417,RPS27A
ncit:C152156,RAPASTINEL
Xenbase:XB-GENE-5823411,mtarc1
chembl:CHEMBL3545359,ARRY-300
chembl:CHEMBL3545418,BMS-779788
HGNC:12632,USP9X
HP:0000482,Microcornea
MGI:5428212,Apc2<sup>tm1Mno</sup>/Apc2<sup>tm1Mno</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
iuphar.ligand:8019,SB-415286
HGNC:27638,SYPL2
ncit:C188265,PELABRESIB
rxcui:18889,BENOXINATE
HP:0008760,Violent behavior
HGNC:7880,CNOT4
iuphar.ligand:12432,CUCURBITACIN B
HGNC:2095,CLU
iuphar.ligand:1264,[123I]IODOPROXYFAN
MGI:1925976,Scaper
chembl:CHEMBL589915,CHEMBL:CHEMBL589915
rxcui:1000146,ESTRADIOL CYPIONATE
iuphar.ligand:4243,LY233053
HGNC:28607,IQCF1
HP:0001629,Ventricular septal defect
chembl:CHEMBL582496,CHEMBL:CHEMBL582496
chembl:CHEMBL1551453,FURATHIOCARB
rxcui:154985,NALBUPHINE HYDROCHLORIDE
iuphar.ligand:8549,BENZOQUINAZOLINONE 12
HP:0008768,Inappropriate sexual behavior
UBERON:0001134,skeletal muscle tissue
iuphar.ligand:5720,(R)-N-OLEOYLTYROSINOL
iuphar.ligand:10232,SUVN-G3031
HP:0011800,Midface retrusion
chembl:CHEMBL586344,CHEMBL:CHEMBL586344
rxcui:10763,TRIAMTERENE
MONDO:0020352,"multiple system atrophy, parkinsonian type"
HGNC:17303,TAF3
HP:0033725,Thin corpus callosum
MONDO:0016624,inherited deficiency anemia
GO:0006811,monoatomic ion transport
chembl:CHEMBL591630,CHEMBL:CHEMBL591630
HP:0012714,Severe hearing impairment
chembl:CHEMBL529640,CHEMBL:CHEMBL529640
iuphar.ligand:5948,CDK2 INHIBITOR III
MGI:3719716,Atcay<sup>ji</sup>/Atcay<sup>ji</sup>  [background:] JIGR
HGNC:445,SETX
ncit:C152216,RIGOSERTIB
iuphar.ligand:7838,BMS-582949
ncit:C97917,GLYCOOPTIMIZED TRASTUZUMAB-GEX
FB:FBgn0275436,PheRS-m
chembl:CHEMBL2436861,TRIMETHYL-[3-(TETRADECANE-1-SULFONYLAMINO)-PROPYL]-AMMONIUM IODIDE
rxcui:110,OXYQUINOLINE
iuphar.ligand:2211,"[PHAA1,D-TYR2,VAL4,ARG6,ARG-NH29]AVP"
CHEBI:58017,5-O-phosphonato-alpha-D-ribofuranosyl diphosphate(5-)
iuphar.ligand:2020,SRIF-28
MONDO:0005188,iatrogenic Kaposi's sarcoma
HP:0100299,Muscle fiber inclusion bodies
rxcui:259319,PIOGLITAZONE HYDROCHLORIDE
HGNC:590,BIRC2
ncit:C166496,COLFORSIN
iuphar.ligand:5777,FLTCHAAR
ncit:C125603,BCL-2 INHIBITOR BCL201
ncit:C571,ANTISERUM
rxcui:1433212,LEVOMILNACIPRAN
chembl:CHEMBL483206,CHEMBL:CHEMBL483206
GO:0047499,calcium-independent phospholipase A2 activity
ncit:C64761,CDK INHIBITOR AT7519
MGI:98397,Src
rxcui:18747,BALSALAZIDE
MONDO:0010200,Wilson disease
HGNC:10432,RPS6KA3
UPHENO:0005500,decreased locomotory behavior
chembl:CHEMBL551288,APOGOSSYPOL
iuphar.ligand:7377,EPZ004777
HGNC:23486,ZCWPW1
iuphar.ligand:12873,PIMICOTINIB
chembl:CHEMBL1412489,CHEMBL:CHEMBL1412489
HP:0032818,Neonatal focal clonic seizure
rxcui:21249,CLOCORTOLONE
HP:0000319,Smooth philtrum
ncit:C81395,METACETAMOL
MONDO:0006302,micropapillary serous carcinoma
ncit:C166588,FEVIPIPRANT
rxcui:232158,ROFECOXIB
HP:0000736,Short attention span
MP:0008921,increased neurotransmitter release
HP:0002439,Frontolimbic dementia
HP:0007098,Paroxysmal choreoathetosis
rxcui:19860,BUTALBITAL
CHEBI:26776,stilbenoid
UBERON:0004023,ganglionic eminence
GO:0032816,positive regulation of natural killer cell activation
rxcui:4025,ERGOTAMINE
drugbank:DB16880,ARCTIGENIN
chembl:CHEMBL3545200,S-222611
FB:FBgn0011230,poe
rxcui:28031,ITRACONAZOLE
rxcui:1659191,SONIDEGIB
HGNC:26515,COQ10A
MP:0001522,impaired swimming
ncit:C121641,CITARINOSTAT
chembl:CHEMBL1374986,BISSALICYL FUMARATE
chembl:CHEMBL537087,CHEMBL:CHEMBL537087
ncit:C74052,IODINE I 131-6-BETA-IODOMETHYL-19-NORCHOLESTEROL
rxcui:253453,PEGINTERFERON ALFA-2B
chembl:CHEMBL259784,CHEMBL:CHEMBL259784
ncit:C107245,AGERAFENIB
MGI:2668535,Hprt1<sup>tm6Detl</sup>/Y  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
chembl:CHEMBL259805,CHEMBL:CHEMBL259805
MGI:3624685,Mecp2<sup>tm1Jae</sup>/Y Tg(Camk2a-cre)93Kln/0  [background:] involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA/J
PomBase:SPCC1259.09c,pdx1
HP:0001545,Anteriorly placed anus
MONDO:0019200,retinitis pigmentosa
MONDO:0100526,"breast-ovarian cancer, familial, susceptibility to"
HGNC:1226,GIPC1
rxcui:60245,IMIDAPRIL
rxcui:120608,PEGINTERFERON ALFA-2A
CHEBI:36836,3beta-hydroxy steroid
iuphar.ligand:216,(+)-NORFENFLURAMINE
HGNC:2765,DEFA6
MONDO:0018053,trichothiodystrophy
ncit:C66376,PHENYL AMINOSALICYLATE
chembl:CHEMBL82242,QUERCITRIN
HP:0031622,Brown anomaly
chembl:CHEMBL599102,CHEMBL:CHEMBL599102
ncit:C83721,FOSBRETABULIN TROMETHAMINE
HGNC:823,ATP5F1A
chembl:CHEMBL590919,CHEMBL:CHEMBL590919
HP:0011705,First degree atrioventricular block
HGNC:30696,WDR36
ZFIN:ZDB-GENE-030131-5175,cox4i1
MP:0008462,abnormal medium spiny neuron morphology
iuphar.ligand:5957,DIACYLGLYCEROL KINASE INHIBITOR II
chembl:CHEMBL172064,E324
CHEBI:17287,N-phosphocreatine
HP:0000070,Ureterocele
chembl:CHEMBL380797,SIRTINOL
rxcui:2389840,VILTOLARSEN
rxcui:6911,METHYSERGIDE
MP:0006219,optic nerve degeneration
chembl:CHEMBL1668777,(R)-SARGACHROMENOL
rxcui:8130,PHENINDIONE
HP:0032727,Focal emotional seizure with agitation
MGI:5476838,Tg(TARDBP*G348C)#Jpj/0  [background:] involves: C3H * C57BL/6
UPHENO:0079834,abnormal irritability behavior
HGNC:17187,OLFM1
rxcui:1426748,IOBENGUANE I-123
chembl:CHEMBL1526240,DIHYDROGAMBOGIC ACID
MONDO:0005113,bacterial infectious disease
chembl:CHEMBL280998,CATECHOL
HGNC:689,ARIH1
ncit:C116863,VOFATAMAB
wikidata:Q29004943,CAELYX
HP:0001279,Syncope
HP:0001399,Hepatic failure
MGI:1921393,Opa1
UBERON:0001155,colon
HGNC:6038,ILF3
iuphar.ligand:271,&ALPHA;-ERGOCRYPTINE
chembl:CHEMBL68534,CHEMBL:CHEMBL68534
HGNC:26944,TMEM138
GO:0004888,transmembrane signaling receptor activity
chembl:CHEMBL1317506,CHEMBL:CHEMBL1317506
chembl:CHEMBL4297684,ABICIPAR PEGOL
iuphar.ligand:2106,SCH 206272
ZFIN:ZDB-GENE-030131-1390,aco2
HP:0007427,Reticulated skin pigmentation
MGI:109185,Ccn3
HGNC:11444,STXBP1
HGNC:7737,NEFH
HP:0010049,Short metacarpal
rxcui:3407,DIGOXIN
CLINVAR:143603,NM_001110792.2(MECP2):c.535C>T (p.Arg179Trp)
GO:0005385,zinc ion transmembrane transporter activity
chembl:CHEMBL64239,CHEMBL:CHEMBL64239
UPHENO:0014064,caudate nucleus atrophy
iuphar.ligand:11340,SBP-7455
HGNC:21107,CEP162
HP:0002938,Lumbar hyperlordosis
rxcui:322167,SOLIFENACIN
ncit:C159200,BCL-2 INHIBITOR
HGNC:7460,MT-ND4L
HGNC:845,ATP5PD
iuphar.ligand:8675,COMPOUND 3 [PMID: 14640538]
MONDO:0001109,petrositis
iuphar.ligand:12492,ISOX-CHA-CHG-ALA-ARG-DPR(4FB)-NH2
iuphar.ligand:581,W54011
drugbank:DB08756,Y-27632
rxcui:121191,RITUXIMAB
ncit:C66569,SULFAPHENAZOLE
chembl:CHEMBL320361,CHEMBL:CHEMBL320361
chembl:CHEMBL3545046,GSK2849466
chembl:CHEMBL3989862,PEFCALCITOL
rxcui:25082,FLOPROPIONE
HP:0032899,Focal orofacial automatism seizure
HGNC:1784,CDKN1A
chembl:CHEMBL4297254,552-02
chembl:CHEMBL547304,CHEMBL:CHEMBL547304
chembl:CHEMBL508030,RHETSININE
chembl:CHEMBL1304363,CHEMBL:CHEMBL1304363
ncit:C169948,ENERISANT
rxcui:54220,XYLOMETAZOLINE HYDROCHLORIDE
Reactome:R-DRE-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL602413,CHEMBL:CHEMBL602413
HP:0001272,Cerebellar atrophy
CL:0000738,leukocyte
ncit:C72637,PRULIFLOXACIN
MONDO:0021063,malignant colon neoplasm
ncit:C118578,VANUCIZUMAB
UPHENO:0080574,decreased extra-ocular muscle strength
HP:0001169,Broad palm
HP:0012713,Moderate hearing impairment
ncit:C72716,BATABULIN
chembl:CHEMBL371523,DIBENZOYLMETHANE
drugbank:DB17554,FF-10501-01
MGI:103007,Epb41l4a
HP:0002220,Melanin pigment aggregation in hair shafts
chembl:CHEMBL1709259,CHEMBL:CHEMBL1709259
chembl:CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE
rxcui:1426886,CYSTEAMINE HYDROCHLORIDE
ncit:C90996,PAMAPIMOD
ncit:C166750,DASOTRALINE
chembl:CHEMBL547656,CHEMBL:CHEMBL547656
ncit:C1112,GELDANAMYCIN
MONDO:0017176,Machado-Joseph disease type 3
MONDO:0014204,"basal ganglia calcification, idiopathic, 5"
HGNC:30551,TXNL4A
HGNC:10858,SIAH2
rxcui:4112,ETHAMSYLATE
HGNC:30863,UQCR10
HGNC:29529,TBL1XR1
rxcui:498509,PEGAPTANIB
rxcui:35829,RANOLAZINE
iuphar.ligand:191,SB 221284
iuphar.ligand:3398,2-THIOUTP
HGNC:3430,ERBB2
HGNC:22977,REG4
NCBIGene:280714,AHR
hemonc:60,BARASERTIB
rxcui:236202,CEFOTIAM HYDROCHLORIDE
ncit:C188595,CIPEPOFOL
UPHENO:0081707,paralysed superior rectus extraocular muscle
rxcui:2672253,GEPIRONE
rxcui:10958,TYRAMINE
HGNC:23338,ACBD5
EMAPA:36921,rectus extraocular muscle
HGNC:12412,TUBB2A
HP:0002888,Ependymoma
rxcui:2052872,PLAZOMICIN SULFATE
chembl:CHEMBL1797708,CHEMBL:CHEMBL1797708
HP:0032733,Focal aware motor seizure with dysarthria/anarthria
rxcui:426,ALANINE
CHEBI:29014,cordycepin
chembl:CHEMBL1371756,GRAVEOLINE
MONDO:0958018,"leukodystrophy, hypomyelinating, 27"
MONDO:0002532,squamous cell neoplasm
HGNC:4585,GRIN2A
MONDO:0006893,Pasteurella hemorrhagic septicemia
iuphar.ligand:8878,AS1949490
ncit:C78838,IMGATUZUMAB
chembl:CHEMBL588327,CHEMBL:CHEMBL588327
iuphar.ligand:7879,BMS-690514
UPHENO:0079534,increased blood role level
iuphar.ligand:11914,INSL3 [A(5-26):B(7-27)]
HGNC:556,AP1G2
rxcui:1043,APOMORPHINE
ncit:C80679,LASOFOXIFENE
iuphar.ligand:8191,COMPOUND 18 [PMID: 20873740]
iuphar.ligand:9807,SUTIMLIMAB
MONDO:0005618,anxiety disorder
MGI:3652375,Fxn<sup>tm1Mkn</sup>/Fxn<sup>tm1Pand</sup>  [background:] involves: 129/Sv * C57BL/6
chembl:CHEMBL526776,CHEMBL:CHEMBL526776
MGI:3829870,Spic<sup>tm1.1Kmm</sup>/Spic<sup>tm1.1Kmm</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6
HGNC:9278,PPM1G
HGNC:15580,PDE4DIP
ncit:C101524,INDUSATUMAB VEDOTIN
drugbank:DB12429,CI-1040
HGNC:26583,PWWP3B
CL:0000119,cerebellar Golgi cell
CHEBI:38925,benzopteridine
HGNC:4385,GNAI2
CHEBI:73693,ketone body
GO:0034241,positive regulation of macrophage fusion
iuphar.ligand:2041,BIM 23197
MGI:3833385,Tg(Thy1-MAPT*K369I)K3Gotz/0  [background:] B6.Cg-Tg(Thy1-MAPT*K369I)K3Gotz
iuphar.ligand:787,CCL11
EMAPA:35228,cerebellum vermis lobule IV
Reactome:R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
MP:0003730,abnormal photoreceptor inner segment morphology
MONDO:0006857,middle cerebral artery infarction
CL:0000117,CNS neuron (sensu Vertebrata)
MP:0000877,abnormal Purkinje cell morphology
HP:0000336,Prominent supraorbital ridges
Reactome:R-BTA-71288,Creatine metabolism
chembl:CHEMBL460508,CHEMBL:CHEMBL460508
ncit:C97663,SAM68 MODULATOR CWP232291
iuphar.ligand:1432,SIB-1893
iuphar.ligand:3529,SB290157
HGNC:18809,TUBA1B
iuphar.ligand:12854,NDI-091143
HGNC:12513,UCHL1
CLINVAR:133202,NM_000540.3(RYR1):c.7360C>T (p.Arg2454Cys)
MONDO:0014282,hereditary spastic paraplegia 72
CHEBI:16469,17beta-estradiol
ncit:C1291,ANTISENSE OLIGONUCLEOTIDES
chembl:CHEMBL1269809,BENZOPHENONE-THIOSEMICARBAZONE
rxcui:3419,DIHYDROERGOTOXINE
drugbank:DB02052,INDIRUBIN-3'-MONOXIME
chembl:CHEMBL344469,"0-HEXYL-1,3-DIAMINE-PLATINUM 2,2-DICHLORIDE"
drugbank:DB11919,6-O-BENZYLGUANINE
HGNC:7876,NOS3
rxcui:6541,ETHOPROPAZINE HYDROCHLORIDE
GO:0048254,snoRNA localization
HGNC:9766,RAB27A
ncit:C1894,ENVIRONMENTAL ESTROGEN
iuphar.ligand:2920,PAMOIC ACID
ncit:C156792,ELRAGLUSIB
CHEBI:3764,clotrimazole
CHEBI:15738,staurosporine
HP:0031008,Lingual dystonia
MONDO:0014331,Moyamoya disease with early-onset achalasia
RGD:13703119,SD-<i>Lamp2<sup>em1</sup></i>
iuphar.ligand:12381,RESENCATINIB
HP:0003387,Decreased number of large peripheral myelinated nerve fibers
iuphar.ligand:2917,JTE-013
rxcui:8761,PROPANTHELINE
MONDO:0014855,"intellectual disability, autosomal dominant 42"
chembl:CHEMBL279678,S-ETOMIDATE
chembl:CHEMBL1341830,CHEMBL:CHEMBL1341830
MONDO:0011818,isolated focal cortical dysplasia type II
ncit:C150248,ERK1/2 INHIBITOR ERAS-007
HGNC:17002,PIAS4
MP:0000551,absent forelimb
iuphar.ligand:4161,CONANTOKIN-G
CHEBI:4469,(S)-amphetamine
NBO:0000120,physical aggression behavior
iuphar.ligand:119,[3H]SUMATRIPTAN
rxcui:2407,CHLORQUINALDOL
HGNC:59,ABCC8
MONDO:0100500,Mendelian neurodevelopmental disorder
chembl:CHEMBL1486366,CHEMBL:CHEMBL1486366
ncit:C106254,TOVORAFENIB
ZFIN:ZDB-GENE-040426-1691,ndufb10
chembl:CHEMBL586033,CHEMBL:CHEMBL586033
HP:0010545,Downbeat nystagmus
rxcui:142444,PROMAZINE HYDROCHLORIDE
iuphar.ligand:12493,ISOX-CHA-CHG-ARK(SULFO-CY5)-NH2
chembl:CHEMBL95704,CHEMBL:CHEMBL95704
MONDO:0001106,kidney failure
MGI:97837,Qki
ncit:C1564,PYRAZOLOACRIDINE
chembl:CHEMBL70141,2-MERCAPTOBENZIMIDAZOLE
CHEBI:453011,ciclopirox
iuphar.ligand:3483,[3H]NELIVAPTAN
MGI:3849439,Tg(Lck-Tal1)4709Led/0  [background:] FVB/N-Tg(Lck-Tal1)4709Led
chembl:CHEMBL1257031,CHEMBL:CHEMBL1257031
MP:0020622,abnormal dorsal striatum cell density
rxcui:2020,CARBIMAZOLE
chembl:CHEMBL1650245,CHEMBL:CHEMBL1650245
drugbank:DB14795,AZD-3759
HGNC:115,ACLY
rxcui:1430441,AFATINIB DIMALEATE
MONDO:0006214,follicular variant thyroid gland papillary carcinoma
MONDO:0007764,"autosomal dominant osteosclerosis, Worth type"
HP:0010549,Weakness due to upper motor neuron dysfunction
ncit:C169934,ELENBECESTAT
rxcui:6904,METHYLTESTOSTERONE
drugbank:DB13174,RHEIN
chembl:CHEMBL114544,CHEMBL:CHEMBL114544
rxcui:2262543,LUSPATERCEPT-AAMT
iuphar.ligand:300,METHYLFURMETHIDE
HP:0011452,Functional abnormality of the middle ear
GO:1903561,extracellular vesicle
MGI:103178,Vegfa
HGNC:16882,HCN4
rxcui:15842,5-METHOXYPSORALEN
ncit:C175876,VIMSELTINIB
HGNC:20376,SUMF1
chembl:CHEMBL1160028,TETRAIDOFLUORESCEIN
CHEBI:16962,cortisone
rxcui:3368,DIENESTROL
HGNC:17168,RAB3GAP2
rxcui:29996,MICRONOMICIN
HP:0032752,Focal impaired awareness emotional seizure with fear/anxiety/panic
chembl:CHEMBL437926,TETRADIFON
iuphar.ligand:4672,OCHRATOXIN A
GO:0035965,cardiolipin acyl-chain remodeling
HGNC:23213,PIGW
rxcui:2610349,BETIBEGLOGENE AUTOTEMCEL
iuphar.ligand:8468,ME0328
iuphar.ligand:8982,INCB-38579
HP:0032882,Focal impaired awareness cognitive seizure with deja vu/jamais vu
MGI:3046797,Tbx1<sup>tm2Bld</sup>/Tbx1<sup>+</sup>  [background:] involves: 129S7/SvEvBrd * C57BL/6
hemonc:38662,FLUMATINIB
ncit:C66417,PIRENPERONE
rxcui:235832,REMOXIPRIDE HYDROCHLORIDE
rxcui:40070,DEXTROTHYROXINE SODIUM
rxcui:2256951,ELEXACAFTOR
HP:0012717,Severe conductive hearing impairment
chembl:CHEMBL92129,CRYPTOLEPINE HYDROCHLORIDE
MGI:5824306,Tg(PDGFB-SNCA/EGFP)78Ema/0  [background:] involves: C57BL/6 * DBA/2
rxcui:68147,CETRORELIX
HGNC:9509,PSEN2
MONDO:0010699,Charcot-Marie-Tooth disease X-linked recessive 5
ncit:C95830,ACLARUBICIN HYDROCHLORIDE
MONDO:0021636,astrocytic tumor
chembl:CHEMBL428789,CHEMBL:CHEMBL428789
HGNC:4234,GEM
MONDO:0011050,microcephaly-cardiac defect-lung malsegmentation syndrome
iuphar.ligand:7885,ENMD-2076
chembl:CHEMBL1235966,SCOULERINE
iuphar.ligand:5016,LIF
iuphar.ligand:11608,EPITINIB
chembl:CHEMBL611494,SALAGEN
chembl:CHEMBL1474,CHEMBL:CHEMBL1474
ncit:C81089,BUTACLAMOL HYDROCHLORIDE
drugbank:DB12878,AV-101
chembl:CHEMBL521941,PEPEROMIN E
rxcui:237112,MYCOPHENOLATE MOFETIL HYDROCHLORIDE
GO:0006515,protein quality control for misfolded or incompletely synthesized proteins
rxcui:18603,AZELASTINE
ncit:C28724,MART-1 ANTIGEN
chembl:CHEMBL3545356,VK5211
iuphar.ligand:7806,PURVALANOL B
HGNC:15449,LGALS13
rxcui:155122,PHENOLPHTHALEIN
drugbank:DB12126,BRADYKININ
HP:0001197,Abnormality of prenatal development or birth
chembl:CHEMBL482050,CHEMBL:CHEMBL482050
ncit:C1529,BATIMASTAT
ncit:C63957,LICOFELONE
HGNC:25223,COQ2
rxcui:35780,ROPIVACAINE
chembl:CHEMBL1256776,CHEMBL:CHEMBL1256776
HGNC:4684,GUCY1A2
iuphar.ligand:574,C5A DES-ARG
chembl:CHEMBL1518369,CUMENE HYDROPEROXIDE
ncit:C155900,FOSMANOGEPIX
HGNC:28212,NAA38
iuphar.ligand:4028,LYSOPHOSPHATIDYLINOSITOL
chembl:CHEMBL375563,CHEMBL:CHEMBL375563
chembl:CHEMBL601146,CHEMBL:CHEMBL601146
HP:0003470,Paralysis
UBERON:0001630,muscle organ
chembl:CHEMBL251230,(S)-NITRENDIPINE
chembl:CHEMBL454511,TRIPHENYL PHOSPHATE
HGNC:10451,RRM1
CHEBI:24436,guanidines
chembl:CHEMBL300389,CHEMBL:CHEMBL300389
HGNC:2315,CPNE2
HGNC:17083,RRS1
HP:0002566,Intestinal malrotation
rxcui:1202,ATENOLOL
MONDO:0025556,isocyanate induced asthma
HGNC:12758,WDR6
rxcui:9066,QUINESTROL
iuphar.ligand:5778,ZM-274773
iuphar.ligand:6409,CTEP
chembl:CHEMBL4297507,DELGOCITINIB
HP:0010873,Cervical spinal cord atrophy
GO:0003714,transcription corepressor activity
ncit:C77912,QUISINOSTAT
iuphar.ligand:6412,VANILLIN
HGNC:18683,EIF4A3
iuphar.ligand:115,TFMPP
ncit:C38139,TALAMPANEL
chembl:CHEMBL452847,CHEMBL:CHEMBL452847
rxcui:10379,TESTOSTERONE
chembl:CHEMBL601534,CHEMBL:CHEMBL601534
HGNC:28027,WDPCP
rxcui:2055929,FOSTAMATINIB DISODIUM
chembl:CHEMBL85194,CHEMBL:CHEMBL85194
NCBIGene:428252,DRD2
ncit:C132991,ALRIZOMADLIN
HP:0030639,Congenital stationary night blindness with abnormal fundus
Xenbase:XB-GENE-5892300,cyp2a6.2
MONDO:0008838,ataxia - deafness - intellectual disability syndrome
iuphar.ligand:5947,CDK1/5 INHIBITOR
drugbank:DB08078,{4-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENOXY)PROPOXY]PHENOXY}ACETIC ACID
rxcui:135447,DONEPEZIL
HGNC:2911,DLST
drugbank:DB12142,DULIGOTUZUMAB
HGNC:1974,CHUK
HGNC:13203,AICDA
MONDO:0005554,rheumatic disorder
UPHENO:0081127,cerebellar vermis hypoplasia
ncit:C106119,SOFITUZUMAB VEDOTIN
rxcui:31994,NORGESTIMATE
MONDO:0005977,tabes dorsalis
iuphar.ligand:6676,(RS)-PPCC
rxcui:203127,MIANSERIN HYDROCHLORIDE
HGNC:3017,DR1
HGNC:28337,C9orf72
HGNC:14957,PUM1
CHEBI:50267,protective agent
MGI:1100537,Mid1
HGNC:13205,STRADB
HGNC:9508,PSEN1
MONDO:0009480,Joubert syndrome with oculorenal defect
rxcui:47111,BIFEMELANE
HP:0005203,Spontaneous esophageal perforation
MP:0006309,decreased retina ganglion cell number
HP:0100490,Camptodactyly of finger
MP:0000756,forelimb paralysis
chembl:CHEMBL592106,CHEMBL:CHEMBL592106
rxcui:20859,CHLOROPROCAINE
MGI:107718,Dnah5
chembl:CHEMBL512908,CHEMBL:CHEMBL512908
HGNC:28912,WDR45
ncit:C81699,MITIGLINIDE
Reactome:R-DRE-390651,Dopamine receptors
HGNC:4876,HERC3
NCBITaxon:2697049,Severe acute respiratory syndrome coronavirus 2
ncit:C87441,BENTAMAPIMOD
MONDO:0958228,"hearing loss, autosomal recessive 122"
UPHENO:0055092,increased reflex
iuphar.ligand:9371,PF-670462
ncit:C90697,OXAPIUM IODIDE
HGNC:19341,CAMK1D
chembl:CHEMBL2269513,MEPANIPYRIM
ncit:C71535,INDOXIMOD
HGNC:9561,PSMD4
chembl:CHEMBL455007,HELIPARVIFOLINE
HP:0000590,Progressive external ophthalmoplegia
rxcui:6673,MECAMYLAMINE
iuphar.ligand:11912,DOTA/EU RELAXIN-3
ncit:C64181,GRAMINE
HGNC:8053,NUDT6
MONDO:0005066,metabolic disease
HP:0004305,Involuntary movements
HGNC:15721,STRN4
drugbank:DB18024,ICG-001
iuphar.ligand:1810,[TYR34]PTH-(1-34) (HUMAN)
ncit:C90894,OCTAVERINE
ncit:C174915,AMCENESTRANT
rxcui:25793,GLIQUIDONE
MONDO:0042964,Machado-Joseph disease type 4
OBA:2020000,age of onset of disease
HP:0008669,Abnormal spermatogenesis
Reactome:R-HSA-8856828,Clathrin-mediated endocytosis
ncit:C83561,BUCILLAMINE
UPHENO:0066726,decreased level of creatine
MP:0002080,prenatal lethality
chembl:CHEMBL2368547,SENNOSIDE A
HGNC:18420,SETD2
iuphar.ligand:5089,VEGFE
CHEBI:15365,acetylsalicylic acid
HGNC:6848,MAP3K1
HGNC:5293,HTR2A
rxcui:18687,BACAMPICILLIN
ncit:C71621,BIRICODAR
iuphar.ligand:9860,VIDOFLUDIMUS
rxcui:6677,MECLOFENAMATE SODIUM
rxcui:236747,PRAMIPEXOLE DIHYDROCHLORIDE
MONDO:0023178,fragile X syndrome type 1
HGNC:9003,PITPNM1
iuphar.ligand:4942,GM-CSF
chembl:CHEMBL504256,FANGCHINOLINE
ncit:C1015,UBENIMEX
iuphar.ligand:4029,2-ARACHIDONOYLGLYCEROLPHOSPHOINOSITOL
HGNC:8016,NSF
HP:0000290,Abnormality of the forehead
HGNC:1914,RCBTB2
HGNC:12500,UBE4B
HP:0000837,Increased circulating gonadotropin level
rxcui:33408,PHENYLTOLOXAMINE
iuphar.ligand:2359,ZD7288
ncit:C64764,EFATUTAZONE DIHYDROCHLORIDE
iuphar.ligand:5445,"N-DOCOSATETRA-7,10,13,16-ENOYLETHANOLAMINE"
drugbank:DB05012,XEN-2174
ncit:C170094,LASMIDITAN SUCCINATE
iuphar.ligand:11959,EGIS-11150
rxcui:9344,RIBAVIRIN
HGNC:12843,YME1L1
ncit:C80868,FALNIDAMOL
HP:0032898,Focal automatism seizure
chembl:CHEMBL609606,CHEMBL:CHEMBL609606
iuphar.ligand:5732,XEN907
HP:0100706,Abnormal oligodendroglia morphology
rxcui:91239,GUANADREL SULFATE
MGI:2446583,Abcd1<sup>tm1Kan</sup>/Abcd1<sup>tm1Kan</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
HGNC:9674,PTPRK
rxcui:142425,BENZPHETAMINE HYDROCHLORIDE
MONDO:0012188,neuronal ceroid lipofuscinosis 9
ncit:C979,LOMETREXOL
chembl:CHEMBL1451921,CHEMBL:CHEMBL1451921
chembl:CHEMBL597035,CHEMBL:CHEMBL597035
ncit:C72923,EFAROXAN
MGI:3722160,Tg(PRNP-APPSweInd)8Dwst/0  [background:] involves: C3H/HeJ * C57BL/6J
MGI:3616169,Gan<sup>tm1Yany</sup>/Gan<sup>tm1Yany</sup>  [background:] Not Specified
HGNC:11642,ZEB1
chembl:CHEMBL528119,CHEMBL:CHEMBL528119
ncit:C77572,CLOROTEPINE
HGNC:3057,DTNA
iuphar.ligand:527,[3H]MK-912
drugbank:DB17145,IT-139
iuphar.ligand:2476,NI2+
ncit:C1168,DIETHYLNORSPERMINE
ncit:C81693,FARGLITAZAR
MONDO:0020752,"myoclonic epilepsy, juvenile, susceptibility to, 1"
HP:0010794,Impaired visuospatial constructive cognition
MONDO:0000389,atelosteogenesis
chembl:CHEMBL133576,ACID BLUE 129
iuphar.ligand:10072,DUAL BRD4/PLK1 INHIBITOR 23
chembl:CHEMBL185885,AES-103
chembl:CHEMBL1288014,CHEMBL:CHEMBL1288014
GO:1902600,proton transmembrane transport
SGD:S000006251,MSF1
HGNC:30785,SAP30BP
iuphar.ligand:4332,UBP141
drugbank:DB18298,PTI-110
MONDO:0015541,hereditary hemophagocytic lymphohistiocytosis
HGNC:9188,POLR2B
HGNC:15908,NAA20
chembl:CHEMBL590666,CHEMBL:CHEMBL590666
rxcui:4816,GLICLAZIDE
ncit:C2167,EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR
rxcui:142424,AMILORIDE HYDROCHLORIDE
chembl:CHEMBL237347,GW559768X
iuphar.ligand:8041,KU-60019
ncit:C1277,WORTMANNIN
MGI:5568998,Mecp2<sup>tm1.1Jtc</sup>/Mecp2<sup>+</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6
chembl:CHEMBL1256813,CHEMBL:CHEMBL1256813
HGNC:2959,DNASE1L3
chembl:CHEMBL171637,PHYSODIC ACID
MONDO:0010747,X-linked dystonia-parkinsonism
HGNC:6331,KIR2DL3
CL:4023154,myelinating glial cell
MONDO:0003939,muscle tissue disorder
HP:0009937,Facial hirsutism
HP:0002960,Autoimmunity
rxcui:8463,PODOFILOX
drugbank:DB05678,SLX-4090
MGI:103149,Uchl1
HGNC:6738,LYPLA2
chembl:CHEMBL1372368,MUNDULONE ACETATE
chembl:CHEMBL2109247,LBY-135
drugbank:DB15055,ABT-639
HGNC:19980,GNPNAT1
iuphar.ligand:4372,INSL3 B CHAIN DIMER ANALOGUE 8
chembl:CHEMBL3545381,PLX-7486
drugbank:DB05169,AT9283
drugbank:DB05785,LGD-1550
CHEBI:32682,L-argininium(1+)
MGI:6865691,Prkcg<sup>em1Jpka</sup>/Prkcg<sup>+</sup>  [background:] FVB/N-Prkcg<sup>em1Jpka</sup>
GO:0004623,phospholipase A2 activity
rxcui:4917,NITROGLYCERIN
chembl:CHEMBL27768,CHEMBL:CHEMBL27768
ncit:C166502,IBODUTANT
rxcui:14845,APRACLONIDINE
ncit:C74115,GIPARMEN
GO:0044782,cilium organization
UPHENO:0079824,decreased role independent continuant level
drugbank:DB15242,MK-0533
FB:FBgn0286222,Fum1
HGNC:23694,GPR161
drugbank:DB05530,CPG 10101
iuphar.ligand:5721,(S)-N-OLEOYLTYROSINOL
chembl:CHEMBL591772,KANZONOL W
chembl:CHEMBL3545173,IRX4310
HGNC:29661,OMA1
HGNC:5467,IGF2R
HP:0025100,Abnormal hippocampus morphology
iuphar.ligand:291,NNC 11-1314
HGNC:17,AADAC
HGNC:3072,DUSP6
rxcui:5487,HYDROCHLOROTHIAZIDE
iuphar.ligand:9796,(S)-23 [PMID: 27933945]
ncit:C427,DIAZOOXONORLEUCINE
ncit:C83573,CALCIMYCIN
CL:0000121,Purkinje cell
ncit:C47698,PYRITHIONE ZINC
iuphar.ligand:4337,UCCF-339
iuphar.ligand:4225,IP5I
iuphar.ligand:2056,"[111IN,90Y]DOTA-LAN"
iuphar.ligand:4597,"3,4-DICHLOROBENZAMIL"
HGNC:11830,TK1
HGNC:16187,SLC52A3
chembl:CHEMBL153,TROLOX
HGNC:3014,DPYSL2
HP:0008151,Prolonged prothrombin time
Reactome:R-BTA-500753,Pyrimidine biosynthesis
HP:0002339,Abnormal caudate nucleus morphology
iuphar.ligand:12438,ARISTOLOCHIC ACID
rxcui:19008,BENZTHIAZIDE
rxcui:41126,FLUTICASONE
ncit:C1216,RETINYL ACETATE
GO:0043279,response to alkaloid
iuphar.ligand:1794,[HIS5]PTH-(1-34) (HUMAN)
MGI:4839653,Tg(Prnp-TARDBP*A315T)23Jlel/0  [background:] involves: C57BL/6 * CD-1 * SJL
HP:0031724,Microtropia
CHEBI:2955,azithromycin
HGNC:2903,DLG4
MONDO:0030990,Kohlschutter-Tonz syndrome-like
drugbank:DB13752,TETRAMETHRIN
HP:0007831,Nonprogressive restrictive external ophthalmoplegia
HGNC:12442,TYR
rxcui:6851,METHOTREXATE
rxcui:2531311,ROSMARINIC ACID
iuphar.ligand:6400,VU0360172
HGNC:7623,MYT1L
HGNC:2505,CTLA4
MP:0005386,behavior/neurological phenotype
MONDO:0013391,sterol carrier protein 2 deficiency
MGI:1277211,Tyrobp
chembl:CHEMBL223575,CHEMBL:CHEMBL223575
HGNC:11034,SLC4A8
MONDO:0010619,X-linked dominant hypophosphatemic rickets
MGI:6107698,Thap1<sup>tm1.2Meeh</sup>/Thap1<sup>+</sup>  [background:] involves: 129S/SvEv * BALB/cJ * C3H * C57BL/6
ncit:C153353,PTEROSTILBENE
HP:0000093,Proteinuria
MGI:97532,Pdha1
rxcui:236475,RIFAMYCIN SODIUM
ncit:C138997,ANLOTINIB
HGNC:7463,MTNR1A
MONDO:0020488,atypical progressive supranuclear palsy syndrome
OBA:2001007,age of onset of hyperlipidemia
HGNC:8857,PEX16
rxcui:203144,PRAVASTATIN SODIUM
drugbank:DB07863,2-CHLORO-5-NITRO-N-PHENYLBENZAMIDE
chembl:CHEMBL1212972,NANAOMYCIN
UPHENO:0048707,increased level of chemical entity
chembl:CHEMBL1095014,AESCULIOSIDE IIC
MONDO:0030993,Tessadori-Van Haaften neurodevelopmental syndrome 3
EMAPA:35906,vein
iuphar.ligand:5927,AMINOPURVALANOL A
HGNC:24941,HNRNPA3
rxcui:644,AMILORIDE
ncit:C131910,ABEQUOLIXRON
iuphar.ligand:5763,JPE1375
ncit:C127116,DUBERMATINIB
MP:0010540,long stride length
HGNC:9204,PON1
rxcui:8338,PIPERACETAZINE
HGNC:16493,ZMIZ1
rxcui:154987,HYDROXYZINE HYDROCHLORIDE
iuphar.ligand:794,[125I]CCL11 (HUMAN)
chembl:CHEMBL1173444,HERACLENOL
HP:0500075,Dissociated horizontal deviation
MP:0008326,abnormal thyrotroph morphology
iuphar.ligand:11529,STM2457
HP:0032850,Focal aware cognitive seizure with expressive dysphasia/aphasia
rxcui:91164,OXYPHENCYCLIMINE HYDROCHLORIDE
ncit:C170306,PEMETREXED TROMETHAMINE
CHEBI:172923,fluorescein (acid form)
GO:0004757,sepiapterin reductase activity
HGNC:11403,STK24
HGNC:23301,PBLD
iuphar.ligand:1756,AR-C67085
chembl:CHEMBL602969,CHEMBL:CHEMBL602969
rxcui:38150,THIPHENAMIL
chembl:CHEMBL312032,CHEMBL:CHEMBL312032
HGNC:3771,FMO3
chembl:CHEMBL241858,ONONETIN
rxcui:2198975,METHYLENE BLUE ANHYDROUS
HP:3000069,Abnormality of lateral rectus extra-ocular muscle
HGNC:4840,HCK
HGNC:14034,MRPL37
chembl:CHEMBL1902591,FLUOXASTROBIN
iuphar.ligand:3822,[3H]GR100679
HGNC:20149,PTGR2
HGNC:9437,EIF2AK2
chembl:CHEMBL578944,CHEMBL:CHEMBL578944
chembl:CHEMBL15134,CHEMBL:CHEMBL15134
iuphar.ligand:11462,TAMRLX
ncit:C29855,THEAFLAVIN
HP:0002307,Drooling
iuphar.ligand:12570,ST-1505
UBERON:0003053,ventricular zone
chembl:CHEMBL3301576,PEGPLERANIB SODIUM
rxcui:1670007,INSULIN DEGLUDEC
MONDO:0044726,psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome
ncit:C83642,CUTAMESINE
rxcui:1433761,FIPRONIL
chembl:CHEMBL1253830,ISOBONDUCELLIN
drugbank:DB13093,TAK-593
ncit:C82249,MONENSIN SODIUM
rxcui:8332,PINDOLOL
UBERON:0003379,cardiac muscle of right atrium
rxcui:142445,PROMETHAZINE HYDROCHLORIDE
iuphar.ligand:2082,"L-803,087"
ncit:C2088,ORNITHINE DECARBOXYLASE INHIBITOR
HP:0002442,Dyscalculia
iuphar.ligand:2131,SB 222200
HP:0009125,Lipodystrophy
iuphar.ligand:10431,E-52862
chembl:CHEMBL3545355,CHF4227
rxcui:3416,DIHYDROERGOCRISTINE
chembl:CHEMBL4297808,PF-06823859
chembl:CHEMBL49055,CHEMBL:CHEMBL49055
CHEBI:28748,doxorubicin
ncit:C77363,DECAMETHONIUM
MONDO:0018800,Kallmann syndrome
MP:0004341,absent scapula
iuphar.ligand:109,CGS-12066
rxcui:203198,PHENMETRAZINE HYDROCHLORIDE
HP:0002917,Hypomagnesemia
ncit:C152466,SULOCTIDIL
iuphar.ligand:337,KT 5720
UBERON:0013694,brain endothelium
MONDO:0008813,arachnoid cyst
rxcui:2180,CEFAZOLIN
rxcui:10205,SULFINPYRAZONE
ncit:C62526,INIPARIB
MONDO:0015134,constitutional neutropenia
HP:0002530,Axial dystonia
rxcui:7779,OXANDROLONE
HP:3000072,Abnormal levator palpebrae superioris morphology
ncit:C91081,AURORA B/C KINASE INHIBITOR GSK1070916A
EMAPA:35838,substantia nigra pars reticulata
CLINVAR:143550,NM_001110792.2(MECP2):c.408G>T (p.Leu136Phe)
MONDO:0013208,cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome
CHEBI:25698,ether
MP:0013219,abnormal substantia nigra pars compacta morphology
chembl:CHEMBL524930,CHEMBL:CHEMBL524930
MONDO:0006230,gastric squamous cell carcinoma
MGI:1858964,Actr1a
HGNC:29548,ECSIT
rxcui:11516,DOXERCALCIFEROL
ncit:C200038,RAF INHIBITOR BDTX-4933
drugbank:DB17276,GVAX
iuphar.ligand:2034,BIM 23030
rxcui:2418,CHOLECALCIFEROL
HP:0005305,Cerebral venous thrombosis
HGNC:35410,TSTD1
rxcui:4278,FAMOTIDINE
UPHENO:0001005,abnormal phenotype by ontology source
GO:0051131,chaperone-mediated protein complex assembly
MGI:6113841,Gatm<sup>em1Btlr</sup>/Gatm<sup>em1Btlr</sup>  [background:] C57BL/6J-Gatm<sup>em1Btlr</sup>
rxcui:49626,ENOXIMONE
MONDO:0009002,"coloboma, ocular, autosomal recessive"
HGNC:6826,MAN2B1
MP:0006335,abnormal hearing electrophysiology
HP:0000324,Facial asymmetry
HP:0001397,Hepatic steatosis
rxcui:614391,ABATACEPT
HGNC:12502,SUMO1
chembl:CHEMBL1523215,CHEMBL:CHEMBL1523215
drugbank:DB03225,D-TRYPTOPHAN
rxcui:1435279,4-AMINOPHENOL
chembl:CHEMBL3545144,TAS-115
HGNC:120,ACOX2
HGNC:11270,SPRY2
CHEBI:26878,tertiary alcohol
HGNC:841,ATP5MC1
iuphar.ligand:3351,LY255283
ncit:C74084,TLR9 AGONIST SD-101
chembl:CHEMBL1164954,CHEMBL:CHEMBL1164954
HGNC:85,ACACB
MGI:1933825,Jam3
HP:0500077,Alternating hyperphoria
rxcui:153329,IRINOTECAN HYDROCHLORIDE
HGNC:8727,PCM1
chembl:CHEMBL1923521,CHEMBL:CHEMBL1923521
rxcui:1895,CALCIUM
chembl:CHEMBL4297229,PRABOTULINUMTOXIN A
ncit:C152327,SELURAMPANEL
HP:0034295,Reduced cerebral white matter volume
HP:0025498,Aceruloplasminemia
drugbank:DB12368,AZD-3839
chembl:CHEMBL1288281,CHEMBL:CHEMBL1288281
iuphar.ligand:7972,WP1066
ncit:C169869,CUSTIRSEN
MONDO:0011264,torsion dystonia 6
rxcui:57330,TRANILAST
rxcui:221067,BUTAMBEN PICRATE
ncit:C77258,ALTANSERIN
chembl:CHEMBL1080648,OXADIAZON
ncit:C169839,CERLAPIRDINE
MONDO:0008083,"ceroid lipofuscinosis, neuronal, 4 (Kufs type)"
HP:0012115,Hepatitis
ncit:C73004,QUINOCIDE
iuphar.ligand:8139,COMPOUND 25B [PMID: 22564207]
HP:0006886,Impaired distal vibration sensation
ncit:C78842,TUBULIN INHIBITOR ALB 109564 DIHYDROCHLORIDE
HGNC:2372,MED23
HP:0012477,Vocal tremor
MONDO:0005768,gastrointestinal tuberculosis
HGNC:616,APOH
ncit:C73285,CARPHENAZINE
ncit:C2651,SILICON PHTHALOCYANINE 4
CL:0002620,skin fibroblast
HP:0001258,Spastic paraplegia
iuphar.ligand:5077,CD40 LIGAND
rxcui:259454,LEVOBUPIVACAINE HYDROCHLORIDE
chembl:CHEMBL4594352,TLC-388
ncit:C116871,SIMOTAXEL
rxcui:82091,PYRILAMINE MALEATE
rxcui:23678,DROMOSTANOLONE
NCBIGene:100859320,NDUFA13
HP:0003198,Myopathy
rxcui:203178,DISOPYRAMIDE PHOSPHATE
chembl:CHEMBL2109494,A27.15
ncit:C70650,TOSEDOSTAT
HGNC:21645,CHCHD2
HGNC:2457,CSNK2A1
HP:0001684,Secundum atrial septal defect
iuphar.ligand:8482,DECYNIUM 22
iuphar.ligand:1808,"[TRP23,TYR36]PTHRP-(1-36)-NH2 (HUMAN)"
chembl:CHEMBL89977,CHEMBL:CHEMBL89977
chembl:CHEMBL190474,CHEMBL:CHEMBL190474
ncit:C95203,C-MET INHIBITOR AMG 337
ncit:C77880,MILATAXEL
iuphar.ligand:5283,U73122
MONDO:0010945,retinitis pigmentosa 17
ncit:C2020,FARNESYL TRANSFERASE INHIBITOR
chembl:CHEMBL1333653,OBTUSAQUINONE
iuphar.ligand:7737,HELATX1
iuphar.ligand:2346,H+
MGI:3027234,nur22/nur22  [background:] Not Specified
ncit:C83520,AFEGOSTAT
iuphar.ligand:11461,R3 B1-22R
HGNC:31849,F8A2
chembl:CHEMBL490829,CHEMBL:CHEMBL490829
HGNC:6912,MATR3
chembl:CHEMBL421486,THUNBERGINOL E
HGNC:22970,KRTAP10-7
chembl:CHEMBL578928,CHEMBL:CHEMBL578928
HP:0031354,Sleep onset insomnia
HP:0008376,"Nasal, dysarthic speech"
rxcui:3995,EPIRUBICIN
rxcui:31901,NITROXOLINE
ncit:C75161,CARISBAMATE
ncit:C84837,PI3K/MTOR KINASE INHIBITOR PF-04691502
iuphar.ligand:9328,TAK-715
CHEBI:21547,N-acetyl-L-aspartic acid
GO:0000492,box C/D snoRNP assembly
iuphar.ligand:5447,L-CYSTEINE SULPHINIC ACID
HP:0003380,Decreased number of peripheral myelinated nerve fibers
CHEBI:78696,cercosporamide
HGNC:24912,LARP7
HP:0010628,Facial palsy
rxcui:59636,BUCLIZINE
drugbank:DB02365,"1,10-PHENANTHROLINE"
MONDO:0013395,retinitis pigmentosa 4
ncit:C77588,CANERTINIB
HGNC:3603,FBN1
chembl:CHEMBL368700,DITHIOLETHIONE
rxcui:2977,CYCLIZINE
rxcui:460132,DARUNAVIR
chembl:CHEMBL301722,PALMITOYL-CARNITINE
chembl:CHEMBL583558,CHEMBL:CHEMBL583558
HGNC:4113,GAK
MONDO:0008962,Griscelli syndrome type 1
iuphar.ligand:9272,SETMELANOTIDE
ncit:C79860,BECAMPANEL
MONDO:0002501,brain glioblastoma
ncit:C1262,TRICIRIBINE PHOSPHATE
MONDO:0015264,cryptogenic organizing pneumonia
HGNC:7450,MTMR2
ncit:C152075,MODOTUXIMAB
iuphar.ligand:312,MUSCARINIC TOXIN 2
ncit:C2057,LAPULEUCEL-T
HP:0000740,Episodic paroxysmal anxiety
NCBIGene:287020,UQCRFS1
MONDO:0020010,infectious disorder of the nervous system
iuphar.ligand:7701,AZD1656
ncit:C65804,GIMATECAN
rxcui:8638,PREDNISOLONE
drugbank:DB16042,SB-773812
MONDO:0030964,"intellectual developmental disorder, autosomal dominant 67"
HGNC:26940,TRMT112
chembl:CHEMBL484640,CHEMBL:CHEMBL484640
MP:0000849,abnormal cerebellum morphology
HP:0007618,Subcutaneous calcification
chembl:CHEMBL32147,2'-HYDROXYCHALCONE
HP:0032911,Focal aware orofacial automatism seizure
MP:0008918,microgliosis
HP:0001290,Generalized hypotonia
chembl:CHEMBL1077126,YESSOTOXIN
chembl:CHEMBL1516890,GW441756X
chembl:CHEMBL546649,CHEMBL:CHEMBL546649
HGNC:4422,GNS
chembl:CHEMBL354663,CHEMBL:CHEMBL354663
HGNC:11571,TARDBP
HP:0004209,Clinodactyly of the 5th finger
HP:0002300,Mutism
HP:0005576,Tubulointerstitial fibrosis
Reactome:R-SSC-71288,Creatine metabolism
iuphar.ligand:10054,SPHINGOMYELIN SYNTHASE 2 INHIBITOR 15W
ncit:C188522,POSDINEMAB
chembl:CHEMBL1367933,CHEMBL:CHEMBL1367933
chembl:CHEMBL252151,CHEMBL:CHEMBL252151
chembl:CHEMBL4650282,DS-1001B
MGI:1860512,Prpf40a
ncit:C645,METHYLNITROSOUREA
MONDO:0010818,retinitis pigmentosa 12
ncit:C88338,VASCULAR DISRUPTING AGENT BNC105P
MONDO:0005445,visceral leishmaniasis
CHEBI:28680,cytarabine
rxcui:1426778,PHENYLMERCURIC ACETATE
RGD:3858,Thrb
iuphar.ligand:2013,KE 108
HP:0000322,Short philtrum
NCBIGene:101902937,LOC101902937
HGNC:18078,ZBTB7A
MONDO:0006715,coronary stenosis
chembl:CHEMBL1467200,CHEMBL:CHEMBL1467200
MGI:1098826,Coq4
HGNC:644,AR
ncit:C152899,VIXOTRIGINE
ncit:C79785,LANPERISONE
rxcui:1908,CALCIUM GLUCONATE
CHEBI:22720,benzodiazepine
iuphar.ligand:12997,COMPOUND 111 [PMID: 37918435]
iuphar.ligand:293,NNC 11-1607
ncit:C80048,CARICOTAMIDE/TRETAZICAR
MONDO:0008021,Cowden syndrome 1
MONDO:0012246,spinocerebellar ataxia type 26
iuphar.ligand:4907,DORSOMORPHIN
HGNC:7869,NOL3
rxcui:22656,DESOGESTREL
iuphar.ligand:1800,"[ILE5,TRP23]PTHRP-(3-36) (HUMAN)"
rxcui:102490,DEXTROMETHORPHAN HYDROBROMIDE
CHEBI:58432,histaminium
chembl:CHEMBL2270444,DESACETYL SALANNIN
iuphar.ligand:130,SB 224289
MP:0005267,abnormal olfactory cortex morphology
rxcui:2106338,AMIFAMPRIDINE
rxcui:82019,FLUNARIZINE HYDROCHLORIDE
HGNC:10600,SCNN1B
chembl:CHEMBL582694,CHEMBL:CHEMBL582694
rxcui:52105,LITHIUM CITRATE
HGNC:8992,PIN4
CHEBI:149836,tigecycline
rxcui:41875,QUINIDINE POLYGALACTURONATE
rxcui:1984,CANTHARIDIN
iuphar.ligand:962,[3H]NEMONAPRIDE
chembl:CHEMBL508494,DAPHNORETIN
MGI:4822572,Tg(CMV-ATXN3*94Q)94Pama/Tg(CMV-ATXN3*94Q)94Pama  [background:] B6.FVB-Tg(CMV-ATXN3*94Q)94Pama
MONDO:0020772,"epilepsy, juvenile absence, susceptibility to, 1"
MGI:104540,Clec3b
HP:0000485,Megalocornea
MGI:3833957,Eno2<sup>tm1(DTA)Hsak</sup>/Eno2<sup>+</sup> Gng7<sup>tm2(cre/PGR)Mmsh</sup>/Gng7<sup>+</sup>  [background:] involves: C57BL/6
rxcui:6672,MEBENDAZOLE
MGI:3793277,Atp7b<sup>tx</sup>/Atp7b<sup>tx</sup>  [background:] DL-Atp7b<sup>tx</sup>
iuphar.ligand:10481,COMPOUND 1 [PMID: 31477924]
chembl:CHEMBL1436980,"4,4'-DIMETHOXYDALBERGIONE"
HP:0004446,Stomatocytosis
HGNC:25082,SMAP2
UPHENO:0077826,abnormal blood nitrogen molecular entity level
chembl:CHEMBL2094573,CHEMBL:CHEMBL2094573
HGNC:8148,OPHN1
HP:0032886,Focal impaired awareness cognitive seizure with expressive dysphasia/aphasia
ncit:C78848,SONOLISIB
rxcui:598,ALPROSTADIL
CHEBI:58092,N-phosphocreatinate(2-)
EMAPA:17787,cerebellum
chembl:CHEMBL462576,KEPONE
ncit:C132269,SAMPATRILAT
CHEBI:36416,mancude organic heterotricyclic parent
iuphar.ligand:8150,GSK579289A
MONDO:0012216,foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome
ncit:C76415,CHINIOFON
iuphar.ligand:8120,COMPOUND 13D [PMID: 23639540]
HGNC:17304,TAF5L
RGD:68327,Hap1
chembl:CHEMBL1529817,ALPHAPRODINE HYDROCHLORIDE
rxcui:132889,LEVONORDEFRIN
drugbank:DB13326,EUFLAVINE
MONDO:0043731,lytic metastatic bone lesion
MONDO:0026419,obsolete isolated corpus callosum agenesis
ncit:C174060,BASROPARIB
HP:0007054,Proximal hyperreflexia
CL:1001579,cerebral cortex glial cell
rxcui:1922448,SAFINAMIDE
rxcui:91071,CYCLIZINE LACTATE
rxcui:1000082,ALCAFTADINE
chembl:CHEMBL1315166,CHEMBL:CHEMBL1315166
ncit:C1462,RADICICOL
ncit:C73280,ABAPERIDONE
rxcui:42676,ERGOTAMINE TARTRATE
CHEBI:36005,docosahexaenoic acid
MGI:1915059,Rmdn3
MONDO:0009745,neuronal ceroid lipofuscinosis 5
HP:0001636,Tetralogy of Fallot
PATO:0070002,basket cell morphology
drugbank:DB14793,RO-5045337
ncit:C65702,FLUACIZINE
rxcui:1091,ARGININE
UPHENO:0003042,abnormal extra-ocular muscle
iuphar.ligand:10137,YH18968
FB:FBgn0005386,ash1
HP:0034339,Pseudoautosomal inheritance
HP:0007047,Atrophy of the dentate nucleus
rxcui:5224,HEPARIN
iuphar.ligand:2212,"[TBAA1,D-TYR(ET)2,VAL4,LYS6,ARG-NH28,DES-GLY9]AVP"
iuphar.ligand:499,WB 4101
ncit:C166786,EDIFOLIGIDE
ncit:C152752,TRIPARANOL
ncit:C65655,FENITROTHION
CHEBI:139592,tertiary alpha-hydroxy ketone
HGNC:10478,RXRB
MP:0030860,patellar dislocation
MONDO:0014651,acrofacial dysostosis Cincinnati type
HGNC:6183,ITSN1
NCBITaxon:10090,Mus musculus
iuphar.ligand:235,ML 10302
drugbank:DB14791,GDC-0425
iuphar.ligand:12298,MOSUNETUZUMAB
chembl:CHEMBL546865,CHEMBL:CHEMBL546865
HP:0002216,Premature graying of hair
ncit:C586,RECOMBINANT INTERLEUKIN-1
chembl:CHEMBL1243244,CHEMBL:CHEMBL1243244
HGNC:9154,PNKP
rxcui:81947,ALPRENOLOL HYDROCHLORIDE
iuphar.ligand:3194,COMPOUND 14 [PMID: 18800762]
chembl:CHEMBL235934,CLAUSINE E
chembl:CHEMBL351569,CHEMBL:CHEMBL351569
HGNC:33280,SEPTIN14
iuphar.ligand:10020,DSM421
chembl:CHEMBL112060,CHEMBL:CHEMBL112060
MONDO:0011647,Alzheimer disease 7
rxcui:72616,SALMETEROL XINAFOATE
iuphar.ligand:12122,COMPOUND 4E [PMID: 35546685]
HP:0002066,Gait ataxia
MP:0008946,abnormal neuron number
chembl:CHEMBL1362503,CHEMBL:CHEMBL1362503
ncit:C169785,APIMOSTINEL
ncit:C97356,CYSTAMINE DIHYDROCHLORIDE
chembl:CHEMBL107430,NRX195183
HP:0032879,Focal impaired awareness seizure with dissociation at onset
iuphar.ligand:1766,BX 048
CHEBI:26338,prostaglandins E
drugbank:DB16909,TIK-301
rxcui:258333,DESOXYCORTICOSTERONE ACETATE
MP:0020543,decreased substantia nigra size
chembl:CHEMBL1609016,CHEMBL:CHEMBL1609016
GO:0006971,hypotonic response
MP:0004924,abnormal behavior
ZFIN:ZDB-FISH-190212-2,abcd1<sup>zc92/zc92</sup>
rxcui:3256,DESOXYCORTICOSTERONE
ncit:C37899,TANESPIMYCIN
HGNC:25439,TANGO2
HP:0010850,EEG with spike-wave complexes
NCBIGene:280682,CS
HGNC:1034,BECN1
chembl:CHEMBL3545274,MK-6913
chembl:CHEMBL318743,TETRAHYDROCURCUMIN
iuphar.ligand:289,AC-42
rxcui:142434,ECONAZOLE NITRATE
chembl:CHEMBL533082,CHEMBL:CHEMBL533082
HGNC:16890,CTDSPL
HGNC:10258,RORA
MONDO:0023558,Kocher-debre-Semelaigne syndrome
HP:0002093,Respiratory insufficiency
ncit:C1560,BREQUINAR
chembl:CHEMBL1355965,DIENOCHLOR
iuphar.ligand:10411,GSK369796
rxcui:9913,SODIUM TETRADECYL SULFATE
GO:1901563,response to camptothecin
iuphar.ligand:9597,REMTOLUMAB
iuphar.ligand:772,CCL8
MGI:103206,Acod1
MONDO:0011834,spinocerebellar ataxia type 18
HP:0010951,Abnormal third ventricle morphology
MGI:4361336,Grin1<sup>tm1.1Ese</sup>/Grin1<sup>tm1.1Ese</sup>  [background:] involves: C57BL/6
iuphar.ligand:5914,AG 1295
rxcui:8080,PERTUSSIS VACCINE
HGNC:9802,RAC2
MONDO:0800464,SQSTM1-related multisystem proteinopathy
iuphar.ligand:6410,VU0404251
HP:0031715,Near exotropia
GO:0055056,D-glucose transmembrane transporter activity
dictyBase:DDB_G0268516,tbcD
UPHENO:0080597,abnormal physical aggression behavior
chembl:CHEMBL1333798,CHEMBL:CHEMBL1333798
ncit:C1655,HMG-COA REDUCTASE INHIBITOR
chembl:CHEMBL1256876,CHEMBL:CHEMBL1256876
iuphar.ligand:4278,OCTANOL
drugbank:DB04652,CORTICOSTERONE
HP:0011160,Focal sensory seizure with gustatory features
HGNC:2917,DLX4
MONDO:0014491,immunodeficiency 37
ncit:C116325,SIREMADLIN
MONDO:0024644,myocardial ischemia
chembl:CHEMBL512164,ISOPIMARIC ACID
SGD:S000002284,CDC48
HP:0002362,Shuffling gait
drugbank:DB05854,CLX-0921
rxcui:1592684,DIRLOTAPIDE
chembl:CHEMBL541388,FASUDIL HYDROCHLORIDE
iuphar.ligand:177,"L-741,626"
ncit:C103826,TALADEGIB
HGNC:34072,C1QTNF9B
drugbank:DB12302,CP-724714
iuphar.ligand:8604,BODIPY-PIRENZEPINE
HGNC:17663,PITRM1
iuphar.ligand:9116,GSK2879552
chembl:CHEMBL1893913,IODOCARB
rxcui:9500,RUTIN
UPHENO:0074383,abnormally decreased rate of vertical activity
HGNC:9207,CNOT8
GO:0007032,endosome organization
HGNC:6235,KCNC3
HP:0001757,High-frequency sensorineural hearing impairment
HP:0009826,Limb undergrowth
iuphar.ligand:8855,SM-122
rxcui:11002,UREA
ncit:C2830,LONTUCIREV
chembl:CHEMBL3545073,AMA0076
MONDO:0017175,Machado-Joseph disease type 2
MONDO:0021545,myomatous neoplasm
rxcui:28872,LOMEFLOXACIN
HGNC:17284,POT1
HGNC:24140,MGAT5B
UPHENO:0035198,abnormally decreased number of myelinated nerve fiber in the nerve
ncit:C175157,NARONAPRIDE
ncit:C72119,GLAFENINE
MP:0020623,increased dorsal striatum cell density
rxcui:153679,LERCANIDIPINE HYDROCHLORIDE
MGI:5696738,Tg(Camk2a-SNCA*)2Mgsp/0 Del(6Snca)1Slab/Del(6Snca)1Slab  [background:] B6JOlaHsd.Cg-Tg(Camk2a-SNCA*)2Mgsp
HP:0000823,Delayed puberty
UBERON:0002263,lentiform nucleus
drugbank:DB15137,VK-2809
HP:0032816,Neonatal multifocal myoclonic seizure
ncit:C76660,EMRICASAN
HP:0032820,Neonatal multifocal clonic seizure
rxcui:18343,ARTEMETHER
MONDO:0011330,spinocerebellar ataxia type 10
HGNC:8029,NTN1
ncit:C1424,SULFORAPHANE
iuphar.ligand:6407,COMPOUND 30 [PMID: 21757343]
GO:0071577,zinc ion transmembrane transport
ncit:C163642,CHLORPYRIFOS-METHYL
chembl:CHEMBL194399,ENDOSULFAN
chembl:CHEMBL1354502,KOPARIN
iuphar.ligand:742,LY320135
iuphar.ligand:708,MG2+
rxcui:1873916,RIBOCICLIB
ncit:C80544,ESFLURBIPROFEN
ncit:C342,CARBOQUONE
HGNC:14253,CERS1
chembl:CHEMBL590186,CHEMBL:CHEMBL590186
MONDO:0002887,bile duct disorder
ncit:C77076,NAMINIDIL
UBERON:0008188,tendon of biceps brachii
iuphar.ligand:572,N-METHYL-PHE-LYS-PRO-D-CHA-CHA-D-ARG-CO2H
EMAPA:35836,substantia nigra pars compacta
ncit:C76536,NIMETAZEPAM
CLINVAR:52475,NM_000059.4(BRCA2):c.8023A>G (p.Ile2675Val)
HP:0001562,Oligohydramnios
drugbank:DB12515,9-AMINOCAMPTOTHECIN
iuphar.ligand:3773,[125I]C3A (HUMAN)
rxcui:11359,LUTEIN
chembl:CHEMBL1374610,CHEMBL:CHEMBL1374610
MP:0005323,dystonia
HGNC:688,RHOJ
HP:0034345,Mendelian inheritance
HP:0030975,Pontine tegmental cap
ncit:C2484,METHAQUALONE HYDROCHLORIDE
CLINVAR:206852,NM_001165963.4(SCN1A):c.4916G>C (p.Arg1639Pro)
ncit:C152146,RAFOXANIDE
chembl:CHEMBL1256510,CHEMBL:CHEMBL1256510
HGNC:17903,MED4
chembl:CHEMBL585686,CHEMBL:CHEMBL585686
HGNC:4951,HLA-DRB3
MP:0000890,thin cerebellar molecular layer
chembl:CHEMBL129177,HARMALOL
ncit:C866,TETRADECANOYLPHORBOL ACETATE
iuphar.ligand:8346,A(4-24)(B7-24)H2
HGNC:7211,MPG
HGNC:11536,TAF2
ncit:C1293,RECOMBINANT TRANSFORMING GROWTH FACTOR-BETA 1
iuphar.ligand:9680,GW766994
MGI:3586912,Tbx1<sup>tm1Pa</sup>/Tbx1<sup>tm1Pa</sup>  [background:] either: (involves: 129) or (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * Swiss Webster)
iuphar.ligand:10067,AFM13
ncit:C80869,TELATINIB
chembl:CHEMBL227075,DIHYDROTANSHINONE I
MONDO:0012444,neurodegeneration with brain iron accumulation 2B
chembl:CHEMBL577222,CHEMBL:CHEMBL577222
iuphar.ligand:326,LITHOCHOLYLCHOLINE
HGNC:26465,YTHDF3
ncit:C61081,"3,4-METHYLENEDIOXYMETHAMPHETAMINE"
ncit:C171748,APABETALONE
MONDO:0021004,brachydactyly
HP:0003074,Hyperglycemia
CHEBI:35469,antidepressant
HGNC:11758,TFG
rxcui:24246,EPIGALLOCATECHIN GALLATE
rxcui:11199,VINBLASTINE SULFATE
ncit:C1538,RECOMBINANT FAS LIGAND
HP:0001601,Laryngomalacia
CHEBI:33860,aromatic amine
MGI:103222,Zbtb16
UPHENO:0076900,decreased thigmotaxis
iuphar.ligand:303,OXOTREMORINE-M
chembl:CHEMBL1255866,METRAZOLINE OXALATE
rxcui:141400,ADEFOVIR DIPIVOXIL
iuphar.ligand:8332,A(&DELTA;10/15C)INSL3
CLINVAR:189754,NM_001110792.2(MECP2):c.1197_1436del (p.Pro400_Pro479del)
rxcui:1427224,FLORBETAPIR F-18
HGNC:11892,TNF
iuphar.ligand:3223,FR260010
ncit:C225,RECOMBINANT INTERFERON ALFA
HP:0000098,Tall stature
HP:0008000,Decreased corneal reflex
chembl:CHEMBL394883,CHEMBL:CHEMBL394883
chembl:CHEMBL4297887,GSK-2586881
rxcui:89785,METHSCOPOLAMINE
MONDO:0012313,short QT syndrome type 2
MP:0020679,abnormal hippocampal fornix total cell area
MONDO:0010184,methylmalonic aciduria and homocystinuria type cblC
HGNC:29021,CEP290
iuphar.ligand:10387,TAK-632
HGNC:11179,SOD1
chembl:CHEMBL4297801,PEGUNIGALSIDASE ALFA
iuphar.ligand:5019,LPS
ncit:C63756,CAFFEIC ACID PHENETHYL ESTER
iuphar.ligand:3927,BRL-54443
UPHENO:0080045,increased inflammatory response in mandible
HP:0002500,Abnormal cerebral white matter morphology
rxcui:15996,MIRTAZAPINE
HP:0031475,Status epilepticus without prominent motor symptoms
wikidata:Q85759692,ETHINYLESTRADIOL/DROSPIRENONE/PRASTERONE
HP:0032730,Focal impaired awareness myoclonic seizure
rxcui:6711,MELATONIN
MP:0002229,neurodegeneration
chembl:CHEMBL473392,ROBOTNIKININ
HP:0032915,Focal aware vocal automatism seizure
HGNC:12420,TUFM
CHEBI:17620,ferulic acid
drugbank:DB05879,AME-527
MGI:3696575,Tg(APP695)3Dbo/0  [background:] B6.C3-Tg(APP695)3Dbo
RGD:1308810,Blm
chembl:CHEMBL545900,CHEMBL:CHEMBL545900
rxcui:5966,IOPAMIDOL
HGNC:11257,SPR
iuphar.ligand:8151,COMPOUND 14 [PMID: 19831390]
MP:0000159,abnormal xiphoid process morphology
chembl:CHEMBL2171778,CHEMBL:CHEMBL2171778
drugbank:DB16860,BENZYL ISOTHIOCYANATE
HP:0003185,Short greater sciatic notch
HP:0001508,Failure to thrive
chembl:CHEMBL513108,DIPLAMINE B
CHEBI:15551,prostaglandin E2
MGI:3037943,Trf<sup>hpx</sup>/Trf<sup>+</sup>  [background:] BALB/cJ-Trf<sup>hpx</sup>
ncit:C152708,TRAFERMIN
HP:0006962,"Gait instability, worse in the dark"
iuphar.ligand:4186,ETHYLISOPROPYLAMILORIDE
HP:0001911,Abnormal granulocyte morphology
HGNC:5261,HSPD1
HGNC:12915,ZNF131
HGNC:4405,GNG3
iuphar.ligand:11906,COMPOUND 10D [PMID: 34855388]
rxcui:30202,MOFEBUTAZONE
chembl:CHEMBL2094567,CHEMBL:CHEMBL2094567
MONDO:0859293,"neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment"
HGNC:11827,TJP1
MGI:3835784,Wfs1<sup>tm1Koks</sup>/Wfs1<sup>tm1Koks</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6
chembl:CHEMBL4650374,APG-2575
ncit:C117288,ISOQUERCETIN
ncit:C527,THERAPEUTIC GONADOTROPIN
GO:0055080,monoatomic cation homeostasis
ZFIN:ZDB-GENE-040426-1963,sucla2
HP:0007476,Anhidrotic ectodermal dysplasia
ncit:C65503,EBSELEN
rxcui:56519,SODIUM SELENITE
HGNC:4953,HLA-DRB5
iuphar.ligand:2636,RT3
MONDO:0014063,mitochondrial complex III deficiency nuclear type 2
chembl:CHEMBL171699,CHEMBL:CHEMBL171699
iuphar.ligand:123,LYSERGOL
chembl:CHEMBL1889303,CHEMBL:CHEMBL1889303
ncit:C152417,SPIRADOLINE
UPHENO:0074367,abnormally decreased rate of motor coordination
CHEBI:36027,stilbenol
HP:0000410,Mixed hearing impairment
rxcui:1433867,DOLUTEGRAVIR SODIUM
iuphar.ligand:7949,AT-9283
chembl:CHEMBL429095,CHEMBL:CHEMBL429095
HP:0002131,Episodic ataxia
Reactome:R-DRE-71288,Creatine metabolism
HP:0002045,Hypothermia
MONDO:0043512,traumatic encephalopathy
ECTO:0000509,
CHEBI:139588,alpha-hydroxy ketone
iuphar.ligand:9874,VUF14862
OBA:2001024,age of onset of Huntington disease
CHEBI:36141,quinone
rxcui:4061,ERYTHROSINE
rxcui:6185,LABETALOL
rxcui:384455,TIGECYCLINE
chembl:CHEMBL609628,CHEMBL:CHEMBL609628
HGNC:697,ARL6IP1
ncit:C118672,TASURGRATINIB
rxcui:267342,SPECTINOMYCIN HYDROCHLORIDE
HP:0002205,Recurrent respiratory infections
HP:0000734,Disinhibition
chembl:CHEMBL1623897,CHEMBL:CHEMBL1623897
HP:0100275,Diffuse cerebellar atrophy
chembl:CHEMBL408980,ANISOCOUMARIN H
iuphar.ligand:7023,OG-L002
ncit:C113652,SEVITERONEL
chembl:CHEMBL2071527,ALTISSIMACOUMARIN E
chembl:CHEMBL1256388,CYSTAMINE HYDROCHLORIDE
rxcui:2362259,CAPMATINIB HYDROCHLORIDE
MGI:102918,Dgkq
chembl:CHEMBL482967,CYC-116
chembl:CHEMBL3545323,PWT-33579
chembl:CHEMBL1872845,BIFENAZATE
NCBIGene:327704,NDUFA4
CHEBI:3766,clozapine
iuphar.ligand:8974,OMIPALISIB
HGNC:16877,MFN2
ncit:C787,PUROMYCIN
HP:0031717,Alternating exotropia
iuphar.ligand:12430,S7958
MP:0000784,forebrain hypoplasia
iuphar.ligand:1733,MRS2698
MGI:3772884,Tg(Prnp-TBP*)71-27Xjl/0  [background:] FVB/N-Tg(Prnp-TBP*)71-27Xjl
iuphar.ligand:8250,SOTULETINIB
CHEBI:27641,cycloheximide
rxcui:2323,CHENODEOXYCHOLIC ACID
ncit:C116074,EMPESERTIB
ncit:C126841,ORDESEKIMAB
HGNC:1490,CAPZA2
chembl:CHEMBL2109389,IMGATUZUMAB
chembl:CHEMBL103583,CHEMBL:CHEMBL103583
HP:0000639,Nystagmus
HGNC:28430,EMC6
ncit:C2210,SELECTIVE CYTOKINE INHIBITORY DRUG CC-1088
MGI:3043693,Atp7b<sup>tm1Tcg</sup>/Atp7b<sup>tm1Tcg</sup>  [background:] involves: 129S1/Sv
Reactome:R-CEL-390650,Histamine receptors
ncit:C90591,C-MET INHIBITOR MK2461
drugbank:DB12380,GDC-0152
chembl:CHEMBL1489812,CHEMBL:CHEMBL1489812
MONDO:0012609,Alzheimer disease 12
chembl:CHEMBL76904,TYRPHOSTIN 23
MONDO:0014942,"developmental and epileptic encephalopathy, 45"
rxcui:6054,ISOPROTERENOL
CHEBI:27369,zwitterion
MONDO:0030087,"diabetes mellitus, permanent neonatal 2"
iuphar.ligand:2060,[125I]TYR11-SRIF-14
MGI:3819146,Dst<sup>dt</sup>/Dst<sup>dt</sup>  [background:] Q-Dst<sup>dt</sup>
MONDO:0030992,"short stature, oligodontia, dysmorphic facies, and motor delay"
HP:0033454,Tube feeding
ncit:C71015,CONATUMUMAB
ncit:C2504,VADIMEZAN
rxcui:6676,MECLIZINE
ncit:C73334,ETAZOLATE
MONDO:0006215,gallbladder adenocarcinoma
iuphar.ligand:2057,"[111IN,90Y]DOTA-NOC"
drugbank:DB16304,TAK-653
rxcui:3292,DEXTROTHYROXINE
iuphar.ligand:793,YM-355179
iuphar.ligand:10091,CRX-555
HGNC:7437,MTHFS
chembl:CHEMBL190333,RWJ-67657
CL:1001607,articular chondrocyte
HP:0000340,Sloping forehead
GO:0031915,positive regulation of synaptic plasticity
chembl:CHEMBL1668775,2'-EPI-TUBERATOLIDE B
ncit:C152278,SABCOMELINE
GO:0031902,late endosome membrane
HP:0003403,EMG: decremental response of compound muscle action potential to repetitive nerve stimulation
ncit:C81112,FENCLONINE
iuphar.ligand:2087,HEMOKININ 1
drugbank:DB15399,BMS-754807
HP:0012506,Small pituitary gland
HP:0012048,Oromandibular dystonia
ncit:C134697,PRALUZATAMAB RAVTANSINE
iuphar.ligand:1992,RELAXIN
UPHENO:0080275,decreased motor coordination
HGNC:12828,XRCC1
HGNC:13703,MAK16
iuphar.ligand:8564,ARI-3531
chembl:CHEMBL4298105,VALZIFLOCEPT
RGD:621615,Hip1r
ncit:C115102,DECITABINE AND CEDAZURIDINE
MGI:1201779,Hnrnph2
MONDO:0014648,Al-Raqad syndrome
HGNC:6944,MCM2
rxcui:10849,TRIPROLIDINE
chembl:CHEMBL469424,ASTERRIC ACID
UBERON:0002167,right lung
HGNC:11448,SUCLA2
MGI:104726,Cplx2
iuphar.ligand:3336,MTEP
ncit:C29020,EQUILIN
rxcui:32638,OXICONAZOLE
ncit:C2665,EDOTECARIN
chembl:CHEMBL520897,TRIADIMEFON
HP:0007994,Peripheral visual field loss
HP:0000819,Diabetes mellitus
HGNC:19681,DUSP13B
MONDO:0010848,spinocerebellar ataxia type 5
HGNC:11357,STAM
iuphar.ligand:166,RO 60-0175
rxcui:358257,TOLVAPTAN
MGI:4459460,Slitrk5<sup>tm2Vlcg</sup>/Slitrk5<sup>tm2Vlcg</sup>  [background:] involves: 129S/Sv * C57BL/6
MONDO:0007182,Machado-Joseph disease
RGD:150521708,SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i>
HP:0020036,Upper limb dysmetria
chembl:CHEMBL578636,CHEMBL:CHEMBL578636
MGI:3841585,Dst<sup>dt-31J</sup>/Dst<sup>dt-31J</sup>  [background:] involves: DBA/1LacJ
ncit:C170264,OSANETANT
MP:0009940,abnormal hippocampus pyramidal cell morphology
CHEBI:85085,KT 5720
MONDO:0013764,Joubert syndrome 16
chembl:CHEMBL4650283,FF-10101
iuphar.ligand:11992,PRUXELUTAMIDE
chembl:CHEMBL1095027,AESCULIOSIDE IIIE
GO:0007601,visual perception
HP:0006938,Impaired vibration sensation at ankles
iuphar.ligand:4049,2-FUROYL-LIGRL[N[3H]PROPIONYL]-O-NH2
drugbank:DB07348,BREFELDIN A
iuphar.ligand:792,RO330-0802/001
drugbank:DB18591,LMB-100
HP:0010839,Increased urinary copper concentration
drugbank:DB07288,N-(4-CHLOROPHENYL)-2-[(PYRIDIN-4-YLMETHYL)AMINO]BENZAMIDE
iuphar.ligand:2012,DES-AA5-[D-TRP8]SRIF
HGNC:9005,PITX2
MONDO:0044871,"dystonia, focal, task-specific"
chembl:CHEMBL1381098,1-NAPHTHYLISOTHIOCYANATE
EMAPA:17458,hindlimb
drugbank:DB16256,NINGETINIB
ncit:C101786,MULTI-AGC KINASE INHIBITOR AT13148
HP:0000588,Optic disc coloboma
rxcui:214582,GLATIRAMER
GO:0000731,DNA synthesis involved in DNA repair
iuphar.ligand:12465,THEAFLAVIN-3′-O-GALLATE
HP:0005910,Rhomboid or triangular shaped 5th finger middle phalanx
iuphar.ligand:11861,PRU-10
HGNC:9249,PPFIBP1
rxcui:1790539,INFLIXIMAB-DYYB
chembl:CHEMBL446452,ARUNDINE
MONDO:0006971,sigmoid neoplasm
HP:0003429,CNS hypomyelination
rxcui:263010,TOSITUMOMAB
CLINVAR:189929,NM_001165963.4(SCN1A):c.2303C>T (p.Pro768Leu)
HP:0006799,Basal ganglia cysts
HGNC:17939,SLC45A1
FB:FBgn0028707,Mt2
MONDO:0001386,visual epilepsy
SGD:S000000534,BIK1
rxcui:753341,SAPROPTERIN DIHYDROCHLORIDE
rxcui:1306111,SULFAQUINOXALINE
MONDO:0018536,adenocarcinoma of gallbladder and extrahepatic biliary tract
HGNC:12582,UQCRB
rxcui:91063,TRIPELENNAMINE HYDROCHLORIDE
iuphar.ligand:9403,RO3280
HGNC:3435,ERCC3
chembl:CHEMBL587620,CHEMBL:CHEMBL587620
chembl:CHEMBL2062862,CHEMBL:CHEMBL2062862
MGI:98331,Snap25
iuphar.ligand:3368,CP105696
HGNC:10648,AIMP1
HGNC:30668,SRPX2
MP:0006060,increased cerebral infarct size
HP:0000965,Cutis marmorata
chembl:CHEMBL267475,FPL-55712
iuphar.ligand:1777,MRS2211
rxcui:195085,EFAVIRENZ
HGNC:9995,RGS13
ncit:C83970,MONATEPIL
FB:FBgn0034756,Cyp6d2
GO:0004111,creatine kinase activity
CHEBI:61692,pyridoisoquinoline
HGNC:7711,NDUFS4
chembl:CHEMBL515252,CHEMBL:CHEMBL515252
iuphar.ligand:5136,AMINOOXYACETIC ACID
HP:0031776,Cyclotropia
Reactome:R-RNO-71288,Creatine metabolism
chembl:CHEMBL600734,CHEMBL:CHEMBL600734
ncit:C81509,PYRROLNITRIN
rxcui:71227,PHENYTOIN SODIUM
chembl:CHEMBL4297717,CD24FC
iuphar.ligand:11562,COMPOUND V [PMID: 29351497]
HGNC:3012,DPYD
chembl:CHEMBL363506,CORALYNE
iuphar.ligand:323,HEXOCYCLIUM
HGNC:1144,BTRC
iuphar.ligand:10475,IBCASERTIB
chembl:CHEMBL1368322,PARAROSANILINE
chembl:CHEMBL1869863,QUINOXYFEN
GO:0006879,intracellular iron ion homeostasis
iuphar.ligand:506,L-765314
ncit:C152926,XANOMELINE
rxcui:4511,FOLIC ACID
HP:0002497,Spastic ataxia
CHEBI:47499,imipramine
HP:0000089,Renal hypoplasia
ncit:C29474,TRANSFERRIN RECEPTOR-TARGETED LIPOSOMAL P53 CDNA
rxcui:1489913,DROXIDOPA
ncit:C53397,BRIVANIB ALANINATE
MONDO:0018666,hepatoblastoma
iuphar.ligand:5655,A-674563
drugbank:DB06181,IMO-2055
ncit:C167023,FRENTIZOLE
CHEBI:27470,folic acid
HGNC:10761,SETDB1
rxcui:1000492,RESVERATROL
iuphar.ligand:8222,BETA-CARBOLINE
RGD:2502,Cyb5r3
iuphar.ligand:3841,"[HYP3,TYR(ME)8]BK"
HGNC:11559,TALDO1
chembl:CHEMBL580159,CHEMBL:CHEMBL580159
chembl:CHEMBL2109281,RG-7600
ncit:C176765,TIZATERKIB
HGNC:654,ARF3
iuphar.ligand:3186,COMPOUND 51 [PMID: 18800762]
MP:0009971,decreased hippocampus pyramidal cell number
iuphar.ligand:66,(S)-FLUROCARAZOLOL
drugbank:DB02285,PROTOPORPHYRIN
iuphar.ligand:11806,GSK329
chembl:CHEMBL2109637,HUHMFG1
PomBase:SPAC22A12.13,mug84
rxcui:3102,DANAZOL
MONDO:0009300,Perrault syndrome 1
MGI:5577182,Tg(Thy1-FUS*)19Vlb/0  [background:] B6.Cg-Tg(Thy1-FUS*)19Vlb
rxcui:203152,ALENDRONATE SODIUM
HGNC:33752,TOMM20L
drugbank:DB07941,PH-797804
rxcui:10869,TROPICAMIDE
iuphar.ligand:12028,COMPOUND 16G [PMID: 35507418]
rxcui:8704,PROCHLORPERAZINE
ncit:C548,THERAPEUTIC HORMONE
chembl:CHEMBL156897,CANTHIN-6-ONE
HGNC:7114,MKRN3
HGNC:17317,TIMM22
MONDO:0010883,pectus excavatum-macrocephaly-dysplastic nails syndrome
ncit:C49061,RIDAFOROLIMUS
chembl:CHEMBL1743260,KARENITECIN
HGNC:11411,CDKL5
MP:0005156,bradykinesia
CHEBI:26125,phytosterols
iuphar.ligand:4975,IL-10
RGD:621595,Vcp
HGNC:3676,FGF2
chembl:CHEMBL600107,CHEMBL:CHEMBL600107
drugbank:DB17087,JNJ-17216498
HGNC:2232,COPB2
CHEBI:17276,phloretin
HP:0033692,Declarative memory loss
rxcui:7394,NIALAMIDE
rxcui:1356715,ETIDRONIC ACID
chembl:CHEMBL28971,FENARIMOL
ncit:C2195,EMEPEPIMUT-S
ncit:C166510,DASOLAMPANEL
rxcui:3350,CLODRONIC ACID
rxcui:3445,DIMERCAPROL
MGI:3574660,Sp9
rxcui:61381,OLANZAPINE
chembl:CHEMBL586078,CHEMBL:CHEMBL586078
chembl:CHEMBL5095024,MP-412
rxcui:7518,NORGESTREL
rxcui:1749,BROMAZEPAM
rxcui:4023,ERGOT ALKALOIDS
chembl:CHEMBL2001019,PF-04217903
ncit:C166484,DONANEMAB
drugbank:DB02567,PD173955
MGI:5751707,Mecp2<sup>tm1.1Irsf</sup>/Y  [background:] involves: 129S2/SvPas * C57BL/6
HGNC:9221,POU5F1
MGI:1309992,Cbr3
ncit:C167334,PEGYLATED SN-38 CONJUGATE PLX038
PATO:0070010,stellate morphology
chembl:CHEMBL444376,CHEMBL:CHEMBL444376
chembl:CHEMBL55814,ATHRAQUINONES A
GO:0032733,positive regulation of interleukin-10 production
MONDO:0005096,squamous cell carcinoma
chembl:CHEMBL172350,EUPAFOLIN
MONDO:0021136,rare
ncit:C152854,VEPALIMOMAB
rxcui:2045726,AVATROMBOPAG
rxcui:8345,PIPERONYL BUTOXIDE
GO:0006729,tetrahydrobiopterin biosynthetic process
iuphar.ligand:9178,ARN726
MP:0003729,abnormal photoreceptor outer segment morphology
iuphar.ligand:6657,GB110
iuphar.ligand:5706,TAMATINIB
ncit:C201077,LYOPHILIZED HUMAN RECOMBINANT INTERFERON-BETA 1A FP-1201
GO:0050890,cognition
HP:0003547,Shoulder girdle muscle weakness
HP:0002100,Recurrent aspiration pneumonia
rxcui:797195,FESOTERODINE
iuphar.ligand:10345,"COMPOUND 3A [BADOLATO ET AL., 2019]"
rxcui:495881,SORAFENIB
HP:0000365,Hearing impairment
chembl:CHEMBL1725279,SP-600125
rxcui:142427,BROMPHENIRAMINE MALEATE
HGNC:4778,H3-4
chembl:CHEMBL553751,SALSOLINOL HYDROBROMIDE
chembl:CHEMBL1256698,CHEMBL:CHEMBL1256698
rxcui:298665,NEPAFENAC
iuphar.ligand:8914,ONATASERTIB
HP:0003073,Hypoalbuminemia
MP:0003240,loss of hippocampal neurons
HGNC:2431,CSE1L
MONDO:0006210,fibrolamellar hepatocellular carcinoma
rxcui:39230,URAPIDIL
MONDO:0020380,autosomal dominant cerebellar ataxia
chembl:CHEMBL41092,CHRYSOPHANOL
rxcui:10517,THIRAM
ncit:C66557,SPICLOMAZINE
HGNC:28746,FUNDC1
HGNC:349,AHSG
iuphar.ligand:6465,GSK2193874
MONDO:0010088,mucosulfatidosis
RGD:62058,Aoc3
rxcui:1348,BECLOMETHASONE DIPROPIONATE
HP:0001664,Torsade de pointes
iuphar.ligand:7765,NP118809
chembl:CHEMBL363160,PHA-680632
HP:0020035,Lower limb dysmetria
MP:0000875,abnormal cerebellar Purkinje cell layer
MONDO:0011137,retinitis pigmentosa 19
iuphar.ligand:3754,(DES 1-8) A-CHAIN INSL3 ANALOGUE
GO:0035973,aggrephagy
CHEBI:29007,ceftriaxone
CHEBI:26051,phosphoamino acid
ncit:C272,ANTIMETABOLITE
chembl:CHEMBL241608,CALYCOSIN
RGD:151356741,SD-Tg(Alb-TAg)Mlcr
chembl:CHEMBL1287866,CHEMBL:CHEMBL1287866
chembl:CHEMBL1795737,CHEMBL:CHEMBL1795737
chembl:CHEMBL585827,CHEMBL:CHEMBL585827
rxcui:2123125,ERDAFITINIB
chembl:CHEMBL449214,GRACILIN A
HGNC:21168,RHOT1
HGNC:5330,IARS1
drugbank:DB17050,RS-39604
UPHENO:0087707,abnormal hippocampus molecular layer morphology
iuphar.ligand:12356,SZUH280
chembl:CHEMBL3707399,CX1739
MONDO:0010586,X-linked Ehlers-Danlos syndrome
HGNC:2861,DHFR
CHEBI:7035,muscimol
HP:0006989,Dysplastic corpus callosum
drugbank:DB04459,"3,4-DICHLOROISOCOUMARIN"
rxcui:1537798,MELENGESTROL ACETATE
iuphar.ligand:2027,BIM 23627
drugbank:DB08770,"4-{2-[(7-AMINO-2-FURAN-2-YL[1,2,4]TRIAZOLO[1,5-A][1,3,5]TRIAZIN-5-YL)AMINO]ETHYL}PHENOL"
ncit:C178318,GUNAGRATINIB
drugbank:DB17882,EPITALON
HP:0032741,Focal aware emotional seizure with paranoia
MONDO:0012630,Alzheimer disease 13
HGNC:2554,CUL4A
chembl:CHEMBL1909354,GW459057A
chembl:CHEMBL494668,CHEMBL:CHEMBL494668
HGNC:693,ARL2
rxcui:3389,DIETHYLPROPION
UBERON:0002000,gluteal muscle
MGI:96721,L1cam
MONDO:0006087,appendix adenocarcinoma
rxcui:1894,CALCITRIOL
iuphar.ligand:5935,BCR-ABL INHIBITOR GNF-2
iuphar.ligand:3536,UCB35625
rxcui:15070,FORMESTANE
iuphar.ligand:8380,AC-RHYPLWR
HGNC:26775,TMEM192
HP:0041056,Hot cross bun sign
UPHENO:0086129,non-functional eyelid
ncit:C121850,CETUXIMAB SAROTALOCAN SODIUM
chembl:CHEMBL3545159,R-333
HP:0000458,Anosmia
rxcui:1545996,METHYLDOPA ANHYDROUS
iuphar.ligand:2227,[3H]D[CHA4]AVP
iuphar.ligand:1267,THIOPERAMIDE
HGNC:16912,EMG1
iuphar.ligand:4326,TP003
drugbank:DB05184,XL228
MGI:107183,Cct8
iuphar.ligand:129,S33084
HGNC:2605,CYP27A1
rxcui:136411,SILDENAFIL
ncit:C99160,ICOTINIB HYDROCHLORIDE
rxcui:6823,METHAQUALONE
iuphar.ligand:2669,EICOSATETRANOIC ACID
MONDO:0000678,simultanagnosia
rxcui:8673,FEPRAZONE
HGNC:14211,BLNK
rxcui:2475952,ACETAMIDE
rxcui:53692,NILVADIPINE
chembl:CHEMBL336095,CHEMBL:CHEMBL336095
iuphar.ligand:11561,COMPOUND IV [PMID: 29351497]
chembl:CHEMBL310934,CHEMBL:CHEMBL310934
chembl:CHEMBL141530,ECHINATIN
iuphar.ligand:9798,DARIGABAT
HGNC:24880,LYPD3
HGNC:4879,HEXB
NCBIGene:416571,NDUFAB1
HP:0011169,Generalized clonic seizure
HP:0008049,Abnormality of the extraocular muscles
HGNC:11957,MED12
MONDO:0018852,achromatopsia
rxcui:24698,FLUDARABINE
MONDO:0017706,disorder of carbohydrate transmembrane transport and absorption
rxcui:10795,TRICLOSAN
ncit:C1087,APAZIQUONE
chembl:CHEMBL548629,CHEMBL:CHEMBL548629
HGNC:3697,FGR
UBERON:0004511,skeletal muscle tissue of rectus abdominis
MONDO:0100079,"developmental and epileptic encephalopathy, 6"
HP:0032814,Neonatal electro-clinical clonic seizure
HGNC:17305,TAF6L
chembl:CHEMBL56542,CHEMBL:CHEMBL56542
ncit:C98213,NIVOCASAN
HP:0012276,Digital flexor tenosynovitis
HGNC:10901,SKP2
GO:0005770,late endosome
ncit:C38461,CASPASE INHIBITOR
chembl:CHEMBL4650291,FPA144
HGNC:4910,HIF1A
HGNC:19347,CUX2
HGNC:2615,CYP2B6
HGNC:13432,RNF19A
chembl:CHEMBL4650517,MESMULOGENE ANCOVACIVEC
HP:0000571,Hypometric saccades
MONDO:0000476,generalized dystonia
HGNC:4803,HADHB
UPHENO:0076901,decreased vibrational conductance of sound to the inner ear
HGNC:14677,DEAF1
ncit:C516,GANGLIOSIDE GM2
HGNC:11763,TFRC
rxcui:236601,SERTACONAZOLE NITRATE
drugbank:DB17495,PEGENZILEUKIN
iuphar.ligand:2032,BIM 23023
rxcui:57789,FLUORESCEIN SODIUM
MGI:6359449,Coq8a<sup>tm1.1Ics</sup>/Coq8a<sup>tm1.1Ics</sup>  [background:] involves: 129S2/SvPas * C57BL/6J * C57BL/6N
iuphar.ligand:7633,VU0010010
iuphar.ligand:8087,YTTRIUM (90Y) CLIVATUZUMAB TETRAXETAN
rxcui:7500,NOMIFENSINE
CHEBI:167095,secondary fatty alcohol
rxcui:34905,PROPARACAINE
HGNC:12871,ZHX1
HGNC:7414,MT-ATP6
chembl:CHEMBL1410006,"6,4'-DIMETHOXYFLAVONE"
iuphar.ligand:4229,JORO SPIDER TOXIN
rxcui:2604689,GANAXOLONE
rxcui:6693,MEFENAMIC ACID
chembl:CHEMBL581187,CHEMBL:CHEMBL581187
MONDO:0006304,minor salivary gland adenocarcinoma
HGNC:7200,MOV10
CHEBI:556075,radicicol
MP:0009997,abnormal cerebellum vermis lobule X morphology
chembl:CHEMBL338115,CHEMBL:CHEMBL338115
chembl:CHEMBL3545139,PS-516895
ncit:C106235,BRILANESTRANT
rxcui:35382,RESORCINOL
UBERON:0001231,nephron tubule
rxcui:11170,VERAPAMIL
HGNC:633,AQP1
ZFIN:ZDB-GENE-040724-254,slc30a9
rxcui:3248,DESLANOSIDE
GO:0006839,mitochondrial transport
rxcui:3706,DYDROGESTERONE
UPHENO:0085081,abnormal mast cell morphology
iuphar.ligand:7846,TCN-201
rxcui:44281,CEVIMELINE
chembl:CHEMBL1378167,DEXAMETHASONE VALARATE
drugbank:DB03428,SU9516
HGNC:12724,VTN
UBERON:0003530,pedal digit skin
drugbank:DB12745,GSK-690693
rxcui:167,ACETAZOLAMIDE
HGNC:3754,FLNA
iuphar.ligand:2340,NA+
CHEBI:75046,phleomycin D1
chembl:CHEMBL36148,(S)-VERAPAMIL
GO:0004340,glucokinase activity
ncit:C174918,EXALUREN
ncit:C126661,APILIMOD DIMESYLATE CAPSULE
chembl:CHEMBL268609,(R)-NITRENDIPINE
ncit:C74065,SIROLIMUS ALBUMIN-BOUND NANOPARTICLES
iuphar.ligand:11889,ZIPALERTINIB
EMAPA:18559,rest of cerebellum
HGNC:2269,COX5B
rxcui:569,EFLORNITHINE
iuphar.ligand:8645,GW853606
iuphar.ligand:7381,RS-100329
MP:0004339,absent clavicle
rxcui:3226,DEQUALINIUM
HGNC:13149,ZNF76
rxcui:1667655,CARIPRAZINE
ncit:C165746,ZOTATIFIN
HGNC:5099,HOXA1
UBERON:0004725,piriform cortex
drugbank:DB11910,MK-0249
chembl:CHEMBL476968,CHEMBL:CHEMBL476968
chembl:CHEMBL1503190,CHEMBL:CHEMBL1503190
iuphar.ligand:4236,L-&BETA;&GAMMA;-MEATP
rxcui:28144,EMEDASTINE
HGNC:5287,HTR1B
rxcui:1841,BUTORPHANOL
rxcui:8353,PIRIBEDIL
MGI:98932,Vim
ncit:C123831,CABIRALIZUMAB
HP:0004325,Decreased body weight
iuphar.ligand:5982,GTP-14564
HGNC:5959,ELP1
NCBIGene:281090,COX4I1
HGNC:29020,ECPAS
drugbank:DB12480,BETULINIC ACID
iuphar.ligand:10304,RN-9893
iuphar.ligand:11783,AZD5991
MONDO:0013923,"microcephaly 9, primary, autosomal recessive"
HP:0032756,Focal impaired awareness cognitive seizure
iuphar.ligand:5689,JNJ-28312141
MONDO:0019502,autosomal recessive non-syndromic intellectual disability
MONDO:0858950,traumatic brain injury
drugbank:DB12818,NM-3
rxcui:37776,TEMOZOLOMIDE
ncit:C62639,BMS-275183
CLINVAR:51579,NC_000013.11:g.32316463G>A
MONDO:0012463,retinitis pigmentosa 35
chembl:CHEMBL1915761,GANODERIOL F
rxcui:1546394,IODINE I-131
chembl:CHEMBL267160,CHEMBL:CHEMBL267160
iuphar.ligand:12936,PCC0105003
chembl:CHEMBL486005,ISOCEPHAELINE
chembl:CHEMBL600862,CHEMBL:CHEMBL600862
chembl:CHEMBL576981,TEBIPENEM
HGNC:7422,MT-CO3
HGNC:10852,SHMT2
rxcui:7514,NORETHINDRONE
GO:0004439,"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity"
rxcui:34706,PROPYLPARABEN
rxcui:1112973,BELATACEPT
HP:0002145,Frontotemporal dementia
RGD:621257,Mtarc2
HGNC:939,BAG3
ncit:C74191,AMPEROZIDE
iuphar.ligand:11734,ZANDATRIGINE
ncit:C101538,MOLIBRESIB
HGNC:8856,PEX14
HP:0002089,Pulmonary hypoplasia
HGNC:18174,STK26
MP:0000780,abnormal corpus callosum morphology
MGI:96067,Htt
MONDO:0012392,2-methylbutyryl-CoA dehydrogenase deficiency
chembl:CHEMBL593211,CHEMBL:CHEMBL593211
chembl:CHEMBL1867091,RIMSULFURON
HP:0007975,Hypometric horizontal saccades
FB:FBgn0261439,SdhA
chembl:CHEMBL530499,CHEMBL:CHEMBL530499
HGNC:11362,STAT1
MONDO:0008875,blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome
CHEBI:28940,calciol
MGI:3639713,Tg(APP695)3Dbo/0 Tg(PSEN1dE9)S9Dbo/0  [background:] involves: C3H/HeJ * C57BL/6J
MGI:5695752,Hap1<sup>tm2Xjl</sup>/Hap1<sup>tm2Xjl</sup> Tg(Camk2a-cre)159Kln/0  [background:] involves: 129S6/SvEvTac * BALB/c * C57BL/6
ncit:C120036,PEPOSERTIB
HP:0002788,Recurrent upper respiratory tract infections
iuphar.ligand:4179,DMCM
CHEBI:2468,secondary alpha-hydroxy ketone
ncit:C99222,ANTI-EGFRVIII ANTIBODY DRUG CONJUGATE AMG 595
HP:0000448,Prominent nose
HGNC:5294,HTR2B
iuphar.ligand:9560,AZ3451
HGNC:17125,TMEM185A
HP:0032801,Focal impaired awareness cognitive seizure with memory impairment
ncit:C105612,DEPATUXIZUMAB MAFODOTIN
ncit:C1393,RECOMBINANT MONOCYTE CHEMOATTRACTANT PROTEIN-1
ncit:C1154,CARBENDAZIM
CHEBI:36835,3alpha-hydroxy steroid
HGNC:11184,SORD
chembl:CHEMBL126804,CHEMBL:CHEMBL126804
HGNC:5237,HSPA4
MGI:103177,Mpz
chembl:CHEMBL1256971,METAPHIT METHANESULFONATE
HGNC:6210,CD82
iuphar.ligand:5560,T1117
iuphar.ligand:12491,I-287
GO:0030218,erythrocyte differentiation
drugbank:DB15335,FORMONONETIN
chembl:CHEMBL1256695,NISOXETINE HYDROCHLORIDE
rxcui:4316,FELODIPINE
HP:0002317,Unsteady gait
CHEBI:2676,amoxicillin
HP:0006813,Focal hemiclonic seizure
ncit:C1773,ENILURACIL
WB:WBGene00007350,sucl-1
iuphar.ligand:10649,COMPOUND 7 [PMID: 31955578]
HGNC:6408,MAFB
HGNC:9588,PTEN
HGNC:18262,MFN1
chembl:CHEMBL4297438,T-817 MALEATE
iuphar.ligand:8136,COMPOUND 2 [PMID: 15546730]
rxcui:9069,QUINIDINE SULFATE
rxcui:326374,NORELGESTROMIN
rxcui:2591476,ABROCITINIB
HP:0032679,Focal non-motor seizure
chembl:CHEMBL2272380,ENDOSULFAN SULFATE
HGNC:236,ADCY5
ncit:C83785,IMAGABALIN
MGI:5489760,Gja8<sup>R205G</sup>/Gja8<sup>R205G</sup>  [background:] B6.Cg-Gja8<sup>R205G</sup>
rxcui:1603852,LAUROCAPRAM
iuphar.ligand:4303,RYANODINE
MP:0000852,small cerebellum
chembl:CHEMBL2028045,CHEMBL:CHEMBL2028045
wikidata:Q29003613,ABILIFY MAINTENA
chembl:CHEMBL1521739,AMODIAQUINE DIHYDROCHLORIDE
HGNC:21062,FARS2
chembl:CHEMBL73930,TANGERETIN
chembl:CHEMBL450288,XANTHOXYLIN
chembl:CHEMBL2108569,INSULIN PEGLISPRO
HP:0010769,Pilonidal sinus
MONDO:0011833,spinocerebellar ataxia type 21
HP:0011935,Decreased urinary urate
ncit:C102881,THIOUREIDOBUTYRONITRILE
HP:0002923,Rheumatoid factor positive
FB:FBgn0015269,Nf1
HP:0002494,Abnormal rapid eye movement sleep
HP:0011474,Childhood onset sensorineural hearing impairment
chembl:CHEMBL1590432,GANGLEOIDIN ACETATE
chembl:CHEMBL452374,NEOCHAMAEJASMIN A
chembl:CHEMBL585651,CHEMBL:CHEMBL585651
iuphar.ligand:6429,COMPOUND 16M [PMID: 19931453]
rxcui:288999,CETRIMONIUM BROMIDE
rxcui:25138,FLUORESCEIN
HP:5200045,Reduced impulse control
iuphar.ligand:11442,EPCORITAMAB
ncit:C182630,PARIDIPRUBART
ncit:C74529,PAGOCLONE
rxcui:7531,NORTRIPTYLINE
ZFIN:ZDB-GENE-040426-2143,mdh2
iuphar.ligand:8133,COMPOUND 10 [PMID: 23147077]
HP:0000623,Supranuclear ophthalmoplegia
HGNC:1160,TWNK
GO:0019463,glycine catabolic process to creatine
drugbank:DB16087,ALFLUTINIB
ncit:C432,DITIOCARB
MGI:2176410,Ppt1<sup>tm1Hof</sup>/Ppt1<sup>tm1Hof</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6J
rxcui:99,6-AMINOCAPROIC ACID
iuphar.ligand:2191,D[LEU4]LVP
HP:0011923,Decreased activity of mitochondrial complex I
HGNC:12362,TSC1
chembl:CHEMBL268291,DIMETHYLFORMAMIDE
MP:0008535,enlarged lateral ventricles
ncit:C71025,TAMIBAROTENE
MONDO:0014033,dystonia 25
ncit:C73830,PYROVALERONE HYDROCHLORIDE
chembl:CHEMBL1719948,MORUSINOL
HGNC:9801,RAC1
rxcui:10633,TOLAZAMIDE
ncit:C48378,SARACATINIB
chembl:CHEMBL170405,ROBINETIN
chembl:CHEMBL3833330,CINPANEMAB
MONDO:0006685,brain hypoxia - ischemia
HGNC:21050,CDKAL1
MGI:2429635,Hrh4
chembl:CHEMBL3545208,AZD3161
HP:0007256,Abnormal pyramidal sign
HGNC:4855,HDC
HGNC:30035,PIK3R5
UBERON:0000006,islet of Langerhans
MONDO:0015681,childhood disintegrative disorder
chembl:CHEMBL1235969,SIMOCYCLINONE D8
HGNC:23156,U2AF2
HP:0010543,Opsoclonus
HGNC:12333,TRPC1
ncit:C88345,ONZIGOLIDE
HGNC:1780,CDK9
HP:0004756,Ventricular tachycardia
HP:0012008,Focal cognitive seizure with illusion
HGNC:7966,NR1H3
rxcui:1767,BROMPHENIRAMINE
MONDO:0007285,cataract 1 multiple types
chembl:CHEMBL465980,ONONIN
rxcui:2396,CHLOROTHIAZIDE
HGNC:3688,FGFR1
ncit:C166632,COBITOLIMOD
GO:0019158,mannokinase activity
MONDO:0958030,immunodeficiency 118
MGI:4438494,Tg(Thy1-TARDBP)4Singh/0  [background:] involves: C57BL/6J * SJL/J
MONDO:0100096,COVID-19
chembl:CHEMBL118745,TRIMETHYL-OCTADECYL-AMMONIUM CHLORIDE
ncit:C38706,GARLIC
HGNC:19967,CCDC88C
HGNC:11539,TAF5
HP:0012847,Epilepsia partialis continua
rxcui:3626,DOMPERIDONE
UBERON:0010222,anatomical line between pupils
iuphar.ligand:229,WAY-163909
chembl:CHEMBL2109396,AMG-888
MGI:3709758,Drd1<sup>tm2Jcd</sup>/Drd1<sup>+</sup> Tg(Camk2a-cre)2Gsc/0  [background:] involves: 129S4/SvJae * FVB/N
MGI:3832324,Slc6a3<sup>tm2(tTA)Xz</sup>/Slc6a3<sup>tm3(tetO)Xz</sup>  [background:] involves: 129X1/SvJ * C57BL/6J
CHEBI:48908,triazolobenzothiazole
UBERON:0002129,cerebellar cortex
UPHENO:0074687,increased inflammatory response in bone element
chembl:CHEMBL1593867,HARMINE HYDROCHLORIDE
rxcui:91169,PSEUDOEPHEDRINE SULFATE
MONDO:0021074,precancerous condition
ncit:C62496,TESEVATINIB
iuphar.ligand:4281,PHENAMIL
HGNC:4401,GNB5
UBERON:0001460,arm
rxcui:1306107,NICOTINE BITARTRATE
chembl:CHEMBL582932,DITHIODIMORPHOLINE
iuphar.ligand:8170,COMPOUND 8H [PMID: 21561767]
HP:0000733,Abnormal repetitive mannerisms
drugbank:DB08577,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE
ncit:C104744,ULIXERTINIB
MONDO:0005395,movement disorder
HP:0002476,Primitive reflex
rxcui:22396,DEFLAZACORT
ncit:C241,ANALGESIC AGENT
HP:0009879,Simplified gyral pattern
MGI:2663350,Clock<sup>m1Jt</sup>/Clock<sup>+</sup>  [background:] C57BL/6-Clock<sup>m1Jt</sup>
rxcui:1311139,SORBIC ACID
MONDO:0100054,idiopathic anaphylaxis
GO:0007283,spermatogenesis
rxcui:1545988,CYCLOPHOSPHAMIDE ANHYDROUS
MONDO:0000480,anismus
HP:0030810,Abnormal tongue physiology
HP:0007209,Facial paralysis
HP:0011344,Severe global developmental delay
HGNC:6037,ILF2
iuphar.ligand:2364,ANANDAMIDE
ncit:C65911,INDECAINIDE HYDROCHLORIDE
chembl:CHEMBL2332352,ARGENTEOSIDE A
rxcui:341248,EZETIMIBE
CLINVAR:194555,NM_021007.3:c.2558G>A
HGNC:26918,SMAGP
rxcui:203126,MAPROTILINE HYDROCHLORIDE
HP:0033687,Short term memory impairment
ncit:C77432,CAREBASTINE
HGNC:2352,CREM
MONDO:0012994,dopa-responsive dystonia due to sepiapterin reductase deficiency
HP:0020049,Exodeviation
MGI:2175044,Gja8<sup>No2</sup>/Gja8<sup>+</sup>  [background:] involves: 101 * C3H
MONDO:0012997,cholestasis-pigmentary retinopathy-cleft palate syndrome
HGNC:7605,MYO6
HP:0025235,Non-rapid eye movement parasomnia
ncit:C79809,DEFACTINIB
ncit:C105402,ENTOSPLETINIB
NCBIGene:327673,NDUFA1
UPHENO:0005411,decreased vertical activity
MONDO:0000605,hypersensitivity reaction disease
CL:0000125,glial cell
Reactome:R-HSA-211945,Phase I - Functionalization of compounds
HP:0032840,Neonatal bilateral symmetric epileptic spasm
HGNC:11728,TERF1
MONDO:0005144,familial amyotrophic lateral sclerosis
HP:0002445,Tetraplegia
MONDO:0100339,Friedreich ataxia
HP:0001100,Heterochromia iridis
GO:0005730,nucleolus
chembl:CHEMBL3545237,HE3235
HGNC:9281,PPP1CA
chembl:CHEMBL1320453,CHEMBL:CHEMBL1320453
CHEBI:59905,dopaminium(1+)
CL:0002543,vein endothelial cell
chembl:CHEMBL1369257,PHENYLSTIBONIC ACID
ncit:C152613,TICRYNAFEN
MONDO:0008114,obsessive-compulsive disorder
chembl:CHEMBL525106,CHEMBL:CHEMBL525106
rxcui:5781,INDOMETHACIN
ncit:C1423,PERFOSFAMIDE
MONDO:0006966,secondary Parkinson disease
ncit:C78449,GLEMBATUMUMAB VEDOTIN
chembl:CHEMBL121556,CHEMBL:CHEMBL121556
ncit:C171664,TRAZPIROBEN
HP:0020042,Double depressor palsy
HP:0000396,Overfolded helix
rxcui:8124,PHENELZINE SULFATE
chembl:CHEMBL591864,CHEMBL:CHEMBL591864
GO:0070830,bicellular tight junction assembly
GO:0050896,response to stimulus
rxcui:722,AMOXAPINE
ncit:C575,IMMUNOTOXIN
rxcui:1309980,SOYBEAN SEED OIL
drugbank:DB02152,K-252A
iuphar.ligand:1262,JB 98064
iuphar.ligand:9642,TCDD
MP:0001393,ataxia
MONDO:0011812,Duane-radial ray syndrome
MONDO:0019170,polyarteritis nodosa
rxcui:859857,SAQUINAVIR MESYLATE
RGD:1562350,Uqcrq
rxcui:35100,PYRITHIONE
iuphar.ligand:5723,AS1907417
rxcui:861640,PITAVASTATIN CALCIUM
chembl:CHEMBL1526572,DERRUSNIN
ncit:C2149,MITOGEN-ACTIVATED PROTEIN KINASE INHIBITOR
iuphar.ligand:2921,DIHYDROSPHINGOSINE 1-PHOSPHATE
iuphar.ligand:9526,MI-503
PomBase:SPAPB17E12.10c,mrm202
CHEBI:19168,17-oxo steroid
chembl:CHEMBL1479103,HAEMATOXYLIN
chembl:CHEMBL591363,CHEMBL:CHEMBL591363
MONDO:0020788,"hypomagnesemia, seizures, and intellectual disability 2"
rxcui:1942950,INOTUZUMAB OZOGAMICIN
HP:0002395,Lower limb hyperreflexia
MONDO:0015059,progressive non-fluent aphasia
chembl:CHEMBL1256689,CHEMBL:CHEMBL1256689
chembl:CHEMBL539507,CLORGYLINE HYDROCHLORIDE
iuphar.ligand:9833,BSAB (CD89-CD20)
iuphar.ligand:76,SB 649915
drugbank:DB18303,DEUCRICTIBANT
chembl:CHEMBL2435339,"(20S,21S)-7-CYCLOHEXYLFLUOROCAMPTOTHECIN"
rxcui:3554,DISULFIRAM
ncit:C114381,TELAGLENASTAT
chembl:CHEMBL1480173,4-METHYLBENZOIC ACID METHYL ESTER
HGNC:3662,FGB
chembl:CHEMBL1543865,CHEMBL:CHEMBL1543865
GO:1902463,protein localization to cell leading edge
rxcui:104696,TRICLOFOS SODIUM
iuphar.ligand:4027,AS1269574
chembl:CHEMBL528724,CHEMBL:CHEMBL528724
drugbank:DB03819,SALICYLHYDROXAMIC ACID
chembl:CHEMBL463701,CHEMBL:CHEMBL463701
CHEBI:67203,"N,N'-(p-xylylidene)bis(aminoguanidine)"
HP:0006990,Myelin-dependent gliosis
iuphar.ligand:2079,"H-C[CYS-PHE-LAGL(N&BETA;ME,BENZOYL)-DTRP-LYS-THR-PHE-CYS]-OH"
rxcui:2179,CEFATRIZINE
HGNC:9402,PRKCG
iuphar.ligand:4052,WAY200070
chembl:CHEMBL4650290,GC1118
MONDO:0000481,cervical dystonia
MONDO:0017763,disorder of iron metabolism and transport
iuphar.ligand:9456,AC-55541
chembl:CHEMBL587579,CHEMBL:CHEMBL587579
iuphar.ligand:9815,CCT196969
rxcui:1356129,SEROTONIN HYDROCHLORIDE
HGNC:707,ARPC4
iuphar.ligand:5617,LAS38096
ncit:C65616,FAMPROFAZONE
ncit:C76464,TALNETANT
drugbank:DB01816,CASTANOSPERMINE
chembl:CHEMBL1477760,GRINIMIBINE
HP:0000641,Dysmetric saccades
MGI:109392,Esr2
iuphar.ligand:2794,"PHOSPHATIDYL (3,5) INOSITOL BISPHOSPHATE"
chembl:CHEMBL203191,KRESOXIM-METHYL
rxcui:1796,BUFEXAMAC
HP:0006850,Hypoplasia of the ventral pons
HP:0100832,Vitreous floaters
chembl:CHEMBL579105,CHEMBL:CHEMBL579105
GO:0004197,cysteine-type endopeptidase activity
rxcui:28889,LORATADINE
iuphar.ligand:4758,[3H]VESAMICOL
HGNC:11450,SUCLG2
rxcui:235988,VENLAFAXINE HYDROCHLORIDE
NCBIGene:100157219,ARNT2
iuphar.ligand:8802,ESTRADIOL DISULFATE
iuphar.ligand:6531,FTI 276
chembl:CHEMBL593366,CHEMBL:CHEMBL593366
drugbank:DB17309,MINNELIDE
CHEBI:28697,21-deoxycortisol
chembl:CHEMBL546597,CHEMBL:CHEMBL546597
iuphar.ligand:175,SPIRAMIDE
MGI:4831138,Cend1<sup>tm1.1Rmat</sup>/Cend1<sup>tm1.1Rmat</sup>  [background:] involves: 129P2/OlaHsd * BALB/cJ * C57BL/6
ncit:C582,DNA INTERCALATING AGENT
MONDO:0009319,pantothenate kinase-associated neurodegeneration
iuphar.ligand:5404,[3H]AZIETOMIDATE
rxcui:60212,ATOVAQUONE
HP:0004374,Hemiplegia/hemiparesis
HP:0001348,Brisk reflexes
chembl:CHEMBL1255966,CHEMBL:CHEMBL1255966
CHEBI:138856,oxolinic acid
HP:0004879,Intermittent hyperventilation
MGI:97890,Rad51
ncit:C74188,ECOPIPAM
GO:0009265,2'-deoxyribonucleotide biosynthetic process
rxcui:10324,TAMOXIFEN
ncit:C173964,FGFR INHIBITOR CPL304110
ncit:C169863,CONTELTINIB
iuphar.ligand:12515,DF3016A
HP:0040303,Decreased serum iron
HGNC:5218,HSD3B2
EMAPA:18558,cerebellum intraventricular portion ventricular layer
rxcui:11636,DROSPIRENONE
MONDO:0008722,short chain acyl-CoA dehydrogenase deficiency
HGNC:935,BACH1
UPHENO:0013936,anatomical entity atrophy
HGNC:6404,KPTN
UPHENO:0088329,abnormally decreased number of neuron in the basal ganglion
chembl:CHEMBL590686,CHEMBL:CHEMBL590686
UPHENO:0069341,decreased size of the caudate nucleus
HGNC:30605,SEPSECS
MONDO:0010826,childhood absence epilepsy
HP:0004886,Congenital laryngeal stridor
NBO:0000371,aquatic locomotion
rxcui:847728,LUMEFANTRINE
chembl:CHEMBL1537417,CHEMBL:CHEMBL1537417
MGI:2388398,Cln8<sup>mnd</sup>/Cln8<sup>mnd</sup>  [background:] B6.KB2/Rn-Cln8<sup>mnd</sup>
iuphar.ligand:9968,SH045
chembl:CHEMBL3545263,LGX-806
iuphar.ligand:9186,ECF506
HGNC:20667,TXNRD3
HP:0002340,Caudate atrophy
HP:0006369,Irregular patellae
HP:0002375,Hypokinesia
CHEBI:134547,TOP-53
HP:0003281,Increased circulating ferritin concentration
GO:0070530,K63-linked polyubiquitin modification-dependent protein binding
drugbank:DB17024,CHELERYTHRINE
rxcui:51296,IDEBENONE
chembl:CHEMBL124267,CHEMBL:CHEMBL124267
drugbank:DB07149,"(7S)-2-(2-AMINOPYRIMIDIN-4-YL)-7-(2-FLUOROETHYL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE"
chembl:CHEMBL528712,CHEMBL:CHEMBL528712
ncit:C83818,INECALCITOL
chembl:CHEMBL1404865,CHEMBL:CHEMBL1404865
FB:FBgn0263929,jvl
HP:0006790,Cerebral cortex with spongiform changes
ncit:C2337,SODIUM BUTYRATE
chembl:CHEMBL521027,CYPRODINIL
rxcui:2059268,OMADACYCLINE TOSYLATE
ncit:C151988,EBVACICLIB
chembl:CHEMBL272621,HYODEOXYCHOLIC_ACID
rxcui:1374845,TRAMIPROSATE
MGI:3629227,Kat6a<sup>tm1Avo</sup>/Kat6a<sup>tm1Avo</sup>  [background:] involves: 129/Sv * BALB/c * FVB/N
HP:0012465,Elevated hepatic iron concentration
iuphar.ligand:1827,TIP39-(7-39) (HUMAN/BOVINE)
HP:0002050,"Macroorchidism, postpubertal"
chembl:CHEMBL455004,CHEMBL:CHEMBL455004
HP:0030183,Impaired visually enhanced vestibulo-ocular reflex
HGNC:9549,PSMC3
ncit:C1892,CHEMOPREVENTIVE AGENT
MONDO:0006203,extrahepatic bile duct squamous cell carcinoma
ncit:C68930,ANTI-HIF-1ALPHA LNA ANTISENSE OLIGONUCLEOTIDE EZN-2968
GO:0071312,cellular response to alkaloid
iuphar.ligand:5651,1-STEAROYL-LYSOPHOSPHATIDYLCHOLINE
HP:0000253,Progressive microcephaly
ZFA:0000861,ventral oblique extraocular muscle
HP:0002349,Focal aware seizure
ncit:C65779,FURAFYLLINE
chembl:CHEMBL63329,CHEMBL:CHEMBL63329
chembl:CHEMBL403308,CHEMBL:CHEMBL403308
MONDO:0010828,retinitis pigmentosa 11
iuphar.ligand:2042,BOC-ATE
HP:0004719,Hyperechogenic kidneys
drugbank:DB05227,APD791
HGNC:20800,SLC35D1
iuphar.ligand:4089,[3H]DIZOCILPINE
rxcui:860647,ASENAPINE MALEATE
rxcui:1742747,"SERINE, D-"
chembl:CHEMBL1095025,AESCULIOSIDE IIID
rxcui:42330,TERFENADINE
HGNC:6469,KYNU
HP:0000752,Hyperactivity
MGI:104615,Cnr1
HGNC:9236,PPARG
MGI:4438492,Tg(Thy1-TARDBP)4Singh/Tg(Thy1-TARDBP)4Singh  [background:] involves: C57BL/6J * SJL/J
chembl:CHEMBL375673,CHEMBL:CHEMBL375673
CHEBI:15727,carnosine
UPHENO:0005625,decreased reflex
chembl:CHEMBL606167,CHEMBL:CHEMBL606167
iuphar.ligand:4287,PIPERIDINE-4-SULPHONIC ACID
ncit:C76940,ESMIRTAZAPINE MALEATE
chembl:CHEMBL1485809,CHEMBL:CHEMBL1485809
MGI:1917205,Fars2
iuphar.ligand:8435,LP-44
HP:0002181,Cerebral edema
MONDO:0010575,deafness-hypogonadism syndrome
ncit:C95729,MERESTINIB
ncit:C1556,PURINE ANTAGONIST
chembl:CHEMBL111743,STROPHANTHIDIN
rxcui:235288,PHENFORMIN HYDROCHLORIDE
chembl:CHEMBL3545431,HMN-214
chembl:CHEMBL1950810,CONICASTEROL E
Reactome:R-CEL-500753,Pyrimidine biosynthesis
MONDO:0007433,dementia/parkinsonism with non-Alzheimer amyloid plaques
GO:0030424,axon
ncit:C71750,AMUVATINIB
chembl:CHEMBL2088731,CHEMBL:CHEMBL2088731
iuphar.ligand:3640,C3A
HGNC:3424,ERAL1
ncit:C64639,CRENOLANIB
ncit:C185864,ICOVAMENIB
ncit:C61564,VINFLUNINE
rxcui:1374,BENSERAZIDE
HGNC:4751,H2BC3
iuphar.ligand:5193,GF109203X
HP:0004429,Recurrent viral infections
HP:5200071,Delayed Echolalia
HP:0031849,Sleep-wake inversion
chembl:CHEMBL260311,CHEMBL:CHEMBL260311
iuphar.ligand:5735,COMPOUND 42 [PMID: 22545772]
ncit:C200319,KRAS G12D INHIBITOR MRTX1133
MONDO:0010094,spondylocarpotarsal synostosis syndrome
HGNC:5031,HNRNPA1
UPHENO:0080036,increased glial cell growth in cerebellum
GO:0002283,neutrophil activation involved in immune response
rxcui:21290,CLOROPHENE
CHEBI:46195,paracetamol
CHEBI:38924,dibenzothiepine
iuphar.ligand:4276,NVP-AAM077
CLINVAR:9325,NM_000059.4(BRCA2):c.5946del (p.Ser1982fs)
MGI:4838205,Tg(Eno2-TOR1A*)13Shas/0  [background:] involves: C3H * C57BL/6J
CL:0000542,lymphocyte
HGNC:14240,SMPD3
iuphar.ligand:1989,RELAXIN
rxcui:235991,ANHYDROUS TACROLIMUS
chembl:CHEMBL1374504,"DALBERGIONE, 4-METHOXY-4'-HYDROXY-"
MONDO:0018670,symptomatic form of fragile X syndrome in female carrier
chembl:CHEMBL1712842,MEPAZINE ACETATE
iuphar.ligand:4226,ISOGUVACINE
iuphar.ligand:107,5-MEOT
MONDO:0009610,3-methylglutaconic aciduria type 1
ncit:C166919,PIRSIDOMINE
FB:FBgn0026761,Trap1
UBERON:0000981,femur
HGNC:12718,VRK1
HGNC:795,ATM
HGNC:17072,ERC1
iuphar.ligand:3530,SB328437
iuphar.ligand:8379,SQ007-5
GO:0032288,myelin assembly
HGNC:1403,CACNB3
rxcui:1810569,ETEPLIRSEN
iuphar.ligand:10469,COVA322
MGI:105047,Psmc5
iuphar.ligand:1807,[PHE23]PTH-(1-34) (HUMAN)
iuphar.ligand:151,[3H]LY334370
rxcui:1369713,POMALIDOMIDE
MONDO:0024276,glandular cell neoplasm
chembl:CHEMBL582287,CHEMBL:CHEMBL582287
ncit:C1674,RECOMBINANT FIBROBLAST GROWTH FACTOR 2
drugbank:DB05010,SGS-742
EMAPA:35212,cerebellum layer
GO:0005080,protein kinase C binding
chembl:CHEMBL1371435,ISOEUGENITOL
rxcui:28627,LEVOCABASTINE
ncit:C1290,RECOMBINANT MACROPHAGE COLONY-STIMULATING FACTOR
GO:0007568,obsolete aging
drugbank:DB11752,BRYOSTATIN 1
CHEBI:15414,S-adenosyl-L-methionine
MP:0009989,abnormal cerebellum vermis lobule II morphology
GO:0030154,cell differentiation
MONDO:0032784,neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements
ncit:C64175,THIOLUTIN
HP:0001257,Spasticity
HP:0007141,Sensorimotor neuropathy
UPHENO:0051613,abnormal independent continuant creatine level
chembl:CHEMBL445153,CHEMBL:CHEMBL445153
iuphar.ligand:11558,COMPOUND I [PMID: 29351497]
chembl:CHEMBL4298192,SUVODIRSEN
HGNC:18345,TENT5A
rxcui:10962,TYROSINE
HP:0002385,Paraparesis
MONDO:0044745,nervous system injury
MONDO:0013853,pontocerebellar hypoplasia type 1B
ncit:C96305,AVAGACESTAT
rxcui:10737,TRAZODONE
chembl:CHEMBL375971,CHEMBL:CHEMBL375971
HP:0001281,Tetany
ncit:C1714,RECOMBINANT FLT3 LIGAND
chembl:CHEMBL1898860,HEXACONAZOLE
iuphar.ligand:4320,TBPS
MONDO:1011336,"nervous system disorder, non-human animal"
HGNC:3058,DTNB
HGNC:11430,STX12
MGI:99400,Atp7a
Xenbase:XB-GENE-982534,dlat
rxcui:6760,MEPROBAMATE
rxcui:1426874,IOFLUPANE I-123
HP:0009139,Osteolysis involving bones of the lower limbs
ncit:C76761,DOCEBENONE
MONDO:0013886,cerebellar dysfunction with variable cognitive and behavioral abnormalities
chembl:CHEMBL227298,CHEMBL:CHEMBL227298
rxcui:4903,GLUTETHIMIDE
UBERON:0035827,right adrenal gland cortex
rxcui:1514,BETAMETHASONE
HP:0012156,Hemophagocytosis
CLINVAR:52516,NM_000059.4(BRCA2):c.8168A>C (p.Asp2723Ala)
MP:0003464,abnormal single cell response threshold
HGNC:21752,SDHAF3
dictyBase:DDB_G0272006,DDB_G0272006
HP:0001800,Hypoplastic toenails
iuphar.ligand:1256,JNJ-5207852
rxcui:194000,CAPECITABINE
ncit:C169814,BRADANICLINE
iuphar.ligand:169,[125I]DOI
chembl:CHEMBL226507,SINENSETIN
ncit:C1012,BENZODIAZEPINE
chembl:CHEMBL1256761,CHEMBL:CHEMBL1256761
HGNC:11199,SOX3
rxcui:1309396,VARDENAFIL HYDROCHLORIDE TRIHYDRATE
iuphar.ligand:8591,ML381
HGNC:28041,AMZ2
drugbank:DB05204,XL418
HGNC:4331,GLS
HGNC:4075,GABRA1
UBERON:0002110,gallbladder
chembl:CHEMBL408563,CHEMBL:CHEMBL408563
ncit:C77949,DERSALAZINE
HP:0012332,Abnormal autonomic nervous system physiology
MONDO:0100062,developmental and epileptic encephalopathy
iuphar.ligand:6684,"1,3-DITOLYLGUANIDINE"
chembl:CHEMBL1483413,CHEMBL:CHEMBL1483413
ncit:C95206,DEPATUXIZUMAB
chembl:CHEMBL116548,CHEMBL:CHEMBL116548
ncit:C1055,CUSTIRSEN SODIUM
Reactome:R-CFA-211945,Phase I - Functionalization of compounds
HP:0012507,Weakness of orbicularis oculi muscle
iuphar.ligand:5179,EHNA
CHEBI:57560,long-chain fatty acid anion
iuphar.ligand:322,HEXAHYDRODIFENIDOL
drugbank:DB12959,IOWH-032
chembl:CHEMBL590947,CHEMBL:CHEMBL590947
chembl:CHEMBL579318,CHEMBL:CHEMBL579318
UPHENO:0079536,increased independent continuant role level
chembl:CHEMBL271579,BROMUCONAZOLE
iuphar.ligand:145,5-MEO-DMT
chembl:CHEMBL527585,CHEMBL:CHEMBL527585
HP:0500073,Abnormal ocular alignment
iuphar.ligand:969,(-)-N-PORPHYNORAPOMORPHINE
rxcui:1652103,ASUNAPREVIR
chembl:CHEMBL582278,CHEMBL:CHEMBL582278
ncit:C73256,BROQUINALDOL
WB:WBGene00019295,pfkb-1.2
HGNC:25090,CMBL
chembl:CHEMBL569419,CHEMBL:CHEMBL569419
rxcui:235483,HYDROCORTISONE SODIUM SUCCINATE
MONDO:0014071,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11"
ncit:C84107,PROADIFEN
HGNC:19312,EAPP
rxcui:1251576,IMIDACLOPRID
drugbank:DB15493,CAMBINOL
chembl:CHEMBL1374535,"3,5-DIPHENYLISOXAZOLE"
rxcui:235752,BEPRIDIL HYDROCHLORIDE
CHEBI:5118,fluoxetine
rxcui:865,ANTAZOLINE
chembl:CHEMBL3707400,INDANTADOL
CHEBI:26255,prenylquinone
HGNC:2172,CNTN2
iuphar.ligand:113,GR-55562
HGNC:12392,DNAJC7
MGI:6431340,Ace2<sup>em1(ACE2)Yowa</sup>/Ace2<sup>em1(ACE2)Yowa</sup>  [background:] C57BL/6-Ace2<sup>em1(ACE2)Yowa</sup>
HGNC:18224,ZRANB1
chembl:CHEMBL3545035,REVEXEPRIDE
chembl:CHEMBL453905,BROMOXYNIL
HGNC:30300,SKIC8
HGNC:9713,PEX19
iuphar.ligand:836,CXCL11
ncit:C49084,IMETELSTAT
MP:0000743,muscle spasm
MGI:1098791,Sepsecs
TS:23,
rxcui:3351,DICHLOROPHEN
chembl:CHEMBL332670,CHEMBL:CHEMBL332670
HGNC:406,ALDH4A1
ncit:C1883,VITAMIN D3 ANALOGUE ILX23-7553
HGNC:12563,UMPS
chembl:CHEMBL52884,CHEMBL:CHEMBL52884
ncit:C1804,RALTITREXED
HGNC:8966,PIGL
GO:0004559,alpha-mannosidase activity
rxcui:1723734,IXAZOMIB CITRATE
chembl:CHEMBL113262,METHOXYARACHIDONOYL FLUOROPHOSPHONATE
MP:0004950,abnormal brain vasculature morphology
chembl:CHEMBL547269,CHEMBL:CHEMBL547269
iuphar.ligand:9362,AZD7545
rxcui:75917,INTERFERON BETA-1A
HGNC:4664,GTF3C1
HGNC:1058,BLM
MONDO:0000482,focal hand dystonia
HGNC:26623,TMEM17
rxcui:203196,PENTAZOCINE LACTATE
chembl:CHEMBL37676,APC-100
MONDO:0016396,pontocerebellar hypoplasia type 1
MONDO:0000321,typhoidal tularemia
RGD:2293729,SHR-<i>Gja8</i><sup>m1-/-Cub</sup>
HGNC:2076,CLN5
ncit:C126687,RINETERKIB
HP:0001539,Omphalocele
FB:FBgn0004573,5-HT7
HGNC:753,ASNS
iuphar.ligand:12503,COMPOUND 6641
HP:0010818,Generalized tonic seizure
HP:0002505,Loss of ambulation
HGNC:13666,AAAS
HGNC:19763,ASB12
iuphar.ligand:2835,GSK4716
HGNC:4923,HK2
HGNC:959,BAX
rxcui:2168587,ENOBOSARM
MGI:99604,Fgf8
ncit:C169761,ACRIZANIB
rxcui:2593691,POMIFERIN
MONDO:0007435,dentatorubral-pallidoluysian atrophy
HP:0009053,Distal lower limb muscle weakness
GO:0070062,extracellular exosome
HP:0004395,Malnutrition
HP:0000297,Facial hypotonia
drugbank:DB05198,CYC116
iuphar.ligand:1814,"PTHRP-(7-34) (HUMAN, RAT, MOUSE)"
ncit:C171663,CENDERITIDE
chembl:CHEMBL68096,CHEMBL:CHEMBL68096
ncit:C76666,PROTOPORPHYRIN DISODIUM
iuphar.ligand:8057,XMD8-92
HP:0003348,Hyperalaninemia
drugbank:DB18455,AVX-470
iuphar.ligand:11557,LY3202626
HP:0002078,Truncal ataxia
chembl:CHEMBL3907479,FGFR INHIBITOR DEBIO 1347
chembl:CHEMBL602946,CHEMBL:CHEMBL602946
ncit:C1433,LIAROZOLE
HP:0001321,Cerebellar hypoplasia
iuphar.ligand:2483,5S-HPETE
rxcui:1314612,ALTRENOGEST
RGD:1566036,Spidr
MGI:102682,Llgl1
HP:0001250,Seizure
rxcui:2107310,PRUCALOPRIDE
chembl:CHEMBL1390650,CHEMBL:CHEMBL1390650
chembl:CHEMBL1728978,CHEMBL:CHEMBL1728978
HP:0002418,Abnormal midbrain morphology
HGNC:17021,ASTN2
HGNC:18902,KRTAP9-4
chembl:CHEMBL2109255,HEFI-1
iuphar.ligand:10095,RO3306
HP:0002015,Dysphagia
rxcui:3429,DIHYDROTACHYSTEROL
rxcui:1356552,PERAMPANEL
UPHENO:0055087,increased thigmotaxis
chembl:CHEMBL2058994,CHEMBL:CHEMBL2058994
HGNC:6548,LDOC1
iuphar.ligand:7658,GINSENOSIDE RG3
iuphar.ligand:6156,SC-41930
iuphar.ligand:9016,LM10
HGNC:4861,HELLS
MGI:5447979,Hhat<sup>Tg(TFAP2A-cre)1Will</sup>/Hhat<sup>Tg(TFAP2A-cre)1Will</sup>  [background:] Not Specified
ncit:C1623,PATUPILONE
ncit:C65355,CYCLIRAMINE MALEATE
HGNC:20371,NDUFA11
HGNC:3327,ELN
chembl:CHEMBL1200782,DEXTROAMPHETAMINE ADIPATE
HGNC:2584,CYLD
iuphar.ligand:7759,RY796
HP:0006443,Patellar aplasia
MGI:3646735,Cyp2b23
drugbank:DB04014,ALSTERPAULLONE
chembl:CHEMBL2103791,ADIPIPLON
ncit:C969,DROLOXIFENE
chembl:CHEMBL1257005,LOBELINE HYDROCHLORIDE
chembl:CHEMBL1481509,CHEMBL:CHEMBL1481509
chembl:CHEMBL17201,CHEMBL:CHEMBL17201
UPHENO:0077910,decreased reflex in pelvic complex
GO:0007033,vacuole organization
chembl:CHEMBL243664,ACACETIN
chembl:CHEMBL2152009,COSMOMYCIN C
iuphar.ligand:7733,GDC-0152
MGI:3624713,Mecp2<sup>tm1.1Bird</sup>/Y  [background:] involves: 129P2/OlaHsd * C57BL/6
drugbank:DB18563,PEMTUMOMAB
rxcui:44151,CLOFARABINE
rxcui:22298,DAPIPRAZOLE
HGNC:29348,THSD7B
HP:0002025,Anal stenosis
HGNC:28163,CCDC28B
CHEBI:8028,perphenazine
MP:0003109,short femur
chembl:CHEMBL533542,CHEMBL:CHEMBL533542
CHEBI:83686,(2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol
HP:0000135,Hypogonadism
HGNC:2652,CYP7B1
HGNC:10992,SLC25A6
MONDO:0000837,bone resorption disease
iuphar.ligand:7943,MK-8776
HP:0000271,Abnormality of the face
ncit:C96532,LOSMAPIMOD
iuphar.ligand:8292,AM7
MONDO:0020040,"46,XY disorder of sex development"
rxcui:9639,SELEGILINE
rxcui:83818,IRBESARTAN
rxcui:357977,SUNITINIB
HP:0000648,Optic atrophy
HP:0100035,Phonic tics
iuphar.ligand:6285,OMEGA-CHLOROACETOPHENONE
chembl:CHEMBL576353,CHEMBL:CHEMBL576353
CHEBI:47779,aminoglycoside
HGNC:9113,PML
rxcui:19478,BISMUTH SUBSALICYLATE
MONDO:0044881,hematopoietic and lymphoid cell neoplasm
chembl:CHEMBL3544963,DS-3078A
CHEBI:6076,itraconazole
rxcui:23437,DIRITHROMYCIN
drugbank:DB16770,MORIN
UPHENO:0080046,increased biological_process in cerebellum
rxcui:115264,IBANDRONATE
chembl:CHEMBL1389794,CHEMBL:CHEMBL1389794
iuphar.ligand:8195,COMPOUND 8 [PMID: 24044867]
HGNC:777,ZFHX3
chembl:CHEMBL478938,GERONTOXANTHONE B
GO:0005739,mitochondrion
WB:WBGene00009812,suca-1
HP:0003118,Increased circulating cortisol level
chembl:CHEMBL3545082,RG-7376
drugbank:DB15356,SLV-334
ncit:C271,ANTIMALARIAL AGENT
rxcui:5509,HYDROQUINONE
MONDO:0027353,autosomal recessive dyskeratosis congenita 4
HP:0011950,Bronchiolitis
HGNC:9796,RABGGTB
iuphar.ligand:5552,N-OLEOYLDOPAMINE
HGNC:29517,DHX58
HP:0031760,Non-accomodative esotropia
iuphar.ligand:5991,ISOGRANULATIMIDE
ncit:C171900,FELCISETRAG
UBERON:0001954,Ammon's horn
HGNC:7421,MT-CO2
MGI:3834579,Slitrk1<sup>tm1Jaru</sup>/Slitrk1<sup>tm1Jaru</sup>  [background:] B6.129P2-Slitrk1<sup>tm1Jaru</sup>
chembl:CHEMBL2094456,CHEMBL:CHEMBL2094456
HGNC:7825,NINJ2
rxcui:10510,THIOTHIXENE
iuphar.ligand:233,BIMU 1
drugbank:DB13939,RAD-140
HP:0011283,Abnormal metencephalon morphology
CHEBI:26979,organic heterotricyclic compound
MGI:98277,Epha4
MONDO:0014880,Duane retraction syndrome 3 with or without deafness
UPHENO:0080598,abnormal emotional behavior
rxcui:1098413,VANDETANIB
Xenbase:XB-GENE-969573,vcp
iuphar.ligand:8724,CCG-63802
ncit:C78118,DENUFOSOL
ncit:C66534,SELETRACETAM
MGI:1342774,Ppargc1a
MGI:3720946,Tg(APP695)3Dbo/0 Tg(PSEN1dE9)S9Dbo/0  [background:] involves: 129S1/Sv * 129X1/SvJ * C3H/HeJ * C57BL/6J
ncit:C166791,OLUMACOSTAT GLASARETIL
HGNC:6075,INPP4B
HGNC:16011,ASB1
MONDO:0013364,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
chembl:CHEMBL479689,PACHYRRIZINE
HGNC:16629,RAPGEF3
chembl:CHEMBL1255936,CHEMBL:CHEMBL1255936
FB:FBgn0037873,SdhC
rxcui:25480,GABAPENTIN
iuphar.ligand:3875,EUROPIUM-LABELLED INSL3
rxcui:203174,DESIPRAMINE HYDROCHLORIDE
HGNC:9137,EXOSC9
iuphar.ligand:10120,ARN19702
HGNC:9976,TRIM13
iuphar.ligand:10402,ZAK INHIBITOR 6P
iuphar.ligand:12257,CACCINH-A01
HGNC:10424,RPS4X
iuphar.ligand:5650,1-PALMITOYL-LYSOPHOSPHATIDYLCHOLINE
rxcui:82036,LINCOMYCIN HYDROCHLORIDE
iuphar.ligand:4261,NADA
chembl:CHEMBL1510164,CHEMBL:CHEMBL1510164
HGNC:667,RHOA
rxcui:42790,MICONAZOLE NITRATE
MONDO:0009744,neuronal ceroid lipofuscinosis 1
HGNC:21308,ELOVL5
chembl:CHEMBL599712,CHEMBL:CHEMBL599712
ncit:C162343,VASCULAR DISRUPTING AGENT BNC105
MP:0001263,weight loss
HGNC:9393,PRKCA
chembl:CHEMBL1514361,NALOXONE METHIODIDE
ncit:C91702,PEGARGIMINASE
MGI:1100856,Mras
MONDO:0007296,spinocerebellar ataxia type 31
MGI:104541,Gcdh
HGNC:23247,DNAL1
HGNC:29005,TRIM66
chembl:CHEMBL2109282,RG-7636
rxcui:658708,ECALLANTIDE
iuphar.ligand:11055,ARN19874
chembl:CHEMBL1287867,CHEMBL:CHEMBL1287867
drugbank:DB05945,MDX-1303
chembl:CHEMBL1386,TRANSPLATIN
rxcui:2562177,SERDEXMETHYLPHENIDATE CHLORIDE
HGNC:4913,HIP1
MGI:1927549,Foxb1
rxcui:1597258,BLINATUMOMAB
iuphar.ligand:9930,HENATINIB
chembl:CHEMBL589723,CHEMBL:CHEMBL589723
iuphar.ligand:11149,GW405833
ncit:C66358,PEROSPIRONE
drugbank:DB05268,ICO-007
rxcui:10847,TRIPELENNAMINE
chembl:CHEMBL598903,CHEMBL:CHEMBL598903
HP:0020081,Pappenheimer bodies
HP:0003200,Ragged-red muscle fibers
drugbank:DB15431,M-2698
HGNC:84,ACACA
MGI:3723505,Tg(HD)63Aron/?  [background:] involves: C57BL/6 * SJL
ncit:C62516,BAFETINIB
MONDO:0010735,Kennedy disease
iuphar.ligand:11896,COMPOUND 14 [PMID: 34333981]
HP:0012639,Abnormal nervous system morphology
HGNC:19884,HOOK1
chembl:CHEMBL2163795,PALMATINE CHLORIDE HYDRATE
GO:0071034,CUT catabolic process
MGI:4418478,Kat6a<sup>tm1Avo</sup>/Kat6a<sup>tm1Avo</sup>  [background:] either: 129 or (involves: 129 * C57BL/6) or (129 * BALB/c * FVB/N)
HGNC:559,AP1S1
chembl:CHEMBL547483,CHEMBL:CHEMBL547483
chembl:CHEMBL343002,CHEMBL:CHEMBL343002
HGNC:33164,H3-5
chembl:CHEMBL1521156,CHEMBL:CHEMBL1521156
HGNC:5241,HSPA8
MONDO:0005574,tauopathy
drugbank:DB01055,MIMOSINE
iuphar.ligand:9189,HS665
MONDO:0021100,breast neoplasm
ncit:C170102,LEMILDIPINE
HP:0005764,Polyarticular arthritis
MONDO:0009696,juvenile myoclonic epilepsy
chembl:CHEMBL585279,CHEMBL:CHEMBL585279
MONDO:0030912,"intellectual disability, autosomal dominant 47"
HP:0008596,Postlingual sensorineural hearing impairment
chembl:CHEMBL1797712,CHEMBL:CHEMBL1797712
HP:0002454,Eye of the tiger anomaly of globus pallidus
MP:0011731,decreased myelin sheath thickness
chembl:CHEMBL541585,CHEMBL:CHEMBL541585
chembl:CHEMBL538965,CHEMBL:CHEMBL538965
chembl:CHEMBL294264,PURPURIN
chembl:CHEMBL600738,CHEMBL:CHEMBL600738
drugbank:DB13756,PERUVOSIDE
MGI:102956,Cdk7
iuphar.ligand:4267,NF449
ZFIN:ZDB-GENE-040426-1858,ndufb8
UPHENO:0080033,increased reflex in pelvic complex
MONDO:0030679,Noonan syndrome 14
MONDO:0004976,amyotrophic lateral sclerosis
ncit:C95920,BLONANSERIN
HGNC:9180,POLG2
drugbank:DB07409,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID"
ncit:C66558,SPIPERONE
ncit:C71717,ALISERTIB
chembl:CHEMBL2109447,LYM-1
drugbank:DB03823,EPIGALLOCATECHIN
CL:0000878,central nervous system macrophage
MONDO:0000226,mineral metabolism disease
HGNC:22202,FAM131B
HP:0012678,Iron accumulation in substantia nigra
chembl:CHEMBL124460,CHEMBL:CHEMBL124460
chembl:CHEMBL428064,CHEMBL:CHEMBL428064
chembl:CHEMBL261123,CHEMBL:CHEMBL261123
EMAPA:16988,brachial plexus
MONDO:0022742,occupational asthma
MONDO:0030918,"intellectual disability, autosomal dominant 52"
rxcui:134547,BENDAMUSTINE
MONDO:0958204,"intellectual developmental disorder, autosomal recessive 81"
GO:0015881,creatine transmembrane transport
iuphar.ligand:1819,"[D-TRP12,TYR34]PTH-(7-34) (BOVINE)"
ncit:C1633,POLYVALENT MELANOMA VACCINE
CHEBI:28201,rotenone
MGI:6278939,Atp2b1<sup>Tg(Thy1-CHMP2B*)1Rene</sup>/Atp2b1<sup>Tg(Thy1-CHMP2B*)1Rene</sup>  [background:] involves: C57BL/6 * DBA/2 * FVB/N
MONDO:0014316,Alzheimer disease 19
UPHENO:0077990,decreased sensory perception of sound in nerve
WB:WBGene00003778,nnt-1
HGNC:25519,ANO10
MONDO:0010428,chromosome Xp11.23-p11.22 duplication syndrome
RGD:619776,Pfkfb3
MONDO:0015281,atrial standstill
rxcui:35220,QUINIDINE GLUCONATE
HP:5200127,Aggression toward non caregivers
chembl:CHEMBL549880,O-METHYLCALOTHRIXIN A
HGNC:3629,FDFT1
HP:0001561,Polyhydramnios
chembl:CHEMBL243796,KURARINONE
chembl:CHEMBL601167,CHEMBL:CHEMBL601167
ncit:C152359,SILIBININ
HGNC:4827,HBB
iuphar.ligand:9585,AZ8838
rxcui:2105844,GLASDEGIB MALEATE
HP:0001638,Cardiomyopathy
MONDO:0044740,salivary gland squamous cell carcinoma
iuphar.ligand:118,[3H]ELETRIPTAN
MONDO:0011816,lathosterolosis
rxcui:9893,NAFCILLIN SODIUM
ncit:C29577,CARBONIC ANHYDRASE INHIBITOR
rxcui:1169,ASPARTIC ACID
rxcui:239,ACLARUBICIN
chembl:CHEMBL125044,CHEMBL:CHEMBL125044
ncit:C105853,RALIMETINIB MESYLATE
iuphar.ligand:2518,FPL64176
iuphar.ligand:12511,QR-6401
ncit:C148485,ANDROGEN RECEPTOR ANTAGONIST ONC1-0013B
HGNC:11106,SMARCD1
HGNC:3578,FAF1
ncit:C78757,LATREPIRDINE
MGI:894323,Ranbp2
rxcui:46303,AMISULPRIDE
ncit:C1934,DIFFERENTIATION INDUCER
rxcui:8136,OXYPHENISATIN
MGI:1889001,Nub1
chembl:CHEMBL526952,CHEMBL:CHEMBL526952
rxcui:47907,CETALKONIUM CHLORIDE
iuphar.ligand:2120,YM44778
PomBase:SPAC4D7.13,prp40
HP:0007000,Morning myoclonic jerks
HGNC:10659,SDC2
MONDO:0006490,vaginal squamous cell carcinoma
MONDO:0100320,post-COVID-19 disorder
HGNC:348,AHR
HP:0011834,Moyamoya phenomenon
ncit:C459,MEDICATION
MP:0001363,increased anxiety-related response
SGD:S000005876,CIN1
MGI:2429434,Ctnna2<sup>cdf</sup>/Ctnna2<sup>cdf</sup>  [background:] C3Sn.C3-Ctnna2<sup>cdf</sup>/J
iuphar.ligand:9712,COMPOUND 5E [PMID: 28580438]
drugbank:DB05241,XL765
ncit:C2411,CEP-2563 DIHYDROCHLORIDE
rxcui:2593184,PENCONAZOLE
rxcui:2103164,LORLATINIB
ncit:C61747,EPIANDROSTERONE
chembl:CHEMBL478754,CHEMBL:CHEMBL478754
ncit:C2554,VACCINE ADJUVANT
iuphar.ligand:8381,COMPOUND 21 [PMID: 25259874]
iuphar.ligand:4011,&ALPHA;-CONOTOXIN TXIA
ZFIN:ZDB-GENE-091204-407,ndufb3
MONDO:0011150,acroosteolysis-keloid-like lesions-premature aging syndrome
HGNC:15761,OSBPL2
ncit:C1150,MAFOSFAMIDE
ncit:C61618,7-ETHYL-10-HYDROXYCAMPTOTHECIN
Reactome:R-HSA-549127,Organic cation transport
iuphar.ligand:3047,(R)-5-DIPHOSPHOMEVALONATE
OBA:2001013,age of onset of type 2 diabetes mellitus
HP:0100503,Low levels of vitamin B1
HGNC:24034,NOC3L
MONDO:0006962,sebaceous adenocarcinoma
MONDO:0000510,synucleinopathy
HP:0003808,Abnormal muscle tone
iuphar.ligand:10385,COMPOUND T.14
rxcui:38865,TROFOSFAMIDE
MONDO:0006467,thyroid gland squamous cell carcinoma
Reactome:R-MMU-211945,Phase I - Functionalization of compounds
chembl:CHEMBL287689,CHEMBL:CHEMBL287689
HGNC:17941,NTM
HP:0002839,Urinary bladder sphincter dysfunction
HP:0100702,Arachnoid cyst
iuphar.ligand:1255,PROXYFAN
HGNC:23534,TUBAL3
ncit:C169864,CONTEZOLID ACEFOSAMIL
chembl:CHEMBL512649,CHEMBL:CHEMBL512649
ncit:C116891,GALUNISERTIB
chembl:CHEMBL524376,CHEMBL:CHEMBL524376
rxcui:1439816,RIOCIGUAT
chembl:CHEMBL1606,CHEMBL:CHEMBL1606
chembl:CHEMBL166112,CHEMBL:CHEMBL166112
ncit:C81376,OXABOLONE CIPIONATE
HP:0004493,Craniofacial hyperostosis
iuphar.ligand:2344,BA2+
chembl:CHEMBL1452227,CHEMBL:CHEMBL1452227
chembl:CHEMBL601353,CHEMBL:CHEMBL601353
UBERON:0007610,tibial artery
rxcui:121243,VORICONAZOLE
MGI:104897,Rest
HGNC:17075,TAB2
MONDO:0013763,Joubert syndrome 15
HP:0011448,Ankle clonus
rxcui:3634,DOTHIEPIN
ncit:C2159,PROTEIN PHOSPHATASE INHIBITOR
rxcui:17311,ALIZAPRIDE
iuphar.ligand:791,RO320-2947/001
HP:0007374,Atrophy/Degeneration involving the caudate nucleus
MONDO:0011844,myoclonic dystonia 15
chembl:CHEMBL1879687,FENBUCONAZOLE
HP:0006572,Subacute progressive viral hepatitis
ncit:C91732,GEDATOLISIB
ncit:C763,PORFIROMYCIN
MGI:5646623,Tg(Camk2a-MAPT*P301L)D35Jiri/0  [background:] Not Specified
iuphar.ligand:12104,COMPOUND 1K [PMID: 35912476]
rxcui:7818,OXYPHENONIUM
GO:0016235,aggresome
MGI:5142236,Tg(Pcp2-TBP*)69Hmhl/0  [background:] involves: FVB/N
rxcui:82055,NEOSTIGMINE BROMIDE
HP:0012664,Reduced left ventricular ejection fraction
MONDO:0030923,frontotemporal dementia and/or amyotrophic lateral sclerosis
ncit:C116876,TASELISIB
CHEBI:6015,isoflurane
HP:0000337,Broad forehead
chembl:CHEMBL476025,CHEMBL:CHEMBL476025
rxcui:7418,NIFLUMIC ACID
chembl:CHEMBL534353,CHEMBL:CHEMBL534353
iuphar.ligand:1326,[125I]NDP-MSH
iuphar.ligand:377,NECA
MGI:1921392,Lonp1
chembl:CHEMBL1256174,CHEMBL:CHEMBL1256174
ncit:C118288,ORAL AZACITIDINE
rxcui:31983,NORETHINDRONE ACETATE
iuphar.ligand:2038,BIM 23060
chembl:CHEMBL23327,PURVALANOLA
rxcui:5556,HYMECROMONE
CHEBI:32807,o-orsellinic acid
iuphar.ligand:2738,CHOLESTEROL SULPHATE
HGNC:29091,ATG13
HGNC:11390,AURKB
HGNC:18714,DCP1A
chembl:CHEMBL533293,CHEMBL:CHEMBL533293
HP:0001688,Sinus bradycardia
rxcui:8149,PHENOXYBENZAMINE
rxcui:142138,MEXILETINE HYDROCHLORIDE
iuphar.ligand:11284,CC-90011
WB:WBGene00015391,sdha-1
iuphar.ligand:8244,TGX-221
ncit:C1426,RECOMBINANT HEREGULIN
HGNC:14682,SPATA1
iuphar.ligand:10119,AM-6120
iuphar.ligand:10501,COMPOUND 16 [PMID: 31525966]
iuphar.ligand:4224,"INS(3,4,5,6)P4"
MGI:3829438,Pten<sup>tm2Mak</sup>/Pten<sup>tm2Mak</sup> Tg(Cyp1a1-cre)1Dwi/0  [background:] involves: 129P2/OlaHsd * C57BL/6 * CBA
MONDO:0005129,cataract
chembl:CHEMBL221907,CUDRAFLAVONE B
MGI:1096391,Nrxn1
ncit:C76907,ALOXISTATIN
chembl:CHEMBL496102,AMG-208
ncit:C2672,EPOTHILONE D
MGI:3722060,Dync1h1<sup>Loa</sup>/Dync1h1<sup>Loa</sup>  [background:] C3H/HeH-Dync1h1<sup>Loa</sup>
chembl:CHEMBL589469,CHEMBL:CHEMBL589469
HGNC:6053,IMPDH2
iuphar.ligand:8053,NVP-2
MONDO:0011679,"craniosynostosis syndrome, autosomal recessive"
MONDO:0018760,DeSanto-Shinawi syndrome
CHEBI:8232,piperacillin
CL:0000110,peptidergic neuron
rxcui:28004,ISOSORBIDE MONONITRATE
chembl:CHEMBL480626,CHEMBL:CHEMBL480626
chembl:CHEMBL1200949,BETAZOLE HYDROCHLORIDE
iuphar.ligand:8795,COMPOUND 7P [PMID: 7861416]
HGNC:7784,NFIA
iuphar.ligand:8194,COMPOUND 15B [PMID: 16539403]
HGNC:10468,RTN2
HP:0000405,Conductive hearing impairment
chembl:CHEMBL2171206,EUCALYPTIN A
HGNC:9325,PPT1
chembl:CHEMBL472656,CHEMBL:CHEMBL472656
ncit:C76093,ALFADEX
MONDO:0006198,endometrial squamous cell carcinoma
MONDO:0012576,"supranuclear palsy, progressive, 3"
HGNC:3814,FOXH1
MONDO:0006153,colon juvenile polyp
rxcui:1922436,CERLIPONASE ALFA
ncit:C47967,CEFAMANDOLE SODIUM
HP:0011168,Focal seizure with eyelid myoclonia
rxcui:253206,VALERIAN ROOT EXTRACT
ncit:C171717,BITHIONOLATE SODIUM
HGNC:11098,SMARCA2
MGI:3722059,Dync1h1<sup>Cra1</sup>/Dync1h1<sup>Cra1</sup>  [background:] C3HeB/FeJ-Dync1h1<sup>Cra1</sup>
MGI:2137414,Kifc5b
MONDO:0024257,hereditary motor neuron disease
chembl:CHEMBL2181040,CHEMBL:CHEMBL2181040
MP:0012690,abnormal stride length
dictyBase:DDB_G0274371,mpheS
UPHENO:0080037,increased biological_process in pelvic complex
MGI:1196281,Dscam
iuphar.ligand:12885,LERZEPARIB
SGD:S000003425,PDX1
Xenbase:XB-GENE-997273,aoc1
ncit:C126113,ZALIFRELIMAB
iuphar.ligand:6169,5-OXO-20-HETE
ncit:C152846,VELDOREOTIDE
HGNC:9317,PPP3R1
rxcui:142440,LIDOCAINE HYDROCHLORIDE
chembl:CHEMBL1688541,FENHEXAMID
iuphar.ligand:2080,"H-C[CYS-PHE-LAGL(N&BETA;ME,BENZOYL)-TRP-LYS-THR-PHE-CYS]-OH"
MGI:103067,Atrx
chembl:CHEMBL71851,SCOPOLETIN
drugbank:DB12696,BMS-582949
ncit:C1654,MULTIVITAMIN
chembl:CHEMBL12658,CHEMBL:CHEMBL12658
CHEBI:28001,vancomycin
iuphar.ligand:2217,"D(CH2)5[TYR(ET)2,VAL4,DES-GLY9]AVP"
ncit:C152496,TALIPEXOLE
MONDO:0011862,hereditary spastic paraplegia 24
drugbank:DB05210,SF1126
MONDO:0700096,human disease
MGI:4941778,Slc6a8<sup>tm1.2Clar</sup>/Y  [background:] involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL
HGNC:28246,IGSF21
chembl:CHEMBL1901818,BROMETHALIN
rxcui:4459,FLUNARIZINE
chembl:CHEMBL16024,DESMEDIPHAM
MONDO:0014062,mitochondrial DNA deletion syndrome with progressive myopathy
ZFIN:ZDB-GENE-050327-58,rufy3
HP:0001591,Bell-shaped thorax
HP:0011819,Submucous cleft soft palate
drugbank:DB08009,SU-11652
iuphar.ligand:10204,NORENDOXIFEN
chembl:CHEMBL529177,CHEMBL:CHEMBL529177
CHEBI:17245,carbon monoxide
ncit:C87695,FENCAMFAMIN
chembl:CHEMBL589734,CHEMBL:CHEMBL589734
chembl:CHEMBL1878267,FLUAZINAM
chembl:CHEMBL490417,CHEMBL:CHEMBL490417
chembl:CHEMBL1935538,CHEMBL:CHEMBL1935538
MONDO:0020753,Orthocoronavirinae infectious disease
HP:0002011,Morphological central nervous system abnormality
ncit:C91098,SODIUM METAARSENITE
HGNC:5291,HTR1E
chembl:CHEMBL276618,4-METHYLDAPHNETIN
HP:0001126,Cryptophthalmos
HGNC:29989,GATAD2A
CHEBI:87185,florfenicol
MGI:107201,Zic4
iuphar.ligand:8018,1-AZAKENPAULLONE
HGNC:15912,NSFL1C
rxcui:7402,NICLOSAMIDE
MONDO:0032673,"basal ganglia calcification, idiopathic, 7, autosomal recessive"
iuphar.ligand:8209,COMPOUND 35 [PMID: 20684608]
CHEBI:28918,(R)-adrenaline
MGI:5751863,"Tg(Hnrnpa2b1-rtTA2S*M2)9Jstr/0 Tg(tetO-FMR1*,-EGFP)#Rkhu/0  [background:] involves: C57BL/6JRj * FVB/N"
chembl:CHEMBL247471,CHEMBL:CHEMBL247471
HGNC:7800,NFKBIL1
iuphar.ligand:8165,COMPOUND 68 [PMID: 24900699]
ncit:C87731,ILEPATRIL
MONDO:0014751,palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome
chembl:CHEMBL1201383,GEMCITABINE TRIPHOSPHATE
chembl:CHEMBL484853,CARNOSIC ACID
chembl:CHEMBL252909,CHELIDAMIC ACID
iuphar.ligand:5126,6-FLUOROTRYPTOPHAN
rxcui:1242987,VISMODEGIB
chembl:CHEMBL506678,SITOGLUSIDE
HGNC:21157,GTF2H5
HGNC:4552,GPT
MGI:3819144,Dst<sup>dt-alb</sup>/Dst<sup>dt-alb</sup>  [background:] BALB/cByJ-Dst<sup>dt-alb</sup>
UPHENO:0080070,aplasia or hypoplasia of patella
iuphar.ligand:11661,TBK1 PROTAC 3I
HGNC:24666,FAF2
MGI:1924785,Gprin3
HP:0000202,Orofacial cleft
ncit:C152121,QUINELORANE
iuphar.ligand:11761,ANUMIGILIMAB
HP:0100807,Long fingers
iuphar.ligand:9664,BML-281
HGNC:5258,HSP90AB1
ncit:C162676,ELZOVANTINIB
rxcui:9384,RIFAMPIN
MGI:104513,Nqo2
rxcui:41289,IBUTILIDE
HGNC:11497,SYNGAP1
chembl:CHEMBL1094690,AESCULIOSIDE IIIA
iuphar.ligand:11478,RY785
NCBIGene:100683938,HTR1F
HGNC:15139,OR10W1
ncit:C84001,NEPADUTANT
MP:0005328,abnormal circulating creatinine level
ZFIN:ZDB-GENE-030131-1058,cs
iuphar.ligand:9450,AVACOPAN
ncit:C2228,APOLIZUMAB
HGNC:3798,FOSL2
HGNC:4512,ADGRG1
MONDO:0100352,episodic kinesigenic dyskinesia 1
CHEBI:4027,cyclophosphamide
ncit:C61587,DANUSERTIB
HGNC:4115,GALC
drugbank:DB15382,SAR-125844
rxcui:1441386,BAZEDOXIFENE
iuphar.ligand:1216,A-317920
chembl:CHEMBL2426136,NAMOLINE
rxcui:70223,ALDESLEUKIN
UBERON:0003631,pedal digit 1
CHEBI:16551,"alpha,alpha-trehalose"
MGI:3829247,Apod<sup>tm1Dsan</sup>/Apod<sup>tm1Dsan</sup>  [background:] either: B6.129X1-Apod<sup>tm1Dsan</sup> or C.129X1-Apod<sup>tm1Dsan</sup>
Xenbase:XB-GENE-481916,psen1
iuphar.ligand:341,ALCURONIUM
chembl:CHEMBL530280,CHEMBL:CHEMBL530280
chembl:CHEMBL374146,CYNAROPICRIN
Xenbase:XB-GENE-969863,naa20
MONDO:0011734,Cardioneuromyopathy with hyaline masses and nemaline rods
iuphar.ligand:11276,ANI9
HP:0001302,Pachygyria
chembl:CHEMBL578294,CHEMBL:CHEMBL578294
chembl:CHEMBL503938,EUPARIN
drugbank:DB12012,PF-04457845
HP:0002478,Progressive spastic quadriplegia
HGNC:29484,TET1
HGNC:1245,C1QC
HP:0007401,Macular atrophy
MONDO:0000426,autosomal dominant disease
HGNC:12485,UBE2I
HGNC:14515,MRPS18A
iuphar.ligand:9691,KBP-7018
chembl:CHEMBL316589,CHEMBL:CHEMBL316589
ncit:C163641,CHLORPYRIFOS
NBO:0000444,eye movement
chembl:CHEMBL1945130,CHEMBL:CHEMBL1945130
MONDO:0006604,rosacea
rxcui:29439,MEDRYSONE
chembl:CHEMBL576781,CHEMBL:CHEMBL576781
ncit:C132046,NELIVAPTAN
iuphar.ligand:1732,AP4A
HGNC:3482,ETFB
iuphar.ligand:142,M-CHLOROPHENYLPIPERAZINE
HP:0002333,Motor deterioration
chembl:CHEMBL601364,CHEMBL:CHEMBL601364
CHEBI:51959,organic tricyclic compound
drugbank:DB04886,CALANOLIDE A
chembl:CHEMBL4297939,DS-1062
rxcui:21254,CHLOPHEDIANOL
chembl:CHEMBL89445,TERPYRIDINE
ncit:C152510,TANZISERTIB
CHEBI:15940,nicotinic acid
SGD:S000003415,QCR9
GO:0042063,gliogenesis
Xenbase:XB-GENE-5886292,tubb3
HGNC:24778,KLRG2
rxcui:236594,AMPHOTERICIN B LIPOSOMAL
UBERON:0000468,multicellular organism
HGNC:5286,HTR1A
rxcui:1597876,NIVOLUMAB
FB:FBgn0031492,Prp40
HP:0002378,Hand tremor
ncit:C1272,RECOMBINANT VASCULAR ENDOTHELIAL GROWTH FACTOR
RGD:6492821,Ndufa13
MGI:102809,Sars1
chembl:CHEMBL1576310,CHEMBL:CHEMBL1576310
HP:0003621,Juvenile onset
WB:WBGene00008053,cdc-48.2
iuphar.ligand:11240,NSC600684
MONDO:0012414,neuronal ceroid lipofuscinosis 10
ncit:C87280,CINACIGUAT
PATO:0000389,acute
rxcui:73178,ILOPERIDONE
MONDO:0957779,neurodevelopmental disorder with language delay and variable cognitive abnormalities
EMAPA:36920,oculomotor muscle
UPHENO:0051763,abnormal multicellular organism chemical entity level
HGNC:13032,ZNF24
drugbank:DB12679,WP-1066
iuphar.ligand:8368,ML321
HGNC:2972,DNM1
iuphar.ligand:12303,T532
rxcui:662281,NILOTINIB
MONDO:0001358,bronchial disorder
iuphar.ligand:7935,MIRDAMETINIB
RGD:621598,Lonp1
MONDO:0008695,chorea-acanthocytosis
HGNC:21246,PNPLA1
chembl:CHEMBL402915,CHEMBL:CHEMBL402915
rxcui:3098,DACARBAZINE
HP:0002356,Writer's cramp
HGNC:5244,HSPA9
MONDO:0014417,spinocerebellar ataxia type 38
CHEBI:17263,estrone
HP:0001491,Congenital fibrosis of extraocular muscles
iuphar.ligand:8605,GSK2194069
chembl:CHEMBL585502,CHEMBL:CHEMBL585502
rxcui:10154,SUCCINYLCHOLINE
HGNC:4651,GTF2E2
GO:0045453,bone resorption
ncit:C128634,THAPSIGARGIN
HP:0032749,Focal impaired awareness emotional seizure with paranoia
chembl:CHEMBL592834,CHEMBL:CHEMBL592834
iuphar.ligand:9372,TBBT
HGNC:20219,PPP4R3A
iuphar.ligand:2511,BAYK 8644
drugsatfda.nda:016727,DRUGSATFDA.NDA:016727
chembl:CHEMBL1366408,CARMINE
chembl:CHEMBL530291,CHEMBL:CHEMBL530291
HGNC:5434,IFNB1
MGI:103262,Yap1
HP:0033688,Long term memory impairment
ncit:C92579,RONICICLIB
ncit:C65248,BEKANAMYCIN
drugbank:DB12756,TAK-901
MGI:5607261,Slc40a1<sup>tm1.1Mmfe</sup>/Slc40a1<sup>+</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6
MGI:1277186,Atg5
iuphar.ligand:5934,BAY 11-7082
MONDO:0012986,bilateral parasagittal parieto-occipital polymicrogyria
UPHENO:0048693,increased level of creatine
HP:0025269,Panic attack
rxcui:25544,GALLIUM NITRATE
HGNC:2079,CLN8
iuphar.ligand:5161,CCP
iuphar.ligand:2312,BICUCULLINE
iuphar.ligand:4338,UCCF-853
chembl:CHEMBL1984884,CHEMBL:CHEMBL1984884
chembl:CHEMBL494083,XANTHOANGELOL
iuphar.ligand:6048,SYK INHIBITOR III
MONDO:0011422,autosomal recessive proximal renal tubular acidosis
HGNC:21351,C6orf141
drugbank:DB12318,BMS-599626
MGI:2448547,Ces2b
MONDO:0010940,inherited susceptibility to asthma
MGI:3778393,Tg(DRD1-ctxA)7Burt/0  [background:] C.Cg-Tg(DRD1-ctxA)7Burt
HP:0004302,Functional motor deficit
chembl:CHEMBL503990,CHEMBL:CHEMBL503990
ncit:C156709,BRIGIMADLIN
iuphar.ligand:5149,BROMOENOL LACTONE
CLINVAR:167702,NM_001042537.1(SLC9A6):c.604-1G>A
HP:0000041,Chordee
MP:0010064,increased circulating creatine level
ncit:C49175,NOTCH SIGNALING PATHWAY INHIBITOR MK0752
ncit:C76651,SUMANIROLE
rxcui:81984,CLOMIPRAMINE HYDROCHLORIDE
HP:0000529,Progressive visual loss
HP:0032900,Focal manual automatism seizure
HP:0000005,Mode of inheritance
HGNC:14502,MRPS10
ZFIN:ZDB-FISH-161111-7,AB + MO1-pank2
MONDO:0100342,malignant glioma
rxcui:1368476,ZERANOL
ncit:C152692,TOMUZOTUXIMAB
ncit:C159499,PI3K/MTOR KINASE INHIBITOR WXFL10030390
chembl:CHEMBL214154,MAYTANSINOL
MP:0005405,axon degeneration
rxcui:91324,MERADIMATE
drugbank:DB07954,3-ISOBUTYL-1-METHYL-7H-XANTHINE
chembl:CHEMBL70501,THUNBERGINOL B
HP:0002315,Headache
rxcui:203146,GOSERELIN ACETATE
FB:FBgn0000996,dup
chembl:CHEMBL194400,HEPTACHLOR
chembl:CHEMBL605959,CHEMBL:CHEMBL605959
iuphar.ligand:7512,MS417
HGNC:11804,TIAL1
HGNC:914,B2M
iuphar.ligand:2745,GUGGULSTERONE
rxcui:2107309,PRUCALOPRIDE SUCCINATE
ncit:C74108,SPIROXATRINE
HGNC:11007,SLC2A3
HP:0032894,Seizure precipitated by febrile infection
rxcui:2620,CLOTHIAPINE
HP:0033206,Hyperactive Achilles reflex
MP:0020616,abnormal dorsal striatum cell number
rxcui:1658314,BREXPIPRAZOLE
chembl:CHEMBL22148,CHEMBL:CHEMBL22148
rxcui:6390,LIDOFLAZINE
HGNC:3261,EIF2B5
HP:0002480,Hepatic encephalopathy
ncit:C79877,ALFIMEPRASE
drugbank:DB11848,MANNOSE 6-PHOSPHATE
iuphar.ligand:4643,[3H]2-DEOXYGLUCOSE
HGNC:5141,HP
HGNC:12261,TRDN
CL:0002608,hippocampal neuron
chembl:CHEMBL537045,CHEMBL:CHEMBL537045
chembl:CHEMBL464135,DYRENE
ZFIN:ZDB-GENE-030910-2,drd2b
rxcui:2898,COUMARIN
HGNC:12017,TPR
iuphar.ligand:3318,PSN375963
iuphar.ligand:4271,NS004
rxcui:1310520,TERIFLUNOMIDE
chembl:CHEMBL579957,CHEMBL:CHEMBL579957
HGNC:8801,PDGFC
ncit:C96709,CINALUKAST
rxcui:155046,PENTOSAN POLYSULFATE
ncit:C80667,FENOBAM ANHYDROUS
ncit:C265,ANTIDEPRESSANT AGENT
HGNC:9719,PEX5
ZFIN:ZDB-GENE-050522-279,capn8
drugbank:DB02999,QUISQUALIC ACID
ncit:C471,ENZYME INHIBITOR
UPHENO:0000538,delayed development of secondary sexual characteristics
Xenbase:XB-GENE-962222,sepsecs
RGD:69287,Sqstm1
iuphar.ligand:12277,COMPOUND 5G [PMID: 36385925]
HGNC:9557,PSMD12
rxcui:1314255,HESPERETIN
HP:0002363,Abnormal brainstem morphology
HGNC:12483,UBE2G2
ncit:C138160,SELITRECTINIB
MONDO:0008637,bifid uvula
HGNC:435,ALOX5
iuphar.ligand:3931,L 755507
rxcui:683693,DESVENLAFAXINE SUCCINATE
drugbank:DB14946,PCO-371
ncit:C63673,ISOPIMPINELLIN
rxcui:2049873,IVOSIDENIB
GO:0000423,mitophagy
chembl:CHEMBL242711,BERGAPTOL
CHEBI:16444,2-acetyllactic acid
HGNC:11986,TOP1
HGNC:19664,GNG8
HP:0000756,Agoraphobia
UPHENO:0081273,basal part of pons hypoplasia
UPHENO:0074632,increased inflammatory response in eyeball of camera-type eye
HP:0030047,Abnormal lateral ventricle morphology
MONDO:0037748,hyperlipoproteinemia
ncit:C2658,ERTUMAXOMAB
HGNC:453,AMBP
rxcui:10395,TETRACYCLINE
WB:WBGene00007352,cdc-48.1
rxcui:26925,HISTAMINE PHOSPHATE
iuphar.ligand:11726,COMPOUND 20 [PMID: 34432979]
HP:0000179,Thick lower lip vermilion
chembl:CHEMBL601744,CHEMBL:CHEMBL601744
ncit:C118948,TALETRECTINIB
chembl:CHEMBL1449187,"3,7-DIMETHOXYFLAVONE"
HGNC:28789,SARAF
rxcui:10231,SULFURIC ACID
iuphar.ligand:10250,DO264
chembl:CHEMBL590636,GANCAONIN L
HGNC:12468,UBC
MONDO:0008758,mitochondrial DNA depletion syndrome 4a
HP:0032903,Focal vocal automatism seizure
HGNC:2158,CNP
chembl:CHEMBL477936,CHEMBL:CHEMBL477936
HGNC:11359,STAR
HP:0006794,Loss of ability to walk in first decade
rxcui:2555,CISPLATIN
MONDO:0011259,retinitis pigmentosa 22
ncit:C152558,TENIDAP
rxcui:1599827,PYRIDOXAL PHOSPHATE ANHYDROUS
ncit:C81359,SECURININE
iuphar.ligand:3259,VU0090157
HGNC:10899,SKP1
Xenbase:XB-GENE-495335,sox17b.2
HGNC:1703,CD83
HP:0000758,Abnormal nonverbal communicative behavior
iuphar.ligand:6600,BW284C51
rxcui:39173,DOXAZOSIN MESYLATE
MP:0000788,abnormal cerebral cortex morphology
HGNC:12012,TPM3
chembl:CHEMBL4594251,NETARSUDIL DIMESYLATE
HGNC:712,ARRB2
chembl:CHEMBL1256984,CHEMBL:CHEMBL1256984
UPHENO:0076720,abnormal cerebellum morphology
MGI:2384495,Mrtfa
GO:0043473,pigmentation
chembl:CHEMBL250892,(R)-MELPHALAN
ncit:C75061,UPIDOSIN
chembl:CHEMBL1091137,CHEMBL:CHEMBL1091137
HP:0002212,Curly hair
ncit:C153379,CADONILIMAB
rxcui:142426,BROMOCRIPTINE MESYLATE
MGI:96247,Hsp90ab1
MONDO:0020573,inherited disease susceptibility
HGNC:16947,ERLIN1
MGI:102889,Vcan
HGNC:17842,GGA1
chembl:CHEMBL2323775,MK-8033
chembl:CHEMBL1887350,BIOALLETHRIN S-CYCLOPENTENYL ISOMER
HGNC:30412,SETD7
chembl:CHEMBL1436035,BISANHYDRORUTILANTINONE
HGNC:2073,TPP1
chembl:CHEMBL3545402,XL-820
rxcui:877510,ROMIDEPSIN
CHEBI:146295,pyranobenzodioxin
HP:0006511,Laryngeal stridor
HP:0000072,Hydroureter
wikidata:Q47520887,ADRIAMYCIN
rxcui:11204,VINDESINE
ncit:C152490,TAFLUPOSIDE
MONDO:0009667,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3"
ncit:C174203,ERK1/2 INHIBITOR JSI-1187
CHEBI:50919,antiemetic
FB:FBgn0031872,ihog
iuphar.ligand:1799,"[ILE5,TRP23]PTHRP-(2-36) (HUMAN)"
ncit:C61745,ENCLOMIPHENE CITRATE
RGD:1309728,Cbr3
HGNC:6392,KIF23
rxcui:6756,MEPHENTERMINE
HGNC:11283,SRC
chembl:CHEMBL2135268,PHENETHYL PHENYLCARBAMATE
ncit:C84870,UPROSERTIB
HGNC:672,RHOG
HP:0020044,Horizontal incomitant strabismus
iuphar.ligand:490,A-119637
iuphar.ligand:8096,BIBF-1202
HGNC:9848,RANBP2
HGNC:9969,RFC1
chembl:CHEMBL535730,CHEMBL:CHEMBL535730
ncit:C151946,TOPICAL POTASSIUM DOBESILATE
HGNC:1913,RCC1
HGNC:10599,SCNN1A
ncit:C118290,ALTIRATINIB
MGI:5513111,Mnx1<sup>tm4(cre)Tmj</sup>/Mnx1<sup>+</sup> Tardbp<sup>tm1.1Ckjs</sup>/Tardbp<sup>tm1.2Cjks</sup>  [background:] involves: 129S1/Sv * C57BL/6J
drugbank:DB03176,KB-141
ncit:C115110,NAQUOTINIB
chembl:CHEMBL4297682,ABBV-257
ncit:C2690,SHO-SAIKO-TO
HP:0002392,EEG with polyspike wave complexes
rxcui:4450,FLUCONAZOLE
HGNC:1989,TBCB
HGNC:26783,RNF185
HP:0002196,Myelopathy
HGNC:12556,UHRF1
HP:0002014,Diarrhea
HP:0005415,Decreased proportion of CD8-positive T cells
iuphar.ligand:3274,VU0255035
chembl:CHEMBL1398631,LAURYL ISOQUINOLINIUM
rxcui:38253,TIAPROFENIC ACID
MGI:3603566,Man2b1<sup>tm1Psa</sup>/Man2b1<sup>tm1Psa</sup>  [background:] involves: 129 * C57BL/6J
HGNC:3332,MARK2
HGNC:30542,SNX29
CLINVAR:143450,NM_001110792.2(MECP2):c.1286A>T (p.Lys429Met)
MP:0001406,abnormal gait
rxcui:1370971,OSPEMIFENE
iuphar.ligand:2208,"[PHAA1,D-TYR(ET)2,LYS6,DES-GLY9]AVP"
chembl:CHEMBL3707355,AZD8108
MONDO:0000828,juvenile-onset Parkinson disease
iuphar.ligand:12304,T440
HGNC:6990,MECP2
rxcui:1368624,ARACHIDONIC ACID
dictyBase:DDB_G0291352,psenA
ncit:C97332,ISO-FLUDELONE
rxcui:595060,RANIBIZUMAB
HGNC:9388,PRKAR1A
rxcui:1546029,MEROPENEM ANHYDROUS
iuphar.ligand:8985,ADRIFORANT
iuphar.ligand:5653,AR231453
GO:0000139,Golgi membrane
HGNC:12024,CRISP2
HGNC:9842,RALGDS
GO:0048536,spleen development
chembl:CHEMBL3545210,SR16234
iuphar.ligand:4238,L655708
ncit:C66524,RUBOXISTAURIN
ncit:C79132,KAINIC ACID
rxcui:3538,CROMOLYN SODIUM
ncit:C82349,AURORA KINASE INHIBITOR AMG 900
ncit:C1846,LERIDISTIM
chembl:CHEMBL601140,CHEMBL:CHEMBL601140
ncit:C121950,XANTHOHUMOL
CHEBI:47804,dibenzoazepine
HP:0002487,Hyperkinetic movements
MGI:107745,Dctn1
Xenbase:XB-GENE-5866629,f8a1
chembl:CHEMBL533965,CHEMBL:CHEMBL533965
HGNC:10592,SCN4B
rxcui:2551,CIPROFLOXACIN
MONDO:0020099,inherited sideroblastic anemia
chembl:CHEMBL459022,TOXYLOXANTHONE C
iuphar.ligand:4065,(-)-(S)-BAYK8644
HP:0007715,Weak extraocular muscles
iuphar.ligand:9375,VTX-11E
HGNC:24340,NAA35
ncit:C171725,ZOTIRACICLIB
HP:0007302,Bipolar affective disorder
UBERON:0006351,principal vein of forelimb
drugbank:DB04297,TRICHOSTATIN A
ncit:C65912,INDOCATE
iuphar.ligand:12002,ABBV-318
UBERON:0006353,principal vein of hindlimb
rxcui:19484,BISOPROLOL
chembl:CHEMBL1255865,IOFETAMINE HYDROCHLORIDE
ncit:C176018,ANTI-CD19 CAR T CELLS PREPARATION
GO:0046872,metal ion binding
CHEBI:16810,2-oxoglutarate(2-)
rxcui:28439,LAMOTRIGINE
iuphar.ligand:9536,RELATLIMAB
MONDO:0100135,Dravet syndrome
drugbank:DB15229,CNV-2197944
rxcui:6979,MINOCYCLINE HYDROCHLORIDE
MGI:3769707,Cyp3a59
CHEBI:35259,benzofurans
HGNC:7427,MT-CYB
ZFIN:ZDB-GENE-030131-7741,zgc:65894
rxcui:203192,NALOXONE HYDROCHLORIDE
ncit:C75193,SODELGLITAZAR
HGNC:10586,SCN1B
rxcui:19874,BUTOBARBITAL
iuphar.ligand:307,4-DAMP
iuphar.ligand:8824,COMPOUND 50 [PMID: 24313754]
rxcui:6916,METOLAZONE
rxcui:2387307,CALCIUM OXYBATE
rxcui:2265678,VOXELOTOR
ncit:C166893,ERYTHROMYCIN ACISTRATE
iuphar.ligand:12463,SCUTELLAREIN
HP:0002047,Malignant hyperthermia
HGNC:8548,P4HB
chembl:CHEMBL1326944,"7,3'-DIMETHOXYFLAVONE"
EMAPA:35226,cerebellum vermis lobule II
chembl:CHEMBL210208,PYROGALLOL RED
MGI:102944,Ube2b
HGNC:20502,SLC39A5
GO:0043231,intracellular membrane-bounded organelle
NCBIGene:282289,NDUFC1
iuphar.ligand:3739,GYPGQV-NH2
chembl:CHEMBL578257,CHEMBL:CHEMBL578257
chembl:CHEMBL520095,CHEMBL:CHEMBL520095
HGNC:574,AP4M1
ncit:C65987,ISRAPAFANT
HGNC:736,NAAA
GO:0005971,ribonucleoside-diphosphate reductase complex
ncit:C78117,COBIPROSTONE
chembl:CHEMBL2107861,ZALUTUMUMAB
chembl:CHEMBL66953,PURPUROGALLIN
FB:FBgn0004888,Scsα1
ncit:C596,IONOMYCIN
rxcui:2197879,PITOLISANT HYDROCHLORIDE
HGNC:11195,SOX2
HP:0032885,Focal impaired awareness cognitive seizure with hallucination
HGNC:28984,WASHC5
HP:0008209,Premature ovarian insufficiency
MGI:4940063,Neurod1<sup>tm1Mjts</sup>/Neurod1<sup>tm1Mjts</sup>  [background:] involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J
HGNC:469,AMPD2
HP:0000668,Hypodontia
CHEBI:55346,anidulafungin
chembl:CHEMBL1098427,HIPPURISTANOL
HP:0004442,Sagittal craniosynostosis
chembl:CHEMBL520275,TRIADIMENOL
Reactome:R-CEL-390666,Serotonin receptors
HP:0001804,Hypoplastic fingernail
CHEBI:27958,cocaine
chembl:CHEMBL588038,CHEMBL:CHEMBL588038
ncit:C84836,HSP90 INHIBITOR LAM-003A
ncit:C2713,PELITINIB
rxcui:588003,MECLOFENAMATE
HP:0032014,Dysmetric vertical saccades
HGNC:3145,TRPV5
HGNC:4914,UBE2K
HP:0031936,Delayed ability to walk
HP:0030638,Congenital stationary night blindness with normal fundus
rxcui:1940643,NERATINIB
iuphar.ligand:8940,IPA-3
MONDO:0044738,Gabriele de Vries syndrome
MONDO:0006640,adrenal gland hyperfunction
UPHENO:0042792,decreased qualitatively organ growth in head
MONDO:0019793,autosomal dominant cerebellar ataxia type III
HGNC:19309,KANK1
MONDO:0024278,proctocolitis
ncit:C156061,MUPADOLIMAB
chembl:CHEMBL85826,CHEMBL:CHEMBL85826
ncit:C87264,MECETRONIUM
MP:0002083,premature death
MONDO:0043543,iatrogenic disease
MONDO:0002125,status epilepticus
CHEBI:58189,GDP(3-)
HGNC:7905,NPHP1
MP:0000436,abnormal head movements
HGNC:7063,MGST2
chembl:CHEMBL91153,"3',4'-DIMETHOXYFLAVONE"
MGI:102779,Fen1
iuphar.ligand:9580,MPI-0485520
ncit:C66687,ZATEBRADINE
iuphar.ligand:9381,PF-562271
GO:0005575,cellular_component
rxcui:4570,FRUCTOSE
MGI:2684657,Psen1<sup>tm1Vln</sup>/Psen1<sup>tm1Vln</sup> Tg(Thy1-cre)1Vln/0  [background:] involves: FVB/N
MP:0000886,abnormal cerebellar granule layer morphology
ncit:C1626,ETALOCIB
iuphar.ligand:2209,"[PHAA1,D-TYR(ET)2,VAL4,LYS6,TYR-NH28,DES-GLY9]AVP"
MGI:5056394,Tg(Prnp-ATN1)150Dbo/?  [background:] involves: C3H * C57BL/6
HGNC:28396,TMEM67
rxcui:480167,LAPATINIB
chembl:CHEMBL2035185,CT-1578
HP:0032700,Focal cognitive seizure with left-right confusion
HGNC:7132,KMT2A
CHEBI:9168,sirolimus
ncit:C65300,CEFONICID SODIUM
UBERON:0001027,sensory nerve
MP:0010769,abnormal survival
MGI:108051,Smad2
UBERON:0002103,hindlimb
HP:0011096,Peripheral demyelination
chembl:CHEMBL532141,CHEMBL:CHEMBL532141
iuphar.ligand:12542,ML-SA5
ncit:C1487,LAVENDUSTIN C
chembl:CHEMBL580353,CHEMBL:CHEMBL580353
chembl:CHEMBL388529,GUTTIFERONE K
chembl:CHEMBL162598,DICYCLOHEXYLCARBODIIMIDE
chembl:CHEMBL8327,DEMETHYL-CANTHARIDIN
chembl:CHEMBL405110,METHYLTHIONINIUM CHLORIDE
rxcui:8076,PERPHENAZINE
iuphar.ligand:7712,AZD7325
HGNC:11460,SUOX
iuphar.ligand:11697,COMPOUND 11D [PMID: 34406006]
HP:0002242,Abnormal intestine morphology
ncit:C65466,DONITRIPTAN
HGNC:10806,SGCB
chembl:CHEMBL1078000,CHEMBL:CHEMBL1078000
HP:0007626,Mandibular osteomyelitis
iuphar.ligand:4999,IL-7
HGNC:4506,GPR50
HGNC:29890,NLRX1
iuphar.ligand:9404,PP2
GO:0071407,cellular response to organic cyclic compound
HGNC:5006,HMGCR
CLINVAR:133026,NM_000540.2(RYR1):c.11958C>G (p.Asp3986Glu)
ncit:C67040,BRIVANIB
HGNC:20858,SLC39A14
HP:0007229,Intracerebral periventricular calcifications
ncit:C101264,VALECOBULIN
iuphar.ligand:4368,[18F]FLUOROETHYLFLUMAZENIL
chembl:CHEMBL275177,CHEMBL:CHEMBL275177
rxcui:9068,QUINIDINE
HGNC:9218,POU4F1
chembl:CHEMBL453207,LYNGBYABELLIN A
MP:0000745,tremors
rxcui:1661743,GLIOTOXIN
MONDO:0035450,aprosencephaly
HGNC:566,AP3B1
HGNC:14931,SIRT3
iuphar.ligand:5996,JNK INHIBITOR IX
rxcui:81985,COCAINE HYDROCHLORIDE
HGNC:4878,HEXA
iuphar.ligand:790,RO116-9132/238
UPHENO:0079842,abnormal anxiety-related behavior
HGNC:29298,CEP152
iuphar.ligand:4371,B-R13/17K H2 RELAXIN
MONDO:0007235,branchiooculofacial syndrome
rxcui:32521,ROCURONIUM BROMIDE
iuphar.ligand:8382,VS-5584
RGD:68337,Htt
rxcui:4502,FLURBIPROFEN
HP:0008373,Puberty and gonadal disorders
MONDO:0005560,brain disorder
RGD:1561555,Fancb
ncit:C161778,GALINPEPIMUT-S
ncit:C177060,LADUVIGLUSIB
rxcui:784649,ASENAPINE
MP:0012090,midbrain hypoplasia
ncit:C77294,CIRAZOLINE
HP:0000786,Primary amenorrhea
chembl:CHEMBL585030,CHEMBL:CHEMBL585030
ncit:C90557,EG5 KINESIN-RELATED MOTOR PROTEIN INHIBITOR 4SC-205
MONDO:0013056,"developmental and epileptic encephalopathy, 39"
HP:0001876,Pancytopenia
HGNC:26456,CFAP54
CHEBI:29623,manumycin A
HP:0011097,Epileptic spasm
HGNC:26344,DEUP1
MGI:3604219,Fmr1<sup>tm1.1Cidz</sup>/Fmr1<sup>tm1.1Cidz</sup> Tg(Pcp2-cre)2Mpin/0  [background:] involves: 129S1/Sv * 129X1/SvJ
HP:0012227,Urethral stricture
HP:0000580,Pigmentary retinopathy
ncit:C88335,ARCHEXIN
iuphar.ligand:2059,"[111IN,90Y]DOTA-TOC"
iuphar.ligand:12612,PIROTINIB
chembl:CHEMBL1224785,MADOLIN A
CL:0000576,monocyte
ncit:C1509,NEUROPROTECTIVE AGENT
chembl:CHEMBL2171794,CHEMBL:CHEMBL2171794
ncit:C52184,ATIPRIMOD
ncit:C1485,RUBITECAN
rxcui:81952,AMPHETAMINE SULFATE
MONDO:0007492,early-onset generalized limb-onset dystonia
WB:WBGene00008379,secs-1
HP:0030880,Raynaud phenomenon
HP:0001733,Pancreatitis
ncit:C1404,PROTEIN KINASE INHIBITOR
chembl:CHEMBL549208,CHEMBL:CHEMBL549208
HP:0007109,Periventricular cysts
chembl:CHEMBL515495,CHEMBL:CHEMBL515495
drugbank:DB15639,AMG-337
ncit:C95722,MUC1-TARGETED PEPTIDE GO-203-2C
rxcui:4678,GANCICLOVIR
chembl:CHEMBL33864,"LIPOIC ACID, ALPHA"
MONDO:0012321,Alzheimer disease 10
HGNC:19990,ANAPC4
MONDO:0016564,progressive supranuclear palsy-progressive non-fluent aphasia syndrome
rxcui:1545999,OXYTETRACYCLINE ANHYDROUS
chembl:CHEMBL160145,ORTHO-PHTHALALDEHYDE
ncit:C65871,HYDROXYSTILBAMIDINE ISETHIONATE
HP:0000148,Vaginal atresia
HGNC:11545,TAF12
chembl:CHEMBL1278089,"CHOLESTAN-3BETA,5ALPHA,6BETA-TRIOL"
HGNC:1460,CAMK2A
drugbank:DB05463,ISS-1018
Reactome:R-DME-500753,Pyrimidine biosynthesis
rxcui:787390,TAPENTADOL
WB:WBGene00000041,aco-2
NCBIGene:768070,TUBB3
MGI:3833683,Atxn3<sup>tm1Isch</sup>/Atxn3<sup>tm1Isch</sup>  [background:] C57BL/6-Atxn3<sup>tm1Isch</sup>
iuphar.ligand:2024,[125I]TYR10-CST14
chembl:CHEMBL4297407,ALTROPANE I-123
iuphar.ligand:8064,BIX02188
ncit:C190345,APINOCALTAMIDE
CHEBI:29687,teicoplanin
MONDO:0060624,"neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter"
CHEBI:27701,oxytetracycline
chembl:CHEMBL313493,METHANESULFONIC ACID METHYL ESTER
rxcui:21090,CICLOPIROX
HP:0100256,Senile plaques
chembl:CHEMBL561679,CHEMBL:CHEMBL561679
HP:0003259,Elevated circulating creatinine concentration
HGNC:1488,CAPZA1
HGNC:10980,SLC25A10
ncit:C60768,VELIPARIB
rxcui:25284,FOSFESTROL
ncit:C81347,CILOBRADINE
CLINVAR:143490,NM_001110792.2(MECP2):c.1497A>G (p.Ter499Trp)
rxcui:1606218,DACLATASVIR
HGNC:10348,RPL37A
HP:0001061,Acne
HGNC:10681,SDHB
rxcui:77674,OCTOCRYLENE
rxcui:5784,INDORAMIN
ncit:C2201,MTOR INHIBITOR
rxcui:39684,EPINASTINE
rxcui:134615,BRIMONIDINE
HP:0000496,Abnormality of eye movement
rxcui:33309,PHENSUXIMIDE
rxcui:1601374,PALBOCICLIB
ncit:C64176,ATRELEUTON
MGI:3813864,Rgsc1152
MGI:3624527,Tor1a<sup>tm2Wtd</sup>/Tor1a<sup>+</sup>  [background:] involves: 129S1/Sv
iuphar.ligand:7020,SGC0946
HP:0001256,"Intellectual disability, mild"
iuphar.ligand:171,ORG-37684
HGNC:6120,IRF5
ncit:C1316,OXIDOPAMINE
chembl:CHEMBL590665,CHEMBL:CHEMBL590665
HGNC:17825,PLAAT3
ZFIN:ZDB-GENE-070524-2,drd1b
ncit:C76315,CILOSTAMIDE
chembl:CHEMBL598883,CHEMBL:CHEMBL598883
HGNC:12269,TREX1
HGNC:1356,ERLIN2
HGNC:20074,PAN2
iuphar.ligand:12424,L-TRP-TRP-TRP
UPHENO:0076286,abnormal role blood level
rxcui:91125,TRIFLUPROMAZINE HYDROCHLORIDE
HP:0000540,Hypermetropia
drugbank:DB05406,GTI-2501
MONDO:0044704,oropharynx squamous cell carcinoma
ncit:C71716,GIVINOSTAT
rxcui:2387309,POTASSIUM OXYBATE
rxcui:71512,PHENOXYBENZAMINE HYDROCHLORIDE
iuphar.ligand:8155,COMPOUND 13A [PMID: 23639540]
chembl:CHEMBL1096435,RO-281675
MONDO:0008945,myoclonic cerebellar dyssynergia
HGNC:20630,ZNF414
MONDO:0012883,acute promyelocytic leukemia
ncit:C174717,OXENDOLONE
HP:0011611,Interrupted aortic arch
GO:0001503,ossification
UBERON:0002336,corpus callosum
EMAPA:19047,cerebellum dorsal part
rxcui:282357,FULVESTRANT
HGNC:28221,UBL7
chembl:CHEMBL191611,CHEMBL:CHEMBL191611
ncit:C171666,CENTANAFADINE
rxcui:1227,AURANOFIN
ncit:C141432,MILADEMETAN
iuphar.ligand:573,C5A
MGI:3586915,Tbx1<sup>tm1Pa</sup>/Tbx1<sup>+</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * Swiss Webster
HP:0002987,Elbow flexion contracture
MONDO:0004323,muscular atrophy
HGNC:25756,TOMM40L
MGI:3819147,Dst<sup>dt</sup>/Dst<sup>dt</sup>  [background:] involves: Q
MGI:1338871,Btrc
ncit:C693,NIMUSTINE
chembl:CHEMBL563777,CHEMBL:CHEMBL563777
dictyBase:DDB_G0272344,htt
CHEBI:29806,fumarate(2-)
HP:0025425,Laryngospasm
GO:0006602,creatinine catabolic process
rxcui:33747,ESTROPIPATE
UBERON:0000331,ileal mucosa
HP:0033646,Absent hippocampal commissure
chembl:CHEMBL592123,CHEMBL:CHEMBL592123
HGNC:11782,TH
chembl:CHEMBL1546228,CHEMBL:CHEMBL1546228
ncit:C198692,PI3K-ALPHA INHIBITOR TOS-358
chembl:CHEMBL1722838,XANTHOANGELOL F
GO:0006541,glutamine metabolic process
chembl:CHEMBL146710,CHEMBL:CHEMBL146710
rxcui:11258,VITAMIN K
ncit:C73036,NEMONAPRIDE
iuphar.ligand:4327,TPA023
rxcui:221138,PHENTERMINE RESIN
iuphar.ligand:12514,BM221
MONDO:0800027,"leukoencephalopathy, diffuse hereditary, with spheroids 1"
HP:0002751,Kyphoscoliosis
iuphar.ligand:10571,CARTPT (76-96)
GO:0005759,mitochondrial matrix
MONDO:0010317,"intellectual disability, X-linked, with or without seizures, arx-related"
iuphar.ligand:3823,[3H]HATRAP
drugbank:DB06082,PX-478
HP:0006482,Abnormality of dental morphology
HP:0002365,Hypoplasia of the brainstem
MP:0008445,increased retina cone cell number
chembl:CHEMBL585902,AMG-548
chembl:CHEMBL592868,ESTROGEN
rxcui:28165,KERACYANIN
chembl:CHEMBL2109288,BIVATUZUMAB MERTANSINE
chembl:CHEMBL2028063,CHEMBL:CHEMBL2028063
rxcui:40169,MORICIZINE
iuphar.ligand:3953,A-841720
iuphar.ligand:4967,IFN-&BETA;
rxcui:720825,SILODOSIN
rxcui:1311567,SULISOBENZONE
rxcui:321952,PIMECROLIMUS
HGNC:9413,PRKDC
MGI:3719717,Atcay<sup>swd</sup>/Atcay<sup>swd</sup>  [background:] Not Specified
rxcui:25025,FINASTERIDE
iuphar.ligand:8434,LP-12
drugbank:DB16038,PLX8394
iuphar.ligand:2069,BIM 23295
rxcui:2183102,PEXIDARTINIB
drugbank:DB16201,ISIS 104838
rxcui:29528,MEQUITAZINE
iuphar.ligand:5030,NEUREGULIN-3
rxcui:513,ALLETHRIN
HGNC:28662,DOHH
OBA:2040159,age of onset of hypertensive disorder
chembl:CHEMBL597251,CHEMBL:CHEMBL597251
rxcui:27929,LANATOSIDE C
chembl:CHEMBL494283,CHEMBL:CHEMBL494283
HGNC:20373,SPG21
CL:0002614,neuron of the substantia nigra
HP:0001327,Photosensitive myoclonic seizure
HGNC:783,ATF1
GO:1901956,positive regulation of retrograde dense core granule transport
rxcui:266573,TOPOTECAN HYDROCHLORIDE
chembl:CHEMBL1530911,CHEMBL:CHEMBL1530911
chembl:CHEMBL1895807,HEXADECYLTRIMETHYLAMMONIUM CHLORIDE
chembl:CHEMBL406557,CHEMBL:CHEMBL406557
iuphar.ligand:8910,SAR407899
iuphar.ligand:6430,COMPOUND 29B [PMID: 20809633]
HGNC:9664,PTPRA
HGNC:1394,CACNA1G
MONDO:0859217,Brunet-Wagner neurodevelopmental syndrome
CHEBI:315019,cilofungin
rxcui:1872441,TELOTRISTAT ETHYL
rxcui:133054,CHLORHEXIDINE DIACETATE
MONDO:0005473,temporomandibular joint disorder
HGNC:9201,POMC
NCBIGene:477762,HTR7
HGNC:2663,DACH1
GO:0031642,negative regulation of myelination
ncit:C88270,OMIPALISIB
ncit:C152168,RECILISIB
HP:0000028,Cryptorchidism
HP:0033259,Non-motor seizure
iuphar.ligand:11525,TAGTOCICLIB
rxcui:32624,OXCARBAZEPINE
HGNC:11960,GIGYF2
rxcui:2467553,LONAFARNIB
HP:0007351,Upper limb postural tremor
iuphar.ligand:2703,GW1929
HP:0001288,Gait disturbance
MONDO:0024507,aniridia 1
ncit:C96429,NAPABUCASIN
MP:0001407,short stride length
drugbank:DB12904,ZSTK-474
MGI:4397490,Ilk<sup>tm9.1Ref</sup>/Ilk<sup>tm9.1Ref</sup>  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
drugbank:DB04331,MONASTROL
rxcui:202723,ORPHENADRINE HYDROCHLORIDE
HGNC:8636,PC
MP:0008587,short photoreceptor outer segment
ncit:C174662,OMARIGLIPTIN
ncit:C170020,GANCOTAMAB
drugbank:DB12241,TAK-733
RGD:1566107,Creb5
MONDO:0014421,glucocorticoid resistance
HP:0003510,Severe short stature
MONDO:0001595,choreatic disease
rxcui:4136,ETHOTOIN
ncit:C29852,REBAMIPIDE
ncit:C102746,PARP/TANKYRASE INHIBITOR 2X-121
chembl:CHEMBL539027,FLUNARIZINE DIHYDROCHLORIDE
MONDO:0011571,"deafness, autosomal dominant 39, with dentinogenesis imperfecta 1"
UBERON:0002031,epithelium of bronchus
ncit:C152128,QUINPIROLE
iuphar.ligand:5086,VEGFB
CHEBI:47724,vancomycin aglycone
ncit:C155765,TRK INHIBITOR
drugbank:DB02272,PORPHOBILINOGEN
chembl:CHEMBL599100,CHEMBL:CHEMBL599100
rxcui:26422,HALOPROGIN
chembl:CHEMBL462880,ISOBOLDINE
ncit:C92575,ONATASERTIB
rxcui:4792,GESTRINONE
ncit:C2234,MURELETECAN
ncit:C83996,NELOTANSERIN
CL:2000012,fibroblast of pedal digit skin
HP:0032791,Focal impaired awareness cognitive seizure with anomia
HGNC:11730,TERT
HP:0010841,Multifocal epileptiform discharges
RGD:3425,Psen1
ncit:C90775,LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
HGNC:16951,IVNS1ABP
iuphar.ligand:7689,&GAMMA;-KTX1.7
HP:0001274,Agenesis of corpus callosum
MONDO:0002492,acute kidney failure
GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process
ncit:C26648,"HER2 INHIBITOR CP-724,714"
drugbank:DB05596,PRX-03140
chembl:CHEMBL3545070,VONAPANITASE
iuphar.ligand:9078,COMPOUND 15 [PMID: 25411721]
MP:0001505,hunched posture
chembl:CHEMBL1513237,(-)-U-50488 METHANE SULFONATE
rxcui:2475861,COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES
Reactome:R-XTR-71288,Creatine metabolism
MONDO:0013745,Joubert syndrome 14
CHEBI:39206,dibenzopyridine
HGNC:5962,IL10
chembl:CHEMBL399491,PYRROLIDINE DITHIOCARBAMATE
rxcui:82004,DIPHENHYDRAMINE CITRATE
MONDO:0020345,obsolete presynaptic congenital myasthenic syndrome
drugbank:DB17043,PHA-767491
ncit:C152706,TRACAZOLATE
iuphar.ligand:8127,COMPOUND 3B [PMID: 23454515]
HP:0002404,Thickened superior cerebellar peduncle
MGI:1931874,Dnajb1
HGNC:11491,SYK
MP:0002066,abnormal motor capabilities/coordination/movement
rxcui:33910,ISRADIPINE
HP:0003743,Genetic anticipation
chembl:CHEMBL396000,METHYLISOTHIOCYANATE
HP:0004331,Decreased skull ossification
Reactome:R-DME-390666,Serotonin receptors
ncit:C118571,TELISOTUZUMAB VEDOTIN
ncit:C166991,NAFITHROMYCIN
chembl:CHEMBL317364,CHEMBL:CHEMBL317364
ncit:C75078,ZUCAPSAICIN
chembl:CHEMBL600968,CHEMBL:CHEMBL600968
rxcui:614373,DEFERASIROX
iuphar.ligand:9108,ARRY-382
chembl:CHEMBL242080,E319
iuphar.ligand:8216,SB-431542
chembl:CHEMBL1884669,SULFENTRAZONE
HGNC:18016,NUP133
GO:0004622,lysophospholipase activity
iuphar.ligand:9129,L779450
HGNC:6088,INSL5
rxcui:267036,METOCLOPRAMIDE HYDROCHLORIDE
iuphar.ligand:9335,YM-254890
iuphar.ligand:1248,DIMAPRIT
rxcui:4460,FLUNITRAZEPAM
HGNC:21397,SCML4
HP:0040293,Right hemiplegia
chembl:CHEMBL601547,CHEMBL:CHEMBL601547
rxcui:1303098,ACLIDINIUM
iuphar.ligand:5494,N-ARACHIDONYL-&GAMMA;-AMINOBUTYRIC ACID
ZFIN:ZDB-GENE-070508-3,drd4b
UBERON:0002313,hippocampus pyramidal layer
iuphar.ligand:1421,BOMA
HP:0100533,Inflammatory abnormality of the eye
MGI:1349441,Mecr
MONDO:0032855,neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies
ncit:C152914,VORASIDENIB
iuphar.ligand:1988,RELAXIN-1
iuphar.ligand:8782,COMPOUND 69 [PMID: 19136975]
chembl:CHEMBL84010,CHEMBL:CHEMBL84010
HGNC:11441,STX6
MONDO:0005267,heart disorder
chembl:CHEMBL95692,SB-242235
iuphar.ligand:9354,DDR-IN-1
rxcui:6084,JOSAMYCIN
iuphar.ligand:835,CXCL10
chembl:CHEMBL2269059,BENOXACOR
MP:0014253,decreased paired-pulse ratio
CHEBI:65173,iloperidone
drugbank:DB17798,AVP-21D9
FB:FBgn0040022,Set1
CHEBI:16389,ubiquinones
ncit:C88580,GANTENERUMAB
chembl:CHEMBL481044,ELEMICIN
HGNC:17287,SUV39H2
chembl:CHEMBL590927,CHEMBL:CHEMBL590927
iuphar.ligand:136,RAUWOLSCINE
iuphar.ligand:764,[125I]CCL5 (HUMAN)
MONDO:0010058,"scapuloperoneal spinal muscular atrophy, autosomal recessive"
FB:FBgn0003044,Pcl
RGD:1308381,Map3k10
iuphar.ligand:11953,LY3372689
iuphar.ligand:5707,R547
iuphar.ligand:4113,9-ANTHROIC ACID
rxcui:236140,TRIFLUPERIDOL HYDROCHLORIDE
iuphar.ligand:11845,COMPOUND 1 [PMID: 34917254]
rxcui:33770,PIRETANIDE
drugbank:DB15029,AZD-8186
drugbank:DB16767,ISORHAMNETIN
HGNC:6113,IRAK2
ncit:C71693,APOMAB
chembl:CHEMBL586024,CHEMBL:CHEMBL586024
chembl:CHEMBL4650230,SIMUFILAM
MONDO:0012391,neuronal ceroid lipofuscinosis 8 northern epilepsy variant
iuphar.ligand:678,"[THI5,8,D-PHE7]BRADYKININ"
HGNC:7907,NPHP3
chembl:CHEMBL454580,GARCINONE E
rxcui:1379,BENZALKONIUM CHLORIDE
MGI:2136690,Cers1
HGNC:11076,NHERF2
chembl:CHEMBL3545027,XL-281
UBERON:0004252,hindlimb stylopod muscle
chembl:CHEMBL101892,SANGIVAMYCIN
ncit:C174727,TILAVONEMAB
rxcui:4507,FLUSPIRILENE
MONDO:0010855,short tarsus-absence of lower eyelashes syndrome
UPHENO:0081739,increased reflex in pectoral complex
HGNC:10055,RNF10
chembl:CHEMBL276473,4'-HYDROXYCHALCONE
dictyBase:DDB_G0276253,DDB_G0276253
HP:0001730,Progressive hearing impairment
CHEBI:5615,halothane
HGNC:2020,CLCN2
HGNC:8609,PARN
rxcui:7440,NITRAZEPAM
chembl:CHEMBL221721,CHEMBL:CHEMBL221721
rxcui:259275,OSELTAMIVIR PHOSPHATE
chembl:CHEMBL533226,CHEMBL:CHEMBL533226
HP:0032013,Hypermetric horizontal saccades
rxcui:23043,DIFLUPREDNATE
HGNC:20344,UBR7
ncit:C81442,RADEZOLID
rxcui:237082,RIZATRIPTAN BENZOATE
MONDO:0016304,classic pantothenate kinase-associated neurodegeneration
MONDO:0001857,Brucella canis brucellosis
chembl:CHEMBL1241268,CHEMBL:CHEMBL1241268
chembl:CHEMBL2071180,CHEMBL:CHEMBL2071180
HP:0000871,Panhypopituitarism
MP:0005247,abnormal extraocular muscle morphology
rxcui:32895,PARAMETHASONE ACETATE
rxcui:1760,BROMOCRIPTINE
HP:0005951,Progressive inspiratory stridor
rxcui:746741,PRAMIPEXOLE
HGNC:29023,PPIP5K1
iuphar.ligand:1423,CPPHA
MP:0000866,cerebellum vermis hypoplasia
HGNC:11237,SPG7
drugbank:DB11397,DICHLORVOS
chembl:CHEMBL600908,CHEMBL:CHEMBL600908
chembl:CHEMBL1255944,CHEMBL:CHEMBL1255944
rxcui:30225,MORNIFLUMATE
ncit:C175163,NIMACIMAB
CHEBI:57945,NADH(2-)
MONDO:0008927,colobomatous optic disc-macular atrophy-chorioretinopathy syndrome
GO:0003010,voluntary skeletal muscle contraction
GO:0001510,RNA methylation
EMAPA:17789,cerebellum marginal layer
WB:WBGene00001017,dnc-1
UPHENO:0051729,abnormal blood creatine level
rxcui:4457,FLUMAZENIL
iuphar.ligand:8943,LY3009120
ncit:C152202,REVEXEPRIDE
rxcui:358262,FOSAMPRENAVIR
MP:0020070,decreased neocortex volume
CHEBI:6827,methicillin
drugbank:DB02010,STAUROSPORINE
MONDO:0700217,neonatal sepsis
MGI:1096343,Lhx8
MGI:107813,Tubb3
MP:0005311,abnormal circulating amino acid level
chembl:CHEMBL1392894,CHEMBL:CHEMBL1392894
drugbank:DB06852,CHIR-124
chembl:CHEMBL602923,CHEMBL:CHEMBL602923
ncit:C73806,ELZASONAN HYDROCHLORIDE
ncit:C66222,NEBOGLAMINE
MGI:4360543,Grin2a<sup>tm1Nak</sup>/Grin2a<sup>tm1Nak</sup> Grin2c<sup>tm1Nak</sup>/Grin2c<sup>tm1Nak</sup>  [background:] involves: 129S/SvEv
HGNC:7775,NFATC1
RGD:628596,Tubb5
iuphar.ligand:673,FR167344
iuphar.ligand:577,"L-156,602"
ncit:C68920,ABEXINOSTAT
MONDO:0014640,frontotemporal dementia and/or amyotrophic lateral sclerosis 3
HGNC:3280,EIF3B
CHEBI:36132,alicyclic ketone
rxcui:5924,INULIN
chembl:CHEMBL577014,CHEMBL:CHEMBL577014
ncit:C157771,CAVROTOLIMOD
iuphar.ligand:1997,RELAXIN-3 (B CHAIN)
rxcui:4919,GLYCINE
MONDO:0020074,progressive myoclonus epilepsy
ncit:C76774,PIFEXOLE
ncit:C124995,LIFIRAFENIB
MGI:4410604,Prnp<sup>tm1Cwe</sup>/Prnp<sup>tm1Cwe</sup> Tg(Prnp-tTA)F959Sbp/0 Tg(tetO-ATXN3)2904Olri/Tg(tetO-ATXN3)2904Olri  [background:] involves: 129S7/SvEvBrd * C57BL/6 * FVB
ncit:C29618,THERAPEUTIC ANDROSTANOLONE
chembl:CHEMBL1346946,"DIBENZ[A,H]ANTHRACENE"
drugbank:DB11974,PF-04691502
rxcui:1148495,CRIZOTINIB
chembl:CHEMBL1322879,"2,3,4-TRIHYDROXY-4'-ETHOXYBENZOPHENONE"
iuphar.ligand:9883,COMPOUND 46C [PMID: 29350534]
chembl:CHEMBL582478,CHEMBL:CHEMBL582478
MONDO:0017137,onchocerciasis
chembl:CHEMBL1256191,CHEMBL:CHEMBL1256191
HGNC:7642,NAPG
rxcui:314521,BENZOXIQUINE
UPHENO:0051787,abnormal urine creatinine level
CHEBI:16414,L-valine
drugbank:DB06999,PLX-4720
chembl:CHEMBL483838,CHEMBL:CHEMBL483838
rxcui:33753,PIPERONAL
ncit:C175203,SERALUTINIB
HP:0008311,Spinal cord posterior columns myelin loss
HGNC:2084,CLPP
drugbank:DB15009,PF-04937319
HGNC:26928,CDV3
MGI:1918673,Epg5
HP:0001152,Saccadic smooth pursuit
HP:0001423,X-linked dominant inheritance
HGNC:7462,MT-ND6
ncit:C76781,NERAMEXANE
HGNC:637,AQP4
chembl:CHEMBL1597273,PERSEITOL
iuphar.ligand:5928,KU-55933
HGNC:33830,MZT1
HGNC:18637,TUBA4B
MGI:5505393,Ndst1<sup>b2b2230Clo</sup>/Ndst1<sup>b2b2230Clo</sup>  [background:] C57BL/6J-Ndst1<sup>b2b2230Clo</sup>
HP:0008765,Auditory hallucinations
chembl:CHEMBL1490332,CHEMBL:CHEMBL1490332
HGNC:11109,SMARCE1
MONDO:0011638,neuroferritinopathy
CLINVAR:189869,NM_001165963.4:c.2792G>A
HP:0032916,Focal aware verbal automatism seizure
iuphar.ligand:11054,LEI-401
CHEBI:57292,succinyl-CoA(5-)
HGNC:25766,CCDC14
drugbank:DB04744,LAWSONE
ncit:C147030,GIREDESTRANT
ZFIN:ZDB-GENE-060526-218,coq4
rxcui:2594,CLOFIBRATE
rxcui:53750,NONOXYNOL-9
ncit:C481,ANTIESTROGEN
HP:0007366,Atrophy/Degeneration affecting the brainstem
CHEBI:35720,enrofloxacin
ncit:C2241,MESMULOGENE ANCOVACIVEC
WB:WBGene00014218,prp-40
ncit:C62517,HSP90 INHIBITOR BIIB021
iuphar.ligand:9461,"L-732,138"
iuphar.ligand:5436,BQCA
iuphar.ligand:12376,DARIZMETINIB
chembl:CHEMBL392068,CHEMBL:CHEMBL392068
drugbank:DB17236,ONO-7579
MP:0020619,abnormal dorsal striatum total cell area
iuphar.ligand:4318,SZ(+)-(S)-202-791
ncit:C187300,ANTI-CD19 CAR T CELLS AT101
chembl:CHEMBL91163,CHEMBL:CHEMBL91163
rxcui:2584303,ASCIMINIB HYDROCHLORIDE
iuphar.ligand:788,MET-CK&BETA;7
MONDO:0014443,Bardet-Biedl syndrome 15
iuphar.ligand:5574,"[ALA1,12,AIB3,GLN10,HARG11,TRP14,ARG19]PTH-(1-28)-NH2 (HUMAN)"
HGNC:1884,CFTR
rxcui:4451,FLUCYTOSINE
HP:0000741,Apathy
ncit:C73039,DAGLUTRIL
rxcui:6446,LISURIDE
GO:0040007,growth
CHEBI:16113,cholesterol
chembl:CHEMBL2108332,BEPERMINOGENE PERPLASMID
chembl:CHEMBL240954,CHEMBL:CHEMBL240954
chembl:CHEMBL1514735,CEFDITORIN PIVOXIL
MONDO:0015140,early-onset autosomal dominant Alzheimer disease
iuphar.ligand:4212,HC-056456
HP:0002721,Immunodeficiency
iuphar.ligand:1251,IMMEPIP
iuphar.ligand:7642,PKI166
HGNC:11466,SUPT3H
chembl:CHEMBL366861,FUMARPROTOCETRARIC ACID
ncit:C103277,ACALISIB
rxcui:2289380,SELUMETINIB
HP:0001371,Flexion contracture
UPHENO:0034171,decreased level of creatine in independent continuant
chembl:CHEMBL525486,CHEMBL:CHEMBL525486
rxcui:24506,VINPOCETINE
chembl:CHEMBL252722,ROBUSTONE
HGNC:16812,COQ8A
NCBIGene:282199,COX6A1
MGI:3606102,nmf356/nmf356  [background:] C57BL/6J-nmf356/J
iuphar.ligand:11104,SL-176
ncit:C95312,ANISOMYCIN
HGNC:18749,RIN1
CHEBI:600520,micafungin
ncit:C83728,GISADENAFIL
ncit:C74072,DACTOLISIB
rxcui:1311389,GALLIC ACID
chembl:CHEMBL259421,CHEMBL:CHEMBL259421
ncit:C38728,PANCREATIC PROTEOLYTIC ENZYMES
rxcui:7992,PENTAERYTHRITOL TETRANITRATE
MGI:3695129,Tg(Syn1-ADCY7)11004Btab/0  [background:] B6.Cg-Tg(Syn1-ADCY7)11004Btab
chembl:CHEMBL2348411,CHEMBL:CHEMBL2348411
HP:0032715,Focal bilateral motor seizure
MONDO:0011823,developmental malformations-deafness-dystonia syndrome
ncit:C2202,TACEDINALINE
chembl:CHEMBL1738936,CHEMBL:CHEMBL1738936
ncit:C511,FOLATE ANTAGONIST
ncit:C70941,COTININE
MONDO:0005265,inflammatory bowel disease
chembl:CHEMBL336467,FUROXAN
chembl:CHEMBL1683024,CHEMBL:CHEMBL1683024
chembl:CHEMBL233930,ASTRAGALIN
chembl:CHEMBL217894,DECYLUBIQUINONE
iuphar.ligand:8051,BMS-265246
CHEBI:27568,selenium atom
rxcui:266565,NELFINAVIR MESYLATE
HGNC:28578,PSTK
HGNC:15506,TSEN34
rxcui:4491,FLUOROMETHOLONE
drugbank:DB06133,DIMETHYLCURCUMIN
CL:0000019,sperm
drugbank:DB04177,DIGITOXIGENIN
HGNC:11365,STAT4
rxcui:2103480,ETANERCEPT-SZZS
iuphar.ligand:4082,[3H]CPP
RGD:1310823,Recql5
rxcui:24346,ERYTHROMYCIN GLUCEPTATE
chembl:CHEMBL1940084,CHEMBL:CHEMBL1940084
iuphar.ligand:8436,LP-211
chembl:CHEMBL2062863,CHEMBL:CHEMBL2062863
ncit:C98054,SILMITASERTIB
iuphar.ligand:1767,BX 667
MONDO:0013674,neurodegeneration with brain iron accumulation 4
rxcui:24192,ENROFLOXACIN
HGNC:7702,NDUFB7
drugbank:DB17029,GO-6976
iuphar.ligand:4182,DIPHENYLAMINE-2-CARBOXYLIC ACID
rxcui:33739,PIPAMPERONE
chembl:CHEMBL2323582,BODILISANT
CHEBI:27013,tocopherol
MONDO:0031031,"intellectual developmental disorder, autosomal recessive 77"
HGNC:589,ATG5
ncit:C174583,BEPRANEMAB
CHEBI:35757,monocarboxylic acid anion
iuphar.ligand:7014,BIX-01294
CHEBI:16643,L-methionine
MP:0008146,asymmetric sternocostal joints
MGI:3613525,Tg(YAC128)53Hay/0  [background:] FVB/N-Tg(YAC128)53Hay
rxcui:1040027,LURASIDONE HYDROCHLORIDE
EMAPA:17077,metencephalon alar plate ventricular layer
ncit:C171870,CANDOXATRIL
MGI:99517,Hspa1b
iuphar.ligand:4296,RO15-4513
chembl:CHEMBL602990,CHEMBL:CHEMBL602990
MONDO:0011178,infantile convulsions and choreoathetosis
UPHENO:0080040,increased glial cell growth in basal ganglion
HGNC:23399,FREM1
iuphar.ligand:5213,L-NAME
UBERON:0001388,gastrocnemius
MONDO:0007163,episodic ataxia type 2
chembl:CHEMBL8483,CHEMBL:CHEMBL8483
HP:0032755,Focal impaired awareness autonomic seizure
iuphar.ligand:8261,(S)-DRF-1042
chembl:CHEMBL1095015,AESCULIOSIDE IIB
chembl:CHEMBL15901,BENZIDINE
HGNC:11655,TCP1
UPHENO:0034296,decreased level of creatinine in independent continuant
ncit:C48416,PICOPLATIN
GO:0015385,sodium:proton antiporter activity
CHEBI:18243,dopamine
rxcui:2593413,SESAMIN
ncit:C61072,SAGOPILONE
CHEBI:58228,carbamoyl phosphate(2-)
MONDO:0019072,intrahepatic cholestasis
iuphar.ligand:11023,DS-1971A
chembl:CHEMBL559876,"2,6-DIDEHYDROPEPEROMIN B"
iuphar.ligand:5275,T0156
chembl:CHEMBL47875,CHEMBL:CHEMBL47875
iuphar.ligand:12004,DS69910557
HP:0007817,Horizontal supranuclear gaze palsy
HGNC:29843,NSMF
ncit:C76400,RAMATROBAN
HGNC:9535,PSMA6
chembl:CHEMBL253786,CHEMBL:CHEMBL253786
ncit:C188286,MIVAVOTINIB CITRATE
chembl:CHEMBL270299,BAY-11-7085
rxcui:1000104,INCOBOTULINUMTOXINA
rxcui:194337,VORINOSTAT
HP:0003481,Segmental peripheral demyelination/remyelination
ncit:C738,PHENCYCLIDINE
NCBIGene:417112,NDUFA8
iuphar.ligand:12186,AMG28
HGNC:28424,TRIR
MGI:2668533,Hprt1<sup>tm4Detl</sup>/Y  [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
MONDO:0014304,hereditary spastic paraplegia 61
HGNC:20856,THAP1
chembl:CHEMBL2109388,FUTUXIMAB
ncit:C166705,MANAGLINAT DIALANETIL
PomBase:SPAC144.17c,SPAC144.17c
chembl:CHEMBL74656,REL-CISAPRIDE
HP:0002187,"Intellectual disability, profound"
ncit:C82696,MEK INHIBITOR RO4987655
rxcui:10502,THIORIDAZINE
chembl:CHEMBL589694,CHEMBL:CHEMBL589694
NCBIGene:281080,CLTC
chembl:CHEMBL303483,PHYLLODULCIN
iuphar.ligand:6000,KENPAULLONE
chembl:CHEMBL1288013,CHEMBL:CHEMBL1288013
ncit:C77417,DEXAMETHASONE DIPROPIONATE
HGNC:11187,SOS1
iuphar.ligand:658,NPC 18565
MP:0010062,decreased creatine level
HP:0012430,Cerebral white matter hypoplasia
rxcui:203180,EPINEPHRINE BITARTRATE
CHEBI:29108,calcium(2+)
CHEBI:50249,anticoagulant
CLINVAR:51985,NC_000013.11:g.32316465del
chembl:CHEMBL1420059,TECNAZENE
HP:0001310,Dysmetria
HGNC:24085,SRPRB
iuphar.ligand:6677,(+)-SKF 10.047
HP:0001751,Abnormal vestibular function
iuphar.ligand:8793,SAR260301
iuphar.ligand:1266,IODOPHENPROPIT
HGNC:4177,GBA1
HGNC:12730,WARS2
chembl:CHEMBL1319047,ANTIAROL
iuphar.ligand:2089,NEUROKININ A
GO:0005789,endoplasmic reticulum membrane
MGI:6286248,Tg(Prnp-MAPT*P301S)50Hiw/0  [background:] B6.Cg-Tg(Prnp-MAPT*P301S)50Hiw
MONDO:0012755,episodic ataxia type 7
MGI:2655513,Hfe<sup>tm1.1Nca</sup>/Hfe<sup>tm1.1Nca</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6J
HP:0011182,Interictal epileptiform activity
chembl:CHEMBL1451216,CHEMBL:CHEMBL1451216
ncit:C74582,NOBERASTINE
chembl:CHEMBL533399,CHEMBL:CHEMBL533399
rxcui:1665336,DIFLUBENZURON
HGNC:11831,TK2
HGNC:29959,TTC33
Reactome:R-CEL-390651,Dopamine receptors
iuphar.ligand:524,ARC-239
CL:0002540,mesenchymal stem cell of the bone marrow
HGNC:9476,HTRA1
iuphar.ligand:5661,AST-487
iuphar.ligand:6148,COMPOUND 4 [PMID: 23083103]
ncit:C62525,VINTAFOLIDE
UPHENO:0068110,increased level of chemical entity in urine
chembl:CHEMBL453418,TRIFORINE
MONDO:0012100,major depressive disorder 2
GO:0004722,protein serine/threonine phosphatase activity
MONDO:0024265,Duane syndrome type 1
HP:0001287,Meningitis
MGI:103027,Tarbp2
HP:0002361,Psychomotor deterioration
HGNC:29605,SH2B3
HP:0002490,Increased CSF lactate
chembl:CHEMBL578390,APX-3330
ncit:C72098,STANOLONE
chembl:CHEMBL2094422,CHEMBL:CHEMBL2094422
ncit:C169780,AMITIFADINE
MGI:2175783,Cln3<sup>tm1Nbm</sup>/Cln3<sup>tm1Nbm</sup>  [background:] involves: 129S6/SvEvTac * NIH Black Swiss
ncit:C28201,BIOCHANIN A
ZP:0137901,"coenzyme Q10 whole organism decreased amount, abnormal"
UBERON:0003701,calcaneal tendon
MP:0001262,decreased body weight
iuphar.ligand:5945,CGP74514A
Reactome:R-BTA-211945,Phase I - Functionalization of compounds
chembl:CHEMBL487194,AILANTHINONE
MONDO:0014464,progressive encephalopathy with leukodystrophy due to DECR deficiency
rxcui:2183103,PEXIDARTINIB HYDROCHLORIDE
rxcui:1939323,VOXILAPREVIR
HGNC:29233,MAVS
HP:0100754,Mania
chembl:CHEMBL4298133,XMAB-2513
iuphar.ligand:3914,TRANS-CINNAMOYL-LIGRLO [N-[3H]PROPIONYL]-NH2
iuphar.ligand:11164,S416
ncit:C117734,SITRAVATINIB
GO:0005764,lysosome
MONDO:0011706,Kufor-Rakeb syndrome
iuphar.ligand:122,DIPROPYL-5-CT
ncit:C170212,NERINETIDE
MONDO:0008564,DiGeorge syndrome
iuphar.ligand:12446,NOBILETIN
chembl:CHEMBL3545006,PWT-33587
MGI:5286128,"Tg(Prnp-HTT*82Q,KRT14-EGFP)C63Dbo/0  [background:] Not Specified"
iuphar.ligand:8337,RELAXIN-3 B CHAIN DIMER
HGNC:12449,TYROBP
MP:0002187,abnormal fibula morphology
chembl:CHEMBL1902519,METRIBUZIN
chembl:CHEMBL1208903,ISOGINKGETIN
MONDO:0021661,coronary atherosclerosis
UBERON:0002421,hippocampal formation
chembl:CHEMBL146855,(S)-MEXILETINE
iuphar.ligand:79,WAY-100135
rxcui:2604036,VALNEMULIN
ncit:C26664,POLYGLUTAMATE CAMPTOTHECIN
wikidata:Q29006438,RHUCIN
MONDO:0009775,Oguchi disease-1
iuphar.ligand:6171,5-OXO-12-HETE
HGNC:17944,EXOSC3
chembl:CHEMBL3183902,BUPIRIMATE
ncit:C83522,AFLOQUALONE
rxcui:51487,IPRIFLAVONE
ncit:C163685,PARATHION
CLINVAR:207248,NM_001042537.1(SLC9A6):c.526-9_526-5del
chembl:CHEMBL498513,CHEMBL:CHEMBL498513
chembl:CHEMBL585964,CHEMBL:CHEMBL585964
FB:FBgn0040388,boi
HP:0011158,Focal sensory seizure with auditory features
HP:0008944,Distal lower limb amyotrophy
ncit:C148229,PI3K/BET INHIBITOR LY294002
chembl:CHEMBL412010,DERRUBONE
HGNC:2939,DNA2
HGNC:2277,COX6A1
UBERON:0001476,deltoid
HGNC:30129,POP1
HP:0100308,Cerebral cortical hemiatrophy
MP:0002216,abnormal seminiferous tubule morphology
HP:0001271,Polyneuropathy
iuphar.ligand:8353,ZM447439
iuphar.ligand:4997,IL-5
HGNC:12757,WDR5
chembl:CHEMBL87568,CHEMBL:CHEMBL87568
iuphar.ligand:1755,ADP&BETA;S
MGI:5689841,Tg(Thy1-TARDBP*)BOddo/Tg(Thy1-TARDBP*)BOddo  [background:] C57BL/6-Tg(Thy1-TARDBP*)BOddo
FB:FBgn0011603,ine
ncit:C101519,EDICOTINIB
iuphar.ligand:10281,PYRAZOLOPYRIMIDINE 4N
chembl:CHEMBL2108058,VANUTIDE CRIDIFICAR
iuphar.ligand:956,(+)-SCH-23390
rxcui:6860,METHYCLOTHIAZIDE
GO:0016339,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
chembl:CHEMBL505670,CHEMBL:CHEMBL505670
MONDO:0011075,retinitis pigmentosa 18
rxcui:72236,FOSPHENYTOIN
chembl:CHEMBL1173380,ERUCIC ACID
chembl:CHEMBL485750,PLUKENETIONE A
HGNC:29683,SLC25A32
UBERON:0006135,myelinated nerve fiber
chembl:CHEMBL39879,DIPYRIDYL
CHEBI:7782,oripavine
CHEBI:79385,YW3548
HGNC:5184,HRH3
iuphar.ligand:8406,CODRITUZUMAB
MGI:104663,Lep
RGD:1311470,Psmd3
HGNC:30528,DNAJC19
ncit:C1261,TRICHOSTATIN A
iuphar.ligand:4294,RN1734
chembl:CHEMBL1222498,PROPANIL
HP:0100315,Lewy bodies
chembl:CHEMBL1079460,CHEMBL:CHEMBL1079460
HGNC:4201,KAT2A
chembl:CHEMBL582099,CHEMBL:CHEMBL582099
HP:0008905,Rhizomelia
chembl:CHEMBL1565335,DIMETHENAMID
chembl:CHEMBL258756,CHEMBL:CHEMBL258756
HGNC:15894,PANK2
rxcui:40575,ZILEUTON
rxcui:42562,CEPHAPIRIN SODIUM
ncit:C1139,KEYHOLE LIMPET HEMOCYANIN
iuphar.ligand:4156,CGS8216
chembl:CHEMBL2062869,CHEMBL:CHEMBL2062869
HP:0032726,Focal impaired awareness hyperkinetic seizure
ncit:C81533,EPROTIROME
ncit:C80864,SANGUINARIUM CHLORIDE
HP:0002211,White forelock
NCBIGene:514749,RAD51
iuphar.ligand:4222,IP3
ZFIN:ZDB-GENE-070928-38,fars2
Xenbase:XB-GENE-947407,tubb4a
HGNC:16744,CIZ1
MONDO:0020846,"intellectual disability, autosomal recessive 64"
ncit:C61311,B-RAF/VEGFR-2 INHIBITOR RAF265
MONDO:0100340,Friedreich ataxia 1
chembl:CHEMBL1420181,CHEMBL:CHEMBL1420181
iuphar.ligand:3765,[125I][TYR8]BRADYKININ
iuphar.ligand:12462,EPICATECHIN GALLATE
MONDO:0018632,11q22.2q22.3 microdeletion syndrome
iuphar.ligand:8980,RN-1
chembl:CHEMBL463065,DESACETYLBUFOTALIN
chembl:CHEMBL3545117,AVE-9940
HGNC:29433,NEXMIF
rxcui:5340,HISTIDINE
chembl:CHEMBL258767,CHEMBL:CHEMBL258767
HP:0032794,Myoclonic seizure
MONDO:0017174,Machado-Joseph disease type 1
MONDO:0014720,autosomal dominant optic atrophy plus syndrome
chembl:CHEMBL536008,CHEMBL:CHEMBL536008
rxcui:5470,HYDRALAZINE
HGNC:5048,HNRNPU
MGI:3822533,Trp73<sup>tm1Mak</sup>/Trp73<sup>tm1Mak</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6J
MGI:3842514,Meg3<sup>tm1Kono</sup>/Meg3<sup>+</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6N * DBA/2
HP:0002908,Conjugated hyperbilirubinemia
HGNC:1120,BTBD1
ncit:C48402,LESTAURTINIB
HP:0007663,Reduced visual acuity
HGNC:2460,CSNK2B
HP:0003864,Bifid humerus
iuphar.ligand:11460,COMPOUND 4 [PMID: 30824200]
chembl:CHEMBL463574,RATANIAPHENOL II
iuphar.ligand:12125,BD-1063
chembl:CHEMBL154709,APOCIDEINE
drugbank:DB17244,G100
chembl:CHEMBL485803,CIMIPRONIDINE
drugbank:DB06345,AR-9281
HGNC:8820,PDYN
chembl:CHEMBL4297680,1018 ISS
drugbank:DB07410,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID
chembl:CHEMBL548540,CHEMBL:CHEMBL548540
MONDO:0005299,brain ischemia
HP:0002079,Hypoplasia of the corpus callosum
rxcui:5553,HYDROXYZINE
HGNC:11850,TLR4
HGNC:10589,SCN2B
chembl:CHEMBL1672332,BUTYRYLHYDROXAMIC ACID
chembl:CHEMBL4802141,CH-1504
rxcui:3251,DESMOPRESSIN
iuphar.ligand:9578,SR8185
iuphar.ligand:11750,GSK3685032
ncit:C73055,RUPATADINE
iuphar.ligand:12516,"EU-DTPA-[SER27, NLE70]HC5A"
HGNC:6701,LRPAP1
ncit:C80631,SOTRASTAURIN ACETATE
MONDO:0011426,aceruloplasminemia
chembl:CHEMBL310798,TYRPHOSTIN 25
rxcui:40137,TAMOXIFEN CITRATE
HGNC:11543,TAF10
chembl:CHEMBL582699,CHEMBL:CHEMBL582699
UBERON:0003499,brain blood vessel
HGNC:3331,EMD
rxcui:9641,SELENIUM
HGNC:25282,NIBAN2
MONDO:0013754,"cutis laxa, autosomal recessive, type 1B"
HGNC:22474,MED13
HGNC:9689,PTS
UPHENO:0080034,increased glial cell growth in substantia nigra
HP:0010546,Muscle fibrillation
FB:FBgn0011582,Dop1R1
HGNC:4588,GRIN2D
chembl:CHEMBL575924,PALBINONE
GO:0000278,mitotic cell cycle
ncit:C170049,IDAZOXAN
HGNC:23720,CREB3L2
rxcui:32385,OLSALAZINE
iuphar.ligand:5085,VEGFA
rxcui:39786,VENLAFAXINE
rxcui:407885,PSEUDOEPHEDRINE POLISTIREX
MGI:3846703,Tg(Slc6a3-PARK2*Q311X)AXwy/0  [background:] FVB/NJ-Tg(Slc6a3-PARK2*Q311X)AXwy
HGNC:30292,G3BP1
MONDO:0002562,demyelinating disease
ncit:C103297,NUCLEOLIN ANTAGONIST IPP-204106N
ncit:C152177,RELENOPRIDE
CHEBI:25712,organoselenium compound
chembl:CHEMBL1213646,CALCDPWW
MGI:99918,Mecp2
chembl:CHEMBL464433,"4',7-DIMETHOXY-5-HYDROXYGENISTEIN"
HP:0020045,Esodeviation
RGD:39457947,SD-<i>Bckdk<sup>m1Dbsa</i></sup>
MONDO:0024457,neurodegeneration with brain iron accumulation 2A
iuphar.ligand:3851,2-FUROYL-LIGRLO-AMIDE
chembl:CHEMBL2172378,CHEMBL:CHEMBL2172378
MONDO:0014395,frontotemporal dementia and/or amyotrophic lateral sclerosis 2
iuphar.ligand:3413,[3H]LTB4
chembl:CHEMBL3545089,IMD-0354
ncit:C88329,VISTUSERTIB
HP:0002121,Generalized non-motor (absence) seizure
rxcui:6472,LOVASTATIN
chembl:CHEMBL600457,GLABRONE
ZFIN:ZDB-GENE-030826-15,higd1a
ncit:C96701,BINDARIT
iuphar.ligand:4208,GV196771A
MONDO:0019037,progressive supranuclear palsy
HGNC:20790,ATG4B
rxcui:5495,HYDROFLUMETHIAZIDE
iuphar.ligand:2616,TETRODOTOXIN
chembl:CHEMBL597449,CHEMBL:CHEMBL597449
MONDO:0017276,frontotemporal dementia
MONDO:0010806,retinitis pigmentosa 13
iuphar.ligand:2187,D[CHA4]AVP
iuphar.ligand:11893,COMPOUND 6 [PMID: 34333981]
UPHENO:0012059,abnormally increased rate of thigmotaxis
GO:0043520,regulation of myosin II filament assembly
HGNC:4563,GRAP2
HP:0001249,Intellectual disability
CHEBI:38777,azetidines
chembl:CHEMBL44072,ENDRIN
chembl:CHEMBL195350,CHEMBL:CHEMBL195350
chembl:CHEMBL601110,CHEMBL:CHEMBL601110
chembl:CHEMBL2108752,PEGAPTANIB OCTASODIUM
iuphar.ligand:11560,COMPOUND III [PMID: 29351497]
chembl:CHEMBL538542,CHEMBL:CHEMBL538542
MGI:103291,Rai1
MGI:103555,Clcn3
drugbank:DB16033,GSK2798745
MP:0000158,absent sternum
rxcui:35185,QUAZEPAM
iuphar.ligand:12705,BAY1217389
chembl:CHEMBL326967,CHLOROETHYLCLONIDINE
chembl:CHEMBL603952,CHEMBL:CHEMBL603952
MONDO:0013501,frontotemporal dementia and/or amyotrophic lateral sclerosis 6
ncit:C74062,MET TYROSINE KINASE INHIBITOR SGX523
ncit:C74043,DUAL IGF-1R/INSR INHIBITOR BMS-754807
iuphar.ligand:5913,AG 112
HGNC:11741,TFAM
HGNC:7694,NDUFAB1
rxcui:91110,SECOBARBITAL SODIUM
HGNC:6535,LDHA
ncit:C142902,AFURESERTIB HYDROCHLORIDE
iuphar.ligand:8901,SR9009
iuphar.ligand:5761,FLPLAR
CHEBI:27644,chlortetracycline
iuphar.ligand:2204,YM 218
iuphar.ligand:1346,6-CL-MLT
HGNC:29878,NIT2
HP:0007354,Amyotrophic lateral sclerosis
chembl:CHEMBL1489988,N-HISTIDYL-2-AMINONAPHTHALENE (BETANA)
iuphar.ligand:758,CCL5
ncit:C76654,SARIZOTAN HYDROCHLORIDE
FB:FBgn0015805,HDAC1
ncit:C1873,APOMINE
ncit:C66468,PROADIFEN HYDROCHLORIDE
rxcui:10691,TRANEXAMIC ACID
HGNC:3071,DUSP5
HGNC:894,AVP
NBO:0000381,thigmotaxis
HGNC:12767,NSD3
rxcui:7393,NIACIN
HP:0009882,Short distal phalanx of finger
iuphar.ligand:8834,COMPOUND D24 [PMID: 24374347]
chembl:CHEMBL2108739,PLACULUMAB
chembl:CHEMBL1414154,ALACHLOR
HGNC:11938,TNFSF8
MONDO:0018531,carcinoma of liver and intrahepatic biliary tract
ncit:C2662,TOPOISOMERASE-II-BETA INHIBITOR RACEMIC XK469
HP:0032735,Focal aware emotional seizure with anger
MONDO:0005336,myopathy
rxcui:1385,BENZBROMARONE
iuphar.ligand:6440,AZD6538
HP:0000643,Blepharospasm
CL:1001580,hippocampal glial cell
HP:0007082,Dilated third ventricle
GO:0090083,regulation of inclusion body assembly
chembl:CHEMBL1256775,PHENAMIL METHANESULFONATE
iuphar.ligand:11361,BRONTICTUZUMAB
iuphar.ligand:9176,WZ4002
ncit:C166842,RUNCACIGUAT
iuphar.ligand:8593,[3H]ACETYLCHOLINE
drugbank:DB05505,NM-702
MGI:94927,Drd5
HGNC:20731,GNB4
HGNC:15468,DYNLRB1
HGNC:10442,RPS9
HGNC:29350,IQCN
UPHENO:0075969,abnormal lateral rectus extra-ocular muscle
RGD:1593180,Slc30a9
GO:0061534,"gamma-aminobutyric acid secretion, neurotransmission"
rxcui:4501,FLURAZEPAM
HGNC:4571,GRIA1
ncit:C28313,ENDOTHELIN RECEPTOR ANTAGONIST
chembl:CHEMBL1989853,CHEMBL:CHEMBL1989853
HP:0012452,Restless legs
HP:0010693,Pulverulent cataract
iuphar.ligand:6940,TAK-070
ncit:C155813,AXATILIMAB
HP:0001328,Specific learning disability
HP:0000982,Palmoplantar keratoderma
ncit:C65876,IBUDILAST
iuphar.ligand:5938,BOHEMINE
chembl:CHEMBL42115,THYROXINE
chembl:CHEMBL421215,CHEMBL:CHEMBL421215
HGNC:8866,PFDN1
iuphar.ligand:12429,S6821
chembl:CHEMBL583584,CHEMBL:CHEMBL583584
ncit:C744,PHOSPHODIESTERASE INHIBITOR
iuphar.ligand:3065,"COMPOUND 1 [OVERHAND ET AL., 1997]"
HP:0012110,Hypoplasia of the pons
MONDO:0017636,hemiparkinsonism-hemiatrophy syndrome
chembl:CHEMBL1256740,CHEMBL:CHEMBL1256740
iuphar.ligand:2507,CLOFILIUM
ncit:C72687,ALEGLITAZAR
rxcui:1546447,4-PHENYLBUTYRIC ACID
HGNC:24466,SYNM
ncit:C65709,FLUDIAZEPAM
MONDO:0011925,congenital merosin-deficient muscular dystrophy 1A
ncit:C186783,ACELLULAR DERMAL MATRIX
HGNC:18603,COL25A1
GO:0032911,negative regulation of transforming growth factor beta1 production
rxcui:1297766,ATORVASTATIN CALCIUM TRIHYDRATE
CLINVAR:143526,NM_001110792.2(MECP2):c.338C>G (p.Pro113Arg)
iuphar.ligand:2122,YM49598
rxcui:1487512,UMECLIDINIUM BROMIDE
HP:0032710,Focal aware cognitive seizure with receptive dysphasia/aphasia
CHEBI:65191,second generation antipsychotic
MP:0010065,decreased circulating creatine level
chembl:CHEMBL271023,CHEMBL:CHEMBL271023
iuphar.ligand:8145,COMPOUND 38 [PMID: 24915291]
MONDO:0000453,short QT syndrome
MONDO:0800301,Friedreich ataxia with retained reflexes
HP:0034316,Thinning of the substantia nigra pars compacta
HGNC:48,ABCB7
FB:FBgn0284243,βTub56D
iuphar.ligand:1257,UCL-2138
chembl:CHEMBL582983,CHEMBL:CHEMBL582983
CHEBI:29919,hydrosulfide
rxcui:221171,THONZONIUM BROMIDE
chembl:CHEMBL531268,CHEMBL:CHEMBL531268
chembl:CHEMBL2109481,ICM3
HGNC:7710,NDUFS3
HGNC:6735,LYN
NCBIGene:327697,NDUFS2
CHEBI:16236,ethanol
HP:0025404,Abnormal visual fixation
rxcui:1310300,COBALT
ncit:C621,RECOMBINANT LYMPHOKINE
wikidata:Q123598631,3K3A-ACTIVATED PROTEIN C
drugbank:DB07662,PD-168393
HP:0008947,Infantile muscular hypotonia
iuphar.ligand:170,ORG 12962
HP:0002335,Agenesis of cerebellar vermis
CHEBI:49167,anti-asthmatic drug
GO:0001540,amyloid-beta binding
rxcui:35255,CISAPRIDE
iuphar.ligand:6683,[3H]PENTAZOCINE
HGNC:16959,YKT6
chembl:CHEMBL546493,CHEMBL:CHEMBL546493
HGNC:6199,JRK
HP:0020217,Focal aware motor seizure
HP:0000286,Epicanthus
ncit:C99562,PARAOXON
rxcui:1011450,DIDECYLDIMETHYLAMMONIUM CHLORIDE
iuphar.ligand:3924,NLX-101
chembl:CHEMBL60824,"4-AMINO-[1,2]NAPHTHOQUINONE"
rxcui:1546871,CLODRONATE DISODIUM
FB:FBgn0000535,eag
MGI:97621,Plk1
Reactome:R-BTA-390651,Dopamine receptors
HP:0007266,Cerebral dysmyelination
rxcui:221094,EMEDASTINE DIFUMARATE
drugbank:DB06656,TAS-106
HP:0001293,Cranial nerve compression
HP:0002983,Micromelia
chembl:CHEMBL524603,CHEMBL:CHEMBL524603
drugbank:DB16056,GZ-389988
iuphar.ligand:6030,PURVALANOL A
iuphar.ligand:12126,COMPOUND 33A [PMID: 35944901]
iuphar.ligand:1787,PTHRP-(1-20)/TIP-(23-39) (HUMAN)
ncit:C174784,IBIPINABANT
HP:0001981,Schistocytosis
ncit:C88585,SOLANEZUMAB
chembl:CHEMBL463563,ISOTHYMONIN
HGNC:23732,PPP2R2D
HGNC:10831,SH3GL2
HP:0003256,Abnormality of the coagulation cascade
chembl:CHEMBL1486690,PYRONIN Y
rxcui:2375531,SYMCLOSENE
iuphar.ligand:304,PENTYLTHIO-TZTP
ncit:C9506,TEGAFUR-URACIL
HGNC:26113,TCTN1
iuphar.ligand:4994,IL-3
iuphar.ligand:5568,"CP55,244"
chembl:CHEMBL454890,CHEMBL:CHEMBL454890
chembl:CHEMBL596836,CHEMBL:CHEMBL596836
chembl:CHEMBL453291,COCLAURINE
HGNC:4702,GYPA
ncit:C66333,PELUBIPROFEN
iuphar.ligand:11209,EMBELIN
HP:0025037,Hypothalamic gliosis
MP:0000880,decreased Purkinje cell number
GO:0002087,regulation of respiratory gaseous exchange by nervous system process
MP:0002062,abnormal associative learning
iuphar.ligand:5740,COMPOUND 23 [PMID: 21444206]
HGNC:20738,SYVN1
chembl:CHEMBL1631540,GSK163090
CL:0000540,neuron
iuphar.ligand:8037,GSK269962A
MONDO:0014185,chromosome 3q13.31 deletion syndrome
ncit:C186393,PESAMPATOR
chembl:CHEMBL486504,N-ACETYLCOLCHINOL
chembl:CHEMBL2109562,CAL
ZFIN:ZDB-GENE-011205-14,mt-co1
MGI:98246,Scn1a
chembl:CHEMBL256250,THIOSEMICARBAZIDE
HP:0000602,Ophthalmoplegia
WB:WBGene00007993,idhb-1
HGNC:14135,PIGQ
MGI:5554934,Clp1<sup>tm1.1Pngr</sup>/Clp1<sup>tm1.1Pngr</sup>  [background:] CBA.Cg-Clp1<sup>tm1.1Pngr</sup>
ncit:C80579,FAXELADOL
CHEBI:24373,glycine derivative
chembl:CHEMBL596633,CHEMBL:CHEMBL596633
CHEBI:52717,bortezomib
rxcui:1243041,IVACAFTOR
rxcui:835827,TESTOSTERONE CYPIONATE
chembl:CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE"
HGNC:20778,TUBB
ncit:C79564,CEFQUINOME
HP:0010536,Central sleep apnea
rxcui:203162,MECLOCYCLINE SULFOSALICYLATE
iuphar.ligand:6271,2-IODOACETAMIDE
iuphar.ligand:1797,"[ILE5,TRP23,TYR36]PTHRP-(1-36)-NH2 (HUMAN)"
iuphar.ligand:5023,MACROPHAGE STIMULATING PROTEIN 1
HGNC:2961,DYNC1H1
MGI:5450673,Tg(Thy1-MAPT*P301S)2541Godt/Tg(Thy1-MAPT*P301S)2541Godt  [background:] involves: C57BL/6J * CBA/Ca
ncit:C113295,PEGILODECAKIN
rxcui:24812,FELBAMATE
chembl:CHEMBL451158,CHEMBL:CHEMBL451158
HP:0003083,Dislocated radial head
EMAPA:17790,cerebellum ventricular layer
rxcui:82084,PROPRANOLOL HYDROCHLORIDE
HGNC:21197,FA2H
MP:0001922,reduced male fertility
MGI:1923401,Cep76
iuphar.ligand:5904,PSB-0739
iuphar.ligand:8781,FIPI
HP:0002384,Focal impaired awareness seizure
chembl:CHEMBL422942,CHEMBL:CHEMBL422942
MP:0013906,absent embryonic telencephalon
iuphar.ligand:4923,FGF-1
CHEBI:17154,nicotinamide
HGNC:16902,BCKDK
ncit:C170207,NEFLAMAPIMOD
HGNC:2288,COX7A2
iuphar.ligand:5196,GSK690693
chembl:CHEMBL1287895,CHEMBL:CHEMBL1287895
HGNC:14896,SPTBN4
MGI:3665286,"Tg(APPswe,PSEN1dE9)85Dbo/0  [background:] B6;C3-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax"
HGNC:6231,KCNB1
HP:0002511,Alzheimer disease
iuphar.ligand:12667,EXAMPLE 15 [WO2015079413]
MONDO:0018996,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2"
ncit:C263,ANTICOAGULANT AGENT
ncit:C1464,TIRAPAZAMINE
CL:2000015,fibroblast of arm
wikidata:Q7246687,PROSAVIN
HP:0012104,Parietal cortical atrophy
MONDO:0700216,RET fusion positive cancer
ncit:C174701,ALCLOFENAC
HP:0006150,Swan neck-like deformities of the fingers
HP:0002599,Head titubation
rxcui:2369389,RIPRETINIB
HGNC:18808,BZW2
iuphar.ligand:8837,COMPOUND 16 [PMID: 19097778]
chembl:CHEMBL536375,CHEMBL:CHEMBL536375
HP:0000657,Oculomotor apraxia
ncit:C187123,PAN-RAF INHIBITOR XP-102
rxcui:322165,THIOSALICYLIC ACID
iuphar.ligand:8108,DENFIVONTINIB
MGI:4950076,Fmr1<sup>tm1Usdn</sup>/Y  [background:] involves: 129S6/SvEvTac * C57BL/6
RGD:1566089,Gapdhl6
rxcui:1788868,4-NONYLPHENOL
rxcui:594680,DOCOSANOL
chembl:CHEMBL2109513,PD-360324
HGNC:30860,LSM11
rxcui:8987,PYRAZINAMIDE
HGNC:12472,UBE2A
rxcui:17941,ANISINDIONE
HP:0007240,Progressive gait ataxia
ncit:C175162,NIHYDRAZONE
HP:0032809,Neonatal electro-clinical seizure
HP:0012045,Retinal flecks
MGI:97542,Pepd
rxcui:253166,"SYNTHETIC CONJUGATED ESTROGENS, A"
iuphar.ligand:8887,ML130
HGNC:3596,FAT2
MGI:2446979,Kif18b
chembl:CHEMBL597452,CHEMBL:CHEMBL597452
rxcui:90540,INDIUM-111
GO:0060291,long-term synaptic potentiation
iuphar.ligand:10507,OMO-1
rxcui:17205,AJMALICINE
HP:0002373,Febrile seizure (within the age range of 3 months to 6 years)
chembl:CHEMBL580324,CHEMBL:CHEMBL580324
chembl:CHEMBL545880,CHEMBL:CHEMBL545880
MGI:5292357,Fmr1<sup>tm1.2Cidz</sup>/Y  [background:] involves: 129P2/OlaHsd * 129/Sv * C57BL/6 * FVB/N
rxcui:34132,PEGASPARGASE
iuphar.ligand:5952,CDK4 INHIBITOR III
UPHENO:0076711,abnormal globus pallidus morphology
HGNC:8579,PAFAH2
rxcui:763450,RILONACEPT
rxcui:2665204,MOMELOTINIB
HGNC:10474,RUVBL1
HGNC:29679,PAM16
HP:0002239,Gastrointestinal hemorrhage
iuphar.ligand:2434,LA3+
iuphar.ligand:12340,LY3410738
MONDO:0011777,Alzheimer disease 8
HP:0002188,Delayed CNS myelination
rxcui:68115,PIROXICAM-BETA-CYCLODEXTRIN
UBERON:0008200,forehead
ncit:C179292,ATR INHIBITOR ART0380
iuphar.ligand:12433,DENATONIUM
chembl:CHEMBL466844,GINSENOSIDE RH1
ncit:C62624,OXIGLUTATIONE
rxcui:6417,THIOCTIC ACID
iuphar.ligand:9693,BAY 61-3606
WB:WBGene00004779,ser-4
CHEBI:30031,succinate(2-)
UBERON:0000922,embryo
MGI:2446595,Abcd1<sup>tm1Ymd</sup>/Y  [background:] involves: 129S/SvEv * C57BL/6J * DBA/2J
UBERON:0000362,renal medulla
HGNC:16871,SPRN
MONDO:0007244,Caffey disease
chembl:CHEMBL551842,LOBARIC ACID
HGNC:30168,PDIA6
chembl:CHEMBL1376,SULINDAC SULFOXIDE
MGI:107511,Art1
chembl:CHEMBL457092,BESTATIN METHYL ESTER
HGNC:405,ALDH3A1
chembl:CHEMBL3542265,LY2452473
iuphar.ligand:6934,CRENEZUMAB
MP:0000864,abnormal cerebellum vermis morphology
HGNC:25470,SUSD4
HGNC:6603,LILRA2
RGD:1309416,Fars2
drugbank:DB12763,MK-1496
HGNC:23537,DHTKD1
HGNC:121,ACOX3
HP:0100559,Lower limb asymmetry
drugbank:DB12929,JNJ-39220675
chembl:CHEMBL269105,CHEMBL:CHEMBL269105
rxcui:139778,TEGASEROD
chembl:CHEMBL1801219,CHEMBL:CHEMBL1801219
iuphar.ligand:12391,VABAMETKIB
iuphar.ligand:2506,R-(+)-METHANANDAMIDE
iuphar.ligand:8475,AZ628
drugbank:DB04267,DIPICOLINIC ACID
iuphar.ligand:1430,PTEB
chembl:CHEMBL584868,CHEMBL:CHEMBL584868
ncit:C146807,ELIMUSERTIB
ncit:C123912,SOVLEPLENIB
HP:0005026,Mesomelic/rhizomelic limb shortening
HGNC:1406,CACNG2
chembl:CHEMBL74675,CHEMBL:CHEMBL74675
chembl:CHEMBL498746,CHEMBL:CHEMBL498746
CLINVAR:143340,NM_001110792.2(MECP2):c.1169C>G (p.Ala390Gly)
ncit:C77259,AMPEROZIDE HYDROCHLORIDE
chembl:CHEMBL590201,CHEMBL:CHEMBL590201
HP:0008551,Microtia
chembl:CHEMBL1256025,CHEMBL:CHEMBL1256025
iuphar.ligand:2453,DIHYDROSPHINGOSINE
iuphar.ligand:295,ARECAIDINE PROPARGYL ESTER
iuphar.ligand:8258,ANIFROLUMAB
HGNC:8657,PCDH12
chembl:CHEMBL52030,CHEMBL:CHEMBL52030
HGNC:28957,EMC1
HP:0031828,Abnormal superficial reflex
HGNC:23161,ALG8
iuphar.ligand:12051,PLAZINEMDOR
UBERON:0004359,corpus epididymis
HP:0032745,Focal aware emotional seizure with laughing
HP:0002143,Abnormal spinal cord morphology
GO:0051228,mitotic spindle disassembly
HGNC:13081,SCAPER
MONDO:0012629,paroxysmal nonkinesigenic dyskinesia 2
chembl:CHEMBL366603,DIALLYLDISULFIDE
iuphar.ligand:12651,"COMPOUND 29 [VIETOR, ET AL., 2023]"
chembl:CHEMBL1331521,"3,6-DIMETHOXYFLAVONE"
FB:FBgn0003189,r
MP:0004694,absent patella
iuphar.ligand:5,5-HYDROXYTRYPTAMINE
ncit:C96752,PARBENDAZOLE
ncit:C81061,DARBUFELONE
iuphar.ligand:12865,CANLITINIB
iuphar.ligand:6651,"3,5-DIIODO-L-TYROSINE"
chembl:CHEMBL1915783,CHEMBL:CHEMBL1915783
HP:0003457,EMG abnormality
ncit:C66019,LIRANAFTATE
rxcui:1535922,RAMUCIRUMAB
chembl:CHEMBL76012,CHEMBL:CHEMBL76012
rxcui:10378,TESTOLACTONE
MP:0000825,dilated lateral ventricle
chembl:CHEMBL147587,ISOQUINE
HGNC:11292,SRI
rxcui:34120,POLYESTRADIOL PHOSPHATE
ncit:C166717,DELPAZOLID
rxcui:114527,VINORELBINE TARTRATE
rxcui:82015,EMETINE HYDROCHLORIDE
HP:0002043,Esophageal stricture
ncit:C169983,FIRSOCOSTAT
MGI:3624719,Mecp2<sup>tm1Bird</sup>/Y Tg(Nes-cre)1Kln/0  [background:] involves: 129P2/OlaHsd * C57BL/6 * SJL
MONDO:0004790,fatty liver disease
rxcui:6131,KETANSERIN
HP:0000933,Posterior fossa cyst at the fourth ventricle
chembl:CHEMBL601968,CHEMBL:CHEMBL601968
chembl:CHEMBL577419,CHEMBL:CHEMBL577419
chembl:CHEMBL301735,HOECHST 33258
MONDO:0024613,bipolar depression
HP:0002643,Neonatal respiratory distress
ncit:C48380,PAN-HER KINASE INHIBITOR AC480
UBERON:0000376,hindlimb stylopod
iuphar.ligand:2686,GW0742X
ncit:C1435,EFAPROXIRAL
rxcui:8050,PERHEXILINE
rxcui:2669967,CAPIVASERTIB
rxcui:17145,MONOBENZONE
MONDO:0000594,pervasive developmental disorder
GO:0042500,"aspartic endopeptidase activity, intramembrane cleaving"
ncit:C98153,INDEGLITAZAR
HGNC:8729,PCNA
CLINVAR:211455,NM_001110792.2(MECP2):c.1273T>C (p.Cys425Arg)
GO:0005355,glucose transmembrane transporter activity
HGNC:9043,PLAA
rxcui:1739745,BRIVARACETAM
ncit:C166567,ACUMAPIMOD
ncit:C80757,BROLAMFETAMINE
ncit:C80063,PATIDEGIB
ncit:C38685,SIPLIZUMAB
rxcui:27340,DESFLURANE
HGNC:30262,PYCR2
iuphar.ligand:8007,BX-912
ncit:C2503,FOSBRETABULIN DISODIUM
MONDO:0030982,sulfide quinone oxidoreductase deficiency
drugbank:DB04183,METHYLMALONIC ACID
ncit:C136987,PATRITUMAB DERUXTECAN
iuphar.ligand:2525,PB2+
HGNC:990,BCL2
iuphar.ligand:8805,COMPOUND 82 [PMID: 21332118]
GO:0015886,heme transport
chembl:CHEMBL590900,CHEMBL:CHEMBL590900
chembl:CHEMBL2178583,CHEMBL:CHEMBL2178583
iuphar.ligand:26,S-15535
ZFIN:ZDB-GENE-030131-5400,zgc:162592
chembl:CHEMBL3545201,TA-5493
MGI:2680668,Foxn1<sup>nu</sup>/Foxn1<sup>nu</sup>  [background:] Not Specified
ZP:0100009,"whole organism quality, abnormal"
HP:0033715,Hippocampal sclerosis
iuphar.ligand:12938,PF-9363
rxcui:1421648,GAMMA-INTERFERON
chembl:CHEMBL3039542,CIMAGLERMIN ALFA
drugbank:DB06518,R-1487
HGNC:9455,PROP1
drugbank:DB18417,PF-05230907
chembl:CHEMBL40919,KAEMPFERIDE
iuphar.ligand:9814,CCT241161
HGNC:28915,BATF3
chembl:CHEMBL1668773,TUBERATOLIDE A
chembl:CHEMBL1256364,CHEMBL:CHEMBL1256364
chembl:CHEMBL544115,CHEMBL:CHEMBL544115
chembl:CHEMBL446315,ERGOCRISTINE
HGNC:2205,CERT1
CHEBI:71337,minocycline(1-)
HP:0032803,Focal impaired awareness cognitive seizure with dysgraphia/agraphia
NBO:0000342,limb coordination
HGNC:1396,CACNA1I
ncit:C142999,TASIDOTIN HYDROCHLORIDE
HP:0000527,Long eyelashes
iuphar.ligand:9839,LIMKI3
ncit:C75191,NAVEGLITAZAR
rxcui:2409,CHLORTHALIDONE
iuphar.ligand:2615,BC-III
HP:0007340,Lower limb muscle weakness
chembl:CHEMBL123040,ALLITRIDIN
chembl:CHEMBL1397270,CHEMBL:CHEMBL1397270
ncit:C247,ACE INHIBITOR
rxcui:38454,TRANDOLAPRIL
drugbank:DB07364,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE"
chembl:CHEMBL579837,CHEMBL:CHEMBL579837
HGNC:4632,GSTM1
HP:0002878,Respiratory failure
ncit:C77316,TEZAMPANEL
rxcui:1482680,LULICONAZOLE
ncit:C171390,RADIX POLYGALAE EXTRACT PDC-1421
drugbank:DB05865,VIT-100
MONDO:0010627,X-linked lymphoproliferative syndrome
HP:0100951,Enlarged fossa interpeduncularis
MONDO:0011144,"ceroid lipofuscinosis, neuronal, 6A"
ncit:C72950,NONABINE
MGI:2450119,Ugt8a<sup>tm1Pop</sup>/Ugt8a<sup>tm1Pop</sup>  [background:] involves: 129P2/OlaHsd * C57BL/6
HGNC:12488,UBE2L3
chembl:CHEMBL547924,CHEMBL:CHEMBL547924
HGNC:1493,CARS1
HGNC:9211,POU2AF1
MONDO:0006694,cerebral atherosclerosis
rxcui:8133,PHENMETRAZINE
HP:0010544,Vertical nystagmus
chembl:CHEMBL1871400,OXYFLUORFEN
chembl:CHEMBL1187120,BL-1021
chembl:CHEMBL59150,CHEMBL:CHEMBL59150
rxcui:2267207,GOLODIRSEN
chembl:CHEMBL3545155,JI-101
PomBase:SPAC22F3.06c,lon1
MONDO:0012438,pontocerebellar hypoplasia type 5
MGI:1097712,Npc1
HGNC:12408,TUBA3C
HGNC:1005,BCL7B
rxcui:23796,EBASTINE
MP:0004434,abnormal cochlear outer hair cell physiology
ncit:C128250,PAN-AKT INHIBITOR ARQ751
chembl:CHEMBL2071526,ALTISSIMACOUMARIN D
iuphar.ligand:6008,MEK1/2 INHIBITOR
HP:0006099,Metacarpophalangeal joint hyperextensibility
HGNC:10461,CLIP1
chembl:CHEMBL586962,CHEMBL:CHEMBL586962
FB:FBgn0031759,Kdm5
HGNC:6176,ITPA
rxcui:28382,LACIDIPINE
ncit:C77971,IMMUNOTHERAPY REGIMEN MKC-1106-MT
MONDO:0013788,Usher syndrome type 3B
MONDO:0000486,craniofacial dystonia
ncit:C48427,LAROTAXEL
chembl:CHEMBL1303948,CHEMBL:CHEMBL1303948
HGNC:12033,TRAF3
ncit:C259,ANTINEOPLASTIC ANTIBIOTIC
MONDO:0044996,cerebral cortex disorder
ncit:C74135,TOMELUKAST
iuphar.ligand:677,WIN 64338
chembl:CHEMBL124006,CHEMBL:CHEMBL124006
HP:0002538,Abnormal cerebral cortex morphology
rxcui:50676,GUANIDINE HYDROCHLORIDE
drugbank:DB05903,KOS-1584
iuphar.ligand:5072,TL6
iuphar.ligand:12614,METATINIB
iuphar.ligand:8106,URMC-099
drugbank:DB06423,ENDOSTATIN
iuphar.ligand:9268,AZ191
HP:0000727,Frontal lobe dementia
drugbank:DB05201,V24343
rxcui:10188,SULFAPYRIDINE
ncit:C190779,FGFR3 INHIBITOR TYRA-300
chembl:CHEMBL71893,ABIETIC ACID
HGNC:16528,DKKL1
ZFIN:ZDB-GENE-030131-8625,tubb4b
chembl:CHEMBL1900921,DEMETON S
iuphar.ligand:12326,ACT-1014-6470
PomBase:SPAC732.02c,fpb26
chembl:CHEMBL83747,PSAMMAPLIN A
MONDO:0019146,inherited susceptibility to mycobacterial diseases
rxcui:140587,CELECOXIB
chembl:CHEMBL584248,CHEMBL:CHEMBL584248
HP:0000348,High forehead
iuphar.ligand:2918,KYNURENIC ACID
ncit:C65777,FUDOSTEINE
chembl:CHEMBL546580,CHEMBL:CHEMBL546580
rxcui:71529,THIETHYLPERAZINE MALEATE
HGNC:6218,KCNA1
iuphar.ligand:9240,AGI-5198
MGI:2446588,Abcd1<sup>tm1Kds</sup>/Abcd1<sup>tm1Kds</sup>  [background:] either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129/Sv * 129S4/SvJae * C57BL/6)
CHEBI:23403,coumarins
iuphar.ligand:9350,VER-246608
chembl:CHEMBL2170369,CHEMBL:CHEMBL2170369
MGI:4414759,Myg1<sup>tm1Mphi</sup>/Myg1<sup>tm1Mphi</sup>  [background:] involves: 129S6/SvEvTac * C57BL/6
CL:0000476,thyrotroph
HGNC:4962,HLA-E
rxcui:106558,PROCAINE HYDROCHLORIDE
chembl:CHEMBL78257,TYRPHOSTIN 51
iuphar.ligand:9788,PRN1371
rxcui:9871,SODIUM DODECYL SULFATE
CHEBI:7735,olanzapine
HP:0001305,Dandy-Walker malformation
ncit:C166576,BRIMAPITIDE
HGNC:6128,IRS4
drugbank:DB05805,NS-2359
ncit:C187335,MUTANT-SELECTIVE PI3K-ALPHA H1047R INHIBITOR LOXO-783
HP:0000719,Inappropriate behavior
iuphar.ligand:342,BRUCINE
HGNC:28490,DIPK2A
iuphar.ligand:11691,ICI-199441
HP:0011931,Abnormal cerebellar peduncle morphology
rxcui:3363,ZALCITABINE
HGNC:12309,ZNHIT3
iuphar.ligand:525,BRL 44408
iuphar.ligand:318,[3H]QNB
ncit:C1890,ADENOVIRUS VECTOR
HGNC:4279,GJA5
CHEBI:41774,tamoxifen
MONDO:0010680,X-linked Emery-Dreifuss muscular dystrophy
chembl:CHEMBL482792,CHEMBL:CHEMBL482792
iuphar.ligand:10577,ABBV-3221
ncit:C65991,ITOPRIDE
HGNC:4510,KISS1R
CHEBI:35627,beta-lactam
rxcui:203150,CETIRIZINE HYDROCHLORIDE
chembl:CHEMBL227959,CHEMBL:CHEMBL227959
MONDO:0008383,rheumatoid arthritis
UPHENO:0085854,absent pyramidal neuron in the Ammon's horn
GO:0044027,negative regulation of gene expression via chromosomal CpG island methylation
chembl:CHEMBL597246,CHEMBL:CHEMBL597246
chembl:CHEMBL602209,CHEMBL:CHEMBL602209
rxcui:1721559,OSIMERTINIB MESYLATE
ncit:C38714,LORVOTUZUMAB MERTANSINE
CHEBI:83779,"1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol"
chembl:CHEMBL1287983,CHEMBL:CHEMBL1287983
iuphar.ligand:8894,CUDC-101
iuphar.ligand:11103,GSK2830371
rxcui:228054,DEXMEDETOMIDINE HYDROCHLORIDE
hemonc:34886,G207
dictyBase:DDB_G0278063,DDB_G0278063
HP:0031931,Ocular flutter
HGNC:30972,SECISBP2
HGNC:18189,EXOSC4
iuphar.ligand:174,AC-90179
MGI:6865686,Prkcg<sup>em1Jpka</sup>/Prkcg<sup>em1Jpka</sup>  [background:] FVB/N-Prkcg<sup>em1Jpka</sup>
HGNC:557,SYNRG
MONDO:0010936,frontotemporal dementia and/or amyotrophic lateral sclerosis 7
HGNC:6606,LILRB2
HGNC:18866,KCNT2
HGNC:8033,NTRK3
ncit:C179330,PI3K-ALPHA INHIBITOR HS-10352
ncit:C142912,ALISERTIB SODIUM
Reactome:R-CFA-549127,Organic cation transport
iuphar.ligand:4321,TETRAHYDRODEOXYCORTICOSTERONE
MONDO:0012344,Alzheimer disease 11
HGNC:33279,ATXN1L
HGNC:8827,PELI1
MONDO:0001161,schizoid personality disorder
rxcui:34625,PROMESTRIENE
HGNC:6732,NCR2
HP:0032688,Focal aware cognitive seizure with dissociation
rxcui:282443,PEMETREXED DISODIUM
iuphar.ligand:9380,BIX02189
chembl:CHEMBL444928,CHEMBL:CHEMBL444928
ncit:C72762,EPALRESTAT
CL:0002336,buccal mucosa cell
ncit:C178401,RISOVALISIB
chembl:CHEMBL2313446,4-TRIETHYLGERMYLPHENOL
MGI:105384,Hspa8
iuphar.ligand:10142,PQR620
ncit:C170281,PABINAFUSP ALFA
chembl:CHEMBL784,IMIDAZOLE ACETIC ACID
HGNC:26317,IMMP1L
MGI:3722277,Tg(YAC72)2511Hay/?  [background:] involves: FVB/N
MONDO:0009889,autosomal recessive polycystic kidney disease
GO:0010970,transport along microtubule
chembl:CHEMBL18824,L-NOREPINEPHRINE
ncit:C71726,QUARFLOXIN
iuphar.ligand:12006,(R)-STU104
iuphar.ligand:2666,PIRINIXIC ACID
HGNC:3098,TOR1A
HGNC:4606,PDIA3
rxcui:14584,ETONOGESTREL
chembl:CHEMBL290914,EMODIC ACID
iuphar.ligand:8567,RS 39066
iuphar.ligand:4314,SITS
iuphar.ligand:9980,PF‐06526290
rxcui:1426931,URSOLIC ACID
rxcui:2265712,GIVOSIRAN
MONDO:0004993,carcinoma
HGNC:15743,ERMAP
iuphar.ligand:4374,EUROPIUM-LABELLED RELAXIN-3-B/INSL5 A CHIMERA
rxcui:2382,PROGUANIL
HGNC:9067,PLD1
ncit:C75238,ECADOTRIL
MONDO:0013946,hypogonadotropic hypogonadism 15 with or without anosmia
HGNC:14867,APOL4
HGNC:60,ABCC9
ncit:C29854,SULINDAC SULFIDE
HGNC:2715,DDAH1
rxcui:2619910,MANGOSTIN
HP:0003336,Abnormal enchondral ossification
rxcui:5833,INOSITOL
iuphar.ligand:11841,SY-5609
HP:0032708,Focal aware cognitive seizure with anomia
MGI:5904595,Trem2<sup>em2Bwef</sup>/Trem2<sup>em2Bwef</sup>  [background:] involves: C57BL/6J * DBA/2J * FVB/N
HP:0012169,Self-biting
HGNC:10405,RPS20
ZFIN:ZDB-GENE-020708-4,thbs4b
HP:0011449,Knee clonus
MONDO:0005093,skin disorder
iuphar.ligand:1642,NOR-BINALTORPHIMINE
chembl:CHEMBL177126,CHEMBL:CHEMBL177126
rxcui:74667,ZALEPLON
HGNC:19118,TNIP2
iuphar.ligand:4853,"[SER11](N-CNP,C-ANP)PBNP2-15"
chembl:CHEMBL1397308,CHEMBL:CHEMBL1397308
WB:WBGene00016393,ndua-13
ncit:C152909,VONAPANITASE
iuphar.ligand:5709,SGX-523
MONDO:0014328,"developmental and epileptic encephalopathy, 19"
CHEBI:85639,(9Z)-12-hydroxyoctadec-9-enoic acid
HGNC:17485,PPP2R3C
HP:0002503,Spinocerebellar tract degeneration
iuphar.ligand:4935,GROWTH ARREST SPECIFIC PROTEIN 6
MONDO:0859306,developmental delay with variable intellectual disability and dysmorphic facies
ncit:C175078,GOSURANEMAB
iuphar.ligand:6451,COMPOUND 53 [PMID: 23434029]
NCBIGene:482814,HTR5A
chembl:CHEMBL475908,CHEMBL:CHEMBL475908
HGNC:10591,SCN4A
UPHENO:0075803,abnormal substantia nigra
chembl:CHEMBL39763,TRITON X
HP:0007146,Bilateral basal ganglia lesions
iuphar.ligand:2461,CAPSAZEPINE
rxcui:253182,"INSULIN, REGULAR, HUMAN"
HP:0001518,Small for gestational age
ncit:C66559,SPIRAMIDE
ncit:C28952,TETRANDRINE
rxcui:2539172,PICROTOXIN
iuphar.ligand:6279,PROSTAGLANDIN A2
MONDO:0006059,nasal cavity squamous cell carcinoma
rxcui:58130,HALOFANTRINE HYDROCHLORIDE
rxcui:2390935,RISDIPLAM
ncit:C175460,FGFR/CSF-1R INHIBITOR 3D185
ncit:C65960,IRAMPANEL
HP:0000189,Narrow palate
HGNC:3229,EGF
rxcui:1649480,IVABRADINE
MGI:3719706,Atcay<sup>ji-hes</sup>/Atcay<sup>ji-hes</sup>  [background:] C3H/HeJ-Atcay<sup>ji-hes</sup>
rxcui:56798,SULCONAZOLE NITRATE
rxcui:7538,NOVOBIOCIN
chembl:CHEMBL1333189,PROPAZINE
UPHENO:0088152,abnormal astrocyte morphology
rxcui:3194,DEOXYCHOLIC ACID
iuphar.ligand:7953,BMS-777607
chembl:CHEMBL578420,CHEMBL:CHEMBL578420
rxcui:141704,EVEROLIMUS
rxcui:91269,GLUTAMIC ACID HYDROCHLORIDE
GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein
HGNC:14492,MRPL41
HP:0001385,Hip dysplasia
CHEBI:25348,methylxanthine
chembl:CHEMBL479650,HEXAHYDROCURCUMIN
chembl:CHEMBL1201535,PHENYLPROPANOLAMINE POLISTIREX
CHEBI:46345,5-fluorouracil
ncit:C2731,RHODACYANINE ANALOG MKT-077
rxcui:5521,HYDROXYCHLOROQUINE
HGNC:2764,DEFA5
UBERON:0001906,subthalamic nucleus
chembl:CHEMBL408653,CHEMBL:CHEMBL408653
chembl:CHEMBL164449,CHEMBL:CHEMBL164449
iuphar.ligand:7763,ANALOG 32 [PMID:18543899]
HGNC:3778,FN1
ncit:C175121,MASUPIRDINE
iuphar.ligand:9554,GSK2982772
ncit:C87245,TESTOSTERONE BUCYCLATE
HGNC:4330,GLRX
MGI:88609,Cyp3a11
CHEBI:4792,enflurane
CHEBI:26509,quinoline alkaloid
HP:0007067,Distal peripheral sensory neuropathy
ncit:C138076,ATM INHIBITOR M 3541
HGNC:315,AFG3L2
rxcui:6465,LOFEPRAMINE
rxcui:261716,GLUCAGON (RDNA)
MONDO:0013560,Hermansky-Pudlak syndrome 8
PomBase:SPAC6F6.01,cch1
rxcui:3266,PHENYLPROPANOLAMINE HYDROCHLORIDE
iuphar.ligand:5270,SCH51866
drugbank:DB16108,TAK-715
iuphar.ligand:4638,[3H]GBR12935
ncit:C163697,QUINALPHOS
MONDO:0060596,neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
iuphar.ligand:9976,KO-947
iuphar.ligand:8210,COMPOUND 27 [PMID: 21123062]
chembl:CHEMBL168276,"3,5-DINITROCATECHOL (OR-486)"
UBERON:0004832,anal region skeletal muscle
chembl:CHEMBL1492044,FLUORESCEIN DIACETATE
chembl:CHEMBL1230095,N-PROPYL BROMIDE
rxcui:6026,ISOFLURANE
ncit:C82256,PROSULTIAMINE
iuphar.ligand:8791,"COMPOUND 33 [TODA ET AL., 2013]"
HP:0001634,Mitral valve prolapse
rxcui:233603,CLEVIDIPINE
rxcui:2562546,HONOKIOL
iuphar.ligand:5674,CHIR-265
HGNC:32225,WIPI2
HP:0031759,Basic constant esotropia
HP:0002470,Nonprogressive cerebellar ataxia
MONDO:0006220,gallbladder squamous cell carcinoma
CHEBI:35443,anthelminthic drug
HGNC:17905,FHOD1
drugbank:DB03285,ISOLIQUIRITIGENIN
ncit:C1406,IDOXIFENE
ncit:C2688,NAB-PACLITAXEL
chembl:CHEMBL582473,CHEMBL:CHEMBL582473
RGD:69329,Mapt
iuphar.ligand:10357,CDK INHIBITOR 4.35
HP:0000252,Microcephaly
HP:0006699,Premature atrial contractions
MP:0021082,abnormal cerebrospinal fluid amyloid beta 42 isoform level
chembl:CHEMBL513494,DIHYDROXYBERGAMOTTIN
HP:0000972,Palmoplantar hyperkeratosis
rxcui:7441,NITRENDIPINE
chembl:CHEMBL591598,CHEMBL:CHEMBL591598
iuphar.ligand:8836,PP1
MONDO:0014349,pontocerebellar hypoplasia type 10
chembl:CHEMBL1079947,LORNEIC ACID A
HGNC:8057,NUFIP1
drugbank:DB05142,ND7001
ncit:C81567,EXIFONE
HP:0032660,Convulsive status epilepticus
MP:0001917,intraventricular hemorrhage
chembl:CHEMBL602418,CHEMBL:CHEMBL602418
ncit:C175871,VENADAPARIB
rxcui:114979,RABEPRAZOLE
rxcui:153972,HYDROXYCHLOROQUINE SULFATE
MONDO:0015548,Huntington disease-like syndrome
GO:0016310,phosphorylation
ncit:C91725,ADAVOSERTIB
CLINVAR:52430,NM_000059.4(BRCA2):c.7879A>T (p.Ile2627Phe)
HP:0001631,Atrial septal defect
chembl:CHEMBL592105,METHYLROSANILINE
MGI:105089,Hsd17b4
HGNC:15924,SALL4
chembl:CHEMBL3545169,AZD1305
rxcui:11205,VINDESINE SULFATE
ncit:C73305,BELOTECAN
iuphar.ligand:6944,OXAZINE 89
rxcui:21212,CLARITHROMYCIN
iuphar.ligand:9058,PF-03654746
HGNC:13082,LTN1
chembl:CHEMBL31929,4'-DEMETHYLEPIPODOPHYLLOTOXIN
iuphar.ligand:12905,DUAL VEGFR/PARP INHIBITOR 14B
rxcui:22033,CYCLOTHIAZIDE
CHEBI:17002,cholesteryl ester
MONDO:0011397,"autosomal dominant cerebellar ataxia, deafness and narcolepsy"
MP:0001442,decreased grooming behavior
HGNC:4816,HARS1
ncit:C75196,TESMILIFENE
iuphar.ligand:8236,I-CBP112
dictyBase:DDB_G0283543,prp40
iuphar.ligand:9802,CFZ533
rxcui:2267574,FAM-TRASTUZUMAB DERUXTECAN-NXKI
rxcui:235743,METFORMIN HYDROCHLORIDE
CLINVAR:133098,NM_000540.3(RYR1):c.14918C>T (p.Pro4973Leu)
HGNC:9891,RBBP8
rxcui:2197878,PITOLISANT
MONDO:0012367,retinitis pigmentosa 31
rxcui:31765,NICOTINE POLACRILEX
HP:0032671,Non-convulsive status epilepticus without coma
GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding
iuphar.ligand:8349,A(4-24)(F23A)H2
HP:0008587,Mild neurosensory hearing impairment
chembl:CHEMBL1256863,CHEMBL:CHEMBL1256863
iuphar.ligand:9908,ONO-8590580
CHEBI:63726,neuroprotective agent
rxcui:2105975,TETRACYCLINE PHOSPHATE COMPLEX
HP:0000636,Upper eyelid coloboma
HP:0032902,Focal perseverative automatism seizure
GO:0045136,development of secondary sexual characteristics
UBERON:0000955,brain
MONDO:0012805,childhood onset GLUT1 deficiency syndrome 2
chembl:CHEMBL601142,CHEMBL:CHEMBL601142
HGNC:28184,CHCHD6
chembl:CHEMBL1708232,TRIMETHIDINIUM
MONDO:0003996,basal ganglia disorder
MONDO:0700088,paroxysmal nonkinesigenic dyskinesia
HP:0001952,Glucose intolerance
HP:0004420,Arterial thrombosis
HP:0009370,Type A brachydactyly
MGI:5759931,Tor1a<sup>tm1Wtd</sup>/Tor1a<sup>+</sup>  [background:] B6;129-Tor1a<sup>tm1Wtd</sup>/J
HP:0007936,Restrictive external ophthalmoplegia
rxcui:1747556,VENETOCLAX
HP:0032732,Focal aware motor seizure with paresis/paralysis
rxcui:3648,DROPERIDOL
chembl:CHEMBL1519327,ZIRAM
ncit:C91100,EMVODODSTAT
ncit:C82251,PRECLAMOL
chembl:CHEMBL1200751,MERCAPTOPURINE
HGNC:17860,SERBP1
ncit:C174930,NAVOCAFTOR
MGI:3522157,Tpp1<sup>tm1Plob</sup>/Tpp1<sup>tm1Plob</sup>  [background:] involves: 129S1/Sv * C57BL/6
GO:0000226,microtubule cytoskeleton organization
drugbank:DB11562,BICUCULLINE
rxcui:42319,NIZATIDINE
HP:0001387,Joint stiffness
HGNC:1455,CALR
chembl:CHEMBL454893,AMBUNOL
chembl:CHEMBL1320798,CHEMBL:CHEMBL1320798
iuphar.ligand:8167,LEUCETTINE L41
MP:0020670,abnormal stria medullaris cell density
chembl:CHEMBL445969,CAULIBUGULONE C
rxcui:42328,ASTEMIZOLE
MP:0009969,abnormal cerebral cortex pyramidal cell morphology
rxcui:10438,THEOPHYLLINE
GO:0006744,ubiquinone biosynthetic process
rxcui:3449,DIMETHINDENE
HP:0000430,Underdeveloped nasal alae
rxcui:281,ACYCLOVIR
HGNC:15559,CHCHD10
hemonc:449,ROCILETINIB
rxcui:52172,CICLOPIROX OLAMINE
rxcui:2475830,VERICIGUAT
iuphar.ligand:11286,EU-DTPA-HC3A
UPHENO:0080600,abnormal aggressive behavior
ncit:C116889,LIPID ENCAPSULATED ANTI-PLK1 SIRNA TKM-PLK1
drugbank:DB17046,PI-103
CHEBI:67194,cannabinoid
HP:0000486,Strabismus
HP:0000711,Restlessness
HP:0001324,Muscle weakness
chembl:CHEMBL605077,CHEMBL:CHEMBL605077
rxcui:2628190,FUTIBATINIB
drugbank:DB17063,ZK-93423
HP:0011470,Nasogastric tube feeding in infancy
drugbank:DB12186,SRT-2104
HGNC:4781,H4C1
rxcui:203207,FLUPHENAZINE HYDROCHLORIDE
chembl:CHEMBL539904,CHLOROBENZILATE
chembl:CHEMBL578741,CHEMBL:CHEMBL578741
CHEBI:57947,creatine zwitterion
chembl:CHEMBL586026,CHEMBL:CHEMBL586026
chembl:CHEMBL598369,CHEMBL:CHEMBL598369
MONDO:0018945,McLeod neuroacanthocytosis syndrome
MGI:6394127,Shank3<sup>tm2.1Bux</sup>/Shank3<sup>tm2.1Bux</sup>  [background:] B6(Cg)-Shank3<sup>tm2.1Bux</sup>
HGNC:18157,TAB1
chembl:CHEMBL260451,CHEMBL:CHEMBL260451
iuphar.ligand:4088,[3H]MDL105519
iuphar.ligand:4213,HC067047
HP:0100852,Abnormal fear/anxiety-related behavior
